JPMorgan Chase & Co. (JPM) 10-K 22 Feb 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Jan. 31, 2022	Jun. 30, 2021
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Current Fiscal Year End Date	--12-31
Entity File Number	1-5805
Entity Registrant Name	JPMorgan Chase & Co
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-2624428
Entity Address, Address Line One	383 Madison Avenue,
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10179
City Area Code	212
Local Phone Number	270-6000
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 461,141,177,226
Entity Common Stock, Shares Outstanding		2,952,808,970
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for the annual meeting of stockholders to be held on May 17, 2022, are incorporated by reference in this Form 10-K in response to Items 10, 11, 12, 13 and 14 of Part III.
Entity Central Index Key	0000019617
Amendment Flag	false
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Common stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock
Trading Symbol	JPM
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD
Trading Symbol	JPM PR D
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE
Trading Symbol	JPM PR C
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG
Trading Symbol	JPM PR J
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJ
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJ
Trading Symbol	JPM PR K
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LL
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LL
Trading Symbol	JPM PR L
Security Exchange Name	NYSE
Depositary Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MM
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MM
Trading Symbol	JPM PR M
Security Exchange Name	NYSE
Alerian MLP Index ETNs due May 24, 2024
Entity Information [Line Items]
Title of 12(b) Security	Alerian MLP Index ETNs due May 24, 2024
Trading Symbol	AMJ
Security Exchange Name	NYSEArca
Guarantee of Callable Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLC
Entity Information [Line Items]
Title of 12(b) Security	Guarantee of Callable Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLC
Trading Symbol	JPM/32
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Firm ID	238
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	New York, NY 10017

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue
Investment banking fees		$ 13,216	$ 9,486	$ 7,501
Principal transactions		16,304	18,021	14,018
Lending- and deposit-related fees		7,032	6,511	6,626
Asset management, administration and commissions		21,029	18,177	16,908
Investment securities gains/(losses)		(345)	802	258
Mortgage fees and related income		2,170	3,091	2,036
Card income		5,102	4,435	5,076
Other income	[1]	4,830	4,865	6,052
Noninterest revenue		69,338	65,388	58,475
Interest income		57,864	64,523	84,040
Interest expense		5,553	9,960	26,795
Net interest income		52,311	54,563	57,245
Total net revenue		121,649	119,951	115,720
Provision for credit losses		(9,256)	17,480	5,585
Noninterest expense
Compensation expense		38,567	34,988	34,155
Occupancy expense		4,516	4,449	4,322
Technology, communications and equipment expense		9,941	10,338	9,821
Professional and outside services		9,814	8,464	8,533
Marketing		3,036	2,476	3,351
Other expense		5,469	5,941	5,087
Total noninterest expense		71,343	66,656	65,269
Income/(loss) before income tax expense/(benefit)		59,562	35,815	44,866
Income tax expense	[1]	11,228	6,684	8,435
Net income/(loss)		48,334	29,131	36,431
Net income applicable to common stockholders		$ 46,503	$ 27,410	$ 34,642
Net income per common share data
Basic earnings per share (in dollars per share)		$ 15.39	$ 8.89	$ 10.75
Diluted earnings per share (in dollars per share)		$ 15.36	$ 8.88	$ 10.72
Weighted-average basic shares (in shares)		3,021.5	3,082.4	3,221.5
Weighted-average diluted shares (in shares)		3,026.6	3,087.4	3,230.4
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net income	$ 48,334	$ 29,131	$ 36,431
Other comprehensive income/(loss), after–tax
Unrealized gains/(losses) on investment securities	(5,540)	4,123	2,855
Translation adjustments, net of hedges	(461)	234	20
Fair value hedges	(19)	19	30
Cash flow hedges	(2,679)	2,320	172
Defined benefit pension and OPEB plans	922	212	964
DVA on fair value option elected liabilities	(293)	(491)	(965)
Total other comprehensive income/(loss), after–tax	(8,070)	6,417	3,076
Comprehensive income	$ 40,264	$ 35,548	$ 39,507

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Assets
Cash and due from banks		$ 26,438	$ 24,874
Deposits with banks		714,396	502,735
Federal funds sold and securities purchased under resale agreements (included $252,720 and $238,015 at fair value)		261,698	296,284
Securities borrowed (included $81,463 and $52,983 at fair value)		206,071	160,635
Trading assets (included assets pledged of $102,710 and $130,645)		433,575	503,126
Available-for-sale securities (amortized cost of $308,254 and $381,729, net of allowance for credit losses; included assets pledged of $18,268 and $32,227)		308,525	388,178
Held-to-maturity securities, net of allowance for credit losses		363,707	201,821
Investment securities, net of allowance for credit losses		672,232	589,999
Loans (included $58,820 and $44,474 at fair value)		1,077,714	1,012,853
Allowance for loan losses		(16,386)	(28,328)
Loans, net of allowance for loan losses		1,061,328	984,525
Accrued interest and accounts receivable		102,570	90,503
Premises and equipment		27,070	27,109
Goodwill, MSRs and other intangible assets		56,691	53,428
Other assets (included $14,753 and $13,827 at fair value and assets pledged of $5,298 and $3,739)	[1]	181,498	151,539
Total assets	[2]	3,743,567	3,384,757
Liabilities
Deposits (included $11,333 and $14,484 at fair value)		2,462,303	2,144,257
Federal funds purchased and securities loaned or sold under repurchase agreements (included $126,435 and $155,735 at fair value)		194,340	215,209
Short-term borrowings (included $20,015 and $16,893 at fair value)		53,594	45,208
Trading liabilities		164,693	170,181
Accounts payable and other liabilities (included $5,651 and $3,476 at fair value)	[1]	262,755	231,285
Beneficial interests issued by consolidated VIEs (included $12 and $41 at fair value)		10,750	17,578
Long-term debt (included $74,934 and $76,817 at fair value)		301,005	281,685
Total liabilities	[2]	3,449,440	3,105,403
Commitments and contingencies (refer to Notes 28, 29 and 30)
Stockholders’ equity
Preferred stock ($1 par value; authorized 200,000,000 shares: issued 3,483,750 and 3,006,250 shares)		34,838	30,063
Common stock ($1 par value; authorized 9,000,000,000 shares; issued 4,104,933,895 shares)		4,105	4,105
Additional paid-in capital		88,415	88,394
Retained earnings		272,268	236,990
Accumulated other comprehensive income		(84)	7,986
Treasury stock, at cost (1,160,784,750 and 1,055,499,435 shares)		(105,415)	(88,184)
Total stockholders’ equity		294,127	279,354
Total liabilities and stockholders’ equity		3,743,567	3,384,757
VIEs consolidated by the Firm
Assets
Trading assets (included assets pledged of $102,710 and $130,645)		2,010	1,934
Loans, net of allowance for loan losses		33,024	37,619
Other assets (included $14,753 and $13,827 at fair value and assets pledged of $5,298 and $3,739)		490	681
Total assets		35,524	40,234
Liabilities
Beneficial interests issued by consolidated VIEs (included $12 and $41 at fair value)		10,750	17,578
All other liabilities		245	233
Total liabilities		$ 10,995	$ 17,811
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.
[2]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Assets pledged	$ 126,300	$ 166,600
Available-for-sale securities, amortized cost	308,254	381,729
Loans	$ 58,820	$ 44,474
Stockholders’ equity
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	3,483,750	3,006,250
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	9,000,000,000	9,000,000,000
Common stock, shares issued (in shares)	4,104,933,895	4,104,933,895
Treasury stock, shares (in shares)	1,160,784,750	1,055,499,435
Trading assets
Assets
Assets pledged	$ 102,710	$ 130,645
Investment securities - AFS
Assets
Assets pledged	18,268	32,227
Other assets
Assets
Assets pledged	5,298	3,739
Recurring
Assets
Federal funds sold and securities purchased under resale agreements	252,720	238,015
Securities borrowed	81,463	52,983
Loans	58,820	44,474
Liabilities
Deposits	11,333	14,484
Federal funds purchased and securities loaned or sold under repurchase agreements	126,435	155,735
Short-term borrowings	20,015	16,893
Accounts payable and other liabilities	5,651	3,476
Beneficial interests issued by consolidated VIEs	12	41
Long-term debt	74,934	76,817
Recurring | Other assets
Assets
Other assets	$ 14,753	$ 13,827

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Total	Preferred stock	Common stock	Additional paid-in capital	Retained earnings	Retained earningsCumulative effect of change in accounting principles	Accumulated other comprehensive income/(loss)	Shares held in RSU Trust, at cost	Treasury stock, at cost
Beginning balance at Dec. 31, 2018		$ 26,068	$ 4,105	$ 89,162	$ 199,202	$ 62	$ (1,507)	$ (21)	$ (60,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance		5,000
Redemption		(4,075)
Shares issued and commitments to issue common stock for employee share-based compensation awards, and related tax effects				(591)
Other				(49)
Net income	$ 36,431				36,431
Dividends declared:
Preferred stock					(1,587)
Common stock ($3.80, $3.60 and $3.40 per share for 2021, 2020 and 2019, respectively)					(10,897)
Other comprehensive income/(loss), after-tax	3,076						3,076
Liquidation of RSU Trust								0
Repurchase			(24,121)						(24,121)
Reissuance									1,566
Ending balance at Dec. 31, 2019	261,330	26,993	4,105	88,522	223,211	(2,650)	1,569	(21)	(83,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance		4,500
Redemption		(1,430)
Shares issued and commitments to issue common stock for employee share-based compensation awards, and related tax effects				(72)
Other				(56)
Net income	29,131				29,131
Dividends declared:
Preferred stock					(1,583)
Common stock ($3.80, $3.60 and $3.40 per share for 2021, 2020 and 2019, respectively)					(11,119)
Other comprehensive income/(loss), after-tax	6,417						6,417
Liquidation of RSU Trust								21
Repurchase			(6,397)						(6,397)
Reissuance									1,262
Ending balance at Dec. 31, 2020	279,354	30,063	4,105	88,394	236,990	$ 0	7,986	0	(88,184)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance		7,350
Redemption		(2,575)
Shares issued and commitments to issue common stock for employee share-based compensation awards, and related tax effects				152
Other				(131)
Net income	48,334				48,334
Dividends declared:
Preferred stock					(1,600)
Common stock ($3.80, $3.60 and $3.40 per share for 2021, 2020 and 2019, respectively)					(11,456)
Other comprehensive income/(loss), after-tax	(8,070)						(8,070)
Liquidation of RSU Trust								0
Repurchase			(18,448)						(18,448)
Reissuance									1,217
Ending balance at Dec. 31, 2021	$ 294,127	$ 34,838	$ 4,105	$ 88,415	$ 272,268		$ (84)	$ 0	$ (105,415)

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Stockholders' Equity [Abstract]
Dividends declared, Common stock (in dollars per share)	$ 3.80	$ 3.60	$ 3.40

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income		$ 48,334	$ 29,131	$ 36,431
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Provision for credit losses		(9,256)	17,480	5,585
Depreciation and amortization		7,932	8,614	8,368
Deferred tax (benefit)/expense(a)	[1]	3,748	(3,573)	1,270
Other		3,274	1,649	1,996
Originations and purchases of loans held-for-sale		(347,864)	(166,504)	(169,289)
Proceeds from sales, securitizations and paydowns of loans held-for-sale		336,413	175,490	171,415
Net change in:
Trading assets		85,710	(148,749)	6,551
Securities borrowed		(45,635)	(20,734)	(27,631)
Accrued interest and accounts receivable		(12,401)	(18,012)	(78)
Other assets	[1]	(11,745)	(42,430)	(17,777)
Trading liabilities		(23,190)	77,198	(14,516)
Accounts payable and other liabilities	[1]	43,162	7,415	(466)
Other operating adjustments		(398)	3,115	2,233
Net cash provided by/(used in) operating activities		78,084	(79,910)	4,092
Net change in:
Federal funds sold and securities purchased under resale agreements		34,473	(47,115)	72,396
Held-to-maturity securities:
Proceeds from paydowns and maturities		50,897	21,360	3,423
Purchases		(111,756)	(12,400)	(13,427)
Available-for-sale securities:
Proceeds from paydowns and maturities		50,075	57,675	52,200
Proceeds from sales		162,748	149,758	70,181
Purchases		(248,785)	(397,145)	(242,149)
Proceeds from sales and securitizations of loans held-for-investment		35,845	23,559	62,095
Other changes in loans, net		(91,797)	(50,263)	(51,743)
All other investing activities, net		(11,044)	(7,341)	(5,035)
Net cash (used in) investing activities		(129,344)	(261,912)	(52,059)
Net change in:
Deposits		293,764	602,765	101,002
Federal funds purchased and securities loaned or sold under repurchase agreements		(20,799)	31,528	1,347
Short-term borrowings		7,773	4,438
Short-term borrowings				(28,561)
Beneficial interests issued by consolidated VIEs		(4,254)	1,347	4,289
Proceeds from long-term borrowings		82,409	78,686	61,085
Payments of long-term borrowings		(54,932)	(105,055)	(69,610)
Proceeds from issuance of preferred stock		7,350	4,500	5,000
Redemption of preferred stock		(2,575)	(1,430)	(4,075)
Treasury stock repurchased		(18,408)	(6,517)	(24,001)
Dividends paid		(12,858)	(12,690)	(12,343)
All other financing activities, net		(1,477)	(927)	(1,146)
Net cash provided by financing activities		275,993	596,645	32,987
Effect of exchange rate changes on cash and due from banks and deposits with banks		(11,508)	9,155	(182)
Net increase/(decrease) in cash and due from banks and deposits with banks		213,225	263,978	(15,162)
Cash and due from banks and deposits with banks at the beginning of the period		527,609	263,631	278,793
Cash and due from banks and deposits with banks at the end of the period		740,834	527,609	263,631
Cash interest paid		5,142	13,077	29,918
Cash income taxes paid, net	[1]	$ 18,737	$ 8,140	$ 6,224
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information on revisions to operating activities.

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of presentation JPMorgan Chase & Co. (“JPMorgan Chase” or the “Firm”), a financial holding company incorporated under Delaware law in 1968, is a leading financial services firm based in the U.S., with operations worldwide. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Refer to Note 32 for a further discussion of the Firm’s business segments. The accounting and financial reporting policies of JPMorgan Chase and its subsidiaries conform to U.S. GAAP. Additionally, where applicable, the policies conform to the accounting and reporting guidelines prescribed by regulatory authorities. Certain amounts reported in prior periods have been reclassified to conform with the current presentation. Notably in the first quarter of 2021, the Firm reclassified certain deferred investment tax credits from accounts payable and other liabilities to other assets to be a reduction to the carrying value of the associated tax-oriented investments. Refer to Note 25 for further information. Consolidation The Consolidated Financial Statements include the accounts of JPMorgan Chase and other entities in which the Firm has a controlling financial interest. All material intercompany balances and transactions have been eliminated. Assets held for clients in an agency or fiduciary capacity by the Firm are not assets of JPMorgan Chase and are not included on the Consolidated balance sheets. The Firm determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity. Voting interest entities Voting interest entities are entities that have sufficient equity and provide the equity investors voting rights that enable them to make significant decisions relating to the entity’s operations. For these types of entities, the Firm’s determination of whether it has a controlling interest is primarily based on the amount of voting equity interests held. Entities in which the Firm has a controlling financial interest, through ownership of the majority of the entities’ voting equity interests, or through other contractual rights that give the Firm control, are consolidated by the Firm. Investments in companies in which the Firm has significant influence over operating and financing decisions (but does not own a majority of the voting equity interests) are accounted for (i) in accordance with the equity method of accounting (which requires the Firm to recognize its proportionate share of the entity’s net earnings), or (ii) at fair value if the fair value option was elected. These investments are generally included in other assets, with income or loss included in noninterest revenue. Certain Firm-sponsored asset management funds are structured as limited partnerships or limited liability companies. For many of these entities, the Firm is the general partner or managing member, but the non-affiliated partners or members have the ability to remove the Firm as the general partner or managing member without cause (i.e., kick-out rights), based on a simple majority vote, or the non-affiliated partners or members have rights to participate in important decisions. Accordingly, the Firm does not consolidate these voting interest entities. However, in the limited cases where the non-managing partners or members do not have substantive kick-out or participating rights, the Firm evaluates the funds as VIEs and consolidates the funds if the Firm is the general partner or managing member and has both power and a potentially significant interest. The Firm’s investment companies and asset management funds have investments in both publicly-held and privately-held entities, including investments in buyouts, growth equity and venture opportunities. These investments are accounted for under investment company guidelines and, accordingly, irrespective of the percentage of equity ownership interests held, are carried on the Consolidated balance sheets at fair value, and are recorded in other assets, with income or loss included in noninterest revenue. If consolidated, the Firm retains the accounting under such specialized investment company guidelines. Variable interest entities VIEs are entities that, by design, either (1) lack sufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties, or (2) have equity investors that do not have the ability to make significant decisions relating to the entity’s operations through voting rights, or do not have the obligation to absorb the expected losses, or do not have the right to receive the residual returns of the entity. The most common type of VIE is an SPE. SPEs are commonly used in securitization transactions in order to isolate certain assets and distribute the cash flows from those assets to investors. The basic SPE structure involves a company selling assets to the SPE; the SPE funds the purchase of those assets by issuing securities to investors. The legal documents that govern the transaction specify how the cash earned on the assets must be allocated to the SPE’s investors and other parties that have rights to those cash flows. SPEs are generally structured to insulate investors from claims on the SPE’s assets by creditors of other entities, including the creditors of the seller of the assets. The primary beneficiary of a VIE (i.e., the party that has a controlling financial interest) is required to consolidate the assets and liabilities of the VIE. The primary beneficiary is the party that has both (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and (2) through its interests in the VIE, the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. To assess whether the Firm has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Firm considers all the facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes, first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (such as asset managers, collateral managers, servicers, or owners of call options or liquidation rights over the VIE’s assets) or have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE. To assess whether the Firm has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Firm considers all of its economic interests, including debt and equity investments, servicing fees, and derivatives or other arrangements deemed to be variable interests in the VIE. This assessment requires that the Firm apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Firm. The Firm performs on-going reassessments of: (1) whether entities previously evaluated under the majority voting-interest framework have become VIEs, based on certain events, and are therefore subject to the VIE consolidation framework; and (2) whether changes in the facts and circumstances regarding the Firm’s involvement with a VIE cause the Firm’s consolidation conclusion to change. Refer to Note 14 for further discussion of the Firm’s VIEs. Revenue recognition Interest income The Firm recognizes interest income on loans, debt securities, and other debt instruments, generally on a level-yield basis, based on the underlying contractual rate. Refer to Note 7 for further discussion of interest income. Revenue from contracts with customers JPMorgan Chase recognizes noninterest revenue from certain contracts with customers , in investment banking fees, deposit-related fees, asset management administration and commissions, and components of card income, when the Firm’s related performance obligations are satisfied. Refer to Note 6 for further discussion of the Firm’s revenue from contracts with customers. Principal transactions revenue JPMorgan Chase carries a portion of its assets and liabilities at fair value. Changes in fair value are reported primarily in principal transactions revenue. Refer to Notes 2 and 3 for further discussion of fair value measurement. Refer to Note 6 for further discussion of principal transactions revenue. Use of estimates in the preparation of consolidated financial statements The preparation of the Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expense, and disclosures of contingent assets and liabilities. Actual results could be different from these estimates. Foreign currency translation JPMorgan Chase revalues assets, liabilities, revenue and expense denominated in non-U.S. currencies into U.S. dollars using applicable exchange rates. Gains and losses relating to translating functional currency financial statements for U.S. reporting are included in the Consolidated statements of comprehensive income. Gains and losses relating to nonfunctional currency transactions, including non-U.S. operations where the functional currency is the U.S. dollar, are reported in the Consolidated statements of income. Offsetting assets and liabilities U.S. GAAP permits entities to present derivative receivables and derivative payables with the same counterparty and the related cash collateral receivables and payables on a net basis on the Consolidated balance sheets when a legally enforceable master netting agreement exists. U.S. GAAP also permits securities sold and purchased under repurchase agreements and securities borrowed or loaned under securities loan agreements to be presented net when specified conditions are met, including the existence of a legally enforceable master netting agreement. The Firm has elected to net such balances where it has determined that the specified conditions are met. The Firm uses master netting agreements to mitigate counterparty credit risk in certain transactions, including derivative contracts, resale, repurchase, securities borrowed and securities loaned agreements. A master netting agreement is a single agreement with a counterparty that permits multiple transactions governed by that agreement to be terminated or accelerated and settled through a single payment in a single currency in the event of a default (e.g., bankruptcy, failure to make a required payment or securities transfer or deliver collateral or margin when due). Upon the exercise of derivatives termination rights by the non-defaulting party (i) all transactions are terminated, (ii) all transactions are valued and the positive values of “in the money” transactions are netted against the negative values of “out of the money” transactions and (iii) the only remaining payment obligation is of one of the parties to pay the netted termination amount. Upon exercise of default rights under repurchase agreements and securities loan agreements in general (i) all transactions are terminated and accelerated, (ii) all values of securities or cash held or to be delivered are calculated, and all such sums are netted against each other and (iii) the only remaining payment obligation is of one of the parties to pay the netted termination amount. Typical master netting agreements for these types of transactions also often contain a collateral/margin agreement that provides for a security interest in, or title transfer of, securities or cash collateral/margin to the party that has the right to demand margin (the “demanding party”). The collateral/margin agreement typically requires a party to transfer collateral/margin to the demanding party with a value equal to the amount of the margin deficit on a net basis across all transactions governed by the master netting agreement, less any threshold. The collateral/margin agreement grants to the demanding party, upon default by the counterparty, the right to set-off any amounts payable by the counterparty against any posted collateral or the cash equivalent of any posted collateral/margin. It also grants to the demanding party the right to liquidate collateral/margin and to apply the proceeds to an amount payable by the counterparty. Refer to Note 5 for further discussion of the Firm’s derivative instruments. Refer to Note 11 for further discussion of the Firm’s securities financing agreements. Statements of cash flows For JPMorgan Chase’s Consolidated statements of cash flows, cash is defined as those amounts included in cash and due from banks and deposits with banks on the Consolidated balance sheets. Accounting standard adopted January 1, 2020 Financial Instruments – Credit Losses (“CECL”) The adoption of this guidance established a single allowance framework for all financial assets measured at amortized cost and certain off-balance sheet credit exposures. This framework requires that management’s estimate reflects credit losses over the instrument’s remaining expected life and considers expected future changes in macroeconomic conditions. Prior to the adoption of the CECL accounting guidance, the Firm’s allowance for credit losses represented management’s estimate of probable credit losses inherent in the Firm’s retained loan portfolios and certain lending-related commitments. The adoption of CECL on January 1, 2020, resulted in a $2.7 billion decrease to retained earnings. Significant accounting policies The following table identifies JPMorgan Chase’s other significant accounting policies and the Note and page where a detailed description of each policy can be found. Fair value measurement Note 2 page 169 Fair value option Note 3 page 190 Derivative instruments Note 5 page 196 Noninterest revenue and noninterest expense Note 6 page 211 Interest income and Interest expense Note 7 page 214 Pension and other postretirement employee benefit plans Note 8 page 215 Employee share-based incentives Note 9 page 218 Investment securities Note 10 page 220 Securities financing activities Note 11 page 226 Loans Note 12 page 229 Allowance for credit losses Note 13 page 248 Variable interest entities Note 14 page 253 Goodwill and Mortgage servicing rights Note 15 page 261 Premises and equipment Note 16 page 265 Leases Note 18 page 266 Long-term debt Note 20 page 269 Earnings per share Note 23 page 274 Income taxes Note 25 page 277 Off–balance sheet lending-related financial instruments, guarantees and other commitments Note 28 page 283 Litigation Note 30 page 290

Fair Value Measurement

Fair Value Measurement	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair value measurement JPMorgan Chase carries a portion of its assets and liabilities at fair value. These assets and liabilities are predominantly carried at fair value on a recurring basis (i.e., assets and liabilities that are measured and reported at fair value on the Firm’s Consolidated balance sheets). Certain assets, liabilities and unfunded lending-related commitments are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is based on quoted market prices or inputs, where available. If prices or quotes are not available, fair value is based on valuation models and other valuation techniques that consider relevant transaction characteristics (such as maturity) and use, as inputs, observable or unobservable market parameters, including yield curves, interest rates, volatilities, prices (such as commodity, equity or debt prices), correlations, foreign exchange rates and credit curves. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value, as described below. The level of precision in estimating unobservable market inputs or other factors can affect the amount of gain or loss recorded for a particular position. Furthermore, while the Firm believes its valuation methods are appropriate and consistent with those of other market participants, the methods and assumptions used reflect management judgment and may vary across the Firm’s businesses and portfolios. The Firm uses various methodologies and assumptions in the determination of fair value. The use of different methodologies or assumptions by other market participants compared with those used by the Firm could result in the Firm deriving a different estimate of fair value at the reporting date. Valuation process Risk-taking functions are responsible for providing fair value estimates for assets and liabilities carried on the Consolidated balance sheets at fair value. The Firm’s Valuation Control Group (“VCG”), which is part of the Firm’s Finance function and independent of the risk-taking functions, is responsible for verifying these estimates and determining any fair value adjustments that may be required to ensure that the Firm’s positions are recorded at fair value. In addition, the Firm’s Valuation Governance Forum (“VGF”), which is composed of senior finance and risk executives, is responsible for overseeing the management of risks arising from valuation activities conducted across the Firm. The Firmwide VGF is chaired by the Firmwide head of the VCG (under the direction of the Firm’s Controller), and includes sub-forums covering the CIB, CCB, CB, AWM and certain corporate functions including Treasury and CIO. Price verification process The VCG verifies fair value estimates provided by the risk-taking functions by leveraging independently derived prices, valuation inputs and other market data, where available. Where independent prices or inputs are not available, the VCG performs additional review to ensure the reasonableness of the estimates. The additional review may include evaluating the limited market activity including client unwinds, benchmarking valuation inputs to those used for similar instruments, decomposing the valuation of structured instruments into individual components, comparing expected to actual cash flows, reviewing profit and loss trends, and reviewing trends in collateral valuation. There are also additional levels of management review for more significant or complex positions. The VCG determines any valuation adjustments that may be required to the estimates provided by the risk-taking functions. No adjustments to quoted prices are applied for instruments classified within level 1 of the fair value hierarchy (refer to the discussion below for further information on the fair value hierarchy). For other positions, judgment is required to assess the need for valuation adjustments to appropriately reflect liquidity considerations, unobservable parameters, and, for certain portfolios that meet specified criteria, the size of the net open risk position. The determination of such adjustments follows a consistent framework across the Firm: • Liquidity valuation adjustments are considered where an observable external price or valuation parameter exists but is of lower reliability, potentially due to lower market activity. Liquidity valuation adjustments are made based on current market conditions. Factors that may be considered in determining the liquidity adjustment include analysis of: (1) the estimated bid-offer spread for the instrument being traded; (2) alternative pricing points for similar instruments in active markets; and (3) the range of reasonable values that the price or parameter could take. • The Firm manages certain portfolios of financial instruments on the basis of net open risk exposure and, as permitted by U.S. GAAP, has elected to estimate the fair value of such portfolios on the basis of a transfer of the entire net open risk position in an orderly transaction. Where this is the case, valuation adjustments may be necessary to reflect the cost of exiting a larger-than-normal market-size net open risk position. Where applied, such adjustments are based on factors that a relevant market participant would consider in the transfer of the net open risk position, including the size of the adverse market move that is likely to occur during the period required to reduce the net open risk position to a normal market-size. • Uncertainty adjustments related to unobservable parameters may be made when positions are valued using prices or input parameters to valuation models that are unobservable due to a lack of market activity or because they cannot be implied from observable market data. Such prices or parameters must be estimated and are, therefore, subject to management judgment. Adjustments are made to reflect the uncertainty inherent in the resulting valuation estimate. • Where appropriate, the Firm also applies adjustments to its estimates of fair value in order to appropriately reflect counterparty credit quality (CVA), the Firm’s own creditworthiness (DVA) and the impact of funding (FVA), using a consistent framework across the Firm. Refer to Credit and funding adjustments on page 186 of this Note for more information on such adjustments. Valuation model review and approval If prices or quotes are not available for an instrument or a similar instrument, fair value is generally determined using valuation models that consider relevant transaction terms such as maturity and use as inputs market-based or independently sourced parameters. Where this is the case the price verification process described above is applied to the inputs in those models. Under the Firm’s Estimations and Model Risk Management Policy, the MRGR reviews and approves new models, as well as material changes to existing models, prior to implementation in the operating environment. In certain circumstances exceptions may be granted to the Firm’s policy to allow a model to be used prior to review or approval. The MRGR may also require the user to take appropriate actions to mitigate the model risk if it is to be used in the interim. These actions will depend on the model and may include, for example, limitation of trading activity. Fair value hierarchy A three-level fair value hierarchy has been established under U.S. GAAP for disclosure of fair value measurements. The fair value hierarchy is based on the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows. • Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. • Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3 – one or more inputs to the valuation methodology are unobservable and significant to the fair value measurement. A financial instrument’s categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The following table describes the valuation methodologies generally used by the Firm to measure its significant products/instruments at fair value, including the general classification of such instruments pursuant to the fair value hierarchy. Product/instrument Valuation methodology Classifications in the fair value hierarchy Securities financing agreements Valuations are based on discounted cash flows, which consider: Predominantly level 2 • Derivative features: refer to the discussion of derivatives below for further information. • Market rates for the respective maturity • Collateral characteristics Loans and lending-related commitments — wholesale Where observable market data is available, valuations are based on: Level 2 or 3 Loans carried at fair value • Observed market prices (circumstances are infrequent) • Relevant broker quotes • Observed market prices for similar instruments Where observable market data is unavailable or limited, valuations are based on discounted cash flows, which consider the following: • Credit spreads derived from the cost of CDS; or benchmark credit curves developed by the Firm, by industry and credit rating • Prepayment speed • Collateral characteristics Loans — consumer Fair value is based on observable market prices for mortgage-backed securities with similar collateral and incorporates adjustments to these prices to account for differences between the securities and the value of the underlying loans, which include credit characteristics, portfolio composition, and liquidity. Predominantly level 2 Loans carried at fair value — conforming residential mortgage loans expected to be sold Investment and trading securities Quoted market prices Level 1 In the absence of quoted market prices, securities are valued based on: Level 2 or 3 • Observable market prices for similar securities • Relevant broker quotes • Discounted cash flows In addition, the following inputs to discounted cash flows are used for the following products: Mortgage- and asset-backed securities specific inputs: • Collateral characteristics • Deal-specific payment and loss allocations • Current market assumptions related to yield, prepayment speed, conditional default rates and loss severity Collateralized loan obligations (“CLOs”) specific inputs: • Collateral characteristics • Deal-specific payment and loss allocations • Expected prepayment speed, conditional default rates, loss severity • Credit spreads • Credit rating data Physical commodities Valued using observable market prices or data. Level 1 or 2 Product/instrument Valuation methodology Classifications in the fair value hierarchy Derivatives Exchange-traded derivatives that are actively traded and valued using the exchange price. Level 1 Derivatives that are valued using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that may use observable or unobservable valuation inputs as well as considering the contractual terms. The key valuation inputs used will depend on the type of derivative and the nature of the underlying instruments and may include equity prices, commodity prices, foreign exchange rates, volatilities, correlations, CDS spreads and recovery rates. Level 2 or 3 In addition, specific inputs used for derivatives that are valued based on models with significant unobservable inputs are as follows: Interest rate and FX exotic options specific inputs include: • Interest rate volatility • Interest rate spread volatility • Interest rate correlation • Interest rate-FX correlation • Foreign exchange correlation • Interest rate curve Structured credit derivatives specific inputs include: • Credit correlation between the underlying debt instruments • CDS spreads and recovery rates Equity option specific inputs include: • Forward equity price • Equity volatility • Equity correlation • Equity-FX correlation • Equity-IR correlation Commodity derivatives specific inputs include: • Forward commodity price • Commodity volatility • Commodity correlation Additionally, adjustments are made to reflect counterparty credit quality (CVA) and the impact of funding (FVA). Refer to page 186 of this Note. Mortgage servicing rights Refer to Mortgage servicing rights in Note 15. Level 3 Private equity direct investments Fair value is estimated using all available information; the range of potential inputs include: Level 2 or 3 • Transaction prices • Trading multiples of comparable public companies • Operating performance of the underlying portfolio company • Adjustments as required, since comparable public companies are not identical to the company being valued, and for company-specific issues and lack of liquidity. • Additional available inputs relevant to the investment. Fund investments (e.g., mutual/collective investment funds, private equity funds, hedge funds, and real estate funds) Net asset value • NAV is supported by the ability to redeem and purchase at the NAV level. Level 1 • Adjustments to the NAV as required, for restrictions on redemption (e.g., lock-up periods or withdrawal limitations) or where observable activity is limited. Level 2 or 3 (a) Beneficial interests issued by consolidated VIEs Valued using observable market information, where available. Level 2 or 3 In the absence of observable market information, valuations are based on the fair value of the underlying assets held by the VIE. (a) Excludes certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient. Product/instrument Valuation methodology Classification in the fair value hierarchy Structured notes (included in deposits, short-term borrowings and long-term debt) • Valuations are based on discounted cash flow analyses that consider the embedded derivative and the terms and payment structure of the note. • The embedded derivative features are considered using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that may use observable or unobservable valuation inputs, depending on the embedded derivative. The specific inputs used vary according to the nature of the embedded derivative features, as described in the discussion above regarding derivatives valuation. Adjustments are then made to this base valuation to reflect the Firm’s own credit risk (DVA). Refer to page 186 of this Note. Level 2 or 3 The following table presents the assets and liabilities reported at fair value as of December 31, 2021 and 2020, by major product category and fair value hierarchy. Assets and liabilities measured at fair value on a recurring basis Fair value hierarchy December 31, 2021 (in millions) Level 1 Level 2 Level 3 Derivative netting adjustments (f) Total fair value Federal funds sold and securities purchased under resale agreements $ — $ 252,720 $ — $ — $ 252,720 Securities borrowed — 81,463 — — 81,463 Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies (a) — 38,944 265 — 39,209 Residential – nonagency — 2,358 28 — 2,386 Commercial – nonagency — 1,506 10 — 1,516 Total mortgage-backed securities — 42,808 303 — 43,111 U.S. Treasury, GSEs and government agencies (a) 68,527 9,181 — — 77,708 Obligations of U.S. states and municipalities — 7,068 7 — 7,075 Certificates of deposit, bankers’ acceptances and commercial paper — 852 — — 852 Non-U.S. government debt securities 26,982 44,581 81 — 71,644 Corporate debt securities — 24,491 332 — 24,823 Loans — 7,366 708 — 8,074 Asset-backed securities — 2,668 26 — 2,694 Total debt instruments 95,509 139,015 1,457 — 235,981 Equity securities 86,904 1,741 662 — 89,307 Physical commodities (b) 5,357 20,788 — — 26,145 Other — 24,850 160 — 25,010 Total debt and equity instruments (c) 187,770 186,394 2,279 — 376,443 Derivative receivables: Interest rate 1,072 267,493 2,020 (248,611) 21,974 Credit — 9,321 518 (8,808) 1,031 Foreign exchange 134 168,590 855 (156,954) 12,625 Equity — 65,139 3,492 (58,650) 9,981 Commodity — 26,232 421 (15,183) 11,470 Total derivative receivables 1,206 536,775 7,306 (488,206) 57,081 Total trading assets (d) 188,976 723,169 9,585 (488,206) 433,524 Available-for-sale securities: Mortgage-backed securities: U.S. GSEs and government agencies (a) 4 72,539 — — 72,543 Residential – nonagency — 6,070 — — 6,070 Commercial – nonagency — 4,949 — — 4,949 Total mortgage-backed securities 4 83,558 — — 83,562 U.S. Treasury and government agencies 177,463 — — — 177,463 Obligations of U.S. states and municipalities — 15,860 — — 15,860 Non-U.S. government debt securities 5,430 10,779 — — 16,209 Corporate debt securities — 160 161 — 321 Asset-backed securities: Collateralized loan obligations — 9,662 — — 9,662 Other — 5,448 — — 5,448 Total available-for-sale securities 182,897 125,467 161 — 308,525 Loans (e) — 56,887 1,933 — 58,820 Mortgage servicing rights — — 5,494 — 5,494 Other assets (d) 9,558 4,139 306 — 14,003 Total assets measured at fair value on a recurring basis $ 381,431 $ 1,243,845 $ 17,479 $ (488,206) $ 1,154,549 Deposits $ — $ 9,016 $ 2,317 $ — $ 11,333 Federal funds purchased and securities loaned or sold under repurchase agreements — 126,435 — — 126,435 Short-term borrowings — 17,534 2,481 — 20,015 Trading liabilities: Debt and equity instruments (c) 87,831 26,716 30 — 114,577 Derivative payables: Interest rate 981 237,714 2,036 (232,537) 8,194 Credit — 10,468 444 (10,032) 880 Foreign exchange 123 174,349 1,274 (161,649) 14,097 Equity — 72,609 7,118 (62,494) 17,233 Commodity — 26,600 1,328 (18,216) 9,712 Total derivative payables 1,104 521,740 12,200 (484,928) 50,116 Total trading liabilities 88,935 548,456 12,230 (484,928) 164,693 Accounts payable and other liabilities 5,115 467 69 — 5,651 Beneficial interests issued by consolidated VIEs — 12 — — 12 Long-term debt — 50,560 24,374 — 74,934 Total liabilities measured at fair value on a recurring basis $ 94,050 $ 752,480 $ 41,471 $ (484,928) $ 403,073 Fair value hierarchy December 31, 2020 (in millions) Level 1 Level 2 Level 3 Derivative netting adjustments (f) Total fair value Federal funds sold and securities purchased under resale agreements $ — $ 238,015 $ — $ — $ 238,015 Securities borrowed — 52,983 — — 52,983 Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies (a) — 68,395 449 — 68,844 Residential – nonagency — 2,138 28 — 2,166 Commercial – nonagency — 1,327 3 — 1,330 Total mortgage-backed securities — 71,860 480 — 72,340 U.S. Treasury, GSEs and government agencies (a) 104,263 10,996 — — 115,259 Obligations of U.S. states and municipalities — 7,184 8 — 7,192 Certificates of deposit, bankers’ acceptances and commercial paper — 1,230 — — 1,230 Non-U.S. government debt securities 26,772 40,671 182 — 67,625 Corporate debt securities — 21,017 507 — 21,524 Loans — 6,101 893 — 6,994 Asset-backed securities — 2,304 28 — 2,332 Total debt instruments 131,035 161,363 2,098 — 294,496 Equity securities 97,035 2,652 476 (g) — 100,163 Physical commodities (b) 6,382 5,189 — — 11,571 Other — 21,351 (g) 49 (g) — 21,400 Total debt and equity instruments (c) 234,452 190,555 2,623 — 427,630 Derivative receivables: Interest rate (g) 2,318 387,023 2,307 (355,923) 35,725 Credit (g) — 12,721 624 (12,665) 680 Foreign exchange 146 205,127 987 (190,479) 15,781 Equity — 67,093 (g) 3,519 (54,125) 16,487 Commodity — 21,272 231 (14,732) 6,771 Total derivative receivables 2,464 693,236 7,668 (627,924) 75,444 Total trading assets (d) 236,916 883,791 10,291 (627,924) 503,074 Available-for-sale securities: Mortgage-backed securities: U.S. GSEs and government agencies (a)(g) 7 113,294 — — 113,301 Residential – nonagency — 10,233 — — 10,233 Commercial – nonagency — 2,856 — — 2,856 Total mortgage-backed securities 7 126,383 — — 126,390 U.S. Treasury and government agencies 201,951 — — — 201,951 Obligations of U.S. states and municipalities — 20,396 — — 20,396 Non-U.S. government debt securities 13,135 9,793 — — 22,928 Corporate debt securities — 216 — — 216 Asset-backed securities: Collateralized loan obligations — 10,048 — — 10,048 Other — 6,249 — — 6,249 Total available-for-sale securities 215,093 173,085 — — 388,178 Loans (e) — 42,169 2,305 — 44,474 Mortgage servicing rights — — 3,276 — 3,276 Other assets (d) 8,110 4,561 538 — 13,209 Total assets measured at fair value on a recurring basis $ 460,119 $ 1,394,604 $ 16,410 $ (627,924) $ 1,243,209 Deposits $ — $ 11,571 $ 2,913 $ — $ 14,484 Federal funds purchased and securities loaned or sold under repurchase agreements — 155,735 — — 155,735 Short-term borrowings — 14,473 2,420 — 16,893 Trading liabilities: Debt and equity instruments (c) 82,669 16,838 51 — 99,558 Derivative payables: Interest rate (g) 2,496 349,442 2,049 (340,975) 13,012 Credit (g) — 13,984 848 (12,837) 1,995 Foreign exchange 132 214,373 1,421 (194,493) 21,433 Equity — 74,032 7,381 (55,515) 25,898 Commodity — 21,767 962 (14,444) 8,285 Total derivative payables 2,628 673,598 12,661 (618,264) 70,623 Total trading liabilities 85,297 690,436 12,712 (618,264) 170,181 Accounts payable and other liabilities 2,895 513 68 — 3,476 Beneficial interests issued by consolidated VIEs — 41 — — 41 Long-term debt — 53,420 23,397 — 76,817 Total liabilities measured at fair value on a recurring basis $ 88,192 $ 926,189 $ 41,510 $ (618,264) $ 437,627 (a) At December 31, 2021 and 2020, included total U.S. GSE obligations of $73.9 billion and $117.6 billion, respectively, which were mortgage-related. (b) Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 5 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented. (c) Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions). (d) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At December 31, 2021 and 2020, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $801 million and $670 million, respectively. Included in these balances at December 31, 2021 and 2020, were trading assets of $51 million and $52 million, respectively, and other assets of $750 million and $618 million, respectively. (e) At December 31, 2021 and 2020, included $26.2 billion and $15.1 billion, respectively, of residential first-lien mortgages, and $8.2 billion and $6.3 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. GSEs and government agencies of $13.6 billion and $8.4 billion, respectively. (f) As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral. (g) Prior-period amounts have been revised to conform with the current presentation. Level 3 valuations The Firm has established well-structured processes for determining fair value, including for instruments where fair value is estimated using significant unobservable inputs (level 3). Refer to pages 169-173 of this Note for further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments. Estimating fair value requires the application of judgment. The type and level of judgment required is largely dependent on the amount of observable market information available to the Firm. For instruments valued using internally developed valuation models and other valuation techniques that use significant unobservable inputs and are therefore classified within level 3 of the fair value hierarchy, judgments used to estimate fair value are more significant than those required when estimating the fair value of instruments classified within levels 1 and 2. In arriving at an estimate of fair value for an instrument within level 3, management must first determine the appropriate valuation model or other valuation technique to use. Second, due to the lack of observability of significant inputs, management must assess relevant empirical data in deriving valuation inputs including transaction details, yield curves, interest rates, prepayment speed, default rates, volatilities, correlations, prices (such as commodity, equity or debt prices), valuations of comparable instruments, foreign exchange rates and credit curves. The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy. The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value. In the Firm’s view, the input range, weighted and arithmetic average values do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter-to-parameter based on the characteristics of the instruments held by the Firm at each balance sheet date. Level 3 inputs (a) December 31, 2021 Product/Instrument Fair value (in millions) Principal valuation technique Unobservable inputs (g) Range of input values Average (i) Residential mortgage-backed securities and loans (b) $ 1,181 Discounted cash flows Yield 0% – 15% 4% Prepayment speed 0% – 15% 14% Conditional default rate 0% – 2% 0% Loss severity 0% – 110% 4% Commercial mortgage-backed securities and loans (c) 391 Market comparables Price $0 – $103 $84 Corporate debt securities 493 Market comparables Price $0 – $154 $87 Loans (d) 1,372 Market comparables Price $5 – $107 $89 Non-U.S. government debt securities 81 Market comparables Price $87 – $103 $96 Net interest rate derivatives (26) Option pricing Interest rate volatility 5bps – 544bps 106bps Interest rate spread volatility 11bps – 23bps 14bps Interest rate correlation (65)% – 87% 25% IR-FX correlation (35)% – 50% (2)% 10 Discounted cash flows Prepayment speed 0% – 30% 8% Net credit derivatives 26 Discounted cash flows Credit correlation 35% – 65% 46% Credit spread 1bps – 4,396bps 384bps Recovery rate 35% – 67% 51% 48 Market comparables Price $0 – $115 $80 Net foreign exchange derivatives (320) Option pricing IR-FX correlation (40)% – 65% 17% (99) Discounted cash flows Prepayment speed 9% 9% Interest rate curve 0% – 28% 4% Net equity derivatives (3,626) Option pricing Forward equity price (h) 63% – 122% 99% Equity volatility 4% – 132% 32% Equity correlation 17% – 100% 55% Equity-FX correlation (79)% – 59% (27)% Equity-IR correlation 15% – 50% 27% Net commodity derivatives (907) Option pricing Oil commodity forward $631 / MT – $747 / MT $689 / MT Industrial metals commodity forward $2,610 / MT – $3,482 / MT $3,046 / MT Commodity volatility 5% – 185% 95% Commodity correlation (50)% – 76% 13% MSRs 5,494 Discounted cash flows Refer to Note 15 Long-term debt, short-term borrowings, and deposits (e) 28,236 Option pricing Interest rate volatility 5bps – 544bps 106bps Interest rate correlation (65)% – 87% 25% IR-FX correlation (35)% – 50% (2)% Equity correlation 17% – 100% 55% Equity-FX correlation (79)% – 59% (27)% Equity-IR correlation 15% – 50% 27% 936 Discounted cash flows Credit correlation 35% – 65% 46% Other level 3 assets and liabilities, net (f) 1,062 (a) The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ. (b) Comprises U.S. GSE and government agency securities of $265 million, nonagency securities of $28 million and non-trading loans of $888 million. (c) Comprises nonagency securities of $10 million, trading loans of $40 million and non-trading loans of $341 million. (d) Comprises trading loans of $668 million and non-trading loans of $704 million. (e) Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables. (f) Includes equity securities of $806 million including $144 million in Other assets, for which quoted prices are not readily available and the fair value is generally based on internal valuation techniques such as EBITDA multiples and comparable analysis. All other level 3 assets and liabilities are insignificant both individually and in aggregate. (g) Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100 . (h) Forward equity price is expressed as a percentage of the current equity price. (i) Amounts represent weighted averages except for derivative-related inputs where arithmetic averages are used. Changes in and ranges of unobservable inputs The following discussion provides a description of the impact on a fair value measurement of a change in each unobservable input in isolation, and the interrelationship between unobservable input

Fair Value Option

Fair Value Option	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Option	Fair value option The fair value option provides an option to elect fair value as an alternative measurement for selected financial assets, financial liabilities, unrecognized firm commitments, and written loan commitments. The Firm has elected to measure certain instruments at fair value for several reasons including to mitigate income statement volatility caused by the differences between the measurement basis of elected instruments (e.g., certain instruments that otherwise would be accounted for on an accrual basis) and the associated risk management arrangements that are accounted for on a fair value basis, as well as to better reflect those instruments that are managed on a fair value basis. The Firm’s election of fair value includes the following instruments: • Loans purchased or originated as part of securitization warehousing activity, subject to bifurcation accounting, or managed on a fair value basis, including lending-related commitments • Certain securities financing agreements • Owned beneficial interests in securitized financial assets that contain embedded credit derivatives, which would otherwise be required to be separately accounted for as a derivative instrument • Structured notes and other hybrid instruments, which are predominantly financial instruments that contain embedded derivatives, that are issued or transacted as part of client-driven activities • Certain long-term beneficial interests issued by CIB’s consolidated securitization trusts where the underlying assets are carried at fair value Changes in fair value under the fair value option election The following table presents the changes in fair value included in the Consolidated statements of income for the years ended December 31, 2021, 2020 and 2019, for items for which the fair value option was elected. The profit and loss information presented below only includes the financial instruments that were elected to be measured at fair value; related risk management instruments, which are required to be measured at fair value, are not included in the table. 2021 2020 2019 December 31, (in millions) Principal transactions All other income Total changes in fair value recorded (e) Principal transactions All other income Total changes in fair value recorded (e) Principal transactions All other income Total changes in fair value recorded (e) Federal funds sold and securities purchased under resale agreements $ (112) $ — $ (112) $ 12 $ — $ 12 $ (36) $ — $ (36) Securities borrowed (200) — (200) 143 — 143 133 — 133 Trading assets: Debt and equity instruments, excluding loans (2,171) (1) (c) (2,172) 2,587 (f) (1) (c) 2,586 2,482 (1) (c) 2,481 Loans reported as trading assets: Changes in instrument-specific credit risk 353 — 353 135 — 135 248 — 248 Other changes in fair value (8) — (8) (19) — (19) (1) — (1) Loans: Changes in instrument-specific credit risk 589 (7) (c) 582 190 7 (c) 197 475 2 (c) 477 Other changes in fair value (139) 2,056 (c) 1,917 470 3,239 (c) 3,709 267 1,224 (c) 1,491 Other assets 12 (26) (d) (14) 103 (65) (d) 38 8 6 (d) 14 Deposits (a) (183) — (183) (726) — (726) (1,730) — (1,730) Federal funds purchased and securities loaned or sold under repurchase agreements 69 — 69 (6) — (6) (8) — (8) Short-term borrowings (a) (366) — (366) 294 — 294 (693) — (693) Trading liabilities 7 — 7 2 — 2 6 — 6 Other liabilities (17) — (17) (94) — (94) (16) — (16) Long-term debt (a)(b) (980) 4 (c)(d) (976) (2,120) (1) (c) (2,121) (6,173) 1 (c) (6,172) (a) Unrealized gains/(losses) due to instrument-specific credit risk (DVA) for liabilities for which the fair value option has been elected are recorded in OCI while realized gains/(losses) are recorded in principal transactions revenue. Realized gains/(losses) due to instrument-specific credit risk recorded in principal transactions revenue were $(15) million and $20 million for the years ended December 31,2021 and 2020, respectively, and were not material for the year ended December 31, 2019. (b) Long-term debt measured at fair value predominantly relates to structured notes. Although the risk associated with the structured notes is actively managed, the gains/(losses) reported in this table do not include the income statement impact of the risk management instruments used to manage such risk. (c) Reported in mortgage fees and related income. (d) Reported in other income. (e) Changes in fair value exclude contractual interest, which is included in interest income and interest expense for all instruments other than certain hybrid financial instruments recorded in CIB. Refer to Note 7 for further information regarding interest income and interest expense. (f) Prior-period amounts have been revised to conform with the current presentation. Determination of instrument-specific credit risk for items for which the fair value option was elected The following describes how the gains and losses that are attributable to changes in instrument-specific credit risk, were determined. • Loans and lending-related commitments: For floating-rate instruments, all changes in value are attributed to instrument-specific credit risk. For fixed-rate instruments, an allocation of the changes in value for the period is made between those changes in value that are interest rate-related and changes in value that are credit-related. Allocations are generally based on an analysis of borrower-specific credit spread and recovery information, where available, or benchmarking to similar entities or industries. • Long-term debt: Changes in value attributable to instrument-specific credit risk were derived principally from observable changes in the Firm’s credit spread as observed in the bond market. • Securities financing agreements: Generally, for these types of agreements, there is a requirement that collateral be maintained with a market value equal to or in excess of the principal amount loaned; as a result, there would be no adjustment or an immaterial adjustment for instrument-specific credit risk related to these agreements. Difference between aggregate fair value and aggregate remaining contractual principal balance outstanding The following table reflects the difference between the aggregate fair value and the aggregate remaining contractual principal balance outstanding as of December 31, 2021 and 2020, for loans, long-term debt and long-term beneficial interests for which the fair value option has been elected. 2021 2020 December 31, (in millions) Contractual principal outstanding Fair value Fair value over/(under) contractual principal outstanding Contractual principal outstanding Fair value Fair value over/(under) contractual principal outstanding Loans Nonaccrual loans Loans reported as trading assets $ 3,263 $ 546 $ (2,717) $ 3,386 $ 555 $ (2,831) Loans 918 797 (121) 1,867 1,507 (360) Subtotal 4,181 1,343 (2,838) 5,253 2,062 (3,191) 90 or more days past due and government guaranteed Loans (a) 293 281 (12) 328 317 (11) All other performing loans (b) Loans reported as trading assets 8,594 7,528 (1,066) 7,917 6,439 (1,478) Loans 57,695 57,742 47 42,022 42,650 628 Subtotal 66,289 65,270 (1,019) 49,939 49,089 (850) Total loans $ 70,763 $ 66,894 $ (3,869) $ 55,520 $ 51,468 $ (4,052) Long-term debt Principal-protected debt $ 35,957 (d) $ 33,799 $ (2,158) $ 40,560 (d) $ 40,526 $ (34) Nonprincipal-protected debt (c) NA 41,135 NA NA 36,291 NA Total long-term debt NA $ 74,934 NA NA $ 76,817 NA Long-term beneficial interests Nonprincipal-protected debt (c) NA $ 12 NA NA $ 41 NA Total long-term beneficial interests NA $ 12 NA NA $ 41 NA (a) These balances are excluded from nonaccrual loans as the loans are insured and/or guaranteed by U.S. government agencies. (b) There were no performing loans that were ninety days or more past due as of December 31, 2021 and 2020. (c) Remaining contractual principal is not applicable to nonprincipal-protected structured notes and long-term beneficial interests. Unlike principal-protected structured notes and long-term beneficial interests, for which the Firm is obligated to return a stated amount of principal at maturity, nonprincipal-protected structured notes and long-term beneficial interests do not obligate the Firm to return a stated amount of principal at maturity, but for structured notes to return an amount based on the performance of an underlying variable or derivative feature embedded in the note. However, investors are exposed to the credit risk of the Firm as issuer for both nonprincipal-protected and principal-protected notes. (d) Where the Firm issues principal-protected zero-coupon or discount notes, the balance reflects the contractual principal payment at maturity or, if applicable, the contractual principal payment at the Firm’s next call date. At December 31, 2021 and 2020, the contractual amount of lending-related commitments for which the fair value option was elected was $11.9 billion and $18.1 billion, respectively, with a corresponding fair value of $10 million and $(39) million, respectively. Refer to Note 28 for further information regarding off-balance sheet lending-related financial instruments. Structured note products by balance sheet classification and risk component The following table presents the fair value of structured notes, by balance sheet classification and the primary risk type. December 31, 2021 December 31, 2020 (in millions) Long-term debt Short-term borrowings Deposits Total Long-term debt Short-term borrowings Deposits Total Risk exposure Interest rate $ 34,127 $ 1 $ 4,860 $ 38,988 $ 38,129 $ 65 $ 5,057 $ 43,251 Credit 6,352 858 — 7,210 6,409 1,022 — 7,431 Foreign exchange 3,386 315 1,066 4,767 3,613 92 — 3,705 Equity 29,317 6,827 5,125 41,269 26,943 5,021 6,893 38,857 Commodity 405 — 3 (a) 408 250 13 232 (a) 495 Total structured notes $ 73,587 $ 8,001 $ 11,054 $ 92,642 $ 75,344 $ 6,213 $ 12,182 $ 93,739 (a) Excludes deposits linked to precious metals for which the fair value option has not been elected of $692 million and $739 million for the years ended December 31, 2021 and 2020, respectively.

Credit Risk Concentrations

Credit Risk Concentrations	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Credit Risk Concentrations	Credit risk concentrations Concentrations of credit risk arise when a number of clients, counterparties or customers are engaged in similar business activities or activities in the same geographic region, or when they have similar economic features that would cause their ability to meet contractual obligations to be similarly affected by changes in economic conditions. JPMorgan Chase regularly monitors various segments of its credit portfolios to assess potential credit risk concentrations and to obtain additional collateral when deemed necessary and permitted under the Firm’s agreements. Senior management is significantly involved in the credit approval and review process, and risk levels are adjusted as needed to reflect the Firm’s risk appetite. In the Firm’s consumer portfolio, concentrations are managed primarily by product and by U.S. geographic region, with a key focus on trends and concentrations at the portfolio level, where potential credit risk concentrations can be remedied through changes in underwriting policies and portfolio guidelines. Refer to Note 12 for additional information on the geographic composition of the Firm’s consumer loan portfolios. In the wholesale portfolio, credit risk concentrations are evaluated primarily by industry and monitored regularly on both an aggregate portfolio level and on an individual client or counterparty basis. The Firm’s wholesale exposure is managed through loan syndications and participations, loan sales, securitizations, credit derivatives, master netting agreements, collateral and other risk-reduction techniques. Refer to Note 12 for additional information on loans. The Firm does not believe that its exposure to any particular loan product or industry segment results in a significant concentration of credit risk. Terms of loan products and collateral coverage are included in the Firm’s assessment when extending credit and establishing its allowance for loan losses. The table below presents both on–balance sheet and off–balance sheet consumer and wholesale credit exposure by the Firm’s three credit portfolio segments as of December 31, 2021 and 2020. The wholesale industry of risk category is generally based on the client or counterparty’s primary business activity. 2021 2020 Credit exposure (h) On-balance sheet Off-balance sheet (j) Credit exposure (h) On-balance sheet Off-balance sheet (j) December 31, (in millions) Loans Derivatives Loans Derivatives Consumer, excluding credit card $ 368,640 $ 323,306 (i) $ — $ 45,334 $ 375,898 $ 318,579 (i) $ — $ 57,319 Credit card (a) 884,830 154,296 — 730,534 802,722 144,216 — 658,506 Total consumer (a) 1,253,470 477,602 — 775,868 1,178,620 462,795 — 715,825 Wholesale (b) Real Estate 155,069 119,753 1,113 34,203 148,498 118,299 1,385 28,814 Individuals and Individual Entities (c) 141,973 130,576 1,317 10,080 122,870 109,746 1,750 11,374 Consumer & Retail 122,789 39,588 2,669 80,532 108,437 39,013 2,802 66,622 Technology, Media & 84,070 17,815 2,640 63,615 72,150 14,687 4,252 53,211 Asset Managers 81,228 41,031 9,351 30,846 66,573 31,059 9,277 26,237 Industrials 66,974 21,652 1,224 44,098 66,470 21,143 1,851 43,476 Healthcare 59,014 18,587 2,575 37,852 60,118 19,405 3,252 37,461 Banks & Finance Cos 54,684 34,217 4,418 16,049 54,032 31,004 8,044 14,984 Oil & Gas 42,606 11,039 6,034 25,533 39,159 11,267 1,643 26,249 Automotive 34,573 11,759 720 22,094 43,331 17,128 5,995 20,208 State & Municipal Govt (d) 33,216 15,322 1,563 16,331 38,286 18,054 2,347 17,885 Utilities 33,203 5,969 3,736 23,498 30,124 4,874 3,340 21,910 Chemicals & Plastics 17,660 5,033 564 12,063 17,176 4,884 856 11,436 Metals & Mining 16,696 5,696 924 10,076 15,542 4,854 882 9,806 Transportation 14,635 5,453 782 8,400 16,232 6,566 1,495 8,171 Insurance 13,926 1,303 2,700 9,923 13,141 1,042 2,527 9,572 Central Govt 11,317 2,889 6,837 1,591 17,025 3,396 12,313 1,316 Financial Markets Infrastructure 4,377 5 2,487 1,885 6,515 19 3,757 2,739 Securities Firms 4,180 469 1,260 2,451 8,048 469 4,838 2,741 All other (e) 111,690 72,198 4,167 35,325 96,527 58,038 2,838 (k) 35,651 Subtotal 1,103,880 560,354 57,081 486,445 1,040,254 514,947 75,444 449,863 Loans held-for-sale and loans at fair value 39,758 39,758 — — 35,111 35,111 — — Receivables from customers (f) 59,645 — — — 47,710 — — — Total wholesale 1,203,283 600,112 57,081 486,445 1,123,075 550,058 75,444 449,863 Total exposure (g)(h) $ 2,456,753 $ 1,077,714 $ 57,081 $ 1,262,313 $ 2,301,695 $ 1,012,853 $ 75,444 $ 1,165,688 (a) Also includes commercial card lending-related commitments primarily in CB and CIB. (b) The industry rankings presented in the table as of December 31, 2020, are based on the industry rankings of the corresponding exposures at December 31, 2021, not actual rankings of such exposures at December 31, 2020. (c) Individuals and Individual Entities predominantly consists of Global Private Bank clients within AWM and includes exposure to personal investment companies and personal and testamentary trusts. (d) In addition to the credit risk exposure to states and municipal governments (both U.S. and non-U.S.) at December 31, 2021 and 2020, noted above, the Firm held: $7.1 billion and $7.2 billion, respectively, of trading assets; $15.9 billion and $20.4 billion, respectively, of AFS securities; and $14.0 billion and $12.8 billion , respectively, of HTM securities, issued by U.S. state and municipal governments. Refer to Note 2 and Note 10 for further information. (e) All other includes: SPEs and Private education and civic organizations, representing approximately 94% and 6%, respectively, at December 31, 2021 and 92% and 8%, respectively, at December 31, 2020 . Refer to Note 14 for more information on exposures to SPEs. (f) Receivables from customers reflect held-for-investment margin loans to brokerage clients in CIB, CCB and AWM that are collateralized by assets maintained in the clients’ brokerage accounts (e.g., cash on deposit, liquid and readily marketable debt or equity securities). Because of this collateralization, no allowance for credit losses is generally held against these receivables. To manage its credit risk the Firm establishes margin requirements and monitors the required margin levels on an ongoing basis, and requires clients to deposit additional cash or other collateral, or to reduce positions, when appropriate. These receivables are reported within accrued interest and accounts receivable on the Firm’s Consolidated balance sheets. (g) Excludes cash placed with banks of $729.6 billion and $516.9 billion, at December 31, 2021 and 2020, respectively, which is predominantly placed with various central banks, primarily Federal Reserve Banks. (h) Credit exposure is net of risk participations and excludes the benefit of credit derivatives used in credit portfolio management activities held against derivative receivables or loans and liquid securities and other cash collateral held against derivative receivables. (i) At December 31, 2021 and 2020, included $5.4 billion and $19.2 billion of loans in Business Banking under the PPP, respectively. PPP loans are guaranteed by the SBA. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs, classify as nonaccrual nor record an allowance for loan losses on these loans. (j) Represents lending-related financial instruments. (k) Prior-period amounts have been revised to conform with the current presentation.

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative instruments Derivative contracts derive their value from underlying asset prices, indices, reference rates, other inputs or a combination of these factors and may expose counterparties to risks and rewards of an underlying asset or liability without having to initially invest in, own or exchange the asset or liability. JPMorgan Chase makes markets in derivatives for clients and also uses derivatives to hedge or manage its own risk exposures. Predominantly all of the Firm’s derivatives are entered into for market-making or risk management purposes. Market-making derivatives The majority of the Firm’s derivatives are entered into for market-making purposes. Clients use derivatives to mitigate or modify interest rate, credit, foreign exchange, equity and commodity risks. The Firm actively manages the risks from its exposure to these derivatives by entering into other derivative contracts or by purchasing or selling other financial instruments that partially or fully offset the exposure from client derivatives. Risk management derivatives The Firm manages certain market and credit risk exposures using derivative instruments, including derivatives in hedge accounting relationships and other derivatives that are used to manage risks associated with specified assets and liabilities. The Firm generally uses interest rate derivatives to manage the risk associated with changes in interest rates. Fixed-rate assets and liabilities appreciate or depreciate in market value as interest rates change. Similarly, interest income and expense increase or decrease as a result of variable-rate assets and liabilities resetting to current market rates, and as a result of the repayment and subsequent origination or issuance of fixed-rate assets and liabilities at current market rates. Gains and losses on the derivative instruments related to these assets and liabilities are expected to substantially offset this variability. Foreign currency derivatives are used to manage the foreign exchange risk associated with certain foreign currency–denominated (i.e., non-U.S. dollar) assets and liabilities and forecasted transactions, as well as the Firm’s net investments in certain non-U.S. subsidiaries or branches whose functional currencies are not the U.S. dollar. As a result of fluctuations in foreign currencies, the U.S. dollar–equivalent values of the foreign currency–denominated assets and liabilities or the forecasted revenues or expenses increase or decrease. Gains or losses on the derivative instruments related to these foreign currency–denominated assets or liabilities, or forecasted transactions, are expected to substantially offset this variability. Commodities derivatives are used to manage the price risk of certain commodities inventories. Gains or losses on these derivative instruments are expected to substantially offset the depreciation or appreciation of the related inventory. Credit derivatives are used to manage the counterparty credit risk associated with loans and lending-related commitments. Credit derivatives compensate the purchaser when the entity referenced in the contract experiences a credit event, such as bankruptcy or a failure to pay an obligation when due. Credit derivatives primarily consist of CDS. Refer to the Credit derivatives section on pages 207-210 of this Note for a further discussion of credit derivatives. Refer to the risk management derivatives gains and losses table on page 207 of this Note, and the hedge accounting gains and losses tables on pages 204-206 of this Note for more information about risk management derivatives. Derivative counterparties and settlement types The Firm enters into OTC derivatives, which are negotiated and settled bilaterally with the derivative counterparty. The Firm also enters into, as principal, certain ETD such as futures and options, and OTC-cleared derivative contracts with CCPs. ETD contracts are generally standardized contracts traded on an exchange and cleared by the CCP, which is the Firm’s counterparty from the inception of the transactions. OTC-cleared derivatives are traded on a bilateral basis and then novated to the CCP for clearing. Derivative clearing services The Firm provides clearing services for clients in which the Firm acts as a clearing member at certain exchanges and clearing houses. The Firm does not reflect the clients’ derivative contracts in its Consolidated Financial Statements. Refer to Note 28 for further information on the Firm’s clearing services. Accounting for derivatives All free-standing derivatives that the Firm executes for its own account are required to be recorded on the Consolidated balance sheets at fair value. As permitted under U.S. GAAP, the Firm nets derivative assets and liabilities, and the related cash collateral receivables and payables, when a legally enforceable master netting agreement exists between the Firm and the derivative counterparty. Refer to Note 1 for further discussion of the offsetting of assets and liabilities. The accounting for changes in value of a derivative depends on whether or not the transaction has been designated and qualifies for hedge accounting. Derivatives that are not designated as hedges are reported and measured at fair value through earnings. The tabular disclosures on pages 200-207 of this Note provide additional information on the amount of, and reporting for, derivative assets, liabilities, gains and losses. Refer to Notes 2 and 3 for a further discussion of derivatives embedded in structured notes. Derivatives designated as hedges The Firm applies hedge accounting to certain derivatives executed for risk management purposes – generally interest rate, foreign exchange and commodity derivatives. However, JPMorgan Chase does not seek to apply hedge accounting to all of the derivatives involved in the Firm’s risk management activities. For example, the Firm does not apply hedge accounting to purchased CDS used to manage the credit risk of loans and lending-related commitments, because of the difficulties in qualifying such contracts as hedges. For the same reason, the Firm does not apply hedge accounting to certain interest rate, foreign exchange, and commodity derivatives used for risk management purposes. To qualify for hedge accounting, a derivative must be highly effective at reducing the risk associated with the exposure being hedged. In addition, for a derivative to be designated as a hedge, the risk management objective and strategy must be documented. Hedge documentation must identify the derivative hedging instrument, the asset or liability or forecasted transaction and type of risk to be hedged, and how the effectiveness of the derivative is assessed prospectively and retrospectively. To assess effectiveness, the Firm uses statistical methods such as regression analysis, nonstatistical methods such as dollar-value comparisons of the change in the fair value of the derivative to the change in the fair value or cash flows of the hedged item, and qualitative comparisons of critical terms and the evaluation of any changes in those terms. The extent to which a derivative has been, and is expected to continue to be, highly effective at offsetting changes in the fair value or cash flows of the hedged item must be assessed and documented at least quarterly. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued. There are three types of hedge accounting designations: fair value hedges, cash flow hedges and net investment hedges. JPMorgan Chase uses fair value hedges primarily to hedge fixed-rate long-term debt, AFS securities and certain commodities inventories. For qualifying fair value hedges, the changes in the fair value of the derivative, and in the value of the hedged item for the risk being hedged, are recognized in earnings. Certain amounts excluded from the assessment of effectiveness are recorded in OCI and recognized in earnings over the life of the derivative. If the hedge relationship is terminated, then the adjustment to the hedged item continues to be reported as part of the basis of the hedged item, and for benchmark interest rate hedges, is amortized to earnings as a yield adjustment. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item – primarily net interest income and principal transactions revenue. JPMorgan Chase uses cash flow hedges primarily to hedge the exposure to variability in forecasted cash flows from floating-rate assets and liabilities and foreign currency–denominated revenue and expense. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in OCI and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item – primarily noninterest revenue, net interest income and compensation expense. If the hedge relationship is terminated, then the change in value of the derivative recorded in AOCI is recognized in earnings when the cash flows that were hedged affect earnings. For hedge relationships that are discontinued because a forecasted transaction is expected to not occur according to the original hedge forecast, any related derivative values recorded in AOCI are immediately recognized in earnings. JPMorgan Chase uses net investment hedges to protect the value of the Firm’s net investments in certain non-U.S. subsidiaries or branches whose functional currencies are not the U.S. dollar. For qualifying net investment hedges, changes in the fair value of the derivatives due to changes in spot foreign exchange rates are recorded in OCI as translation adjustments. Amounts excluded from the assessment of effectiveness are recorded directly in earnings. The following table outlines the Firm’s primary uses of derivatives and the related hedge accounting designation or disclosure category. Type of Derivative Use of Derivative Designation and disclosure Affected segment or unit Page reference Manage specifically identified risk exposures in qualifying hedge accounting relationships: • Interest rate Hedge fixed rate assets and liabilities Fair value hedge Corporate 204-205 • Interest rate Hedge floating-rate assets and liabilities Cash flow hedge Corporate 206 • Foreign exchange Hedge foreign currency-denominated assets and liabilities Fair value hedge Corporate 204-205 • Foreign exchange Hedge foreign currency-denominated forecasted revenue and expense Cash flow hedge Corporate 206 • Foreign exchange Hedge the value of the Firm’s investments in non-U.S. dollar functional currency entities Net investment hedge Corporate 206 • Commodity Hedge commodity inventory Fair value hedge CIB, AWM 204-205 Manage specifically identified risk exposures not designated in qualifying hedge accounting relationships: • Interest rate Manage the risk associated with mortgage commitments, warehouse loans and MSRs Specified risk management CCB 207 • Credit Manage the credit risk associated with wholesale lending exposures Specified risk management CIB 207 • Interest rate and foreign exchange Manage the risk associated with certain other specified assets and liabilities Specified risk management Corporate 207 Market-making derivatives and other activities: • Various Market-making and related risk management Market-making and other CIB 207 • Various Other derivatives Market-making and other CIB, AWM, Corporate 207 Notional amount of derivative contracts The following table summarizes the notional amount of free-standing derivative contracts outstanding as of December 31, 2021 and 2020. Notional amounts (b) December 31, (in billions) 2021 2020 Interest rate contracts Swaps $ 24,075 $ 20,990 (c) Futures and forwards 2,520 3,057 Written options 3,018 3,375 Purchased options 3,188 3,675 Total interest rate contracts 32,801 31,097 Credit derivatives (a) 1,053 1,197 (c) Foreign exchange contracts Cross-currency swaps 4,112 3,924 Spot, futures and forwards 7,679 6,871 Written options 741 830 Purchased options 727 825 Total foreign exchange contracts 13,259 12,450 Equity contracts Swaps 612 448 Futures and forwards 139 140 Written options 654 668 (c) Purchased options 598 610 (c) Total equity contracts 2,003 1,866 Commodity contracts Swaps 185 138 Spot, futures and forwards 188 198 Written options 135 124 Purchased options 111 105 Total commodity contracts 619 565 Total derivative notional amounts $ 49,735 $ 47,175 (a) Refer to the Credit derivatives discussion on pages 207-210 for more information on volumes and types of credit derivative contracts. (b) Represents the sum of gross long and gross short third-party notional derivative contracts. (c) Prior-period amounts have been revised to conform with the current presentation. Impact of derivatives on the Consolidated balance sheets The following table summarizes information on derivative receivables and payables (before and after netting adjustments) that are reflected on the Firm’s Consolidated balance sheets as of December 31, 2021 and 2020, by accounting designation (e.g., whether the derivatives were designated in qualifying hedge accounting relationships or not) and contract type. Free-standing derivative receivables and payables (a) Gross derivative receivables Gross derivative payables December 31, 2021 Not designated as hedges Designated as hedges Total derivative receivables Net derivative receivables (b) Not designated as hedges Designated as hedges Total derivative payables Net derivative payables (b) Trading assets and liabilities Interest rate $ 270,562 $ 23 $ 270,585 $ 21,974 $ 240,731 $ — $ 240,731 $ 8,194 Credit 9,839 — 9,839 1,031 10,912 — 10,912 880 Foreign exchange 169,186 393 169,579 12,625 174,622 1,124 175,746 14,097 Equity 68,631 — 68,631 9,981 79,727 — 79,727 17,233 Commodity 21,233 5,420 26,653 11,470 20,837 7,091 27,928 9,712 Total fair value of trading assets and liabilities $ 539,451 $ 5,836 $ 545,287 $ 57,081 $ 526,829 $ 8,215 $ 535,044 $ 50,116 Gross derivative receivables Gross derivative payables December 31, 2020 Not designated as hedges Designated as hedges Total derivative receivables Net derivative receivables (b) Not designated as hedges Designated as hedges Total derivative payables Net derivative payables (b) Trading assets and liabilities Interest rate $ 390,817 (c) $ 831 $ 391,648 $ 35,725 $ 353,987 (c) $ — $ 353,987 $ 13,012 Credit 13,345 (c) — 13,345 680 14,832 (c) — 14,832 1,995 Foreign exchange 205,359 901 206,260 15,781 214,229 1,697 215,926 21,433 Equity 70,612 (c) — 70,612 16,487 (c) 81,413 — 81,413 25,898 Commodity 20,579 924 21,503 6,771 20,834 1,895 22,729 8,285 Total fair value of trading assets and liabilities $ 700,712 $ 2,656 $ 703,368 $ 75,444 $ 685,295 $ 3,592 $ 688,887 $ 70,623 (a) Balances exclude structured notes for which the fair value option has been elected. Refer to Note 3 for further information. (b) As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral receivables and payables when a legally enforceable master netting agreement exists. (c) Prior-period amounts have been revised to conform with the current presentation. Derivatives netting The following tables present, as of December 31, 2021 and 2020, gross and net derivative receivables and payables by contract and settlement type. Derivative receivables and payables, as well as the related cash collateral from the same counterparty, have been netted on the Consolidated balance sheets where the Firm has obtained an appropriate legal opinion with respect to the master netting agreement. Where such a legal opinion has not been either sought or obtained, amounts are not eligible for netting on the Consolidated balance sheets, and those derivative receivables and payables are shown separately in the tables below. In addition to the cash collateral received and transferred that is presented on a net basis with derivative receivables and payables, the Firm receives and transfers additional collateral (financial instruments and cash). These amounts mitigate counterparty credit risk associated with the Firm’s derivative instruments, but are not eligible for net presentation: • collateral that consists of liquid securities and other cash collateral held at third-party custodians, which are shown separately as " Collateral not nettable on the Consolidated balance sheets " in the tables below, up to the fair value exposure amount. For the purpose of this disclosure, the definition of liquid securities is consistent with the definition of high quality liquid assets as defined in the LCR rule; • the amount of collateral held or transferred that exceeds the fair value exposure at the individual counterparty level, as of the date presented, which is excluded from the tables below; and • collateral held or transferred that relates to derivative receivables or payables where an appropriate legal opinion has not been either sought or obtained with respect to the master netting agreement, which is excluded from the tables below. 2021 2020 December 31, (in millions) Gross derivative receivables Amounts netted on the Consolidated balance sheets Net derivative receivables Gross derivative receivables Amounts netted on the Consolidated balance sheets Net U.S. GAAP nettable derivative receivables Interest rate contracts: OTC $ 251,953 $ (234,283) $ 17,670 $ 367,214 (e) $ (337,609) (e) $ 29,605 OTC–cleared 14,144 (13,839) 305 18,340 (17,919) 421 Exchange-traded (a) 498 (489) 9 554 (395) 159 Total interest rate contracts 266,595 (248,611) 17,984 386,108 (355,923) 30,185 Credit contracts: OTC 8,035 (7,177) 858 8,894 (e) (8,356) (e) 538 OTC–cleared 1,671 (1,631) 40 4,326 (4,309) 17 Total credit contracts 9,706 (8,808) 898 13,220 (12,665) 555 Foreign exchange contracts: OTC 166,185 (156,251) 9,934 201,349 (189,655) 11,694 OTC–cleared 789 (703) 86 834 (819) 15 Exchange-traded (a) 6 — 6 35 (5) 30 Total foreign exchange contracts 166,980 (156,954) 10,026 202,218 (190,479) 11,739 Equity contracts: OTC 25,704 (23,977) 1,727 29,844 (e) (27,374) 2,470 Exchange-traded (a) 36,095 (34,673) 1,422 28,294 (26,751) 1,543 Total equity contracts 61,799 (58,650) 3,149 58,138 (54,125) 4,013 Commodity contracts: OTC 15,063 (6,868) 8,195 10,924 (7,901) 3,023 OTC–cleared 49 (49) — 20 (20) — Exchange-traded (a) 8,279 (8,266) 13 6,833 (6,811) 22 Total commodity contracts 23,391 (15,183) 8,208 17,777 (14,732) 3,045 Derivative receivables with appropriate legal opinion 528,471 (488,206) 40,265 (d) 677,461 (627,924) 49,537 (d) Derivative receivables where an appropriate legal opinion has not been either sought or obtained 16,816 16,816 25,907 25,907 Total derivative receivables recognized on the Consolidated balance sheets $ 545,287 $ 57,081 $ 703,368 $ 75,444 Collateral not nettable on the Consolidated balance sheets (b)(c) (10,102) (14,806) Net amounts $ 46,979 $ 60,638 2021 2020 December 31, (in millions) Gross derivative payables Amounts netted on the Consolidated balance sheets Net derivative payables Gross derivative payables Amounts netted on the Consolidated balance sheets Net U.S. GAAP nettable derivative payables Interest rate contracts: OTC $ 223,576 $ (216,757) $ 6,819 $ 332,214 (e) $ (321,140) (e) $ 11,074 OTC–cleared 15,695 (15,492) 203 19,710 (19,494) 216 Exchange-traded (a) 292 (288) 4 358 (341) 17 Total interest rate contracts 239,563 (232,537) 7,026 352,282 (340,975) 11,307 Credit contracts: OTC 9,021 (8,421) 600 10,311 (e) (8,781) (e) 1,530 OTC–cleared 1,679 (1,611) 68 4,075 (4,056) 19 Total credit contracts 10,700 (10,032) 668 14,386 (12,837) 1,549 Foreign exchange contracts: OTC 171,610 (160,946) 10,664 210,803 (193,672) 17,131 OTC–cleared 706 (703) 3 836 (819) 17 Exchange-traded (a) 7 — 7 34 (2) 32 Total foreign exchange contracts 172,323 (161,649) 10,674 211,673 (194,493) 17,180 Equity contracts: OTC 31,379 (27,830) 3,549 35,330 (28,763) 6,567 Exchange-traded (a) 40,621 (34,664) 5,957 34,491 (26,752) 7,739 Total equity contracts 72,000 (62,494) 9,506 69,821 (55,515) 14,306 Commodity contracts: OTC 14,874 (9,667) 5,207 10,365 (7,544) 2,821 OTC–cleared 73 (73) — 32 (32) — Exchange-traded (a) 8,954 (8,476) 478 7,391 (6,868) 523 Total commodity contracts 23,901 (18,216) 5,685 17,788 (14,444) 3,344 Derivative payables with appropriate legal opinion 518,487 (484,928) 33,559 (d) 665,950 (618,264) 47,686 (d) Derivative payables where an appropriate legal opinion has not been either sought or obtained 16,557 16,557 22,937 22,937 Total derivative payables recognized on the Consolidated balance sheets $ 535,044 $ 50,116 $ 688,887 $ 70,623 Collateral not nettable on the Consolidated balance sheets (b)(c) (5,872) (11,964) Net amounts $ 44,244 $ 58,659 (a) Exchange-traded derivative balances that relate to futures contracts are settled daily. (b) Includes liquid securities and other cash collateral held at third-party custodians related to derivative instruments where an appropriate legal opinion has been obtained. For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. (c) Derivative collateral relates only to OTC and OTC-cleared derivative instruments. (d) Net derivatives receivable included cash collateral netted of $67.6 billion and $88.0 billion at December 31, 2021 and 2020, respectively. Net derivatives payable included cash collateral netted of $64.3 billion and $78.4 billion at December 31, 2021 and 2020, respectively. Derivative cash collateral relates to OTC and OTC-cleared derivative instruments. (e) Prior-period amounts have been revised to conform with the current presentation. Liquidity risk and credit-related contingent features In addition to the specific market risks introduced by each derivative contract type, derivatives expose JPMorgan Chase to credit risk — the risk that derivative counterparties may fail to meet their payment obligations under the derivative contracts and the collateral, if any, held by the Firm proves to be of insufficient value to cover the payment obligation. It is the policy of JPMorgan Chase to actively pursue, where possible, the use of legally enforceable master netting arrangements and collateral agreements to mitigate derivative counterparty credit risk inherent in derivative receivables. While derivative receivables expose the Firm to credit risk, derivative payables expose the Firm to liquidity risk, as the derivative contracts typically require the Firm to post cash or securities collateral with counterparties as the fair value of the contracts moves in the counterparties’ favor or upon specified downgrades in the Firm’s and its subsidiaries’ respective credit ratings. Certain derivative contracts also provide for termination of the contract, generally upon a downgrade of either the Firm or the counterparty, at the fair value of the derivative contracts. The following table shows the aggregate fair value of net derivative payables related to OTC and OTC-cleared derivatives that contain contingent collateral or termination features that may be triggered upon a ratings downgrade, and the associated collateral the Firm has posted in the normal course of business, at December 31, 2021 and 2020. OTC and OTC-cleared derivative payables containing downgrade triggers December 31, (in millions) 2021 2020 Aggregate fair value of net derivative payables $ 20,114 $ 26,945 (a) Collateral posted 19,402 26,289 (a) Prior-period amount has been revised to conform with the current presentation. The following table shows the impact of a single-notch and two-notch downgrade of the long-term issuer ratings of JPMorgan Chase & Co. and its subsidiaries, predominantly JPMorgan Chase Bank, N.A., at December 31, 2021 and 2020, related to OTC and OTC-cleared derivative contracts with contingent collateral or termination features that may be triggered upon a ratings downgrade. Derivatives contracts generally require additional collateral to be posted or terminations to be triggered when the predefined rating threshold is breached. A downgrade by a single rating agency that does not result in a rating lower than a preexisting corresponding rating provided by another major rating agency will generally not result in additional collateral (except in certain instances in which additional initial margin may be required upon a ratings downgrade), nor in termination payment requirements. The liquidity impact in the table is calculated based upon a downgrade below the lowest current rating of the rating agencies referred to in the derivative contract. Liquidity impact of downgrade triggers on OTC and OTC-cleared derivatives 2021 2020 December 31, (in millions) Single-notch downgrade Two-notch downgrade Single-notch downgrade Two-notch downgrade Amount of additional collateral to be posted upon downgrade (a) $ 219 $ 1,577 $ 119 $ 1,243 Amount required to settle contracts with termination triggers upon downgrade (b) 98 787 153 1,682 (c) (a) Includes the additional collateral to be posted for initial margin. (b) Amounts represent fair values of derivative payables, and do not reflect collateral posted. (c) Prior-period amount has been revised to conform with the current presentation. Derivatives executed in contemplation of a sale of the underlying financial asset In certain instances the Firm enters into transactions in which it transfers financial assets but maintains the economic exposure to the transferred assets by entering into a derivative with the same counterparty in contemplation of the initial transfer. The Firm generally accounts for such transfers as collateralized financing transactions as described in Note 11, but in limited circumstances they may qualify to be accounted for as a sale and a derivative under U.S. GAAP. The amount of such transfers accounted for as a sale where the associated derivative was outstanding was not material at both December 31, 2021 and 2020. Impact of derivatives on the Consolidated statements of income The following tables provide information related to gains and losses recorded on derivatives based on their hedge accounting designation or purpose. Fair value hedge gains and losses The following tables present derivative instruments, by contract type, used in fair value hedge accounting relationships, as well as pre-tax gains/(losses) recorded on such derivatives and the related hedged items for the years ended December 31, 2021, 2020 and 2019, respectively. The Firm includes gains/(losses) on the hedging derivative in the same line item in the Consolidated statements of income as the related hedged item. Gains/(losses) recorded in income Income statement impact of (e) OCI impact Year ended December 31, 2021 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ (4,323) $ 6,363 $ 2,040 $ — $ 2,159 $ — Foreign exchange (c) (1,317) 1,349 32 (286) 32 (26) Commodity (d) (9,609) 9,710 101 — 72 — Total $ (15,249) $ 17,422 $ 2,173 $ (286) $ 2,263 $ (26) Gains/(losses) recorded in income Income statement impact of excluded components (e) OCI impact Year ended December 31, 2020 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ 2,962 $ (1,889) $ 1,073 $ — $ 1,093 $ — Foreign exchange (c) 793 (619) 174 (457) 174 25 Commodity (d) (2,507) 2,650 143 — 137 — Total $ 1,248 $ 142 $ 1,390 $ (457) $ 1,404 $ 25 Gains/(losses) recorded in income Income statement impact of excluded components (e) OCI impact Year ended December 31, 2019 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ 3,204 $ (2,373) $ 831 $ — $ 828 $ — Foreign exchange (c) 154 328 482 (866) 482 39 Commodity (d) (77) 148 71 — 63 — Total $ 3,281 $ (1,897) $ 1,384 $ (866) $ 1,373 $ 39 (a) Primarily consists of hedges of the benchmark (e.g., London Interbank Offered Rate (“LIBOR”), Secured Overnight Financing Rate (“SOFR”)) interest rate risk of fixed-rate long-term debt and AFS securities. Gains and losses were recorded in net interest income. (b) Excludes the amortization expense associated with the inception hedge accounting adjustment applied to the hedged item. This expense is recorded in net interest income and substantially offsets the income statement impact of the excluded components. Also excludes the accrual of interest on interest rate swaps and the related hedged items. (c) Primarily consists of hedges of the foreign currency risk of long-term debt and AFS securities for changes in spot foreign currency rates. Gains and losses related to the derivatives and the hedged items due to changes in foreign currency rates and the income statement impact of excluded components were recorded primarily in principal transactions revenue and net interest income. (d) Consists of overall fair value hedges of physical commodities inventories that are generally carried at the lower of cost or net realizable value (net realizable value approximates fair value). Gains and losses were recorded in principal transactions revenue. (e) The assessment of hedge effectiveness excludes certain components of the changes in fair values of the derivatives and hedged items such as forward points on foreign exchange forward contracts, time values and cross-currency basis spreads. Excluded components may impact earnings either through amortization of the initial amount over the life of the derivative or through fair value changes recognized in the current period. (f) Represents the change in value of amounts excluded from the assessment of effectiveness under the amortization approach, predominantly cross-currency basis spreads. The amount excluded at inception of the hedge is recognized in earnings over the life of the derivative. As of December 31, 2021 and 2020, the following amounts were recorded on the Consolidated balance sheets related to certain cumulative fair value hedge basis adjustments that are expected to reverse through the income statement in future periods as an adjustment to yield. Carrying amount of the hedged items (a)(b) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items: December 31, 2021 Active hedging relationships (d) Discontinued hedging relationships (d)(e) Total Assets Investment securities - AFS $ 65,746 (c) $ 417 $ 661 $ 1,078 Liabilities Long-term debt $ 195,642 $ (1,999) $ 8,834 $ 6,835 Beneficial interests issued by consolidated VIEs 749 — (1) (1) Carrying amount of the hedged items (a)(b) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items: December 31, 2020 Active hedging relationships (d) Discontinued hedging relationships (d)(e) Total Assets Investment securities - AFS $ 139,684 (c) $ 3,572 $ 847 $ 4,419 Liabilities Long-term debt $ 177,611 $ 3,194 $ 11,473 $ 14,667 Beneficial interests issued by consolidated VIEs 746 — (3) (3) (a) Excludes physical commodities with a carrying value of $25.7 billion and $11.5 billion at December 31, 2021 and 2020, respectively, to which the Firm applies fair value hedge accounting. As a result of the application of hedge accounting, these inventories are carried at fair value, thus recognizing unrealized gains and losses in current periods. Since the Firm exits these positions at fair value, there is no incremental impact to net income in future periods. (b) Excludes hedged items where only foreign currency risk is the designated hedged risk, as basis adjustments related to foreign currency hedges will not reverse through the income statement in future periods. At December 31, 2021 and 2020, the carrying amount excluded for AFS securities is $14.0 billion and $14.5 billion, respectively, and for long-term debt is $10.8 billion and $6.6 billion, respectively. (c) Carrying amount represents the amortized cost, net of allowance if applicable. Refer to Note 10 for additional information. (d) Positive amounts related to assets represent cumulative fair value hedge basis adjustments that will reduce net interest income in future periods. Positive (negative) amounts related to liabilities represent cumulative fair value hedge basis adjustments that will increase (reduce) net interest in

Noninterest Revenue and Noninte

Noninterest Revenue and Noninterest Expense	12 Months Ended
	Dec. 31, 2021
Noninterest Income (Expense) [Abstract]
Noninterest Revenue and Noninterest Expense	Noninterest revenue and noninterest expense Noninterest revenue The Firm records noninterest revenue from certain contracts with customers in investment banking fees, deposit-related fees, asset management, administration, and commissions, and components of card income. The related contracts are often terminable on demand and the Firm has no remaining obligation to deliver future services. For arrangements with a fixed term, the Firm may commit to deliver services in the future. Revenue associated with these remaining performance obligations typically depends on the occurrence of future events or underlying asset values, and is not recognized until the outcome of those events or values are known. Investment banking fees This revenue category includes debt and equity underwriting and advisory fees. As an underwriter, the Firm helps clients raise capital via public offering and private placement of various types of debt and equity instruments. Underwriting fees are primarily based on the issuance price and quantity of the underlying instruments, and are recognized as revenue typically upon execution of the client’s transaction. The Firm also manages and syndicates loan arrangements. Credit arrangement and syndication fees, included within debt underwriting fees, are recorded as revenue after satisfying certain retention, timing and yield criteria. The Firm also provides advisory services, by assisting its clients with mergers and acquisitions, divestitures, restructuring and other complex transactions. Advisory fees are recognized as revenue typically upon execution of the client’s transaction. The following table presents the components of investment banking fees. Year ended December 31, 2021 2020 2019 Underwriting Equity $ 3,969 $ 2,759 $ 1,648 Debt 4,853 4,362 3,513 Total underwriting 8,822 7,121 5,161 Advisory 4,394 2,365 2,340 Total investment banking fees $ 13,216 $ 9,486 $ 7,501 Investment banking fees are earned primarily by CIB. Refer to Note 32 for segment results. Principal transactions Principal transactions revenue is driven by many factors, including: • the bid-offer spread, which is the difference between the price at which a market participant is willing and able to sell an instrument to the Firm and the price at which another market participant is willing and able to buy it from the Firm, and vice versa; and • realized and unrealized gains and losses on financial instruments and commodities transactions, including those accounted for under the fair value option, primarily used in client-driven market-making activities, and on private equity investments. – Realized gains and losses result from the sale of instruments, closing out or termination of transactions, or interim cash payments. – Unrealized gains and losses result from changes in valuation. In connection with its client-driven market-making activities, the Firm transacts in debt and equity instruments, derivatives and commodities, including physical commodities inventories and financial instruments that reference commodities. Principal transactions revenue also includes realized and unrealized gains and losses related to: • derivatives designated in qualifying hedge accounting relationships, primarily fair value hedges of commodity and foreign exchange risk; • derivatives used for specific risk management purposes, primarily to mitigate credit risk and foreign exchange risk. Refer to Note 5 for further information on the income statement classification of gains and losses from derivatives activities. In the financial commodity markets, the Firm transacts in OTC derivatives (e.g., swaps, forwards, options) and ETD that reference a wide range of underlying commodities. In the physical commodity markets, the Firm primarily purchases and sells precious and base metals and may hold other commodities inventories under financing and other arrangements with clients. The following table presents all realized and unrealized gains and losses recorded in principal transactions revenue. This table excludes interest income and interest expense on trading assets and liabilities, which are an integral part of the overall performance of the Firm’s client-driven market-making activities in CIB and fund deployment activities in Treasury and CIO. Refer to Note 7 for further information on interest income and interest expense. Trading revenue is presented primarily by instrument type. The Firm’s client-driven market-making businesses generally utilize a variety of instrument types in connection with their market-making and related risk-management activities; accordingly, the trading revenue presented in the table below is not representative of the total revenue of any individual LOB. Year ended December 31, 2021 2020 2019 Trading revenue by instrument type Interest rate (a) $ 1,646 $ 2,575 $ 2,739 Credit (b) 2,691 2,753 1,628 Foreign exchange 2,787 4,253 3,179 Equity 7,773 6,171 5,589 Commodity 1,428 2,088 1,133 Total trading revenue 16,325 17,840 14,268 Private equity gains/(losses) (21) 181 (250) Principal transactions $ 16,304 $ 18,021 $ 14,018 (a) Includes the impact of changes in funding valuation adjustments on derivatives. (b) Includes the impact of changes in credit valuation adjustments on derivatives, net of the associated hedging activities. Principal transactions revenue is earned primarily by CIB. Refer to Note 32 for segment results. Lending- and deposit-related fees Lending-related fees include fees earned from loan commitments, standby letters of credit, financial guarantees, and other loan-servicing activities. Deposit-related fees include fees earned from providing overdraft and other deposit account services, and from performing cash management activities. Lending- and deposit-related fees in this revenue category are recognized over the period in which the related service is provided. The following table presents the components of lending- and deposit-related fees. Year ended December 31, (in millions) 2021 2020 2019 Lending-related fees $ 1,472 $ 1,271 $ 1,184 Deposit-related fees 5,560 5,240 5,442 Total lending- and deposit-related fees $ 7,032 $ 6,511 $ 6,626 Lending- and deposit-related fees are earned by CCB, CIB, CB, and AWM. Refer to Note 32 for segment results. Asset management, administration and commissions This revenue category includes fees from investment management and related services, custody, brokerage services and other products. The Firm manages assets on behalf of its clients, including investors in Firm-sponsored funds and owners of separately managed investment accounts. Management fees are typically based on the value of assets under management and are collected and recognized at the end of each period over which the management services are provided and the value of the managed assets is known. The Firm also receives performance-based management fees, which are earned based on exceeding certain benchmarks or other performance targets and are accrued and recognized when the probability of reversal is remote, typically at the end of the related billing period. The Firm has contractual arrangements with third parties to provide distribution and other services in connection with its asset management activities. Amounts paid to these third-party service providers are generally recorded in professional and outside services expense. The following table presents the components of Firmwide asset management, administration and commissions. Year ended December 31, 2021 2020 2019 Asset management fees Investment management fees (a) $ 14,027 $ 11,694 $ 10,865 All other asset management fees (b) 378 338 315 Total asset management fees 14,405 12,032 11,180 Total administration fees (c) 2,554 2,249 2,197 Commissions and other fees Brokerage commissions (d) 3,046 2,959 2,439 All other commissions and fees 1,024 937 1,092 Total commissions and fees 4,070 3,896 3,531 Total asset management, administration and commissions $ 21,029 $ 18,177 $ 16,908 (a) Represents fees earned from managing assets on behalf of the Firm’s clients, including investors in Firm-sponsored funds and owners of separately managed investment accounts. (b) Represents fees for services that are ancillary to investment management services, such as commissions earned on the sales or distribution of mutual funds to clients. These fees are recorded as revenue at the time the service is rendered or, in the case of certain distribution fees based on the underlying fund’s asset value and/or investor redemption, recorded over time as the investor remains in the fund or upon investor redemption. (c) Predominantly includes fees for custody, securities lending, funds services and securities clearance. These fees are recorded as revenue over the period in which the related service is provided. (d) Represents commissions earned when the Firm acts as a broker, by facilitating its clients’ purchases and sales of securities and other financial instruments. Brokerage commissions are collected and recognized as revenue upon occurrence of the client transaction. The Firm reports certain costs paid to third-party clearing houses and exchanges net against commission revenue. Asset management, administration and commissions are earned primarily by AWM, CIB and CCB. Refer to Note 32 for segment results. Mortgage fees and related income This revenue category reflects CCB’s Home Lending production and net mortgage servicing revenue. Production revenue includes fees and income recognized as earned on mortgage loans originated with the intent to sell, and the impact of risk management activities associated with the mortgage pipeline and warehouse loans. Production revenue also includes gains and losses on sales and lower of cost or fair value adjustments on mortgage loans held-for-sale (excluding certain repurchased loans insured by U.S. government agencies), and changes in the fair value of financial instruments measured under the fair value option. Net mortgage servicing revenue includes operating revenue earned from servicing third-party mortgage loans, which is recognized over the period in which the service is provided; changes in the fair value of MSRs; the impact of risk management activities associated with MSRs; and gains and losses on securitization of excess mortgage servicing. Net mortgage servicing revenue also includes gains and losses on sales and lower of cost or fair value adjustments of certain repurchased loans insured by U.S. government agencies. Refer to Note 15 for further information on risk management activities and MSRs. Net interest income from mortgage loans is recorded in interest income. Card income This revenue category includes interchange and other income from credit and debit card transactions; and fees earned from processing card transactions for merchants, both of which are recognized when purchases are made by a cardholder and presented net of certain transaction-related costs. Card income also includes account origination costs and annual fees, which are deferred and recognized on a straight-line basis over a 12-month period. Certain credit card products offer the cardholder the ability to earn points based on account activity, which the cardholder can choose to redeem for cash and non-cash rewards. The cost to the Firm related to these proprietary rewards programs varies based on multiple factors including the terms and conditions of the rewards programs, cardholder activity, cardholder reward redemption rates and cardholder reward selections. The Firm maintains a liability for its obligations under its rewards programs and reports the current-period cost as a reduction of card income. Credit card revenue sharing agreements The Firm has contractual agreements with numerous co-brand partners that grant the Firm exclusive rights to issue co-branded credit card products and market them to the customers of such partners. These partners endorse the co-brand credit card programs and provide their customer or member lists to the Firm. The partners may also conduct marketing activities and provide rewards redeemable under their own loyalty programs that the Firm will grant to co-brand credit cardholders based on account activity. The terms of these agreements generally range from five The Firm typically makes payments to the co-brand credit card partners based on the cost of partners’ marketing activities and loyalty program rewards provided to credit cardholders, new account originations and sales volumes. Payments to partners based on marketing efforts undertaken by the partners are expensed by the Firm as incurred and reported as marketing expense. Payments for partner loyalty program rewards are reported as a reduction of card income when incurred. Payments to partners based on new credit card account originations are accounted for as direct loan origination costs and are deferred and recognized as a reduction of card income on a straight-line basis over a 12-month period. Payments to partners based on sales volumes are reported as a reduction of card income when the related interchange income is earned. The following table presents the components of card income: Year ended December 31, 2021 2020 2019 Interchange and merchant processing income $ 23,592 $ 18,563 $ 20,370 Reward costs and partner payments (17,868) (13,637) (14,540) Other card income (a) (622) (491) (754) Total card income $ 5,102 $ 4,435 $ 5,076 (a) Predominantly represents the amortization of account origination costs and annual fees, which are deferred and recognized on a straight-line basis over a 12-month period. Card income is earned primarily by CCB, CIB and CB. Refer to Note 32 for segment results. Refer to Note 18 for information on operating lease income included within other income . Noninterest expense Other expense Other expense on the Firm’s Consolidated statements of income included the following: Year ended December 31, 2021 2020 2019 Legal expense $ 426 $ 1,115 $ 239

Interest Income and Interest Ex

Interest Income and Interest Expense	12 Months Ended
	Dec. 31, 2021
Interest Income (Expense), Net [Abstract]
Interest Income and Interest Expense	Interest income and Interest expense Interest income and interest expense are recorded in the Consolidated statements of income and classified based on the nature of the underlying asset or liability. The following table presents the components of interest income and interest expense: Year ended December 31, 2021 2020 2019 Interest income Loans (a) $ 41,537 $ 43,758 $ 51,855 Taxable securities 6,460 7,843 7,962 Non-taxable securities (b) 1,063 1,184 1,329 Total investment securities (a) 7,523 9,027 9,291 Trading assets - debt instruments 6,825 7,832 9,141 Federal funds sold and securities purchased under resale agreements 958 2,436 6,146 Securities borrowed (c) (385) (302) 1,574 Deposits with banks 512 749 3,887 All other interest-earning assets (d) 894 1,023 2,146 Total interest income $ 57,864 $ 64,523 $ 84,040 Interest expense Interest bearing deposits $ 531 $ 2,357 $ 8,957 Federal funds purchased and securities loaned or sold under repurchase agreements 274 1,058 4,630 Short-term borrowings (e) 126 372 1,248 Trading liabilities - debt and all other interest-bearing liabilities (c)(f) 257 195 2,585 Long-term debt 4,282 5,764 8,807 Beneficial interest issued by consolidated VIEs 83 214 568 Total interest expense $ 5,553 $ 9,960 $ 26,795 Net interest income $ 52,311 $ 54,563 $ 57,245 Provision for credit losses (9,256) 17,480 5,585 Net interest income after provision for credit losses $ 61,567 $ 37,083 $ 51,660 (a) Includes the amortization/accretion of unearned income (e.g., purchase premiums/discounts and net deferred fees/costs). (b) Represents securities that are tax-exempt for U.S. federal income tax purposes. (c) Negative interest income is related to the impact of current interest rates combined with the fees paid on client-driven securities borrowed balances. The negative interest expense related to prime brokerage customer payables is recognized in interest expense and reported within trading liabilities - debt and all other interest-bearing liabilities. (d) Includes interest earned on brokerage-related held-for-investment customer receivables, which are classified in accrued interest and accounts receivable, and all other interest-earning assets, which are classified in other assets on the Consolidated balance sheets. (e) Includes commercial paper. (f) All other interest-bearing liabilities includes interest expense on brokerage-related customer payables.

Pension and Other Postretiremen

Pension and Other Postretirement Employee Benefit Plans	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Pension and Other Postretirement Employee Benefit Plans	Pension and other postretirement employee benefit plans The Firm has various defined benefit pension plans and OPEB plans that provide benefits to its employees in the U.S. and certain non-U.S. locations. Substantially all the defined benefit pension plans are closed to new participants. The principal defined benefit pension plan in the U.S., which covered substantially all U.S. employees, was closed to new participants and frozen for existing participants on January 1, 2020, (and January 1, 2019 for new hires on or after December 2, 2017). Interest credits continue to accrue to participants’ accounts based on their accumulated balances. The Firm maintains funded and unfunded postretirement benefit plans that provide medical and life insurance for certain eligible employees and retirees as well as their dependents covered under these programs. None of these plans have a material impact on the Firm’s Consolidated Financial Statements. The Firm also provides a qualified defined contribution plan in the U.S. and maintains other similar arrangements in certain non-U.S. locations. The most significant of these plans is the JPMorgan Chase 401(k) Savings Plan (“the 401(k) Savings Plan”), which covers substantially all U.S. employees. Employees can contribute to the 401(k) Savings Plan on a pretax and/or Roth 401(k) after-tax basis. The Firm makes an annual matching contribution as well as an annual profit-sharing contribution to the 401(k) Savings Plan on behalf of eligible participants. The following table presents the pretax benefit obligations, plan assets, the net funded status, and the amounts recorded in AOCI on the Consolidated balance sheets for the Firm’s defined benefit pension and OPEB plans. As of or for the year ended December 31, Defined benefit (in millions) 2021 2020 Projected benefit obligations $ (18,046) $ (19,137) Fair value of plan assets 25,692 25,417 Net funded status 7,646 6,280 Accumulated other comprehensive income/(loss) (453) (1,586) The weighted-average discount rate used to value the benefit obligations as of December 31, 2021 and 2020, was 2.54% and 2.17%, respectively. Gains and losses Gains or losses resulting from changes in the benefit obligation and the fair value of plan assets are recorded in OCI. Amortization of net gains or losses are recognized as part of the net periodic benefit cost over subsequent periods, if, as of the beginning of the year, the net gain or loss exceeds 10% of the greater of the projected benefit obligation or the fair value of the plan assets. Amortization is generally over the average expected remaining lifetime of plan participants, given the frozen status of most plans. For the years ended December 31, 2021 and 2020, the net gain was predominantly attributable to a market-driven increase in the fair value of plan assets and changes in the discount rate. The following table presents the components of net periodic benefit costs reported in the Consolidated statements of income for the Firm’s defined benefit pension, defined contribution and OPEB plans, and in other comprehensive income for the defined benefit pension and OPEB plans. Pension and OPEB plans Year ended December 31, (in millions) 2021 2020 2019 Total net periodic defined benefit plan cost/(credit) $ (201) $ (285) $ 144 Total defined contribution plans 1,333 1,332 952 Total pension and OPEB cost included in noninterest expense $ 1,132 $ 1,047 $ 1,096 Total recognized in other comprehensive income $ (1,129) $ (214) $ (1,157) The following table presents the weighted-average actuarial assumptions used to determine the net periodic benefit costs for the defined benefit pension and OPEB plans. Defined benefit pension and OPEB plans Year ended December 31, 2021 2020 2019 Discount rate 2.17 % 2.93 % 3.89 % Expected long-term rate of return on plan assets 2.97 % 3.91 % 5.08 % Plan assumptions The Firm’s expected long-term rate of return is a blended weighted average, by asset allocation of the projected long-term returns for the various asset classes, taking into consideration local market conditions and the specific allocation of plan assets. Returns on asset classes are developed using a forward-looking approach and are not strictly based on historical returns, with consideration given to current market conditions and the portfolio mix of each plan. The discount rates used in determining the benefit obligations are generally provided by the Firm’s actuaries, with the Firm’s principal defined benefit pension plan using a rate that was selected by reference to the yields on portfolios of bonds with maturity dates and coupons that closely match each of the plan’s projected cash flows. Investment strategy and asset allocation The assets of the Firm’s defined benefit pension plans are held in various trusts and are invested in well-diversified portfolios of equity and fixed income securities, cash and cash equivalents, and alternative investments. The Firm regularly reviews the asset allocations and asset managers, as well as other factors that could impact the portfolios, which are rebalanced when deemed necessary. The approved asset allocation ranges by asset class for the Firm’s principal defined benefit plan are 42-100% debt securities, 0-40% equity securities, 0-3% real estate, and 0-12% alternatives as of December 31, 2021. As of December 31, 2021, assets held by the Firm’s defined benefit pension and OPEB plans do not include securities issued by JPMorgan Chase or its affiliates, except through indirect exposures through investments in exchange traded funds, mutual funds and collective investment funds managed by third-parties. The defined benefit pension and OPEB plans hold investments that are sponsored or managed by affiliates of JPMorgan Chase in the amount of $2.5 billion and $2.7 billion, as of December 31, 2021 and 2020, respectively. Fair value measurement of the plans’ assets and liabilities Refer to Note 2 for information on fair value measurements, including descriptions of level 1, 2, and 3 of the fair value hierarchy and the valuation methods employed by the Firm. Pension plan assets and liabilities measured at fair value Defined benefit pension and OPEB plans 2021 2020 December 31 , (in millions) Level 1 (a) Level 2 (b) Level 3 (c) Total fair value Level 1 (a) Level 2 (b) Level 3 (c) Total fair value Assets measured at fair value classified in fair value hierarchy $ 6,541 $ 12,315 $ 3,172 $ 22,028 $ 7,031 $ 12,384 $ 2,952 $ 22,367 Assets measured at fair value using NAV as practical expedient not classified in fair value hierarchy 3,960 3,651 Net defined benefit pension plan payables not classified in fair value hierarchy (296) (601) Total fair value of plan assets $ 25,692 $ 25,417 (a) Consists largely of equity securities. (b) Consists largely of corporate debt securities. (c) Consists of corporate-owned life insurance policies and participating annuity contracts. Changes in level 3 fair value measurements using significant unobservable inputs Investments classified in level 3 of the fair value hierarchy increased $220 million in 2021 from $3.0 billion to $3.2 billion, predominantly due to $332 million in unrealized gains, partially offset by $94 million in settlements. In 2020, there was an increase of $263 million, from $2.7 billion to $3.0 billion consisting of $343 million in unrealized gains and $33 million of transfers into level 3, partially offset by $118 million in settlements. Estimated future benefit payments The following table presents benefit payments expected to be paid for the defined benefit pension and OPEB plans for the years indicated. Year ended December 31, Defined benefit pension and OPEB plans 2022 $ 1,124 2023 1,106 2024 1,082 2025 1,036 2026 1,016 Years 2027–2031 4,740

Employee Share-Based Incentives

Employee Share-Based Incentives	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Employee Share-Based Incentives	Employee share-based incentives Employee share-based awards In 2021, 2020 and 2019, JPMorgan Chase granted long-term share-based awards to certain employees under its LTIP, as amended and restated effective May 15, 2018, and subsequently amended effective May 18, 2021. Under the terms of the LTIP, as of December 31, 2021, 83 million shares of common stock were available for issuance through May 2025. The LTIP is the only active plan under which the Firm is currently granting share-based incentive awards. In the following discussion, the LTIP, plus prior Firm plans and plans assumed as the result of acquisitions, are referred to collectively as the “LTI Plans,” and such plans constitute the Firm’s share-based incentive plans. RSUs are awarded at no cost to the recipient upon their grant. Generally, RSUs are granted annually and vest at a rate of 50% after two years and 50% after three years and are converted into shares of common stock as of the vesting date. In addition, RSUs typically include full-career eligibility provisions, which allow employees to continue to vest upon voluntary termination based on age or service-related requirements, subject to post-employment and other restrictions. All RSU awards are subject to forfeiture until vested and contain clawback provisions that may result in cancellation under certain specified circumstances. Predominantly all RSUs entitle the recipient to receive cash payments equivalent to any dividends paid on the underlying common stock during the period the RSUs are outstanding. Performance share units (“PSUs”) are granted annually, and approved by the Firm’s Board of Directors, to members of the Firm’s Operating Committee under the variable compensation program. PSUs are subject to the Firm’s achievement of specified performance criteria over a three Once the PSUs and dividend equivalent share units have vested, the shares of common stock that are delivered, after applicable tax withholding, must be held for an additional two five eight Under the LTI Plans, stock appreciation rights (“SARs”) and stock options have generally been granted with an exercise price equal to the fair value of JPMorgan Chase’s common stock on the grant date. SARs and stock options generally expire ten years after the grant date. In 2021, the Firm awarded its Chairman and CEO and its President and Chief Operating Officer 1.5 million and 750,000 SARs, respectively. There were no material grants of SARs or stock options in 2020 and 2019. The Firm separately recognizes compensation expense for each tranche of each award, net of estimated forfeitures, as if it were a separate award with its own vesting date. Generally, for each tranche granted, compensation expense is recognized on a straight-line basis from the grant date until the vesting date of the respective tranche, provided that the employees will not become full-career eligible during the vesting period. For awards with full-career eligibility provisions and awards granted with no future substantive service requirement, the Firm accrues the estimated value of awards expected to be awarded to employees as of the grant date without giving consideration to the impact of post-employment restrictions. For each tranche granted to employees who will become full-career eligible during the vesting period, compensation expense is recognized on a straight-line basis from the grant date until the earlier of the employee’s full-career eligibility date or the vesting date of the respective tranche. The Firm’s policy for issuing shares upon settlement of employee share-based incentive awards is to issue either new shares of common stock or treasury shares. During 2021, 2020 and 2019, the Firm settled all of its employee share-based awards by issuing treasury shares. Refer to Note 23 for further information on the classification of share-based awards for purposes of calculating earnings per share. RSUs, PSUs, SARs and stock options activity Generally, compensation expense for RSUs and PSUs is measured based on the number of units granted multiplied by the stock price at the grant date, and for SARs and stock options, is measured at the grant date using the Black-Scholes valuation model. Compensation expense for these awards is recognized in net income as described previously. The following table summarizes JPMorgan Chase’s RSUs, PSUs, SARs and stock options activity for 2021. RSUs/PSUs SARs/Options Year ended December 31, 2021 Number of Weighted-average grant Number of awards Weighted-average exercise price Weighted-average remaining contractual life Aggregate intrinsic value (in thousands, except weighted-average data, and where otherwise stated) Outstanding, January 1 47,510 $ 112.85 3,124 $ 41.25 Granted 20,347 138.98 2,250 152.19 Exercised or vested (20,235) 107.26 (2,005) 39.08 Forfeited (2,217) 126.77 — — Canceled NA NA — — Outstanding, December 31 45,405 $ 126.32 3,369 $ 116.62 6.8 $ 141,872 Exercisable, December 31 NA NA 1,119 45.14 0.9 127,030 The total fair value of RSUs that vested during the years ended December 31, 2021, 2020 and 2019, was $2.9 billion, $2.8 billion and $2.9 billion, respectively. The total intrinsic value of options exercised during the years ended December 31, 2021, 2020 and 2019, was $232 million, $182 million and $503 million, respectively. Compensation expense The Firm recognized the following noncash compensation expense related to its various employee share-based incentive plans in its Consolidated statements of income. Year ended December 31, (in millions) 2021 2020 2019 Cost of prior grants of RSUs, PSUs, SARs and stock options that are amortized over their applicable vesting periods $ 1,161 $ 1,101 $ 1,141 Accrual of estimated costs of share-based awards to be granted in future periods, predominantly those to full-career eligible employees 1,768 1,350 1,115 Total noncash compensation expense related to employee share-based incentive plans $ 2,929 $ 2,451 $ 2,256 Tax benefits Income tax benefits (including tax benefits from dividends or d ividend equivalents) related to share-based incentive arrangements recognized in the Firm’s Consolidated statements of income for the years ended December 31, 2021, 2020 and 2019, were $957 million, $837 million and $895 million, respectively.

Investment Securities

Investment Securities	12 Months Ended
	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Investment Securities	Investment securities Investment securities consist of debt securities that are classified as AFS or HTM. Debt securities classified as trading assets are discussed in Note 2. Predominantly all of the Firm’s AFS and HTM securities are held by Treasury and CIO in connection with its asset-liability management activities. AFS securities are carried at fair value on the Consolidated balance sheets. Unrealized gains and losses, after any applicable hedge accounting adjustments or allowance for credit losses, are reported in AOCI. The specific identification method is used to determine realized gains and losses on AFS securities, which are included in investment securities gains/(losses) on the Consolidated statements of income. HTM securities, which the Firm has the intent and ability to hold until maturity, are carried at amortized cost, net of allowance for credit losses, on the Consolidated balance sheets. For both AFS and HTM securities, purchase discounts or premiums are generally amortized into interest income on a level-yield basis over the contractual life of the security. However, premiums on certain callable debt securities are amortized to the earliest call date. During the second quarter of 2021, the Firm transferred $104.5 billion of investment securities from AFS to HTM for capital management purposes. AOCI included pretax unrealized gains of $425 million on the securities at the date of transfer. Unrealized gains or losses at the date of transfer of these securities continue to be reported in AOCI and are amortized into interest income on a level-yield basis over the remaining life of the securities. This amortization will offset the effect on interest income of the amortization of the premium or discount resulting from the transfer recorded at fair value. Transfers of securities from AFS to HTM are non-cash transactions and are recorded at fair value. The amortized costs and estimated fair values of the investment securities portfolio were as follows for the dates indicated. 2021 2020 December 31, (in millions) Amortized cost (b)(c) Gross unrealized gains Gross unrealized losses Fair Amortized cost (b)(c) Gross unrealized gains Gross unrealized losses Fair Available-for-sale securities Mortgage-backed securities: U.S. GSEs and government agencies $ 72,800 $ 736 $ 993 $ 72,543 $ 110,979 $ 2,372 $ 50 $ 113,301 Residential: U.S. 2,128 38 2 2,164 6,246 224 3 6,467 Non-U.S. 3,882 25 1 3,906 3,751 20 5 3,766 Commercial 4,944 22 17 4,949 2,819 71 34 2,856 Total mortgage-backed securities 83,754 821 1,013 83,562 123,795 2,687 92 126,390 U.S. Treasury and government agencies 178,038 668 1,243 177,463 199,910 2,141 100 201,951 Obligations of U.S. states and municipalities 14,890 972 2 15,860 18,993 1,404 1 20,396 Non-U.S. government debt securities 16,163 92 46 16,209 22,587 354 13 22,928 Corporate debt securities 332 8 19 321 215 4 3 216 Asset-backed securities: Collateralized loan obligations 9,674 6 18 9,662 10,055 24 31 10,048 Other 5,403 47 2 5,448 6,174 91 16 6,249 Total available-for-sale securities 308,254 2,614 2,343 308,525 381,729 6,705 256 388,178 Held-to-maturity securities (a) Mortgage-backed securities: U.S. GSEs and government agencies 102,556 1,400 853 103,103 107,889 2,968 29 110,828 U.S. Residential 7,316 1 106 7,211 4,345 8 30 4,323 Commercial 3,730 11 54 3,687 2,602 77 — 2,679 Total mortgage-backed securities 113,602 1,412 1,013 114,001 114,836 3,053 59 117,830 U.S. Treasury and government agencies 185,204 169 2,103 183,270 53,184 50 — 53,234 Obligations of U.S. states and municipalities 13,985 453 44 14,394 12,751 519 — 13,270 Asset-backed securities: Collateralized loan obligations 48,869 75 22 48,922 21,050 90 2 21,138 Other 2,047 1 7 2,041 — — — — Total held-to-maturity securities 363,707 2,110 3,189 362,628 201,821 3,712 61 205,472 Total investment securities, net of allowance for credit losses $ 671,961 $ 4,724 $ 5,532 $ 671,153 $ 583,550 $ 10,417 $ 317 $ 593,650 (a) The Firm purchased $111.8 billion, $12.4 billion and $13.4 billion of HTM securities for the years ended December 31, 2021, 2020 and 2019, respectively. (b) The amortized cost of investment securities is reported net of allowance for credit losses of $42 million and $78 million at December 31, 2021 and 2020, respectively. (c) Excludes $1.9 billion and $2.1 billion of accrued interest receivables at December 31, 2021 and 2020, respectively, included in accrued interest and accounts receivables on the Consolidated balance sheets. The Firm generally does not recognize an allowance for credit losses on accrued interest receivables, consistent with its policy to write them off no later than 90 days past due by reversing interest income. The Firm did not reverse through interest income any accrued interest receivables for the years ended December 31, 2021 and 2020. At December 31, 2021 , the investment securities portfolio consisted of debt securities with an average credit rating of AA+ (based upon external ratings where available, and where not available, based primarily upon internal risk ratings). Risk ratings are used to identify the credit quality of securities and differentiate risk within the portfolio. The Firm’s internal risk ratings generally align with the qualitative characteristics (e.g., borrower capacity to meet financial commitments and vulnerability to changes in the economic environment) defined by S&P and Moody’s, however the quantitative characteristics (e.g., probability of default (“PD”) and loss given default (“LGD”)) may differ as they reflect internal historical experiences and assumptions. Risk ratings are assigned at acquisition, reviewed on a regular and ongoing basis by Credit Risk Management and adjusted as necessary over the life of the investment for updated information affecting the issuer’s ability to fulfill its obligations. AFS securities impairment The following tables present the fair value and gross unrealized losses by aging category for AFS securities at December 31, 2021 and 2020. The tables exclude U.S. Treasury and government agency securities and U.S. GSE and government agency MBS with unrealized losses of $2.2 billion and $150 million, at December 31, 2021 and 2020, respectively; changes in the value of these securities are generally driven by changes in interest rates rather than changes in their credit profile given the explicit or implicit guarantees provided by the U.S. government. Available-for-sale securities with gross unrealized losses Less than 12 months 12 months or more December 31, 2021 (in millions) Fair value Gross Fair value Gross Total fair value Total gross unrealized losses Available-for-sale securities Mortgage-backed securities: Residential: U.S. $ 303 $ 1 $ 45 $ 1 $ 348 $ 2 Non-U.S. 133 1 — — 133 1 Commercial 2,557 5 349 12 2,906 17 Total mortgage-backed securities 2,993 7 394 13 3,387 20 Obligations of U.S. states and municipalities 120 2 — — 120 2 Non-U.S. government debt securities 5,060 37 510 9 5,570 46 Corporate debt securities 166 1 46 18 212 19 Asset-backed securities: Collateralized loan obligations 8,110 18 208 — 8,318 18 Other 89 — 178 2 267 2 Total available-for-sale securities with gross unrealized losses $ 16,538 $ 65 $ 1,336 $ 42 $ 17,874 $ 107 Available-for-sale securities with gross unrealized losses Less than 12 months 12 months or more December 31, 2020 (in millions) Fair value Gross Fair value Gross Total fair value Total gross unrealized losses Available-for-sale securities Mortgage-backed securities: Residential: U.S. $ 562 $ 3 $ 32 $ — $ 594 $ 3 Non-U.S. 2,507 4 235 1 2,742 5 Commercial 699 18 124 16 823 34 Total mortgage-backed securities 3,768 25 391 17 4,159 42 Obligations of U.S. states and municipalities 49 1 — — 49 1 Non-U.S. government debt securities 2,709 9 968 4 3,677 13 Corporate debt securities 91 3 5 — 96 3 Asset-backed securities: Collateralized loan obligations 5,248 18 2,645 13 7,893 31 Other 268 1 685 15 953 16 Total available-for-sale securities with gross unrealized losses $ 12,133 $ 57 $ 4,694 $ 49 $ 16,827 $ 106 AFS securities are considered impaired if the fair value is less than the amortized cost. The Firm recognizes impairment losses in earnings if the Firm has the intent to sell the debt security, or if it is more likely than not that the Firm will be required to sell the debt security before recovery of its amortized cost. In these circumstances the impairment loss recognized in investment securities gains/(losses) is equal to the full difference between the amortized cost (net of allowance if applicable) and the fair value of the security. For impaired debt securities that the Firm has the intent and ability to hold, the securities are evaluated to determine if a credit loss exists. If it is determined that a credit loss exists, that loss is recognized as an allowance for credit losses through the provision for credit losses in the Consolidated Statements of Income, limited by the amount of impairment. Any impairment not due to credit losses is recorded in OCI. Factors considered in evaluating credit losses include adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a security; and payment structure of the security. When assessing securities issued in a securitization for credit losses, the Firm estimates cash flows considering relevant market and economic data, underlying loan-level data, and structural features of the securitization, such as subordination, excess spread, overcollateralization or other forms of credit enhancement, and compares the losses projected for the underlying collateral (“pool losses”) against the level of credit enhancement in the securitization structure to determine whether these features are sufficient to absorb the pool losses, or whether a credit loss exists. For beneficial interests in securitizations that are rated below “AA” at their acquisition, or that can be contractually prepaid or otherwise settled in such a way that the Firm would not recover substantially all of its recorded investment, the Firm evaluates impairment for credit losses when there is an adverse change in expected cash flows. HTM securities – credit risk Allowance for credit losses The allowance for credit losses represents expected credit losses over the remaining expected life of HTM securities. The allowance for credit losses on HTM obligations of U.S. states and municipalities and commercial mortgage-backed securities is calculated by applying statistical credit loss factors (estimated PD and LGD) to the amortized cost. The credit loss factors are derived using a weighted average of five internally developed eight-quarter macroeconomic scenarios, followed by a single year straight-line interpolation to revert to long run historical information for periods beyond the forecast period. Refer to Note 13 for further information on the eight-quarter macroeconomic forecast. The allowance for credit losses on HTM collateralized loan obligations and U.S. residential mortgage-backed securities is calculated as the difference between the amortized cost and the present value of the cash flows expected to be collected, discounted at the security’s effective interest rate. These cash flow estimates are developed based on expectations of underlying collateral performance derived using the eight-quarter macroeconomic forecast and the single year straight-line interpolation, as well as considering the structural features of the security. The application of different inputs and assumptions into the calculation of the allowance for credit losses is subject to significant management judgment, and emphasizing one input or assumption over another, or considering other inputs or assumptions, could affect the estimate of the allowance for credit losses on HTM securities. Credit quality indicator The primary credit quality indicator for HTM securities is the risk rating assigned to each security. At both December 31, 2021 and 2020, all HTM securities were rated investment grade and were current and accruing, with approximately 98% rated at least AA+. Allowance for credit losses on investment securities The allowance for credit losses on investment securities was $42 million and $78 million as of December 31, 2021 and 2020, respectively. The allowance for credit losses on investment securities as of December 31, 2020 included a $10 million cumulative-effect adjustment to retained earnings upon the adoption of CECL on January 1, 2020. Selected impacts of investment securities on the Consolidated statements of income Year ended December 31, 2021 2020 2019 Realized gains $ 595 $ 3,080 $ 650 Realized losses (940) (2,278) (392) Investment securities gains/(losses) $ (345) $ 802 $ 258 Provision for credit losses $ (36) $ 68 NA Effective January 1, 2020, the Firm adopted the CECL accounting guidance. Refer to Note 1 for further information. Contractual maturities and yields The following table presents the amortized cost and estimated fair value at December 31, 2021, of JPMorgan Chase’s investment securities portfolio by contractual maturity. By remaining maturity Due in one Due after one year through five years Due after five years through 10 years Due after 10 years (b) Total Available-for-sale securities Mortgage-backed securities Amortized cost $ 8 $ 3,771 $ 4,823 $ 75,155 $ 83,757 Fair value 8 3,783 5,094 74,677 83,562 Average yield (a) 0.52 % 1.53 % 1.75 % 2.25 % 2.19 % U.S. Treasury and government agencies Amortized cost $ 7,774 $ 146,817 $ 14,618 $ 8,829 $ 178,038 Fair value 7,802 146,050 14,554 9,057 177,463 Average yield (a) 1.01 % 0.55 % 0.61 % 0.54 % 0.57 % Obligations of U.S. states and municipalities Amortized cost $ 13 $ 142 $ 1,285 $ 13,450 $ 14,890 Fair value 13 146 1,346 14,355 15,860 Average yield (a) 4.06 % 4.38 % 4.84 % 4.89 % 4.88 % Non-U.S. government debt securities Amortized cost $ 7,211 $ 5,491 $ 3,461 $ — $ 16,163 Fair value 7,224 5,532 3,453 — 16,209 Average yield (a) 2.34 % 2.53 % 1.09 % — % 2.14 % Corporate debt securities Amortized cost $ — $ 301 $ 31 $ — $ 332 Fair value — 290 31 — 321 Average yield (a) — % 10.03 % 1.61 % — % 9.25 % Asset-backed securities Amortized cost $ 2,500 $ 799 $ 3,369 $ 8,409 $ 15,077 Fair value 2,500 800 3,372 8,438 15,110 Average yield (a) 1.35 % 1.88 % 1.25 % 1.28 % 1.32 % Total available-for-sale securities Amortized cost $ 17,506 $ 157,321 $ 27,587 $ 105,843 $ 308,257 Fair value 17,547 156,601 27,850 106,527 308,525 Average yield (a) 1.61 % 0.67 % 1.15 % 2.37 % 1.35 % Held-to-maturity securities Mortgage-backed securities Amortized cost $ — $ 1,322 $ 11,495 $ 100,791 $ 113,608 Fair value — 1,338 11,814 100,849 114,001 Average yield (a) — % 1.76 % 2.43 % 2.83 % 2.78 % U.S. Treasury and government agencies Amortized cost $ 25,706 $ 92,845 $ 66,653 $ — $ 185,204 Fair value 25,675 91,727 65,868 — 183,270 Average yield (a) 0.54 % 0.74 % 1.26 % — % 0.90 % Obligations of U.S. states and municipalities Amortized cost $ 35 $ 76 $ 1,192 $ 12,715 $ 14,018 Fair value 35 76 1,240 13,043 14,394 Average yield (a) 3.72 % 2.72 % 3.74 % 3.83 % 3.82 % Asset-backed securities Amortized cost $ — $ — $ 13,402 $ 37,514 $ 50,916 Fair value — — 13,449 37,514 50,963 Average yield (a) — % — % 1.18 % 1.30 % 1.27 % Total held-to-maturity securities Amortized cost $ 25,741 $ 94,243 $ 92,742 $ 151,020 $ 363,746 Fair value 25,710 93,141 92,371 151,406 362,628 Average yield (a) 0.54 % 0.76 % 1.43 % 2.53 % 1.65 % (a) Average yield is computed using the effective yield of each security owned at the end of the period, weighted based on the amortized cost of each security. The effective yield considers the contractual coupon, amortization of premiums and accretion of discounts, and the effect of related hedging derivatives. Taxable-equivalent amounts are used where applicable. The effective yield excludes unscheduled principal prepayments; and accordingly, actual maturities of securities may differ from their contractual or expected maturities as certain securities may be prepaid. However, for certain callable debt securities, the average yield is calculated to the earliest call date. (b) Substantially all of the Firm’s U.S. residential MBS and collateralized mortgage obligations are due in 10 years or more, based on contractual maturity. The estimated weighted-average life, which reflects anticipated future prepayments, is approximately 6 years for agency residential MBS, 4 years for agency residential collateralized mortgage obligations and 3 years for nonagency residential collateralized mortgage obligations.

Securities Financing Activities

Securities Financing Activities	12 Months Ended
	Dec. 31, 2021
Securities Financing Transactions Disclosures [Abstract]
Securities Financing Activities	Securities financing activities JPMorgan Chase enters into resale, repurchase, securities borrowed and securities loaned agreements (collectively, “securities financing agreements”) primarily to finance the Firm’s inventory positions, acquire securities to cover short sales, accommodate customers’ financing needs, settle other securities obligations and to deploy the Firm’s excess cash. Securities financing agreements are treated as collateralized financings on the Firm’s Consolidated balance sheets. Where appropriate under applicable accounting guidance, securities financing agreements with the same counterparty are reported on a net basis. Refer to Note 1 for further discussion of the offsetting of assets and liabilities. Fees received and paid in connection with securities financing agreements are recorded over the life of the agreement in interest income and interest expense on the Consolidated statements of income. The Firm has elected the fair value option for certain securities financing agreements. Refer to Note 3 for further information regarding the fair value option. The securities financing agreements for which the fair value option has been elected are reported within securities purchased under resale agreements, securities loaned or sold under repurchase agreements, and securities borrowed on the Consolidated balance sheets. Generally, for agreements carried at fair value, current-period interest accruals are recorded within interest income and interest expense, with changes in fair value reported in principal transactions revenue. However, for financial instruments containing embedded derivatives that would be separately accounted for in accordance with accounting guidance for hybrid instruments, all changes in fair value, including any interest elements, are reported in principal transactions revenue. Securities financing agreements not elected under the fair value option are measured at amortized cost. As a result of the Firm’s credit risk mitigation practices described below, the Firm did not hold any allowance for credit losses with respect to resale and securities borrowed arrangements as of December 31, 2021 and 2020. Credit risk mitigation practices Securities financing agreements expose the Firm primarily to credit and liquidity risk. To manage these risks, the Firm monitors the value of the underlying securities (predominantly high-quality securities collateral, including government-issued debt and U.S. GSEs and government agencies MBS) that it has received from or provided to its counterparties compared to the value of cash proceeds and exchanged collateral, and either requests additional collateral or returns securities or collateral when appropriate. Margin levels are initially established based upon the counterparty, the type of underlying securities, and the permissible collateral, and are monitored on an ongoing basis. In resale and securities borrowed agreements, the Firm is exposed to credit risk to the extent that the value of the securities received is less than initial cash principal advanced and any collateral amounts exchanged. In repurchase and securities loaned agreements, credit risk exposure arises to the extent that the value of underlying securities advanced exceeds the value of the initial cash principal received, and any collateral amounts exchanged. Additionally, the Firm typically enters into master netting agreements and other similar arrangements with its counterparties, which provide for the right to liquidate the underlying securities and any collateral amounts exchanged in the event of a counterparty default. It is also the Firm’s policy to take possession, where possible, of the securities underlying resale and securities borrowed agreements. Refer to Note 29 for further information regarding assets pledged and collateral received in securities financing agreements. The table below summarizes the gross and net amounts of the Firm’s securities financing agreements, as of December 31, 2021 and 2020. When the Firm has obtained an appropriate legal opinion with respect to a master netting agreement with a counterparty and where other relevant netting criteria under U.S. GAAP are met, the Firm nets, on the Consolidated balance sheets, the balances outstanding under its securities financing agreements with the same counterparty. In addition, the Firm exchanges securities and/or cash collateral with its counterparty to reduce the economic exposure with the counterparty, but such collateral is not eligible for net Consolidated balance sheet presentation. Where the Firm has obtained an appropriate legal opinion with respect to the counterparty master netting agreement, such collateral, along with securities financing balances that do not meet all these relevant netting criteria under U.S. GAAP, is presented in the table below as “Amounts not nettable on the Consolidated balance sheets,” and reduces the “Net amounts” presented. Where a legal opinion has not been either sought or obtained, the securities financing balances are presented gross in the “Net amounts” below. In transactions where the Firm is acting as the lender in a securities-for-securities lending agreement and receives securities that can be pledged or sold as collateral, the Firm recognizes the securities received at fair value within other assets and the obligation to return those securities within accounts payable and other liabilities on the Consolidated balance sheets. 2021 December 31, (in millions) Gross amounts Amounts netted on the Consolidated balance sheets Amounts presented on the Consolidated balance sheets Amounts not nettable on the Consolidated balance sheets (b) Net amounts (c) Assets Securities purchased under resale agreements $ 604,724 $ (343,093) $ 261,631 $ (245,588) $ 16,043 Securities borrowed 250,333 (44,262) 206,071 (154,599) 51,472 Liabilities Securities sold under repurchase agreements $ 532,899 $ (343,093) $ 189,806 $ (166,456) $ 23,350 Securities loaned and other (a) 52,610 (44,262) 8,348 (8,133) 215 2020 December 31, (in millions) Gross amounts Amounts netted on the Consolidated balance sheets Amounts presented on the Consolidated balance sheets Amounts not nettable on the Consolidated balance sheets (b) Net amounts (c) Assets Securities purchased under resale agreements $ 666,467 $ (370,183) $ 296,284 $ (273,206) $ 23,078 Securities borrowed 193,700 (33,065) 160,635 (115,219) 45,416 Liabilities Securities sold under repurchase agreements $ 578,060 $ (370,183) $ 207,877 $ (191,980) $ 15,897 Securities loaned and other (a) 41,366 (33,065) 8,301 (8,257) 44 (a) Includes securities-for-securities lending agreements of $5.6 billion and $3.4 billion at December 31, 2021 and 2020, respectively, accounted for at fair value, where the Firm is acting as lender. (b) In some cases, collateral exchanged with a counterparty exceeds the net asset or liability balance with that counterparty. In such cases, the amounts reported in this column are limited to the related net asset or liability with that counterparty. (c) Includes securities financing agreements that provide collateral rights, but where an appropriate legal opinion with respect to the master netting agreement has not been either sought or obtained. At December 31, 2021 and 2020, included $13.9 billion and $17.0 billion, respectively, of securities purchased under resale agreements; $46.4 billion and $42.1 billion, respectively, of securities borrowed; $21.6 billion and $14.5 billion, respectively, of securities sold under repurchase agreements; and $198 million and $8 million, respectively, of securities loaned and other. The tables below present as of December 31, 2021 and 2020 the types of financial assets pledged in securities financing agreements and the remaining contractual maturity of the securities financing agreements. Gross liability balance 2021 2020 December 31, (in millions) Securities sold under repurchase agreements Securities loaned and other Securities sold under repurchase agreements Securities loaned and other Mortgage-backed securities: U.S. GSEs and government agencies $ 37,046 $ — $ 56,744 $ — Residential - nonagency 1,508 — 1,016 — Commercial - nonagency 1,463 — 855 — U.S. Treasury, GSEs and government agencies 241,578 358 315,834 143 Obligations of U.S. states and municipalities 1,916 7 1,525 2 Non-U.S. government debt 174,971 1,572 157,563 1,730 Corporate debt securities 38,180 1,619 22,849 1,864 Asset-backed securities 1,211 — 694 — Equity securities 35,026 49,054 20,980 37,627 Total $ 532,899 $ 52,610 $ 578,060 $ 41,366 Remaining contractual maturity of the agreements Overnight and continuous Greater than 2021 (in millions) Up to 30 days 30 – 90 days Total Total securities sold under repurchase agreements $ 195,035 $ 231,171 $ 47,201 $ 59,492 $ 532,899 Total securities loaned and other 50,034 1,701 — 875 52,610 Remaining contractual maturity of the agreements Overnight and continuous Greater than 2020 (in millions) Up to 30 days 30 – 90 days Total Total securities sold under repurchase agreements $ 238,667 $ 230,980 $ 70,777 $ 37,636 $ 578,060 Total securities loaned and other 37,887 1,647 500 1,332 41,366 Transfers not qualifying for sale accounting

Loans

Loans	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Loans	Loans Loan accounting framework The accounting for a loan depends on management’s strategy for the loan. The Firm accounts for loans based on the following categories: • Originated or purchased loans held-for-investment (i.e., “retained”) • Loans held-for-sale • Loans at fair value The following provides a detailed accounting discussion of the Firm’s loans by category: Loans held-for-investment Originated or purchased loans held-for-investment, including PCD, are recorded at amortized cost, reflecting the principal amount outstanding, net of the following: unamortized deferred loan fees, costs, premiums or discounts; charge-offs; collection of cash; and foreign exchange. Credit card loans also include billed finance charges and fees. Interest income Interest income on performing loans held-for-investment is accrued and recognized as interest income at the contractual rate of interest. Purchase price discounts or premiums, as well as net deferred loan fees or costs, are amortized into interest income over the contractual life of the loan as an adjustment of yield. The Firm classifies accrued interest on loans, including accrued but unbilled interest on credit card loans, in accrued interest and accounts receivables on the Consolidated balance sheets. For credit card loans, accrued interest once billed is then recognized in the loan balances, with the related allowance recorded in the allowance for credit losses. Changes in the allowance for credit losses on accrued interest on credit card loans are recognized in the provision for credit losses and charge-offs are recognized by reversing interest income. Expected losses related to accrued interest on certain performing, modified loans to borrowers impacted by COVID-19 are considered in the Firm’s allowance for loan losses. For other loans, the Firm generally does not recognize an allowance for credit losses on accrued interest receivables, consistent with its policy to write them off no later than 90 days past due by reversing interest income. Nonaccrual loans Nonaccrual loans are those on which the accrual of interest has been suspended. Loans (other than credit card loans and certain consumer loans insured by U.S. government agencies) are placed on nonaccrual status and considered nonperforming when full payment of principal and interest is not expected, regardless of delinquency status, or when principal and interest has been in default for a period of 90 days or more, unless the loan is both well-secured and in the process of collection. A loan is determined to be past due when the minimum payment is not received from the borrower by the contractually specified due date or for certain loans (e.g., residential real estate loans), when a monthly payment is due and unpaid for 30 days or more. Finally, collateral-dependent loans are typically maintained on nonaccrual status. On the date a loan is placed on nonaccrual status, all interest accrued but not collected is reversed against interest income. In addition, the amortization of deferred amounts is suspended. Interest income on nonaccrual loans may be recognized as cash interest payments are received (i.e., on a cash basis) if the recorded loan balance is deemed fully collectible; however, if there is doubt regarding the ultimate collectibility of the recorded loan balance, all interest cash receipts are applied to reduce the carrying value of the loan (the cost recovery method). For consumer loans, application of this policy typically results in the Firm recognizing interest income on nonaccrual consumer loans on a cash basis. A loan may be returned to accrual status when repayment is reasonably assured and there has been demonstrated performance under the terms of the loan or, if applicable, the terms of the restructured loan. As permitted by regulatory guidance, credit card loans are generally exempt from being placed on nonaccrual status; accordingly, interest and fees related to credit card loans continue to accrue until the loan is charged off or paid in full. Allowance for loan losses The allowance for loan losses represents the estimated expected credit losses in the held-for-investment loan portfolio at the balance sheet date and is recognized on the balance sheet as a contra asset, which brings the amortized cost to the net carrying value. Changes in the allowance for loan losses are recorded in the provision for credit losses on the Firm’s Consolidated statements of income. Refer to Note 13 for further information on the Firm’s accounting policies for the allowance for loan losses. Charge-offs Consumer loans are generally charged off or charged down to the lower of the amortized cost or the net realizable value of the underlying collateral (i.e., fair value less estimated costs to sell), with an offset to the allowance for loan losses, upon reaching specified stages of delinquency in accordance with standards established by the FFIEC. Residential real estate loans, unmodified credit card loans and scored business banking loans are generally charged off no later than 180 days past due. Scored auto and modified credit card loans are charged off no later than 120 days past due. Certain consumer loans are charged off or charged down to their net realizable value earlier than the FFIEC charge-off standards in certain circumstances as follows: • Loans modified in a TDR that are determined to be collateral-dependent. • Loans to borrowers who have experienced an event that suggests a loss is either known or highly certain are subject to accelerated charge-off standards (e.g., residential real estate and auto loans are charged off or charged down within 60 days of receiving notification of a bankruptcy filing). • Auto loans upon repossession of the automobile. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs on the government-guaranteed portion of loans. Wholesale loans are charged off when it is highly certain that a loss has been realized. The determination of whether to recognize a charge-off includes many factors, including the prioritization of the Firm’s claim in bankruptcy, expectations of the workout/restructuring of the loan and valuation of the borrower’s equity or the loan collateral. When a loan is charged down to the lower of its amortized cost or the estimated net realizable value of the underlying collateral, the determination of the fair value of the collateral depends on the type of collateral (e.g., securities, real estate). In cases where the collateral is in the form of liquid securities, the fair value is based on quoted market prices or broker quotes. For illiquid securities or other financial assets, the fair value of the collateral is generally estimated using a discounted cash flow model. For residential real estate loans, collateral values are based upon external valuation sources. When it becomes likely that a borrower is either unable or unwilling to pay, the Firm utilizes a broker’s price opinion, appraisal and/or an automated valuation model of the home based on an exterior-only valuation (“exterior opinions”), which is then updated at least every 12 months, or more frequently depending on various market factors. As soon as practicable after the Firm receives the property in satisfaction of a debt (e.g., by taking legal title or physical possession), the Firm generally obtains an appraisal based on an inspection that includes the interior of the home (“interior appraisals”). Exterior opinions and interior appraisals are discounted based upon the Firm’s experience with actual liquidation values as compared with the estimated values provided by exterior opinions and interior appraisals, considering state-specific factors. For commercial real estate loans, collateral values are generally based on appraisals from internal and external valuation sources. Collateral values are typically updated every six result in obtaining appraisal updates or broker price opinions at more frequent intervals. Loans held-for-sale Loans held-for-sale are measured at the lower of cost or fair value, with valuation changes recorded in noninterest revenue. For consumer loans, the valuation is performed on a portfolio basis. For wholesale loans, the valuation is performed on an individual loan basis. Interest income on loans held-for-sale is accrued and recognized based on the contractual rate of interest. Loan origination fees or costs and purchase price discounts or premiums are deferred in a contra loan account until the related loan is sold. The deferred fees or costs and discounts or premiums are an adjustment to the basis of the loan and therefore are included in the periodic determination of the lower of cost or fair value adjustments and/or the gain or loss recognized at the time of sale. Because these loans are recognized at the lower of cost or fair value, the Firm’s allowance for loan losses and charge-off policies do not apply to these loans. However, loans held-for-sale are subject to the nonaccrual policies described above. Loans at fair value Loans for which the fair value option has been elected are measured at fair value, with changes in fair value recorded in noninterest revenue. Interest income on these loans is accrued and recognized based on the contractual rate of interest. Changes in fair value are recognized in noninterest revenue. Loan origination fees are recognized upfront in noninterest revenue. Loan origination costs are recognized in the associated expense category as incurred. Because these loans are recognized at fair value, the Firm’s allowance for loan losses and charge-off policies do not apply to these loans. However, loans at fair value are subject to the nonaccrual policies described above. Refer to Note 3 for further information on the Firm’s elections of fair value accounting under the fair value option. Refer to Note 2 and Note 3 for further information on loans carried at fair value and classified as trading assets. Loan classification changes Loans in the held-for-investment portfolio that management decides to sell are transferred to the held-for-sale portfolio at the lower of cost or fair value on the date of transfer. Credit-related losses are charged against the allowance for loan losses; non-credit related losses such as those due to changes in interest rates or foreign currency exchange rates are recognized in noninterest revenue. In the event that management decides to retain a loan in the held-for-sale portfolio, the loan is transferred to the held-for-investment portfolio at amortized cost on the date of transfer. These loans are subsequently assessed for impairment based on the Firm’s allowance methodology. Refer to Note 13 for a further discussion of the methodologies used in establishing the Firm’s allowance for loan losses. Loan modifications The Firm seeks to modify certain loans in conjunction with its loss mitigation activities. Through the modification, JPMorgan Chase grants one or more concessions to a borrower who is experiencing financial difficulty in order to minimize the Firm’s economic loss and avoid foreclosure or repossession of the collateral, and to ultimately maximize payments received by the Firm from the borrower. The concessions granted vary by program and by borrower-specific characteristics, and may include interest rate reductions, term extensions, payment delays, principal forgiveness, or the acceptance of equity or other assets in lieu of payments. Such modifications are accounted for and reported as TDRs. Loans with short-term and other insignificant modifications that are not considered concessions are not TDRs. Loans, except for credit card loans, modified in a TDR are generally placed on nonaccrual status, although in many cases such loans were already on nonaccrual status prior to modification. These loans may be returned to performing status (the accrual of interest is resumed) if the following criteria are met: (i) the borrower has performed under the modified terms for a minimum of six months and/or six payments, and (ii) the Firm has an expectation that repayment of the modified loan is reasonably assured based on, for example, the borrower’s debt capacity and level of future earnings, collateral values, LTV ratios, and other current market considerations. In certain limited and well-defined circumstances in which the loan is current at the modification date, such loans are not placed on nonaccrual status at the time of modification. Loans modified in TDRs are generally measured for impairment using the Firm’s established asset-specific allowance methodology, which considers the expected re-default rates for the modified loans. A loan modified in a TDR generally remains subject to the asset-specific component of the allowance throughout its remaining life, regardless of whether the loan is performing and has been returned to accrual status. Refer to Note 13 for further discussion of the methodology used to estimate the Firm’s asset-specific allowance. The Firm granted various forms of assistance to customers and clients impacted by the COVID-19 pandemic, including payment deferrals and covenant modifications. The majority of the Firm’s COVID-19 related loan modifications have not been considered TDRs because: • they represent short-term or other insignificant modifications, whether under the Firm’s regular loan modification assessments or as permitted by regulatory guidance, or • the Firm elected to suspend TDR accounting guidance under the option provided by the CARES Act, as extended by the Consolidated Appropriations Act and which expired on January 1, 2022. To the extent that certain modifications did not meet any of the above criteria, the Firm accounted for them as TDRs. As permitted by regulatory guidance, the Firm did not place loans with deferrals granted due to COVID-19 on nonaccrual status where such loans were not otherwise reportable as nonaccrual. The Firm considered expected losses of principal and accrued interest associated with all COVID-19 related loan modifications in its allowance for credit losses. Assistance provided in response to the COVID-19 pandemic could delay the recognition of delinquencies, nonaccrual status, and net charge-offs for those customers who would have otherwise moved into past due or nonaccrual status. Foreclosed property The Firm acquires property from borrowers through loan restructurings, workouts, and foreclosures. Property acquired may include real property (e.g., residential real estate, land, and buildings) and commercial and personal property (e.g., automobiles, aircraft, railcars, and ships). The Firm recognizes foreclosed property upon receiving assets in satisfaction of a loan (e.g., by taking legal title or physical possession). For loans collateralized by real property, the Firm generally recognizes the asset received at foreclosure sale or upon the execution of a deed in lieu of foreclosure transaction with the borrower. Foreclosed assets are reported in other assets on the Consolidated balance sheets and initially recognized at fair value less estimated costs to sell. Each quarter the fair value of the acquired property is reviewed and adjusted, if necessary, to the lower of cost or fair value. Subsequent adjustments to fair value are charged/credited to noninterest revenue. Operating expense, such as real estate taxes and maintenance, are charged to other expense. Foreclosures have resumed after having been temporarily suspended in response to the COVID-19 pandemic. Loan portfolio The Firm’s loan portfolio is divided into three portfolio segments, which are the same segments used by the Firm to determine the allowance for loan losses: Consumer, excluding credit card; Credit card; and Wholesale. Within each portfolio segment the Firm monitors and assesses the credit risk in the following classes of loans, based on the risk characteristics of each loan class. Consumer, excluding credit card Credit card Wholesale (c)(d) • Residential real estate (a) • Auto and other (b) • Credit card loans • Secured by real estate • Commercial and industrial • Other (e) (a) Includes scored mortgage and home equity loans held in CCB and AWM, and scored mortgage loans held in CIB and Corporate. (b) Includes scored auto and business banking loans and overdrafts. (c) Includes loans held in CIB, CB, AWM, Corporate as well as risk-rated loans held in CCB, including business banking and auto dealer loans for which the wholesale methodology is applied when determining the allowance for loan losses. (d) The wholesale portfolio segment's classes align with loan classifications as defined by the bank regulatory agencies, based on the loan's collateral, purpose, and type of borrower. (e) Includes loans to financial institutions, states and political subdivisions, SPEs, nonprofits, personal investment companies and trusts, as well as loans to individuals and individual entities (predominantly Global Private Bank clients within AWM). Refer to Note 14 for more information on SPEs. The following tables summarize the Firm’s loan balances by portfolio segment. December 31, 2021 Consumer, excluding credit card Credit card Wholesale Total (a)(b) (in millions) Retained $ 295,556 $ 154,296 $ 560,354 $ 1,010,206 Held-for-sale 1,287 — 7,401 8,688 At fair value 26,463 — 32,357 58,820 Total $ 323,306 $ 154,296 $ 600,112 $ 1,077,714 December 31, 2020 Consumer, excluding credit card Credit card Wholesale Total (a)(b) (in millions) Retained $ 302,127 $ 143,432 $ 514,947 $ 960,506 Held-for-sale 1,305 784 5,784 7,873 At fair value 15,147 — 29,327 44,474 Total $ 318,579 $ 144,216 $ 550,058 $ 1,012,853 (a) Excludes $2.7 billion and $2.9 billion of accrued interest receivables at December 31, 2021 and 2020, respectively. The Firm wrote off accrued interest receivables of $56 million and $121 million for the years ended December 31, 2021 and 2020, respectively. (b) Loans (other than those for which the fair value option has been elected) are presented net of unamortized discounts and premiums and net deferred loan fees or costs. These amounts were not material as of December 31, 2021 and 2020. The following tables provide information about the carrying value of retained loans purchased, sold and reclassified to held-for-sale during the periods indicated. Loans that were reclassified to held-for-sale and sold in a subsequent period are excluded from the sales line of this table. 2021 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 515 (b)(c) $ — $ 1,122 $ 1,637 Sales 799 — 31,022 31,821 Retained loans reclassified to held-for-sale (a) 1,225 — 2,178 3,403 2020 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 3,474 (b)(c) $ — $ 1,159 $ 4,633 Sales 352 — 17,916 18,268 Retained loans reclassified to held-for-sale (a) 2,084 787 1,580 4,451 2019 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 1,282 (b)(c) $ — $ 1,291 $ 2,573 Sales 30,474 — 23,445 53,919 Retained loans reclassified to held-for-sale (a) 9,188 — 2,371 11,559 (a) Reclassifications of loans to held-for-sale are non-cash transactions. (b) Predominantly includes purchases of residential real estate loans, including the Firm’s voluntary repurchases of certain delinquent loans from loan pools as permitted by Government National Mortgage Association (“Ginnie Mae”) guidelines for the years ended December 31, 2021, 2020 and 2019. The Firm typically elects to repurchase these delinquent loans as it continues to service them and/or manage the foreclosure process in accordance with applicable requirements of Ginnie Mae, FHA, RHS, and/or VA. (c) Excludes purchases of retained loans of $25.8 billion, $16.3 billion and $16.6 billion for the years ended December 31, 2021, 2020 and 2019, respectively, which are predominantly sourced through the correspondent origination channel and underwritten in accordance with the Firm’s standards. The amount of purchases of retained loans at December 31, 2020 has been revised to conform with the current presentation. Gains and losses on sales of loans Consumer, excluding credit card loan portfolio Consumer loans, excluding credit card loans, consist primarily of scored residential mortgages, home equity loans and lines of credit, auto and business banking loans, with a focus on serving the prime consumer credit market. The portfolio also includes home equity loans secured by junior liens, prime mortgage loans with an interest-only payment period, and certain payment-option loans that may result in negative amortization. The following table provides information about retained consumer loans, excluding credit card, by class. December 31, (in millions) 2021 2020 Residential real estate $ 224,795 $ 225,302 Auto and other (a) 70,761 76,825 Total retained loans $ 295,556 $ 302,127 (a) At December 31, 2021 and 2020, included $5.4 billion and $19.2 billion of loans, respectively, in Business Banking under the PPP. Delinquency rates are the primary credit quality indicator for consumer loans. Loans that are more than 30 days past due provide an early warning of borrowers who may be experiencing financial difficulties and/or who may be unable or unwilling to repay the loan. As the loan continues to age, it becomes more clear whether the borrower is likely to be unable or unwilling to pay. In the case of residential real estate loans, late-stage delinquencies (greater than 150 days past due) are a strong indicator of loans that will ultimately result in a foreclosure or similar liquidation transaction. In addition to delinquency rates, other credit quality indicators for consumer loans vary based on the class of loan, as follows: • For residential real estate loans, the current estimated LTV ratio, or the combined LTV ratio in the case of junior lien loans, is an indicator of the potential loss severity in the event of default. Additionally, LTV or combined LTV ratios can provide insight into a borrower’s continued willingness to pay, as the delinquency rate of high-LTV loans tends to be greater than that for loans where the borrower has equity in the collateral. The geographic distribution of the loan collateral also provides insight as to the credit quality of the portfolio, as factors such as the regional economy, home price changes and specific events such as natural disasters, will affect credit quality. The borrower’s current or “refreshed” FICO score is a secondary credit quality indicator for certain loans, as FICO scores are an indication of the borrower’s credit payment history. Thus, a loan to a borrower with a low FICO score (less than 660) is considered to be of higher risk than a loan to a borrower with a higher FICO score. Further, a loan to a borrower with a high LTV ratio and a low FICO score is at greater risk of default than a loan to a borrower that has both a high LTV ratio and a high FICO score. • For scored auto and business banking loans, geographic distribution is an indicator of the credit performance of the portfolio. Similar to residential real estate loans, geographic distribution provides insights into the portfolio performance based on regional economic activity and events. Residential real estate The following tables provide information on delinquency, which is the primary credit quality indicator for retained residential real estate loans. (in millions, except ratios) December 31, 2021 Term loans by origination year (d) Revolving loans Total 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Loan delinquency (a)(b) Current $ 68,742 $ 48,334 $ 18,428 $ 7,929 $ 11,684 $ 49,147 $ 6,392 $ 11,807 $ 222,463 30–149 days past due 13 23 27 27 22 578 11 182 883 150 or more days past due — 11 21 25 33 1,069 6 284 1,449 Total retained loans $ 68,755 $ 48,368 $ 18,476 $ 7,981 $ 11,739 $ 50,794 $ 6,409 $ 12,273 $ 224,795 % of 30+ days past due to total retained loans (c) 0.02 % 0.07 % 0.26 % 0.65 % 0.47 % 3.18 % 0.27 % 3.80 % 1.02 % (in millions, except ratios) December 31, 2020 Term loans by origination year (d) Revolving loans Total 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Loan delinquency (a)(b) Current $ 56,576 (e) $ 31,820 $ 13,900 $ 20,410 $ 27,978 $ 49,218 (e) $ 7,902 (e) $ 15,260 (e) $ 223,064 30–149 days past due 9 25 20 22 29 674 21 245 1,045 150 or more days past due 3 14 10 18 18 844 22 264 1,193 Total retained loans $ 56,588 $ 31,859 $ 13,930 $ 20,450 $ 28,025 $ 50,736 $ 7,945 $ 15,769 $ 225,302 % of 30+ days past due to total retained loans (c) 0.02 % 0.12 % 0.22 % 0.20 % 0.17 % 2.91 % (e) 0.54 % (e) 3.23 % (e) 0.98 % (a) Individual delinquency classifications include mortgage loans insured by U.S. government agencies as follows: current included $35 million and $36 million; 30–149 days past due included $11 million and $16 million; and 150 or more days past due included $20 million and $24 million at December 31, 2021 and 2020, respectively. (b) At December 31, 2021 and 2020, loans under payment deferral programs offered in response to the COVID-19 pandemic which are still within their deferral period and performing according to their modified terms are generally not considered delinquent. (c) At December 31, 2021 and 2020, residential real estate loans excluded mortgage loans insured by U.S. government agencies of $31 million and $40 million, respectively, that are 30 or more days past due. These amounts have been excluded based upon the government guarantee. (d) Purchased loans are included in the year in which they were originated. (e) Prior-period amounts have been revised to conform with the current presentation. Approximately 37% of the total revolving loans are senior lien loans; the remaining balance are junior lien loans. The lien position the Firm holds is considered in the Firm’s allowance for credit losses. Revolving loans that have been converted to term loans have higher delinquency rates than those that are still within the revolving period. That is primarily because the fully-amortizing payment that is generally required for those products is higher than the minimum payment options available for revolving loans within the revolving period. Nonaccrual loans and other credit quality indicators The following table provides information on nonaccrual and other credit quality indicators for retained residential real estate loans. (in millions, except weighted-average data) December 31, 2021 December 31, 2020 Nonaccrual loans (a)(b)(c)(d) $ 4,759 $ 5,313 90 or more days past due and government guaranteed (e) 24 33 Current estimated LTV ratios (f)(g)(h)(i) Greater than 125% and refreshed FICO scores: Equal to or greater than 660 $ 2 $ 6 Less than 660 2 12 101% to 125% and refreshed FICO scores: Equal to or greater than 660 37 38 Less than 660 15 44 80% to 100% and refreshed FICO scores: Equal to or greater than 660 2,701 2,177 Less than 660 89 239 Less than 80% and refreshed FICO scores: Equal to or greater than 660 209,295 208,238 Less than 660 9,658 11,980 No FICO/LTV available 2,930 2,492 U.S. government-guaranteed 66 76 Total retained loans $ 224,795 $ 225,302 Weighted average LTV ratio (f)(j) 50 % 54 % Weighted average FICO (g)(j) 765 763 Geographic region (k) California $ 71,383 $ 73,444 New York 32,545 32,287 Florida 16,182 13,981 Texas 13,865 13,773 Illinois 11,565 13,130 Colorado 8,885 8,235 Washington 8,292 7,917 New Jersey 6,832 7,227 Massachusetts 6,105 5,784 Connecticut 5,242 5,024 All other (l) 43,899 44,500 Total retained loans $ 224,795 $ 225,302 (a) Includes collateral-dependent residential real estate loans that are charged down to the fair value of the underlying collateral less costs to sell. The Firm reports, in accordance with regulatory guidance, residential real estate loans that have been discharged under Chapter 7 bankruptcy and not reaffirmed by the borrower (“Chapter 7 loans”) as collateral-dependent nonaccrual TDRs, regardless of their delinquency status. At December 31, 2021, approximately 7% of Chapter 7 residential real estate loans were 30 days or more past due. (b) Generally, all consumer nonaccrual loans have an allowance. In accordance with regulatory guidance, certain nonaccrual loans that are considered collateral-dependent have been charged down to the lower of amortized cost or the fair value of their underlying collateral less costs to sell. If the value of the underlying collateral improves subsequent to the charge down, the related allowance may be negative. (c) Interest income on nonaccrual loans recognized on a cash basis was $172 million and $161 million for the years ended December 31, 2021 and 2020, respectively. (d) Generally excludes loans under payment deferral programs offered in response to the COVID-19 pandemic. Includes loans to customers that have exited COVID-19 payment related deferral programs and are 90 or more days past due, predominantly all of which were considered collateral-dependent at time of exit. (e) These balances are excluded from nonaccrual loans as the loans are guaranteed by U.S government agencies. Typically the principal balance of the loans is insured and interest is guaranteed at a specified reimbursement rate subject to meeting agreed-upon servicing guidelines. At December 31, 2021 and 2020, these balances were no longer accruing interest based on the agreed-upon servicing guidelines. There were no loans that were not guaranteed by U.S. government agencies that are 90 or more days past due and still accruing interest at December 31, 2021 and 2020. (f) Represents the aggregate unpaid principal balance of loans divided by the estimated current property value. Current property values are estimated, at a minimum, quarterly, based on home valuation models using nationally recognized home price index valuation estimates incorporating actual data to the extent available and forecasted data where actual data is not available. Current estimated combined LTV for junior lien home equity loans considers all available lien positions, as well as unused lines, related to the property. (g) Refreshed FICO scores represent each borrower’s most recent credit score, which is obtained by the Firm on at least a quarterly basis. (h) At December 31, 2021 and 2020, included residential real estate loans, primarily held in LLCs in AWM that did not have a refreshed FICO score. These loans have been included in a FICO band based on management’s estimation of the borrower’s credit quality. (i) Prior-period amounts have been revised to conform with the current presentation. (j) Excludes loans with no FICO and/or LTV data available. (k) The geographic regions presented in the table are ordered based on the magnitude of the corresponding loan balances at December 31, 2021. (l) At December 31, 2021 and 2020, included mortgage loans insured by U.S. government agencies of $66 million and $76 million, respectively. These amounts have been excluded from the geographic regions presented based upon the government guarantee. Loan modifications Modifications of residential real estate loans, where the Firm grants concessions to borrowers who are experiencing financial difficulty are generally accounted for and reported as TDRs. Loans with short-term or other insignificant modifications that are not considered concessions are not TDRs nor are loans for which the Firm has elected to suspend TDR accounting guidance under the option provided by the CARES Act. The carrying value of new TDRs was $866 million, $819 million and $490 million for the years ended December 31, 2021, 2020 and 2019, respectively. There were no additional commitments to lend to borrowers whose residential real estate loans have been modified in TDRs. Nature and extent of modifications The Firm’s proprietary modification programs as well as government programs, including U.S. GSE programs, generally provide various concessions to financially troubled borrowers including, but not limited to, interest rate reductions, term or payment extensions and delays of principal and/or interest payments that would otherwise have been required under the terms of the original agreement. The following table provides information about how residential real estate loans were modified in TDRs under the Firm’s loss mitigation programs described above during the periods presented. This table excludes Chapter 7 loans where the sole concession granted is the discharge of debt, loans with short-term or other insignificant modifications that are not considered concessions, and loans for which the Firm has elected to suspend TDR accounting guidance under the option provided by the CARES Act. Year ended Decemb

Allowance for Credit Losses

Allowance for Credit Losses	12 Months Ended
	Dec. 31, 2021
Credit Loss [Abstract]
Allowance for Credit Losses	Allowance for credit losses The Firm’s allowance for credit losses represents management's estimate of expected credit losses over the remaining expected life of the Firm's financial assets measured at amortized cost and certain off-balance sheet lending-related commitments. The allowance for credit losses comprises: • the allowance for loan losses, which covers the Firm’s retained loan portfolios (scored and risk-rated) and is presented separately on the Consolidated balance sheets, • the allowance for lending-related commitments, which is presented on the Consolidated balance sheets in accounts payable and other liabilities, and • the allowance for credit losses on investment securities, which is recognized within investment securities on the Consolidated balance sheets. The income statement effect of all changes in the allowance for credit losses is recognized in the provision for credit losses. Determining the appropriateness of the allowance for credit losses is complex and requires significant judgment by management about the effect of matters that are inherently uncertain. At least quarterly, the allowance for credit losses is reviewed by the CRO, the CFO and the Controller of the Firm. Subsequent evaluations of credit exposures, considering the macroeconomic conditions, forecasts and other factors then prevailing, may result in significant changes in the allowance for credit losses in future periods. The Firm’s policies used to determine its allowance for loan losses and its allowance for lending-related commitments are described in the following paragraphs. Refer to Note 10 for a description of the policies used to determine the allowance for credit losses on investment securities. Methodology for allowances for loan losses and lending-related commitments The allowance for loan losses and allowance for lending-related commitments represents expected credit losses over the remaining expected life of retained loans and lending-related commitments that are not unconditionally cancellable. The Firm does not record an allowance for future draws on unconditionally cancellable lending-related commitments (e.g., credit cards). Expected losses related to accrued interest on credit card loans and certain performing, modified loans to borrowers impacted by COVID-19 are considered in the Firm’s allowance for loan losses. However, the Firm does not record an allowance on other accrued interest receivables, due to its policy to write t hese receivables off no later than 90 days past due by reversing interest income. The expected life of each instrument is determined by considering its contractual term, expected prepayments, cancellation features, and certain extension and call options. The expected life of funded credit card loans is generally estimated by considering expected future payments on the credit card account, and determining how much of those amounts should be allocated to repayments of the funded loan balance (as of the balance sheet date) versus other account activity. This allocation is made using an approach that incorporates the payment application requirements of the Credit Card Accountability Responsibility and Disclosure Act of 2009, generally paying down the highest interest rate balances first. The estimate of expected credit losses includes expected recoveries of amounts previously charged off or expected to be charged off, even if such recoveries result in a negative allowance. Collective and Individual Assessments When calculating the allowance for loan losses and the allowance for lending-related commitments, the Firm assesses whether exposures share similar risk characteristics. If similar risk characteristics exist, the Firm estimates expected credit losses collectively, considering the risk associated with a particular pool and the probability that the exposures within the pool will deteriorate or default. The assessment of risk characteristics is subject to significant management judgment. Emphasizing one characteristic over another or considering additional characteristics could affect the allowance. • Relevant risk characteristics for the consumer portfolio include product type, delinquency status, current FICO scores, geographic distribution, and, for collateralized loans, current LTV ratios. • Relevant risk characteristics for the wholesale portfolio include LOB, geography, risk rating, delinquency status, level and type of collateral, industry, credit enhancement, product type, facility purpose, tenor, and payment terms. The majority of the Firm’s credit exposures share risk characteristics with other similar exposures, and as a result are collectively assessed for impairment (“portfolio-based component”). The portfolio-based component covers consumer loans, performing risk-rated loans and certain lending-related commitments. If an exposure does not share risk characteristics with other exposures, the Firm generally estimates expected credit losses on an individual basis, considering expected repayment and conditions impacting that individual exposure (“asset-specific component”). The asset-specific component covers modified PCD loans, loans modified or reasonably expected to be modified in a TDR, collateral-dependent loans, as well as, risk-rated loans that have been placed on nonaccrual status. Portfolio-based component The portfolio-based component begins with a quantitative calculation that considers the likelihood of the borrower changing delinquency status or moving from one risk rating to another. The quantitative calculation covers expected credit losses over an instrument’s expected life and is estimated by applying credit loss factors to the Firm’s estimated exposure at default. The credit loss factors incorporate the probability of borrower default as well as loss severity in the event of default. They are derived using a weighted average of five internally developed macroeconomic scenarios over an eight-quarter forecast period, followed by a single year straight-line interpolation to revert to long run historical information for periods beyond the eight-quarter forecast period. The five macroeconomic scenarios consist of a central, relative adverse, extreme adverse, relative upside and extreme upside scenario, and are updated by the Firm’s central forecasting team. The scenarios take into consideration the Firm’s macroeconomic outlook, internal perspectives from subject matter experts across the Firm, and market consensus and involve a governed process that incorporates feedback from senior management across LOBs, Corporate Finance and Risk Management. The quantitative calculation is adjusted to take into consideration model imprecision, emerging risk assessments, trends and other subjective factors that are not yet reflected in the calculation. These adjustments are accomplished in part by analyzing the historical loss experience, including during stressed periods, for each major product or model. Management applies judgment in making this adjustment, including taking into account uncertainties associated with the economic and political conditions, quality of underwriting standards, borrower behavior, credit concentrations or deterioration within an industry, product or portfolio, as well as other relevant internal and external factors affecting the credit quality of the portfolio. In certain instances, the interrelationships between these factors create further uncertainties. The application of different inputs into the quantitative calculation, and the assumptions used by management to adjust the quantitative calculation, are subject to significant management judgment, and emphasizing one input or assumption over another, or considering other inputs or assumptions, could affect the estimate of the allowance for loan losses and the allowance for lending-related commitments. Asset-specific component To determine the asset-specific component of the allowance, collateral-dependent loans (including those loans for which foreclosure is probable) and larger, nonaccrual risk-rated loans in the wholesale portfolio segment are generally evaluated individually, while smaller loans (both scored and risk-rated) are aggregated for evaluation using factors relevant for the respective class of assets. The Firm generally measures the asset-specific allowance as the difference between the amortized cost of the loan and the present value of the cash flows expected to be collected, discounted at the loan’s original effective interest rate. Subsequent changes in impairment are generally recognized as an adjustment to the allowance for loan losses. For collateral-dependent loans, the fair value of collateral less estimated costs to sell is used to determine the charge-off amount for declines in value (to reduce the amortized cost of the loan to the fair value of collateral) or the amount of negative allowance that should be recognized (for recoveries of prior charge-offs associated with improvements in the fair value of collateral). The asset-specific component of the allowance for loans that have been or are expected to be modified in TDRs incorporates the effect of the modification on the loan’s expected cash flows (including forgone interest, principal forgiveness, as well as other concessions), and also the potential for redefault. For residential real estate loans modified in or expected to be modified in TDRs, the Firm develops product-specific probability of default estimates, which are applied at a loan level to compute expected losses. In developing these probabilities of default, the Firm considers the relationship between the credit quality characteristics of the underlying loans and certain assumptions about housing prices and unemployment, based upon industry-wide data. The Firm also considers its own historical loss experience to-date based on actual redefaulted modified loans. For credit card loans modified in or expected to be modified in TDRs, expected losses incorporate projected delinquencies and charge-offs based on the Firm’s historical experience by type of modification program. For wholesale loans modified or expected to be modified in TDRs, expected losses incorporate management’s expectation of the borrower’s ability to repay under the modified terms. Estimating the timing and amounts of future cash flows is highly judgmental as these cash flow projections rely upon estimates such as loss severities, asset valuations, default rates (including redefault rates on modified loans), the amounts and timing of interest or principal payments (including any expected prepayments) or other factors that are reflective of current and expected market conditions. These estimates are, in turn, dependent on factors such as the duration of current overall economic conditions, industry, portfolio, or borrower-specific factors, the expected outcome of insolvency proceedings as well as, in certain circumstances, other economic factors. All of these estimates and assumptions require significant management judgment and certain assumptions are highly subjective. Allowance for credit losses and related information The table below summarizes information about the allowances for credit losses, and includes a breakdown of loans and lending-related commitments by impairment methodology. Refer to Note 10 for further information on the allowance for credit losses on investment securities. (Table continued on next page) 2021 Year ended December 31, Consumer, Credit card Wholesale Total Allowance for loan losses Beginning balance at January 1, $ 3,636 $ 17,800 $ 6,892 $ 28,328 Cumulative effect of a change in accounting principle (a) NA NA NA NA Gross charge-offs 630 3,651 283 4,564 Gross recoveries collected (619) (939) (141) (1,699) Net charge-offs 11 2,712 142 2,865 Write-offs of PCI loans (b) NA NA NA NA Provision for loan losses (1,858) (4,838) (2,375) (9,071) Other (2) — (4) (6) Ending balance at December 31, $ 1,765 $ 10,250 $ 4,371 $ 16,386 Allowance for lending-related commitments Beginning balance at January 1, $ 187 $ — $ 2,222 $ 2,409 Cumulative effect of a change in accounting principle (a) NA NA NA NA Provision for lending-related commitments (75) — (74) (149) Other 1 — — 1 Ending balance at December 31, $ 113 $ — $ 2,148 $ 2,261 Total allowance for investment securities NA NA NA $ 42 Total allowance for credit losses $ 1,878 $ 10,250 $ 6,519 $ 18,689 Allowance for loan losses by impairment methodology Asset-specific (c) $ (665) $ 313 $ 263 $ (89) Portfolio-based 2,430 9,937 4,108 16,475 PCI NA NA NA NA Total allowance for loan losses $ 1,765 $ 10,250 $ 4,371 $ 16,386 Loans by impairment methodology Asset-specific (c) $ 13,919 $ 987 $ 2,255 $ 17,161 Portfolio-based 281,637 153,309 558,099 993,045 PCI NA NA NA NA Total retained loans $ 295,556 $ 154,296 $ 560,354 $ 1,010,206 Collateral-dependent loans Net charge-offs $ 33 $ — $ 38 $ 71 Loans measured at fair value of collateral less cost to sell 4,472 — 617 5,089 Allowance for lending-related commitments by impairment methodology Asset-specific $ — $ — $ 167 $ 167 Portfolio-based 113 — 1,981 2,094 Total allowance for lending-related commitments (d) $ 113 $ — $ 2,148 $ 2,261 Lending-related commitments by impairment methodology Asset-specific $ — $ — $ 764 $ 764 Portfolio-based (e) 29,588 — 453,571 483,159 Total lending-related commitments $ 29,588 $ — $ 454,335 $ 483,923 (a) Represents the impact to allowance for credit losses upon the adoption of CECL on January 1, 2020. Refer to Note 1 for further information. (b) Prior to the adoption of CECL, write-offs of PCI loans were recorded against the allowance for loan losses when actual losses for a pool exceeded estimated losses that were recorded as purchase accounting adjustments at the time of acquisition. A write-off of a PCI loan was recognized when the underlying loan was removed from a pool. (c) Includes collateral dependent loans, including those considered TDRs and those for which foreclosure is deemed probable, modified PCD loans and non-collateral dependent loans that have been modified or are reasonably expected to be modified in a TDR. Also includes risk-rated loans that have been placed on nonaccrual status for the wholesale portfolio segment. The asset-specific credit card allowance for loans modified, or reasonably expected to be modified, in a TDR is calculated based on the loans’ original contractual interest rates and does not consider any incremental penalty rates. (d) The allowance for lending-related commitments is reported in accounts payable and other liabilities on the Consolidated balance sheets. (e) At December 31, 2021, 2020 and 2019, lending-related commitments excluded $15.7 billion, $19.5 billion and $9.8 billion, respectively, for the consumer, excluding credit card portfolio segment; $730.5 billion, $658.5 billion and $650.7 billion, respectively, for the credit card portfolio segment; and $32.1 billion, $25.3 billion and $24.1 billion, respectively, for the wholesale portfolio segment, which were not subject to the allowance for lending-related commitments. Prior-period amount for wholesale lending-related commitments, including the amount not subject to allowance, has been revised to conform with the current presentation. (table continued from previous page) 2020 2019 Consumer, Credit card Wholesale Total Consumer, Credit card Wholesale Total $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 3,434 $ 5,184 $ 4,827 $ 13,445 297 5,517 (1,642) 4,172 NA NA NA NA 805 5,077 954 6,836 902 5,436 472 6,810 (631) (791) (155) (1,577) (536) (588) (57) (1,181) 174 4,286 799 5,259 366 4,848 415 5,629 NA NA NA NA 151 — — 151 974 10,886 4,431 16,291 (378) 5,348 479 5,449 1 — — 1 (1) (1) 11 9 $ 3,636 $ 17,800 $ 6,892 $ 28,328 $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 12 $ — $ 1,179 $ 1,191 $ 12 $ — $ 1,043 $ 1,055 133 — (35) 98 NA NA NA NA 42 — 1,079 1,121 — — 136 136 — — (1) (1) — — — — $ 187 $ — $ 2,222 $ 2,409 $ 12 $ — $ 1,179 $ 1,191 NA NA NA $ 78 NA NA NA NA $ 3,823 $ 17,800 $ 9,114 $ 30,815 $ 2,550 $ 5,683 $ 6,081 $ 14,314 $ (7) $ 633 $ 682 $ 1,308 $ 75 $ 477 $ 295 $ 847 3,643 17,167 6,210 27,020 1,476 5,206 4,607 11,289 NA NA NA NA 987 — — 987 $ 3,636 $ 17,800 $ 6,892 $ 28,328 $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 16,648 $ 1,375 $ 3,606 $ 21,629 $ 5,961 $ 1,452 $ 1,123 $ 8,536 285,479 142,057 511,341 938,877 268,675 167,472 480,555 916,702 NA NA NA NA 20,363 — — 20,363 $ 302,127 $ 143,432 $ 514,947 $ 960,506 $ 294,999 $ 168,924 $ 481,678 $ 945,601 $ 133 $ — $ 76 $ 209 $ 46 $ — $ 36 $ 82 4,956 — 188 5,144 2,053 — 87 2,140 $ — $ — $ 114 $ 114 $ — $ — $ 102 $ 102 187 — 2,108 2,295 12 — 1,077 1,089 $ 187 $ — $ 2,222 $ 2,409 $ 12 $ — $ 1,179 $ 1,191 $ — $ — $ 577 $ 577 $ — $ — $ 474 $ 474 37,783 — 423,993 461,776 30,417 — 392,967 423,384 $ 37,783 $ — $ 424,570 $ 462,353 $ 30,417 $ — $ 393,441 $ 423,858 Discussion of changes in the allowance The allowance for credit losses as of December 31, 2021 was $18.7 billion, a decrease from $30.8 billion at December 31, 2020. The decrease in the allowance for credit losses was primarily driven by improvements in the macroeconomic environment, consisting of: • a $9.5 billion reduction in consumer, predominantly in the credit card portfolio; and • a $2.6 billion net reduction in wholesale, across the LOBs. The Firm’s allowance for credit losses is estimated using a weighted average of five internally developed macroeconomic scenarios. As of December 31, 2021, the Firm assigned more balanced weightings to both its adverse and upside scenarios compared to the significant weighting that the Firm placed on its adverse scenarios as of December 31, 2020, reflecting the sustained improvement and resilience of the macroeconomic environment, despite the ongoing impact of the COVID-19 pandemic. In addition, because the impact of the COVID-19 pandemic and governmental actions taken in response to the pandemic caused a dislocation in certain historical relationships used for modeling credit loss estimates, the Firm continues to place reliance on management judgment and make adjustments specific to that dislocation, although to a lesser extent than in 2020. The allowance for credit losses of $18.7 billion reflects remaining uncertainties, including the potential impact that additional waves or variants of COVID-19 may have on the pace of economic growth and near-term supply chain disruptions. The Firm’s central case assumptions reflected U.S. unemployment rates and year over year growth in U.S. real GDP as follows: Assumptions at December 31, 2021 2Q22 4Q22 2Q23 U.S. unemployment rate (a) 4.2 % 4.0 % 3.9 % YoY growth in U.S. real GDP (b) 3.1 % 2.8 % 2.1 % Assumptions at December 31, 2020 2Q21 4Q21 2Q22 U.S. unemployment rate (a) 6.8 % 5.7 % 5.1 % YoY growth in U.S. real GDP (b) 9.2 % 3.5 % 3.9 % (a) Reflects quarterly average of forecasted U.S. unemployment rate. (b) As of December 31, 2021, the year over year growth in U.S. real GDP in the forecast horizon of the central scenario is calculated as the percent change in U.S. real GDP levels from the prior year. This year over year growth rate replaces the previously disclosed pandemic-focused measure of the cumulative change in U.S. real GDP from pre-pandemic conditions at December 31, 2019. Prior periods have been revised to conform with the current presentation. Subsequent changes to this forecast and related estimates will be reflected in the provision for credit losses in future periods. Refer to Critical Accounting Estimates Used by the Firm on pages 150-153 for further information on the allowance for credit losses and related management judgments. Refer to Consumer Credit Portfolio on pages 110-116, Wholesale Credit Portfolio on pages 117-128 for additional information on the consumer and wholesale credit portfolios.

Variable Interest Entities

Variable Interest Entities	12 Months Ended
	Dec. 31, 2021
Variable Interest Entities [Abstract]
Variable Interest Entities	Variable interest entities Refer to Note 1 on page 165 for a further description of JPMorgan Chase’s accounting policies regarding consolidation of VIEs. The following table summarizes the most significant types of Firm-sponsored VIEs by business segment. The Firm considers a “Firm-sponsored” VIE to include any entity where: (1) JPMorgan Chase is the primary beneficiary of the structure; (2) the VIE is used by JPMorgan Chase to securitize Firm assets; (3) the VIE issues financial instruments with the JPMorgan Chase name; or (4) the entity is a JPMorgan Chase–administered asset-backed commercial paper conduit. Line of Business Transaction Type Activity 2021 Form 10-K CCB Credit card securitization trusts Securitization of originated credit card receivables 253-254 Mortgage securitization trusts Servicing and securitization of both originated and purchased residential mortgages 254-256 CIB Mortgage and other securitization trusts Securitization of both originated and purchased residential and commercial mortgages, and other consumer loans 254-256 Multi-seller conduits Assisting clients in accessing the financial markets in a cost-efficient manner and structuring transactions to meet investor needs 256 Municipal bond vehicles Financing of municipal bond investments 256-257 The Firm’s other business segments are also involved with VIEs (both third-party and Firm-sponsored), but to a lesser extent, as follows: • Asset & Wealth Management: AWM sponsors and manages certain funds that are deemed VIEs. As asset manager of the funds, AWM earns a fee based on assets managed; the fee varies with each fund’s investment objective and is competitively priced. For fund entities that qualify as VIEs, AWM’s interests are, in certain cases, considered to be significant variable interests that result in consolidation of the financial results of these entities. • Commercial Banking: CB provides financing and lending-related services to a wide spectrum of clients, including certain third-party-sponsored entities that may meet the definition of a VIE. CB does not control the activities of these entities and does not consolidate these entities. CB’s maximum loss exposure, regardless of whether the entity is a VIE, is generally limited to loans and lending-related commitments which are reported and disclosed in the same manner as any other third-party transaction. • Corporate : Corporate is involved with entities that may meet the definition of VIEs; however these entities are generally subject to specialized investment company accounting, which does not require the consolidation of investments, including VIEs. In addition, Treasury and CIO invest in securities generally issued by third parties which may meet the definition of VIEs (e.g., issuers of asset-backed securities). In general, the Firm does not have the power to direct the significant activities of these entities and therefore does not consolidate these entities. Refer to Note 10 for further information on the Firm’s investment securities portfolio. In addition, CIB also invests in and provides financing and other services to VIEs sponsored by third parties. Refer to pages 257-258 of this Note for more information on consolidated VIE assets and liabilities as well as the VIEs sponsored by third parties. Significant Firm-sponsored variable interest entities Credit card securitizations CCB’s Card business may securitize originated credit card loans, primarily through the Chase Issuance Trust (the “Trust”). The Firm’s continuing involvement in credit card securitizations includes servicing the receivables, retaining an undivided seller’s interest in the receivables, retaining certain senior and subordinated securities and maintaining escrow accounts. The Firm consolidates the assets and liabilities of its sponsored credit card trusts as it is considered to be the primary beneficiary of these securitization trusts based on the Firm’s ability to direct the activities of these VIEs through its servicing responsibilities and other duties, including making decisions as to the receivables that are transferred into those trusts and as to any related modifications and workouts. Additionally, the nature and extent of the Firm’s other continuing involvement with the trusts, as indicated above, obligates the Firm to absorb losses and gives the Firm the right to receive certain benefits from these VIEs that could potentially be significant. The underlying securitized credit card receivables and other assets of the securitization trusts are available only for payment of the beneficial interests issued by the securitization trusts; they are not available to pay the Firm’s other obligations or the claims of the Firm’s creditors. The agreements with the credit card securitization trusts require the Firm to maintain a minimum undivided interest in the credit card trusts (generally 5%). As of December 31, 2021 and 2020, the Firm held undivided interests in Firm-sponsored credit card securitization trusts of $7.1 billion and $5.4 billion, respectively. The Firm maintained an average undivided interest in principal receivables owned by those trusts of approximately 57% and 39% for the years ended December 31, 2021 and 2020, respectively. The Firm did not retain any senior securities and retained $1.5 billion of subordinated securities in certain of its credit card securitization trusts at both December 31, 2021 and 2020. The Firm’s undivided interests in the credit card trusts and securities retained are eliminated in consolidation. Firm-sponsored mortgage and other securitization trusts The Firm securitizes (or has securitized) originated and purchased residential mortgages, commercial mortgages and other consumer loans primarily in its CCB and CIB businesses. Depending on the particular transaction, as well as the respective business involved, the Firm may act as the servicer of the loans and/or retain certain beneficial interests in the securitization trusts. The following tables present the total unpaid principal amount of assets held in Firm-sponsored private-label securitization entities, including those in which the Firm has continuing involvement, and those that are consolidated by the Firm. Continuing involvement includes servicing the loans, holding senior interests or subordinated interests (including amounts required to be held pursuant to credit risk retention rules), recourse or guarantee arrangements, and derivative contracts. In certain instances, the Firm’s only continuing involvement is servicing the loans. The Firm’s maximum loss exposure from retained and purchased interests is the carrying value of these interests. Principal amount outstanding JPMorgan Chase interest in securitized assets in nonconsolidated VIEs (c)(d)(e) December 31, 2021 Total assets held by securitization VIEs Assets Assets held in nonconsolidated securitization VIEs with continuing involvement Trading assets Investment securities Other financial assets Total interests held by JPMorgan Chase Securitization-related (a) Residential mortgage: Prime/Alt-A and option ARMs $ 55,085 $ 942 $ 47,029 $ 974 $ 684 $ 95 $ 1,753 Subprime 10,966 27 10,115 2 — — 2 Commercial and other (b) 150,694 — 93,698 671 3,274 506 4,451 Total $ 216,745 $ 969 $ 150,842 $ 1,647 $ 3,958 $ 601 $ 6,206 Principal amount outstanding JPMorgan Chase interest in securitized assets in nonconsolidated VIEs (c)(d)(e) December 31, 2020 Total assets held by securitization VIEs Assets Assets held in nonconsolidated securitization VIEs with continuing involvement Trading assets Investment securities Other financial assets Total interests held by JPMorgan Chase Securitization-related (a) Residential mortgage: Prime/Alt-A and option ARMs $ 49,644 $ 1,693 $ 41,265 $ 574 $ 724 $ — $ 1,298 Subprime 12,896 46 12,154 9 — — 9 Commercial and other (b) 119,732 — 92,351 955 1,549 262 2,766 Total $ 182,272 $ 1,739 $ 145,770 $ 1,538 $ 2,273 $ 262 $ 4,073 (a) Excludes U.S. GSEs and government agency securitizations and re-securitizations, which are not Firm-sponsored. (b) Consists of securities backed by commercial real estate loans and non-mortgage-related consumer receivables purchased from third parties. (c) Excludes the following: retained servicing; securities retained from loan sales and securitization activity related to U.S. GSEs and government agencies; interest rate and foreign exchange derivatives primarily used to manage interest rate and foreign exchange risks of securitization entities; senior and subordinated securities of $145 million and $36 million, respectively, at December 31, 2021, and $105 million and $40 million, respectively, at December 31, 2020, which the Firm purchased in connection with CIB’s secondary market-making activities. (d) Includes interests held in re-securitization transactions. (e) As of December 31, 2021 and 2020, 79% and 73%, respectively, of the Firm’s retained securitization interests, which are predominantly carried at fair value and include amounts required to be held pursuant to credit risk retention rules, were risk-rated “A” or better, on an S&P-equivalent basis. The retained interests in prime residential mortgages consisted of $1.6 billion and $1.3 billion of investment-grade retained interests, and $131 million and $41 million of noninvestment-grade retained interests at December 31, 2021 and 2020, respectively. The retained interests in commercial and other securitization trusts consisted of $3.5 billion and $2.0 billion of investment-grade retained interests, and $929 million and $753 million of noninvestment-grade retained interests at December 31, 2021 and 2020, respectively. Residential mortgage The Firm securitizes residential mortgage loans originated by CCB, as well as residential mortgage loans purchased from third parties by either CCB or CIB. CCB generally retains servicing for all residential mortgage loans it originated or purchased, and for certain mortgage loans purchased by CIB. For securitizations of loans serviced by CCB, the Firm has the power to direct the significant activities of the VIE because it is responsible for decisions related to loan modifications and workouts. CCB may also retain an interest upon securitization. In addition, CIB engages in underwriting and trading activities involving securities issued by Firm-sponsored securitization trusts. As a result, CIB at times retains senior and/or subordinated interests (including residual interests and amounts required to be held pursuant to credit risk retention rules) in residential mortgage securitizations at the time of securitization, and/or reacquires positions in the secondary market in the normal course of business. In certain instances, as a result of the positions retained or reacquired by CIB or held by Treasury and CIO or CCB, when considered together with the servicing arrangements entered into by CCB, the Firm is deemed to be the primary beneficiary of certain securitization trusts. The Firm does not consolidate residential mortgage securitizations (Firm-sponsored or third-party-sponsored) when it is not the servicer (and therefore does not have the power to direct the most significant activities of the trust) or does not hold a beneficial interest in the trust that could potentially be significant to the trust. Commercial mortgages and other consumer securitizations CIB originates and securitizes commercial mortgage loans, and engages in underwriting and trading activities involving the securities issued by securitization trusts. CIB may retain unsold senior and/or subordinated interests (including amounts required to be held pursuant to credit risk retention rules) in commercial mortgage securitizations at the time of securitization but, generally, the Firm does not service commercial loan securitizations. Treasury and CIO may choose to invest in these securitizations as well. For commercial mortgage securitizations the power to direct the significant activities of the VIE generally is held by the servicer or investors in a specified class of securities (“controlling class”). The Firm generally does not retain an interest in the controlling class in its sponsored commercial mortgage securitization transactions. Re-securitizations The Firm engages in certain re-securitization transactions in which debt securities are transferred to a VIE in exchange for new beneficial interests. These transfers occur in connection with both U.S. GSEs and government agency sponsored VIEs, which are backed by residential mortgages. The Firm’s consolidation analysis is largely dependent on the Firm’s role and interest in the re-securitization trusts. The following table presents the principal amount of securities transferred to re-securitization VIEs. Year ended December 31, 2021 2020 2019 Transfers of securities to VIEs U.S. GSEs and government agencies $ 53,923 $ 46,123 $ 25,852 Most re-securitizations with which the Firm is involved are client-driven transactions in which a specific client or group of clients is seeking a specific return or risk profile. For these transactions, the Firm has concluded that the decision-making power of the entity is shared between the Firm and its clients, considering the joint effort and decisions in establishing the re-securitization trust and its assets, as well as the significant economic interest the client holds in the re-securitization trust; therefore the Firm does not consolidate the re-securitization VIE. The Firm did not transfer any private label securities to re-securitization VIEs during 2021, 2020 and 2019, respectively, and retained interests in any such Firm-sponsored VIEs as of December 31, 2021 and 2020 were immaterial. Additionally, the Firm may invest in beneficial interests of third-party-sponsored re-securitizations and generally purchases these interests in the secondary market. In these circumstances, the Firm does not have the unilateral ability to direct the most significant activities of the re-securitization trust, either because it was not involved in the initial design of the trust, or the Firm was involved with an independent third-party sponsor and demonstrated shared power over the creation of the trust; therefore, the Firm does not consolidate the re-securitization VIE. The following table presents information on the Firm's interests in nonconsolidated re-securitization VIEs. Nonconsolidated December 31, 2021 2020 U.S. GSEs and government agencies Interest in VIEs $ 1,947 $ 2,631 As of December 31, 2021 and 2020, the Firm did not consolidate any U.S. GSE and government agency re-securitization VIEs or any Firm-sponsored private-label re-securitization VIEs. Multi-seller conduits Multi-seller conduit entities are separate bankruptcy remote entities that provide secured financing, collateralized by pools of receivables and other financial assets, to customers of the Firm. The conduits fund their financing facilities through the issuance of highly rated commercial paper. The primary source of repayment of the commercial paper is the cash flows from the pools of assets. In most instances, the assets are structured with deal-specific credit enhancements provided to the conduits by the customers (i.e., sellers) or other third parties. Deal-specific credit enhancements are generally structured to cover a multiple of historical losses expected on the pool of assets, and are typically in the form of overcollateralization provided by the seller. The deal-specific credit enhancements mitigate the Firm’s potential losses on its agreements with the conduits. To ensure timely repayment of the commercial paper, and to provide the conduits with funding to provide financing to customers in the event that the conduits do not obtain funding in the commercial paper market, each asset pool financed by the conduits has a minimum 100% deal-specific liquidity facility associated with it provided by JPMorgan Chase Bank, N.A. JPMorgan Chase Bank, N.A. also provides the multi-seller conduit vehicles with uncommitted program-wide liquidity facilities and program-wide credit enhancement in the form of standby letters of credit. The amount of program-wide credit enhancement required is based upon commercial paper issuance and approximates 10% of the outstanding balance of commercial paper. The Firm consolidates its Firm-administered multi-seller conduits, as the Firm has both the power to direct the significant activities of the conduits and a potentially significant economic interest in the conduits. As administrative agent and in its role in structuring transactions, the Firm makes decisions regarding asset types and credit quality, and manages the commercial paper funding needs of the conduits. The Firm’s interests that could potentially be significant to the VIEs include the fees received as administrative agent and liquidity and program-wide credit enhancement provider, as well as the potential exposure created by the liquidity and credit enhancement facilities provided to the conduits. In the normal course of business, JPMorgan Chase makes markets in and invests in commercial paper issued by the Firm-administered multi-seller conduits. The Firm held $13.7 billion and $13.5 billion of the commercial paper issued by the Firm-administered multi-seller conduits at December 31, 2021 and 2020, respectively, which have been eliminated in consolidation. The Firm’s investments reflect the Firm’s funding needs and capacity and were not driven by market illiquidity. Other than the amounts required to be held pursuant to credit risk retention rules, the Firm is not obligated under any agreement to purchase the commercial paper issued by the Firm-administered multi-seller conduits. Deal-specific liquidity facilities, program-wide liquidity and credit enhancement provided by the Firm have been eliminated in consolidation. The Firm or the Firm-administered multi-seller conduits provide lending-related commitments to certain clients of the Firm-administered multi-seller conduits. The unfunded commitments were $13.4 billion and $12.2 billion at December 31, 2021 and 2020, respectively, and are reported as off-balance sheet lending-related commitments in other unfunded commitments to extend credit. Refer to Note 28 for more information on off-balance sheet lending-related commitments. Municipal bond vehicles Municipal bond vehicles or tender option bond (“TOB”) trusts allow institutions to finance their municipal bond investments at short-term rates. In a typical TOB transaction, the trust purchases highly rated municipal bond(s) of a single issuer and funds the purchase by issuing two types of securities: (1) puttable floating-rate certificates (“floaters”) and (2) inverse floating-rate residual interests (“residuals”). The floaters are typically purchased by money market funds or other short-term investors and may be tendered, with requisite notice, to the TOB trust. The residuals are retained by the investor seeking to finance its municipal bond investment. TOB transactions where the residual is held by a third-party investor are typically known as customer TOB trusts, and non-customer TOB trusts are transactions where the Residual is retained by the Firm. Customer TOB trusts are sponsored by a third party. The Firm serves as sponsor for all non-customer TOB transactions. The Firm may provide various services to a TOB trust, including remarketing agent, liquidity or tender option provider, and/or sponsor. J.P. Morgan Securities LLC may serve as a remarketing agent on the floaters for TOB trusts. The remarketing agent is responsible for establishing the periodic variable rate on the floaters, conducting the initial placement and remarketing tendered floaters. The remarketing agent may, but is not obligated to, make markets in floaters. Floaters held by the Firm were not material during 2021 and 2020. JPMorgan Chase Bank, N.A. or J.P. Morgan Securities LLC often serves as the sole liquidity or tender option provider for the TOB trusts. The liquidity provider’s obligation to perform is conditional and is limited by certain events (“Termination Events”), which include bankruptcy or failure to pay by the municipal bond issuer or credit enhancement provider, an event of taxability on the municipal bonds or the immediate downgrade of the municipal bond to below investment grade. In addition, the liquidity provider’s exposure is typically further limited by the high credit quality of the underlying municipal bonds, the excess collateralization in the vehicle, or, in certain transactions, the reimbursement agreements with the Residual holders. Holders of the floaters may “put,” or tender, their floaters to the TOB trust. If the remarketing agent cannot successfully remarket the floaters to another investor, the liquidity provider either provides a loan to the TOB trust for the TOB trust’s purchase of the floaters, or it directly purchases the tendered floaters. TOB trusts are considered to be variable interest entities. The Firm consolidates non-customer TOB trusts because as the Residual holder, the Firm has the right to make decisions that significantly impact the economic performance of the municipal bond vehicle, and it has the right to receive benefits and bear losses that could potentially be significant to the municipal bond vehicle. Consolidated VIE assets and liabilities The following table presents information on assets and liabilities related to VIEs consolidated by the Firm as of December 31, 2021 and 2020. Assets Liabilities December 31, 2021 Trading assets Loans Other (c) Total assets (d) Beneficial interests in VIE assets (e) Other (f) Total VIE program type Firm-sponsored credit card trusts $ — $ 11,108 $ 102 $ 11,210 $ 2,397 $ 1 $ 2,398 Firm-administered multi-seller conduits 1 19,883 71 19,955 6,198 41 6,239 Municipal bond vehicles 2,009 — 2 2,011 1,976 — 1,976 Mortgage securitization entities (a) — 955 32 987 179 85 264 Other — 1,078 (b) 283 1,361 — 118 118 Total $ 2,010 $ 33,024 $ 490 $ 35,524 $ 10,750 $ 245 $ 10,995 Assets Liabilities December 31, 2020 Trading assets Loans Other (c) Total assets (d) Beneficial interests in VIE assets (e) Other (f) Total VIE program type Firm-sponsored credit card trusts $ — $ 11,962 $ 148 $ 12,110 $ 4,943 $ 3 $ 4,946 Firm-administered multi-seller conduits 2 23,787 188 23,977 10,523 33 10,556 Municipal bond vehicles 1,930 — 2 1,932 1,902 — 1,902 Mortgage securitization entities (a) — 1,694 94 1,788 210 108 318 Other 2 176 249 427 — 89 89 Total $ 1,934 $ 37,619 $ 681 $ 40,234 $ 17,578 $ 233 $ 17,811 (a) Includes residential and commercial mortgage securitizations. (b) Largely includes purchased supply chain finance receivables and purchased auto loan securitizations in CIB. (c) Includes assets classified as cash and other assets on the Consolidated balance sheets. (d) The assets of the consolidated VIEs included in the program types above are used to settle the liabilities of those entities. The assets and liabilities include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. (e) The interest-bearing beneficial interest liabilities issued by consolidated VIEs are classified in the line item on the Consolidated balance sheets titled, “Beneficial interests issued by consolidated variable interest entities.” The holders of these beneficial interests generally do not have recourse to the general credit of JPMorgan Chase. Included in beneficial interests in VIE assets are long-term beneficial interests of $2.6 billion and $5.2 billion at December 31, 2021 and 2020, respectively. (f) Includes liabilities classified as accounts payable and other liabilities on the Consolidated balance sheets. VIEs sponsored by third parties The Firm enters into transactions with VIEs structured by other parties. These include, for example, acting as a derivative counterparty, liquidity provider, investor, underwriter, placement agent, remarketing agent, trustee or custodian. These transactions are conducted at arm’s-length, and individual credit decisions are based on the analysis of the specific VIE, taking into consideration the quality of the underlying assets. Where the Firm does not have the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, or a variable interest that could potentially be significant, the Firm generally does not consolidate the VIE, but it records and reports these positions on its Consolidated balance sheets in the same manner it would record and report positions in respect of any other third-party transaction. Tax credit vehicles The Firm holds investments in unconsolidated tax credit vehicles, which are limited partnerships and similar entities that own and operate affordable housing, energy, and other projects. These entities are primarily considered VIEs. A third party is typically the general partner or managing member and has control over the significant activities of the tax credit vehicles, and accordingly the Firm does not consolidate tax credit vehicles. The Firm generally invests in these partnerships as a limited partner and earns a return primarily through the receipt of tax credits allocated to the projects. The maximum loss exposure, represented by equity investments and funding commitments, was $26.8 billion and $23.6 billion, of which $9.4 billion and $8.7 billion was unfunded at December 31, 2021 and 2020, respectively. The prior-period maximum loss exposure amount has been revised to conform with the current presentation. The Firm assesses each project and to reduce the risk of loss, may withhold varying amounts of its capital investment until the project qualifies for tax credits. Refer to Note 25 for further information on affordable housing tax credits. Refer to Note 28 for more information on off-balance sheet lending-related commitments. Customer municipal bond vehicles (TOB trusts) The Firm may provide various services to customer TOB trusts, including remarketing agent, liquidity or tender option provider. In certain customer TOB transactions, the Firm, as liquidity provider, has entered into a reimbursement agreement with the Residual holder. In those transactions, upon the termination of the vehicle, the Firm has recourse to the third-party Residual holders for any shortfall. The Firm does not have any intent to protect Residual holders from potential losses on any of the underlying municipal bonds. The Firm does not consolidate customer TOB trusts, since the Firm does not have the power to make decisions that significantly impact the economic performance of the municipal bond vehicle. The Firm’s maximum exposure as a liquidity provider to customer TOB trusts at December 31, 2021 and 2020, was $6.8 billion and $6.7 billion, respectively. The fair value of assets held by such VIEs at both December 31, 2021 and 2020 was $10.5 billion. Loan securitizations The Firm has securitized and sold a variety of loans, including residential mortgages, credit card receivables, and commercial mortgages. The purposes of these securitization transactions were to satisfy investor demand and to generate liquidity for the Firm. For loan securitizations in which the Firm is not required to consolidate the trust, the Firm records the transfer of the loan receivable to the trust as a sale when all of the following accounting criteria for a sale are met: (1) the transferred financial assets are legally isolated from the Firm’s creditors; (2) the transferee or beneficial interest holder can pledge or exchange the transferred financial assets; and (3) the Firm does not maintain effective control over the transferred financial assets (e.g., the Firm cannot repurchase the transferred assets before their maturity and it does not have the ability to unilaterally cause the holder to return the transferred assets). For loan securitizations accounted for as a sale, the Firm recognizes a gain or loss based on the difference between the value of proceeds received (including cash, beneficial interests, or servicing assets received) and the carrying value of the assets sold. Gains and losses on securitizations are reported in noninterest revenue. Securitization activity The following table provides information related to the Firm’s securitization activities for the years ended December 31, 2021, 2020 and 2019, related to assets held in Firm-sponsored securitization entities that were not consolidated by the Firm, and where sale accounting was achieved at the time of the securitization. 2021 2020 2019 Year ended December 31, Residential mortgage (d) Commercial and other (e) Residential mortgage (d) Commercial and other (e) Residential mortgage (d) Commercial and other (e) Principal securitized $ 23,876 $ 14,917 $ 7,103 $ 6,624 $ 9,957 $ 9,390 All cash flows during the period: (a) Proceeds received from loan sales as financial instruments (b)(c) $ 24,450 $ 15,044 $ 7,321 $ 6,865 $ 10,238 $ 9,544 Servicing fees collected 153 1 211 1 287 2 Cash flows received on interests 578 273 801 239 507 237 (a) Excludes re-securitization transactions. (b) Predominantly includes Level 2 assets. (c) The carrying value of the loans accounted for at fair value approximated the proceeds received upon loan sale. (d) Represents prime mortgages. Excludes loan securitization activity related to U.S. GSEs and government agencies. (e) Includes commercial mortgage and other consumer loans. Key assumptions used to value retained interests originated during the year are shown in the table below. Year ended December 31, 2021 2020 2019 Residential mortgage retained interest: Weighted-average life (in years) 3.9 4.7 4.8 Weighted-average discount rate 3.3 % 8.2 % 7.4 % Commercial mortgage retained interest: Weighted-average life (in years) 6.0 6.9 6.4 Weighted-average discount rate 1.2 % 3.0 % 4.1 % Loans and excess MSRs sold to U.S. government-sponsored enterprises and loans in securitization transactions pursuant to Ginnie Mae guidelines In addition to the amounts reported in the securitization activity tables above, the Firm, in the normal course of business, sells originated and purchased mortgage loans and certain originated excess MSRs on a nonrecourse basis, predominantly to U.S. GSEs. These loans and excess MSRs are sold primarily for the purpose of securitization by the U.S. GSEs, who provide certain guarantee provisions (e.g., credit enhancement of the loans). The Firm also sells loans into securitization transactions pursuant to Ginnie Mae guidelines; these loans are typically insured or guaranteed by another U.S. government agency. The Firm does not consolidate the securitization vehicles underlying these transactions as it is not the primary beneficiary. For a limited number of loan sales, the Firm is obligated to share a portion of the credit risk associated with the sold loans with the purchaser. Refer to Note 28 for additional information about the Firm’s loan sales- and securitization-related indemnifications. Refer to Note 15 for additional information on MSRs. The following table summarizes the activities related to loans sold to the U.S. GSEs, and loans in securitization transactions pursuant to Ginnie Mae guidelines. Year ended December 31, 2021 2020 2019 Carrying value of loans sold $ 105,035 $ 81,153 $ 92,349 Proceeds received from loan sales as cash $ 161 $ 45 $ 73 Proceeds from loan sales as securities (a)(b) 103,286 80,186 91,422 Total proceeds received from loan sales (c) $ 103,447 $ 80,231 $ 91,495 Gains/(losses) on loan sales (d)(e) $ 9 $ 6 $ 499 (a) Includes securities from U.S. GSEs and Ginnie Mae that are generally sold shortly after receipt or retained as part of the Firm’s investment securities portfolio. (b) Included in Level 2 assets. (c) Excludes the value of MSRs retained upon the sale of loans. (d) Gains/(losses) on loan sales include the value of MSRs. (e) The carrying value of the loans accounted for at fair value approximated the proceeds received upon loan sale. Options to repurchase delinquent loans In addition to the Firm’s obligation to repurchase certain loans due to material breaches of representations and warranties as discussed in Note 28, the Firm also has the option to repurchase delinquent loans that it services for Ginnie Mae loan pools, as well as for other U.S. government agencies under certain arrangements. The Firm typically elects to repurchase delinquent loans from Ginnie Mae loan pools as it continues to service them and/or manage the foreclosure process in accordance with the applicable requirements, and such loans continue to be insured or guaranteed. When the Firm’s repurchase option becomes exercisable, such loans must be reported on the Consol

Goodwill and Mortgage Servicing

Goodwill and Mortgage Servicing Rights	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Mortgage Servicing Rights	Goodwill and Mortgage servicing rights Goodwill Goodwill is recorded upon completion of a business combination as the difference between the purchase price and the fair value of the net assets acquired, and can be adjusted up to one year from the acquisition date as more information is obtained about the fair value of assets acquired and liabilities assumed. Subsequent to initial recognition, goodwill is not amortized but is tested for impairment during the fourth quarter of each fiscal year, or more often if events or circumstances, such as adverse changes in the business climate, indicate that there may be an impairment. The goodwill associated with each business combination is allocated to the related reporting units, which are generally determined based on how the Firm’s businesses are managed and how they are reviewed. The following table presents goodwill attributed to the reportable business segments and Corporate. December 31, (in millions) 2021 2020 2019 Consumer & Community Banking $ 31,474 $ 31,311 $ 30,133 Corporate & Investment Bank 7,906 7,913 7,901 Commercial Banking 2,986 2,985 2,982 Asset & Wealth Management 7,222 7,039 6,807 Corporate (a) 727 — — Total goodwill $ 50,315 $ 49,248 $ 47,823 (a) For goodwill in Corporate acquired in the third quarter of 2021, the Firm elected to perform a qualitative impairment assessment, as permitted under U.S. GAAP. The following table presents changes in the carrying amount of goodwill. Year ended December 31, (in millions) 2021 2020 2019 Balance at beginning of period $ 49,248 $ 47,823 $ 47,471 Changes during the period from: Business combinations (a) 1,124 1,412 349 Other (b) (57) 13 3 Balance at December 31, $ 50,315 $ 49,248 $ 47,823 (a) For 2021, represents estimated goodwill associated with the acquisitions of Nutmeg in Corporate, OpenInvest and Campbell Global in AWM, and Frank and The Infatuation in CCB. For 2020, represents estimated goodwill associated with the acquisitions of cxLoyalty in CCB and 55ip in AWM. For 2019, represents goodwill associated with the acquisition of InstaMed. This goodwill was allocated to CIB, CB and CCB. (b) Primarily foreign currency adjustments and adjustments to goodwill related to prior period acquisitions. Goodwill impairment testing The Firm’s goodwill was not impaired at December 31, 2021, 2020 and 2019 . Effective January 1, 2020, the Firm adopted new accounting guidance related to goodwill impairment testing. The adoption of the guidance requires recognition of an impairment loss when the estimated fair value of a reporting unit falls below its carrying value. It eliminated the requirement that an impairment loss be recognized only if the estimated implied fair value of the goodwill is below its carrying value. The goodwill impairment test is generally performed by comparing the current fair value of each reporting unit with its carrying value. If the fair value is in excess of the carrying value, then the reporting unit’s goodwill is considered not to be impaired. If the fair value is less than the carrying value, then an impairment charge is recognized for the amount by which the reporting unit’s carrying value exceeds its fair value, up to the amount of goodwill allocated to that reporting unit. The Firm uses the reporting units’ allocated capital plus goodwill and other intangible assets as a proxy for the carrying values of equity for the reporting units in the goodwill impairment testing. Reporting unit equity is determined on a similar basis as the allocation of capital to the LOBs which takes into consideration a variety of factors including capital levels of similarly rated peers and applicable regulatory capital requirements. Proposed LOB capital levels are incorporated into the Firm’s annual budget process, which is reviewed by the Firm’s Board of Directors. Allocated capital is further reviewed periodically and updated as needed. The primary method the Firm uses to estimate the fair value of its reporting units is the income approach. This approach projects cash flows for the forecast period and uses the perpetuity growth method to calculate terminal values. These cash flows and terminal values are then discounted using an appropriate discount rate. Projections of cash flows are based on the reporting units’ earnings forecasts which are reviewed with senior management of the Firm. The discount rate used for each reporting unit represents an estimate of the cost of equity for that reporting unit and is determined considering the Firm’s overall estimated cost of equity (estimated using the Capital Asset Pricing Model), as adjusted for the risk characteristics specific to each reporting unit (for example, for higher levels of risk or uncertainty associated with the business or management’s forecasts and assumptions). To assess the reasonableness of the discount rates used for each reporting unit, management compares the discount rate to the estimated cost of equity for publicly traded institutions with similar businesses and risk characteristics. In addition, the weighted average cost of equity (aggregating the various reporting units) is compared with the Firm’s overall estimated cost of equity to ensure reasonableness. The valuations derived from the discounted cash flow analysis are then compared with market-based trading and transaction multiples for relevant competitors. Trading and transaction comparables are used as general indicators to assess the overall reasonableness of the estimated fair values, although precise conclusions generally cannot be drawn due to the differences that naturally exist between the Firm’s businesses and competitor institutions. Management also takes into consideration a comparison between the aggregate fair values of the Firm’s reporting units and JPMorgan Chase’s market capitalization. In evaluating this comparison, management considers several factors, including (i) a control premium that would exist in a market transaction, (ii) factors related to the level of execution risk that would exist at the Firmwide level that do not exist at the reporting unit level and (iii) short-term market volatility and other factors that do not directly affect the value of individual reporting units. Unanticipated declines in business performance, increases in credit losses, increases in capital requirements, as well as deterioration in economic or market conditions, adverse regulatory or legislative changes or increases in the estimated market cost of equity, could cause the estimated fair values of the Firm’s reporting units to decline in the future, which could result in a material impairment charge to earnings in a future period related to some portion of the associated goodwill. Mortgage servicing rights MSRs represent the fair value of expected future cash flows for performing servicing activities for others. The fair value considers estimated future servicing fees and ancillary revenue, offset by estimated costs to service the loans, and generally declines over time as net servicing cash flows are received, effectively amortizing the MSR asset against contractual servicing and ancillary fee income. MSRs are either purchased from third parties or recognized upon sale or securitization of mortgage loans if servicing is retained. As permitted by U.S. GAAP, the Firm has elected to account for its MSRs at fair value. The Firm treats its MSRs as a single class of servicing assets based on the availability of market inputs used to measure the fair value of its MSR asset and its treatment of MSRs as one aggregate pool for risk management purposes. The Firm estimates the fair value of MSRs using an option-adjusted spread (“OAS”) model, which projects MSR cash flows over multiple interest rate scenarios in conjunction with the Firm’s prepayment model, and then discounts these cash flows at risk-adjusted rates. The model considers portfolio characteristics, contractually specified servicing fees, prepayment assumptions, delinquency rates, costs to service, late charges and other ancillary revenue, and other economic factors. The Firm compares fair value estimates and assumptions to observable market data where available, and also considers recent market activity and actual portfolio experience. The fair value of MSRs is sensitive to changes in interest rates, including their effect on prepayment speeds. MSRs typically decrease in value when interest rates decline because declining interest rates tend to increase prepayments and therefore reduce the expected life of the net servicing cash flows that comprise the MSR asset. Conversely, securities (e.g., mortgage-backed securities), and certain derivatives (e.g., those for which the Firm receives fixed-rate interest payments) increase in value when interest rates decline. JPMorgan Chase uses combinations of derivatives and securities to manage the risk of changes in the fair value of MSRs. The intent is to offset any interest-rate related changes in the fair value of MSRs with changes in the fair value of the related risk management instruments. The following table summarizes MSR activity for the years ended December 31, 2021, 2020 and 2019. As of or for the year ended December 31, (in millions, except where otherwise noted) 2021 2020 2019 Fair value at beginning of period $ 3,276 $ 4,699 $ 6,130 MSR activity: Originations of MSRs 1,659 944 1,384 Purchase of MSRs 1,363 248 105 Disposition of MSRs (a) (114) (176) (789) Net additions/(dispositions) 2,908 1,016 700 Changes due to collection/realization of expected cash flows (788) (899) (951) Changes in valuation due to inputs and assumptions: Changes due to market interest rates and other (b) 404 (1,568) (893) Changes in valuation due to other inputs and assumptions: Projected cash flows (e.g., cost to service) 109 (54) (333) (e) Discount rates — 199 153 Prepayment model changes and other (c) (415) (117) (107) Total changes in valuation due to other inputs and assumptions (306) 28 (287) Total changes in valuation due to inputs and assumptions 98 (1,540) (1,180) Fair value at December 31, $ 5,494 $ 3,276 $ 4,699 Change in unrealized gains/(losses) included in income related to MSRs held at December 31, $ 98 $ (1,540) $ (1,180) Contractual service fees, late fees and other ancillary fees included in income 1,298 1,325 1,639 Third-party mortgage loans serviced at December 31, (in billions) 520 448 522 Servicer advances, net of an allowance for uncollectible amounts, at December 31, (in billions) (d) 1.6 1.8 2.0 (a) Includes excess MSRs transferred to agency-sponsored trusts in exchange for stripped mortgage backed securities (“SMBS”) for the years ended December 31, 2020 and 2019. In each transaction, a portion of the SMBS was acquired by third parties at the transaction date; the Firm acquired the remaining balance of those SMBS as trading securities. (b) Represents both the impact of changes in estimated future prepayments due to changes in market interest rates, and the difference between actual and expected prepayments. (c) Represents changes in prepayments other than those attributable to changes in market interest rates. (d) Represents amounts the Firm pays as the servicer (e.g., scheduled principal and interest, taxes and insurance), which will generally be reimbursed within a short period of time after the advance from future cash flows from the trust or the underlying loans. The Firm’s credit risk associated with these servicer advances is minimal because reimbursement of the advances is typically senior to all cash payments to investors. In addition, the Firm maintains the right to stop payment to investors if the collateral is insufficient to cover the advance. However, certain of these servicer advances may not be recoverable if they were not made in accordance with applicable rules and agreements. (e) The decrease in projected cash flows was largely related to default servicing assumption updates. The following table presents the components of mortgage fees and related income (including the impact of MSR risk management activities) for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, 2021 2020 2019 CCB mortgage fees and related income Production revenue $ 2,215 $ 2,629 $ 1,618 Net mortgage servicing revenue: Operating revenue: Loan servicing revenue 1,257 1,367 1,533 Changes in MSR asset fair value due to collection/realization of expected cash flows (788) (899) (951) Total operating revenue 469 468 582 Risk management: Changes in MSR asset fair value due to market interest rates and other (a) 404 (1,568) (893) Other changes in MSR asset fair value due to other inputs and assumptions in model (b) (306) 28 (287) Change in derivative fair value and other (623) 1,522 1,015 Total risk management (525) (18) (165) Total net mortgage servicing revenue (56) 450 417 Total CCB mortgage fees and related income 2,159 3,079 2,035 All other 11 12 1 Mortgage fees and related income $ 2,170 $ 3,091 $ 2,036 (a) Represents both the impact of changes in estimated future prepayments due to changes in market interest rates, and the difference between actual and expected prepayments. (b) Represents the aggregate impact of changes in model inputs and assumptions such as projected cash flows (e.g., cost to service), discount rates and changes in prepayments other than those attributable to changes in market interest rates (e.g., changes in prepayments due to changes in home prices). The table below outlines the key economic assumptions used to determine the fair value of the Firm’s MSRs at December 31, 2021 and 2020, and outlines the sensitivities of those fair values to immediate adverse changes in those assumptions, as defined below. December 31, 2021 2020 Weighted-average prepayment speed assumption (constant prepayment rate) 9.90 % 14.90 % Impact on fair value of 10% adverse change $ (210) $ (206) Impact on fair value of 20% adverse change (404) (392) Weighted-average option adjusted spread (a) 6.44 % 7.19 % Impact on fair value of 100 basis points adverse change $ (225) $ (134) Impact on fair value of 200 basis points adverse change (433) (258) (a) Includes the impact of operational risk and regulatory capital. Changes in fair value based on variations in assumptions generally cannot be easily extrapolated, because the relationship of the change in the assumptions to the change in fair value are often highly interrelated and may not be linear. In this table, the effect that a change in a particular assumption may have on the fair value is calculated without changing any other assumption. In reality, changes in one factor may result in changes in another, which would either magnify or counteract the impact of the initial change.

Premises and Equipment

Premises and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Premises and Equipment	Premises and equipmentPremises and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. JPMorgan Chase computes depreciation using the straight-line method over the estimated useful life of an asset. For leasehold improvements, the Firm uses the straight-line method computed over the lesser of the remainder of the lease term, or estimated useful life of the improvements. JPMorgan Chase capitalizes certain costs associated with the acquisition or development of internal-use software. Once the software is ready for its intended use, these costs are amortized on a straight-line basis over the software’s expected useful life and reviewed for impairment on an ongoing basis.

Deposits

Deposits	12 Months Ended
	Dec. 31, 2021
Deposits [Abstract]
Deposits	Deposits At December 31, 2021 and 2020, noninterest-bearing and interest-bearing deposits were as follows. December 31, (in millions) 2021 2020 U.S. offices Noninterest-bearing (included $8,115 and $9,873 at fair value) (a) $ 638,879 $ 572,711 Interest-bearing (included $629 and $2,567 at fair value) (a) 1,432,578 1,197,032 Total deposits in U.S. offices 2,071,457 1,769,743 Non-U.S. offices Noninterest-bearing (included $2,420 and $1,486 at fair value) (a) 26,229 23,435 Interest-bearing (included $169 and $558 at fair value) (a) 364,617 351,079 Total deposits in non-U.S. offices 390,846 374,514 Total deposits $ 2,462,303 $ 2,144,257 (a) Includes structured notes classified as deposits for which the fair value option has been elected. Refer to Note 3 for further discussion. At December 31, 2021 and 2020, time deposits in denominations that met or exceeded the insured limit were as follows. December 31, (in millions) 2021 2020 U.S. offices $ 38,970 $ 33,812 Non-U.S. offices (a) 54,535 50,776 (b) Total $ 93,505 $ 84,588 (a) Represents all time deposits in non-U.S.offices as these deposits typically exceed the insured limit. (b) Prior-period amount has been revised to conform with the current presentation. At December 31, 2021, the maturities of interest-bearing time deposits were as follows. December 31, 2021 U.S. Non-U.S. Total 2022 $ 47,595 $ 50,805 $ 98,400 2023 771 308 1,079 2024 269 10 279 2025 202 38 240 2026 169 821 990 After 5 years 484 132 616 Total $ 49,490 $ 52,114 $ 101,604

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	Leases Firm as lessee At December 31, 2021, JPMorgan Chase and its subsidiaries were obligated under a number of noncancellable leases, predominantly operating leases for premises and equipment used primarily for business purposes. These leases generally have terms of 20 years or less, determined based on the contractual maturity of the lease, and include periods covered by options to extend or terminate the lease when the Firm is reasonably certain that it will exercise those options. All leases with lease terms greater than twelve months are reported as a lease liability with a corresponding right-of-use (“ROU”) asset. None of these lease agreements impose restrictions on the Firm’s ability to pay dividends, engage in debt or equity financing transactions or enter into further lease agreements. Certain of these leases contain escalation clauses that will increase rental payments based on maintenance, utility and tax increases, which are non-lease components. The Firm elected not to separate lease and non-lease components of a contract for its real estate leases. As such, real estate lease payments represent payments on both lease and non-lease components. Operating lease liabilities and ROU assets are recognized at the lease commencement date based on the present value of the future minimum lease payments over the lease term. The future lease payments are discounted at a rate that represents the Firm’s collateralized borrowing rate for financing instruments of a similar term and are included in accounts payable and other liabilities. The operating lease ROU asset, included in premises and equipment, also includes any lease prepayments made, plus initial direct costs incurred, less any lease incentives received. Rental expense associated with operating leases is recognized on a straight-line basis over the lease term, and generally included in occupancy expense in the Consolidated statements of income. The following tables provide information related to the Firm’s operating leases: December 31, 2021 2020 Right-of-use assets $ 7,888 $ 8,006 Lease liabilities 8,328 8,508 Weighted average remaining lease term (in years) 8.5 8.7 Weighted average discount rate 3.40 % 3.48 % Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities - operating cash flows $ 1,656 $ 1,626 Supplemental non-cash information Right-of-use assets obtained in exchange for operating lease obligations $ 1,167 $ 1,350 Year ended December 31, 2021 2020 Rental expense Gross rental expense $ 2,086 $ 2,094 Sublease rental income (129) (166) Net rental expense $ 1,957 $ 1,928 The following table presents future payments under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 1,572 2023 1,435 2024 1,285 2025 1,115 2026 862 After 2026 3,453 Total future minimum lease payments 9,722 Less: Imputed interest (1,394) Total $ 8,328 In addition to the table above, as of December 31, 2021, the Firm had additional future operating lease commitments of $0.9 billion that were signed but had not yet commenced. These operating leases will commence between 2022 and 2023 with lease terms up to 22 years. Firm as lessor The Firm provides auto and equipment lease financing to its customers through lease arrangements with lease terms that may contain renewal, termination and/or purchase options. The Firm’s lease financings are predominantly auto operating leases. These assets subject to operating leases are recognized in other assets on the Firm’s Consolidated balance sheets and are depreciated on a straight-line basis over the lease term to reduce the asset to its estimated residual value. Depreciation expense is included in technology, communications and equipment expense in the Consolidated statements of income. The Firm’s lease income is generally recognized on a straight-line basis over the lease term and is included in other income in the Consolidated statements of income. On a periodic basis, the Firm assesses leased assets for impairment, and if the carrying amount of the leased asset exceeds the undiscounted cash flows from the lease payments and the estimated residual value upon disposition of the leased asset, an impairment loss is recognized. The risk of loss on auto and equipment leased assets relating to the residual value of the leased assets is monitored through projections of the asset residual values at lease origination and periodic review of residual values, and is mitigated through arrangements with certain manufacturers or lessees. The following table presents the carrying value of assets subject to leases reported on the Consolidated balance sheets: December 31, 2021 2020 Carrying value of assets subject to operating leases, net of accumulated depreciation $ 17,553 $ 21,155 Accumulated depreciation 5,737 6,388 The following table presents the Firm’s operating lease income and the related depreciation expense on the Consolidated statements of income: Year ended December 31, (in millions) 2021 2020 2019 Operating lease income $ 4,914 $ 5,539 $ 5,455 Depreciation expense 3,380 4,257 4,157 The following table presents future receipts under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 2,984 2023 1,674 2024 559 2025 48 2026 43 After 2026 — Total future minimum lease receipts $ 5,308
Leases	Leases Firm as lessee At December 31, 2021, JPMorgan Chase and its subsidiaries were obligated under a number of noncancellable leases, predominantly operating leases for premises and equipment used primarily for business purposes. These leases generally have terms of 20 years or less, determined based on the contractual maturity of the lease, and include periods covered by options to extend or terminate the lease when the Firm is reasonably certain that it will exercise those options. All leases with lease terms greater than twelve months are reported as a lease liability with a corresponding right-of-use (“ROU”) asset. None of these lease agreements impose restrictions on the Firm’s ability to pay dividends, engage in debt or equity financing transactions or enter into further lease agreements. Certain of these leases contain escalation clauses that will increase rental payments based on maintenance, utility and tax increases, which are non-lease components. The Firm elected not to separate lease and non-lease components of a contract for its real estate leases. As such, real estate lease payments represent payments on both lease and non-lease components. Operating lease liabilities and ROU assets are recognized at the lease commencement date based on the present value of the future minimum lease payments over the lease term. The future lease payments are discounted at a rate that represents the Firm’s collateralized borrowing rate for financing instruments of a similar term and are included in accounts payable and other liabilities. The operating lease ROU asset, included in premises and equipment, also includes any lease prepayments made, plus initial direct costs incurred, less any lease incentives received. Rental expense associated with operating leases is recognized on a straight-line basis over the lease term, and generally included in occupancy expense in the Consolidated statements of income. The following tables provide information related to the Firm’s operating leases: December 31, 2021 2020 Right-of-use assets $ 7,888 $ 8,006 Lease liabilities 8,328 8,508 Weighted average remaining lease term (in years) 8.5 8.7 Weighted average discount rate 3.40 % 3.48 % Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities - operating cash flows $ 1,656 $ 1,626 Supplemental non-cash information Right-of-use assets obtained in exchange for operating lease obligations $ 1,167 $ 1,350 Year ended December 31, 2021 2020 Rental expense Gross rental expense $ 2,086 $ 2,094 Sublease rental income (129) (166) Net rental expense $ 1,957 $ 1,928 The following table presents future payments under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 1,572 2023 1,435 2024 1,285 2025 1,115 2026 862 After 2026 3,453 Total future minimum lease payments 9,722 Less: Imputed interest (1,394) Total $ 8,328 In addition to the table above, as of December 31, 2021, the Firm had additional future operating lease commitments of $0.9 billion that were signed but had not yet commenced. These operating leases will commence between 2022 and 2023 with lease terms up to 22 years. Firm as lessor The Firm provides auto and equipment lease financing to its customers through lease arrangements with lease terms that may contain renewal, termination and/or purchase options. The Firm’s lease financings are predominantly auto operating leases. These assets subject to operating leases are recognized in other assets on the Firm’s Consolidated balance sheets and are depreciated on a straight-line basis over the lease term to reduce the asset to its estimated residual value. Depreciation expense is included in technology, communications and equipment expense in the Consolidated statements of income. The Firm’s lease income is generally recognized on a straight-line basis over the lease term and is included in other income in the Consolidated statements of income. On a periodic basis, the Firm assesses leased assets for impairment, and if the carrying amount of the leased asset exceeds the undiscounted cash flows from the lease payments and the estimated residual value upon disposition of the leased asset, an impairment loss is recognized. The risk of loss on auto and equipment leased assets relating to the residual value of the leased assets is monitored through projections of the asset residual values at lease origination and periodic review of residual values, and is mitigated through arrangements with certain manufacturers or lessees. The following table presents the carrying value of assets subject to leases reported on the Consolidated balance sheets: December 31, 2021 2020 Carrying value of assets subject to operating leases, net of accumulated depreciation $ 17,553 $ 21,155 Accumulated depreciation 5,737 6,388 The following table presents the Firm’s operating lease income and the related depreciation expense on the Consolidated statements of income: Year ended December 31, (in millions) 2021 2020 2019 Operating lease income $ 4,914 $ 5,539 $ 5,455 Depreciation expense 3,380 4,257 4,157 The following table presents future receipts under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 2,984 2023 1,674 2024 559 2025 48 2026 43 After 2026 — Total future minimum lease receipts $ 5,308

Accounts Payable and Other Liab

Accounts Payable and Other Liabilities	12 Months Ended
	Dec. 31, 2021
Accounts Payable and Accrued Liabilities [Abstract]
Accounts Payable and Other Liabilities	Accounts payable and other liabilities Accounts payable and other liabilities consist of brokerage payables, which include payables to customers and payables related to security purchases that did not settle, as well as other accrued expenses, such as credit card rewards liability, operating lease liabilities, income tax payables, and litigation reserves. The following table details the components of accounts payable and other liabilities. December 31, (in millions) 2021 2020 Brokerage payables $ 169,172 $ 140,291 Other payables and liabilities (a)(b) 93,583 90,994 Total accounts payable and other liabilities $ 262,755 $ 231,285 (a) Includes credit card rewards liability of $9.8 billion and $7.7 billion at December 31, 2021 and 2020, respectively. (b) Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Long-term Debt

Long-term Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Long-term Debt	Long-term debt JPMorgan Chase issues long-term debt denominated in various currencies, predominantly U.S. dollars, with both fixed and variable interest rates. Included in senior and subordinated debt below are various equity-linked or other indexed instruments, which the Firm has elected to measure at fair value. Changes in fair value are recorded in principal transactions revenue in the Consolidated statements of income, except for unrealized gains/(losses) due to DVA which are recorded in OCI. The following table is a summary of long-term debt carrying values (including unamortized premiums and discounts, issuance costs, valuation adjustments and fair value adjustments, where applicable) by remaining contractual maturity as of December 31, 2021. By remaining maturity at 2021 2020 Under 1 year 1-5 years After 5 years Total Total Parent company Senior debt: Fixed rate $ 9,900 $ 71,001 $ 121,469 $ 202,370 $ 180,208 (h) Variable rate 845 9,106 3,392 13,343 11,877 (h) Interest rates (a) 2.93 % 2.22 % 3.00 % 2.67 % 2.97 % Subordinated debt: Fixed rate $ — $ 8,168 $ 10,101 $ 18,269 $ 19,255 Variable rate — — — — 9 Interest rates (a) — % 4.21 % 4.28 % 4.24 % 4.24 % Subtotal $ 10,745 $ 88,275 $ 134,962 $ 233,982 $ 211,349 Subsidiaries Federal Home Loan Banks advances: Fixed rate $ 8 $ 45 $ 57 $ 110 $ 123 Variable rate — 11,000 — 11,000 14,000 Interest rates (a) 5.53 % 0.19 % 6.14 % 0.23 % 0.34 % Senior debt: Fixed rate $ 775 $ 4,701 $ 10,028 $ 15,504 $ 16,227 (h) Variable rate 11,248 19,896 7,003 38,147 37,642 (h) Interest rates (a) 4.55 % 4.92% 1.64 % 2.09 % 2.28 % Subordinated debt: Fixed rate $ — $ 287 $ — $ 287 $ 309 Variable rate — — — — — Interest rates (a) — % 8.25 % — % 8.25 % 8.25 % Subtotal $ 12,031 $ 35,929 $ 17,088 $ 65,048 $ 68,301 Junior subordinated debt: Fixed rate $ — $ — $ 678 $ 678 $ 738 Variable rate — — 1,297 1,297 1,297 Interest rates (a) — % — % 3.20 % 3.20 % 3.26 % Subtotal $ — $ — $ 1,975 $ 1,975 $ 2,035 Total long-term debt (b)(c)(d) $ 22,776 $ 124,204 $ 154,025 $ 301,005 (f)(g) $ 281,685 Long-term beneficial interests: Fixed rate $ 748 $ 999 $ — $ 1,747 $ 2,369 Variable rate 650 — 179 829 2,784 Interest rates (a) 1.39 % 1.53 % 3.24 % 1.57 % 1.30 % Total long-term beneficial interests (e) $ 1,398 $ 999 $ 179 $ 2,576 $ 5,153 (a) The interest rates shown are the weighted average of contractual rates in effect at December 31, 2021 and 2020, respectively, including non-U.S. dollar fixed- and variable-rate issuances, which excludes the effects of the associated derivative instruments used in hedge accounting relationships, if applicable. The interest rates shown exclude structured notes accounted for at fair value. (b) Included long-term debt of $14.1 billion and $17.2 billion secured by assets totaling $170.6 billion and $166.4 billion at December 31, 2021 and 2020, respectively. The amount of long-term debt secured by assets does not include amounts related to hybrid instruments. (c) Included $74.9 billion and $76.8 billion of long-term debt accounted for at fair value at December 31, 2021 and 2020, respectively. (d) Included $15.8 billion and $16.1 billion of outstanding zero-coupon notes at December 31, 2021 and 2020, respectively. The aggregate principal amount of these notes at their respective maturities is $46.4 billion and $45.3 billion, respectively. The aggregate principal amount reflects the contractual principal payment at maturity, which may exceed the contractual principal payment at the Firm’s next call date, if applicable. (e) Included on the Consolidated balance sheets in beneficial interests issued by consolidated VIEs. Also included $12 million and $41 million accounted for at fair value at December 31, 2021 and 2020, respectively. Excluded short-term commercial paper and other short-term beneficial interests of $8.2 billion and $12.4 billion at December 31, 2021 and 2020, respectively. (f) At December 31, 2021, long-term debt in the aggregate of $185.0 billion was redeemable at the option of JPMorgan Chase, in whole or in part, prior to maturity, based on the terms specified in the respective instruments. (g) The aggregate carrying values of debt that matures in each of the five years subsequent to 2021 is $22.8 billion in 2022, $32.6 billion in 2023, $36.4 billion in 2024, $26.1 billion in 2025 and $29.1 billion in 2026. (h) Prior-period amounts have been revised to conform with the current presentation. The weighted-average contractual interest rates for total long-term debt excluding structured notes accounted for at fair value were 2.67% and 2.89% as of December 31, 2021 and 2020, respectively. In order to modify exposure to interest rate and currency exchange rate movements, JPMorgan Chase utilizes derivative instruments, primarily interest rate and cross-currency interest rate swaps, in conjunction with some of its debt issuances. The use of these instruments modifies the Firm’s interest expense on the associated debt. The modified weighted-average interest rates for total long-term debt, including the effects of related derivative instruments, were 1.43% and 1.59% as of December 31, 2021 and 2020, respectively. JPMorgan Chase & Co. has guaranteed certain long-term debt of its subsidiaries, including structured notes. These guarantees rank on parity with the Firm’s other unsecured and unsubordinated indebtedness. The amount of such guaranteed long-term debt and structured notes was $16.4 billion and $13.8 billion at December 31, 2021 and 2020, respectively. The Firm’s unsecured debt does not contain requirements that would call for an acceleration of payments, maturities or changes in the structure of the existing debt, provide any limitations on future borrowings or require additional collateral, based on unfavorable changes in the Firm’s credit ratings, financial ratios, earnings or stock price.

Preferred Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Preferred Stock	Preferred stock At December 31, 2021 and 2020, JPMorgan Chase was authorized to issue 200 million shares of preferred stock, in one or more series, with a par value of $1 per share. In the event of a liquidation or dissolution of the Firm, JPMorgan Chase’s preferred stock then outstanding takes precedence over the Firm’s common stock with respect to the payment of dividends and the distribution of assets. The following is a summary of JPMorgan Chase’s non-cumulative preferred stock outstanding as of December 31, 2021 and 2020. Shares (a) Carrying value Issue date Contractual rate Earliest redemption date (b) Floating annualized rate (c) Dividend declared per share (d) December 31, December 31, Year ended December 31, 2021 2020 2021 2020 2021 2020 2019 Fixed-rate: Series P — — $ — $ — 2/5/2013 — % 3/1/2018 NA $— $— $545.00 Series T — — — — 1/30/2014 — 3/1/2019 NA — — 167.50 Series W — — — — 6/23/2014 — 9/1/2019 NA — — 472.50 Series Y — — — — 2/12/2015 — 3/1/2020 NA — 153.13 612.52 Series AA — 142,500 — 1,425 6/4/2015 — 9/1/2020 NA 305.00 610.00 610.00 Series BB — 115,000 — 1,150 7/29/2015 — 9/1/2020 NA 307.50 615.00 615.00 Series DD 169,625 169,625 1,696 1,696 9/21/2018 5.750 12/1/2023 NA 575.00 575.00 575.00 Series EE 185,000 185,000 1,850 1,850 1/24/2019 6.000 3/1/2024 NA 600.00 600.00 511.67 (e) Series GG 90,000 90,000 900 900 11/7/2019 4.750 12/1/2024 NA 475.00 506.67 NA (e) Series JJ 150,000 — 1,500 — 3/17/2021 4.550 6/1/2026 NA 321.03 NA NA (e) Series LL 185,000 — 1,850 — 5/20/2021 4.625 6/1/2026 NA 245.39 NA NA (e) Series MM 200,000 — 2,000 — 7/29/2021 4.200 9/1/2026 NA 142.33 NA NA (e) Fixed-to-floating-rate: Series I 293,375 293,375 $ 2,934 $ 2,934 4/23/2008 LIBOR + 3.47% 4/30/2018 LIBOR + 3.47% $370.38 $428.03 $593.23 Series Q 150,000 150,000 1,500 1,500 4/23/2013 5.150 5/1/2023 LIBOR + 3.25 515.00 515.00 515.00 Series R 150,000 150,000 1,500 1,500 7/29/2013 6.000 8/1/2023 LIBOR + 3.30 600.00 600.00 600.00 Series S 200,000 200,000 2,000 2,000 1/22/2014 6.750 2/1/2024 LIBOR + 3.78 675.00 675.00 675.00 Series U 100,000 100,000 1,000 1,000 3/10/2014 6.125 4/30/2024 LIBOR + 3.33 612.50 612.50 612.50 Series V 250,000 250,000 2,500 2,500 6/9/2014 LIBOR + 3.32% 7/1/2019 LIBOR + 3.32 353.65 436.85 534.09 (f) Series X 160,000 160,000 1,600 1,600 9/23/2014 6.100 10/1/2024 LIBOR + 3.33 610.00 610.00 610.00 Series Z 200,000 200,000 2,000 2,000 4/21/2015 LIBOR + 3.80% 5/1/2020 LIBOR + 3.80 401.44 453.52 530.00 (g) Series CC 125,750 125,750 1,258 1,258 10/20/2017 4.625 11/1/2022 LIBOR + 2.58 462.50 462.50 462.50 Series FF 225,000 225,000 2,250 2,250 7/31/2019 5.000 8/1/2024 SOFR + 3.38 500.00 500.00 251.39 (e) Series HH 300,000 300,000 3,000 3,000 1/23/2020 4.600 2/1/2025 SOFR + 3.125 460.00 470.22 NA (e) Series II 150,000 150,000 1,500 1,500 2/24/2020 4.000 4/1/2025 SOFR + 2.745 400.00 341.11 NA (e) Series KK 200,000 — 2,000 — 5/12/2021 3.650 6/1/2026 CMT + 2.85 201.76 NA NA (e) Total preferred stock 3,483,750 3,006,250 $ 34,838 $ 30,063 (a) Represented by depositary shares. (b) Fixed-to-floating rate notes convert to a floating rate at the earliest redemption date. (c) Floating annualized rate includes three-month LIBOR, three-month term SOFR or five-year Constant Maturity Treasury ("CMT") rate, as applicable, plus the spreads noted above. (d) Dividends are declared quarterly. Dividends are payable quarterly on fixed-rate preferred stock. Dividends are payable semiannually on fixed-to-floating-rate preferred stock while at a fixed rate, and payable quarterly after converting to a floating rate. (e) The initial dividend declared is prorated based on the number of days outstanding for the period. Dividends were declared quarterly thereafter at the contractual rate. (f) The dividend rate for Series V preferred stock became floating and payable quarterly starting on July 1, 2019; prior to which the dividend rate was fixed at 5% or $250.00 per share payable semi annually. (g) The dividend rate for Series Z preferred stock became floating and payable quarterly starting on May 1, 2020; prior to which the dividend rate was fixed at 5.3% or $265.00 per share payable semi annually. Each series of preferred stock has a liquidation value and redemption price per share of $10,000, plus accrued but unpaid dividends. The aggregate liquidation value was $35.2 billion at December 31, 2021. Redemptions On February 1, 2022, the Firm redeemed all $2.0 billion of its fixed-to-floating rate non-cumulative preferred stock, Series Z. On June 1, 2021, the Firm redeemed all $1.43 billion of its 6.10% non-cumulative preferred stock, Series AA and all $1.15 billion of its 6.15% non-cumulative preferred stock, Series BB. On March 1, 2020, the Firm redeemed all $1.43 billion of its 6.125% non-cumulative preferred stock, Series Y. Redemption rights Each series of the Firm’s preferred stock may be redeemed on any dividend payment date on or after the earliest redemption date for that series. All outstanding preferred stock series except Series I may also be redeemed following a “capital treatment event,” as described in the terms of each series. Any redemption of the Firm’s preferred stock is subject to non-objection from the Board of Governors of the Federal Reserve System (the “Federal Reserve”).

Common Stock

Common Stock	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Common Stock	Common stock At December 31, 2021 and 2020, JPMorgan Chase was authorized to issue 9.0 billion shares of common stock with a par value of $1 per share. Common shares issued (reissuances from treasury) by JPMorgan Chase during the years ended December 31, 2021, 2020 and 2019 were as follows. Year ended December 31, 2021 2020 2019 Total issued – balance at January 1 4,104.9 4,104.9 4,104.9 Treasury – balance at January 1 (1,055.5) (1,020.9) (829.1) Repurchase (119.7) (50.0) (213.0) Reissuance: Employee benefits and compensation plans 13.5 14.2 20.4 Employee stock purchase plans 0.9 1.2 0.8 Total reissuance 14.4 15.4 21.2 Total treasury – balance at December 31 (1,160.8) (1,055.5) (1,020.9) Outstanding at December 31 2,944.1 3,049.4 3,084.0 On December 18, 2020, the Federal Reserve announced that all large banks, including the Firm, could resume share repurchases commencing in the first quarter of 2021. Subsequently, the Firm announced that its Board of Directors authorized a new common share repurchase program for up to $30 billion. As directed by the Federal Reserve, total net repurchases and common stock dividends in the first and second quarters of 2021 were restricted and could not exceed the average of the Firm’s net income for the four preceding calendar quarters. On June 24, 2021, the Federal Reserve announced that the temporary restrictions on capital distributions would expire on June 30, 2021 as a result of the Firm remaining above its minimum risk-based capital requirements under the 2021 CCAR stress test. Effective July 1, 2021, the Firm became subject to the normal capital distribution restrictions provided under the regulatory capital framework. The Firm continues to be authorized to repurchase common shares under its existing common share repurchase program previously approved by the Board of Directors. The following table sets forth the Firm’s repurchases of common stock for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, (in millions) 2021 2020 (a) 2019 Total number of shares of common stock repurchased 119.7 50.0 213.0 Aggregate purchase price of common stock repurchases $ 18,448 $ 6,397 $ 24,121 (a) On March 15, 2020, in response to the economic disruptions caused by the COVID-19 pandemic, the Firm temporarily suspended repurchases of its common stock. Subsequently, the Federal Reserve directed all large banks, including the Firm, to discontinue net share repurchases through the end of 2020. The authorization to repurchase common shares is utilized at management’s discretion, and the timing of purchases and the exact amount of common shares that may be repurchased is subject to various factors, including market conditions; legal and regulatory considerations affecting the amount and timing of repurchase activity; the Firm’s capital position (taking into account goodwill and intangibles); internal capital generation; and alternative investment opportunities. The repurchase program does not include specific price targets or timetables; may be suspended by management at any time; and may be executed through open market purchases or privately negotiated transactions, or utilizing Rule 10b5-1 plans, which are written trading plans that the Firm may enter into from time to time under Rule 10b5-1 of the Securities Exchange Act of 1934 and which allow the Firm to repurchase its common shares during periods when it may otherwise not be repurchasing common shares —for example, during internal trading blackout periods. As of December 31, 2021, approximately 58.3 million shares of common stock were reserved for issuance under various employee incentive, compensation, option and stock purchase plans, and directors’ compensation plans.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings per share Basic earnings per share (“EPS”) is calculated using the two-class method. Under the two-class method, all earnings (distributed and undistributed) are allocated to common stock and participating securities. JPMorgan Chase grants RSUs under its share-based compensation programs, predominantly all of which entitle recipients to receive nonforfeitable dividends during the vesting period on a basis equivalent to dividends paid to holders of the Firm’s common stock. These unvested RSUs meet the definition of participating securities based on their respective rights to receive nonforfeitable dividends, and they are treated as a separate class of securities in computing basic EPS. Participating securities are not included as incremental shares in computing diluted EPS; refer to Note 9 for additional information. Diluted EPS incorporates the potential impact of contingently issuable shares, including awards which require future service as a condition of delivery of the underlying common stock. Diluted EPS is calculated under both the two-class and treasury stock methods, and the more dilutive amount is reported. For each of the periods presented in the table below, diluted EPS calculated under the two-class method was more dilutive. The following table presents the calculation of net income applicable to common stockholders and basic and diluted EPS for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, 2021 2020 2019 Basic earnings per share Net income $ 48,334 $ 29,131 $ 36,431 Less: Preferred stock dividends 1,600 1,583 1,587 Net income applicable to common equity 46,734 27,548 34,844 Less: Dividends and undistributed earnings allocated to participating securities 231 138 202 Net income applicable to common stockholders $ 46,503 $ 27,410 $ 34,642 Total weighted-average basic shares outstanding 3,021.5 3,082.4 3,221.5 Net income per share $ 15.39 $ 8.89 $ 10.75 Diluted earnings per share Net income applicable to common stockholders $ 46,503 $ 27,410 $ 34,642 Total weighted-average basic shares outstanding 3,021.5 3,082.4 3,221.5 Add: Dilutive impact of SARs and employee stock options, unvested PSUs and nondividend-earning RSUs, and warrants 5.1 5.0 8.9 Total weighted-average diluted shares outstanding 3,026.6 3,087.4 3,230.4 Net income per share $ 15.36 $ 8.88 $ 10.72

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income/(Loss)	12 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income/(Loss)	Accumulated other comprehensive income/(loss) AOCI includes the after-tax change in unrealized gains and losses on investment securities, foreign currency translation adjustments (including the impact of related derivatives), fair value changes of excluded components on fair value hedges, cash flow hedging activities, net loss and prior service costs/(credit) related to the Firm’s defined benefit pension and OPEB plans, and fair value option-elected liabilities arising from changes in the Firm’s own credit risk (DVA). Year ended December 31, Unrealized Translation adjustments, net of hedges Fair value Cash flow hedges Defined benefit pension and OPEB plans DVA on fair value option elected liabilities Accumulated other comprehensive income/(loss) Balance at December 31, 2018 $ 1,202 $ (727) $ (161) $ (109) $ (2,308) $ 596 $ (1,507) Net change 2,855 20 30 172 964 (965) 3,076 Balance at December 31, 2019 $ 4,057 $ (707) $ (131) $ 63 $ (1,344) $ (369) $ 1,569 Net change 4,123 234 19 2,320 212 (491) 6,417 Balance at December 31, 2020 $ 8,180 $ (473) $ (112) $ 2,383 $ (1,132) $ (860) $ 7,986 Net change (5,540) (461) (19) (2,679) 922 (293) (8,070) Balance at December 31, 2021 $ 2,640 (a) $ (934) $ (131) $ (296) $ (210) $ (1,153) $ (84) (a) Includes after-tax net unamortized unrealized gains of $2.4 billion related to AFS securities that have been transferred to HTM. Refer to Note 10 for further information. The following table presents the pre-tax and after-tax changes in the components of OCI. 2021 2020 2019 Year ended December 31, (in millions) Pre-tax Tax effect After-tax Pre-tax Tax effect After-tax Pre-tax Tax effect After-tax Unrealized gains/(losses) on investment securities: Net unrealized gains/(losses) arising during the period $ (7,634) $ 1,832 $ (5,802) $ 6,228 $ (1,495) $ 4,733 $ 4,025 $ (974) $ 3,051 Reclassification adjustment for realized (gains)/losses included in net income (a) 345 (83) 262 (802) 192 (610) (258) 62 (196) Net change (7,289) 1,749 (5,540) 5,426 (1,303) 4,123 3,767 (912) 2,855 Translation adjustments (b) : Translation (2,447) 125 (2,322) 1,407 (103) 1,304 (49) 33 (16) Hedges 2,452 (591) 1,861 (1,411) 341 (1,070) 46 (10) 36 Net change 5 (466) (461) (4) 238 234 (3) 23 20 Fair value hedges, net change (c) : (26) 7 (19) 25 (6) 19 39 (9) 30 Cash flow hedges: Net unrealized gains/(losses) arising during the period (2,303) 553 (1,750) 3,623 (870) 2,753 122 (28) 94 Reclassification adjustment for realized (gains)/losses included in net income (d) (1,222) 293 (929) (570) 137 (433) 103 (25) 78 Net change (3,525) 846 (2,679) 3,053 (733) 2,320 225 (53) 172 Defined benefit pension and OPEB plans, net change: 1,129 (207) 922 214 (2) 212 1,157 (193) 964 DVA on fair value option elected liabilities, net change: (393) 100 (293) (648) 157 (491) (1,264) 299 (965) Total other comprehensive income/(loss) $ (10,099) $ 2,029 $ (8,070) $ 8,066 $ (1,649) $ 6,417 $ 3,921 $ (845) $ 3,076 (a) The pre-tax amount is reported in Investment securities gains/(losses) in the Consolidated statements of income. (b) Reclassifications of pre-tax realized gains/(losses) on translation adjustments and related hedges are reported in other income/expense in the Consolidated statements of income. During the year ended December 31, 2021, the Firm reclassified a net pre-tax loss of $7 million to other expense related to the liquidation of certain legal entities, driven by cumulative translation adjustments. During the year ended December 31, 2020, the Firm reclassified a net pre-tax gain of $6 million to other income related to the liquidation of legal entities, $3 million related to net investment hedge gains and $3 million related to cumulative translation adjustments. During the year ended December 31, 2019, the Firm reclassified net pre-tax gains of $7 million to other income and $1 million to other expense, respectively. These amounts, which related to the liquidation of certain legal entities, are comprised of $18 million related to net investment hedge gains and $10 million related to cumulative translation adjustments. (c) Represents changes in fair value of cross-currency swaps attributable to changes in cross-currency basis spreads, which are excluded from the assessment of hedge effectiveness and recorded in other comprehensive income. The initial cost of cross-currency basis spreads is recognized in earnings as part of the accrual of interest on the cross-currency swap. (d) The pre-tax amounts are primarily recorded in noninterest revenue, net interest income and compensation expense in the Consolidated statements of income.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income taxes JPMorgan Chase and its eligible subsidiaries file a consolidated U.S. federal income tax return. JPMorgan Chase uses the asset and liability method to provide income taxes on all transactions recorded in the Consolidated Financial Statements. This method requires that income taxes reflect the expected future tax consequences of temporary differences between the carrying amounts of assets or liabilities for book and tax purposes. Accordingly, a deferred tax asset or liability for each temporary difference is determined based on the tax rates that the Firm expects to be in effect when the underlying items of income and expense are realized. JPMorgan Chase’s expense for income taxes includes the current and deferred portions of that expense. A valuation allowance is established to reduce deferred tax assets to the amount the Firm expects to realize. Due to the inherent complexities arising from the nature of the Firm’s businesses, and from conducting business and being taxed in a substantial number of jurisdictions, significant judgments and estimates are required to be made. Agreement of tax liabilities between JPMorgan Chase and the many tax jurisdictions in which the Firm files tax returns may not be finalized for several years. Thus, the Firm’s final tax-related assets and liabilities may ultimately be different from those currently reported. In the first quarter of 2021, the Firm reclassified certain deferred investment tax credits from accounts payable and other liabilities to other assets to be a reduction to the carrying value of the associated tax-oriented investments. The reclassification also resulted in an increase in income tax expense and a corresponding increase in other income, with no effect on net income. Prior-period amounts have been revised to conform with the current presentation, including the Firm’s effective income tax rate. Effective tax rate and expense The following table presents a reconciliation of the applicable statutory U.S. federal income tax rate to the effective tax rate. Effective tax rate Year ended December 31, 2021 2020 2019 Statutory U.S. federal tax rate 21.0 % 21.0 % 21.0 % Increase/(decrease) in tax rate resulting from: U.S. state and local income taxes, net of U.S. federal income tax benefit 3.0 2.5 3.5 Tax-exempt income (0.9) (1.6) (1.4) Non-U.S. earnings 0.1 1.4 1.8 Business tax credits (4.2) (5.4) (a) (3.8) (a) Tax audit resolutions — — (2.3) Other, net (0.1) 0.8 (a) — Effective tax rate 18.9 % 18.7 % 18.8 % (a) Prior-period amounts have been revised to conform with the current presentation. The following table reflects the components of income tax expense/(benefit) included in the Consolidated statements of income. Income tax expense/(benefit) Year ended December 31, 2021 2020 2019 Current income tax expense/(benefit) U.S. federal $ 2,865 $ 5,759 $ 3,284 Non-U.S. 2,718 2,705 2,103 U.S. state and local 1,897 1,793 1,778 Total current income tax expense/(benefit) 7,480 10,257 7,165 Deferred income tax expense/(benefit) U.S. federal 3,460 (2,776) (a) 1,030 (a) Non-U.S. (101) (126) 20 U.S. state and local 389 (671) 220 Total deferred income tax 3,748 (3,573) 1,270 Total income tax expense $ 11,228 $ 6,684 $ 8,435 (a) Prior-period amount has been revised to conform with the current presentation. Total income tax expense includes $69 million tax expense, and $72 million and $1.1 billion of tax benefits recorded in 2021, 2020, and 2019, respectively, resulting from the resolution of tax audits. Tax effect of items recorded in stockholders’ equity The preceding table does not reflect the tax effect of certain items that are recorded each period directly in stockholders’ equity. The tax effect of all items recorded directly to stockholders’ equity resulted in an increase of $2.0 billion in 2021 and decreases of $827 million and Results from non-U.S. earnings The following table presents the U.S. and non-U.S. components of income before income tax expense. Year ended December 31, 2021 2020 2019 U.S. $ 50,126 $ 27,312 (b) $ 36,991 (b) Non-U.S. (a) 9,436 8,503 7,875 Income before income tax expense $ 59,562 $ 35,815 $ 44,866 (a) For purposes of this table, non-U.S. income is defined as income generated from operations located outside the U.S. (b) Prior-period amount has been revised to conform with the current presentation. Deferred taxes Deferred income tax expense/(benefit) results from differences between assets and liabilities measured for financial reporting purposes versus income tax return purposes. Deferred tax assets are recognized if, in management’s judgment, their realizability is determined to be more likely than not. If a deferred tax asset is determined to be unrealizable, a valuation allowance is established. The significant components of deferred tax assets and liabilities are reflected in the following table. December 31, (in millions) 2021 2020 Deferred tax assets Allowance for loan losses $ 4,345 $ 7,270 Employee benefits 987 1,104 Accrued expenses and other 3,955 3,332 Non-U.S. operations 900 849 Tax attribute carryforwards 615 757 Gross deferred tax assets 10,802 13,312 Valuation allowance (378) (560) Deferred tax assets, net of valuation allowance $ 10,424 $ 12,752 Deferred tax liabilities Depreciation and amortization $ 3,289 $ 3,329 Mortgage servicing rights, net of hedges 2,049 2,184 Leasing transactions 4,227 5,124 Other, net 4,459 6,025 Gross deferred tax liabilities 14,024 16,662 Net deferred tax (liabilities)/assets $ (3,600) $ (3,910) JPMorgan Chase has recorded deferred tax assets of $615 million at December 31, 2021, in connection with U.S. federal and non-U.S. NOL carryforwards and other tax attributes, FTC carryforwards, and state and local capital loss carryforwards. At December 31, 2021, total U.S. federal NOL carryforwards were $972 million, non-U.S. NOL carryforwards were $210 million, FTC carryforwards were $258 million, state and local capital loss carryforwards were $1.1 billion, and other U.S. federal tax attributes were $359 million. If not utilized, a portion of the U.S. federal NOL carryforwards and other U.S. federal tax attributes will expire between 2026 and 2037 whereas others have an unlimited carryforward period. Similarly, certain non-U.S. NOL carryforwards will expire between 2026 and 2036 whereas others have an unlimited carryforward period. The FTC carryforwards will expire between 2029 and 2030, and the state and local capital loss carryforwards will expire in 2022. The valuation allowance at December 31, 2021, was due to the state and local capital loss carryforwards, FTC carryforwards, and certain non-U.S. deferred tax assets, including NOL carryforwards. Unrecognized tax benefits At December 31, 2021, 2020 and 2019, JPMorgan Chase’s unrecognized tax benefits, excluding related interest expense and penalties, were $4.6 billion, $4.3 billion and $4.0 billion, respectively, of which $3.4 billion, $3.1 billion and $2.8 billion, respectively, if recognized, would reduce the annual effective tax rate. Included in the amount of unrecognized tax benefits are certain items that would not affect the effective tax rate if they were recognized in the Consolidated statements of income. These unrecognized items include the tax effect of certain temporary differences, the portion of gross state and local unrecognized tax benefits that would be offset by the benefit from associated U.S. federal income tax deductions, and the portion of gross non-U.S. unrecognized tax benefits that would have offsets in other jurisdictions. JPMorgan Chase is presently under audit by a number of taxing authorities, most notably by the Internal Revenue Service as summarized in the Tax examination status table below. As JPMorgan Chase is presently under audit by a number of taxing authorities, it is reasonably possible that over the next 12 months the resolution of these examinations may increase or decrease the gross balance of unrecognized tax benefits by as much as approximately $300 million. Upon settlement of an audit, the change in the unrecognized tax benefit would result from payment or income statement recognition. The following table presents a reconciliation of the beginning and ending amount of unrecognized tax benefits. Year ended December 31, 2021 2020 2019 Balance at January 1, $ 4,250 $ 4,024 $ 4,861 Increases based on tax positions related to the current period 798 685 871 Increases based on tax positions related to prior periods 393 362 10 Decreases based on tax positions related to prior periods (657) (705) (706) Decreases related to cash settlements with taxing authorities (148) (116) (1,012) Balance at December 31, $ 4,636 $ 4,250 $ 4,024 After-tax interest expense/(benefit) and penalties related to income tax liabilities recognized in income tax expense were $174 million, $147 million and $(52) million in 2021, 2020 and 2019, respectively. Tax examination status JPMorgan Chase is continually under examination by the Internal Revenue Service, by taxing authorities throughout the world, and by many state and local jurisdictions throughout the U.S. The following table summarizes the status of significant income tax examinations of JPMorgan Chase and its consolidated subsidiaries as of December 31, 2021. Periods under examination Status JPMorgan Chase – U.S. 2011 – 2013 Field examination of amended returns JPMorgan Chase – U.S. 2014 - 2018 Field Examination JPMorgan Chase – New York State 2012 - 2014 Field Examination JPMorgan Chase – New York City 2015 - 2017 Field Examination JPMorgan Chase – California 2011 – 2012 Field Examination JPMorgan Chase – U.K. 2006 – 2019 Field examination of certain select entities

Restricted Cash, Other Restrict

Restricted Cash, Other Restricted Assets and Intercompany Funds Transfers	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Restricted Cash, Other Restricted Assets and Intercompany Funds Transfers	Restricted cash, other restricted assets and intercompany funds transfers Restricted cash and other restricted assets Certain of the Firm’s cash and other assets are restricted as to withdrawal or usage. These restrictions are imposed by various regulatory authorities based on the particular activities of the Firm’s subsidiaries. The business of JPMorgan Chase Bank, N.A. is subject to examination and regulation by the OCC. The Bank is a member of the U.S. Federal Reserve System, and its deposits in the U.S. are insured by the FDIC, subject to applicable limits. The Firm is required to maintain cash reserves at certain non-US central banks. The Firm is also subject to rules and regulations established by other U.S. and non U.S. regulators. As part of its compliance with the respective regulatory requirements, the Firm’s broker-dealer activities are subject to certain restrictions on cash and other assets. The following table presents the components of the Firm’s restricted cash: December 31, (in billions) 2021 2020 Segregated for the benefit of securities and cleared derivative customers 14.6 19.3 Cash reserves at non-U.S. central banks and held for other general purposes 5.1 5.1 Total restricted cash (a) $ 19.7 $ 24.4 (a) Comprises $18.4 billion and $22.7 billion in deposits with banks, and $1.3 billion and $1.7 billion in cash and due from banks on the Consolidated balance sheets as of December 31, 2021 and 2020, respectively. Also, as of December 31, 2021 and 2020, the Firm had the following other restricted assets: • Cash and securities pledged with clearing organizations for the benefit of customers of $47.5 billion and $37.2 billion, respectively. • Securities with a fair value of $30.0 billion and $1.3 billion, respectively, were also restricted in relation to customer activity. Intercompany funds transfers Restrictions imposed by U.S. federal law prohibit JPMorgan Chase Bank, N.A., and its subsidiaries, from lending to JPMorgan Chase & Co. (“Parent Company”) and certain of its affiliates unless the loans are secured in specified amounts. Such secured loans provided by any banking subsidiary to the Parent Company or to any particular affiliate, together with certain other transactions with such affiliate (collectively referred to as “covered transactions”), must be made on terms and conditions that are consistent with safe and sound banking practices. In addition, unless collateralized with cash or US Government debt obligations, covered transactions are generally limited to 10% of the banking subsidiary’s total capital, as determined by the risk-based capital guidelines; the aggregate amount of covered transactions between any banking subsidiary and all of its affiliates is limited to 20% of the banking subsidiary’s total capital. The Parent Company’s two principal subsidiaries are JPMorgan Chase Bank, N.A. and JPMorgan Chase Holdings LLC, an intermediate holding company (the “IHC”). The IHC generally holds the stock of JPMorgan Chase’s subsidiaries other than JPMorgan Chase Bank, N.A. and its subsidiaries. The IHC also owns other assets and provides intercompany loans to the Parent Company. The Parent Company is obligated to contribute to the IHC substantially all the net proceeds received from securities issuances (including issuances of senior and subordinated debt securities and of preferred and common stock). The principal sources of income and funding for the Parent Company are dividends from JPMorgan Chase Bank, N.A. and dividends and extensions of credit from the IHC. In addition to dividend restrictions set forth in statutes and regulations, the Federal Reserve, the OCC and the FDIC have authority under the Financial Institutions Supervisory Act to prohibit or to limit the payment of dividends by the banking organizations they supervise, including the Parent Company and its subsidiaries that are banks or bank holding companies, if, in the banking regulator’s opinion, payment of a dividend would constitute an unsafe or unsound practice in light of the financial condition of the banking organization. The IHC is prohibited from paying dividends or extending credit to the Parent Company if certain capital or liquidity “thresholds” are breached or if limits are otherwise imposed by the Parent Company’s management or Board of Directors. At January 1, 2022, the Parent Company’s banking subsidiaries could pay, in the aggregate, approximately $20 billion in dividends to their respective bank holding companies without the prior approval of their relevant banking regulators. The capacity to pay dividends in 2022 will be supplemented by the banking subsidiaries’ earnings during the year.

Regulatory Capital

Regulatory Capital	12 Months Ended
	Dec. 31, 2021
Banking Regulation [Abstract]
Regulatory Capital	Regulatory capital The Federal Reserve establishes capital requirements, including well-capitalized requirements, for the consolidated financial holding company. The OCC establishes similar minimum capital requirements and standards for the Firm’s principal IDI subsidiary, JPMorgan Chase Bank, N.A. The capital rules under Basel III establish minimum capital ratios and overall capital adequacy standards for large and internationally active U.S. bank holding companies and banks, including the Firm and its IDI subsidiaries, including JPMorgan Chase Bank, N.A. Two comprehensive approaches are prescribed for calculating RWA: a standardized approach (“Basel III Standardized”), and an advanced approach (“Basel III Advanced”). For each of the risk-based capital ratios, the capital adequacy of the Firm and JPMorgan Chase Bank, N.A. is evaluated against the lower of the Standardized or Advanced approaches compared to their respective regulatory capital ratio requirements. The three components of regulatory capital under the Basel III rules are as illustrated below: Under the risk-based capital and leverage-based guidelines of the Federal Reserve, JPMorgan Chase is required to maintain minimum ratios for CET1 capital, Tier 1 capital, Total capital, Tier 1 leverage and the SLR. Failure to meet these minimum requirements could cause the Federal Reserve to take action. IDI subsidiaries are also subject to these capital requirements established by their respective primary regulators . The following table presents the risk-based regulatory capital ratio requirements and well-capitalized ratios to which the Firm and its IDI subsidiaries were subject as of December 31, 2021 and 2020. Standardized capital ratio requirements Advanced capital ratio requirements Well-capitalized ratios BHC (a)(b) IDI (c) BHC (a) IDI (c) BHC (d) IDI (e) Risk-based capital ratios CET1 capital 11.2 % 7.0 % 10.5 % 7.0 % NA 6.5 % Tier 1 capital 12.7 8.5 12.0 8.5 6.0 % 8.0 Total capital 14.7 10.5 14.0 10.5 10.0 10.0 Note: The table above is as defined by the regulations issued by the Federal Reserve, OCC and FDIC and to which the Firm and its IDI subsidiaries are subject. (a) Represents the regulatory capital ratio requirements applicable to the Firm. The CET1, Tier 1 and Total capital ratio requirements each include a respective minimum requirement plus a GSIB surcharge of 3.5% as calculated under Method 2; plus a 3.2% SCB for Basel III Standardized ratios and a fixed 2.5% capital conservation buffer for Basel III Advanced ratios. The countercyclical buffer is currently set to 0% by the federal banking agencies. (b) For the period ended December 31, 2020, the CET1, Tier 1, and Total capital ratio requirements under Basel III Standardized applicable to the Firm were 11.3%, 12.8% and 14.8%, respectively. (c) Represents requirements for JPMorgan Chase’s IDI subsidiaries. The CET1, Tier 1 and Total capital ratio requirements include a fixed capital conservation buffer requirement of 2.5% that is applicable to the IDI subsidiaries. The IDI subsidiaries are not subject to the GSIB surcharge. (d) Represents requirements for bank holding companies pursuant to regulations issued by the Federal Reserve. (e) Represents requirements for IDI subsidiaries pursuant to regulations issued under the FDIC Improvement Act. The following table presents the leverage-based regulatory capital ratio requirements and well-capitalized ratios to which the Firm and its IDI subsidiaries were subject as of December 31, 2021 and 2020. Capital ratio requirements (a) Well-capitalized ratios BHC IDI BHC (b) IDI Leverage-based capital ratios Tier 1 leverage 4.0 % 4.0 % NA 5.0 % SLR 5.0 6.0 NA 6.0 Note: The table above is as defined by the regulations issued by the Federal Reserve, OCC and FDIC and to which the Firm and its IDI subsidiaries are subject. (a) Represents minimum SLR requirement of 3.0%, as well as supplementary leverage buffer requirements of 2.0% and 3.0% for BHC and IDI subsidiaries, respectively. (b) The Federal Reserve's regulations do not establish well-capitalized thresholds for these measures for BHCs. Current Expected Credit Losses The Firm elected to apply the CECL capital transition provisions as permitted by the federal banking agencies delaying the effects of CECL on regulatory capital for two years until January 1, 2022, followed by a three-year transition period (“CECL capital transition provisions”). As of December 31, 2021, the capital metrics of the Firm reflected the benefit of the CECL capital transition provisions of $2.9 billion, which will be phased in at 25% per year beginning January 1, 2022. The CECL capital transition provisions have also been incorporated into Tier 2 capital, adjusted average assets, and total leverage exposure and are also subject to the three-year transition period beginning January 1, 2022. The following tables present risk-based capital metrics under both the Basel III Standardized and Basel III Advanced approaches and leverage-based capital metrics for JPMorgan Chase and JPMorgan Chase Bank, N.A. As of December 31, 2021 and 2020, JPMorgan Chase and JPMorgan Chase Bank, N.A. were well-capitalized and met all capital requirements to which each was subject. December 31, 2021 Basel III Standardized Basel III Advanced JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) Risk-based capital metrics: CET1 capital $ 213,942 $ 266,907 $ 213,942 $ 266,907 Tier 1 capital 246,162 266,910 246,162 266,910 Total capital 274,900 281,826 265,796 272,299 Risk-weighted assets 1,638,900 1,582,280 1,547,920 1,392,847 CET1 capital ratio 13.1 % 16.9 % 13.8 % 19.2 % Tier 1 capital ratio 15.0 16.9 15.9 19.2 Total capital ratio 16.8 17.8 17.2 19.5 December 31, 2020 Basel III Standardized Basel III Advanced JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) Risk-based capital metrics: CET1 capital $ 205,078 $ 234,235 $ 205,078 $ 234,235 Tier 1 capital 234,844 234,237 234,844 234,237 Total capital 269,923 252,045 257,228 239,673 Risk-weighted assets 1,560,609 1,492,138 1,484,431 1,343,185 CET1 capital ratio 13.1 % 15.7 % 13.8 % 17.4 % Tier 1 capital ratio 15.0 15.7 15.8 17.4 Total capital ratio 17.3 16.9 17.3 17.8 (a) The capital metrics reflect the CECL capital transition provisions. Additionally, loans originated under the PPP receive a zero percent risk weight. Three months ended December 31, 2021 December 31, 2020 JPMorgan Chase & Co. (b) JPMorgan Chase Bank, N.A. (b) JPMorgan (b)(c) JPMorgan (b)(c) Leverage-based capital metrics: Adjusted average assets (a) $ 3,782,035 $ 3,334,925 $ 3,353,319 $ 2,970,285 Tier 1 leverage ratio 6.5 % 8.0 % 7.0 % 7.9 % Total leverage exposure $ 4,571,789 $ 4,119,286 $ 3,401,542 $ 3,688,797 SLR 5.4 % 6.5 % 6.9 % 6.3 % (a) Adjusted average assets, for purposes of calculating the leverage ratio, includes total quarterly average assets adjusted for on-balance sheet assets that are subject to deduction from Tier 1 capital, predominantly goodwill and other intangible assets. (b) The capital metrics reflect the CECL capital transition provisions.

Off-balance Sheet Lending-relat

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments	12 Months Ended
	Dec. 31, 2021
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments	Off–balance sheet lending-related financial instruments, guarantees, and other commitments JPMorgan Chase provides lending-related financial instruments (e.g., commitments and guarantees) to address the financing needs of its customers and clients. The contractual amount of these financial instruments represents the maximum possible credit risk to the Firm should the customer or client draw upon the commitment or the Firm be required to fulfill its obligation under the guarantee, and should the customer or client subsequently fail to perform according to the terms of the contract. Most of these commitments and guarantees have historically been refinanced, extended, cancelled, or expired without being drawn or a default occurring. As a result, the total contractual amount of these instruments is not, in the Firm’s view, representative of its expected future credit exposure or funding requirements. To provide for expected credit losses in wholesale and certain consumer lending-related commitments, an allowance for credit losses on lending-related commitments is maintained. Refer to Note 13 for further information regarding the allowance for credit losses on lending-related commitments. The following table summarizes the contractual amounts and carrying values of off-balance sheet lending-related financial instruments, guarantees and other commitments at December 31, 2021 and 2020. The amounts in the table below for credit card and home equity lending-related commitments represent the total available credit for these products. The Firm has not experienced, and does not anticipate, that all available lines of credit for these products will be utilized at the same time. The Firm can reduce or cancel credit card lines of credit by providing the borrower notice or, in some cases as permitted by law, without notice. In addition, the Firm typically closes credit card lines when the borrower is 60 days or more past due. The Firm may reduce or close HELOCs when there are significant decreases in the value of the underlying property, or when there has been a demonstrable decline in the creditworthiness of the borrower. Off–balance sheet lending-related financial instruments, guarantees and other commitments Contractual amount Carrying value (i) 2021 2020 2021 2020 By remaining maturity at December 31, Expires in 1 year or less Expires after Expires after Expires after 5 years Total Total Lending-related Consumer, excluding credit card: Residential Real Estate (a) $ 15,649 $ 2,216 $ 5,797 $ 9,334 $ 32,996 $ 46,047 100 148 Auto and other 11,387 — — 951 12,338 11,272 2 — Total consumer, excluding credit card 27,036 2,216 5,797 10,285 45,334 57,319 102 148 Credit card (b) 730,534 — — — 730,534 658,506 — — Total consumer (b)(c) 757,570 2,216 5,797 10,285 775,868 715,825 102 148 Wholesale: Other unfunded commitments to extend credit (d) 101,983 167,137 160,301 24,046 453,467 415,828 2,037 2,148 Standby letters of credit and other financial guarantees (d) 15,092 8,261 4,015 1,162 28,530 30,982 476 443 Other letters of credit (d) 3,854 498 96 — 4,448 3,053 9 14 Total wholesale (c) 120,929 175,896 164,412 25,208 486,445 449,863 2,522 2,605 Total lending-related $ 878,499 $ 178,112 $ 170,209 $ 35,493 $ 1,262,313 $ 1,165,688 $ 2,624 $ 2,753 Other guarantees and commitments Securities lending indemnification agreements and guarantees (e) $ 337,770 $ — $ — $ — $ 337,770 $ 250,418 $ — $ — Derivatives qualifying as guarantees 3,119 396 12,296 39,919 55,730 54,415 475 322 Unsettled resale and securities borrowed agreements 101,553 2,128 — — 103,681 102,355 (h) 1 2 Unsettled repurchase and securities loaned agreements 73,631 632 — — 74,263 104,901 — (1) Loan sale and securitization-related indemnifications: Mortgage repurchase liability NA NA NA NA NA NA 61 84 Loans sold with recourse NA NA NA NA 827 889 19 23 Exchange & clearing house guarantees and commitments (f) 182,701 — — — 182,701 142,003 — — Other guarantees and commitments (g) 5,028 2,980 283 2,199 10,490 9,639 (h) 69 52 (a) Includes certain commitments to purchase loans from correspondents. (b) Also includes commercial card lending-related commitments primarily in CB and CIB. (c) Predominantly all consumer and wholesale lending-related commitments are in the U.S. (d) At December 31, 2021 and 2020, reflected the contractual amount net of risk participations totaling $44 million and $72 million, respectively, for other unfunded commitments to extend credit; $7.9 billion and $8.5 billion, respectively, for standby letters of credit and other financial guarantees; and $451 million and $357 million, respectively, for other letters of credit. In regulatory filings with the Federal Reserve these commitments are shown gross of risk participations. (e) At December 31, 2021 and 2020, collateral held by the Firm in support of securities lending indemnification agreements was $357.4 billion and $264.3 billion, respectively. Securities lending collateral primarily consists of cash, G7 government securities, and securities issued by U.S. GSEs and government agencies. (f) At December 31, 2021 and 2020, includes guarantees to the Fixed Income Clearing Corporation under the sponsored member repo program and commitments and guarantees associated with the Firm’s membership in certain clearing houses. (g) At December 31, 2021 and 2020, primarily includes unfunded commitments related to certain tax-oriented equity investments, unfunded commitments to purchase secondary market loans, and other equity investment commitments. (h) Prior-period amounts have been revised to conform with the current presentation . (i) For lending-related products, the carrying value represents the allowance for lending-related commitments and the guarantee liability; for derivative-related products, and lending-related commitments for which the fair value option was elected, the carrying value represents the fair value. Other unfunded commitments to extend credit Other unfunded commitments to extend credit generally consist of commitments for working capital and general corporate purposes, extensions of credit to support commercial paper facilities and bond financings in the event that those obligations cannot be remarketed to new investors, as well as committed liquidity facilities to clearing organizations. The Firm also issues commitments under multipurpose facilities which could be drawn upon in several forms, including the issuance of a standby letter of credit. Guarantees U.S. GAAP requires that a guarantor recognize, at the inception of a guarantee, a liability in an amount equal to the fair value of the obligation undertaken in issuing the guarantee. U.S. GAAP defines a guarantee as a contract that contingently requires the guarantor to pay a guaranteed party based upon: (a) changes in an underlying asset, liability or equity security of the guaranteed party; or (b) a third party’s failure to perform under a specified agreement. The Firm considers the following off–balance sheet arrangements to be guarantees under U.S. GAAP: standby letters of credit and other financial guarantees, securities lending indemnifications, certain indemnification agreements included within third-party contractual arrangements, certain derivative contracts and the guarantees under the sponsored member repo program. As required by U.S. GAAP, the Firm initially records guarantees at the inception date fair value of the non-contingent obligation assumed (e.g., the amount of consideration received or the net present value of the premium receivable). For these obligations, the Firm records this fair value amount in other liabilities with an offsetting entry recorded in cash (for premiums received), or other assets (for premiums receivable). Any premium receivable recorded in other assets is reduced as cash is received under the contract, and the fair value of the liability recorded at inception is amortized into income as lending and deposit-related fees over the life of the guarantee contract. The lending-related contingent obligation is recognized based on expected credit losses in addition to, and separate from, any non-contingent obligation. Non-lending-related contingent obligations are recognized when the liability becomes probable and reasonably estimable. These obligations are not recognized if the estimated amount is less than the carrying amount of any non-contingent liability recognized at inception (adjusted for any amortization). Examples of non-lending-related contingent obligations include indemnifications provided in sales agreements, where a portion of the sale proceeds is allocated to the guarantee, which adjusts the gain or loss that would otherwise result from the transaction. For these indemnifications, the initial liability is amortized to income as the Firm’s risk is reduced (i.e., over time or when the indemnification expires). The contractual amount and carrying value of guarantees and indemnifications are included in the table on page 284. For additional information on the guarantees, see below. Standby letters of credit and other financial guarantees Standby letters of credit and other financial guarantees are conditional lending commitments issued by the Firm to guarantee the performance of a client or customer to a third party under certain arrangements, such as commercial paper facilities, bond financings, acquisition financings, trade financings and similar transactions. The following table summarizes the contractual amount and carrying value of standby letters of credit and other financial guarantees and other letters of credit arrangements as of December 31, 2021 and 2020. Standby letters of credit, other financial guarantees and other letters of credit 2021 2020 December 31, Standby letters of credit and Other letters Standby letters of credit and Other letters Investment-grade (a) $ 19,998 $ 3,087 $ 22,850 $ 2,263 Noninvestment-grade (a) 8,532 1,361 8,132 790 Total contractual amount $ 28,530 $ 4,448 $ 30,982 $ 3,053 Allowance for lending-related commitments $ 123 $ 9 $ 80 $ 14 Guarantee liability 353 — 363 — Total carrying value $ 476 $ 9 $ 443 $ 14 Commitments with collateral $ 14,511 $ 999 $ 17,238 $ 498 (a) The ratings scale is based on the Firm’s internal risk ratings. Refer to Note 12 for further information on internal risk ratings. Securities lending indemnifications Through the Firm’s securities lending program, counterparties’ securities, via custodial and non-custodial arrangements, may be lent to third parties. As part of this program, the Firm provides an indemnification in the lending agreements which protects the lender against the failure of the borrower to return the lent securities. To minimize its liability under these indemnification agreements, the Firm obtains cash or other highly liquid collateral with a market value exceeding 100% of the value of the securities on loan from the borrower. Collateral is marked to market daily to help assure that collateralization is adequate. Additional collateral is called from the borrower if a shortfall exists, or collateral may be released to the borrower in the event of overcollateralization. If a borrower defaults, the Firm would use the collateral held to purchase replacement securities in the market or to credit the lending client or counterparty with the cash equivalent thereof. The cash collateral held by the Firm may be invested on behalf of the client in indemnified resale agreements, whereby the Firm indemnifies the client against the loss of principal invested. To minimize its liability under these agreements, the Firm obtains collateral with a market value exceeding 100% of the principal invested. Derivatives qualifying as guarantees The Firm transacts in certain derivative contracts that have the characteristics of a guarantee under U.S. GAAP. These contracts include written put options that require the Firm to purchase assets upon exercise by the option holder at a specified price by a specified date in the future. The Firm may enter into written put option contracts in order to meet client needs, or for other trading purposes. The terms of written put options are typically five years or less. Derivatives deemed to be guarantees also includes stable value contracts, commonly referred to as “stable value products”, that require the Firm to make a payment of the difference between the market value and the book value of a counterparty’s reference portfolio of assets in the event that market value is less than book value and certain other conditions have been met. Stable value products are transacted in order to allow investors to realize investment returns with less volatility than an unprotected portfolio. These contracts are typically longer-term or may have no stated maturity, but allow the Firm to elect to terminate the contract under certain conditions. The notional value of derivative guarantees generally represents the Firm’s maximum exposure. However, exposure to certain stable value products is contractually limited to a substantially lower percentage of the notional amount. The fair value of derivative guarantees reflects the probability, in the Firm’s view, of whether the Firm will be required to perform under the contract. The Firm reduces exposures to these contracts by entering into offsetting transactions, or by entering into contracts that hedge the market risk related to the derivative guarantees. The following table summarizes the derivatives qualifying as guarantees as of December 31, 2021 and 2020. (in millions) December 31, 2021 December 31, 2020 Notional amounts Derivative guarantees $ 55,730 $ 54,415 Stable value contracts with contractually limited exposure 29,778 27,752 Maximum exposure of stable value contracts with contractually limited exposure 2,882 2,803 Fair value Derivative payables 475 322 In addition to derivative contracts that meet the characteristics of a guarantee, the Firm is both a purchaser and seller of credit protection in the credit derivatives market. Refer to Note 5 for a further discussion of credit derivatives. Unsettled securities financing agreements In the normal course of business, the Firm enters into resale and securities borrowed agreements. At settlement, these commitments result in the Firm advancing cash to and receiving securities collateral from the counterparty. The Firm also enters into repurchase and securities loaned agreements. At settlement, these commitments result in the Firm receiving cash from and providing securities collateral to the counterparty. Such agreements settle at a future date. These agreements generally do not meet the definition of a derivative, and therefore, are not recorded on the Consolidated balance sheets until settlement date. These agreements predominantly have regular-way settlement terms. Refer to Note 11 for a further discussion of securities financing agreements. Loan sales- and securitization-related indemnifications Mortgage repurchase liability In connection with the Firm’s mortgage loan sale and securitization activities with U.S. GSEs the Firm has made representations and warranties that the loans sold meet certain requirements, and that may require the Firm to repurchase mortgage loans and/or indemnify the loan purchaser if such representations and warranties are breached by the Firm. Private label securitizations The liability related to repurchase demands associated with private label securitizations is separately evaluated by the Firm in establishing its litigation reserves. Refer to Note 30 for additional information regarding litigation. Loans sold with recourse The Firm provides servicing for mortgages and certain commercial lending products on both a recourse and nonrecourse basis. In nonrecourse servicing, the principal credit risk to the Firm is the cost of temporary servicing advances of funds (i.e., normal servicing advances). In recourse servicing, the servicer agrees to share credit risk with the owner of the mortgage loans, such as Fannie Mae or Freddie Mac or a private investor, insurer or guarantor. Losses on recourse servicing predominantly occur when foreclosure sales proceeds of the property underlying a defaulted loan are less than the sum of the outstanding principal balance, plus accrued interest on the loan and the cost of holding and disposing of the underlying property. The Firm’s securitizations are predominantly nonrecourse, thereby effectively transferring the risk of future credit losses to the purchaser of the mortgage-backed securities issued by the trust. At December 31, 2021 and 2020, the unpaid principal balance of loans sold with recourse totaled $827 million and $889 million, respectively. The carrying value of the related liability that the Firm has recorded in accounts payable and other liabilities on the Consolidated balance sheets, which is representative of the Firm’s view of the likelihood it will have to perform under its recourse obligations, was $19 million and $23 million at December 31, 2021 and 2020, respectively. Other off-balance sheet arrangements Indemnification agreements – general In connection with issuing securities to investors outside the U.S., the Firm may agree to pay additional amounts to the holders of the securities in the event that, due to a change in tax law, certain types of withholding taxes are imposed on payments on the securities. The terms of the securities may also give the Firm the right to redeem the securities if such additional amounts are payable. The Firm may also enter into indemnification clauses in connection with the licensing of software to clients (“software licensees”) or when it sells a business or assets to a third party (“third-party purchasers”), pursuant to which it indemnifies software licensees for claims of liability or damages that may occur subsequent to the licensing of the software, or third-party purchasers for losses they may incur due to actions taken by the Firm prior to the sale of the business or assets. It is difficult to estimate the Firm’s maximum exposure under these indemnification arrangements, since this would require an assessment of future changes in tax law and future claims that may be made against the Firm that have not yet occurred. However, based on historical experience, management expects the risk of loss to be remote. Merchant charge-backs Under the rules of payment networks, the Firm, in its role as a merchant acquirer, retains a contingent liability for disputed processed credit and debit card transactions that result in a charge-back to the merchant. If a dispute is resolved in the cardholder’s favor, Merchant Services will (through the cardholder’s issuing bank) credit or refund the amount to the cardholder and will charge back the transaction to the merchant. If Merchant Services is unable to collect the amount from the merchant, Merchant Services will bear the loss for the amount credited or refunded to the cardholder. Merchant Services mitigates this risk by withholding future settlements, retaining cash reserve accounts or obtaining other collateral. In addition, Merchant Services recognizes a valuation allowance that covers the payment or performance risk to the Firm related to charge-backs. For the years ended December 31, 2021, 2020 and 2019, Merchant Services processed an aggregate volume of $1,886.7 billion, $1,597.3 billion, and $1,511.5 billion, respectively. Clearing Services – Client Credit Risk The Firm provides clearing services for clients by entering into securities purchases and sales and derivative contracts with CCPs, including ETDs such as futures and options, as well as OTC-cleared derivative contracts. As a clearing member, the Firm stands behind the performance of its clients, collects cash and securities collateral (margin) as well as any settlement amounts due from or to clients, and remits them to the relevant CCP or client in whole or part. There are two types of margin: variation margin is posted on a daily basis based on the value of clients’ derivative contracts and initial margin is posted at inception of a derivative contract, generally on the basis of the potential changes in the variation margin requirement for the contract. As a clearing member, the Firm is exposed to the risk of nonperformance by its clients, but is not liable to clients for the performance of the CCPs. Where possible, the Firm seeks to mitigate its risk to the client through the collection of appropriate amounts of margin at inception and throughout the life of the transactions. The Firm can also cease providing clearing services if clients do not adhere to their obligations under the clearing agreement. In the event of nonperformance by a client, the Firm would close out the client’s positions and access available margin. The CCP would utilize any margin it holds to make itself whole, with any remaining shortfalls required to be paid by the Firm as a clearing member. The Firm reflects its exposure to nonperformance risk of the client through the recognition of margin receivables from clients and margin payables to CCPs; the clients’ underlying securities or derivative contracts are not reflected in the Firm’s Consolidated Financial Statements. It is difficult to estimate the Firm’s maximum possible exposure through its role as a clearing member, as this would require an assessment of transactions that clients may execute in the future. However, based upon historical experience, and the credit risk mitigants available to the Firm, management believes it is unlikely that the Firm will have to make any material payments under these arrangements and the risk of loss is expected to be remote. Refer to Note 5 for information on the derivatives that the Firm executes for its own account and records in its Consolidated Financial Statements. Exchange & Clearing House Memberships The Firm is a member of several securities and derivative exchanges and clearing houses, both in the U.S. and other countries, and it provides clearing services to its clients. Membership in some of these organizations requires the Firm to pay a pro rata share of the losses incurred by the organization as a result of the default of another member. Such obligations vary with different organizations. These obligations may be limited to the amount (or a multiple of the amount) of the Firm’s contribution to the guarantee fund maintained by a clearing house or exchange as part of the resources available to cover any losses in the event of a member default. Alternatively, these obligations may also include a pro rata share of the residual losses after applying the guarantee fund. Additionally, certain clearing houses require the Firm as a member to pay a pro rata share of losses that may result from the clearing house’s investment of guarantee fund contributions and initial margin, unrelated to and independent of the default of another member. Generally a payment would only be required should such losses exceed the resources of the clearing house or exchange that are contractually required to absorb the losses in the first instance. In certain cases, it is difficult to estimate the Firm’s maximum possible exposure under these membership agreements, since this would require an assessment of future claims that may be made against the Firm that have not yet occurred. However, based on historical experience, management expects the risk of loss to the Firm to be remote. Where the Firm’s maximum possible exposure can be estimated, the amount is disclosed in the table on page 284, in the Exchange & clearing house guarantees and commitments line. Sponsored member repo program The Firm acts as a sponsoring member to clear eligible overnight and term resale and repurchase agreements through the Government Securities Division of the Fixed Income Clearing Corporation (“FICC”) on behalf of clients that become sponsored members under the FICC’s rules. The Firm also guarantees to the FICC the prompt and full payment and performance of its sponsored member clients’ respective obligations under the FICC’s rules. The Firm minimizes its liability under these guarantees by obtaining a security interest in the cash or high-quality securities collateral that the clients place with the clearing house; therefore, the Firm expects the risk of loss to be remote. The Firm’s maximum possible exposure, without taking into consideration the associated collateral, is included in the Exchange & clearing house guarantees and commitments line on page 284. Refer to Note 11 for additional information on credit risk mitigation practices on resale agreements and the types of collateral pledged under repurchase agreements. Guarantees of subsidiaries In the normal course of business, the Parent Company may provide counterparties with guarantees of certain of the trading and other obligations of its subsidiaries on a contract-by-contract basis, as negotiated with the Firm’s counterparties. The obligations of the subsidiaries are included on the Firm’s Consolidated balance sheets or are reflected as off-balance sheet commitments; therefore, the Parent Company has not recognized a separate liability for these guarantees. The Firm believes that the occurrence of any event that would trigger payments by the Parent Company under these guarantees is remote. The Parent Company has guaranteed certain long-term debt and structured notes of its subsidiaries, including JPMorgan Chase Financial Company LLC (“JPMFC”), a 100%-owned finance subsidiary. All securities issued by JPMFC are fully and unconditionally guaranteed by the Parent Company and no other subsidiary of the parent company guarantees these securities. These guarantees, which rank on a parity with the Firm’s unsecured and unsubordinated indebtedness, are not included in the table on page 284 of this Note. Refer to Note 20 for additional information.

Pledged Assets and Collateral

Pledged Assets and Collateral	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Pledged Assets and Collateral	Pledged assets and collateral Pledged assets The Firm pledges financial assets that it owns to maintain potential borrowing capacity at discount windows with Federal Reserve banks, various other central banks and FHLBs. Additionally, the Firm pledges assets for other purposes, including to collateralize repurchase and other securities financing agreements, to cover short sales and to collateralize derivative contracts and deposits. Certain of these pledged assets may be sold or repledged or otherwise used by the secured parties and are parenthetically identified on the Consolidated balance sheets as assets pledged. The following table presents the Firm’s pledged assets. December 31, (in billions) 2021 2020 Assets that may be sold or repledged or otherwise used by secured parties $ 126.3 $ 166.6 Assets that may not be sold or repledged or otherwise used by secured parties 112.0 113.9 Assets pledged at Federal Reserve banks and FHLBs 476.4 455.3 Total pledged assets $ 714.7 $ 735.8 Total pledged assets do not include assets of consolidated VIEs; these assets are used to settle the liabilities of those entities. Refer to Note 14 for additional information on assets and liabilities of consolidated VIEs. Refer to Note 11 for additional information on the Firm’s securities financing activities. Refer to Note 20 for additional information on the Firm’s long-term debt. The significant components of the Firm’s pledged assets were as follows. December 31, (in billions) 2021 2020 Investment securities $ 80.1 $ 80.2 Loans 428.5 420.5 Trading assets and other 206.1 235.1 Total pledged assets $ 714.7 $ 735.8 Collateral The Firm accepts financial assets as collateral that it is permitted to sell or repledge, deliver or otherwise use. This collateral is generally obtained under resale and other securities financing agreements, prime brokerage-related held-for-investment customer receivables and derivative contracts. Collateral is generally used under repurchase and other securities financing agreements, to cover short sales, and to collateralize derivative contracts and deposits. The following table presents the fair value of collateral accepted. December 31, (in billions) 2021 2020 Collateral permitted to be sold or repledged, delivered, or otherwise used $ 1,471.3 $ 1,451.7 Collateral sold, repledged, delivered or otherwise used 1,111.0 1,038.9

Litigation

Litigation	12 Months Ended
	Dec. 31, 2021
Litigation [Abstract]
Litigation	Litigation Contingencies As of December 31, 2021, the Firm and its subsidiaries and affiliates are defendants or respondents in numerous legal proceedings, including private, civil litigations, government investigations or regulatory enforcement matters. The litigations range from individual actions involving a single plaintiff to class action lawsuits with potentially millions of class members. Investigations and regulatory enforcement matters involve both formal and informal proceedings, by both governmental agencies and self-regulatory organizations. These legal proceedings are at varying stages of adjudication, arbitration or investigation, and involve each of the Firm’s lines of business and several geographies and a wide variety of claims (including common law tort and contract claims and statutory antitrust, securities and consumer protection claims), some of which present novel legal theories. The Firm believes the estimate of the aggregate range of reasonably possible losses, in excess of reserves established, for its legal proceedings is from $0 to approximately $1.5 billion at December 31, 2021. This estimated aggregate range of reasonably possible losses was based upon information available as of that date for those proceedings in which the Firm believes that an estimate of reasonably possible loss can be made. For certain matters, the Firm does not believe that such an estimate can be made, as of that date. The Firm’s estimate of the aggregate range of reasonably possible losses involves significant judgment, given: • the number, variety and varying stages of the proceedings, including the fact that many are in preliminary stages, • the existence in many such proceedings of multiple defendants, including the Firm, whose share of liability (if any) has yet to be determined, • the numerous yet-unresolved issues in many of the proceedings, including issues regarding class certification and the scope of many of the claims, and • the attendant uncertainty of the various potential outcomes of such proceedings, including where the Firm has made assumptions concerning future rulings by the court or other adjudicator, or about the behavior or incentives of adverse parties or regulatory authorities, and those assumptions prove to be incorrect. In addition, the outcome of a particular proceeding may be a result which the Firm did not take into account in its estimate because the Firm had deemed the likelihood of that outcome to be remote. Accordingly, the Firm’s estimate of the aggregate range of reasonably possible losses will change from time to time, and actual losses may vary significantly. Set forth below are descriptions of the Firm’s material legal proceedings. Amrapali . India’s Enforcement Directorate (“ED”) is investigating J.P.Morgan India Private Limited in connection with investments made in 2010 and 2012 by two offshore funds formerly managed by JPMorgan Chase entities into residential housing projects developed by the Amrapali Group (“Amrapali”). In 2017, numerous creditors filed civil claims against Amrapali, including petitions brought by home buyers relating to delays in delivering or failure to deliver residential units. The home buyers’ petitions have been overseen by the Supreme Court of India and are ongoing. In August 2021, the ED issued an order fining J.P. Morgan India Private Limited approximately $31.5 million. The Firm is appealing the order and the fine. Relatedly, in July 2019, the Supreme Court of India issued an order making preliminary findings that Amrapali and other parties, including unspecified JPMorgan Chase entities and the offshore funds that had invested in the projects, violated certain currency control and money laundering provisions, and ordering the ED to conduct a further inquiry under India’s Prevention of Money Laundering Act (“PMLA”) and Foreign Exchange Management Act (“FEMA”). In May 2020, the ED attached approximately $25 million from J.P. Morgan India Private Limited in connection with the criminal PMLA investigation. The Firm is responding to and cooperating with the PMLA investigation. Federal Republic of Nigeria Litigation. JPMorgan Chase Bank, N.A. operated an escrow and depository account for the Federal Government of Nigeria (“FGN”) and two major international oil companies. The account held approximately $1.1 billion in connection with a dispute among the clients over rights to an oil field. Following the settlement of the dispute, JPMorgan Chase Bank, N.A. paid out the monies in the account in 2011 and 2013 in accordance with directions received from its clients. In November 2017, the Federal Republic of Nigeria (“FRN”) commenced a claim in the English High Court for approximately $875 million in payments made out of the accounts. The FRN, claiming to be the same entity as the FGN, alleges that the payments were instructed as part of a complex fraud not involving JPMorgan Chase Bank, N.A., but that JPMorgan Chase Bank, N.A. was or should have been on notice that the payments may be fraudulent. JPMorgan Chase Bank, N.A. applied for summary judgment and was unsuccessful. The claim is ongoing and a trial commenced in February 2022. Foreign Exchange Investigations and Litigation. The Firm previously reported settlements with certain government authorities relating to its foreign exchange (“FX”) sales and trading activities and controls related to those activities. Among those resolutions, in May 2015, the Firm pleaded guilty to a single violation of federal antitrust law. The Department of Labor granted the Firm a five-year exemption of disqualification that allows the Firm and its affiliates to continue to rely on the Qualified Professional Asset Manager exemption under the Employee Retirement Income Security Act (“ERISA”) until January 2023. The Firm will need the Department of Labor to approve a further exemption to cover the remainder of the ten-year disqualification period following the antitrust plea. The only remaining FX-related governmental inquiry is a South Africa Competition Commission matter which is currently pending before the South Africa Competition Tribunal. With respect to civil litigation matters, in August 2018, the United States District Court for the Southern District of New York granted final approval to the Firm’s settlement of a consolidated class action brought by U.S.-based plaintiffs, which principally alleged violations of federal antitrust laws based on an alleged conspiracy to manipulate foreign exchange rates and also sought damages on behalf of persons who transacted in FX futures and options on futures. Certain members of the settlement class filed requests to the Court to be excluded from the class, and certain of them filed a complaint against the Firm and other foreign exchange dealers in November 2018. A number of these actions remain pending. Further, a putative class action has been filed against the Firm and other foreign exchange dealers on behalf of certain consumers who purchased foreign currencies at allegedly inflated rates. Another putative class action was brought against the Firm and other foreign exchange dealers on behalf of purported indirect purchasers of FX instruments. In 2020, the Court approved a settlement by the Firm and 11 other defendants of that class action for a total of $10 million. In addition, some FX-related individual and putative class actions based on similar alleged underlying conduct have been filed outside the U.S., including in the U.K., Israel, the Netherlands, Brazil and Australia. Inquiries Concerning Preservation Requirements . In December 2021 certain of the Firm’s subsidiaries entered into resolutions with the U.S. Securities and Exchange Commission (“SEC”) and the U.S. Commodity Futures Trading Commission (“CFTC”) to resolve their respective civil investigations of compliance with records preservation requirements applicable to broker-dealer firms, swap dealers and futures commission merchants. The SEC and CFTC found that J.P. Morgan Securities LLC did not maintain copies of certain communications required to be maintained under their respective record keeping rules, where such communications were sent or received by employees over electronic messaging channels that had not been approved for employee use by the Firm. The CFTC resolution also included JPMorgan Chase Bank, N.A. and J.P. Morgan Securities plc as swap dealers. The SEC and CFTC also found related supervision failures. Under these resolutions, J.P. Morgan Securities LLC paid a $125 million civil monetary penalty to the SEC, and J.P. Morgan Securities LLC, JPMorgan Chase Bank, N.A. and J.P. Morgan Securities plc paid a total $75 million civil monetary penalty to the CFTC. The Firm continues to respond to requests for information and other material from certain authorities concerning its compliance with records preservation requirements in connection with business communications sent over electronic messaging channels that have not been approved by the Firm. The Firm is cooperating with these inquiries. Interchange Litigation . Groups of merchants and retail associations filed a series of class action complaints alleging that Visa and Mastercard, as well as certain banks, conspired to set the price of credit and debit card interchange fees and enacted related rules in violation of antitrust laws. In 2012, the parties initially settled the cases for a cash payment, a temporary reduction of credit card interchange, and modifications to certain credit card network rules. In 2017, after the approval of that settlement was reversed on appeal, the case was remanded to the United States District Court for the Eastern District of New York for further proceedings consistent with the appellate decision. The original class action was divided into two separate actions, one seeking primarily monetary relief and the other seeking primarily injunctive relief. In September 2018, the parties to the monetary class action finalized an agreement which amends and supersedes the prior settlement agreement. Pursuant to this settlement, the defendants collectively contributed an additional $900 million to the approximately $5.3 billion previously held in escrow from the original settlement. In December 2019, the amended settlement agreement was approved by the District Court. Certain merchants appealed the District Court’s approval order, and those appeals are pending. Based on the percentage of merchants that opted out of the amended class settlement, $700 million has been returned to the defendants from the settlement escrow in accordance with the settlement agreement. The injunctive class action continues separately, and in September 2021, the District Court granted plaintiffs’ motion for class certification in part, and denied the motion in part. In addition, certain merchants have filed individual actions raising similar allegations against Visa and Mastercard, as well as against the Firm and other banks, and some of those actions remain pending. LIBOR and Other Benchmark Rate Investigations and Litigation . JPMorgan Chase has responded to inquiries from various governmental agencies and entities around the world relating primarily to the British Bankers Association’s ("BBA") London Interbank Offered Rate (“LIBOR”) for various currencies and the European Banking Federation’s Euro Interbank Offered Rate (“EURIBOR”). The Swiss Competition Commission’s investigation relating to EURIBOR, to which the Firm and other banks are subject, continues. In December 2016, the European Commission issued a decision against the Firm and other banks finding an infringement of European antitrust rules relating to EURIBOR. The Firm has filed an appeal of that decision with the European General Court, and that appeal is pending. In addition, the Firm has been named as a defendant along with other banks in various individual and putative class actions related to benchmark rates, including U.S. dollar LIBOR. In actions related to U.S. dollar LIBOR during the period that it was administered by the BBA, the Firm has obtained dismissal of certain actions and resolved certain other actions, and others are in various stages of litigation. The United States District Court for the Southern District of New York has granted class certification of antitrust claims related to bonds and interest rate swaps sold directly by the defendants, including the Firm. A consolidated putative class action related to the period that U.S. dollar LIBOR was administered by ICE Benchmark Administration has been dismissed. In addition, a group of individual plaintiffs filed a lawsuit asserting antitrust claims, alleging that the Firm and other defendants were engaged in an unlawful agreement to set U.S. dollar LIBOR and conspired to monopolize the market for LIBOR-based consumer loans and credit cards. Defendants moved to dismiss plaintiffs’ complaint. In December 2021, the court denied plaintiffs’ motions for a preliminary injunction seeking to enjoin defendants from setting U.S. dollar LIBOR and enforcing any financial instruments that rely on U.S. dollar LIBOR. The Firm’s settlements of putative class actions related to Swiss franc LIBOR, the Singapore Interbank Offered Rate and the Singapore Swap Offer Rate, and the Australian Bank Bill Swap Reference Rate remain subject to court approval. Metals and U.S. Treasuries Investigations and Litigation and Related Inquiries. The Firm previously reported that it and/or certain of its subsidiaries had entered into resolutions with the U.S. Department of Justice (“DOJ”), the U.S. Commodity Futures Trading Commission (“CFTC”) and the U.S. Securities and Exchange Commission (“SEC”), which, collectively, resolved those agencies’ respective investigations relating to historical trading practices by former employees in the precious metals and U.S. treasuries markets and related conduct from 2008 to 2016. The Firm entered into a Deferred Prosecution Agreement (“DPA”) with the DOJ in which it agreed to the filing of a criminal information charging JPMorgan Chase & Co. with two counts of wire fraud and agreed, along with JPMorgan Chase Bank, N.A. and J.P. Morgan Securities LLC, to certain terms and obligations as set forth therein. Under the terms of the DPA, the criminal information will be dismissed after three years, provided that JPMorgan Chase & Co., JPMorgan Chase Bank, N.A. and J.P. Morgan Securities LLC fully comply with all of their obligations. Across the three resolutions with the DOJ, CFTC and SEC, JPMorgan Chase & Co., JPMorgan Chase Bank, N.A. and J.P. Morgan Securities LLC agreed to pay a total monetary amount of approximately $920 million. A portion of the total monetary amount includes victim compensation payments. Several putative class action complaints have been filed in the United States District Court for the Southern District of New York against the Firm and certain former employees, alleging a precious metals futures and options price manipulation scheme in violation of the Commodity Exchange Act. Some of the complaints also allege unjust enrichment and deceptive acts or practices under the General Business Law of the State of New York. The Court consolidated these putative class actions, and, in December 2021, the Court preliminarily approved a settlement among the parties. In addition, several putative class actions were filed in the United States District Courts for the Northern District of Illinois and Southern District of New York against the Firm, alleging manipulation of U.S. Treasury futures and options, and bringing claims under the Commodity Exchange Act. The actions in the Northern District of Illinois were transferred to the Southern District of New York. The Court consolidated these putative class actions, and, in December 2021, the Court preliminarily approved a settlement among the parties. In Canada, plaintiffs have moved to commence putative class action proceedings based on similar alleged underlying conduct related to precious metals. In October 2020, two putative class action complaints were filed under the Securities Exchange Act of 1934 in the United States District Court for the Eastern District of New York against the Firm and certain individual defendants on behalf of shareholders who acquired shares during the putative class period alleging that certain SEC filings of the Firm were materially false or misleading in that they did not disclose certain information relating to the above-referenced investigations. The Court consolidated these putative class actions in January 2021. Plaintiffs filed their second amended complaint in May 2021, which additionally alleged that certain orders in precious metals futures contracts placed by precious metals futures traders during the putative class period were materially false and misleading. Defendants have moved to dismiss. Securities Lending Antitrust Litigation . JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC, J.P. Morgan Prime, Inc., and J.P. Morgan Strategic Securities Lending Corp. are named as defendants in a putative class action filed in the United States District Court for the Southern District of New York. The complaint asserts violations of federal antitrust law and New York State common law in connection with an alleged conspiracy to prevent the emergence of anonymous exchange trading for securities lending transactions. Defendants’ motion to dismiss the complaint was denied. Plaintiffs have moved to certify a class in this action, which defendants are opposing. * * * In addition to the various legal proceedings discussed above, JPMorgan Chase and its subsidiaries are named as defendants or are otherwise involved in a substantial number of other legal proceedings. The Firm believes it has meritorious defenses to the claims asserted against it in its currently outstanding legal proceedings and it intends to defend itself vigorously. Additional legal proceedings may be initiated from time to time in the future. The Firm has established reserves for several hundred of its currently outstanding legal proceedings. In accordance with the provisions of U.S. GAAP for contingencies, the Firm accrues for a litigation-related liability when it is probable that such a liability has been incurred and the amount of the loss can be reasonably estimated. The Firm evaluates its outstanding legal proceedings each quarter to assess its litigation reserves, and makes adjustments in such reserves, upward or downward, as appropriate, based on management’s best judgment after consultation with counsel. The Firm’s legal expense was $426 million, $1.1 billion and $239 million for the years ended December 31, 2021, 2020 and 2019, respectively. There is no assurance that the Firm’s litigation reserves will not need to be adjusted in the future. In view of the inherent difficulty of predicting the outcome of legal proceedings, particularly where the claimants seek very large or indeterminate damages, or where the matters present novel legal theories, involve a large number of parties or are in early stages of discovery, the Firm cannot state with confidence what will be the eventual outcomes of the currently pending matters, the timing of their ultimate resolution or the eventual losses, fines, penalties or consequences related to those matters. JPMorgan Chase believes, based upon its current knowledge and after consultation with counsel, consideration of the material legal proceedings described above and after taking into account its current litigation reserves and its estimated aggregate range of possible losses, that the other legal proceedings currently pending against it should not have a material adverse effect on the Firm’s consolidated financial condition. The Firm notes, however, that in light of the uncertainties involved in such proceedings, there is no assurance that the ultimate resolution of these matters will not significantly exceed the reserves it has currently accrued or that a matter will not have material reputational consequences. As a result, the outcome of a particular matter may be material to JPMorgan Chase’s operating results for a particular period, depending on, among other factors, the size of the loss or liability imposed and the level of JPMorgan Chase’s income for that period.

International Operations

International Operations	12 Months Ended
	Dec. 31, 2021
Segments, Geographical Areas [Abstract]
International Operations	International operations The following table presents income statement and balance sheet-related information for JPMorgan Chase by major international geographic area. The Firm defines international activities for purposes of this footnote presentation as business transactions that involve clients residing outside of the U.S., and the information presented below is based predominantly on the domicile of the client, the location from which the client relationship is managed, booking location or the location of the trading desk. However, many of the Firm’s U.S. operations serve international businesses. As the Firm’s operations are highly integrated, estimates and subjective assumptions have been made to apportion revenue and expense between U.S. and international operations. These estimates and assumptions are consistent with the allocations used for the Firm’s segment reporting as set forth in Note 32. The Firm’s long-lived assets for the periods presented are not considered by management to be significant in relation to total assets. The majority of the Firm’s long-lived assets are located in the U.S. As of or for the year ended December 31, Revenue (c) Expense (d) Income before income tax Net income Total assets 2021 Europe/Middle East/Africa $ 16,561 $ 10,833 $ 5,728 $ 4,202 $ 517,904 (e) Asia-Pacific 9,654 6,372 3,282 2,300 277,897 Latin America/Caribbean 2,756 1,589 1,167 878 61,657 Total international 28,971 18,794 10,177 7,380 857,458 North America (a) 92,678 43,293 49,385 40,954 2,886,109 Total $ 121,649 $ 62,087 $ 59,562 $ 48,334 $ 3,743,567 2020 (b) Europe/Middle East/Africa $ 16,566 $ 10,987 $ 5,579 $ 3,868 $ 530,687 (e) Asia-Pacific 9,289 5,558 3,731 2,630 252,553 Latin America/Caribbean 2,740 1,590 1,150 837 61,980 Total international 28,595 18,135 10,460 7,335 845,220 North America (a) 91,356 66,001 25,355 21,796 2,539,537 Total $ 119,951 $ 84,136 $ 35,815 $ 29,131 $ 3,384,757 2019 (b) Europe/Middle East/Africa $ 15,887 $ 9,860 $ 6,027 $ 4,158 $ 391,369 (e) Asia-Pacific 7,254 5,060 2,194 1,467 183,023 Latin America/Caribbean 2,405 1,561 844 609 47,820 Total international 25,546 16,481 9,065 6,234 622,212 North America (a) 90,174 54,373 35,801 30,197 2,064,265 Total $ 115,720 $ 70,854 $ 44,866 $ 36,431 $ 2,686,477 (a) Substantially reflects the U.S. (b) Prior-period amounts have been revised to conform with the current presentation . (c) Revenue is composed of net interest income and noninterest revenue. (d) Expense is composed of noninterest expense and the provision for credit losses. (e) Total assets for the U.K. were approximately $365 billion, $353 billion and $309 billion at December 31, 2021, 2020 and 2019, respectively.

Business Segments

Business Segments	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Business Segments	Business segments The Firm is managed on an LOB basis. There are four major reportable business segments – Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking and Asset & Wealth Management. In addition, there is a Corporate segment.The business segments are determined based on the products and services provided, or the type of customer served, and they reflect the manner in which financial information is evaluated by the Firm’s Operating Committee. Segment results are presented on a managed basis. Refer to Segment results of this footnote for a further discussion of JPMorgan Chase’s business segments. The following is a description of each of the Firm’s business segments, and the products and services they provide to their respective client bases. Consumer & Community Banking Consumer & Community Banking offers services to consumers and businesses through bank branches, ATMs, digital (including mobile and online) and telephone banking. CCB is organized into Consumer & Business Banking (including Consumer Banking, J.P. Morgan Wealth Management and Business Banking), Home Lending (including Home Lending Production, Home Lending Servicing and Real Estate Portfolios) and Card & Auto. Consumer & Business Banking offers deposit, investment and lending products, payments and services to consumers, and lending, deposit, and cash management and payment solutions to small businesses. Home Lending includes mortgage origination and servicing activities, as well as portfolios consisting of residential mortgages and home equity loans. Card & Auto issues credit cards to consumers and small businesses and originates and services auto loans and leases. Corporate & Investment Bank The Corporate & Investment Bank, which consists of Banking and Markets & Securities Services, offers a broad suite of investment banking, market-making, prime brokerage, and treasury and securities products and services to a global client base of corporations, investors, financial institutions, merchants, government and municipal entities. Banking offers a full range of investment banking products and services in all major capital markets, including advising on corporate strategy and structure, capital-raising in equity and debt markets, as well as loan origination and syndication. Banking also includes Payments, which provides payments services enabling clients to manage payments and receipts globally, and cross-border financing. Markets & Securities Services includes Markets, a global market-maker across products, including cash and derivative instruments, which also offers sophisticated risk management solutions, prime brokerage, and research. Markets & Securities Services also includes Securities Services, a leading global custodian which provides custody, fund accounting and administration, and securities lending products principally for asset managers, insurance companies and public and private investment funds. Commercial Banking Commercial Banking provides comprehensive financial solutions, including lending, payments, investment banking and asset management products across three primary client segments: Middle Market Banking, Corporate Client Banking and Commercial Real Estate Banking. Other includes amounts not aligned with a primary client segment. Middle Market Banking covers small and midsized companies, local governments and nonprofit clients. Corporate Client Banking covers large corporations. Commercial Real Estate Banking covers investors, developers, and owners of multifamily, office, retail, industrial and affordable housing properties. Asset & Wealth Management Asset & Wealth Management, with client assets of $4.3 trillion, is a global leader in investment and wealth management. Asset Management Offers multi-asset investment management solutions across equities, fixed income, alternatives and money market funds to institutional and retail investors providing for a broad range of clients’ investment needs. Global Private Bank Provides retirement products and services, brokerage, custody, trusts and estates, loans, mortgages, deposits and investment management to high net worth clients. The majority of AWM’s client assets are in actively managed portfolios. Corporate The Corporate segment consists of Treasury and Chief Investment Office and Other Corporate, which includes corporate staff functions and expense that is centrally managed. Treasury and CIO is predominantly responsible for measuring, monitoring, reporting and managing the Firm’s liquidity, funding, capital, structural interest rate and foreign exchange risks. The major Other Corporate functions include Real Estate, Technology, Legal, Corporate Finance, Human Resources, Internal Audit, Risk Management, Compliance, Control Management, Corporate Responsibility and various Other Corporate groups. Segment results The following table provides a summary of the Firm’s segment results as of or for the years ended December 31, 2021, 2020 and 2019, on a managed basis. The Firm’s definition of managed basis starts with the reported U.S. GAAP results and includes certain reclassifications to present total net revenue for the Firm (and each of the reportable business segments) on an FTE basis. Accordingly, revenue from investments that receive tax credits and tax-exempt securities is presented in the managed results on a basis comparable to taxable investments and securities. This allows management to assess the comparability of revenue from year-to-year arising from both taxable and tax-exempt sources. The corresponding income tax impact related to tax-exempt items is recorded within income tax expense/(benefit). These adjustments have no impact on net income as reported by the Firm as a whole or by the LOBs. Capital allocation Each business segment is allocated capital by taking into consideration a variety of factors including capital levels of similarly rated peers and applicable regulatory capital requirements. ROE is measured and internal targets for expected returns are established as key measures of a business segment’s performance. The Firm’s allocation methodology incorporates Basel III Standardized RWA, Basel III Advanced RWA, the GSIB surcharge, and a simulation of capital in a severe stress environment. The assumptions and methodologies used to allocate capital are periodically reassessed and as a result, the capital allocated to the LOBs may change from time to time. Segment results and reconciliation (a) (Table continued on next page) As of or for the year ended Consumer & Community Banking Corporate & Investment Bank Commercial Banking Asset & Wealth Management 2021 2020 2019 2021 2020 2019 2021 2020 2019 2021 2020 2019 Noninterest revenue $ 17,286 $ 17,740 $ 17,796 $ 38,209 $ 35,120 $ 30,060 $ 3,929 $ 3,067 $ 2,710 $ 13,071 $ 10,822 $ 10,236 Net interest income 32,787 33,528 37,337 13,540 14,164 9,205 6,079 6,246 6,554 3,886 3,418 3,355 Total net revenue 50,073 51,268 55,133 51,749 49,284 39,265 10,008 9,313 9,264 16,957 14,240 13,591 Provision for credit losses (6,989) 12,312 4,954 (1,174) 2,726 277 (947) 2,113 296 (227) 263 59 Noninterest expense 29,256 27,990 28,276 25,325 23,538 22,444 4,041 3,798 3,735 10,919 9,957 9,747 Income/(loss) before income tax expense/(benefit) 27,806 10,966 21,903 27,598 23,020 16,544 6,914 3,402 5,233 6,265 4,020 3,785 Income tax expense/(benefit) 6,876 2,749 5,362 6,464 5,926 4,590 1,668 824 1,275 1,528 1,028 918 Net income/(loss) $ 20,930 $ 8,217 $ 16,541 $ 21,134 $ 17,094 $ 11,954 $ 5,246 $ 2,578 $ 3,958 $ 4,737 $ 2,992 $ 2,867 Average equity $ 50,000 $ 52,000 $ 52,000 $ 83,000 $ 80,000 $ 80,000 $ 24,000 $ 22,000 $ 22,000 $ 14,000 $ 10,500 $ 10,500 Total assets 500,370 496,705 541,367 1,259,896 1,095,926 (b) 913,803 (b) 230,776 228,911 220,514 234,425 203,384 173,175 Return on equity 41 % 15 % 31 % 25 % 20 % 14 % 21 % 11 % 17 % 33 % 28 % 26 % Overhead ratio 58 55 51 49 48 57 40 41 40 64 70 72 (Table continued from previous page) As of or for the year ended Corporate Reconciling Items (a) Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Noninterest revenue $ 68 $ 1,199 $ (114) $ (3,225) $ (2,560) (b) $ (2,213) (b) $ 69,338 $ 65,388 $ 58,475 (b) Net interest income (3,551) (2,375) 1,325 (430) (418) (531) 52,311 54,563 57,245 Total net revenue (3,483) (1,176) 1,211 (3,655) (2,978) (2,744) 121,649 119,951 115,720 Provision for credit losses 81 66 (1) — — — (9,256) 17,480 5,585 Noninterest expense 1,802 1,373 1,067 — — — 71,343 66,656 65,269 Income/(loss) before income tax expense/(benefit) (5,366) (2,615) 145 (3,655) (2,978) (2,744) 59,562 35,815 44,866 Income tax expense/(benefit) (1,653) (865) (966) (3,655) (2,978) (b) (2,744) (b) 11,228 6,684 8,435 (b) Net income/(loss) $ (3,713) $ (1,750) $ 1,111 $ — $ — $ — $ 48,334 $ 29,131 $ 36,431 Average equity $ 79,968 $ 72,365 $ 68,407 $ — $ — $ — $ 250,968 $ 236,865 $ 232,907 Total assets 1,518,100 1,359,831 837,618 NA NA NA 3,743,567 3,384,757 2,686,477 (b) Return on equity NM NM NM NM NM NM 19 % 12 % 15 % Overhead ratio NM NM NM NM NM NM 59 56 56 (b) (a) Segment results on a managed basis reflect revenue on a FTE basis with the corresponding income tax impact recorded within income tax expense/(benefit). These adjustments are eliminated in reconciling items to arrive at the Firm’s reported U.S. GAAP results. (b) Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Parent Company

Parent Company	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Parent Company	Parent Company The following tables present Parent Company-only financial statements. Statements of income and comprehensive income Year ended December 31, 2021 2020 2019 Income Dividends from subsidiaries and affiliates: Bank and bank holding company $ 10,000 $ 6,000 $ 26,000 Non-bank (a) — — — Interest income from subsidiaries 32 63 223 Other income/(expense) from subsidiaries: Bank and bank holding company 859 2,019 2,738 Non-bank 366 (569) 197 Other income/(expense) 1,137 205 (1,731) Total income 12,394 7,718 27,427 Expense Interest expense/(income) to subsidiaries and affiliates (a) 5,353 (8,830) (5,303) Other interest expense/(income) (1,349) 14,150 13,246 Noninterest expense 2,637 2,222 1,992 Total expense 6,641 7,542 9,935 Income before income tax benefit and undistributed net income of subsidiaries 5,753 176 17,492 Income tax benefit 1,329 1,324 2,033 Equity in undistributed net income of subsidiaries 41,252 27,631 16,906 Net income $ 48,334 $ 29,131 $ 36,431 Other comprehensive income/(loss), net (8,070) 6,417 3,076 Comprehensive income $ 40,264 $ 35,548 $ 39,507 Balance sheets December 31, (in millions) 2021 2020 Assets Cash and due from banks $ 36 $ 54 Deposits with banking subsidiaries 6,809 6,811 Trading assets 2,293 1,775 Advances to, and receivables from, subsidiaries: Bank and bank holding company 431 27 Non-bank 50 86 Investments (at equity) in subsidiaries and affiliates: Bank and bank holding company 545,635 508,602 Non-bank 1,007 1,011 Other assets 12,220 10,058 Total assets $ 568,481 $ 528,424 Liabilities and stockholders’ equity Borrowings from, and payables to, subsidiaries and affiliates (a) $ 28,039 $ 25,150 Short-term borrowings 1,018 924 Other liabilities 9,340 9,612 Long-term debt (b)(c) 235,957 213,384 Total liabilities (c) 274,354 249,070 Total stockholders’ equity 294,127 279,354 Total liabilities and stockholders’ equity $ 568,481 $ 528,424 Statements of cash flows Year ended December 31, 2021 2020 2019 Operating activities Net income $ 48,334 $ 29,131 $ 36,431 Less: Net income of subsidiaries and affiliates (a) 51,252 33,631 42,906 Parent company net loss (2,918) (4,500) (6,475) Cash dividends from subsidiaries and affiliates (a) 10,000 6,000 26,000 Other operating adjustments (12,677) 15,357 9,862 Net cash provided by/(used in) operating activities (5,595) 16,857 29,387 Investing activities Net change in: Advances to and investments in subsidiaries and affiliates, net (3,000) (2,663) (6) (e) All other investing activities, net 31 24 71 Net cash provided by/(used in) investing activities (2,969) (2,639) 65 Financing activities Net change in: Borrowings from subsidiaries and affiliates (a) 2,647 1,425 2,941 Short-term borrowings — (20) (56) Proceeds from long-term borrowings 49,169 37,312 25,569 Payments of long-term borrowings (15,543) (34,194) (21,226) Proceeds from issuance of preferred stock 7,350 4,500 5,000 Redemption of preferred stock (2,575) (1,430) (4,075) Treasury stock repurchased (18,408) (6,517) (24,001) Dividends paid (12,858) (12,690) (12,343) All other financing activities, net (1,238) (1,080) (1,290) Net cash provided by/(used in) financing activities 8,544 (12,694) (29,481) Net increase/(decrease) in cash and due from banks and deposits with banking subsidiaries (20) 1,524 (29) Cash and due from banks and deposits with banking subsidiaries at the beginning of the year 6,865 5,341 5,370 Cash and due from banks and deposits with banking subsidiaries at the end of the year $ 6,845 $ 6,865 $ 5,341 Cash interest paid $ 4,065 $ 5,445 $ 7,957 Cash income taxes paid, net (d) 15,259 5,366 3,910 (a) Affiliates include trusts that issued guaranteed capital debt securities (“issuer trusts”). (b) At December 31, 2021, long-term debt that contractually matures in 2022 through 2026 totaled $10.7 billion, $16.6 billion, $24.2 billion, $22.8 billion, and $24.7 billion, respectively. (c) Refer to Notes 20 and 28 for information regarding the Parent Company’s guarantees of its subsidiaries’ obligations. (d) Represents payments, net of refunds, made by the Parent Company to various taxing authorities and includes taxes paid on behalf of certain of its subsidiaries that are subsequently reimbursed. The reimbursements were $13.9 billion, $8.3 billion, and $6.4 billion for the years ended December 31, 2021, 2020, and 2019, respectively. (e) As a result of the merger of Chase Bank USA, N.A. with and into JPMorgan Chase Bank, N.A., JPMorgan Chase Bank, N.A. distributed $13.5 billion to the Parent company as a return of capital, which the Parent company contributed to the IHC.

Basis of Presentation (Policies

Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation policy	The accounting and financial reporting policies of JPMorgan Chase and its subsidiaries conform to U.S. GAAP. Additionally, where applicable, the policies conform to the accounting and reporting guidelines prescribed by regulatory authorities.
Reclassifications policy	Certain amounts reported in prior periods have been reclassified to conform with the current presentation. Notably in the first quarter of 2021, the Firm reclassified certain deferred investment tax credits from accounts payable and other liabilities to other assets to be a reduction to the carrying value of the associated tax-oriented investments.
Consolidation policy	The Consolidated Financial Statements include the accounts of JPMorgan Chase and other entities in which the Firm has a controlling financial interest. All material intercompany balances and transactions have been eliminated. Assets held for clients in an agency or fiduciary capacity by the Firm are not assets of JPMorgan Chase and are not included on the Consolidated balance sheets. The Firm determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity. Voting interest entities Voting interest entities are entities that have sufficient equity and provide the equity investors voting rights that enable them to make significant decisions relating to the entity’s operations. For these types of entities, the Firm’s determination of whether it has a controlling interest is primarily based on the amount of voting equity interests held. Entities in which the Firm has a controlling financial interest, through ownership of the majority of the entities’ voting equity interests, or through other contractual rights that give the Firm control, are consolidated by the Firm. Investments in companies in which the Firm has significant influence over operating and financing decisions (but does not own a majority of the voting equity interests) are accounted for (i) in accordance with the equity method of accounting (which requires the Firm to recognize its proportionate share of the entity’s net earnings), or (ii) at fair value if the fair value option was elected. These investments are generally included in other assets, with income or loss included in noninterest revenue. Certain Firm-sponsored asset management funds are structured as limited partnerships or limited liability companies. For many of these entities, the Firm is the general partner or managing member, but the non-affiliated partners or members have the ability to remove the Firm as the general partner or managing member without cause (i.e., kick-out rights), based on a simple majority vote, or the non-affiliated partners or members have rights to participate in important decisions. Accordingly, the Firm does not consolidate these voting interest entities. However, in the limited cases where the non-managing partners or members do not have substantive kick-out or participating rights, the Firm evaluates the funds as VIEs and consolidates the funds if the Firm is the general partner or managing member and has both power and a potentially significant interest. The Firm’s investment companies and asset management funds have investments in both publicly-held and privately-held entities, including investments in buyouts, growth equity and venture opportunities. These investments are accounted for under investment company guidelines and, accordingly, irrespective of the percentage of equity ownership interests held, are carried on the Consolidated balance sheets at fair value, and are recorded in other assets, with income or loss included in noninterest revenue. If consolidated, the Firm retains the accounting under such specialized investment company guidelines. Variable interest entities VIEs are entities that, by design, either (1) lack sufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties, or (2) have equity investors that do not have the ability to make significant decisions relating to the entity’s operations through voting rights, or do not have the obligation to absorb the expected losses, or do not have the right to receive the residual returns of the entity. The most common type of VIE is an SPE. SPEs are commonly used in securitization transactions in order to isolate certain assets and distribute the cash flows from those assets to investors. The basic SPE structure involves a company selling assets to the SPE; the SPE funds the purchase of those assets by issuing securities to investors. The legal documents that govern the transaction specify how the cash earned on the assets must be allocated to the SPE’s investors and other parties that have rights to those cash flows. SPEs are generally structured to insulate investors from claims on the SPE’s assets by creditors of other entities, including the creditors of the seller of the assets. The primary beneficiary of a VIE (i.e., the party that has a controlling financial interest) is required to consolidate the assets and liabilities of the VIE. The primary beneficiary is the party that has both (1) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and (2) through its interests in the VIE, the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. To assess whether the Firm has the power to direct the activities of a VIE that most significantly impact the VIE’s economic performance, the Firm considers all the facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes, first, identifying the activities that most significantly impact the VIE’s economic performance; and second, identifying which party, if any, has power over those activities. In general, the parties that make the most significant decisions affecting the VIE (such as asset managers, collateral managers, servicers, or owners of call options or liquidation rights over the VIE’s assets) or have the right to unilaterally remove those decision-makers are deemed to have the power to direct the activities of a VIE. To assess whether the Firm has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, the Firm considers all of its economic interests, including debt and equity investments, servicing fees, and derivatives or other arrangements deemed to be variable interests in the VIE. This assessment requires that the Firm apply judgment in determining whether these interests, in the aggregate, are considered potentially significant to the VIE. Factors considered in assessing significance include: the design of the VIE, including its capitalization structure; subordination of interests; payment priority; relative share of interests held across various classes within the VIE’s capital structure; and the reasons why the interests are held by the Firm. The Firm performs on-going reassessments of: (1) whether entities previously evaluated under the majority voting-interest framework have become VIEs, based on certain events, and are therefore subject to the VIE consolidation framework; and (2) whether changes in the facts and circumstances regarding the Firm’s involvement with a VIE cause the Firm’s consolidation conclusion to change.
Revenue recognition policy	Interest income The Firm recognizes interest income on loans, debt securities, and other debt instruments, generally on a level-yield basis, based on the underlying contractual rate. Refer to Note 7 for further discussion of interest income. Revenue from contracts with customers JPMorgan Chase recognizes noninterest revenue from certain contracts with customers , in investment banking fees, deposit-related fees, asset management administration and commissions, and components of card income, when the Firm’s related performance obligations are satisfied. Refer to Note 6 for further discussion of the Firm’s revenue from contracts with customers. Investment banking fees This revenue category includes debt and equity underwriting and advisory fees. As an underwriter, the Firm helps clients raise capital via public offering and private placement of various types of debt and equity instruments. Underwriting fees are primarily based on the issuance price and quantity of the underlying instruments, and are recognized as revenue typically upon execution of the client’s transaction. The Firm also manages and syndicates loan arrangements. Credit arrangement and syndication fees, included within debt underwriting fees, are recorded as revenue after satisfying certain retention, timing and yield criteria. The Firm also provides advisory services, by assisting its clients with mergers and acquisitions, divestitures, restructuring and other complex transactions. Advisory fees are recognized as revenue typically upon execution of the client’s transaction. Principal transactions Principal transactions revenue is driven by many factors, including: • the bid-offer spread, which is the difference between the price at which a market participant is willing and able to sell an instrument to the Firm and the price at which another market participant is willing and able to buy it from the Firm, and vice versa; and • realized and unrealized gains and losses on financial instruments and commodities transactions, including those accounted for under the fair value option, primarily used in client-driven market-making activities, and on private equity investments. – Realized gains and losses result from the sale of instruments, closing out or termination of transactions, or interim cash payments. – Unrealized gains and losses result from changes in valuation. In connection with its client-driven market-making activities, the Firm transacts in debt and equity instruments, derivatives and commodities, including physical commodities inventories and financial instruments that reference commodities. Principal transactions revenue also includes realized and unrealized gains and losses related to: • derivatives designated in qualifying hedge accounting relationships, primarily fair value hedges of commodity and foreign exchange risk; • derivatives used for specific risk management purposes, primarily to mitigate credit risk and foreign exchange risk. Refer to Note 5 for further information on the income statement classification of gains and losses from derivatives activities. In the financial commodity markets, the Firm transacts in OTC derivatives (e.g., swaps, forwards, options) and ETD that reference a wide range of underlying commodities. In the physical commodity markets, the Firm primarily purchases and sells precious and base metals and may hold other commodities inventories under financing and other arrangements with clients. Lending- and deposit-related fees Lending-related fees include fees earned from loan commitments, standby letters of credit, financial guarantees, and other loan-servicing activities. Deposit-related fees include fees earned from providing overdraft and other deposit account services, and from performing cash management activities. Lending- and deposit-related fees in this revenue category are recognized over the period in which the related service is provided. Asset management, administration and commissions This revenue category includes fees from investment management and related services, custody, brokerage services and other products. The Firm manages assets on behalf of its clients, including investors in Firm-sponsored funds and owners of separately managed investment accounts. Management fees are typically based on the value of assets under management and are collected and recognized at the end of each period over which the management services are provided and the value of the managed assets is known. The Firm also receives performance-based management fees, which are earned based on exceeding certain benchmarks or other performance targets and are accrued and recognized when the probability of reversal is remote, typically at the end of the related billing period. The Firm has contractual arrangements with third parties to provide distribution and other services in connection with its asset management activities. Amounts paid to these third-party service providers are generally recorded in professional and Mortgage fees and related income This revenue category reflects CCB’s Home Lending production and net mortgage servicing revenue. Production revenue includes fees and income recognized as earned on mortgage loans originated with the intent to sell, and the impact of risk management activities associated with the mortgage pipeline and warehouse loans. Production revenue also includes gains and losses on sales and lower of cost or fair value adjustments on mortgage loans held-for-sale (excluding certain repurchased loans insured by U.S. government agencies), and changes in the fair value of financial instruments measured under the fair value option. Net mortgage servicing revenue includes operating revenue earned from servicing third-party mortgage loans, which is recognized over the period in which the service is provided; changes in the fair value of MSRs; the impact of risk management activities associated with MSRs; and gains and losses on securitization of excess mortgage servicing. Net mortgage servicing revenue also includes gains and losses on sales and lower of cost or fair value adjustments of certain repurchased loans insured by U.S. government agencies. Refer to Note 15 for further information on risk management activities and MSRs. Net interest income from mortgage loans is recorded in interest income. Card income This revenue category includes interchange and other income from credit and debit card transactions; and fees earned from processing card transactions for merchants, both of which are recognized when purchases are made by a cardholder and presented net of certain transaction-related costs. Card income also includes account origination costs and annual fees, which are deferred and recognized on a straight-line basis over a 12-month period. Certain credit card products offer the cardholder the ability to earn points based on account activity, which the cardholder can choose to redeem for cash and non-cash rewards. The cost to the Firm related to these proprietary rewards programs varies based on multiple factors including the terms and conditions of the rewards programs, cardholder activity, cardholder reward redemption rates and cardholder reward selections. The Firm maintains a liability for its obligations under its rewards programs and reports the current-period cost as a reduction of card income. Credit card revenue sharing agreements The Firm has contractual agreements with numerous co-brand partners that grant the Firm exclusive rights to issue co-branded credit card products and market them to the customers of such partners. These partners endorse the co-brand credit card programs and provide their customer or member lists to the Firm. The partners may also conduct marketing activities and provide rewards redeemable under their own loyalty programs that the Firm will grant to co-brand credit cardholders based on account activity. The terms of these agreements generally range from five
Use of estimates in the preparation of consolidated financial statements policy	The preparation of the Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expense, and disclosures of contingent assets and liabilities. Actual results could be different from these estimates.
Foreign currency translation policy	JPMorgan Chase revalues assets, liabilities, revenue and expense denominated in non-U.S. currencies into U.S. dollars using applicable exchange rates. Gains and losses relating to translating functional currency financial statements for U.S. reporting are included in the Consolidated statements of comprehensive income. Gains and losses relating to nonfunctional currency transactions, including non-U.S. operations where the functional currency is the U.S. dollar, are reported in the Consolidated statements of income.
Offsetting assets and liabilities policy	U.S. GAAP permits entities to present derivative receivables and derivative payables with the same counterparty and the related cash collateral receivables and payables on a net basis on the Consolidated balance sheets when a legally enforceable master netting agreement exists. U.S. GAAP also permits securities sold and purchased under repurchase agreements and securities borrowed or loaned under securities loan agreements to be presented net when specified conditions are met, including the existence of a legally enforceable master netting agreement. The Firm has elected to net such balances where it has determined that the specified conditions are met. The Firm uses master netting agreements to mitigate counterparty credit risk in certain transactions, including derivative contracts, resale, repurchase, securities borrowed and securities loaned agreements. A master netting agreement is a single agreement with a counterparty that permits multiple transactions governed by that agreement to be terminated or accelerated and settled through a single payment in a single currency in the event of a default (e.g., bankruptcy, failure to make a required payment or securities transfer or deliver collateral or margin when due). Upon the exercise of derivatives termination rights by the non-defaulting party (i) all transactions are terminated, (ii) all transactions are valued and the positive values of “in the money” transactions are netted against the negative values of “out of the money” transactions and (iii) the only remaining payment obligation is of one of the parties to pay the netted termination amount. Upon exercise of default rights under repurchase agreements and securities loan agreements in general (i) all transactions are terminated and accelerated, (ii) all values of securities or cash held or to be delivered are calculated, and all such sums are netted against each other and (iii) the only remaining payment obligation is of one of the parties to pay the netted termination amount. Typical master netting agreements for these types of transactions also often contain a collateral/margin agreement that provides for a security interest in, or title transfer of, securities or cash collateral/margin to the party that has the right to demand margin (the “demanding party”). The collateral/margin agreement typically requires a party to transfer collateral/margin to the demanding party with a value equal to the amount of the margin deficit on a net basis across all transactions governed by the master netting agreement, less any threshold. The collateral/margin agreement grants to the demanding party, upon default by the counterparty, the right to set-off any amounts payable by the counterparty against any posted collateral or the cash equivalent of any posted collateral/margin. It also grants to the demanding party the right to liquidate collateral/margin and to apply the proceeds to an amount payable by the counterparty.
Statements of cash flows policy	For JPMorgan Chase’s Consolidated statements of cash flows, cash is defined as those amounts included in cash and due from banks and deposits with banks on the Consolidated balance sheets.
Accounting standard adopted January 1, 2020	Accounting standard adopted January 1, 2020 Financial Instruments – Credit Losses (“CECL”) The adoption of this guidance established a single allowance framework for all financial assets measured at amortized cost and certain off-balance sheet credit exposures. This framework requires that management’s estimate reflects credit losses over the instrument’s remaining expected life and considers expected future changes in macroeconomic conditions. Prior to the adoption of the CECL accounting guidance, the Firm’s allowance for credit losses represented management’s estimate of probable credit losses inherent in the Firm’s retained loan portfolios and certain lending-related commitments. The adoption of CECL on January 1, 2020, resulted in a $2.7 billion decrease to retained earnings.
Fair value policy	JPMorgan Chase carries a portion of its assets and liabilities at fair value. These assets and liabilities are predominantly carried at fair value on a recurring basis (i.e., assets and liabilities that are measured and reported at fair value on the Firm’s Consolidated balance sheets). Certain assets, liabilities and unfunded lending-related commitments are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment).
Fair value option policy	The fair value option provides an option to elect fair value as an alternative measurement for selected financial assets, financial liabilities, unrecognized firm commitments, and written loan commitments. The Firm has elected to measure certain instruments at fair value for several reasons including to mitigate income statement volatility caused by the differences between the measurement basis of elected instruments (e.g., certain instruments that otherwise would be accounted for on an accrual basis) and the associated risk management arrangements that are accounted for on a fair value basis, as well as to better reflect those instruments that are managed on a fair value basis. The Firm’s election of fair value includes the following instruments: • Loans purchased or originated as part of securitization warehousing activity, subject to bifurcation accounting, or managed on a fair value basis, including lending-related commitments • Certain securities financing agreements • Owned beneficial interests in securitized financial assets that contain embedded credit derivatives, which would otherwise be required to be separately accounted for as a derivative instrument • Structured notes and other hybrid instruments, which are predominantly financial instruments that contain embedded derivatives, that are issued or transacted as part of client-driven activities
Derivatives policy	All free-standing derivatives that the Firm executes for its own account are required to be recorded on the Consolidated balance sheets at fair value. As permitted under U.S. GAAP, the Firm nets derivative assets and liabilities, and the related cash collateral receivables and payables, when a legally enforceable master netting agreement exists between the Firm and the derivative counterparty. Refer to Note 1 for further discussion of the offsetting of assets and liabilities. The accounting for changes in value of a derivative depends on whether or not the transaction has been designated and qualifies for hedge accounting. Derivatives that are not designated as hedges are reported and measured at fair value through earnings. The tabular disclosures on pages 200-207 of this Note provide additional information on the amount of, and reporting for, derivative assets, liabilities, gains and losses. Refer to Notes 2 and 3 for a further discussion of derivatives embedded in structured notes. Derivatives designated as hedges The Firm applies hedge accounting to certain derivatives executed for risk management purposes – generally interest rate, foreign exchange and commodity derivatives. However, JPMorgan Chase does not seek to apply hedge accounting to all of the derivatives involved in the Firm’s risk management activities. For example, the Firm does not apply hedge accounting to purchased CDS used to manage the credit risk of loans and lending-related commitments, because of the difficulties in qualifying such contracts as hedges. For the same reason, the Firm does not apply hedge accounting to certain interest rate, foreign exchange, and commodity derivatives used for risk management purposes. To qualify for hedge accounting, a derivative must be highly effective at reducing the risk associated with the exposure being hedged. In addition, for a derivative to be designated as a hedge, the risk management objective and strategy must be documented. Hedge documentation must identify the derivative hedging instrument, the asset or liability or forecasted transaction and type of risk to be hedged, and how the effectiveness of the derivative is assessed prospectively and retrospectively. To assess effectiveness, the Firm uses statistical methods such as regression analysis, nonstatistical methods such as dollar-value comparisons of the change in the fair value of the derivative to the change in the fair value or cash flows of the hedged item, and qualitative comparisons of critical terms and the evaluation of any changes in those terms. The extent to which a derivative has been, and is expected to continue to be, highly effective at offsetting changes in the fair value or cash flows of the hedged item must be assessed and documented at least quarterly. If it is determined that a derivative is not highly effective at hedging the designated exposure, hedge accounting is discontinued. There are three types of hedge accounting designations: fair value hedges, cash flow hedges and net investment hedges. JPMorgan Chase uses fair value hedges primarily to hedge fixed-rate long-term debt, AFS securities and certain commodities inventories. For qualifying fair value hedges, the changes in the fair value of the derivative, and in the value of the hedged item for the risk being hedged, are recognized in earnings. Certain amounts excluded from the assessment of effectiveness are recorded in OCI and recognized in earnings over the life of the derivative. If the hedge relationship is terminated, then the adjustment to the hedged item continues to be reported as part of the basis of the hedged item, and for benchmark interest rate hedges, is amortized to earnings as a yield adjustment. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item – primarily net interest income and principal transactions revenue. JPMorgan Chase uses cash flow hedges primarily to hedge the exposure to variability in forecasted cash flows from floating-rate assets and liabilities and foreign currency–denominated revenue and expense. For qualifying cash flow
Interest income and interest expense policy	Interest income and interest expense includes the current-period interest accruals for financial instruments measured at fair value, except for derivatives and financial instruments containing embedded derivatives that would be separately accounted for in accordance with U.S. GAAP, absent the fair value option election; for those instruments, all changes in fair value including any interest elements, are primarily reported in principal transactions revenue. For financial instruments that are not measured at fair value, the related interest is included within interest income or interest expense, as applicable. Refer to Notes 12, 10, 11 and 20 for further information on accounting for interest income and interest expense related to loans, investment securities, securities financing activities (i.e., securities purchased or sold under resale or repurchase agreements; securities borrowed; and securities loaned) and long-term debt, respectively.
Pension and other postretirement plans policy	The Firm has various defined benefit pension plans and OPEB plans that provide benefits to its employees in the U.S. and certain non-U.S. locations. Substantially all the defined benefit pension plans are closed to new participants. The principal defined benefit pension plan in the U.S., which covered substantially all U.S. employees, was closed to new participants and frozen for existing participants on January 1, 2020, (and January 1, 2019 for new hires on or after December 2, 2017). Interest credits continue to accrue to participants’ accounts based on their accumulated balances. The Firm maintains funded and unfunded postretirement benefit plans that provide medical and life insurance for certain eligible employees and retirees as well as their
Share-based compensation, option and incentive plans policy	RSUs are awarded at no cost to the recipient upon their grant. Generally, RSUs are granted annually and vest at a rate of 50% after two years and 50% after three years and are converted into shares of common stock as of the vesting date. In addition, RSUs typically include full-career eligibility provisions, which allow employees to continue to vest upon voluntary termination based on age or service-related requirements, subject to post-employment and other restrictions. All RSU awards are subject to forfeiture until vested and contain clawback provisions that may result in cancellation under certain specified circumstances. Predominantly all RSUs entitle the recipient to receive cash payments equivalent to any dividends paid on the underlying common stock during the period the RSUs are outstanding. Performance share units (“PSUs”) are granted annually, and approved by the Firm’s Board of Directors, to members of the Firm’s Operating Committee under the variable compensation program. PSUs are subject to the Firm’s achievement of specified performance criteria over a three Once the PSUs and dividend equivalent share units have vested, the shares of common stock that are delivered, after applicable tax withholding, must be held for an additional two five eight Under the LTI Plans, stock appreciation rights (“SARs”) and stock options have generally been granted with an exercise price equal to the fair value of JPMorgan Chase’s common stock on the grant date. SARs and stock options generally expire ten years after the grant date. In 2021, the Firm awarded its Chairman and CEO and its President and Chief Operating Officer 1.5 million and 750,000 SARs, respectively. There were no material grants of SARs or stock options in 2020 and 2019. The Firm separately recognizes compensation expense for each tranche of each award, net of estimated forfeitures, as if it were a separate award with its own vesting date. Generally, for each tranche granted, compensation expense is recognized on a straight-line basis from the grant date until the vesting date of the respective tranche, provided that the employees will not become full-career eligible during the vesting period. For awards with full-career eligibility provisions and awards granted with no future substantive service requirement, the Firm accrues the estimated value of awards expected to be awarded to employees as of the grant date without giving consideration to the impact of post-employment restrictions. For each tranche granted to employees who will become full-career eligible during the vesting period, compensation expense is recognized on a straight-line basis from the grant date until the earlier of the employee’s full-career eligibility date or the vesting date of the respective tranche.
Loans receivable policy	The accounting for a loan depends on management’s strategy for the loan. The Firm accounts for loans based on the following categories: • Originated or purchased loans held-for-investment (i.e., “retained”) • Loans held-for-sale • Loans at fair value The following provides a detailed accounting discussion of the Firm’s loans by category: Loans held-for-investment Originated or purchased loans held-for-investment, including PCD, are recorded at amortized cost, reflecting the principal amount outstanding, net of the following: unamortized deferred loan fees, costs, premiums or discounts; charge-offs; collection of cash; and foreign exchange. Credit card loans also include billed finance charges and fees. Interest income Interest income on performing loans held-for-investment is accrued and recognized as interest income at the contractual rate of interest. Purchase price discounts or premiums, as well as net deferred loan fees or costs, are amortized into interest income over the contractual life of the loan as an adjustment of yield. The Firm classifies accrued interest on loans, including accrued but unbilled interest on credit card loans, in accrued interest and accounts receivables on the Consolidated balance sheets. For credit card loans, accrued interest once billed is then recognized in the loan balances, with the related allowance recorded in the allowance for credit losses. Changes in the allowance for credit losses on accrued interest on credit card loans are recognized in the provision for credit losses and charge-offs are recognized by reversing interest income. Expected losses related to accrued interest on certain performing, modified loans to borrowers impacted by COVID-19 are considered in the Firm’s allowance for loan losses. For other loans, the Firm generally does not recognize an allowance for credit losses on accrued interest receivables, consistent with its policy to write them off no later than 90 days past due by reversing interest income. Nonaccrual loans Nonaccrual loans are those on which the accrual of interest has been suspended. Loans (other than credit card loans and certain consumer loans insured by U.S. government agencies) are placed on nonaccrual status and considered nonperforming when full payment of principal and interest is not expected, regardless of delinquency status, or when principal and interest has been in default for a period of 90 days or more, unless the loan is both well-secured and in the process of collection. A loan is determined to be past due when the minimum payment is not received from the borrower by the contractually specified due date or for certain loans (e.g., residential real estate loans), when a monthly payment is due and unpaid for 30 days or more. Finally, collateral-dependent loans are typically maintained on nonaccrual status. On the date a loan is placed on nonaccrual status, all interest accrued but not collected is reversed against interest income. In addition, the amortization of deferred amounts is suspended. Interest income on nonaccrual loans may be recognized as cash interest payments are received (i.e., on a cash basis) if the recorded loan balance is deemed fully collectible; however, if there is doubt regarding the ultimate collectibility of the recorded loan balance, all interest cash receipts are applied to reduce the carrying value of the loan (the cost recovery method). For consumer loans, application of this policy typically results in the Firm recognizing interest income on nonaccrual consumer loans on a cash basis. A loan may be returned to accrual status when repayment is reasonably assured and there has been demonstrated performance under the terms of the loan or, if applicable, the terms of the restructured loan. As permitted by regulatory guidance, credit card loans are generally exempt from being placed on nonaccrual status; accordingly, interest and fees related to credit card loans continue to accrue until the loan is charged off or paid in full. Allowance for loan losses The allowance for loan losses represents the estimated expected credit losses in the held-for-investment loan portfolio at the balance sheet date and is recognized on the balance sheet as a contra asset, which brings the amortized cost to the net carrying value. Changes in the allowance for loan losses are recorded in the provision for credit losses on the Firm’s Consolidated statements of income. Refer to Note 13 for further information on the Firm’s accounting policies for the allowance for loan losses. Charge-offs Consumer loans are generally charged off or charged down to the lower of the amortized cost or the net realizable value of the underlying collateral (i.e., fair value less estimated costs to sell), with an offset to the allowance for loan losses, upon reaching specified stages of delinquency in accordance with standards established by the FFIEC. Residential real estate loans, unmodified credit card loans and scored business banking loans are generally charged off no later than 180 days past due. Scored auto and modified credit card loans are charged off no later than 120 days past due. Certain consumer loans are charged off or charged down to their net realizable value earlier than the FFIEC charge-off standards in certain circumstances as follows: • Loans modified in a TDR that are determined to be collateral-dependent. • Loans to borrowers who have experienced an event that suggests a loss is either known or highly certain are subject to accelerated charge-off standards (e.g., residential real estate and auto loans are charged off or charged down within 60 days of receiving notification of a bankruptcy filing). • Auto loans upon repossession of the automobile. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs on the government-guaranteed portion of loans. Wholesale loans are charged off when it is highly certain that a loss has been realized. The determination of whether to recognize a charge-off includes many factors, including the prioritization of the Firm’s claim in bankruptcy, expectations of the workout/restructuring of the loan and valuation of the borrower’s equity or the loan collateral. When a loan is charged down to the lower of its amortized cost or the estimated net realizable value of the underlying collateral, the determination of the fair value of the collateral depends on the type of collateral (e.g., securities, real estate). In cases where the collateral is in the form of liquid securities, the fair value is based on quoted market prices or broker quotes. For illiquid securities or other financial assets, the fair value of the collateral is generally estimated using a discounted cash flow model. For residential real estate loans, collateral values are based upon external valuation sources. When it becomes likely that a borrower is either unable or unwilling to pay, the Firm utilizes a broker’s price opinion, appraisal and/or an automated valuation model of the home based on an exterior-only valuation (“exterior opinions”), which is then updated at least every 12 months, or more frequently depending on various market factors. As soon as practicable after the Firm receives the property in satisfaction of a debt (e.g., by taking legal title or physical possession), the Firm generally obtains an appraisal based on an inspection that includes the interior of the home (“interior appraisals”). Exterior opinions and interior appraisals are discounted based upon the Firm’s experience with actual liquidation values as compared with the estimated values provided by exterior opinions and interior appraisals, considering state-specific factors. For commercial real estate loans, collateral values are generally based on appraisals from internal and external valuation sources. Collateral values are typically updated every six result in obtaining appraisal updates or broker price opinions at more frequent intervals. Loans held-for-sale Loans held-for-sale are measured at the lower of cost or fair value, with valuation changes recorded in noninterest revenue. For consumer loans, the valuation is performed on a portfolio basis. For wholesale loans, the valuation is performed on an individual loan basis. Interest income on loans held-for-sale is accrued and recognized based on the contractual rate of interest. Loan origination fees or costs and purchase price discounts or premiums are deferred in a contra loan account until the related loan is sold. The deferred fees or costs and discounts or premiums are an adjustment to the basis of the loan and therefore are included in the periodic determination of the lower of cost or fair value adjustments and/or the gain or loss recognized at the time of sale. Because these loans are recognized at the lower of cost or fair value, the Firm’s allowance for loan losses and charge-off policies do not apply to these loans. However, loans held-for-sale are subject to the nonaccrual policies described above. Loans at fair value Loans for which the fair value option has been elected are measured at fair value, with changes in fair value recorded in noninterest revenue. Interest income on these loans is accrued and recognized based on the contractual rate of interest. Changes in fair value are recognized in noninterest revenue. Loan origination fees are recognized upfront in noninterest revenue. Loan origination costs are recognized in the associated expense category as incurred. Because these loans are recognized at fair value, the Firm’s allowance for loan losses and charge-off policies do not apply to these loans. However, loans at fair value are subject to the nonaccrual policies described above. Refer to Note 3 for further information on the Firm’s elections of fair value accounting under the fair value option. Refer to Note 2 and Note 3 for further information on loans carried at fair value and classified as trading assets. Loan classification changes Loans in the held-for-investment portfolio that management decides to sell are transferred to the held-for-sale portfolio at the lower of cost or fair value on the date of transfer. Credit-related losses are charged against the allowance for loan losses; non-credit related losses such as those due to changes in interest rates or foreign currency exchange rates are recognized in noninterest revenue. In the event that management decides to retain a loan in the held-for-sale portfolio, the loan is transferred to the held-for-investment portfolio at amortized cost on the date of transfer. These loans are subsequently assessed for impairment based on the Firm’s allowance methodology. Refer to Note 13 for a further discussion of the methodologies used in establishing the Firm’s allowance for loan losses. Loan modifications The Firm seeks to modify certain loans in conjunction with its loss mitigation activities. Through the modification, JPMorgan Chase grants one or more concessions to a borrower who is experiencing financial difficulty in order to minimize the Firm’s economic loss and avoid foreclosure or repossession of the collateral, and to ultimately maximize payments received by the Firm from the borrower. The concessions granted vary by program and by borrower-specific characteristics, and may include interest rate reductions, term extensions, payment delays, principal forgiveness, or the acceptance of equity or other assets in lieu of payments. Such modifications are accounted for and reported as TDRs. Loans with short-term and other insignificant modifications that are not considered concessions are not TDRs. Loans, except for credit card loans, modified in a TDR are generally placed on nonaccrual status, although in many cases such loans were already on nonaccrual status prior to modification. These loans may be returned to performing status (the accrual of interest is resumed) if the following criteria are met: (i) the borrower has performed under the modified terms for a minimum of six months and/or six payments, and (ii) the Firm has an expectation that repayment of the modified loan is reasonably assured based on, for example, the borrower’s debt capacity and level of future earnings, collateral values, LTV ratios, and other current market considerations. In certain limited and well-defined circumstances in which the loan is current at the modification date, such loans are not placed on nonaccrual status at the time of modification. Loans modified in TDRs are generally measured for impairment using the Firm’s established asset-specific allowance methodology, which considers the expected re-default rates for the modified loans. A loan modified in a TDR generally remains subject to the asset-specific component of the allowance throughout its remaining life, regardless of whether the loan is performing and has been returned to accrual status. Refer to Note 13 for further discussion of the methodology used to estimate the Firm’s asset-specific allowance. The Firm granted various forms of assistance to customers and clients impacted by the COVID-19 pandemic, including payment deferrals and covenant modifications. The majority of the Firm’s COVID-19 related loan modifications have not been considered TDRs because: • they represent short-term or other insignificant modifications, whether under the Firm’s regular loan modification assessments or as permitted by regulatory guidance, or • the Firm elected to suspend TDR accounting guidance under the option provided by the CARES Act, as extended by the Consolidated Appropriations Act and which expired on January 1, 2022. To the extent that certain modifications did not meet any of the above criteria, the Firm accounted for them as TDRs. As permitted by regulatory guidance, the Firm did not place loans with deferrals granted due to COVID-19 on nonaccrual status where such loans were not otherwise reportable as nonaccrual. The Firm considered expected losses of principal and accrued interest associated with all COVID-19 related loan modifications in its allowance for credit losses. Assistance provided in response to the COVID-19 pandemic could delay the recognition of delinquencies, nonaccrual status, and net charge-offs for those customers who would have otherwise moved into past due or nonaccrual status. Foreclosed property The Firm acquires property from borrowers through loan restructurings, workouts, and foreclosures. Property acquired may include real property (e.g., residential real estate, land, and buildings) and commercial and personal property (e.g., automobiles, aircraft, railcars, and ships). The Firm recognizes foreclosed property upon receiving assets in satisfaction of a loan (e.g., by taking legal title or physical possession). For loans collateralized by real property, the Firm generally recognizes the asset received at foreclosure sale or upon the execution of a deed in lieu of foreclosure transaction with the borrower. Foreclosed assets are reported in other assets on the Consolidated balance sheets and initially recognized at fair value less estimated costs to sell. Each quarter the fair value of the acquired property is reviewed and adjusted, if necessary, to the lower of cost or fair value. Subsequent adjustments to fair value are charged/credited to noninterest revenue. Operating expense, such as real estate taxes and maintenance, are charged to other expense.
Allowance for credit losses policy	The Firm’s allowance for credit losses represents management's estimate of expected credit losses over the remaining expected life of the Firm's financial assets measured at amortized cost and certain off-balance sheet lending-related commitments. The allowance for credit losses comprises: • the allowance for loan losses, which covers the Firm’s retained loan portfolios (scored and risk-rated) and is presented separately on the Consolidated balance sheets, • the allowance for lending-related commitments, which is presented on the Consolidated balance sheets in accounts payable and other liabilities, and • the allowance for credit losses on investment securities, which is recognized within investment securities on the Consolidated balance sheets. The income statement effect of all changes in the allowance for credit losses is recognized in the provision for credit losses. Determining the appropriateness of the allowance for credit losses is complex and requires significant judgment by management about the effect of matters that are inherently uncertain. At least quarterly, the allowance for credit losses is reviewed by the CRO, the CFO and the Controller of the Firm. Subsequent evaluations of credit exposures, considering the macroeconomic conditions, forecasts and other factors then prevailing, may result in significant changes in the allowance for credit losses in future periods. The Firm’s policies used to determine its allowance for loan losses and its allowance for lending-related commitments are described in the following paragraphs. Refer to Note 10 for a description of the policies used to determine the allowance for credit losses on investment securities. Methodology for allowances for loan losses and lending-related commitments The allowance for loan losses and allowance for lending-related commitments represents expected credit losses over the remaining expected life of retained loans and lending-related commitments that are not unconditionally cancellable. The Firm does not record an allowance for future draws on unconditionally cancellable lending-related commitments (e.g., credit cards). Expected losses related to accrued interest on credit card loans and certain performing, modified loans to borrowers impacted by COVID-19 are considered in the Firm’s allowance for loan losses. However, the Firm does not record an allowance on other accrued interest receivables, due to its policy to write t hese receivables off no later than 90 days past due by reversing interest income. The expected life of each instrument is determined by considering its contractual term, expected prepayments, cancellation features, and certain extension and call options. The expected life of funded credit card loans is generally estimated by considering expected future payments on the credit card account, and determining how much of those amounts should be allocated to repayments of the funded loan balance (as of the balance sheet date) versus other account activity. This allocation is made using an approach that incorporates the payment application requirements of the Credit Card Accountability Responsibility and Disclosure Act of 2009, generally paying down the highest interest rate balances first. The estimate of expected credit losses includes expected recoveries of amounts previously charged off or expected to be charged off, even if such recoveries result in a negative allowance. Collective and Individual Assessments When calculating the allowance for loan losses and the allowance for lending-related commitments, the Firm assesses whether exposures share similar risk characteristics. If similar risk characteristics exist, the Firm estimates expected credit losses collectively, considering the risk associated with a particular pool and the probability that the exposures within the pool will deteriorate or default. The assessment of risk characteristics is subject to significant management judgment. Emphasizing one characteristic over another or considering additional characteristics could affect the allowance. • Relevant risk characteristics for the consumer portfolio include product type, delinquency status, current FICO scores, geographic distribution, and, for collateralized loans, current LTV ratios. • Relevant risk characteristics for the wholesale portfolio include LOB, geography, risk rating, delinquency status, level and type of collateral, industry, credit enhancement, product type, facility purpose, tenor, and payment terms. The majority of the Firm’s credit exposures share risk characteristics with other similar exposures, and as a result are collectively assessed for impairment (“portfolio-based component”). The portfolio-based component covers consumer loans, performing risk-rated loans and certain lending-related commitments. If an exposure does not share risk characteristics with other exposures, the Firm generally estimates expected credit losses on an individual basis, considering expected repayment and conditions impacting that individual exposure (“asset-specific component”). The asset-specific component covers modified PCD loans, loans modified or reasonably expected to be modified in a TDR, collateral-dependent loans, as well as, risk-rated loans that have been placed on nonaccrual status. Portfolio-based component The portfolio-based component begins with a quantitative calculation that considers the likelihood of the borrower changing delinquency status or moving from one risk rating to another. The quantitative calculation covers expected credit losses over an instrument’s expected life and is estimated by applying credit loss factors to the Firm’s estimated exposure at default. The credit loss factors incorporate the probability of borrower default as well as loss severity in the event of default. They are derived using a weighted average of five internally developed macroeconomic scenarios over an eight-quarter forecast period, followed by a single year straight-line interpolation to revert to long run historical information for periods beyond the eight-quarter forecast period. The five macroeconomic scenarios consist of a central, relative adverse, extreme adverse, relative upside and extreme upside scenario, and are updated by the Firm’s central forecasting team. The scenarios take into consideration the Firm’s macroeconomic outlook, internal perspectives from subject matter experts across the Firm, and market consensus and involve a governed process that incorporates feedback from senior management across LOBs, Corporate Finance and Risk Management. The quantitative calculation is adjusted to take into consideration model imprecision, emerging risk assessments, trends and other subjective factors that are not yet reflected in the calculation. These adjustments are accomplished in part by analyzing the historical loss experience, including during stressed periods, for each major product or model. Management applies judgment in making this adjustment, including taking into account uncertainties associated with the economic and political conditions, quality of underwriting standards, borrower behavior, credit concentrations or deterioration within an industry, product or portfolio, as well as other relevant internal and external factors affecting the credit quality of the portfolio. In certain instances, the interrelationships between these factors create further uncertainties. The application of different inputs into the quantitative calculation, and the assumptions used by management to adjust the quantitative calculation, are subject to significant management judgment, and emphasizing one input or assumption over another, or considering other inputs or assumptions, could affect the estimate of the allowance for loan losses and the allowance for lending-related commitments. Asset-specific component To determine the asset-specific component of the allowance, collateral-dependent loans (including those loans for which foreclosure is probable) and larger, nonaccrual risk-rated loans in the wholesale portfolio segment are generally evaluated individually, while smaller loans (both scored and risk-rated) are aggregated for evaluation using factors relevant for the respective class of assets. The Firm generally measures the asset-specific allowance as the difference between the amortized cost of the loan and the present value of the cash flows expected to be collected, discounted at the loan’s original effective interest rate. Subsequent changes in impairment are generally recognized as an adjustment to the allowance for loan losses. For collateral-dependent loans, the fair value of collateral less estimated costs to sell is used to determine the charge-off amount for declines in value (to reduce the amortized cost of the loan to the fair value of collateral) or the amount of negative allowance that should be recognized (for recoveries of prior charge-offs associated with improvements in the fair value of collateral). The asset-specific component of the allowance for loans that have been or are expected to be modified in TDRs incorporates the effect of the modification on the loan’s expected cash flows (including forgone interest, principal forgiveness, as well as other concessions), and also the potential for redefault. For residential real estate loans modified in or expected to be modified in TDRs, the Firm develops product-specific probability of default estimates, which are applied at a loan level to compute expected losses. In developing these probabilities of default, the Firm considers the relationship between the credit quality characteristics of the underlying loans and certain assumptions about housing prices and unemployment, based upon industry-wide data. The Firm also considers its own historical loss experience to-date based on actual redefaulted modified loans. For credit card loans modified in or expected to be modified in TDRs, expected losses incorporate projected delinquencies and charge-offs based on the Firm’s historical experience by type of modification program. For wholesale loans modified or expected to be modified in TDRs, expected losses incorporate management’s expectation of the borrower’s ability to repay under the modified terms.
Loan securitizations policy	The Firm has securitized and sold a variety of loans, including residential mortgages, credit card receivables, and commercial mortgages. The purposes of these securitization transactions were to satisfy investor demand and to generate liquidity for the Firm. For loan securitizations in which the Firm is not required to consolidate the trust, the Firm records the transfer of the loan receivable to the trust as a sale when all of the following accounting criteria for a sale are met: (1) the transferred financial assets are legally isolated from the Firm’s creditors; (2) the transferee or beneficial interest holder can pledge or exchange the transferred financial assets; and (3) the Firm does not maintain effective control over the transferred financial assets (e.g., the Firm cannot repurchase the transferred assets before their maturity and it does not have the ability to unilaterally cause the holder to return the transferred assets). For loan securitizations accounted for as a sale, the Firm recognizes a gain or loss based on the difference between the value of proceeds received (including cash, beneficial interests, or servicing assets received) and the carrying value of the assets sold. Gains and losses on securitizations are reported in noninterest revenue.
Goodwill policy	Goodwill is recorded upon completion of a business combination as the difference between the purchase price and the fair value of the net assets acquired, and can be adjusted up to one year from the acquisition date as more information is obtained about the fair value of assets acquired and liabilities assumed. Subsequent to initial recognition, goodwill is not amortized but is tested for impairment during the fourth quarter of each fiscal year, or more often if events or circumstances, such as adverse changes in the business climate, indicate that there may be an impairment.The goodwill associated with each business combination is allocated to the related reporting units, which are generally determined based on how the Firm’s businesses are managed and how they are reviewed.
Mortgage servicing rights policy	MSRs represent the fair value of expected future cash flows for performing servicing activities for others. The fair value considers estimated future servicing fees and ancillary revenue, offset by estimated costs to service the loans, and generally declines over time as net servicing cash flows are received, effectively amortizing the MSR asset against contractual servicing and ancillary fee income. MSRs are either purchased from third parties or recognized upon sale or securitization of mortgage loans if servicing is retained.As permitted by U.S. GAAP, the Firm has elected to account for its MSRs at fair value. The Firm treats its MSRs as a single class of servicing assets based on the availability of market inputs used to measure the fair value of its MSR asset and its treatment of MSRs as one aggregate pool for risk management purposes. The Firm estimates the fair value of MSRs using an option-adjusted spread (“OAS”) model, which projects MSR cash flows over multiple interest rate scenarios in conjunction with the Firm’s prepayment model, and then discounts these cash flows at risk-adjusted rates. The model considers portfolio characteristics, contractually specified servicing fees, prepayment assumptions, delinquency rates, costs to service, late charges and other ancillary revenue, and other economic factors. The Firm compares fair value estimates and assumptions to observable market data where available, and also considers recent market activity and actual portfolio experience.
Premises and equipment policy	Premises and equipment, including leasehold improvements, are carried at cost less accumulated depreciation and amortization. JPMorgan Chase computes depreciation using the straight-line method over the estimated useful life of an asset. For leasehold improvements, the Firm uses the straight-line method computed over the lesser of the remainder of the lease term, or estimated useful life of the improvements.
Internal use software policy	JPMorgan Chase capitalizes certain costs associated with the acquisition or development of internal-use software. Once the software is ready for its intended use, these costs are amortized on a straight-line basis over the software’s expected useful life and reviewed for impairment on an ongoing basis.
Debt policy	JPMorgan Chase issues long-term debt denominated in various currencies, predominantly U.S. dollars, with both fixed and variable interest rates. Included in senior and subordinated debt below are various equity-linked or other indexed instruments, which the Firm has elected to measure at fair value. Changes in fair value are recorded in principal transactions revenue in the Consolidated statements of income, except for unrealized gains/(losses) due to DVA which are recorded in OCI.
Earnings per share policy	Basic earnings per share (“EPS”) is calculated using the two-class method. Under the two-class method, all earnings (distributed and undistributed) are allocated to common stock and participating securities. JPMorgan Chase grants RSUs under its share-based compensation programs, predominantly all of which entitle recipients to receive nonforfeitable dividends during the vesting period on a basis equivalent to dividends paid to holders of the Firm’s common stock. These unvested RSUs meet the definition of participating securities based on their respective rights to receive nonforfeitable dividends, and they are treated as a separate class of securities in computing basic EPS. Participating securities are not included as incremental shares in computing diluted EPS; refer to Note 9 for additional information. Diluted EPS incorporates the potential impact of contingently issuable shares, including awards which require future service as a condition of delivery of the underlying common stock. Diluted EPS is calculated under both the two-class and treasury stock methods, and the more dilutive amount is reported. For each of the periods presented in the table below, diluted EPS calculated under the two-class method was more dilutive.
Income tax policy	JPMorgan Chase and its eligible subsidiaries file a consolidated U.S. federal income tax return. JPMorgan Chase uses the asset and liability method to provide income taxes on all transactions recorded in the Consolidated Financial Statements. This method requires that income taxes reflect the expected future tax consequences of temporary differences between the carrying amounts of assets or liabilities for book and tax purposes. Accordingly, a deferred tax asset or liability for each temporary difference is determined based on the tax rates that the Firm expects to be in effect when the underlying items of income and expense are realized. JPMorgan Chase’s expense for income taxes includes the current and deferred portions of that expense. A valuation allowance is established to reduce deferred tax assets to the amount the Firm expects to realize.
Off-balance sheet credit exposure policy	To provide for expected credit losses in wholesale and certain consumer lending-related commitments, an allowance for credit losses on lending-related commitments is maintained. U.S. GAAP requires that a guarantor recognize, at the inception of a guarantee, a liability in an amount equal to the fair value of the obligation undertaken in issuing the guarantee. U.S. GAAP defines a guarantee as a contract that contingently requires the guarantor to pay a guaranteed party based upon: (a) changes in an underlying asset, liability or equity security of the guaranteed party; or (b) a third party’s failure to perform under a specified agreement. The Firm considers the following off–balance sheet arrangements to be guarantees under U.S. GAAP: standby letters of credit and other financial guarantees, securities lending indemnifications, certain indemnification agreements included within third-party contractual arrangements, certain derivative contracts and the guarantees under the sponsored member repo program. As required by U.S. GAAP, the Firm initially records guarantees at the inception date fair value of the non-contingent obligation assumed (e.g., the amount of consideration received or the net present value of the premium receivable). For these obligations, the Firm records this fair value amount in other liabilities with an offsetting entry recorded in cash (for premiums received), or other assets (for premiums receivable). Any premium receivable recorded in other assets is reduced as cash is received under the contract, and the fair value of the liability recorded at inception is amortized into income as lending and deposit-related fees over the life of the guarantee contract. The lending-related contingent obligation is recognized based on expected credit losses in addition to, and separate from, any non-contingent obligation. Non-lending-related contingent obligations are recognized when the liability becomes probable and reasonably estimable. These obligations are not recognized if the estimated amount is less than the carrying amount of any non-contingent liability recognized at inception (adjusted for any amortization). Examples of non-lending-related contingent obligations include indemnifications provided in sales agreements, where a portion of the sale proceeds is allocated to the guarantee, which adjusts the gain or loss that would otherwise result from the transaction. For these indemnifications, the initial liability is amortized to income as the Firm’s risk is reduced (i.e., over time or when the indemnification expires). The contractual amount and carrying value of guarantees and indemnifications are included in the table on page 284.

Basis of Presentation (Tables)

Basis of Presentation (Tables)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of significant accounting policies	The following table identifies JPMorgan Chase’s other significant accounting policies and the Note and page where a detailed description of each policy can be found. Fair value measurement Note 2 page 169 Fair value option Note 3 page 190 Derivative instruments Note 5 page 196 Noninterest revenue and noninterest expense Note 6 page 211 Interest income and Interest expense Note 7 page 214 Pension and other postretirement employee benefit plans Note 8 page 215 Employee share-based incentives Note 9 page 218 Investment securities Note 10 page 220 Securities financing activities Note 11 page 226 Loans Note 12 page 229 Allowance for credit losses Note 13 page 248 Variable interest entities Note 14 page 253 Goodwill and Mortgage servicing rights Note 15 page 261 Premises and equipment Note 16 page 265 Leases Note 18 page 266 Long-term debt Note 20 page 269 Earnings per share Note 23 page 274 Income taxes Note 25 page 277 Off–balance sheet lending-related financial instruments, guarantees and other commitments Note 28 page 283 Litigation Note 30 page 290

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of fair value methodologies	The following table describes the valuation methodologies generally used by the Firm to measure its significant products/instruments at fair value, including the general classification of such instruments pursuant to the fair value hierarchy. Product/instrument Valuation methodology Classifications in the fair value hierarchy Securities financing agreements Valuations are based on discounted cash flows, which consider: Predominantly level 2 • Derivative features: refer to the discussion of derivatives below for further information. • Market rates for the respective maturity • Collateral characteristics Loans and lending-related commitments — wholesale Where observable market data is available, valuations are based on: Level 2 or 3 Loans carried at fair value • Observed market prices (circumstances are infrequent) • Relevant broker quotes • Observed market prices for similar instruments Where observable market data is unavailable or limited, valuations are based on discounted cash flows, which consider the following: • Credit spreads derived from the cost of CDS; or benchmark credit curves developed by the Firm, by industry and credit rating • Prepayment speed • Collateral characteristics Loans — consumer Fair value is based on observable market prices for mortgage-backed securities with similar collateral and incorporates adjustments to these prices to account for differences between the securities and the value of the underlying loans, which include credit characteristics, portfolio composition, and liquidity. Predominantly level 2 Loans carried at fair value — conforming residential mortgage loans expected to be sold Investment and trading securities Quoted market prices Level 1 In the absence of quoted market prices, securities are valued based on: Level 2 or 3 • Observable market prices for similar securities • Relevant broker quotes • Discounted cash flows In addition, the following inputs to discounted cash flows are used for the following products: Mortgage- and asset-backed securities specific inputs: • Collateral characteristics • Deal-specific payment and loss allocations • Current market assumptions related to yield, prepayment speed, conditional default rates and loss severity Collateralized loan obligations (“CLOs”) specific inputs: • Collateral characteristics • Deal-specific payment and loss allocations • Expected prepayment speed, conditional default rates, loss severity • Credit spreads • Credit rating data Physical commodities Valued using observable market prices or data. Level 1 or 2 Product/instrument Valuation methodology Classifications in the fair value hierarchy Derivatives Exchange-traded derivatives that are actively traded and valued using the exchange price. Level 1 Derivatives that are valued using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that may use observable or unobservable valuation inputs as well as considering the contractual terms. The key valuation inputs used will depend on the type of derivative and the nature of the underlying instruments and may include equity prices, commodity prices, foreign exchange rates, volatilities, correlations, CDS spreads and recovery rates. Level 2 or 3 In addition, specific inputs used for derivatives that are valued based on models with significant unobservable inputs are as follows: Interest rate and FX exotic options specific inputs include: • Interest rate volatility • Interest rate spread volatility • Interest rate correlation • Interest rate-FX correlation • Foreign exchange correlation • Interest rate curve Structured credit derivatives specific inputs include: • Credit correlation between the underlying debt instruments • CDS spreads and recovery rates Equity option specific inputs include: • Forward equity price • Equity volatility • Equity correlation • Equity-FX correlation • Equity-IR correlation Commodity derivatives specific inputs include: • Forward commodity price • Commodity volatility • Commodity correlation Additionally, adjustments are made to reflect counterparty credit quality (CVA) and the impact of funding (FVA). Refer to page 186 of this Note. Mortgage servicing rights Refer to Mortgage servicing rights in Note 15. Level 3 Private equity direct investments Fair value is estimated using all available information; the range of potential inputs include: Level 2 or 3 • Transaction prices • Trading multiples of comparable public companies • Operating performance of the underlying portfolio company • Adjustments as required, since comparable public companies are not identical to the company being valued, and for company-specific issues and lack of liquidity. • Additional available inputs relevant to the investment. Fund investments (e.g., mutual/collective investment funds, private equity funds, hedge funds, and real estate funds) Net asset value • NAV is supported by the ability to redeem and purchase at the NAV level. Level 1 • Adjustments to the NAV as required, for restrictions on redemption (e.g., lock-up periods or withdrawal limitations) or where observable activity is limited. Level 2 or 3 (a) Beneficial interests issued by consolidated VIEs Valued using observable market information, where available. Level 2 or 3 In the absence of observable market information, valuations are based on the fair value of the underlying assets held by the VIE. (a) Excludes certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient. Product/instrument Valuation methodology Classification in the fair value hierarchy Structured notes (included in deposits, short-term borrowings and long-term debt) • Valuations are based on discounted cash flow analyses that consider the embedded derivative and the terms and payment structure of the note. • The embedded derivative features are considered using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that may use observable or unobservable valuation inputs, depending on the embedded derivative. The specific inputs used vary according to the nature of the embedded derivative features, as described in the discussion above regarding derivatives valuation. Adjustments are then made to this base valuation to reflect the Firm’s own credit risk (DVA). Refer to page 186 of this Note. Level 2 or 3
Assets and liabilities measured at fair value on a recurring basis	The following table presents the assets and liabilities reported at fair value as of December 31, 2021 and 2020, by major product category and fair value hierarchy. Assets and liabilities measured at fair value on a recurring basis Fair value hierarchy December 31, 2021 (in millions) Level 1 Level 2 Level 3 Derivative netting adjustments (f) Total fair value Federal funds sold and securities purchased under resale agreements $ — $ 252,720 $ — $ — $ 252,720 Securities borrowed — 81,463 — — 81,463 Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies (a) — 38,944 265 — 39,209 Residential – nonagency — 2,358 28 — 2,386 Commercial – nonagency — 1,506 10 — 1,516 Total mortgage-backed securities — 42,808 303 — 43,111 U.S. Treasury, GSEs and government agencies (a) 68,527 9,181 — — 77,708 Obligations of U.S. states and municipalities — 7,068 7 — 7,075 Certificates of deposit, bankers’ acceptances and commercial paper — 852 — — 852 Non-U.S. government debt securities 26,982 44,581 81 — 71,644 Corporate debt securities — 24,491 332 — 24,823 Loans — 7,366 708 — 8,074 Asset-backed securities — 2,668 26 — 2,694 Total debt instruments 95,509 139,015 1,457 — 235,981 Equity securities 86,904 1,741 662 — 89,307 Physical commodities (b) 5,357 20,788 — — 26,145 Other — 24,850 160 — 25,010 Total debt and equity instruments (c) 187,770 186,394 2,279 — 376,443 Derivative receivables: Interest rate 1,072 267,493 2,020 (248,611) 21,974 Credit — 9,321 518 (8,808) 1,031 Foreign exchange 134 168,590 855 (156,954) 12,625 Equity — 65,139 3,492 (58,650) 9,981 Commodity — 26,232 421 (15,183) 11,470 Total derivative receivables 1,206 536,775 7,306 (488,206) 57,081 Total trading assets (d) 188,976 723,169 9,585 (488,206) 433,524 Available-for-sale securities: Mortgage-backed securities: U.S. GSEs and government agencies (a) 4 72,539 — — 72,543 Residential – nonagency — 6,070 — — 6,070 Commercial – nonagency — 4,949 — — 4,949 Total mortgage-backed securities 4 83,558 — — 83,562 U.S. Treasury and government agencies 177,463 — — — 177,463 Obligations of U.S. states and municipalities — 15,860 — — 15,860 Non-U.S. government debt securities 5,430 10,779 — — 16,209 Corporate debt securities — 160 161 — 321 Asset-backed securities: Collateralized loan obligations — 9,662 — — 9,662 Other — 5,448 — — 5,448 Total available-for-sale securities 182,897 125,467 161 — 308,525 Loans (e) — 56,887 1,933 — 58,820 Mortgage servicing rights — — 5,494 — 5,494 Other assets (d) 9,558 4,139 306 — 14,003 Total assets measured at fair value on a recurring basis $ 381,431 $ 1,243,845 $ 17,479 $ (488,206) $ 1,154,549 Deposits $ — $ 9,016 $ 2,317 $ — $ 11,333 Federal funds purchased and securities loaned or sold under repurchase agreements — 126,435 — — 126,435 Short-term borrowings — 17,534 2,481 — 20,015 Trading liabilities: Debt and equity instruments (c) 87,831 26,716 30 — 114,577 Derivative payables: Interest rate 981 237,714 2,036 (232,537) 8,194 Credit — 10,468 444 (10,032) 880 Foreign exchange 123 174,349 1,274 (161,649) 14,097 Equity — 72,609 7,118 (62,494) 17,233 Commodity — 26,600 1,328 (18,216) 9,712 Total derivative payables 1,104 521,740 12,200 (484,928) 50,116 Total trading liabilities 88,935 548,456 12,230 (484,928) 164,693 Accounts payable and other liabilities 5,115 467 69 — 5,651 Beneficial interests issued by consolidated VIEs — 12 — — 12 Long-term debt — 50,560 24,374 — 74,934 Total liabilities measured at fair value on a recurring basis $ 94,050 $ 752,480 $ 41,471 $ (484,928) $ 403,073 Fair value hierarchy December 31, 2020 (in millions) Level 1 Level 2 Level 3 Derivative netting adjustments (f) Total fair value Federal funds sold and securities purchased under resale agreements $ — $ 238,015 $ — $ — $ 238,015 Securities borrowed — 52,983 — — 52,983 Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies (a) — 68,395 449 — 68,844 Residential – nonagency — 2,138 28 — 2,166 Commercial – nonagency — 1,327 3 — 1,330 Total mortgage-backed securities — 71,860 480 — 72,340 U.S. Treasury, GSEs and government agencies (a) 104,263 10,996 — — 115,259 Obligations of U.S. states and municipalities — 7,184 8 — 7,192 Certificates of deposit, bankers’ acceptances and commercial paper — 1,230 — — 1,230 Non-U.S. government debt securities 26,772 40,671 182 — 67,625 Corporate debt securities — 21,017 507 — 21,524 Loans — 6,101 893 — 6,994 Asset-backed securities — 2,304 28 — 2,332 Total debt instruments 131,035 161,363 2,098 — 294,496 Equity securities 97,035 2,652 476 (g) — 100,163 Physical commodities (b) 6,382 5,189 — — 11,571 Other — 21,351 (g) 49 (g) — 21,400 Total debt and equity instruments (c) 234,452 190,555 2,623 — 427,630 Derivative receivables: Interest rate (g) 2,318 387,023 2,307 (355,923) 35,725 Credit (g) — 12,721 624 (12,665) 680 Foreign exchange 146 205,127 987 (190,479) 15,781 Equity — 67,093 (g) 3,519 (54,125) 16,487 Commodity — 21,272 231 (14,732) 6,771 Total derivative receivables 2,464 693,236 7,668 (627,924) 75,444 Total trading assets (d) 236,916 883,791 10,291 (627,924) 503,074 Available-for-sale securities: Mortgage-backed securities: U.S. GSEs and government agencies (a)(g) 7 113,294 — — 113,301 Residential – nonagency — 10,233 — — 10,233 Commercial – nonagency — 2,856 — — 2,856 Total mortgage-backed securities 7 126,383 — — 126,390 U.S. Treasury and government agencies 201,951 — — — 201,951 Obligations of U.S. states and municipalities — 20,396 — — 20,396 Non-U.S. government debt securities 13,135 9,793 — — 22,928 Corporate debt securities — 216 — — 216 Asset-backed securities: Collateralized loan obligations — 10,048 — — 10,048 Other — 6,249 — — 6,249 Total available-for-sale securities 215,093 173,085 — — 388,178 Loans (e) — 42,169 2,305 — 44,474 Mortgage servicing rights — — 3,276 — 3,276 Other assets (d) 8,110 4,561 538 — 13,209 Total assets measured at fair value on a recurring basis $ 460,119 $ 1,394,604 $ 16,410 $ (627,924) $ 1,243,209 Deposits $ — $ 11,571 $ 2,913 $ — $ 14,484 Federal funds purchased and securities loaned or sold under repurchase agreements — 155,735 — — 155,735 Short-term borrowings — 14,473 2,420 — 16,893 Trading liabilities: Debt and equity instruments (c) 82,669 16,838 51 — 99,558 Derivative payables: Interest rate (g) 2,496 349,442 2,049 (340,975) 13,012 Credit (g) — 13,984 848 (12,837) 1,995 Foreign exchange 132 214,373 1,421 (194,493) 21,433 Equity — 74,032 7,381 (55,515) 25,898 Commodity — 21,767 962 (14,444) 8,285 Total derivative payables 2,628 673,598 12,661 (618,264) 70,623 Total trading liabilities 85,297 690,436 12,712 (618,264) 170,181 Accounts payable and other liabilities 2,895 513 68 — 3,476 Beneficial interests issued by consolidated VIEs — 41 — — 41 Long-term debt — 53,420 23,397 — 76,817 Total liabilities measured at fair value on a recurring basis $ 88,192 $ 926,189 $ 41,510 $ (618,264) $ 437,627 (a) At December 31, 2021 and 2020, included total U.S. GSE obligations of $73.9 billion and $117.6 billion, respectively, which were mortgage-related. (b) Physical commodities inventories are generally accounted for at the lower of cost or net realizable value. “Net realizable value” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, net realizable value approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when net realizable value is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. Refer to Note 5 for a further discussion of the Firm’s hedge accounting relationships. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented. (c) Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions). (d) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not required to be classified in the fair value hierarchy. At December 31, 2021 and 2020, the fair values of these investments, which include certain hedge funds, private equity funds, real estate and other funds, were $801 million and $670 million, respectively. Included in these balances at December 31, 2021 and 2020, were trading assets of $51 million and $52 million, respectively, and other assets of $750 million and $618 million, respectively. (e) At December 31, 2021 and 2020, included $26.2 billion and $15.1 billion, respectively, of residential first-lien mortgages, and $8.2 billion and $6.3 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. GSEs and government agencies of $13.6 billion and $8.4 billion, respectively. (f) As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. The level 3 balances would be reduced if netting were applied, including the netting benefit associated with cash collateral. (g) Prior-period amounts have been revised to conform with the current presentation.
Fair value inputs, assets and liabilities, quantitative information	The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and the weighted or arithmetic averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy. The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value. Level 3 inputs (a) December 31, 2021 Product/Instrument Fair value (in millions) Principal valuation technique Unobservable inputs (g) Range of input values Average (i) Residential mortgage-backed securities and loans (b) $ 1,181 Discounted cash flows Yield 0% – 15% 4% Prepayment speed 0% – 15% 14% Conditional default rate 0% – 2% 0% Loss severity 0% – 110% 4% Commercial mortgage-backed securities and loans (c) 391 Market comparables Price $0 – $103 $84 Corporate debt securities 493 Market comparables Price $0 – $154 $87 Loans (d) 1,372 Market comparables Price $5 – $107 $89 Non-U.S. government debt securities 81 Market comparables Price $87 – $103 $96 Net interest rate derivatives (26) Option pricing Interest rate volatility 5bps – 544bps 106bps Interest rate spread volatility 11bps – 23bps 14bps Interest rate correlation (65)% – 87% 25% IR-FX correlation (35)% – 50% (2)% 10 Discounted cash flows Prepayment speed 0% – 30% 8% Net credit derivatives 26 Discounted cash flows Credit correlation 35% – 65% 46% Credit spread 1bps – 4,396bps 384bps Recovery rate 35% – 67% 51% 48 Market comparables Price $0 – $115 $80 Net foreign exchange derivatives (320) Option pricing IR-FX correlation (40)% – 65% 17% (99) Discounted cash flows Prepayment speed 9% 9% Interest rate curve 0% – 28% 4% Net equity derivatives (3,626) Option pricing Forward equity price (h) 63% – 122% 99% Equity volatility 4% – 132% 32% Equity correlation 17% – 100% 55% Equity-FX correlation (79)% – 59% (27)% Equity-IR correlation 15% – 50% 27% Net commodity derivatives (907) Option pricing Oil commodity forward $631 / MT – $747 / MT $689 / MT Industrial metals commodity forward $2,610 / MT – $3,482 / MT $3,046 / MT Commodity volatility 5% – 185% 95% Commodity correlation (50)% – 76% 13% MSRs 5,494 Discounted cash flows Refer to Note 15 Long-term debt, short-term borrowings, and deposits (e) 28,236 Option pricing Interest rate volatility 5bps – 544bps 106bps Interest rate correlation (65)% – 87% 25% IR-FX correlation (35)% – 50% (2)% Equity correlation 17% – 100% 55% Equity-FX correlation (79)% – 59% (27)% Equity-IR correlation 15% – 50% 27% 936 Discounted cash flows Credit correlation 35% – 65% 46% Other level 3 assets and liabilities, net (f) 1,062 (a) The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. Furthermore, the inputs presented for each valuation technique in the table are, in some cases, not applicable to every instrument valued using the technique as the characteristics of the instruments can differ. (b) Comprises U.S. GSE and government agency securities of $265 million, nonagency securities of $28 million and non-trading loans of $888 million. (c) Comprises nonagency securities of $10 million, trading loans of $40 million and non-trading loans of $341 million. (d) Comprises trading loans of $668 million and non-trading loans of $704 million. (e) Long-term debt, short-term borrowings and deposits include structured notes issued by the Firm that are financial instruments that typically contain embedded derivatives. The estimation of the fair value of structured notes includes the derivative features embedded within the instrument. The significant unobservable inputs are broadly consistent with those presented for derivative receivables. (f) Includes equity securities of $806 million including $144 million in Other assets, for which quoted prices are not readily available and the fair value is generally based on internal valuation techniques such as EBITDA multiples and comparable analysis. All other level 3 assets and liabilities are insignificant both individually and in aggregate. (g) Price is a significant unobservable input for certain instruments. When quoted market prices are not readily available, reliance is generally placed on price-based internal valuation techniques. The price input is expressed assuming a par value of $100 . (h) Forward equity price is expressed as a percentage of the current equity price. (i) Amounts represent weighted averages except for derivative-related inputs where arithmetic averages are used.
Changes in level 3 recurring fair value measurements	The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the years ended December 31, 2021, 2020 and 2019. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable inputs to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments. Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2021 Total realized/unrealized gains/(losses) Transfers into Transfers (out of) level 3 Fair value at Dec. 31, 2021 Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2021 Purchases (f) Sales Settlements (g) Assets: (a) Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies $ 449 $ (28) $ 21 $ (67) $ (110) $ 1 $ (1) $ 265 $ (31) Residential – nonagency 28 — 26 (24) (5) 4 (1) 28 (3) Commercial – nonagency 3 5 12 (7) (17) 14 — 10 (2) Total mortgage-backed securities 480 (23) 59 (98) (132) 19 (2) 303 (36) Obligations of U.S. states and municipalities 8 — — — (1) — — 7 — Non-U.S. government debt securities 182 (14) 359 (332) (7) — (107) 81 (10) Corporate debt securities 507 (23) 404 (489) (4) 162 (225) 332 (16) Loans 893 2 994 (669) (287) 648 (873) 708 (20) Asset-backed securities 28 28 76 (99) (2) 2 (7) 26 (2) Total debt instruments 2,098 (30) 1,892 (1,687) (433) 831 (1,214) 1,457 (84) Equity securities 476 (77) 378 (168) — 164 (111) 662 (335) Other 49 74 233 — (98) 5 (103) 160 31 Total trading assets – debt and equity instruments 2,623 (33) (c) 2,503 (1,855) (531) 1,000 (1,428) 2,279 (388) (c) Net derivative receivables: (b) Interest rate 258 1,789 116 (192) (2,011) 112 (88) (16) 282 Credit (224) 130 6 (12) 146 34 (6) 74 141 Foreign exchange (434) (209) 110 (110) 222 (12) 14 (419) 13 Equity (3,862) (480) 1,285 (2,813) 1,758 315 171 (3,626) (155) Commodity (731) (728) 145 (493) 916 (4) (12) (907) (426) Total net derivative receivables (4,993) 502 (c) 1,662 (3,620) 1,031 445 79 (4,894) (145) (c) Available-for-sale securities: Mortgage-backed securities — — — — — — — — — Corporate debt securities — (1) 162 — — — — 161 (1) Total available-for-sale securities — (1) 162 — — — — 161 (1) Loans 2,305 (87) (c) 612 (439) (965) 1,301 (794) 1,933 (59) (c) Mortgage servicing rights 3,276 98 (d) 3,022 (114) (788) — — 5,494 98 (d) Other assets 538 16 (c) 9 (17) (239) — (1) 306 11 (c) Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2021 Total realized/unrealized (gains)/losses Transfers (out of) level 3 Fair value at Dec. 31, 2021 Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2021 Purchases Sales Issuances Settlements (g) Transfers into Liabilities: (a) Deposits $ 2,913 $ (80) (c)(e) $ — $ — $ 431 $ (467) $ 2 $ (482) $ 2,317 $ (77) (c)(e) Short-term borrowings 2,420 (1,391) (c)(e) — — 6,823 (5,308) 9 (72) 2,481 (83) (c)(e) Trading liabilities – debt and equity instruments 51 (8) (c) (101) 38 — — 64 (14) 30 (157) (c) Accounts payable and other liabilities 68 8 (c) — 1 — — — (8) 69 8 (c) Beneficial interests issued by consolidated VIEs — — — — — — — — — — Long-term debt 23,397 369 (c)(e) — — 13,505 (12,191) 103 (809) 24,374 87 (c)(e) Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2020 Total realized/unrealized gains/(losses) Transfers (out of) level 3 Fair value at Dec. 31, 2020 Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2020 Purchases (f) Sales Settlements (g) Transfers into Assets: (a) Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies $ 797 $ (172) $ 134 $ (149) $ (161) $ — $ — $ 449 $ (150) Residential – nonagency 23 2 15 (5) (4) — (3) 28 (1) Commercial – nonagency 4 — 1 — (1) 2 (3) 3 — Total mortgage-backed securities 824 (170) 150 (154) (166) 2 (6) 480 (151) Obligations of U.S. states and municipalities 10 — — (1) (1) — — 8 — Non-U.S. government debt securities 155 21 281 (245) (7) — (23) 182 11 Corporate debt securities 558 (23) 582 (205) (236) 411 (580) 507 (25) Loans 673 (73) 1,112 (484) (182) 791 (944) 893 (40) Asset-backed securities 37 (3) 44 (40) (9) 9 (10) 28 (4) Total debt instruments 2,257 (248) 2,169 (1,129) (601) 1,213 (1,563) 2,098 (209) Equity securities (h) 196 (137) 412 (376) (1) 535 (153) 476 (82) Other (h) 232 333 229 (9) (497) 6 (245) 49 268 Total trading assets – debt and equity instruments 2,685 (52) (c) 2,810 (1,514) (1,099) 1,754 (1,961) 2,623 (23) (c) Net derivative receivables: (b) Interest rate (332) 2,682 308 (148) (2,228) (332) 308 258 325 Credit (139) (212) 73 (154) 181 59 (32) (224) (110) Foreign exchange (607) 49 49 (24) 83 13 3 (434) 116 Equity (3,395) (65) 1,664 (2,317) 1,162 (935) 24 (3,862) (556) Commodity (16) (546) 27 (241) 356 (310) (1) (731) 267 Total net derivative receivables (4,489) 1,908 (c) 2,121 (2,884) (446) (1,505) 302 (4,993) 42 (c) Available-for-sale securities: Mortgage-backed securities 1 — — — (1) — — — — Corporate debt securities — — — — — — — — — Total available-for-sale securities 1 — — — (1) — — — — Loans 516 (243) (c) 962 (84) (733) 2,571 (684) 2,305 (18) (c) Mortgage servicing rights 4,699 (1,540) (d) 1,192 (176) (899) — — 3,276 (1,540) (d) Other assets 917 (63) (c) 75 (104) (320) 40 (7) 538 (3) (c) Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2020 Total realized/unrealized (gains)/losses Transfers (out of) level 3 Fair value at Dec. 31, 2020 Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2020 Purchases Sales Issuances Settlements (g) Transfers into Liabilities: (a) Deposits $ 3,360 $ 165 (c)(e) $ — $ — $ 671 $ (605) $ 265 $ (943) $ 2,913 $ 455 (c)(e) Short-term borrowings 1,674 (338) (c)(e) — — 5,140 (4,115) 105 (46) 2,420 143 (c)(e) Trading liabilities – debt and equity instruments 41 (2) (c) (126) 14 — (4) 136 (8) 51 (1) (c) Accounts payable and other liabilities 45 33 (c) (87) 37 — — 47 (7) 68 28 (c) Beneficial interests issued by consolidated VIEs — — — — — — — — — — Long-term debt 23,339 40 (c)(e) — — 9,883 (9,833) 1,250 (1,282) 23,397 1,920 (c)(e) Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2019 Total realized/unrealized gains/(losses) Transfers (out of) level 3 Fair value at Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2019 Purchases (f) Sales Settlements (g) Transfers into Assets: (a) Trading assets: Debt instruments: Mortgage-backed securities: U.S. GSEs and government agencies $ 549 $ (62) $ 773 $ (310) $ (134) $ 1 $ (20) $ 797 $ (58) Residential – nonagency 64 25 83 (86) (20) 15 (58) 23 2 Commercial – nonagency 11 2 20 (26) (14) 15 (4) 4 1 Total mortgage-backed securities 624 (35) 876 (422) (168) 31 (82) 824 (55) Obligations of U.S. states and municipalities 689 13 85 (159) (8) — (610) 10 13 Non-U.S. government debt securities 155 1 290 (287) — 14 (18) 155 4 Corporate debt securities 334 47 437 (247) (52) 112 (73) 558 40 Loans 738 29 456 (519) (82) 437 (386) 673 13 Asset-backed securities 127 — 37 (93) (40) 28 (22) 37 (3) Total debt instruments 2,667 55 2,181 (1,727) (350) 622 (1,191) 2,257 12 Equity securities 232 (41) 58 (103) (22) 181 (109) 196 (18) Other 301 (36) 50 (26) (54) 2 (5) 232 91 Total trading assets – debt and equity instruments 3,200 (22) (c) 2,289 (1,856) (426) 805 (1,305) 2,685 85 (c) Net derivative receivables: (b) Interest rate (38) (394) 109 (125) 5 (7) 118 (332) (599) Credit (107) (36) 20 (9) 8 29 (44) (139) (127) Foreign exchange (297) (551) 17 (67) 312 (22) 1 (607) (380) Equity (2,225) (310) 397 (573) (503) (405) 224 (3,395) (1,608) Commodity (1,129) 497 36 (348) 89 (6) 845 (16) 130 Total net derivative receivables (3,796) (794) (c) 579 (1,122) (89) (411) 1,144 (4,489) (2,584) (c) Available-for-sale securities: Mortgage-backed securities 1 — — — — — — 1 — Corporate debt securities — — — — — — — — — Total available-for-sale securities 1 — — — — — — 1 — Loans 856 59 (c) 236 (188) (482) 188 (153) 516 38 (c) Mortgage servicing rights 6,130 (1,180) (d) 1,489 (789) (951) — — 4,699 (1,180) (d) Other assets 1,161 (150) (c) 229 (166) (156) 6 (7) 917 (180) (c) Fair value measurements using significant unobservable inputs Year ended Fair value at January 1, 2019 Total realized/unrealized (gains)/losses Transfers into Transfers (out of) level 3 Fair value at Dec. 31, 2019 Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2019 Purchases Sales Issuances Settlements (g) Liabilities: (a) Deposits $ 4,169 $ 278 (c)(e) $ — $ — $ 916 $ (806) $ 12 $ (1,209) $ 3,360 $ 307 (c)(e) Short-term borrowings 1,523 229 (c)(e) — — 3,441 (3,356) 85 (248) 1,674 155 (c)(e) Trading liabilities – debt and equity instruments 50 2 (c) (22) 41 — 1 16 (47) 41 3 (c) Accounts payable and other liabilities 10 (2) (c) (84) 115 — — 6 — 45 29 (c) Beneficial interests issued by consolidated VIEs 1 (1) (c) — — — — — — — — Long-term debt 19,418 2,815 (c)(e) — — 10,441 (8,538) 651 (1,448) 23,339 2,822 (c)(e) (a) Level 3 assets at fair value as a percentage of total Firm assets at fair value (including assets measured at fair value on a nonrecurring basis) were 2%, 1% and 2% at December 31, 2021, 2020 and 2019, respectively. Level 3 liabilities at fair value as a percentage of total Firm liabilities at fair value (including liabilities measured at fair value on a nonrecurring basis) were 10%, 9% and 16% at December 31, 2021, 2020 and 2019, respectively. (b) All level 3 derivatives are presented on a net basis, irrespective of underlying counterparty. (c) Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans, and lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income. (d) Changes in fair value for MSRs are reported in mortgage fees and related income. (e) Realized (gains)/losses due to DVA for fair value option elected liabilities are reported in principal transactions revenue, and were not material for the years ended December 31, 2021, 2020 and 2019. Unrealized (gains)/losses are reported in OCI, and they were $258 million, $221 million and $319 million for the years ended December 31, 2021, 2020 and 2019, respectively. (f) Loan originations are included in purchases. (g) Includes financial assets and liabilities that have matured, been partially or fully repaid, impacts of modifications, deconsolidations associated with beneficial interests in VIEs and other items. (h) Prior-period amounts have been revised to conform with the current presentation.
Impact of credit adjustments on earnings	The following table provides the impact of credit and funding adjustments on principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. The FVA presented below includes the impact of the Firm’s own credit quality on the inception value of liabilities as well as the impact of changes in the Firm’s own credit quality over time. Year ended December 31, 2021 2020 2019 Credit and funding adjustments: Derivatives CVA $ 362 $ (337) $ 241 Derivatives FVA 47 (64) 199
Assets and liabilities measured at fair value on a nonrecurring basis	The following tables present the assets and liabilities held as of December 31, 2021 and 2020, for which nonrecurring fair value adjustments were recorded during the years ended December 31, 2021 and 2020, by major product category and fair value hierarchy. Fair value hierarchy Total fair value December 31, 2021 (in millions) Level 1 Level 2 Level 3 Loans $ — $ 1,006 $ 856 (b) $ 1,862 Other assets (a) — 4 1,612 1,616 Total assets measured at fair value on a nonrecurring basis $ — $ 1,010 $ 2,468 $ 3,478 Accounts payable and other liabilities — — 3 3 Total liabilities measured at fair value on a nonrecurring basis $ — $ — $ 3 $ 3 Fair value hierarchy Total fair value December 31, 2020 (in millions) Level 1 Level 2 Level 3 Loans $ — $ 1,611 $ 972 $ 2,583 Other assets — 5 979 984 Total assets measured at fair value on a nonrecurring basis $ — $ 1,616 $ 1,951 $ 3,567 Accounts payable and other liabilities — — 12 12 Total liabilities measured at fair value on a nonrecurring basis $ — $ — $ 12 $ 12 (a) Primarily includes equity securities without readily determinable fair values that were adjusted based on observable price changes in orderly transactions from an identical or similar investment of the same issuer (measurement alternative). Of the $1.6 billion in level 3 assets measured at fair value on a nonrecurring basis as of December 31, 2021, $1.5 billion related to equity securities adjusted based on the measurement alternative. These equity securities are classified as level 3 due to the infrequency of the observable prices and/or the restrictions on the shares. (b) Of the $856 million in level 3 assets measured at fair value on a nonrecurring basis as of December 31, 2021, $254 million related to residential real estate loans carried at the net realizable value of the underlying collateral (e.g., collateral-dependent loans). These amounts are classified as level 3 as they are valued using information from broker’s price opinions, appraisals and automated valuation models and discounted based upon the Firm’s experience with actual liquidation values. These discounts ranged from 12% to 45% with a weighted average of 25%. The following table presents the total change in value of assets and liabilities for which fair value adjustments have been recognized for the years ended December 31, 2021, 2020 and 2019, related to assets and liabilities held at those dates. December 31, (in millions) 2021 2020 2019 Loans $ (72) $ (393) $ (274) Other assets (a) 344 (529) 182 Accounts payable and other liabilities 5 (11) — Total nonrecurring fair value gains/(losses) $ 277 $ (933) $ (92) (a) Included $379 million, $(134) million and $201 million for the years ended December 31, 2021, 2020 and 2019, respectively, of net gains/(losses) as a result of the measurement alternative.
Carrying value of equity securities without readily determinable fair values	The following table presents the carrying value of equity securities without readily determinable fair values held as of December 31, 2021 and 2020, that are measured under the measurement alternative and the related adjustments recorded during the periods presented for those securities with observable price changes. These securities are included in the nonrecurring fair value tables when applicable price changes are observable. As of or for the year ended December 31, (in millions) 2021 2020 Other assets Carrying value (a) $ 3,642 $ 2,368 Upward carrying value changes (b) 432 167 Downward carrying value changes/impairment (c) (53) (301) (a) The period-end carrying values reflect cumulative purchases and sales in addition to upward and downward carrying value changes. (b) The cumulative upward carrying value changes between January 1, 2018 and December 31, 2021 were $1.0 billion. (c) The cumulative downward carrying value changes/impairment between January 1, 2018 and December 31, 2021 were $(369) million
Carrying value and estimated fair value of financial assets and liabilities	The following table presents by fair value hierarchy classification the carrying values and estimated fair values at December 31, 2021 and 2020, of financial assets and liabilities, excluding financial instruments that are carried at fair value on a recurring basis, and their classification within the fair value hierarchy. December 31, 2021 December 31, 2020 Estimated fair value hierarchy Estimated fair value hierarchy (in billions) Carrying Level 1 Level 2 Level 3 Total estimated Carrying Level 1 Level 2 Level 3 Total estimated Financial assets Cash and due from banks $ 26.4 $ 26.4 $ — $ — $ 26.4 $ 24.9 $ 24.9 $ — $ — $ 24.9 Deposits with banks 714.4 714.4 — — 714.4 502.7 502.7 — — 502.7 Accrued interest and accounts receivable 102.1 — 102.0 0.1 102.1 89.4 — 89.3 0.1 89.4 Federal funds sold and securities purchased under resale agreements 9.0 — 9.0 — 9.0 58.3 — 58.3 — 58.3 Securities borrowed 124.6 — 124.6 — 124.6 107.7 — 107.7 — 107.7 Investment securities, held-to-maturity 363.7 183.3 179.3 — 362.6 201.8 53.2 152.3 — 205.5 Loans, net of allowance for loan losses (a) 1,002.5 — 202.1 821.1 1,023.2 940.1 — 210.9 755.6 966.5 Other 98.7 — 97.4 1.4 98.8 81.8 — 80.0 1.9 81.9 Financial liabilities Deposits $ 2,451.0 $ — $ 2,451.0 $ — $ 2,451.0 $ 2,129.8 $ — $ 2,128.9 $ — $ 2,128.9 Federal funds purchased and securities loaned or sold under repurchase agreements 67.9 — 67.9 — 67.9 59.5 — 59.5 — 59.5 Short-term borrowings 33.6 — 33.6 — 33.6 28.3 — 28.3 — 28.3 Accounts payable and other liabilities 217.6 — 212.1 4.9 217.0 186.6 — 181.9 4.3 186.2 Beneficial interests issued by consolidated VIEs 10.7 — 10.8 — 10.8 17.5 — 17.6 — 17.6 Long-term debt 226.0 — 229.5 3.1 232.6 204.8 — 209.2 3.2 212.4
The carrying value and estimated fair value of wholesale lending- related commitments	The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets. The carrying value and the estimated fair value of these wholesale lending-related commitments were as follows for the periods indicated. December 31, 2021 December 31, 2020 Estimated fair value hierarchy Estimated fair value hierarchy (in billions) Carrying value (a)(b) Level 1 Level 2 Level 3 Total estimated fair value Carrying value (a)(b) Level 1 Level 2 Level 3 Total estimated fair value Wholesale lending-related commitments $ 2.1 $ — $ — $ 2.9 $ 2.9 $ 2.2 $ — $ — $ 2.1 $ 2.1 (a) Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which is recognized at fair value at the inception of the guarantees.

Fair Value Option (Tables)

Fair Value Option (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Changes in fair value under the fair value option election	The following table presents the changes in fair value included in the Consolidated statements of income for the years ended December 31, 2021, 2020 and 2019, for items for which the fair value option was elected. The profit and loss information presented below only includes the financial instruments that were elected to be measured at fair value; related risk management instruments, which are required to be measured at fair value, are not included in the table. 2021 2020 2019 December 31, (in millions) Principal transactions All other income Total changes in fair value recorded (e) Principal transactions All other income Total changes in fair value recorded (e) Principal transactions All other income Total changes in fair value recorded (e) Federal funds sold and securities purchased under resale agreements $ (112) $ — $ (112) $ 12 $ — $ 12 $ (36) $ — $ (36) Securities borrowed (200) — (200) 143 — 143 133 — 133 Trading assets: Debt and equity instruments, excluding loans (2,171) (1) (c) (2,172) 2,587 (f) (1) (c) 2,586 2,482 (1) (c) 2,481 Loans reported as trading assets: Changes in instrument-specific credit risk 353 — 353 135 — 135 248 — 248 Other changes in fair value (8) — (8) (19) — (19) (1) — (1) Loans: Changes in instrument-specific credit risk 589 (7) (c) 582 190 7 (c) 197 475 2 (c) 477 Other changes in fair value (139) 2,056 (c) 1,917 470 3,239 (c) 3,709 267 1,224 (c) 1,491 Other assets 12 (26) (d) (14) 103 (65) (d) 38 8 6 (d) 14 Deposits (a) (183) — (183) (726) — (726) (1,730) — (1,730) Federal funds purchased and securities loaned or sold under repurchase agreements 69 — 69 (6) — (6) (8) — (8) Short-term borrowings (a) (366) — (366) 294 — 294 (693) — (693) Trading liabilities 7 — 7 2 — 2 6 — 6 Other liabilities (17) — (17) (94) — (94) (16) — (16) Long-term debt (a)(b) (980) 4 (c)(d) (976) (2,120) (1) (c) (2,121) (6,173) 1 (c) (6,172) (a) Unrealized gains/(losses) due to instrument-specific credit risk (DVA) for liabilities for which the fair value option has been elected are recorded in OCI while realized gains/(losses) are recorded in principal transactions revenue. Realized gains/(losses) due to instrument-specific credit risk recorded in principal transactions revenue were $(15) million and $20 million for the years ended December 31,2021 and 2020, respectively, and were not material for the year ended December 31, 2019. (b) Long-term debt measured at fair value predominantly relates to structured notes. Although the risk associated with the structured notes is actively managed, the gains/(losses) reported in this table do not include the income statement impact of the risk management instruments used to manage such risk. (c) Reported in mortgage fees and related income. (d) Reported in other income. (e) Changes in fair value exclude contractual interest, which is included in interest income and interest expense for all instruments other than certain hybrid financial instruments recorded in CIB. Refer to Note 7 for further information regarding interest income and interest expense. (f) Prior-period amounts have been revised to conform with the current presentation.
Difference between aggregate fair value and aggregate remaining contractual principal balance outstanding	The following table reflects the difference between the aggregate fair value and the aggregate remaining contractual principal balance outstanding as of December 31, 2021 and 2020, for loans, long-term debt and long-term beneficial interests for which the fair value option has been elected. 2021 2020 December 31, (in millions) Contractual principal outstanding Fair value Fair value over/(under) contractual principal outstanding Contractual principal outstanding Fair value Fair value over/(under) contractual principal outstanding Loans Nonaccrual loans Loans reported as trading assets $ 3,263 $ 546 $ (2,717) $ 3,386 $ 555 $ (2,831) Loans 918 797 (121) 1,867 1,507 (360) Subtotal 4,181 1,343 (2,838) 5,253 2,062 (3,191) 90 or more days past due and government guaranteed Loans (a) 293 281 (12) 328 317 (11) All other performing loans (b) Loans reported as trading assets 8,594 7,528 (1,066) 7,917 6,439 (1,478) Loans 57,695 57,742 47 42,022 42,650 628 Subtotal 66,289 65,270 (1,019) 49,939 49,089 (850) Total loans $ 70,763 $ 66,894 $ (3,869) $ 55,520 $ 51,468 $ (4,052) Long-term debt Principal-protected debt $ 35,957 (d) $ 33,799 $ (2,158) $ 40,560 (d) $ 40,526 $ (34) Nonprincipal-protected debt (c) NA 41,135 NA NA 36,291 NA Total long-term debt NA $ 74,934 NA NA $ 76,817 NA Long-term beneficial interests Nonprincipal-protected debt (c) NA $ 12 NA NA $ 41 NA Total long-term beneficial interests NA $ 12 NA NA $ 41 NA (a) These balances are excluded from nonaccrual loans as the loans are insured and/or guaranteed by U.S. government agencies. (b) There were no performing loans that were ninety days or more past due as of December 31, 2021 and 2020. (c) Remaining contractual principal is not applicable to nonprincipal-protected structured notes and long-term beneficial interests. Unlike principal-protected structured notes and long-term beneficial interests, for which the Firm is obligated to return a stated amount of principal at maturity, nonprincipal-protected structured notes and long-term beneficial interests do not obligate the Firm to return a stated amount of principal at maturity, but for structured notes to return an amount based on the performance of an underlying variable or derivative feature embedded in the note. However, investors are exposed to the credit risk of the Firm as issuer for both nonprincipal-protected and principal-protected notes. (d) Where the Firm issues principal-protected zero-coupon or discount notes, the balance reflects the contractual principal payment at maturity or, if applicable, the contractual principal payment at the Firm’s next call date.
Fair value option, structured notes by balance sheet classification and primary embedded derivative risk	The following table presents the fair value of structured notes, by balance sheet classification and the primary risk type. December 31, 2021 December 31, 2020 (in millions) Long-term debt Short-term borrowings Deposits Total Long-term debt Short-term borrowings Deposits Total Risk exposure Interest rate $ 34,127 $ 1 $ 4,860 $ 38,988 $ 38,129 $ 65 $ 5,057 $ 43,251 Credit 6,352 858 — 7,210 6,409 1,022 — 7,431 Foreign exchange 3,386 315 1,066 4,767 3,613 92 — 3,705 Equity 29,317 6,827 5,125 41,269 26,943 5,021 6,893 38,857 Commodity 405 — 3 (a) 408 250 13 232 (a) 495 Total structured notes $ 73,587 $ 8,001 $ 11,054 $ 92,642 $ 75,344 $ 6,213 $ 12,182 $ 93,739 (a) Excludes deposits linked to precious metals for which the fair value option has not been elected of $692 million and $739 million for the years ended December 31, 2021 and 2020, respectively.

Credit Risk Concentrations (Tab

Credit Risk Concentrations (Tables)	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Concentrations of credit exposure	The table below presents both on–balance sheet and off–balance sheet consumer and wholesale credit exposure by the Firm’s three credit portfolio segments as of December 31, 2021 and 2020. The wholesale industry of risk category is generally based on the client or counterparty’s primary business activity. 2021 2020 Credit exposure (h) On-balance sheet Off-balance sheet (j) Credit exposure (h) On-balance sheet Off-balance sheet (j) December 31, (in millions) Loans Derivatives Loans Derivatives Consumer, excluding credit card $ 368,640 $ 323,306 (i) $ — $ 45,334 $ 375,898 $ 318,579 (i) $ — $ 57,319 Credit card (a) 884,830 154,296 — 730,534 802,722 144,216 — 658,506 Total consumer (a) 1,253,470 477,602 — 775,868 1,178,620 462,795 — 715,825 Wholesale (b) Real Estate 155,069 119,753 1,113 34,203 148,498 118,299 1,385 28,814 Individuals and Individual Entities (c) 141,973 130,576 1,317 10,080 122,870 109,746 1,750 11,374 Consumer & Retail 122,789 39,588 2,669 80,532 108,437 39,013 2,802 66,622 Technology, Media & 84,070 17,815 2,640 63,615 72,150 14,687 4,252 53,211 Asset Managers 81,228 41,031 9,351 30,846 66,573 31,059 9,277 26,237 Industrials 66,974 21,652 1,224 44,098 66,470 21,143 1,851 43,476 Healthcare 59,014 18,587 2,575 37,852 60,118 19,405 3,252 37,461 Banks & Finance Cos 54,684 34,217 4,418 16,049 54,032 31,004 8,044 14,984 Oil & Gas 42,606 11,039 6,034 25,533 39,159 11,267 1,643 26,249 Automotive 34,573 11,759 720 22,094 43,331 17,128 5,995 20,208 State & Municipal Govt (d) 33,216 15,322 1,563 16,331 38,286 18,054 2,347 17,885 Utilities 33,203 5,969 3,736 23,498 30,124 4,874 3,340 21,910 Chemicals & Plastics 17,660 5,033 564 12,063 17,176 4,884 856 11,436 Metals & Mining 16,696 5,696 924 10,076 15,542 4,854 882 9,806 Transportation 14,635 5,453 782 8,400 16,232 6,566 1,495 8,171 Insurance 13,926 1,303 2,700 9,923 13,141 1,042 2,527 9,572 Central Govt 11,317 2,889 6,837 1,591 17,025 3,396 12,313 1,316 Financial Markets Infrastructure 4,377 5 2,487 1,885 6,515 19 3,757 2,739 Securities Firms 4,180 469 1,260 2,451 8,048 469 4,838 2,741 All other (e) 111,690 72,198 4,167 35,325 96,527 58,038 2,838 (k) 35,651 Subtotal 1,103,880 560,354 57,081 486,445 1,040,254 514,947 75,444 449,863 Loans held-for-sale and loans at fair value 39,758 39,758 — — 35,111 35,111 — — Receivables from customers (f) 59,645 — — — 47,710 — — — Total wholesale 1,203,283 600,112 57,081 486,445 1,123,075 550,058 75,444 449,863 Total exposure (g)(h) $ 2,456,753 $ 1,077,714 $ 57,081 $ 1,262,313 $ 2,301,695 $ 1,012,853 $ 75,444 $ 1,165,688 (a) Also includes commercial card lending-related commitments primarily in CB and CIB. (b) The industry rankings presented in the table as of December 31, 2020, are based on the industry rankings of the corresponding exposures at December 31, 2021, not actual rankings of such exposures at December 31, 2020. (c) Individuals and Individual Entities predominantly consists of Global Private Bank clients within AWM and includes exposure to personal investment companies and personal and testamentary trusts. (d) In addition to the credit risk exposure to states and municipal governments (both U.S. and non-U.S.) at December 31, 2021 and 2020, noted above, the Firm held: $7.1 billion and $7.2 billion, respectively, of trading assets; $15.9 billion and $20.4 billion, respectively, of AFS securities; and $14.0 billion and $12.8 billion , respectively, of HTM securities, issued by U.S. state and municipal governments. Refer to Note 2 and Note 10 for further information. (e) All other includes: SPEs and Private education and civic organizations, representing approximately 94% and 6%, respectively, at December 31, 2021 and 92% and 8%, respectively, at December 31, 2020 . Refer to Note 14 for more information on exposures to SPEs. (f) Receivables from customers reflect held-for-investment margin loans to brokerage clients in CIB, CCB and AWM that are collateralized by assets maintained in the clients’ brokerage accounts (e.g., cash on deposit, liquid and readily marketable debt or equity securities). Because of this collateralization, no allowance for credit losses is generally held against these receivables. To manage its credit risk the Firm establishes margin requirements and monitors the required margin levels on an ongoing basis, and requires clients to deposit additional cash or other collateral, or to reduce positions, when appropriate. These receivables are reported within accrued interest and accounts receivable on the Firm’s Consolidated balance sheets. (g) Excludes cash placed with banks of $729.6 billion and $516.9 billion, at December 31, 2021 and 2020, respectively, which is predominantly placed with various central banks, primarily Federal Reserve Banks. (h) Credit exposure is net of risk participations and excludes the benefit of credit derivatives used in credit portfolio management activities held against derivative receivables or loans and liquid securities and other cash collateral held against derivative receivables. (i) At December 31, 2021 and 2020, included $5.4 billion and $19.2 billion of loans in Business Banking under the PPP, respectively. PPP loans are guaranteed by the SBA. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs, classify as nonaccrual nor record an allowance for loan losses on these loans. (j) Represents lending-related financial instruments. (k) Prior-period amounts have been revised to conform with the current presentation.

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of uses and disclosure of derivatives	The following table outlines the Firm’s primary uses of derivatives and the related hedge accounting designation or disclosure category. Type of Derivative Use of Derivative Designation and disclosure Affected segment or unit Page reference Manage specifically identified risk exposures in qualifying hedge accounting relationships: • Interest rate Hedge fixed rate assets and liabilities Fair value hedge Corporate 204-205 • Interest rate Hedge floating-rate assets and liabilities Cash flow hedge Corporate 206 • Foreign exchange Hedge foreign currency-denominated assets and liabilities Fair value hedge Corporate 204-205 • Foreign exchange Hedge foreign currency-denominated forecasted revenue and expense Cash flow hedge Corporate 206 • Foreign exchange Hedge the value of the Firm’s investments in non-U.S. dollar functional currency entities Net investment hedge Corporate 206 • Commodity Hedge commodity inventory Fair value hedge CIB, AWM 204-205 Manage specifically identified risk exposures not designated in qualifying hedge accounting relationships: • Interest rate Manage the risk associated with mortgage commitments, warehouse loans and MSRs Specified risk management CCB 207 • Credit Manage the credit risk associated with wholesale lending exposures Specified risk management CIB 207 • Interest rate and foreign exchange Manage the risk associated with certain other specified assets and liabilities Specified risk management Corporate 207 Market-making derivatives and other activities: • Various Market-making and related risk management Market-making and other CIB 207 • Various Other derivatives Market-making and other CIB, AWM, Corporate 207
Notional amount of derivative contracts	The following table summarizes the notional amount of free-standing derivative contracts outstanding as of December 31, 2021 and 2020. Notional amounts (b) December 31, (in billions) 2021 2020 Interest rate contracts Swaps $ 24,075 $ 20,990 (c) Futures and forwards 2,520 3,057 Written options 3,018 3,375 Purchased options 3,188 3,675 Total interest rate contracts 32,801 31,097 Credit derivatives (a) 1,053 1,197 (c) Foreign exchange contracts Cross-currency swaps 4,112 3,924 Spot, futures and forwards 7,679 6,871 Written options 741 830 Purchased options 727 825 Total foreign exchange contracts 13,259 12,450 Equity contracts Swaps 612 448 Futures and forwards 139 140 Written options 654 668 (c) Purchased options 598 610 (c) Total equity contracts 2,003 1,866 Commodity contracts Swaps 185 138 Spot, futures and forwards 188 198 Written options 135 124 Purchased options 111 105 Total commodity contracts 619 565 Total derivative notional amounts $ 49,735 $ 47,175 (a) Refer to the Credit derivatives discussion on pages 207-210 for more information on volumes and types of credit derivative contracts. (b) Represents the sum of gross long and gross short third-party notional derivative contracts. (c) Prior-period amounts have been revised to conform with the current presentation.
Impact of derivatives on the Consolidated Balance Sheets	The following table summarizes information on derivative receivables and payables (before and after netting adjustments) that are reflected on the Firm’s Consolidated balance sheets as of December 31, 2021 and 2020, by accounting designation (e.g., whether the derivatives were designated in qualifying hedge accounting relationships or not) and contract type. Free-standing derivative receivables and payables (a) Gross derivative receivables Gross derivative payables December 31, 2021 Not designated as hedges Designated as hedges Total derivative receivables Net derivative receivables (b) Not designated as hedges Designated as hedges Total derivative payables Net derivative payables (b) Trading assets and liabilities Interest rate $ 270,562 $ 23 $ 270,585 $ 21,974 $ 240,731 $ — $ 240,731 $ 8,194 Credit 9,839 — 9,839 1,031 10,912 — 10,912 880 Foreign exchange 169,186 393 169,579 12,625 174,622 1,124 175,746 14,097 Equity 68,631 — 68,631 9,981 79,727 — 79,727 17,233 Commodity 21,233 5,420 26,653 11,470 20,837 7,091 27,928 9,712 Total fair value of trading assets and liabilities $ 539,451 $ 5,836 $ 545,287 $ 57,081 $ 526,829 $ 8,215 $ 535,044 $ 50,116 Gross derivative receivables Gross derivative payables December 31, 2020 Not designated as hedges Designated as hedges Total derivative receivables Net derivative receivables (b) Not designated as hedges Designated as hedges Total derivative payables Net derivative payables (b) Trading assets and liabilities Interest rate $ 390,817 (c) $ 831 $ 391,648 $ 35,725 $ 353,987 (c) $ — $ 353,987 $ 13,012 Credit 13,345 (c) — 13,345 680 14,832 (c) — 14,832 1,995 Foreign exchange 205,359 901 206,260 15,781 214,229 1,697 215,926 21,433 Equity 70,612 (c) — 70,612 16,487 (c) 81,413 — 81,413 25,898 Commodity 20,579 924 21,503 6,771 20,834 1,895 22,729 8,285 Total fair value of trading assets and liabilities $ 700,712 $ 2,656 $ 703,368 $ 75,444 $ 685,295 $ 3,592 $ 688,887 $ 70,623 (a) Balances exclude structured notes for which the fair value option has been elected. Refer to Note 3 for further information. (b) As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral receivables and payables when a legally enforceable master netting agreement exists. (c) Prior-period amounts have been revised to conform with the current presentation.
Offsetting assets	The following tables present, as of December 31, 2021 and 2020, gross and net derivative receivables and payables by contract and settlement type. Derivative receivables and payables, as well as the related cash collateral from the same counterparty, have been netted on the Consolidated balance sheets where the Firm has obtained an appropriate legal opinion with respect to the master netting agreement. Where such a legal opinion has not been either sought or obtained, amounts are not eligible for netting on the Consolidated balance sheets, and those derivative receivables and payables are shown separately in the tables below. In addition to the cash collateral received and transferred that is presented on a net basis with derivative receivables and payables, the Firm receives and transfers additional collateral (financial instruments and cash). These amounts mitigate counterparty credit risk associated with the Firm’s derivative instruments, but are not eligible for net presentation: • collateral that consists of liquid securities and other cash collateral held at third-party custodians, which are shown separately as " Collateral not nettable on the Consolidated balance sheets " in the tables below, up to the fair value exposure amount. For the purpose of this disclosure, the definition of liquid securities is consistent with the definition of high quality liquid assets as defined in the LCR rule; • the amount of collateral held or transferred that exceeds the fair value exposure at the individual counterparty level, as of the date presented, which is excluded from the tables below; and • collateral held or transferred that relates to derivative receivables or payables where an appropriate legal opinion has not been either sought or obtained with respect to the master netting agreement, which is excluded from the tables below. 2021 2020 December 31, (in millions) Gross derivative receivables Amounts netted on the Consolidated balance sheets Net derivative receivables Gross derivative receivables Amounts netted on the Consolidated balance sheets Net U.S. GAAP nettable derivative receivables Interest rate contracts: OTC $ 251,953 $ (234,283) $ 17,670 $ 367,214 (e) $ (337,609) (e) $ 29,605 OTC–cleared 14,144 (13,839) 305 18,340 (17,919) 421 Exchange-traded (a) 498 (489) 9 554 (395) 159 Total interest rate contracts 266,595 (248,611) 17,984 386,108 (355,923) 30,185 Credit contracts: OTC 8,035 (7,177) 858 8,894 (e) (8,356) (e) 538 OTC–cleared 1,671 (1,631) 40 4,326 (4,309) 17 Total credit contracts 9,706 (8,808) 898 13,220 (12,665) 555 Foreign exchange contracts: OTC 166,185 (156,251) 9,934 201,349 (189,655) 11,694 OTC–cleared 789 (703) 86 834 (819) 15 Exchange-traded (a) 6 — 6 35 (5) 30 Total foreign exchange contracts 166,980 (156,954) 10,026 202,218 (190,479) 11,739 Equity contracts: OTC 25,704 (23,977) 1,727 29,844 (e) (27,374) 2,470 Exchange-traded (a) 36,095 (34,673) 1,422 28,294 (26,751) 1,543 Total equity contracts 61,799 (58,650) 3,149 58,138 (54,125) 4,013 Commodity contracts: OTC 15,063 (6,868) 8,195 10,924 (7,901) 3,023 OTC–cleared 49 (49) — 20 (20) — Exchange-traded (a) 8,279 (8,266) 13 6,833 (6,811) 22 Total commodity contracts 23,391 (15,183) 8,208 17,777 (14,732) 3,045 Derivative receivables with appropriate legal opinion 528,471 (488,206) 40,265 (d) 677,461 (627,924) 49,537 (d) Derivative receivables where an appropriate legal opinion has not been either sought or obtained 16,816 16,816 25,907 25,907 Total derivative receivables recognized on the Consolidated balance sheets $ 545,287 $ 57,081 $ 703,368 $ 75,444 Collateral not nettable on the Consolidated balance sheets (b)(c) (10,102) (14,806) Net amounts $ 46,979 $ 60,638
Offsetting liabilities	2021 2020 December 31, (in millions) Gross derivative payables Amounts netted on the Consolidated balance sheets Net derivative payables Gross derivative payables Amounts netted on the Consolidated balance sheets Net U.S. GAAP nettable derivative payables Interest rate contracts: OTC $ 223,576 $ (216,757) $ 6,819 $ 332,214 (e) $ (321,140) (e) $ 11,074 OTC–cleared 15,695 (15,492) 203 19,710 (19,494) 216 Exchange-traded (a) 292 (288) 4 358 (341) 17 Total interest rate contracts 239,563 (232,537) 7,026 352,282 (340,975) 11,307 Credit contracts: OTC 9,021 (8,421) 600 10,311 (e) (8,781) (e) 1,530 OTC–cleared 1,679 (1,611) 68 4,075 (4,056) 19 Total credit contracts 10,700 (10,032) 668 14,386 (12,837) 1,549 Foreign exchange contracts: OTC 171,610 (160,946) 10,664 210,803 (193,672) 17,131 OTC–cleared 706 (703) 3 836 (819) 17 Exchange-traded (a) 7 — 7 34 (2) 32 Total foreign exchange contracts 172,323 (161,649) 10,674 211,673 (194,493) 17,180 Equity contracts: OTC 31,379 (27,830) 3,549 35,330 (28,763) 6,567 Exchange-traded (a) 40,621 (34,664) 5,957 34,491 (26,752) 7,739 Total equity contracts 72,000 (62,494) 9,506 69,821 (55,515) 14,306 Commodity contracts: OTC 14,874 (9,667) 5,207 10,365 (7,544) 2,821 OTC–cleared 73 (73) — 32 (32) — Exchange-traded (a) 8,954 (8,476) 478 7,391 (6,868) 523 Total commodity contracts 23,901 (18,216) 5,685 17,788 (14,444) 3,344 Derivative payables with appropriate legal opinion 518,487 (484,928) 33,559 (d) 665,950 (618,264) 47,686 (d) Derivative payables where an appropriate legal opinion has not been either sought or obtained 16,557 16,557 22,937 22,937 Total derivative payables recognized on the Consolidated balance sheets $ 535,044 $ 50,116 $ 688,887 $ 70,623 Collateral not nettable on the Consolidated balance sheets (b)(c) (5,872) (11,964) Net amounts $ 44,244 $ 58,659 (a) Exchange-traded derivative balances that relate to futures contracts are settled daily. (b) Includes liquid securities and other cash collateral held at third-party custodians related to derivative instruments where an appropriate legal opinion has been obtained. For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. (c) Derivative collateral relates only to OTC and OTC-cleared derivative instruments. (d) Net derivatives receivable included cash collateral netted of $67.6 billion and $88.0 billion at December 31, 2021 and 2020, respectively. Net derivatives payable included cash collateral netted of $64.3 billion and $78.4 billion at December 31, 2021 and 2020, respectively. Derivative cash collateral relates to OTC and OTC-cleared derivative instruments. (e) Prior-period amounts have been revised to conform with the current presentation.
Current credit risk of derivative receivables and liquidity risk of derivative payables	The following table shows the aggregate fair value of net derivative payables related to OTC and OTC-cleared derivatives that contain contingent collateral or termination features that may be triggered upon a ratings downgrade, and the associated collateral the Firm has posted in the normal course of business, at December 31, 2021 and 2020. OTC and OTC-cleared derivative payables containing downgrade triggers December 31, (in millions) 2021 2020 Aggregate fair value of net derivative payables $ 20,114 $ 26,945 (a) Collateral posted 19,402 26,289 (a) Prior-period amount has been revised to conform with the current presentation. The following table shows the impact of a single-notch and two-notch downgrade of the long-term issuer ratings of JPMorgan Chase & Co. and its subsidiaries, predominantly JPMorgan Chase Bank, N.A., at December 31, 2021 and 2020, related to OTC and OTC-cleared derivative contracts with contingent collateral or termination features that may be triggered upon a ratings downgrade. Derivatives contracts generally require additional collateral to be posted or terminations to be triggered when the predefined rating threshold is breached. A downgrade by a single rating agency that does not result in a rating lower than a preexisting corresponding rating provided by another major rating agency will generally not result in additional collateral (except in certain instances in which additional initial margin may be required upon a ratings downgrade), nor in termination payment requirements. The liquidity impact in the table is calculated based upon a downgrade below the lowest current rating of the rating agencies referred to in the derivative contract. Liquidity impact of downgrade triggers on OTC and OTC-cleared derivatives 2021 2020 December 31, (in millions) Single-notch downgrade Two-notch downgrade Single-notch downgrade Two-notch downgrade Amount of additional collateral to be posted upon downgrade (a) $ 219 $ 1,577 $ 119 $ 1,243 Amount required to settle contracts with termination triggers upon downgrade (b) 98 787 153 1,682 (c) (a) Includes the additional collateral to be posted for initial margin. (b) Amounts represent fair values of derivative payables, and do not reflect collateral posted. (c) Prior-period amount has been revised to conform with the current presentation.
Fair value hedge gains and losses	The following tables present derivative instruments, by contract type, used in fair value hedge accounting relationships, as well as pre-tax gains/(losses) recorded on such derivatives and the related hedged items for the years ended December 31, 2021, 2020 and 2019, respectively. The Firm includes gains/(losses) on the hedging derivative in the same line item in the Consolidated statements of income as the related hedged item. Gains/(losses) recorded in income Income statement impact of (e) OCI impact Year ended December 31, 2021 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ (4,323) $ 6,363 $ 2,040 $ — $ 2,159 $ — Foreign exchange (c) (1,317) 1,349 32 (286) 32 (26) Commodity (d) (9,609) 9,710 101 — 72 — Total $ (15,249) $ 17,422 $ 2,173 $ (286) $ 2,263 $ (26) Gains/(losses) recorded in income Income statement impact of excluded components (e) OCI impact Year ended December 31, 2020 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ 2,962 $ (1,889) $ 1,073 $ — $ 1,093 $ — Foreign exchange (c) 793 (619) 174 (457) 174 25 Commodity (d) (2,507) 2,650 143 — 137 — Total $ 1,248 $ 142 $ 1,390 $ (457) $ 1,404 $ 25 Gains/(losses) recorded in income Income statement impact of excluded components (e) OCI impact Year ended December 31, 2019 Derivatives Hedged items Income statement impact Amortization approach Changes in fair value Derivatives - Gains/(losses) recorded in OCI (f) Contract type Interest rate (a)(b) $ 3,204 $ (2,373) $ 831 $ — $ 828 $ — Foreign exchange (c) 154 328 482 (866) 482 39 Commodity (d) (77) 148 71 — 63 — Total $ 3,281 $ (1,897) $ 1,384 $ (866) $ 1,373 $ 39 (a) Primarily consists of hedges of the benchmark (e.g., London Interbank Offered Rate (“LIBOR”), Secured Overnight Financing Rate (“SOFR”)) interest rate risk of fixed-rate long-term debt and AFS securities. Gains and losses were recorded in net interest income. (b) Excludes the amortization expense associated with the inception hedge accounting adjustment applied to the hedged item. This expense is recorded in net interest income and substantially offsets the income statement impact of the excluded components. Also excludes the accrual of interest on interest rate swaps and the related hedged items. (c) Primarily consists of hedges of the foreign currency risk of long-term debt and AFS securities for changes in spot foreign currency rates. Gains and losses related to the derivatives and the hedged items due to changes in foreign currency rates and the income statement impact of excluded components were recorded primarily in principal transactions revenue and net interest income. (d) Consists of overall fair value hedges of physical commodities inventories that are generally carried at the lower of cost or net realizable value (net realizable value approximates fair value). Gains and losses were recorded in principal transactions revenue. (e) The assessment of hedge effectiveness excludes certain components of the changes in fair values of the derivatives and hedged items such as forward points on foreign exchange forward contracts, time values and cross-currency basis spreads. Excluded components may impact earnings either through amortization of the initial amount over the life of the derivative or through fair value changes recognized in the current period. (f) Represents the change in value of amounts excluded from the assessment of effectiveness under the amortization approach, predominantly cross-currency basis spreads. The amount excluded at inception of the hedge is recognized in earnings over the life of the derivative.
Schedule of amounts recorded on Consolidated Balance Sheets related to certain cumulative fair value hedge basis adjustments	As of December 31, 2021 and 2020, the following amounts were recorded on the Consolidated balance sheets related to certain cumulative fair value hedge basis adjustments that are expected to reverse through the income statement in future periods as an adjustment to yield. Carrying amount of the hedged items (a)(b) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items: December 31, 2021 Active hedging relationships (d) Discontinued hedging relationships (d)(e) Total Assets Investment securities - AFS $ 65,746 (c) $ 417 $ 661 $ 1,078 Liabilities Long-term debt $ 195,642 $ (1,999) $ 8,834 $ 6,835 Beneficial interests issued by consolidated VIEs 749 — (1) (1) Carrying amount of the hedged items (a)(b) Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items: December 31, 2020 Active hedging relationships (d) Discontinued hedging relationships (d)(e) Total Assets Investment securities - AFS $ 139,684 (c) $ 3,572 $ 847 $ 4,419 Liabilities Long-term debt $ 177,611 $ 3,194 $ 11,473 $ 14,667 Beneficial interests issued by consolidated VIEs 746 — (3) (3) (a) Excludes physical commodities with a carrying value of $25.7 billion and $11.5 billion at December 31, 2021 and 2020, respectively, to which the Firm applies fair value hedge accounting. As a result of the application of hedge accounting, these inventories are carried at fair value, thus recognizing unrealized gains and losses in current periods. Since the Firm exits these positions at fair value, there is no incremental impact to net income in future periods. (b) Excludes hedged items where only foreign currency risk is the designated hedged risk, as basis adjustments related to foreign currency hedges will not reverse through the income statement in future periods. At December 31, 2021 and 2020, the carrying amount excluded for AFS securities is $14.0 billion and $14.5 billion, respectively, and for long-term debt is $10.8 billion and $6.6 billion, respectively. (c) Carrying amount represents the amortized cost, net of allowance if applicable. Refer to Note 10 for additional information. (d) Positive amounts related to assets represent cumulative fair value hedge basis adjustments that will reduce net interest income in future periods. Positive (negative) amounts related to liabilities represent cumulative fair value hedge basis adjustments that will increase (reduce) net interest income in future periods. (e) Represents basis adjustments existing on the balance sheet date associated with hedged items that have been de-designated from qualifying fair value hedging relationships.
Cash flow hedge gains and losses	The following tables present derivative instruments, by contract type, used in cash flow hedge accounting relationships, and the pre-tax gains/(losses) recorded on such derivatives, for the years ended December 31, 2021, 2020 and 2019, respectively. The Firm includes the gains/(losses) on the hedging derivative in the same line item in the Consolidated statements of income as the change in cash flows on the related hedged item. Derivatives gains/(losses) recorded in income and other comprehensive income/(loss) Year ended December 31, 2021 Amounts reclassified from AOCI to income Amounts recorded in OCI Total change in OCI for period Contract type Interest rate (a) $ 1,032 $ (2,370) $ (3,402) Foreign exchange (b) 190 67 (123) Total $ 1,222 $ (2,303) $ (3,525) Derivatives gains/(losses) recorded in income and other comprehensive income/(loss) Year ended December 31, 2020 Amounts reclassified from AOCI to income Amounts recorded in OCI Total change Contract type Interest rate (a) $ 570 $ 3,582 $ 3,012 Foreign exchange (b) — 41 41 Total $ 570 $ 3,623 $ 3,053 Derivatives gains/(losses) recorded in income and other comprehensive income/(loss) Year ended December 31, 2019 Amounts reclassified from AOCI to income Amounts recorded in OCI Total change Contract type Interest rate (a) $ (28) $ (3) $ 25 Foreign exchange (b) (75) 125 200 Total $ (103) $ 122 $ 225 (a) Primarily consists of hedges of contractually specified floating-rate (e.g., LIBOR and SOFR-indexed) assets and liabilities. Gains and losses were recorded in net interest income. (b) Primarily consists of hedges of the foreign currency risk of non-U.S. dollar-denominated revenue and expense. The income statement classification of gains and losses follows the hedged item – primarily noninterest revenue and compensation expense.
Net investment hedge gains and losses	The following table presents hedging instruments, by contract type, that were used in net investment hedge accounting relationships, and the pre-tax gains/(losses) recorded on such instruments for the years ended December 31, 2021, 2020 and 2019. 2021 2020 2019 Year ended December 31, Amounts recorded in income (a)(b) Amounts recorded in Amounts recorded in income (a)(b) Amounts recorded in Amounts recorded in income (a)(b) Amounts recorded in Foreign exchange derivatives $(228) $2,452 $(122) $(1,408) $72 $64 (a) Certain components of hedging derivatives are permitted to be excluded from the assessment of hedge effectiveness, such as forward points on foreign exchange forward contracts. The Firm elects to record changes in fair value of these amounts directly in other income. (b) Excludes amounts reclassified from AOCI to income on the sale or liquidation of hedged entities. The amount reclassified for the year ended December 31, 2021 was not material. The Firm reclassified net pre-tax gains of $3 million and $18 million to other income related to the liquidation of certain legal entities during the years ended December 31, 2020 and 2019, respectively. Refer to Note 24 for further information.
Risk management derivatives gains and losses (not designated as hedging instruments)	The following table presents pre-tax gains/(losses) recorded on a limited number of derivatives, not designated in hedge accounting relationships, that are used to manage risks associated with certain specified assets and liabilities, including certain risks arising from mortgage commitments, warehouse loans, MSRs, wholesale lending exposures, and foreign currency denominated assets and liabilities. Derivatives gains/(losses) Year ended December 31, 2021 2020 2019 Contract type Interest rate (a) $ 1,078 $ 2,994 $ 1,491 Credit (b) (94) (176) (30) Foreign exchange (c) 94 43 (5) Total $ 1,078 $ 2,861 $ 1,456 (a) Primarily represents interest rate derivatives used to hedge the interest rate risk inherent in mortgage commitments, warehouse loans and MSRs, as well as written commitments to originate warehouse loans. Gains and losses were recorded predominantly in mortgage fees and related income. (b) Relates to credit derivatives used to mitigate credit risk associated with lending exposures in the Firm’s wholesale businesses. These derivatives do not include credit derivatives used to mitigate counterparty credit risk arising from derivative receivables, which is included in gains and losses on derivatives related to market-making activities and other derivatives. Gains and losses were recorded in principal transactions revenue. (c) Primarily relates to derivatives used to mitigate foreign exchange risk of specified foreign currency-denominated assets and liabilities. Gains and losses were recorded in principal transactions revenue.
Credit derivatives and credit-related notes	Total credit derivatives and credit-related notes Maximum payout/Notional amount Protection sold Protection purchased with identical underlyings (c) Net protection (sold)/purchased (d) Other protection purchased (e) December 31, 2021 (in millions) Credit derivatives Credit default swaps $ (443,481) $ 458,180 $ 14,699 $ 2,269 Other credit derivatives (a) (56,130) 79,586 23,456 13,435 Total credit derivatives (499,611) 537,766 38,155 15,704 Credit-related notes (b) — — — 9,437 Total $ (499,611) $ 537,766 $ 38,155 $ 25,141 Maximum payout/Notional amount Protection sold Protection purchased with identical underlyings (c) Net protection (sold)/purchased (d) Other protection purchased (e) December 31, 2020 (in millions) Credit derivatives Credit default swaps $ (533,900) (f) $ 552,021 (f) $ 18,121 $ 2,786 (f) Other credit derivatives (a) (40,084) 57,344 17,260 10,630 (f) Total credit derivatives (573,984) 609,365 35,381 13,416 Credit-related notes (b) — — — 10,248 Total $ (573,984) $ 609,365 $ 35,381 $ 23,664 (a) Other credit derivatives predominantly consist of credit swap options and total return swaps. (b) Represents Other protection purchased by CIB, primarily in its market-making businesses. (c) Represents the total notional amount of protection purchased where the underlying reference instrument is identical to the reference instrument on protection sold; the notional amount of protection purchased for each individual identical underlying reference instrument may be greater or lower than the notional amount of protection sold. (d) Does not take into account the fair value of the reference obligation at the time of settlement, which would generally reduce the amount the seller of protection pays to the buyer of protection in determining settlement value. (e) Represents protection purchased by the Firm on referenced instruments (single-name, portfolio or index) where the Firm has not sold any protection on the identical reference instrument. (f) Prior-period amounts have been revised to conform with the current presentation.
Protection sold - credit derivatives and credit-related notes ratings/maturity profile	The following tables summarize the notional amounts by the ratings, maturity profile, and total fair value, of credit derivatives as of December 31, 2021 and 2020, where JPMorgan Chase is the seller of protection. The maturity profile is based on the remaining contractual maturity of the credit derivative contracts. The ratings profile is based on the rating of the reference entity on which the credit derivative contract is based. The ratings and maturity profile of credit derivatives where JPMorgan Chase is the purchaser of protection are comparable to the profile reflected below. Protection sold – credit derivatives ratings (a) /maturity profile December 31, 2021 <1 year 1–5 years >5 years Total notional amount Fair value of receivables (b) Fair value of payables (b) Net fair value Risk rating of reference entity Investment-grade $ (91,155) $ (255,106) $ (29,035) $ (375,296) $ 3,645 $ (623) $ 3,022 Noninvestment-grade (32,175) (84,851) (7,289) (124,315) 2,630 (2,003) 627 Total $ (123,330) $ (339,957) $ (36,324) $ (499,611) $ 6,275 $ (2,626) $ 3,649 December 31, 2020 <1 year 1–5 years >5 years Total notional amount Fair value of receivables (b) Fair value of payables (b) Net fair value Risk rating of reference entity Investment-grade $ (93,529) (c) $ (306,830) (c) $ (35,326) $ (435,685) $ 5,372 (c) $ (834) (c) $ 4,538 Noninvestment-grade (31,809) (97,337) (9,153) (138,299) 3,953 (2,542) 1,411 Total $ (125,338) $ (404,167) $ (44,479) $ (573,984) $ 9,325 $ (3,376) $ 5,949 (a) The ratings scale is primarily based on external credit ratings defined by S&P and Moody’s. (b) Amounts are shown on a gross basis, before the benefit of legally enforceable master netting agreements including cash collateral netting. (c) Prior-period amounts have been revised to conform with the current presentation.

Noninterest Revenue and Nonin_2

Noninterest Revenue and Noninterest Expense (Tables)	12 Months Ended
	Dec. 31, 2021
Noninterest Income (Expense) [Abstract]
Components of investment banking fees	The following table presents the components of investment banking fees. Year ended December 31, 2021 2020 2019 Underwriting Equity $ 3,969 $ 2,759 $ 1,648 Debt 4,853 4,362 3,513 Total underwriting 8,822 7,121 5,161 Advisory 4,394 2,365 2,340 Total investment banking fees $ 13,216 $ 9,486 $ 7,501
Principal transactions revenue	The following table presents all realized and unrealized gains and losses recorded in principal transactions revenue. This table excludes interest income and interest expense on trading assets and liabilities, which are an integral part of the overall performance of the Firm’s client-driven market-making activities in CIB and fund deployment activities in Treasury and CIO. Refer to Note 7 for further information on interest income and interest expense. Trading revenue is presented primarily by instrument type. The Firm’s client-driven market-making businesses generally utilize a variety of instrument types in connection with their market-making and related risk-management activities; accordingly, the trading revenue presented in the table below is not representative of the total revenue of any individual LOB. Year ended December 31, 2021 2020 2019 Trading revenue by instrument type Interest rate (a) $ 1,646 $ 2,575 $ 2,739 Credit (b) 2,691 2,753 1,628 Foreign exchange 2,787 4,253 3,179 Equity 7,773 6,171 5,589 Commodity 1,428 2,088 1,133 Total trading revenue 16,325 17,840 14,268 Private equity gains/(losses) (21) 181 (250) Principal transactions $ 16,304 $ 18,021 $ 14,018 (a) Includes the impact of changes in funding valuation adjustments on derivatives. (b) Includes the impact of changes in credit valuation adjustments on derivatives, net of the associated hedging activities.
Components of lending and deposit-related fees	The following table presents the components of lending- and deposit-related fees. Year ended December 31, (in millions) 2021 2020 2019 Lending-related fees $ 1,472 $ 1,271 $ 1,184 Deposit-related fees 5,560 5,240 5,442 Total lending- and deposit-related fees $ 7,032 $ 6,511 $ 6,626
Components of asset management, administration and commissions	The following table presents the components of Firmwide asset management, administration and commissions. Year ended December 31, 2021 2020 2019 Asset management fees Investment management fees (a) $ 14,027 $ 11,694 $ 10,865 All other asset management fees (b) 378 338 315 Total asset management fees 14,405 12,032 11,180 Total administration fees (c) 2,554 2,249 2,197 Commissions and other fees Brokerage commissions (d) 3,046 2,959 2,439 All other commissions and fees 1,024 937 1,092 Total commissions and fees 4,070 3,896 3,531 Total asset management, administration and commissions $ 21,029 $ 18,177 $ 16,908 (a) Represents fees earned from managing assets on behalf of the Firm’s clients, including investors in Firm-sponsored funds and owners of separately managed investment accounts. (b) Represents fees for services that are ancillary to investment management services, such as commissions earned on the sales or distribution of mutual funds to clients. These fees are recorded as revenue at the time the service is rendered or, in the case of certain distribution fees based on the underlying fund’s asset value and/or investor redemption, recorded over time as the investor remains in the fund or upon investor redemption. (c) Predominantly includes fees for custody, securities lending, funds services and securities clearance. These fees are recorded as revenue over the period in which the related service is provided. (d) Represents commissions earned when the Firm acts as a broker, by facilitating its clients’ purchases and sales of securities and other financial instruments. Brokerage commissions are collected and recognized as revenue upon occurrence of the client transaction. The Firm reports certain costs paid to third-party clearing houses and exchanges net against commission revenue.
Schedule of components of card income	The following table presents the components of card income: Year ended December 31, 2021 2020 2019 Interchange and merchant processing income $ 23,592 $ 18,563 $ 20,370 Reward costs and partner payments (17,868) (13,637) (14,540) Other card income (a) (622) (491) (754) Total card income $ 5,102 $ 4,435 $ 5,076 (a) Predominantly represents the amortization of account origination costs and annual fees, which are deferred and recognized on a straight-line basis over a 12-month period.
Components of noninterest expense	Other expense on the Firm’s Consolidated statements of income included the following: Year ended December 31, 2021 2020 2019 Legal expense $ 426 $ 1,115 $ 239

Interest Income and Interest _2

Interest Income and Interest Expense (Tables)	12 Months Ended
	Dec. 31, 2021
Interest Income (Expense), Net [Abstract]
Details of interest income and interest expense	The following table presents the components of interest income and interest expense: Year ended December 31, 2021 2020 2019 Interest income Loans (a) $ 41,537 $ 43,758 $ 51,855 Taxable securities 6,460 7,843 7,962 Non-taxable securities (b) 1,063 1,184 1,329 Total investment securities (a) 7,523 9,027 9,291 Trading assets - debt instruments 6,825 7,832 9,141 Federal funds sold and securities purchased under resale agreements 958 2,436 6,146 Securities borrowed (c) (385) (302) 1,574 Deposits with banks 512 749 3,887 All other interest-earning assets (d) 894 1,023 2,146 Total interest income $ 57,864 $ 64,523 $ 84,040 Interest expense Interest bearing deposits $ 531 $ 2,357 $ 8,957 Federal funds purchased and securities loaned or sold under repurchase agreements 274 1,058 4,630 Short-term borrowings (e) 126 372 1,248 Trading liabilities - debt and all other interest-bearing liabilities (c)(f) 257 195 2,585 Long-term debt 4,282 5,764 8,807 Beneficial interest issued by consolidated VIEs 83 214 568 Total interest expense $ 5,553 $ 9,960 $ 26,795 Net interest income $ 52,311 $ 54,563 $ 57,245 Provision for credit losses (9,256) 17,480 5,585 Net interest income after provision for credit losses $ 61,567 $ 37,083 $ 51,660 (a) Includes the amortization/accretion of unearned income (e.g., purchase premiums/discounts and net deferred fees/costs). (b) Represents securities that are tax-exempt for U.S. federal income tax purposes. (c) Negative interest income is related to the impact of current interest rates combined with the fees paid on client-driven securities borrowed balances. The negative interest expense related to prime brokerage customer payables is recognized in interest expense and reported within trading liabilities - debt and all other interest-bearing liabilities. (d) Includes interest earned on brokerage-related held-for-investment customer receivables, which are classified in accrued interest and accounts receivable, and all other interest-earning assets, which are classified in other assets on the Consolidated balance sheets. (e) Includes commercial paper. (f) All other interest-bearing liabilities includes interest expense on brokerage-related customer payables.

Pension and Other Postretirem_2

Pension and Other Postretirement Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Summary of benefit obligations, plan assets, net funded status and amounts recorded in AOCI	The following table presents the pretax benefit obligations, plan assets, the net funded status, and the amounts recorded in AOCI on the Consolidated balance sheets for the Firm’s defined benefit pension and OPEB plans. As of or for the year ended December 31, Defined benefit (in millions) 2021 2020 Projected benefit obligations $ (18,046) $ (19,137) Fair value of plan assets 25,692 25,417 Net funded status 7,646 6,280 Accumulated other comprehensive income/(loss) (453) (1,586)
Components of net periodic benefit costs reported in the Consolidated statements of income and other comprehensive income	The following table presents the components of net periodic benefit costs reported in the Consolidated statements of income for the Firm’s defined benefit pension, defined contribution and OPEB plans, and in other comprehensive income for the defined benefit pension and OPEB plans. Pension and OPEB plans Year ended December 31, (in millions) 2021 2020 2019 Total net periodic defined benefit plan cost/(credit) $ (201) $ (285) $ 144 Total defined contribution plans 1,333 1,332 952 Total pension and OPEB cost included in noninterest expense $ 1,132 $ 1,047 $ 1,096 Total recognized in other comprehensive income $ (1,129) $ (214) $ (1,157)
Weighted-average actuarial assumptions	The following table presents the weighted-average actuarial assumptions used to determine the net periodic benefit costs for the defined benefit pension and OPEB plans. Defined benefit pension and OPEB plans Year ended December 31, 2021 2020 2019 Discount rate 2.17 % 2.93 % 3.89 % Expected long-term rate of return on plan assets 2.97 % 3.91 % 5.08 %
Pension and OPEB plan assets and liabilities measured at fair value	Pension plan assets and liabilities measured at fair value Defined benefit pension and OPEB plans 2021 2020 December 31 , (in millions) Level 1 (a) Level 2 (b) Level 3 (c) Total fair value Level 1 (a) Level 2 (b) Level 3 (c) Total fair value Assets measured at fair value classified in fair value hierarchy $ 6,541 $ 12,315 $ 3,172 $ 22,028 $ 7,031 $ 12,384 $ 2,952 $ 22,367 Assets measured at fair value using NAV as practical expedient not classified in fair value hierarchy 3,960 3,651 Net defined benefit pension plan payables not classified in fair value hierarchy (296) (601) Total fair value of plan assets $ 25,692 $ 25,417 (a) Consists largely of equity securities. (b) Consists largely of corporate debt securities. (c) Consists of corporate-owned life insurance policies and participating annuity contracts.
Estimated future benefit payments	The following table presents benefit payments expected to be paid for the defined benefit pension and OPEB plans for the years indicated. Year ended December 31, Defined benefit pension and OPEB plans 2022 $ 1,124 2023 1,106 2024 1,082 2025 1,036 2026 1,016 Years 2027–2031 4,740

Employee Share-Based Incentiv_2

Employee Share-Based Incentives (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Summary of RSUs, PSUs, and SARs and stock options activity	The following table summarizes JPMorgan Chase’s RSUs, PSUs, SARs and stock options activity for 2021. RSUs/PSUs SARs/Options Year ended December 31, 2021 Number of Weighted-average grant Number of awards Weighted-average exercise price Weighted-average remaining contractual life Aggregate intrinsic value (in thousands, except weighted-average data, and where otherwise stated) Outstanding, January 1 47,510 $ 112.85 3,124 $ 41.25 Granted 20,347 138.98 2,250 152.19 Exercised or vested (20,235) 107.26 (2,005) 39.08 Forfeited (2,217) 126.77 — — Canceled NA NA — — Outstanding, December 31 45,405 $ 126.32 3,369 $ 116.62 6.8 $ 141,872 Exercisable, December 31 NA NA 1,119 45.14 0.9 127,030
Noncash compensation expense related to employee share-based incentive plans	The Firm recognized the following noncash compensation expense related to its various employee share-based incentive plans in its Consolidated statements of income. Year ended December 31, (in millions) 2021 2020 2019 Cost of prior grants of RSUs, PSUs, SARs and stock options that are amortized over their applicable vesting periods $ 1,161 $ 1,101 $ 1,141 Accrual of estimated costs of share-based awards to be granted in future periods, predominantly those to full-career eligible employees 1,768 1,350 1,115 Total noncash compensation expense related to employee share-based incentive plans $ 2,929 $ 2,451 $ 2,256

Investment Securities (Tables)

Investment Securities (Tables)	12 Months Ended
	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Amortized costs and estimated fair values	The amortized costs and estimated fair values of the investment securities portfolio were as follows for the dates indicated. 2021 2020 December 31, (in millions) Amortized cost (b)(c) Gross unrealized gains Gross unrealized losses Fair Amortized cost (b)(c) Gross unrealized gains Gross unrealized losses Fair Available-for-sale securities Mortgage-backed securities: U.S. GSEs and government agencies $ 72,800 $ 736 $ 993 $ 72,543 $ 110,979 $ 2,372 $ 50 $ 113,301 Residential: U.S. 2,128 38 2 2,164 6,246 224 3 6,467 Non-U.S. 3,882 25 1 3,906 3,751 20 5 3,766 Commercial 4,944 22 17 4,949 2,819 71 34 2,856 Total mortgage-backed securities 83,754 821 1,013 83,562 123,795 2,687 92 126,390 U.S. Treasury and government agencies 178,038 668 1,243 177,463 199,910 2,141 100 201,951 Obligations of U.S. states and municipalities 14,890 972 2 15,860 18,993 1,404 1 20,396 Non-U.S. government debt securities 16,163 92 46 16,209 22,587 354 13 22,928 Corporate debt securities 332 8 19 321 215 4 3 216 Asset-backed securities: Collateralized loan obligations 9,674 6 18 9,662 10,055 24 31 10,048 Other 5,403 47 2 5,448 6,174 91 16 6,249 Total available-for-sale securities 308,254 2,614 2,343 308,525 381,729 6,705 256 388,178 Held-to-maturity securities (a) Mortgage-backed securities: U.S. GSEs and government agencies 102,556 1,400 853 103,103 107,889 2,968 29 110,828 U.S. Residential 7,316 1 106 7,211 4,345 8 30 4,323 Commercial 3,730 11 54 3,687 2,602 77 — 2,679 Total mortgage-backed securities 113,602 1,412 1,013 114,001 114,836 3,053 59 117,830 U.S. Treasury and government agencies 185,204 169 2,103 183,270 53,184 50 — 53,234 Obligations of U.S. states and municipalities 13,985 453 44 14,394 12,751 519 — 13,270 Asset-backed securities: Collateralized loan obligations 48,869 75 22 48,922 21,050 90 2 21,138 Other 2,047 1 7 2,041 — — — — Total held-to-maturity securities 363,707 2,110 3,189 362,628 201,821 3,712 61 205,472 Total investment securities, net of allowance for credit losses $ 671,961 $ 4,724 $ 5,532 $ 671,153 $ 583,550 $ 10,417 $ 317 $ 593,650 (a) The Firm purchased $111.8 billion, $12.4 billion and $13.4 billion of HTM securities for the years ended December 31, 2021, 2020 and 2019, respectively. (b) The amortized cost of investment securities is reported net of allowance for credit losses of $42 million and $78 million at December 31, 2021 and 2020, respectively. (c) Excludes $1.9 billion and $2.1 billion of accrued interest receivables at December 31, 2021 and 2020, respectively, included in accrued interest and accounts receivables on the Consolidated balance sheets. The Firm generally does not recognize an allowance for credit losses on accrued interest receivables, consistent with its policy to write them off no later than 90 days past due by reversing interest income. The Firm did not reverse through interest income any accrued interest receivables for the years ended December 31, 2021 and 2020.
Securities impairment	The following tables present the fair value and gross unrealized losses by aging category for AFS securities at December 31, 2021 and 2020. The tables exclude U.S. Treasury and government agency securities and U.S. GSE and government agency MBS with unrealized losses of $2.2 billion and $150 million, at December 31, 2021 and 2020, respectively; changes in the value of these securities are generally driven by changes in interest rates rather than changes in their credit profile given the explicit or implicit guarantees provided by the U.S. government. Available-for-sale securities with gross unrealized losses Less than 12 months 12 months or more December 31, 2021 (in millions) Fair value Gross Fair value Gross Total fair value Total gross unrealized losses Available-for-sale securities Mortgage-backed securities: Residential: U.S. $ 303 $ 1 $ 45 $ 1 $ 348 $ 2 Non-U.S. 133 1 — — 133 1 Commercial 2,557 5 349 12 2,906 17 Total mortgage-backed securities 2,993 7 394 13 3,387 20 Obligations of U.S. states and municipalities 120 2 — — 120 2 Non-U.S. government debt securities 5,060 37 510 9 5,570 46 Corporate debt securities 166 1 46 18 212 19 Asset-backed securities: Collateralized loan obligations 8,110 18 208 — 8,318 18 Other 89 — 178 2 267 2 Total available-for-sale securities with gross unrealized losses $ 16,538 $ 65 $ 1,336 $ 42 $ 17,874 $ 107 Available-for-sale securities with gross unrealized losses Less than 12 months 12 months or more December 31, 2020 (in millions) Fair value Gross Fair value Gross Total fair value Total gross unrealized losses Available-for-sale securities Mortgage-backed securities: Residential: U.S. $ 562 $ 3 $ 32 $ — $ 594 $ 3 Non-U.S. 2,507 4 235 1 2,742 5 Commercial 699 18 124 16 823 34 Total mortgage-backed securities 3,768 25 391 17 4,159 42 Obligations of U.S. states and municipalities 49 1 — — 49 1 Non-U.S. government debt securities 2,709 9 968 4 3,677 13 Corporate debt securities 91 3 5 — 96 3 Asset-backed securities: Collateralized loan obligations 5,248 18 2,645 13 7,893 31 Other 268 1 685 15 953 16 Total available-for-sale securities with gross unrealized losses $ 12,133 $ 57 $ 4,694 $ 49 $ 16,827 $ 106
Securities gains and losses and provision for credit loss	Year ended December 31, 2021 2020 2019 Realized gains $ 595 $ 3,080 $ 650 Realized losses (940) (2,278) (392) Investment securities gains/(losses) $ (345) $ 802 $ 258 Provision for credit losses $ (36) $ 68 NA
Amortized cost and estimated fair value by contractual maturity	The following table presents the amortized cost and estimated fair value at December 31, 2021, of JPMorgan Chase’s investment securities portfolio by contractual maturity. By remaining maturity Due in one Due after one year through five years Due after five years through 10 years Due after 10 years (b) Total Available-for-sale securities Mortgage-backed securities Amortized cost $ 8 $ 3,771 $ 4,823 $ 75,155 $ 83,757 Fair value 8 3,783 5,094 74,677 83,562 Average yield (a) 0.52 % 1.53 % 1.75 % 2.25 % 2.19 % U.S. Treasury and government agencies Amortized cost $ 7,774 $ 146,817 $ 14,618 $ 8,829 $ 178,038 Fair value 7,802 146,050 14,554 9,057 177,463 Average yield (a) 1.01 % 0.55 % 0.61 % 0.54 % 0.57 % Obligations of U.S. states and municipalities Amortized cost $ 13 $ 142 $ 1,285 $ 13,450 $ 14,890 Fair value 13 146 1,346 14,355 15,860 Average yield (a) 4.06 % 4.38 % 4.84 % 4.89 % 4.88 % Non-U.S. government debt securities Amortized cost $ 7,211 $ 5,491 $ 3,461 $ — $ 16,163 Fair value 7,224 5,532 3,453 — 16,209 Average yield (a) 2.34 % 2.53 % 1.09 % — % 2.14 % Corporate debt securities Amortized cost $ — $ 301 $ 31 $ — $ 332 Fair value — 290 31 — 321 Average yield (a) — % 10.03 % 1.61 % — % 9.25 % Asset-backed securities Amortized cost $ 2,500 $ 799 $ 3,369 $ 8,409 $ 15,077 Fair value 2,500 800 3,372 8,438 15,110 Average yield (a) 1.35 % 1.88 % 1.25 % 1.28 % 1.32 % Total available-for-sale securities Amortized cost $ 17,506 $ 157,321 $ 27,587 $ 105,843 $ 308,257 Fair value 17,547 156,601 27,850 106,527 308,525 Average yield (a) 1.61 % 0.67 % 1.15 % 2.37 % 1.35 % Held-to-maturity securities Mortgage-backed securities Amortized cost $ — $ 1,322 $ 11,495 $ 100,791 $ 113,608 Fair value — 1,338 11,814 100,849 114,001 Average yield (a) — % 1.76 % 2.43 % 2.83 % 2.78 % U.S. Treasury and government agencies Amortized cost $ 25,706 $ 92,845 $ 66,653 $ — $ 185,204 Fair value 25,675 91,727 65,868 — 183,270 Average yield (a) 0.54 % 0.74 % 1.26 % — % 0.90 % Obligations of U.S. states and municipalities Amortized cost $ 35 $ 76 $ 1,192 $ 12,715 $ 14,018 Fair value 35 76 1,240 13,043 14,394 Average yield (a) 3.72 % 2.72 % 3.74 % 3.83 % 3.82 % Asset-backed securities Amortized cost $ — $ — $ 13,402 $ 37,514 $ 50,916 Fair value — — 13,449 37,514 50,963 Average yield (a) — % — % 1.18 % 1.30 % 1.27 % Total held-to-maturity securities Amortized cost $ 25,741 $ 94,243 $ 92,742 $ 151,020 $ 363,746 Fair value 25,710 93,141 92,371 151,406 362,628 Average yield (a) 0.54 % 0.76 % 1.43 % 2.53 % 1.65 % (a) Average yield is computed using the effective yield of each security owned at the end of the period, weighted based on the amortized cost of each security. The effective yield considers the contractual coupon, amortization of premiums and accretion of discounts, and the effect of related hedging derivatives. Taxable-equivalent amounts are used where applicable. The effective yield excludes unscheduled principal prepayments; and accordingly, actual maturities of securities may differ from their contractual or expected maturities as certain securities may be prepaid. However, for certain callable debt securities, the average yield is calculated to the earliest call date. (b) Substantially all of the Firm’s U.S. residential MBS and collateralized mortgage obligations are due in 10 years or more, based on contractual maturity. The estimated weighted-average life, which reflects anticipated future prepayments, is approximately 6 years for agency residential MBS, 4 years for agency residential collateralized mortgage obligations and 3 years for nonagency residential collateralized mortgage obligations.

Securities Financing Activiti_2

Securities Financing Activities (Tables)	12 Months Ended
	Dec. 31, 2021
Securities Financing Transactions Disclosures [Abstract]
Schedule of securities sold under repurchase agreements, netting & securities loaned	The table below summarizes the gross and net amounts of the Firm’s securities financing agreements, as of December 31, 2021 and 2020. When the Firm has obtained an appropriate legal opinion with respect to a master netting agreement with a counterparty and where other relevant netting criteria under U.S. GAAP are met, the Firm nets, on the Consolidated balance sheets, the balances outstanding under its securities financing agreements with the same counterparty. In addition, the Firm exchanges securities and/or cash collateral with its counterparty to reduce the economic exposure with the counterparty, but such collateral is not eligible for net Consolidated balance sheet presentation. Where the Firm has obtained an appropriate legal opinion with respect to the counterparty master netting agreement, such collateral, along with securities financing balances that do not meet all these relevant netting criteria under U.S. GAAP, is presented in the table below as “Amounts not nettable on the Consolidated balance sheets,” and reduces the “Net amounts” presented. Where a legal opinion has not been either sought or obtained, the securities financing balances are presented gross in the “Net amounts” below. In transactions where the Firm is acting as the lender in a securities-for-securities lending agreement and receives securities that can be pledged or sold as collateral, the Firm recognizes the securities received at fair value within other assets and the obligation to return those securities within accounts payable and other liabilities on the Consolidated balance sheets. 2021 December 31, (in millions) Gross amounts Amounts netted on the Consolidated balance sheets Amounts presented on the Consolidated balance sheets Amounts not nettable on the Consolidated balance sheets (b) Net amounts (c) Assets Securities purchased under resale agreements $ 604,724 $ (343,093) $ 261,631 $ (245,588) $ 16,043 Securities borrowed 250,333 (44,262) 206,071 (154,599) 51,472 Liabilities Securities sold under repurchase agreements $ 532,899 $ (343,093) $ 189,806 $ (166,456) $ 23,350 Securities loaned and other (a) 52,610 (44,262) 8,348 (8,133) 215 2020 December 31, (in millions) Gross amounts Amounts netted on the Consolidated balance sheets Amounts presented on the Consolidated balance sheets Amounts not nettable on the Consolidated balance sheets (b) Net amounts (c) Assets Securities purchased under resale agreements $ 666,467 $ (370,183) $ 296,284 $ (273,206) $ 23,078 Securities borrowed 193,700 (33,065) 160,635 (115,219) 45,416 Liabilities Securities sold under repurchase agreements $ 578,060 $ (370,183) $ 207,877 $ (191,980) $ 15,897 Securities loaned and other (a) 41,366 (33,065) 8,301 (8,257) 44 (a) Includes securities-for-securities lending agreements of $5.6 billion and $3.4 billion at December 31, 2021 and 2020, respectively, accounted for at fair value, where the Firm is acting as lender. (b) In some cases, collateral exchanged with a counterparty exceeds the net asset or liability balance with that counterparty. In such cases, the amounts reported in this column are limited to the related net asset or liability with that counterparty. (c) Includes securities financing agreements that provide collateral rights, but where an appropriate legal opinion with respect to the master netting agreement has not been either sought or obtained. At December 31, 2021 and 2020, included $13.9 billion and $17.0 billion, respectively, of securities purchased under resale agreements; $46.4 billion and $42.1 billion, respectively, of securities borrowed; $21.6 billion and $14.5 billion, respectively, of securities sold under repurchase agreements; and $198 million and $8 million, respectively, of securities loaned and other.
Schedule of types of assets pledged in secured financing transactions	The tables below present as of December 31, 2021 and 2020 the types of financial assets pledged in securities financing agreements and the remaining contractual maturity of the securities financing agreements. Gross liability balance 2021 2020 December 31, (in millions) Securities sold under repurchase agreements Securities loaned and other Securities sold under repurchase agreements Securities loaned and other Mortgage-backed securities: U.S. GSEs and government agencies $ 37,046 $ — $ 56,744 $ — Residential - nonagency 1,508 — 1,016 — Commercial - nonagency 1,463 — 855 — U.S. Treasury, GSEs and government agencies 241,578 358 315,834 143 Obligations of U.S. states and municipalities 1,916 7 1,525 2 Non-U.S. government debt 174,971 1,572 157,563 1,730 Corporate debt securities 38,180 1,619 22,849 1,864 Asset-backed securities 1,211 — 694 — Equity securities 35,026 49,054 20,980 37,627 Total $ 532,899 $ 52,610 $ 578,060 $ 41,366 Remaining contractual maturity of the agreements Overnight and continuous Greater than 2021 (in millions) Up to 30 days 30 – 90 days Total Total securities sold under repurchase agreements $ 195,035 $ 231,171 $ 47,201 $ 59,492 $ 532,899 Total securities loaned and other 50,034 1,701 — 875 52,610 Remaining contractual maturity of the agreements Overnight and continuous Greater than 2020 (in millions) Up to 30 days 30 – 90 days Total Total securities sold under repurchase agreements $ 238,667 $ 230,980 $ 70,777 $ 37,636 $ 578,060 Total securities loaned and other 37,887 1,647 500 1,332 41,366

Loans (Tables)

Loans (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Loan portfolio segment descriptions	The Firm’s loan portfolio is divided into three portfolio segments, which are the same segments used by the Firm to determine the allowance for loan losses: Consumer, excluding credit card; Credit card; and Wholesale. Within each portfolio segment the Firm monitors and assesses the credit risk in the following classes of loans, based on the risk characteristics of each loan class. Consumer, excluding credit card Credit card Wholesale (c)(d) • Residential real estate (a) • Auto and other (b) • Credit card loans • Secured by real estate • Commercial and industrial • Other (e) (a) Includes scored mortgage and home equity loans held in CCB and AWM, and scored mortgage loans held in CIB and Corporate. (b) Includes scored auto and business banking loans and overdrafts. (c) Includes loans held in CIB, CB, AWM, Corporate as well as risk-rated loans held in CCB, including business banking and auto dealer loans for which the wholesale methodology is applied when determining the allowance for loan losses. (d) The wholesale portfolio segment's classes align with loan classifications as defined by the bank regulatory agencies, based on the loan's collateral, purpose, and type of borrower. (e) Includes loans to financial institutions, states and political subdivisions, SPEs, nonprofits, personal investment companies and trusts, as well as loans to individuals and individual entities (predominantly Global Private Bank clients within AWM). Refer to Note 14 for more information on SPEs.
Schedule of loans by portfolio segment	The following tables summarize the Firm’s loan balances by portfolio segment. December 31, 2021 Consumer, excluding credit card Credit card Wholesale Total (a)(b) (in millions) Retained $ 295,556 $ 154,296 $ 560,354 $ 1,010,206 Held-for-sale 1,287 — 7,401 8,688 At fair value 26,463 — 32,357 58,820 Total $ 323,306 $ 154,296 $ 600,112 $ 1,077,714 December 31, 2020 Consumer, excluding credit card Credit card Wholesale Total (a)(b) (in millions) Retained $ 302,127 $ 143,432 $ 514,947 $ 960,506 Held-for-sale 1,305 784 5,784 7,873 At fair value 15,147 — 29,327 44,474 Total $ 318,579 $ 144,216 $ 550,058 $ 1,012,853 (a) Excludes $2.7 billion and $2.9 billion of accrued interest receivables at December 31, 2021 and 2020, respectively. The Firm wrote off accrued interest receivables of $56 million and $121 million for the years ended December 31, 2021 and 2020, respectively. (b) Loans (other than those for which the fair value option has been elected) are presented net of unamortized discounts and premiums and net deferred loan fees or costs. These amounts were not material as of December 31, 2021 and 2020. The following table provides information about retained consumer loans, excluding credit card, by class. December 31, (in millions) 2021 2020 Residential real estate $ 224,795 $ 225,302 Auto and other (a) 70,761 76,825 Total retained loans $ 295,556 $ 302,127
Schedule of retained loans purchased, sold and reclassified to held-for-sale	The following tables provide information about the carrying value of retained loans purchased, sold and reclassified to held-for-sale during the periods indicated. Loans that were reclassified to held-for-sale and sold in a subsequent period are excluded from the sales line of this table. 2021 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 515 (b)(c) $ — $ 1,122 $ 1,637 Sales 799 — 31,022 31,821 Retained loans reclassified to held-for-sale (a) 1,225 — 2,178 3,403 2020 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 3,474 (b)(c) $ — $ 1,159 $ 4,633 Sales 352 — 17,916 18,268 Retained loans reclassified to held-for-sale (a) 2,084 787 1,580 4,451 2019 Year ended December 31, Consumer, excluding Credit card Wholesale Total Purchases $ 1,282 (b)(c) $ — $ 1,291 $ 2,573 Sales 30,474 — 23,445 53,919 Retained loans reclassified to held-for-sale (a) 9,188 — 2,371 11,559 (a) Reclassifications of loans to held-for-sale are non-cash transactions. (b) Predominantly includes purchases of residential real estate loans, including the Firm’s voluntary repurchases of certain delinquent loans from loan pools as permitted by Government National Mortgage Association (“Ginnie Mae”) guidelines for the years ended December 31, 2021, 2020 and 2019. The Firm typically elects to repurchase these delinquent loans as it continues to service them and/or manage the foreclosure process in accordance with applicable requirements of Ginnie Mae, FHA, RHS, and/or VA. (c) Excludes purchases of retained loans of $25.8 billion, $16.3 billion and $16.6 billion for the years ended December 31, 2021, 2020 and 2019, respectively, which are predominantly sourced through the correspondent origination channel and underwritten in accordance with the Firm’s standards. The amount of purchases of retained loans at December 31, 2020 has been revised to conform with the current presentation.
Schedule of financing receivable credit quality indicators	The following tables provide information on delinquency, which is the primary credit quality indicator for retained residential real estate loans. (in millions, except ratios) December 31, 2021 Term loans by origination year (d) Revolving loans Total 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Loan delinquency (a)(b) Current $ 68,742 $ 48,334 $ 18,428 $ 7,929 $ 11,684 $ 49,147 $ 6,392 $ 11,807 $ 222,463 30–149 days past due 13 23 27 27 22 578 11 182 883 150 or more days past due — 11 21 25 33 1,069 6 284 1,449 Total retained loans $ 68,755 $ 48,368 $ 18,476 $ 7,981 $ 11,739 $ 50,794 $ 6,409 $ 12,273 $ 224,795 % of 30+ days past due to total retained loans (c) 0.02 % 0.07 % 0.26 % 0.65 % 0.47 % 3.18 % 0.27 % 3.80 % 1.02 % (in millions, except ratios) December 31, 2020 Term loans by origination year (d) Revolving loans Total 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Loan delinquency (a)(b) Current $ 56,576 (e) $ 31,820 $ 13,900 $ 20,410 $ 27,978 $ 49,218 (e) $ 7,902 (e) $ 15,260 (e) $ 223,064 30–149 days past due 9 25 20 22 29 674 21 245 1,045 150 or more days past due 3 14 10 18 18 844 22 264 1,193 Total retained loans $ 56,588 $ 31,859 $ 13,930 $ 20,450 $ 28,025 $ 50,736 $ 7,945 $ 15,769 $ 225,302 % of 30+ days past due to total retained loans (c) 0.02 % 0.12 % 0.22 % 0.20 % 0.17 % 2.91 % (e) 0.54 % (e) 3.23 % (e) 0.98 % (a) Individual delinquency classifications include mortgage loans insured by U.S. government agencies as follows: current included $35 million and $36 million; 30–149 days past due included $11 million and $16 million; and 150 or more days past due included $20 million and $24 million at December 31, 2021 and 2020, respectively. (b) At December 31, 2021 and 2020, loans under payment deferral programs offered in response to the COVID-19 pandemic which are still within their deferral period and performing according to their modified terms are generally not considered delinquent. (c) At December 31, 2021 and 2020, residential real estate loans excluded mortgage loans insured by U.S. government agencies of $31 million and $40 million, respectively, that are 30 or more days past due. These amounts have been excluded based upon the government guarantee. (d) Purchased loans are included in the year in which they were originated. (e) Prior-period amounts have been revised to conform with the current presentation. The following table provides information on nonaccrual and other credit quality indicators for retained residential real estate loans. (in millions, except weighted-average data) December 31, 2021 December 31, 2020 Nonaccrual loans (a)(b)(c)(d) $ 4,759 $ 5,313 90 or more days past due and government guaranteed (e) 24 33 Current estimated LTV ratios (f)(g)(h)(i) Greater than 125% and refreshed FICO scores: Equal to or greater than 660 $ 2 $ 6 Less than 660 2 12 101% to 125% and refreshed FICO scores: Equal to or greater than 660 37 38 Less than 660 15 44 80% to 100% and refreshed FICO scores: Equal to or greater than 660 2,701 2,177 Less than 660 89 239 Less than 80% and refreshed FICO scores: Equal to or greater than 660 209,295 208,238 Less than 660 9,658 11,980 No FICO/LTV available 2,930 2,492 U.S. government-guaranteed 66 76 Total retained loans $ 224,795 $ 225,302 Weighted average LTV ratio (f)(j) 50 % 54 % Weighted average FICO (g)(j) 765 763 Geographic region (k) California $ 71,383 $ 73,444 New York 32,545 32,287 Florida 16,182 13,981 Texas 13,865 13,773 Illinois 11,565 13,130 Colorado 8,885 8,235 Washington 8,292 7,917 New Jersey 6,832 7,227 Massachusetts 6,105 5,784 Connecticut 5,242 5,024 All other (l) 43,899 44,500 Total retained loans $ 224,795 $ 225,302 (a) Includes collateral-dependent residential real estate loans that are charged down to the fair value of the underlying collateral less costs to sell. The Firm reports, in accordance with regulatory guidance, residential real estate loans that have been discharged under Chapter 7 bankruptcy and not reaffirmed by the borrower (“Chapter 7 loans”) as collateral-dependent nonaccrual TDRs, regardless of their delinquency status. At December 31, 2021, approximately 7% of Chapter 7 residential real estate loans were 30 days or more past due. (b) Generally, all consumer nonaccrual loans have an allowance. In accordance with regulatory guidance, certain nonaccrual loans that are considered collateral-dependent have been charged down to the lower of amortized cost or the fair value of their underlying collateral less costs to sell. If the value of the underlying collateral improves subsequent to the charge down, the related allowance may be negative. (c) Interest income on nonaccrual loans recognized on a cash basis was $172 million and $161 million for the years ended December 31, 2021 and 2020, respectively. (d) Generally excludes loans under payment deferral programs offered in response to the COVID-19 pandemic. Includes loans to customers that have exited COVID-19 payment related deferral programs and are 90 or more days past due, predominantly all of which were considered collateral-dependent at time of exit. (e) These balances are excluded from nonaccrual loans as the loans are guaranteed by U.S government agencies. Typically the principal balance of the loans is insured and interest is guaranteed at a specified reimbursement rate subject to meeting agreed-upon servicing guidelines. At December 31, 2021 and 2020, these balances were no longer accruing interest based on the agreed-upon servicing guidelines. There were no loans that were not guaranteed by U.S. government agencies that are 90 or more days past due and still accruing interest at December 31, 2021 and 2020. (f) Represents the aggregate unpaid principal balance of loans divided by the estimated current property value. Current property values are estimated, at a minimum, quarterly, based on home valuation models using nationally recognized home price index valuation estimates incorporating actual data to the extent available and forecasted data where actual data is not available. Current estimated combined LTV for junior lien home equity loans considers all available lien positions, as well as unused lines, related to the property. (g) Refreshed FICO scores represent each borrower’s most recent credit score, which is obtained by the Firm on at least a quarterly basis. (h) At December 31, 2021 and 2020, included residential real estate loans, primarily held in LLCs in AWM that did not have a refreshed FICO score. These loans have been included in a FICO band based on management’s estimation of the borrower’s credit quality. (i) Prior-period amounts have been revised to conform with the current presentation. (j) Excludes loans with no FICO and/or LTV data available. (k) The geographic regions presented in the table are ordered based on the magnitude of the corresponding loan balances at December 31, 2021. (l) At December 31, 2021 and 2020, included mortgage loans insured by U.S. government agencies of $66 million and $76 million, respectively. These amounts have been excluded from the geographic regions presented based upon the government guarantee. The following tables provide information on delinquency, which is the primary credit quality indicator for retained auto and other consumer loans. December 31, 2021 (in millions, except ratios) Term loans by origination year Revolving loans 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Total Loan delinquency (a) Current $ 35,323 (c) $ 18,324 (c) $ 7,443 $ 3,671 $ 1,800 $ 666 $ 2,242 $ 120 $ 69,589 30–119 days past due 192 720 88 53 31 21 12 6 1,123 120 or more days past due — 35 — — 1 1 5 7 49 Total retained loans $ 35,515 $ 19,079 $ 7,531 $ 3,724 $ 1,832 $ 688 $ 2,259 $ 133 $ 70,761 % of 30+ days past due to total retained loans (b) 0.54 % 0.47 % 1.17 % 1.42 % 1.75 % 3.20 % 0.75 % 9.77 % 1.66 % December 31, 2020 (in millions, except ratios) Term loans by origination year Revolving loans 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Total Loan delinquency (a) Current $ 46,169 (d) $ 12,829 $ 7,367 $ 4,521 $ 2,058 $ 742 $ 2,517 $ 158 $ 76,361 30–119 days past due 97 107 77 53 42 23 30 17 446 120 or more days past due — — — 1 — 1 8 8 18 Total retained loans $ 46,266 $ 12,936 $ 7,444 $ 4,575 $ 2,100 $ 766 $ 2,555 $ 183 $ 76,825 % of 30+ days past due to total retained loans 0.21 % 0.83 % 1.03 % 1.18 % 2.00 % 3.13 % 1.49 % 13.66 % 0.60 % (a) At December 31, 2021 and 2020, loans under payment deferral programs offered in response to the COVID-19 pandemic which are still within their deferral period and performing according to their modified terms are generally not considered delinquent. (b) At December 31, 2021, auto and other loans excluded $667 million of PPP loans guaranteed by the SBA that are 30 or more days past due. These amounts have been excluded based upon the SBA guarantee. At December 31, 2020, all PPP loans guaranteed by the SBA were current. (c) At December 31, 2021, included $4.4 billion of loans originated in 2021 and $1.0 billion of loans originated in 2020 in Business Banking under the PPP. PPP loans are guaranteed by the SBA. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs, classify as nonaccrual nor record an allowance for loan losses on these loans. (d) At December 31, 2020, included $19.2 billion of loans in Business Banking under the PPP. The following table provides information on nonaccrual and other credit quality indicators for retained auto and other consumer loans. (in millions, except ratios) Total Auto and other December 31, 2021 December 31, 2020 Nonaccrual loans (a)(b)(c) 119 151 Geographic region (d) California $ 11,163 $ 12,302 Texas 7,859 8,235 New York 5,848 8,824 Florida 4,901 4,668 Illinois 2,930 3,768 New Jersey 2,355 2,646 Pennsylvania 2,004 1,924 Arizona 1,887 2,465 Ohio 1,843 2,163 Louisiana 1,801 1,808 All other 28,170 28,022 Total retained loans $ 70,761 $ 76,825 (a) At December 31, 2021, nonaccrual loans excluded $506 million of PPP loans 90 or more days past due and guaranteed by the SBA, of which $35 million is no longer accruing interest based on the guidelines set by the SBA. Typically the principal balance of the loans is insured and interest is guaranteed at a specified reimbursement rate subject to meeting the guidelines set by the SBA. There were no loans that were not guaranteed by the SBA that are 90 or more days past due and still accruing interest at December 31, 2021 and 2020. (b) Generally, all consumer nonaccrual loans have an allowance. In accordance with regulatory guidance, certain nonaccrual loans that are considered collateral-dependent have been charged down to the lower of amortized cost or the fair value of their underlying collateral less costs to sell. If the value of the underlying collateral improves subsequent to the charge down, the related allowance may be negative. (c) Interest income on nonaccrual loans recognized on a cash basis was not material for the years ended December 31, 2021 and 2020. (d) The geographic regions presented in this table are ordered based on the magnitude of the corresponding loan balances at December 31, 2021. The following tables provide information on delinquency, which is the primary credit quality indicator for retained credit card loans. (in millions, except ratios) December 31, 2021 Within the revolving period Converted to term loans (b) Total Loan delinquency (a) Current and less than 30 days past due $ 151,798 $ 901 $ 152,699 30–89 days past due and still accruing 770 59 829 90 or more days past due and still accruing 741 27 768 Total retained loans $ 153,309 $ 987 $ 154,296 Loan delinquency ratios % of 30+ days past due to total retained loans 0.99 % 8.71 % 1.04 % % of 90+ days past due to total retained loans 0.48 2.74 0.50 (in millions, except ratios) December 31, 2020 Within the revolving period Converted to term loans (b) Total Loan delinquency (a) Current and less than 30 days past due $ 139,783 $ 1,239 $ 141,022 30–89 days past due and still accruing 997 94 1,091 90 or more days past due and still accruing 1,277 42 1,319 Total retained loans $ 142,057 $ 1,375 $ 143,432 Loan delinquency ratios % of 30+ days past due to total retained loans 1.60 % 9.89 % 1.68 % % of 90+ days past due to total retained loans 0.90 3.05 0.92 (a) At December 31, 2021 and 2020, loans under payment deferral programs offered in response to the COVID-19 pandemic which are still within their deferral period and performing according to their modified terms are generally not considered delinquent. (b) Represents TDRs. The following table provides information on other credit quality indicators for retained credit card loans. (in millions, except ratios) December 31, 2021 December 31, 2020 Geographic region (a) California $ 23,030 $ 20,921 Texas 15,879 14,544 New York 12,652 11,919 Florida 10,412 9,562 Illinois 8,530 8,006 New Jersey 6,367 5,927 Ohio 4,923 4,673 Pennsylvania 4,708 4,476 Colorado 4,573 4,092 Michigan 3,773 3,553 All other 59,449 55,759 Total retained loans $ 154,296 $ 143,432 Percentage of portfolio based on carrying value with estimated refreshed FICO scores Equal to or greater than 660 88.5 % 85.9 % Less than 660 11.3 13.9 No FICO available 0.2 0.2 (a) The geographic regions presented in the table are ordered based on the magnitude of the corresponding loan balances at December 31, 2021. The following tables provide information on internal risk rating, which is the primary credit quality indicator for retained wholesale loans. December 31, Secured by real estate Commercial and industrial Other (b) Total retained loans 2021 2020 2021 2020 2021 2020 2021 2020 Loans by risk ratings Investment-grade $ 92,369 $ 90,147 $ 75,783 $ 71,917 $ 241,859 $ 217,209 $ 410,011 $ 379,273 Noninvestment- grade: Noncriticized 22,495 26,129 62,039 57,870 52,440 33,053 136,974 117,052 Criticized performing 3,645 3,234 6,900 10,991 770 1,079 11,315 15,304 Criticized nonaccrual (a) 326 483 969 1,931 759 904 2,054 3,318 Total noninvestment- grade 26,466 29,846 69,908 70,792 53,969 35,036 150,343 135,674 Total retained loans $ 118,835 $ 119,993 $ 145,691 $ 142,709 $ 295,828 $ 252,245 $ 560,354 $ 514,947 % of investment-grade to total retained loans 77.73 % 75.13 % 52.02 % 50.39 % 81.76 % 86.11 % 73.17 % 73.65 % % of total criticized to total retained loans 3.34 3.10 5.40 9.05 0.52 0.79 2.39 3.62 % of criticized nonaccrual to total retained loans 0.27 0.40 0.67 1.35 0.26 0.36 0.37 0.64 (a) At December 31, 2021, nonaccrual loans excluded $127 million of PPP loans 90 or more days past due and guaranteed by the SBA, predominantly in commercial and industrial. (b) Includes loans to financial institutions, states and political subdivisions, SPEs, nonprofits, personal investment companies and trusts, as well as loans to individuals and individual entities (predominantly Global Private Bank clients within AWM). Refer to Note 14 for more information on SPEs. Secured by real estate (in millions) December 31, 2021 Term loans by origination year Revolving loans 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 23,346 $ 16,030 $ 17,265 $ 8,103 $ 7,325 $ 19,066 $ 1,226 $ 8 $ 92,369 Noninvestment-grade 5,364 3,826 4,564 3,806 2,834 5,613 458 1 26,466 Total retained loans $ 28,710 $ 19,856 $ 21,829 $ 11,909 $ 10,159 $ 24,679 $ 1,684 $ 9 $ 118,835 Secured by real estate (in millions) December 31, 2020 Term loans by origination year (a) Revolving loans 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 17,004 $ 19,870 $ 12,448 $ 11,218 $ 13,611 $ 14,898 $ 1,098 $ — $ 90,147 Noninvestment-grade 4,998 6,027 5,886 4,184 3,738 4,523 489 1 29,846 Total retained loans $ 22,002 $ 25,897 $ 18,334 $ 15,402 $ 17,349 $ 19,421 $ 1,587 $ 1 $ 119,993 (a) Prior-period amounts have been revised to conform with the current presentation. Commercial and industrial (in millions) December 31, 2021 Term loans by origination year Revolving loans 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 21,342 $ 6,268 $ 3,609 $ 1,269 $ 1,108 $ 819 $ 41,367 $ 1 $ 75,783 (a) Noninvestment-grade 19,314 7,112 4,559 2,177 930 430 35,312 74 69,908 Total retained loans $ 40,656 $ 13,380 $ 8,168 $ 3,446 $ 2,038 $ 1,249 $ 76,679 $ 75 $ 145,691 Commercial and industrial (in millions) December 31, 2020 Term loans by origination year (b) Revolving loans 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 21,233 $ 7,341 $ 2,950 $ 1,756 $ 1,034 $ 1,178 $ 36,424 $ 1 $ 71,917 (c) Noninvestment-grade 15,488 9,189 5,470 2,323 611 786 36,852 73 70,792 Total retained loans $ 36,721 $ 16,530 $ 8,420 $ 4,079 $ 1,645 $ 1,964 $ 73,276 $ 74 $ 142,709 (a) At December 31, 2021, $1.1 billion of the $1.3 billion total PPP loans in the wholesale portfolio were commercial and industrial. Of the $1.1 billion, $698 million were originated in 2021 and $396 million were originated in 2020. PPP loans are guaranteed by the SBA and considered investment-grade. Other than in certain limited circumstances, the Firm typically does not recognize charge-offs, classify as nonaccrual nor record an allowance for loan losses on these loans. (b) Prior-period amounts have been revised to conform with the current presentation. (c) At December 31, 2020, $7.4 billion of the $8.0 billion total PPP loans in the wholesale portfolio were commercial and industrial. Other (a) (in millions) December 31, 2021 Term loans by origination year Revolving loans 2021 2020 2019 2018 2017 Prior to 2017 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 26,782 $ 17,829 $ 6,125 $ 2,885 $ 3,868 $ 7,651 $ 176,118 $ 601 $ 241,859 Noninvestment-grade 16,905 2,399 1,455 935 218 467 31,585 5 53,969 Total retained loans $ 43,687 $ 20,228 $ 7,580 $ 3,820 $ 4,086 $ 8,118 $ 207,703 $ 606 $ 295,828 Other (a) (in millions) December 31, 2020 Term loans by origination year (b) Revolving loans 2020 2019 2018 2017 2016 Prior to 2016 Within the revolving period Converted to term loans Total Loans by risk ratings Investment-grade $ 33,190 $ 11,116 $ 7,455 $ 6,804 $ 4,089 $ 8,252 $ 145,524 $ 779 $ 217,209 Noninvestment-grade 5,048 2,231 1,660 553 175 535 24,710 124 35,036 Total retained loans $ 38,238 $ 13,347 $ 9,115 $ 7,357 $ 4,264 $ 8,787 $ 170,234 $ 903 $ 252,245 (a) Includes loans to financial institutions, states and political subdivisions, SPEs, nonprofits, personal investment companies and trusts, as well as loans to individuals and individual entities (predominantly Global Private Bank clients within AWM). Refer to Note 14 for more information on SPEs. (b) Prior-period amounts have been revised to conform with the current presentation. The following table presents additional information on retained loans secured by real estate within the Wholesale portfolio, which consists of loans secured wholly or substantially by a lien or liens on real property at origination. Multifamily lending includes financing for acquisition, leasing and construction of apartment buildings. Other commercial lending largely includes financing for acquisition, leasing and construction, largely for office, retail and industrial real estate. Included in secured by real estate loans is $5.7 billion and $6.4 billion as of December 31, 2021 and 2020, respectively, of construction and development loans made to finance land development and on-site construction of commercial, industrial, residential, or farm buildings . December 31, Multifamily Other Commercial Total retained loans secured by real estate 2021 2020 2021 2020 2021 2020 Retained loans secured by real estate $ 73,801 $ 73,078 $ 45,034 $ 46,915 $ 118,835 $ 119,993 Criticized 1,671 1,144 2,300 2,573 3,971 3,717 % of total criticized to total retained loans secured by real estate 2.26 % 1.57 % 5.11 % 5.48 % 3.34 % 3.10 % Criticized nonaccrual $ 91 $ 56 $ 235 $ 427 $ 326 $ 483 % of criticized nonaccrual loans to total retained loans secured by real estate 0.12 % 0.08 % 0.52 % 0.91 % 0.27 % 0.40 % Geographic distribution and delinquency The following table provides information on the geographic distribution and delinquency for retained wholesale loans. Secured by real estate Commercial Other Total December 31, 2021 2020 2021 2020 2021 2020 2021 2020 Loans by geographic distribution (a) Total U.S. $ 115,732 $ 116,990 $ 106,449 $ 109,273 $ 215,750 $ 180,583 $ 437,931 $ 406,846 Total non-U.S. 3,103 3,003 39,242 33,436 80,078 71,662 122,423 108,101 Total retained loans $ 118,835 $ 119,993 $ 145,691 $ 142,709 $ 295,828 $ 252,245 $ 560,354 $ 514,947 Loan delinquency (b) Current and less than 30 days past due and still accruing $ 118,163 $ 118,894 $ 143,459 $ 140,100 $ 293,358 $ 249,713 $ 554,980 $ 508,707 30–89 days past due and still accruing 331 601 1,193 658 1,590 1,606 3,114 2,865 90 or more days past due and still accruing (c) 15 15 70 20 121 22 206 57 Criticized nonaccrual (d) 326 483 969 1,931 759 904 2,054 3,318 Total retained loans $ 118,835 $ 119,993 $ 145,691 $ 142,709 $ 295,828 $ 252,245 $ 560,354 $ 514,947 (a) The U.S. and non-U.S. distribution is determined based predominantly on the domicile of the borrower. (b) At December 31, 2021 and December 31, 2020, loans under payment deferral programs offered in response to the COVID-19 pandemic which are still within their deferral period and performing according to their modified terms are generally not considered delinquent. The credit quality of wholesale loans is assessed primarily through ongoing review and monitoring of an obligor’s ability to meet contractual obligations rather than relying on the past due status, which is generally a lagging indicator of credit quality. (c) Represents loans that are considered well-collateralized and therefore still accruing interest. (d) At December 31, 2021, nonaccrual loans excluded $127 million of PPP loans 90 or more days past due and guaranteed by the SBA, predominantly in commercial and industrial.
Troubled debt restructuring on financing receivables nature and extent of modifications	The following table provides information about how residential real estate loans were modified in TDRs under the Firm’s loss mitigation programs described above during the periods presented. This table excludes Chapter 7 loans where the sole concession granted is the discharge of debt, loans with short-term or other insignificant modifications that are not considered concessions, and loans for which the Firm has elected to suspend TDR accounting guidance under the option provided by the CARES Act. Year ended December 31, 2021 2020 2019 Number of loans approved for a trial modification 6,246 5,522 5,872 Number of loans permanently modified 4,588 6,850 4,918 Concession granted: (a) Interest rate reduction 74 % 50 % 77 % Term or payment extension 53 49 71 Principal and/or interest deferred 23 14 13 Principal forgiveness 2 2 5 Other (b) 36 66 63 (a) Represents concessions granted in permanent modifications as a percentage of the number of loans permanently modified. The sum of the percentages exceeds 100% because predominantly all of the modifications include more than one type of concession. Concessions offered on trial modifications are generally consistent with those granted on permanent modifications.
Troubled debt restructuring on financing receivables, financial effects of modifications and re-defaults	The following table provides information about the financial effects of the various concessions granted in modifications of residential real estate loans under the loss mitigation programs described above and about redefaults of certain loans modified in TDRs for the periods presented. The following table presents only the financial effects of permanent modifications and do not include temporary concessions offered through trial modifications. This table also excludes Chapter 7 loans where the sole concession granted is the discharge of debt, loans with short-term or other insignificant modifications that are not considered concessions, and loans for which the Firm has elected to suspend TDR accounting guidance under the option provided by the CARES Act. Year ended December 31, 2021 2020 2019 Weighted-average interest rate of loans with interest rate reductions – before TDR 4.54 % 5.09 % 5.68 % Weighted-average interest rate of loans with interest rate reductions – after TDR 2.92 3.28 3.81 Weighted-average remaining contractual term (in years) of loans with term or payment extensions – before TDR 23 22 20 Weighted-average remaining contractual term (in years) of loans with term or payment extensions – after TDR 38 39 39 Charge-offs recognized upon permanent modification $ — $ 5 $ 1 Principal deferred 28 16 19 Principal forgiven 1 5 7 Balance of loans that redefaulted within one year of permanent modification (a) $ 160 $ 199 $ 166 (a) Represents loans permanently modified in TDRs that experienced a payment default in the periods presented, and for which the payment default occurred within one year of the modification. The dollar amounts presented represent the balance of such loans at the end of the reporting period in which such loans defaulted. For residential real estate loans modified in TDRs, payment default is deemed to occur when the loan becomes two contractual payments past due. In the event that a modified loan redefaults, it will generally be liquidated through foreclosure or another similar type of liquidation transaction. Redefaults of loans modified within the last twelve months may not be representative of ultimate redefault levels. The following table provides information about the financial effects of the concessions granted on credit card loans modified in TDRs and redefaults for the periods presented. For all periods disclosed, new enrollments were less than 1% of total retained credit card loans. Year ended December 31, 2021 2020 2019 Balance of new TDRs (a) $ 393 $ 818 $ 961 Weighted-average interest rate of loans – before TDR 17.75 % 18.04 % 19.07 % Weighted-average interest rate of loans – after TDR 5.14 4.64 4.70 Balance of loans that redefaulted within one year of modification (b) $ 57 $ 110 $ 148 (a) Represents the outstanding balance prior to modification. (b) Represents loans modified in TDRs that experienced a payment default in the periods presented, and for which the payment default occurred within one year of the modification. The amounts presented represent the balance of such loans as of the end of the quarter in which they defaulted.
Schedule of nonaccrual loans	The following table provides information on retained wholesale nonaccrual loans. December 31, Secured by real estate Commercial Other Total 2021 2020 2021 2020 2021 2020 2021 2020 Nonaccrual loans (a) With an allowance $ 254 $ 351 $ 604 $ 1,667 $ 286 $ 800 $ 1,144 $ 2,818 Without an allowance (b) 72 132 365 264 473 104 910 500 Total nonaccrual loans (c) $ 326 $ 483 $ 969 $ 1,931 $ 759 $ 904 $ 2,054 $ 3,318 (a) Loans that were modified in response to the COVID-19 pandemic continue to be risk-rated in accordance with the Firm’s overall credit risk management framework. As of December 31, 2021, substantially all of these loans were considered performing. (b) When the discounted cash flows or collateral value equals or exceeds the amortized cost of the loan, the loan does not require an allowance. This typically occurs when the loans have been partially charged off and/or there have been interest payments received and applied to the loan balance. (c) Interest income on nonaccrual loans recognized on a cash basis were not material for the years ended December 31, 2021 and 2020.

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	12 Months Ended
	Dec. 31, 2021
Credit Loss [Abstract]
Allowance for credit losses on financing receivables	The table below summarizes information about the allowances for credit losses, and includes a breakdown of loans and lending-related commitments by impairment methodology. Refer to Note 10 for further information on the allowance for credit losses on investment securities. (Table continued on next page) 2021 Year ended December 31, Consumer, Credit card Wholesale Total Allowance for loan losses Beginning balance at January 1, $ 3,636 $ 17,800 $ 6,892 $ 28,328 Cumulative effect of a change in accounting principle (a) NA NA NA NA Gross charge-offs 630 3,651 283 4,564 Gross recoveries collected (619) (939) (141) (1,699) Net charge-offs 11 2,712 142 2,865 Write-offs of PCI loans (b) NA NA NA NA Provision for loan losses (1,858) (4,838) (2,375) (9,071) Other (2) — (4) (6) Ending balance at December 31, $ 1,765 $ 10,250 $ 4,371 $ 16,386 Allowance for lending-related commitments Beginning balance at January 1, $ 187 $ — $ 2,222 $ 2,409 Cumulative effect of a change in accounting principle (a) NA NA NA NA Provision for lending-related commitments (75) — (74) (149) Other 1 — — 1 Ending balance at December 31, $ 113 $ — $ 2,148 $ 2,261 Total allowance for investment securities NA NA NA $ 42 Total allowance for credit losses $ 1,878 $ 10,250 $ 6,519 $ 18,689 Allowance for loan losses by impairment methodology Asset-specific (c) $ (665) $ 313 $ 263 $ (89) Portfolio-based 2,430 9,937 4,108 16,475 PCI NA NA NA NA Total allowance for loan losses $ 1,765 $ 10,250 $ 4,371 $ 16,386 Loans by impairment methodology Asset-specific (c) $ 13,919 $ 987 $ 2,255 $ 17,161 Portfolio-based 281,637 153,309 558,099 993,045 PCI NA NA NA NA Total retained loans $ 295,556 $ 154,296 $ 560,354 $ 1,010,206 Collateral-dependent loans Net charge-offs $ 33 $ — $ 38 $ 71 Loans measured at fair value of collateral less cost to sell 4,472 — 617 5,089 Allowance for lending-related commitments by impairment methodology Asset-specific $ — $ — $ 167 $ 167 Portfolio-based 113 — 1,981 2,094 Total allowance for lending-related commitments (d) $ 113 $ — $ 2,148 $ 2,261 Lending-related commitments by impairment methodology Asset-specific $ — $ — $ 764 $ 764 Portfolio-based (e) 29,588 — 453,571 483,159 Total lending-related commitments $ 29,588 $ — $ 454,335 $ 483,923 (a) Represents the impact to allowance for credit losses upon the adoption of CECL on January 1, 2020. Refer to Note 1 for further information. (b) Prior to the adoption of CECL, write-offs of PCI loans were recorded against the allowance for loan losses when actual losses for a pool exceeded estimated losses that were recorded as purchase accounting adjustments at the time of acquisition. A write-off of a PCI loan was recognized when the underlying loan was removed from a pool. (c) Includes collateral dependent loans, including those considered TDRs and those for which foreclosure is deemed probable, modified PCD loans and non-collateral dependent loans that have been modified or are reasonably expected to be modified in a TDR. Also includes risk-rated loans that have been placed on nonaccrual status for the wholesale portfolio segment. The asset-specific credit card allowance for loans modified, or reasonably expected to be modified, in a TDR is calculated based on the loans’ original contractual interest rates and does not consider any incremental penalty rates. (d) The allowance for lending-related commitments is reported in accounts payable and other liabilities on the Consolidated balance sheets. (e) At December 31, 2021, 2020 and 2019, lending-related commitments excluded $15.7 billion, $19.5 billion and $9.8 billion, respectively, for the consumer, excluding credit card portfolio segment; $730.5 billion, $658.5 billion and $650.7 billion, respectively, for the credit card portfolio segment; and $32.1 billion, $25.3 billion and $24.1 billion, respectively, for the wholesale portfolio segment, which were not subject to the allowance for lending-related commitments. Prior-period amount for wholesale lending-related commitments, including the amount not subject to allowance, has been revised to conform with the current presentation. (table continued from previous page) 2020 2019 Consumer, Credit card Wholesale Total Consumer, Credit card Wholesale Total $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 3,434 $ 5,184 $ 4,827 $ 13,445 297 5,517 (1,642) 4,172 NA NA NA NA 805 5,077 954 6,836 902 5,436 472 6,810 (631) (791) (155) (1,577) (536) (588) (57) (1,181) 174 4,286 799 5,259 366 4,848 415 5,629 NA NA NA NA 151 — — 151 974 10,886 4,431 16,291 (378) 5,348 479 5,449 1 — — 1 (1) (1) 11 9 $ 3,636 $ 17,800 $ 6,892 $ 28,328 $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 12 $ — $ 1,179 $ 1,191 $ 12 $ — $ 1,043 $ 1,055 133 — (35) 98 NA NA NA NA 42 — 1,079 1,121 — — 136 136 — — (1) (1) — — — — $ 187 $ — $ 2,222 $ 2,409 $ 12 $ — $ 1,179 $ 1,191 NA NA NA $ 78 NA NA NA NA $ 3,823 $ 17,800 $ 9,114 $ 30,815 $ 2,550 $ 5,683 $ 6,081 $ 14,314 $ (7) $ 633 $ 682 $ 1,308 $ 75 $ 477 $ 295 $ 847 3,643 17,167 6,210 27,020 1,476 5,206 4,607 11,289 NA NA NA NA 987 — — 987 $ 3,636 $ 17,800 $ 6,892 $ 28,328 $ 2,538 $ 5,683 $ 4,902 $ 13,123 $ 16,648 $ 1,375 $ 3,606 $ 21,629 $ 5,961 $ 1,452 $ 1,123 $ 8,536 285,479 142,057 511,341 938,877 268,675 167,472 480,555 916,702 NA NA NA NA 20,363 — — 20,363 $ 302,127 $ 143,432 $ 514,947 $ 960,506 $ 294,999 $ 168,924 $ 481,678 $ 945,601 $ 133 $ — $ 76 $ 209 $ 46 $ — $ 36 $ 82 4,956 — 188 5,144 2,053 — 87 2,140 $ — $ — $ 114 $ 114 $ — $ — $ 102 $ 102 187 — 2,108 2,295 12 — 1,077 1,089 $ 187 $ — $ 2,222 $ 2,409 $ 12 $ — $ 1,179 $ 1,191 $ — $ — $ 577 $ 577 $ — $ — $ 474 $ 474 37,783 — 423,993 461,776 30,417 — 392,967 423,384 $ 37,783 $ — $ 424,570 $ 462,353 $ 30,417 $ — $ 393,441 $ 423,858
U.S. unemployment rates and cumulative change in U.S. real GDP	The Firm’s central case assumptions reflected U.S. unemployment rates and year over year growth in U.S. real GDP as follows: Assumptions at December 31, 2021 2Q22 4Q22 2Q23 U.S. unemployment rate (a) 4.2 % 4.0 % 3.9 % YoY growth in U.S. real GDP (b) 3.1 % 2.8 % 2.1 % Assumptions at December 31, 2020 2Q21 4Q21 2Q22 U.S. unemployment rate (a) 6.8 % 5.7 % 5.1 % YoY growth in U.S. real GDP (b) 9.2 % 3.5 % 3.9 % (a) Reflects quarterly average of forecasted U.S. unemployment rate. (b) As of December 31, 2021, the year over year growth in U.S. real GDP in the forecast horizon of the central scenario is calculated as the percent change in U.S. real GDP levels from the prior year. This year over year growth rate replaces the previously disclosed pandemic-focused measure of the cumulative change in U.S. real GDP from pre-pandemic conditions at December 31, 2019. Prior periods have been revised to conform with the current presentation.

Variable Interest Entities (Tab

Variable Interest Entities (Tables)	12 Months Ended
	Dec. 31, 2021
Variable Interest Entities [Abstract]
Schedule of significant types of variable interest entities by business segment	The following table summarizes the most significant types of Firm-sponsored VIEs by business segment. The Firm considers a “Firm-sponsored” VIE to include any entity where: (1) JPMorgan Chase is the primary beneficiary of the structure; (2) the VIE is used by JPMorgan Chase to securitize Firm assets; (3) the VIE issues financial instruments with the JPMorgan Chase name; or (4) the entity is a JPMorgan Chase–administered asset-backed commercial paper conduit. Line of Business Transaction Type Activity 2021 Form 10-K CCB Credit card securitization trusts Securitization of originated credit card receivables 253-254 Mortgage securitization trusts Servicing and securitization of both originated and purchased residential mortgages 254-256 CIB Mortgage and other securitization trusts Securitization of both originated and purchased residential and commercial mortgages, and other consumer loans 254-256 Multi-seller conduits Assisting clients in accessing the financial markets in a cost-efficient manner and structuring transactions to meet investor needs 256 Municipal bond vehicles Financing of municipal bond investments 256-257
Firm-sponsored mortgage and other consumer securitization trusts	The following tables present the total unpaid principal amount of assets held in Firm-sponsored private-label securitization entities, including those in which the Firm has continuing involvement, and those that are consolidated by the Firm. Continuing involvement includes servicing the loans, holding senior interests or subordinated interests (including amounts required to be held pursuant to credit risk retention rules), recourse or guarantee arrangements, and derivative contracts. In certain instances, the Firm’s only continuing involvement is servicing the loans. The Firm’s maximum loss exposure from retained and purchased interests is the carrying value of these interests. Principal amount outstanding JPMorgan Chase interest in securitized assets in nonconsolidated VIEs (c)(d)(e) December 31, 2021 Total assets held by securitization VIEs Assets Assets held in nonconsolidated securitization VIEs with continuing involvement Trading assets Investment securities Other financial assets Total interests held by JPMorgan Chase Securitization-related (a) Residential mortgage: Prime/Alt-A and option ARMs $ 55,085 $ 942 $ 47,029 $ 974 $ 684 $ 95 $ 1,753 Subprime 10,966 27 10,115 2 — — 2 Commercial and other (b) 150,694 — 93,698 671 3,274 506 4,451 Total $ 216,745 $ 969 $ 150,842 $ 1,647 $ 3,958 $ 601 $ 6,206 Principal amount outstanding JPMorgan Chase interest in securitized assets in nonconsolidated VIEs (c)(d)(e) December 31, 2020 Total assets held by securitization VIEs Assets Assets held in nonconsolidated securitization VIEs with continuing involvement Trading assets Investment securities Other financial assets Total interests held by JPMorgan Chase Securitization-related (a) Residential mortgage: Prime/Alt-A and option ARMs $ 49,644 $ 1,693 $ 41,265 $ 574 $ 724 $ — $ 1,298 Subprime 12,896 46 12,154 9 — — 9 Commercial and other (b) 119,732 — 92,351 955 1,549 262 2,766 Total $ 182,272 $ 1,739 $ 145,770 $ 1,538 $ 2,273 $ 262 $ 4,073 (a) Excludes U.S. GSEs and government agency securitizations and re-securitizations, which are not Firm-sponsored. (b) Consists of securities backed by commercial real estate loans and non-mortgage-related consumer receivables purchased from third parties. (c) Excludes the following: retained servicing; securities retained from loan sales and securitization activity related to U.S. GSEs and government agencies; interest rate and foreign exchange derivatives primarily used to manage interest rate and foreign exchange risks of securitization entities; senior and subordinated securities of $145 million and $36 million, respectively, at December 31, 2021, and $105 million and $40 million, respectively, at December 31, 2020, which the Firm purchased in connection with CIB’s secondary market-making activities. (d) Includes interests held in re-securitization transactions. (e) As of December 31, 2021 and 2020, 79% and 73%, respectively, of the Firm’s retained securitization interests, which are predominantly carried at fair value and include amounts required to be held pursuant to credit risk retention rules, were risk-rated “A” or better, on an S&P-equivalent basis. The retained interests in prime residential mortgages consisted of $1.6 billion and $1.3 billion of investment-grade retained interests, and $131 million and $41 million of noninvestment-grade retained interests at December 31, 2021 and 2020, respectively. The retained interests in commercial and other securitization trusts consisted of $3.5 billion and $2.0 billion of investment-grade retained interests, and $929 million and $753 million of noninvestment-grade retained interests at December 31, 2021 and 2020, respectively.
Schedule of re-securitizations	The following table presents the principal amount of securities transferred to re-securitization VIEs. Year ended December 31, 2021 2020 2019 Transfers of securities to VIEs U.S. GSEs and government agencies $ 53,923 $ 46,123 $ 25,852 The following table presents information on the Firm's interests in nonconsolidated re-securitization VIEs. Nonconsolidated December 31, 2021 2020 U.S. GSEs and government agencies Interest in VIEs $ 1,947 $ 2,631
Information on assets and liabilities related to VIEs that are consolidated by the Firm	The following table presents information on assets and liabilities related to VIEs consolidated by the Firm as of December 31, 2021 and 2020. Assets Liabilities December 31, 2021 Trading assets Loans Other (c) Total assets (d) Beneficial interests in VIE assets (e) Other (f) Total VIE program type Firm-sponsored credit card trusts $ — $ 11,108 $ 102 $ 11,210 $ 2,397 $ 1 $ 2,398 Firm-administered multi-seller conduits 1 19,883 71 19,955 6,198 41 6,239 Municipal bond vehicles 2,009 — 2 2,011 1,976 — 1,976 Mortgage securitization entities (a) — 955 32 987 179 85 264 Other — 1,078 (b) 283 1,361 — 118 118 Total $ 2,010 $ 33,024 $ 490 $ 35,524 $ 10,750 $ 245 $ 10,995 Assets Liabilities December 31, 2020 Trading assets Loans Other (c) Total assets (d) Beneficial interests in VIE assets (e) Other (f) Total VIE program type Firm-sponsored credit card trusts $ — $ 11,962 $ 148 $ 12,110 $ 4,943 $ 3 $ 4,946 Firm-administered multi-seller conduits 2 23,787 188 23,977 10,523 33 10,556 Municipal bond vehicles 1,930 — 2 1,932 1,902 — 1,902 Mortgage securitization entities (a) — 1,694 94 1,788 210 108 318 Other 2 176 249 427 — 89 89 Total $ 1,934 $ 37,619 $ 681 $ 40,234 $ 17,578 $ 233 $ 17,811 (a) Includes residential and commercial mortgage securitizations. (b) Largely includes purchased supply chain finance receivables and purchased auto loan securitizations in CIB. (c) Includes assets classified as cash and other assets on the Consolidated balance sheets. (d) The assets of the consolidated VIEs included in the program types above are used to settle the liabilities of those entities. The assets and liabilities include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. (e) The interest-bearing beneficial interest liabilities issued by consolidated VIEs are classified in the line item on the Consolidated balance sheets titled, “Beneficial interests issued by consolidated variable interest entities.” The holders of these beneficial interests generally do not have recourse to the general credit of JPMorgan Chase. Included in beneficial interests in VIE assets are long-term beneficial interests of $2.6 billion and $5.2 billion at December 31, 2021 and 2020, respectively. (f) Includes liabilities classified as accounts payable and other liabilities on the Consolidated balance sheets.
Securitization activities	The following table provides information related to the Firm’s securitization activities for the years ended December 31, 2021, 2020 and 2019, related to assets held in Firm-sponsored securitization entities that were not consolidated by the Firm, and where sale accounting was achieved at the time of the securitization. 2021 2020 2019 Year ended December 31, Residential mortgage (d) Commercial and other (e) Residential mortgage (d) Commercial and other (e) Residential mortgage (d) Commercial and other (e) Principal securitized $ 23,876 $ 14,917 $ 7,103 $ 6,624 $ 9,957 $ 9,390 All cash flows during the period: (a) Proceeds received from loan sales as financial instruments (b)(c) $ 24,450 $ 15,044 $ 7,321 $ 6,865 $ 10,238 $ 9,544 Servicing fees collected 153 1 211 1 287 2 Cash flows received on interests 578 273 801 239 507 237 (a) Excludes re-securitization transactions. (b) Predominantly includes Level 2 assets. (c) The carrying value of the loans accounted for at fair value approximated the proceeds received upon loan sale. (d) Represents prime mortgages. Excludes loan securitization activity related to U.S. GSEs and government agencies. (e) Includes commercial mortgage and other consumer loans. Key assumptions used to value retained interests originated during the year are shown in the table below. Year ended December 31, 2021 2020 2019 Residential mortgage retained interest: Weighted-average life (in years) 3.9 4.7 4.8 Weighted-average discount rate 3.3 % 8.2 % 7.4 % Commercial mortgage retained interest: Weighted-average life (in years) 6.0 6.9 6.4 Weighted-average discount rate 1.2 % 3.0 % 4.1 %
Summary of loan sale activities	The following table summarizes the activities related to loans sold to the U.S. GSEs, and loans in securitization transactions pursuant to Ginnie Mae guidelines. Year ended December 31, 2021 2020 2019 Carrying value of loans sold $ 105,035 $ 81,153 $ 92,349 Proceeds received from loan sales as cash $ 161 $ 45 $ 73 Proceeds from loan sales as securities (a)(b) 103,286 80,186 91,422 Total proceeds received from loan sales (c) $ 103,447 $ 80,231 $ 91,495 Gains/(losses) on loan sales (d)(e) $ 9 $ 6 $ 499 (a) Includes securities from U.S. GSEs and Ginnie Mae that are generally sold shortly after receipt or retained as part of the Firm’s investment securities portfolio. (b) Included in Level 2 assets. (c) Excludes the value of MSRs retained upon the sale of loans. (d) Gains/(losses) on loan sales include the value of MSRs. (e) The carrying value of the loans accounted for at fair value approximated the proceeds received upon loan sale.
Schedule of loans repurchased and options to repurchase delinquent loans	The following table presents loans the Firm repurchased or had an option to repurchase, real estate owned, and foreclosed government-guaranteed residential mortgage loans recognized on the Firm’s Consolidated balance sheets as of December 31, 2021 and 2020. Substantially all of these loans and real estate are insured or guaranteed by U.S. government agencies. December 31, 2021 2020 Loans repurchased or option to repurchase (a) $ 1,022 $ 1,413 Real estate owned 5 9 Foreclosed government-guaranteed residential mortgage loans (b) 36 64 (a) Predominantly all of these amounts relate to loans that have been repurchased from Ginnie Mae loan pools. (b) Relates to voluntary repurchases of loans, which are included in accrued interest and accounts receivable.
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets	The table below includes information about components of and delinquencies related to nonconsolidated securitized financial assets held in Firm-sponsored private-label securitization entities, in which the Firm has continuing involvement as of December 31, 2021 and 2020. Securitized assets 90 days past due Net liquidation losses As of or for the year ended December 31, (in millions) 2021 2020 2021 2020 2021 2020 Securitized loans Residential mortgage: Prime/ Alt-A & option ARMs $ 47,029 $ 41,265 $ 2,466 $ 4,988 $ 17 $ 212 Subprime 10,115 12,154 1,609 2,406 16 179 Commercial and other 93,698 92,351 1,456 5,958 288 30 Total loans securitized $ 150,842 $ 145,770 $ 5,531 $ 13,352 $ 321 $ 421

Goodwill and Mortgage Servici_2

Goodwill and Mortgage Servicing Rights (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill attributed to the business segments	The following table presents goodwill attributed to the reportable business segments and Corporate. December 31, (in millions) 2021 2020 2019 Consumer & Community Banking $ 31,474 $ 31,311 $ 30,133 Corporate & Investment Bank 7,906 7,913 7,901 Commercial Banking 2,986 2,985 2,982 Asset & Wealth Management 7,222 7,039 6,807 Corporate (a) 727 — — Total goodwill $ 50,315 $ 49,248 $ 47,823 (a) For goodwill in Corporate acquired in the third quarter of 2021, the Firm elected to perform a qualitative impairment assessment, as permitted under U.S. GAAP. The following table presents changes in the carrying amount of goodwill. Year ended December 31, (in millions) 2021 2020 2019 Balance at beginning of period $ 49,248 $ 47,823 $ 47,471 Changes during the period from: Business combinations (a) 1,124 1,412 349 Other (b) (57) 13 3 Balance at December 31, $ 50,315 $ 49,248 $ 47,823 (a) For 2021, represents estimated goodwill associated with the acquisitions of Nutmeg in Corporate, OpenInvest and Campbell Global in AWM, and Frank and The Infatuation in CCB. For 2020, represents estimated goodwill associated with the acquisitions of cxLoyalty in CCB and 55ip in AWM. For 2019, represents goodwill associated with the acquisition of InstaMed. This goodwill was allocated to CIB, CB and CCB. (b) Primarily foreign currency adjustments and adjustments to goodwill related to prior period acquisitions.
Mortgage servicing rights activity	The following table summarizes MSR activity for the years ended December 31, 2021, 2020 and 2019. As of or for the year ended December 31, (in millions, except where otherwise noted) 2021 2020 2019 Fair value at beginning of period $ 3,276 $ 4,699 $ 6,130 MSR activity: Originations of MSRs 1,659 944 1,384 Purchase of MSRs 1,363 248 105 Disposition of MSRs (a) (114) (176) (789) Net additions/(dispositions) 2,908 1,016 700 Changes due to collection/realization of expected cash flows (788) (899) (951) Changes in valuation due to inputs and assumptions: Changes due to market interest rates and other (b) 404 (1,568) (893) Changes in valuation due to other inputs and assumptions: Projected cash flows (e.g., cost to service) 109 (54) (333) (e) Discount rates — 199 153 Prepayment model changes and other (c) (415) (117) (107) Total changes in valuation due to other inputs and assumptions (306) 28 (287) Total changes in valuation due to inputs and assumptions 98 (1,540) (1,180) Fair value at December 31, $ 5,494 $ 3,276 $ 4,699 Change in unrealized gains/(losses) included in income related to MSRs held at December 31, $ 98 $ (1,540) $ (1,180) Contractual service fees, late fees and other ancillary fees included in income 1,298 1,325 1,639 Third-party mortgage loans serviced at December 31, (in billions) 520 448 522 Servicer advances, net of an allowance for uncollectible amounts, at December 31, (in billions) (d) 1.6 1.8 2.0 (a) Includes excess MSRs transferred to agency-sponsored trusts in exchange for stripped mortgage backed securities (“SMBS”) for the years ended December 31, 2020 and 2019. In each transaction, a portion of the SMBS was acquired by third parties at the transaction date; the Firm acquired the remaining balance of those SMBS as trading securities. (b) Represents both the impact of changes in estimated future prepayments due to changes in market interest rates, and the difference between actual and expected prepayments. (c) Represents changes in prepayments other than those attributable to changes in market interest rates. (d) Represents amounts the Firm pays as the servicer (e.g., scheduled principal and interest, taxes and insurance), which will generally be reimbursed within a short period of time after the advance from future cash flows from the trust or the underlying loans. The Firm’s credit risk associated with these servicer advances is minimal because reimbursement of the advances is typically senior to all cash payments to investors. In addition, the Firm maintains the right to stop payment to investors if the collateral is insufficient to cover the advance. However, certain of these servicer advances may not be recoverable if they were not made in accordance with applicable rules and agreements. (e) The decrease in projected cash flows was largely related to default servicing assumption updates.
CCB mortgage fees and related income	The following table presents the components of mortgage fees and related income (including the impact of MSR risk management activities) for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, 2021 2020 2019 CCB mortgage fees and related income Production revenue $ 2,215 $ 2,629 $ 1,618 Net mortgage servicing revenue: Operating revenue: Loan servicing revenue 1,257 1,367 1,533 Changes in MSR asset fair value due to collection/realization of expected cash flows (788) (899) (951) Total operating revenue 469 468 582 Risk management: Changes in MSR asset fair value due to market interest rates and other (a) 404 (1,568) (893) Other changes in MSR asset fair value due to other inputs and assumptions in model (b) (306) 28 (287) Change in derivative fair value and other (623) 1,522 1,015 Total risk management (525) (18) (165) Total net mortgage servicing revenue (56) 450 417 Total CCB mortgage fees and related income 2,159 3,079 2,035 All other 11 12 1 Mortgage fees and related income $ 2,170 $ 3,091 $ 2,036 (a) Represents both the impact of changes in estimated future prepayments due to changes in market interest rates, and the difference between actual and expected prepayments. (b) Represents the aggregate impact of changes in model inputs and assumptions such as projected cash flows (e.g., cost to service), discount rates and changes in prepayments other than those attributable to changes in market interest rates (e.g., changes in prepayments due to changes in home prices).
Key economic assumptions used to determine the fair value of the Firm's Mortgage Servicing Rights (MSRs)	The table below outlines the key economic assumptions used to determine the fair value of the Firm’s MSRs at December 31, 2021 and 2020, and outlines the sensitivities of those fair values to immediate adverse changes in those assumptions, as defined below. December 31, 2021 2020 Weighted-average prepayment speed assumption (constant prepayment rate) 9.90 % 14.90 % Impact on fair value of 10% adverse change $ (210) $ (206) Impact on fair value of 20% adverse change (404) (392) Weighted-average option adjusted spread (a) 6.44 % 7.19 % Impact on fair value of 100 basis points adverse change $ (225) $ (134) Impact on fair value of 200 basis points adverse change (433) (258) (a) Includes the impact of operational risk and regulatory capital.

Deposits (Tables)

Deposits (Tables)	12 Months Ended
	Dec. 31, 2021
Deposits [Abstract]
Noninterest-bearing and interest-bearing deposits	At December 31, 2021 and 2020, noninterest-bearing and interest-bearing deposits were as follows. December 31, (in millions) 2021 2020 U.S. offices Noninterest-bearing (included $8,115 and $9,873 at fair value) (a) $ 638,879 $ 572,711 Interest-bearing (included $629 and $2,567 at fair value) (a) 1,432,578 1,197,032 Total deposits in U.S. offices 2,071,457 1,769,743 Non-U.S. offices Noninterest-bearing (included $2,420 and $1,486 at fair value) (a) 26,229 23,435 Interest-bearing (included $169 and $558 at fair value) (a) 364,617 351,079 Total deposits in non-U.S. offices 390,846 374,514 Total deposits $ 2,462,303 $ 2,144,257 (a) Includes structured notes classified as deposits for which the fair value option has been elected. Refer to Note 3 for further discussion.
Time deposits $250,000 or more	At December 31, 2021 and 2020, time deposits in denominations that met or exceeded the insured limit were as follows. December 31, (in millions) 2021 2020 U.S. offices $ 38,970 $ 33,812 Non-U.S. offices (a) 54,535 50,776 (b) Total $ 93,505 $ 84,588 (a) Represents all time deposits in non-U.S.offices as these deposits typically exceed the insured limit. (b) Prior-period amount has been revised to conform with the current presentation.
Time deposits, by maturity	At December 31, 2021, the maturities of interest-bearing time deposits were as follows. December 31, 2021 U.S. Non-U.S. Total 2022 $ 47,595 $ 50,805 $ 98,400 2023 771 308 1,079 2024 269 10 279 2025 202 38 240 2026 169 821 990 After 5 years 484 132 616 Total $ 49,490 $ 52,114 $ 101,604

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Schedule of information related to operating leases	The following tables provide information related to the Firm’s operating leases: December 31, 2021 2020 Right-of-use assets $ 7,888 $ 8,006 Lease liabilities 8,328 8,508 Weighted average remaining lease term (in years) 8.5 8.7 Weighted average discount rate 3.40 % 3.48 % Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities - operating cash flows $ 1,656 $ 1,626 Supplemental non-cash information Right-of-use assets obtained in exchange for operating lease obligations $ 1,167 $ 1,350 Year ended December 31, 2021 2020 Rental expense Gross rental expense $ 2,086 $ 2,094 Sublease rental income (129) (166) Net rental expense $ 1,957 $ 1,928
Schedule of future payments under operating leases	The following table presents future payments under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 1,572 2023 1,435 2024 1,285 2025 1,115 2026 862 After 2026 3,453 Total future minimum lease payments 9,722 Less: Imputed interest (1,394) Total $ 8,328
Schedule of carrying value of assets subject to leases	The following table presents the carrying value of assets subject to leases reported on the Consolidated balance sheets: December 31, 2021 2020 Carrying value of assets subject to operating leases, net of accumulated depreciation $ 17,553 $ 21,155 Accumulated depreciation 5,737 6,388
Schedule of operating lease income and related depreciation expense	The following table presents the Firm’s operating lease income and the related depreciation expense on the Consolidated statements of income: Year ended December 31, (in millions) 2021 2020 2019 Operating lease income $ 4,914 $ 5,539 $ 5,455 Depreciation expense 3,380 4,257 4,157
Schedule of future receipts under operating leases	The following table presents future receipts under operating leases as of December 31, 2021: Year ended December 31, (in millions) 2022 $ 2,984 2023 1,674 2024 559 2025 48 2026 43 After 2026 — Total future minimum lease receipts $ 5,308

Accounts Payable and Other Li_2

Accounts Payable and Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Accounts Payable and Accrued Liabilities [Abstract]
Components of accounts payable and other liabilities	The following table details the components of accounts payable and other liabilities. December 31, (in millions) 2021 2020 Brokerage payables $ 169,172 $ 140,291 Other payables and liabilities (a)(b) 93,583 90,994 Total accounts payable and other liabilities $ 262,755 $ 231,285 (a) Includes credit card rewards liability of $9.8 billion and $7.7 billion at December 31, 2021 and 2020, respectively. (b) Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Long-term Debt (Tables)

Long-term Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Schedule of long-term debt instruments	The following table is a summary of long-term debt carrying values (including unamortized premiums and discounts, issuance costs, valuation adjustments and fair value adjustments, where applicable) by remaining contractual maturity as of December 31, 2021. By remaining maturity at 2021 2020 Under 1 year 1-5 years After 5 years Total Total Parent company Senior debt: Fixed rate $ 9,900 $ 71,001 $ 121,469 $ 202,370 $ 180,208 (h) Variable rate 845 9,106 3,392 13,343 11,877 (h) Interest rates (a) 2.93 % 2.22 % 3.00 % 2.67 % 2.97 % Subordinated debt: Fixed rate $ — $ 8,168 $ 10,101 $ 18,269 $ 19,255 Variable rate — — — — 9 Interest rates (a) — % 4.21 % 4.28 % 4.24 % 4.24 % Subtotal $ 10,745 $ 88,275 $ 134,962 $ 233,982 $ 211,349 Subsidiaries Federal Home Loan Banks advances: Fixed rate $ 8 $ 45 $ 57 $ 110 $ 123 Variable rate — 11,000 — 11,000 14,000 Interest rates (a) 5.53 % 0.19 % 6.14 % 0.23 % 0.34 % Senior debt: Fixed rate $ 775 $ 4,701 $ 10,028 $ 15,504 $ 16,227 (h) Variable rate 11,248 19,896 7,003 38,147 37,642 (h) Interest rates (a) 4.55 % 4.92% 1.64 % 2.09 % 2.28 % Subordinated debt: Fixed rate $ — $ 287 $ — $ 287 $ 309 Variable rate — — — — — Interest rates (a) — % 8.25 % — % 8.25 % 8.25 % Subtotal $ 12,031 $ 35,929 $ 17,088 $ 65,048 $ 68,301 Junior subordinated debt: Fixed rate $ — $ — $ 678 $ 678 $ 738 Variable rate — — 1,297 1,297 1,297 Interest rates (a) — % — % 3.20 % 3.20 % 3.26 % Subtotal $ — $ — $ 1,975 $ 1,975 $ 2,035 Total long-term debt (b)(c)(d) $ 22,776 $ 124,204 $ 154,025 $ 301,005 (f)(g) $ 281,685 Long-term beneficial interests: Fixed rate $ 748 $ 999 $ — $ 1,747 $ 2,369 Variable rate 650 — 179 829 2,784 Interest rates (a) 1.39 % 1.53 % 3.24 % 1.57 % 1.30 % Total long-term beneficial interests (e) $ 1,398 $ 999 $ 179 $ 2,576 $ 5,153 (a) The interest rates shown are the weighted average of contractual rates in effect at December 31, 2021 and 2020, respectively, including non-U.S. dollar fixed- and variable-rate issuances, which excludes the effects of the associated derivative instruments used in hedge accounting relationships, if applicable. The interest rates shown exclude structured notes accounted for at fair value. (b) Included long-term debt of $14.1 billion and $17.2 billion secured by assets totaling $170.6 billion and $166.4 billion at December 31, 2021 and 2020, respectively. The amount of long-term debt secured by assets does not include amounts related to hybrid instruments. (c) Included $74.9 billion and $76.8 billion of long-term debt accounted for at fair value at December 31, 2021 and 2020, respectively. (d) Included $15.8 billion and $16.1 billion of outstanding zero-coupon notes at December 31, 2021 and 2020, respectively. The aggregate principal amount of these notes at their respective maturities is $46.4 billion and $45.3 billion, respectively. The aggregate principal amount reflects the contractual principal payment at maturity, which may exceed the contractual principal payment at the Firm’s next call date, if applicable. (e) Included on the Consolidated balance sheets in beneficial interests issued by consolidated VIEs. Also included $12 million and $41 million accounted for at fair value at December 31, 2021 and 2020, respectively. Excluded short-term commercial paper and other short-term beneficial interests of $8.2 billion and $12.4 billion at December 31, 2021 and 2020, respectively. (f) At December 31, 2021, long-term debt in the aggregate of $185.0 billion was redeemable at the option of JPMorgan Chase, in whole or in part, prior to maturity, based on the terms specified in the respective instruments. (g) The aggregate carrying values of debt that matures in each of the five years subsequent to 2021 is $22.8 billion in 2022, $32.6 billion in 2023, $36.4 billion in 2024, $26.1 billion in 2025 and $29.1 billion in 2026. (h) Prior-period amounts have been revised to conform with the current presentation.
Schedule of maturities of long-term debt	The following table is a summary of long-term debt carrying values (including unamortized premiums and discounts, issuance costs, valuation adjustments and fair value adjustments, where applicable) by remaining contractual maturity as of December 31, 2021. By remaining maturity at 2021 2020 Under 1 year 1-5 years After 5 years Total Total Parent company Senior debt: Fixed rate $ 9,900 $ 71,001 $ 121,469 $ 202,370 $ 180,208 (h) Variable rate 845 9,106 3,392 13,343 11,877 (h) Interest rates (a) 2.93 % 2.22 % 3.00 % 2.67 % 2.97 % Subordinated debt: Fixed rate $ — $ 8,168 $ 10,101 $ 18,269 $ 19,255 Variable rate — — — — 9 Interest rates (a) — % 4.21 % 4.28 % 4.24 % 4.24 % Subtotal $ 10,745 $ 88,275 $ 134,962 $ 233,982 $ 211,349 Subsidiaries Federal Home Loan Banks advances: Fixed rate $ 8 $ 45 $ 57 $ 110 $ 123 Variable rate — 11,000 — 11,000 14,000 Interest rates (a) 5.53 % 0.19 % 6.14 % 0.23 % 0.34 % Senior debt: Fixed rate $ 775 $ 4,701 $ 10,028 $ 15,504 $ 16,227 (h) Variable rate 11,248 19,896 7,003 38,147 37,642 (h) Interest rates (a) 4.55 % 4.92% 1.64 % 2.09 % 2.28 % Subordinated debt: Fixed rate $ — $ 287 $ — $ 287 $ 309 Variable rate — — — — — Interest rates (a) — % 8.25 % — % 8.25 % 8.25 % Subtotal $ 12,031 $ 35,929 $ 17,088 $ 65,048 $ 68,301 Junior subordinated debt: Fixed rate $ — $ — $ 678 $ 678 $ 738 Variable rate — — 1,297 1,297 1,297 Interest rates (a) — % — % 3.20 % 3.20 % 3.26 % Subtotal $ — $ — $ 1,975 $ 1,975 $ 2,035 Total long-term debt (b)(c)(d) $ 22,776 $ 124,204 $ 154,025 $ 301,005 (f)(g) $ 281,685 Long-term beneficial interests: Fixed rate $ 748 $ 999 $ — $ 1,747 $ 2,369 Variable rate 650 — 179 829 2,784 Interest rates (a) 1.39 % 1.53 % 3.24 % 1.57 % 1.30 % Total long-term beneficial interests (e) $ 1,398 $ 999 $ 179 $ 2,576 $ 5,153 (a) The interest rates shown are the weighted average of contractual rates in effect at December 31, 2021 and 2020, respectively, including non-U.S. dollar fixed- and variable-rate issuances, which excludes the effects of the associated derivative instruments used in hedge accounting relationships, if applicable. The interest rates shown exclude structured notes accounted for at fair value. (b) Included long-term debt of $14.1 billion and $17.2 billion secured by assets totaling $170.6 billion and $166.4 billion at December 31, 2021 and 2020, respectively. The amount of long-term debt secured by assets does not include amounts related to hybrid instruments. (c) Included $74.9 billion and $76.8 billion of long-term debt accounted for at fair value at December 31, 2021 and 2020, respectively. (d) Included $15.8 billion and $16.1 billion of outstanding zero-coupon notes at December 31, 2021 and 2020, respectively. The aggregate principal amount of these notes at their respective maturities is $46.4 billion and $45.3 billion, respectively. The aggregate principal amount reflects the contractual principal payment at maturity, which may exceed the contractual principal payment at the Firm’s next call date, if applicable. (e) Included on the Consolidated balance sheets in beneficial interests issued by consolidated VIEs. Also included $12 million and $41 million accounted for at fair value at December 31, 2021 and 2020, respectively. Excluded short-term commercial paper and other short-term beneficial interests of $8.2 billion and $12.4 billion at December 31, 2021 and 2020, respectively. (f) At December 31, 2021, long-term debt in the aggregate of $185.0 billion was redeemable at the option of JPMorgan Chase, in whole or in part, prior to maturity, based on the terms specified in the respective instruments. (g) The aggregate carrying values of debt that matures in each of the five years subsequent to 2021 is $22.8 billion in 2022, $32.6 billion in 2023, $36.4 billion in 2024, $26.1 billion in 2025 and $29.1 billion in 2026. (h) Prior-period amounts have been revised to conform with the current presentation.

Preferred Stock (Tables)

Preferred Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of stock by class	The following is a summary of JPMorgan Chase’s non-cumulative preferred stock outstanding as of December 31, 2021 and 2020. Shares (a) Carrying value Issue date Contractual rate Earliest redemption date (b) Floating annualized rate (c) Dividend declared per share (d) December 31, December 31, Year ended December 31, 2021 2020 2021 2020 2021 2020 2019 Fixed-rate: Series P — — $ — $ — 2/5/2013 — % 3/1/2018 NA $— $— $545.00 Series T — — — — 1/30/2014 — 3/1/2019 NA — — 167.50 Series W — — — — 6/23/2014 — 9/1/2019 NA — — 472.50 Series Y — — — — 2/12/2015 — 3/1/2020 NA — 153.13 612.52 Series AA — 142,500 — 1,425 6/4/2015 — 9/1/2020 NA 305.00 610.00 610.00 Series BB — 115,000 — 1,150 7/29/2015 — 9/1/2020 NA 307.50 615.00 615.00 Series DD 169,625 169,625 1,696 1,696 9/21/2018 5.750 12/1/2023 NA 575.00 575.00 575.00 Series EE 185,000 185,000 1,850 1,850 1/24/2019 6.000 3/1/2024 NA 600.00 600.00 511.67 (e) Series GG 90,000 90,000 900 900 11/7/2019 4.750 12/1/2024 NA 475.00 506.67 NA (e) Series JJ 150,000 — 1,500 — 3/17/2021 4.550 6/1/2026 NA 321.03 NA NA (e) Series LL 185,000 — 1,850 — 5/20/2021 4.625 6/1/2026 NA 245.39 NA NA (e) Series MM 200,000 — 2,000 — 7/29/2021 4.200 9/1/2026 NA 142.33 NA NA (e) Fixed-to-floating-rate: Series I 293,375 293,375 $ 2,934 $ 2,934 4/23/2008 LIBOR + 3.47% 4/30/2018 LIBOR + 3.47% $370.38 $428.03 $593.23 Series Q 150,000 150,000 1,500 1,500 4/23/2013 5.150 5/1/2023 LIBOR + 3.25 515.00 515.00 515.00 Series R 150,000 150,000 1,500 1,500 7/29/2013 6.000 8/1/2023 LIBOR + 3.30 600.00 600.00 600.00 Series S 200,000 200,000 2,000 2,000 1/22/2014 6.750 2/1/2024 LIBOR + 3.78 675.00 675.00 675.00 Series U 100,000 100,000 1,000 1,000 3/10/2014 6.125 4/30/2024 LIBOR + 3.33 612.50 612.50 612.50 Series V 250,000 250,000 2,500 2,500 6/9/2014 LIBOR + 3.32% 7/1/2019 LIBOR + 3.32 353.65 436.85 534.09 (f) Series X 160,000 160,000 1,600 1,600 9/23/2014 6.100 10/1/2024 LIBOR + 3.33 610.00 610.00 610.00 Series Z 200,000 200,000 2,000 2,000 4/21/2015 LIBOR + 3.80% 5/1/2020 LIBOR + 3.80 401.44 453.52 530.00 (g) Series CC 125,750 125,750 1,258 1,258 10/20/2017 4.625 11/1/2022 LIBOR + 2.58 462.50 462.50 462.50 Series FF 225,000 225,000 2,250 2,250 7/31/2019 5.000 8/1/2024 SOFR + 3.38 500.00 500.00 251.39 (e) Series HH 300,000 300,000 3,000 3,000 1/23/2020 4.600 2/1/2025 SOFR + 3.125 460.00 470.22 NA (e) Series II 150,000 150,000 1,500 1,500 2/24/2020 4.000 4/1/2025 SOFR + 2.745 400.00 341.11 NA (e) Series KK 200,000 — 2,000 — 5/12/2021 3.650 6/1/2026 CMT + 2.85 201.76 NA NA (e) Total preferred stock 3,483,750 3,006,250 $ 34,838 $ 30,063 (a) Represented by depositary shares. (b) Fixed-to-floating rate notes convert to a floating rate at the earliest redemption date. (c) Floating annualized rate includes three-month LIBOR, three-month term SOFR or five-year Constant Maturity Treasury ("CMT") rate, as applicable, plus the spreads noted above. (d) Dividends are declared quarterly. Dividends are payable quarterly on fixed-rate preferred stock. Dividends are payable semiannually on fixed-to-floating-rate preferred stock while at a fixed rate, and payable quarterly after converting to a floating rate. (e) The initial dividend declared is prorated based on the number of days outstanding for the period. Dividends were declared quarterly thereafter at the contractual rate. (f) The dividend rate for Series V preferred stock became floating and payable quarterly starting on July 1, 2019; prior to which the dividend rate was fixed at 5% or $250.00 per share payable semi annually. (g) The dividend rate for Series Z preferred stock became floating and payable quarterly starting on May 1, 2020; prior to which the dividend rate was fixed at 5.3% or $265.00 per share payable semi annually. Common shares issued (reissuances from treasury) by JPMorgan Chase during the years ended December 31, 2021, 2020 and 2019 were as follows. Year ended December 31, 2021 2020 2019 Total issued – balance at January 1 4,104.9 4,104.9 4,104.9 Treasury – balance at January 1 (1,055.5) (1,020.9) (829.1) Repurchase (119.7) (50.0) (213.0) Reissuance: Employee benefits and compensation plans 13.5 14.2 20.4 Employee stock purchase plans 0.9 1.2 0.8 Total reissuance 14.4 15.4 21.2 Total treasury – balance at December 31 (1,160.8) (1,055.5) (1,020.9) Outstanding at December 31 2,944.1 3,049.4 3,084.0

Common Stock (Tables)

Common Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of stock by class	The following is a summary of JPMorgan Chase’s non-cumulative preferred stock outstanding as of December 31, 2021 and 2020. Shares (a) Carrying value Issue date Contractual rate Earliest redemption date (b) Floating annualized rate (c) Dividend declared per share (d) December 31, December 31, Year ended December 31, 2021 2020 2021 2020 2021 2020 2019 Fixed-rate: Series P — — $ — $ — 2/5/2013 — % 3/1/2018 NA $— $— $545.00 Series T — — — — 1/30/2014 — 3/1/2019 NA — — 167.50 Series W — — — — 6/23/2014 — 9/1/2019 NA — — 472.50 Series Y — — — — 2/12/2015 — 3/1/2020 NA — 153.13 612.52 Series AA — 142,500 — 1,425 6/4/2015 — 9/1/2020 NA 305.00 610.00 610.00 Series BB — 115,000 — 1,150 7/29/2015 — 9/1/2020 NA 307.50 615.00 615.00 Series DD 169,625 169,625 1,696 1,696 9/21/2018 5.750 12/1/2023 NA 575.00 575.00 575.00 Series EE 185,000 185,000 1,850 1,850 1/24/2019 6.000 3/1/2024 NA 600.00 600.00 511.67 (e) Series GG 90,000 90,000 900 900 11/7/2019 4.750 12/1/2024 NA 475.00 506.67 NA (e) Series JJ 150,000 — 1,500 — 3/17/2021 4.550 6/1/2026 NA 321.03 NA NA (e) Series LL 185,000 — 1,850 — 5/20/2021 4.625 6/1/2026 NA 245.39 NA NA (e) Series MM 200,000 — 2,000 — 7/29/2021 4.200 9/1/2026 NA 142.33 NA NA (e) Fixed-to-floating-rate: Series I 293,375 293,375 $ 2,934 $ 2,934 4/23/2008 LIBOR + 3.47% 4/30/2018 LIBOR + 3.47% $370.38 $428.03 $593.23 Series Q 150,000 150,000 1,500 1,500 4/23/2013 5.150 5/1/2023 LIBOR + 3.25 515.00 515.00 515.00 Series R 150,000 150,000 1,500 1,500 7/29/2013 6.000 8/1/2023 LIBOR + 3.30 600.00 600.00 600.00 Series S 200,000 200,000 2,000 2,000 1/22/2014 6.750 2/1/2024 LIBOR + 3.78 675.00 675.00 675.00 Series U 100,000 100,000 1,000 1,000 3/10/2014 6.125 4/30/2024 LIBOR + 3.33 612.50 612.50 612.50 Series V 250,000 250,000 2,500 2,500 6/9/2014 LIBOR + 3.32% 7/1/2019 LIBOR + 3.32 353.65 436.85 534.09 (f) Series X 160,000 160,000 1,600 1,600 9/23/2014 6.100 10/1/2024 LIBOR + 3.33 610.00 610.00 610.00 Series Z 200,000 200,000 2,000 2,000 4/21/2015 LIBOR + 3.80% 5/1/2020 LIBOR + 3.80 401.44 453.52 530.00 (g) Series CC 125,750 125,750 1,258 1,258 10/20/2017 4.625 11/1/2022 LIBOR + 2.58 462.50 462.50 462.50 Series FF 225,000 225,000 2,250 2,250 7/31/2019 5.000 8/1/2024 SOFR + 3.38 500.00 500.00 251.39 (e) Series HH 300,000 300,000 3,000 3,000 1/23/2020 4.600 2/1/2025 SOFR + 3.125 460.00 470.22 NA (e) Series II 150,000 150,000 1,500 1,500 2/24/2020 4.000 4/1/2025 SOFR + 2.745 400.00 341.11 NA (e) Series KK 200,000 — 2,000 — 5/12/2021 3.650 6/1/2026 CMT + 2.85 201.76 NA NA (e) Total preferred stock 3,483,750 3,006,250 $ 34,838 $ 30,063 (a) Represented by depositary shares. (b) Fixed-to-floating rate notes convert to a floating rate at the earliest redemption date. (c) Floating annualized rate includes three-month LIBOR, three-month term SOFR or five-year Constant Maturity Treasury ("CMT") rate, as applicable, plus the spreads noted above. (d) Dividends are declared quarterly. Dividends are payable quarterly on fixed-rate preferred stock. Dividends are payable semiannually on fixed-to-floating-rate preferred stock while at a fixed rate, and payable quarterly after converting to a floating rate. (e) The initial dividend declared is prorated based on the number of days outstanding for the period. Dividends were declared quarterly thereafter at the contractual rate. (f) The dividend rate for Series V preferred stock became floating and payable quarterly starting on July 1, 2019; prior to which the dividend rate was fixed at 5% or $250.00 per share payable semi annually. (g) The dividend rate for Series Z preferred stock became floating and payable quarterly starting on May 1, 2020; prior to which the dividend rate was fixed at 5.3% or $265.00 per share payable semi annually. Common shares issued (reissuances from treasury) by JPMorgan Chase during the years ended December 31, 2021, 2020 and 2019 were as follows. Year ended December 31, 2021 2020 2019 Total issued – balance at January 1 4,104.9 4,104.9 4,104.9 Treasury – balance at January 1 (1,055.5) (1,020.9) (829.1) Repurchase (119.7) (50.0) (213.0) Reissuance: Employee benefits and compensation plans 13.5 14.2 20.4 Employee stock purchase plans 0.9 1.2 0.8 Total reissuance 14.4 15.4 21.2 Total treasury – balance at December 31 (1,160.8) (1,055.5) (1,020.9) Outstanding at December 31 2,944.1 3,049.4 3,084.0
Schedule of common equity repurchases	The following table sets forth the Firm’s repurchases of common stock for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, (in millions) 2021 2020 (a) 2019 Total number of shares of common stock repurchased 119.7 50.0 213.0 Aggregate purchase price of common stock repurchases $ 18,448 $ 6,397 $ 24,121 (a) On March 15, 2020, in response to the economic disruptions caused by the COVID-19 pandemic, the Firm temporarily suspended repurchases of its common stock. Subsequently, the Federal Reserve directed all large banks, including the Firm, to discontinue net share repurchases through the end of 2020.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of earnings per share basic and diluted	The following table presents the calculation of net income applicable to common stockholders and basic and diluted EPS for the years ended December 31, 2021, 2020 and 2019. Year ended December 31, 2021 2020 2019 Basic earnings per share Net income $ 48,334 $ 29,131 $ 36,431 Less: Preferred stock dividends 1,600 1,583 1,587 Net income applicable to common equity 46,734 27,548 34,844 Less: Dividends and undistributed earnings allocated to participating securities 231 138 202 Net income applicable to common stockholders $ 46,503 $ 27,410 $ 34,642 Total weighted-average basic shares outstanding 3,021.5 3,082.4 3,221.5 Net income per share $ 15.39 $ 8.89 $ 10.75 Diluted earnings per share Net income applicable to common stockholders $ 46,503 $ 27,410 $ 34,642 Total weighted-average basic shares outstanding 3,021.5 3,082.4 3,221.5 Add: Dilutive impact of SARs and employee stock options, unvested PSUs and nondividend-earning RSUs, and warrants 5.1 5.0 8.9 Total weighted-average diluted shares outstanding 3,026.6 3,087.4 3,230.4 Net income per share $ 15.36 $ 8.88 $ 10.72

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income/(Loss) (Tables)	12 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated other comprehensive income/(loss)	AOCI includes the after-tax change in unrealized gains and losses on investment securities, foreign currency translation adjustments (including the impact of related derivatives), fair value changes of excluded components on fair value hedges, cash flow hedging activities, net loss and prior service costs/(credit) related to the Firm’s defined benefit pension and OPEB plans, and fair value option-elected liabilities arising from changes in the Firm’s own credit risk (DVA). Year ended December 31, Unrealized Translation adjustments, net of hedges Fair value Cash flow hedges Defined benefit pension and OPEB plans DVA on fair value option elected liabilities Accumulated other comprehensive income/(loss) Balance at December 31, 2018 $ 1,202 $ (727) $ (161) $ (109) $ (2,308) $ 596 $ (1,507) Net change 2,855 20 30 172 964 (965) 3,076 Balance at December 31, 2019 $ 4,057 $ (707) $ (131) $ 63 $ (1,344) $ (369) $ 1,569 Net change 4,123 234 19 2,320 212 (491) 6,417 Balance at December 31, 2020 $ 8,180 $ (473) $ (112) $ 2,383 $ (1,132) $ (860) $ 7,986 Net change (5,540) (461) (19) (2,679) 922 (293) (8,070) Balance at December 31, 2021 $ 2,640 (a) $ (934) $ (131) $ (296) $ (210) $ (1,153) $ (84) (a) Includes after-tax net unamortized unrealized gains of $2.4 billion related to AFS securities that have been transferred to HTM. Refer to Note 10 for further information.
Changes of the components of accumulated other comprehensive income (loss)	The following table presents the pre-tax and after-tax changes in the components of OCI. 2021 2020 2019 Year ended December 31, (in millions) Pre-tax Tax effect After-tax Pre-tax Tax effect After-tax Pre-tax Tax effect After-tax Unrealized gains/(losses) on investment securities: Net unrealized gains/(losses) arising during the period $ (7,634) $ 1,832 $ (5,802) $ 6,228 $ (1,495) $ 4,733 $ 4,025 $ (974) $ 3,051 Reclassification adjustment for realized (gains)/losses included in net income (a) 345 (83) 262 (802) 192 (610) (258) 62 (196) Net change (7,289) 1,749 (5,540) 5,426 (1,303) 4,123 3,767 (912) 2,855 Translation adjustments (b) : Translation (2,447) 125 (2,322) 1,407 (103) 1,304 (49) 33 (16) Hedges 2,452 (591) 1,861 (1,411) 341 (1,070) 46 (10) 36 Net change 5 (466) (461) (4) 238 234 (3) 23 20 Fair value hedges, net change (c) : (26) 7 (19) 25 (6) 19 39 (9) 30 Cash flow hedges: Net unrealized gains/(losses) arising during the period (2,303) 553 (1,750) 3,623 (870) 2,753 122 (28) 94 Reclassification adjustment for realized (gains)/losses included in net income (d) (1,222) 293 (929) (570) 137 (433) 103 (25) 78 Net change (3,525) 846 (2,679) 3,053 (733) 2,320 225 (53) 172 Defined benefit pension and OPEB plans, net change: 1,129 (207) 922 214 (2) 212 1,157 (193) 964 DVA on fair value option elected liabilities, net change: (393) 100 (293) (648) 157 (491) (1,264) 299 (965) Total other comprehensive income/(loss) $ (10,099) $ 2,029 $ (8,070) $ 8,066 $ (1,649) $ 6,417 $ 3,921 $ (845) $ 3,076 (a) The pre-tax amount is reported in Investment securities gains/(losses) in the Consolidated statements of income. (b) Reclassifications of pre-tax realized gains/(losses) on translation adjustments and related hedges are reported in other income/expense in the Consolidated statements of income. During the year ended December 31, 2021, the Firm reclassified a net pre-tax loss of $7 million to other expense related to the liquidation of certain legal entities, driven by cumulative translation adjustments. During the year ended December 31, 2020, the Firm reclassified a net pre-tax gain of $6 million to other income related to the liquidation of legal entities, $3 million related to net investment hedge gains and $3 million related to cumulative translation adjustments. During the year ended December 31, 2019, the Firm reclassified net pre-tax gains of $7 million to other income and $1 million to other expense, respectively. These amounts, which related to the liquidation of certain legal entities, are comprised of $18 million related to net investment hedge gains and $10 million related to cumulative translation adjustments. (c) Represents changes in fair value of cross-currency swaps attributable to changes in cross-currency basis spreads, which are excluded from the assessment of hedge effectiveness and recorded in other comprehensive income. The initial cost of cross-currency basis spreads is recognized in earnings as part of the accrual of interest on the cross-currency swap. (d) The pre-tax amounts are primarily recorded in noninterest revenue, net interest income and compensation expense in the Consolidated statements of income.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Reconciliation of the applicable statutory U.S. income tax rate to the effective tax rate the effective tax rate	The following table presents a reconciliation of the applicable statutory U.S. federal income tax rate to the effective tax rate. Effective tax rate Year ended December 31, 2021 2020 2019 Statutory U.S. federal tax rate 21.0 % 21.0 % 21.0 % Increase/(decrease) in tax rate resulting from: U.S. state and local income taxes, net of U.S. federal income tax benefit 3.0 2.5 3.5 Tax-exempt income (0.9) (1.6) (1.4) Non-U.S. earnings 0.1 1.4 1.8 Business tax credits (4.2) (5.4) (a) (3.8) (a) Tax audit resolutions — — (2.3) Other, net (0.1) 0.8 (a) — Effective tax rate 18.9 % 18.7 % 18.8 %
Components of income tax expense/(benefit) included in the Consolidated Statements of Income	The following table reflects the components of income tax expense/(benefit) included in the Consolidated statements of income. Income tax expense/(benefit) Year ended December 31, 2021 2020 2019 Current income tax expense/(benefit) U.S. federal $ 2,865 $ 5,759 $ 3,284 Non-U.S. 2,718 2,705 2,103 U.S. state and local 1,897 1,793 1,778 Total current income tax expense/(benefit) 7,480 10,257 7,165 Deferred income tax expense/(benefit) U.S. federal 3,460 (2,776) (a) 1,030 (a) Non-U.S. (101) (126) 20 U.S. state and local 389 (671) 220 Total deferred income tax 3,748 (3,573) 1,270 Total income tax expense $ 11,228 $ 6,684 $ 8,435 (a) Prior-period amount has been revised to conform with the current presentation.
U.S. and non-U.S. components of income before income tax expense/(benefit)	The following table presents the U.S. and non-U.S. components of income before income tax expense. Year ended December 31, 2021 2020 2019 U.S. $ 50,126 $ 27,312 (b) $ 36,991 (b) Non-U.S. (a) 9,436 8,503 7,875 Income before income tax expense $ 59,562 $ 35,815 $ 44,866 (a) For purposes of this table, non-U.S. income is defined as income generated from operations located outside the U.S. (b) Prior-period amount has been revised to conform with the current presentation.
Significant components of deferred tax assets and liabilities	The significant components of deferred tax assets and liabilities are reflected in the following table. December 31, (in millions) 2021 2020 Deferred tax assets Allowance for loan losses $ 4,345 $ 7,270 Employee benefits 987 1,104 Accrued expenses and other 3,955 3,332 Non-U.S. operations 900 849 Tax attribute carryforwards 615 757 Gross deferred tax assets 10,802 13,312 Valuation allowance (378) (560) Deferred tax assets, net of valuation allowance $ 10,424 $ 12,752 Deferred tax liabilities Depreciation and amortization $ 3,289 $ 3,329 Mortgage servicing rights, net of hedges 2,049 2,184 Leasing transactions 4,227 5,124 Other, net 4,459 6,025 Gross deferred tax liabilities 14,024 16,662 Net deferred tax (liabilities)/assets $ (3,600) $ (3,910)
Reconciliation of the beginning and ending amount of unrecognized tax benefits	The following table presents a reconciliation of the beginning and ending amount of unrecognized tax benefits. Year ended December 31, 2021 2020 2019 Balance at January 1, $ 4,250 $ 4,024 $ 4,861 Increases based on tax positions related to the current period 798 685 871 Increases based on tax positions related to prior periods 393 362 10 Decreases based on tax positions related to prior periods (657) (705) (706) Decreases related to cash settlements with taxing authorities (148) (116) (1,012) Balance at December 31, $ 4,636 $ 4,250 $ 4,024
Tax examination status	JPMorgan Chase is continually under examination by the Internal Revenue Service, by taxing authorities throughout the world, and by many state and local jurisdictions throughout the U.S. The following table summarizes the status of significant income tax examinations of JPMorgan Chase and its consolidated subsidiaries as of December 31, 2021. Periods under examination Status JPMorgan Chase – U.S. 2011 – 2013 Field examination of amended returns JPMorgan Chase – U.S. 2014 - 2018 Field Examination JPMorgan Chase – New York State 2012 - 2014 Field Examination JPMorgan Chase – New York City 2015 - 2017 Field Examination JPMorgan Chase – California 2011 – 2012 Field Examination JPMorgan Chase – U.K. 2006 – 2019 Field examination of certain select entities

Restricted Cash, Other Restri_2

Restricted Cash, Other Restricted Assets and Intercompany Funds Transfers (Tables)	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Components of restricted cash	The following table presents the components of the Firm’s restricted cash: December 31, (in billions) 2021 2020 Segregated for the benefit of securities and cleared derivative customers 14.6 19.3 Cash reserves at non-U.S. central banks and held for other general purposes 5.1 5.1 Total restricted cash (a) $ 19.7 $ 24.4 (a) Comprises $18.4 billion and $22.7 billion in deposits with banks, and $1.3 billion and $1.7 billion in cash and due from banks on the Consolidated balance sheets as of December 31, 2021 and 2020, respectively.

Regulatory Capital (Tables)

Regulatory Capital (Tables)	12 Months Ended
	Dec. 31, 2021
Banking Regulation [Abstract]
Reconciliation of the Firm's regulatory capital, assets and risk-based capital ratios	The following table presents the risk-based regulatory capital ratio requirements and well-capitalized ratios to which the Firm and its IDI subsidiaries were subject as of December 31, 2021 and 2020. Standardized capital ratio requirements Advanced capital ratio requirements Well-capitalized ratios BHC (a)(b) IDI (c) BHC (a) IDI (c) BHC (d) IDI (e) Risk-based capital ratios CET1 capital 11.2 % 7.0 % 10.5 % 7.0 % NA 6.5 % Tier 1 capital 12.7 8.5 12.0 8.5 6.0 % 8.0 Total capital 14.7 10.5 14.0 10.5 10.0 10.0 Note: The table above is as defined by the regulations issued by the Federal Reserve, OCC and FDIC and to which the Firm and its IDI subsidiaries are subject. (a) Represents the regulatory capital ratio requirements applicable to the Firm. The CET1, Tier 1 and Total capital ratio requirements each include a respective minimum requirement plus a GSIB surcharge of 3.5% as calculated under Method 2; plus a 3.2% SCB for Basel III Standardized ratios and a fixed 2.5% capital conservation buffer for Basel III Advanced ratios. The countercyclical buffer is currently set to 0% by the federal banking agencies. (b) For the period ended December 31, 2020, the CET1, Tier 1, and Total capital ratio requirements under Basel III Standardized applicable to the Firm were 11.3%, 12.8% and 14.8%, respectively. (c) Represents requirements for JPMorgan Chase’s IDI subsidiaries. The CET1, Tier 1 and Total capital ratio requirements include a fixed capital conservation buffer requirement of 2.5% that is applicable to the IDI subsidiaries. The IDI subsidiaries are not subject to the GSIB surcharge. (d) Represents requirements for bank holding companies pursuant to regulations issued by the Federal Reserve. (e) Represents requirements for IDI subsidiaries pursuant to regulations issued under the FDIC Improvement Act. The following table presents the leverage-based regulatory capital ratio requirements and well-capitalized ratios to which the Firm and its IDI subsidiaries were subject as of December 31, 2021 and 2020. Capital ratio requirements (a) Well-capitalized ratios BHC IDI BHC (b) IDI Leverage-based capital ratios Tier 1 leverage 4.0 % 4.0 % NA 5.0 % SLR 5.0 6.0 NA 6.0 Note: The table above is as defined by the regulations issued by the Federal Reserve, OCC and FDIC and to which the Firm and its IDI subsidiaries are subject. (a) Represents minimum SLR requirement of 3.0%, as well as supplementary leverage buffer requirements of 2.0% and 3.0% for BHC and IDI subsidiaries, respectively. (b) The Federal Reserve's regulations do not establish well-capitalized thresholds for these measures for BHCs. The following tables present risk-based capital metrics under both the Basel III Standardized and Basel III Advanced approaches and leverage-based capital metrics for JPMorgan Chase and JPMorgan Chase Bank, N.A. As of December 31, 2021 and 2020, JPMorgan Chase and JPMorgan Chase Bank, N.A. were well-capitalized and met all capital requirements to which each was subject. December 31, 2021 Basel III Standardized Basel III Advanced JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) Risk-based capital metrics: CET1 capital $ 213,942 $ 266,907 $ 213,942 $ 266,907 Tier 1 capital 246,162 266,910 246,162 266,910 Total capital 274,900 281,826 265,796 272,299 Risk-weighted assets 1,638,900 1,582,280 1,547,920 1,392,847 CET1 capital ratio 13.1 % 16.9 % 13.8 % 19.2 % Tier 1 capital ratio 15.0 16.9 15.9 19.2 Total capital ratio 16.8 17.8 17.2 19.5 December 31, 2020 Basel III Standardized Basel III Advanced JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) JPMorgan Chase & Co. (a) JPMorgan Chase Bank, N.A. (a) Risk-based capital metrics: CET1 capital $ 205,078 $ 234,235 $ 205,078 $ 234,235 Tier 1 capital 234,844 234,237 234,844 234,237 Total capital 269,923 252,045 257,228 239,673 Risk-weighted assets 1,560,609 1,492,138 1,484,431 1,343,185 CET1 capital ratio 13.1 % 15.7 % 13.8 % 17.4 % Tier 1 capital ratio 15.0 15.7 15.8 17.4 Total capital ratio 17.3 16.9 17.3 17.8 (a) The capital metrics reflect the CECL capital transition provisions. Additionally, loans originated under the PPP receive a zero percent risk weight. Three months ended December 31, 2021 December 31, 2020 JPMorgan Chase & Co. (b) JPMorgan Chase Bank, N.A. (b) JPMorgan (b)(c) JPMorgan (b)(c) Leverage-based capital metrics: Adjusted average assets (a) $ 3,782,035 $ 3,334,925 $ 3,353,319 $ 2,970,285 Tier 1 leverage ratio 6.5 % 8.0 % 7.0 % 7.9 % Total leverage exposure $ 4,571,789 $ 4,119,286 $ 3,401,542 $ 3,688,797 SLR 5.4 % 6.5 % 6.9 % 6.3 % (a) Adjusted average assets, for purposes of calculating the leverage ratio, includes total quarterly average assets adjusted for on-balance sheet assets that are subject to deduction from Tier 1 capital, predominantly goodwill and other intangible assets. (b) The capital metrics reflect the CECL capital transition provisions.

Off-balance Sheet Lending-rel_2

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments (Tables)	12 Months Ended
	Dec. 31, 2021
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Off-balance sheet lending related financial instruments, guarantees and other commitments	Off–balance sheet lending-related financial instruments, guarantees and other commitments Contractual amount Carrying value (i) 2021 2020 2021 2020 By remaining maturity at December 31, Expires in 1 year or less Expires after Expires after Expires after 5 years Total Total Lending-related Consumer, excluding credit card: Residential Real Estate (a) $ 15,649 $ 2,216 $ 5,797 $ 9,334 $ 32,996 $ 46,047 100 148 Auto and other 11,387 — — 951 12,338 11,272 2 — Total consumer, excluding credit card 27,036 2,216 5,797 10,285 45,334 57,319 102 148 Credit card (b) 730,534 — — — 730,534 658,506 — — Total consumer (b)(c) 757,570 2,216 5,797 10,285 775,868 715,825 102 148 Wholesale: Other unfunded commitments to extend credit (d) 101,983 167,137 160,301 24,046 453,467 415,828 2,037 2,148 Standby letters of credit and other financial guarantees (d) 15,092 8,261 4,015 1,162 28,530 30,982 476 443 Other letters of credit (d) 3,854 498 96 — 4,448 3,053 9 14 Total wholesale (c) 120,929 175,896 164,412 25,208 486,445 449,863 2,522 2,605 Total lending-related $ 878,499 $ 178,112 $ 170,209 $ 35,493 $ 1,262,313 $ 1,165,688 $ 2,624 $ 2,753 Other guarantees and commitments Securities lending indemnification agreements and guarantees (e) $ 337,770 $ — $ — $ — $ 337,770 $ 250,418 $ — $ — Derivatives qualifying as guarantees 3,119 396 12,296 39,919 55,730 54,415 475 322 Unsettled resale and securities borrowed agreements 101,553 2,128 — — 103,681 102,355 (h) 1 2 Unsettled repurchase and securities loaned agreements 73,631 632 — — 74,263 104,901 — (1) Loan sale and securitization-related indemnifications: Mortgage repurchase liability NA NA NA NA NA NA 61 84 Loans sold with recourse NA NA NA NA 827 889 19 23 Exchange & clearing house guarantees and commitments (f) 182,701 — — — 182,701 142,003 — — Other guarantees and commitments (g) 5,028 2,980 283 2,199 10,490 9,639 (h) 69 52 (a) Includes certain commitments to purchase loans from correspondents. (b) Also includes commercial card lending-related commitments primarily in CB and CIB. (c) Predominantly all consumer and wholesale lending-related commitments are in the U.S. (d) At December 31, 2021 and 2020, reflected the contractual amount net of risk participations totaling $44 million and $72 million, respectively, for other unfunded commitments to extend credit; $7.9 billion and $8.5 billion, respectively, for standby letters of credit and other financial guarantees; and $451 million and $357 million, respectively, for other letters of credit. In regulatory filings with the Federal Reserve these commitments are shown gross of risk participations. (e) At December 31, 2021 and 2020, collateral held by the Firm in support of securities lending indemnification agreements was $357.4 billion and $264.3 billion, respectively. Securities lending collateral primarily consists of cash, G7 government securities, and securities issued by U.S. GSEs and government agencies. (f) At December 31, 2021 and 2020, includes guarantees to the Fixed Income Clearing Corporation under the sponsored member repo program and commitments and guarantees associated with the Firm’s membership in certain clearing houses. (g) At December 31, 2021 and 2020, primarily includes unfunded commitments related to certain tax-oriented equity investments, unfunded commitments to purchase secondary market loans, and other equity investment commitments. (h) Prior-period amounts have been revised to conform with the current presentation . (i) For lending-related products, the carrying value represents the allowance for lending-related commitments and the guarantee liability; for derivative-related products, and lending-related commitments for which the fair value option was elected, the carrying value represents the fair value.
Standby letters of credit, other financial guarantees and other letters of credit	The following table summarizes the contractual amount and carrying value of standby letters of credit and other financial guarantees and other letters of credit arrangements as of December 31, 2021 and 2020. Standby letters of credit, other financial guarantees and other letters of credit 2021 2020 December 31, Standby letters of credit and Other letters Standby letters of credit and Other letters Investment-grade (a) $ 19,998 $ 3,087 $ 22,850 $ 2,263 Noninvestment-grade (a) 8,532 1,361 8,132 790 Total contractual amount $ 28,530 $ 4,448 $ 30,982 $ 3,053 Allowance for lending-related commitments $ 123 $ 9 $ 80 $ 14 Guarantee liability 353 — 363 — Total carrying value $ 476 $ 9 $ 443 $ 14 Commitments with collateral $ 14,511 $ 999 $ 17,238 $ 498 (a) The ratings scale is based on the Firm’s internal risk ratings. Refer to Note 12 for further information on internal risk ratings.
Schedule of derivatives qualifying as guarantees	The following table summarizes the derivatives qualifying as guarantees as of December 31, 2021 and 2020. (in millions) December 31, 2021 December 31, 2020 Notional amounts Derivative guarantees $ 55,730 $ 54,415 Stable value contracts with contractually limited exposure 29,778 27,752 Maximum exposure of stable value contracts with contractually limited exposure 2,882 2,803 Fair value Derivative payables 475 322

Pledged Assets and Collateral (

Pledged Assets and Collateral (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of pledged assets	The following table presents the Firm’s pledged assets. December 31, (in billions) 2021 2020 Assets that may be sold or repledged or otherwise used by secured parties $ 126.3 $ 166.6 Assets that may not be sold or repledged or otherwise used by secured parties 112.0 113.9 Assets pledged at Federal Reserve banks and FHLBs 476.4 455.3 Total pledged assets $ 714.7 $ 735.8 December 31, (in billions) 2021 2020 Investment securities $ 80.1 $ 80.2 Loans 428.5 420.5 Trading assets and other 206.1 235.1 Total pledged assets $ 714.7 $ 735.8
Schedule of collateral received	The following table presents the fair value of collateral accepted. December 31, (in billions) 2021 2020 Collateral permitted to be sold or repledged, delivered, or otherwise used $ 1,471.3 $ 1,451.7 Collateral sold, repledged, delivered or otherwise used 1,111.0 1,038.9

International Operations (Table

International Operations (Tables)	12 Months Ended
	Dec. 31, 2021
Segments, Geographical Areas [Abstract]
Schedule of revenue from external customers attributed to foreign countries by geographic area	The following table presents income statement and balance sheet-related information for JPMorgan Chase by major international geographic area. The Firm defines international activities for purposes of this footnote presentation as business transactions that involve clients residing outside of the U.S., and the information presented below is based predominantly on the domicile of the client, the location from which the client relationship is managed, booking location or the location of the trading desk. However, many of the Firm’s U.S. operations serve international businesses. As the Firm’s operations are highly integrated, estimates and subjective assumptions have been made to apportion revenue and expense between U.S. and international operations. These estimates and assumptions are consistent with the allocations used for the Firm’s segment reporting as set forth in Note 32. The Firm’s long-lived assets for the periods presented are not considered by management to be significant in relation to total assets. The majority of the Firm’s long-lived assets are located in the U.S. As of or for the year ended December 31, Revenue (c) Expense (d) Income before income tax Net income Total assets 2021 Europe/Middle East/Africa $ 16,561 $ 10,833 $ 5,728 $ 4,202 $ 517,904 (e) Asia-Pacific 9,654 6,372 3,282 2,300 277,897 Latin America/Caribbean 2,756 1,589 1,167 878 61,657 Total international 28,971 18,794 10,177 7,380 857,458 North America (a) 92,678 43,293 49,385 40,954 2,886,109 Total $ 121,649 $ 62,087 $ 59,562 $ 48,334 $ 3,743,567 2020 (b) Europe/Middle East/Africa $ 16,566 $ 10,987 $ 5,579 $ 3,868 $ 530,687 (e) Asia-Pacific 9,289 5,558 3,731 2,630 252,553 Latin America/Caribbean 2,740 1,590 1,150 837 61,980 Total international 28,595 18,135 10,460 7,335 845,220 North America (a) 91,356 66,001 25,355 21,796 2,539,537 Total $ 119,951 $ 84,136 $ 35,815 $ 29,131 $ 3,384,757 2019 (b) Europe/Middle East/Africa $ 15,887 $ 9,860 $ 6,027 $ 4,158 $ 391,369 (e) Asia-Pacific 7,254 5,060 2,194 1,467 183,023 Latin America/Caribbean 2,405 1,561 844 609 47,820 Total international 25,546 16,481 9,065 6,234 622,212 North America (a) 90,174 54,373 35,801 30,197 2,064,265 Total $ 115,720 $ 70,854 $ 44,866 $ 36,431 $ 2,686,477 (a) Substantially reflects the U.S. (b) Prior-period amounts have been revised to conform with the current presentation . (c) Revenue is composed of net interest income and noninterest revenue. (d) Expense is composed of noninterest expense and the provision for credit losses. (e) Total assets for the U.K. were approximately $365 billion, $353 billion and $309 billion at December 31, 2021, 2020 and 2019, respectively.

Business Segments (Tables)

Business Segments (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment results and reconciliation	The following table provides a summary of the Firm’s segment results as of or for the years ended December 31, 2021, 2020 and 2019, on a managed basis. The Firm’s definition of managed basis starts with the reported U.S. GAAP results and includes certain reclassifications to present total net revenue for the Firm (and each of the reportable business segments) on an FTE basis. Accordingly, revenue from investments that receive tax credits and tax-exempt securities is presented in the managed results on a basis comparable to taxable investments and securities. This allows management to assess the comparability of revenue from year-to-year arising from both taxable and tax-exempt sources. The corresponding income tax impact related to tax-exempt items is recorded within income tax expense/(benefit). These adjustments have no impact on net income as reported by the Firm as a whole or by the LOBs. Capital allocation Each business segment is allocated capital by taking into consideration a variety of factors including capital levels of similarly rated peers and applicable regulatory capital requirements. ROE is measured and internal targets for expected returns are established as key measures of a business segment’s performance. The Firm’s allocation methodology incorporates Basel III Standardized RWA, Basel III Advanced RWA, the GSIB surcharge, and a simulation of capital in a severe stress environment. The assumptions and methodologies used to allocate capital are periodically reassessed and as a result, the capital allocated to the LOBs may change from time to time. Segment results and reconciliation (a) (Table continued on next page) As of or for the year ended Consumer & Community Banking Corporate & Investment Bank Commercial Banking Asset & Wealth Management 2021 2020 2019 2021 2020 2019 2021 2020 2019 2021 2020 2019 Noninterest revenue $ 17,286 $ 17,740 $ 17,796 $ 38,209 $ 35,120 $ 30,060 $ 3,929 $ 3,067 $ 2,710 $ 13,071 $ 10,822 $ 10,236 Net interest income 32,787 33,528 37,337 13,540 14,164 9,205 6,079 6,246 6,554 3,886 3,418 3,355 Total net revenue 50,073 51,268 55,133 51,749 49,284 39,265 10,008 9,313 9,264 16,957 14,240 13,591 Provision for credit losses (6,989) 12,312 4,954 (1,174) 2,726 277 (947) 2,113 296 (227) 263 59 Noninterest expense 29,256 27,990 28,276 25,325 23,538 22,444 4,041 3,798 3,735 10,919 9,957 9,747 Income/(loss) before income tax expense/(benefit) 27,806 10,966 21,903 27,598 23,020 16,544 6,914 3,402 5,233 6,265 4,020 3,785 Income tax expense/(benefit) 6,876 2,749 5,362 6,464 5,926 4,590 1,668 824 1,275 1,528 1,028 918 Net income/(loss) $ 20,930 $ 8,217 $ 16,541 $ 21,134 $ 17,094 $ 11,954 $ 5,246 $ 2,578 $ 3,958 $ 4,737 $ 2,992 $ 2,867 Average equity $ 50,000 $ 52,000 $ 52,000 $ 83,000 $ 80,000 $ 80,000 $ 24,000 $ 22,000 $ 22,000 $ 14,000 $ 10,500 $ 10,500 Total assets 500,370 496,705 541,367 1,259,896 1,095,926 (b) 913,803 (b) 230,776 228,911 220,514 234,425 203,384 173,175 Return on equity 41 % 15 % 31 % 25 % 20 % 14 % 21 % 11 % 17 % 33 % 28 % 26 % Overhead ratio 58 55 51 49 48 57 40 41 40 64 70 72 (Table continued from previous page) As of or for the year ended Corporate Reconciling Items (a) Total 2021 2020 2019 2021 2020 2019 2021 2020 2019 Noninterest revenue $ 68 $ 1,199 $ (114) $ (3,225) $ (2,560) (b) $ (2,213) (b) $ 69,338 $ 65,388 $ 58,475 (b) Net interest income (3,551) (2,375) 1,325 (430) (418) (531) 52,311 54,563 57,245 Total net revenue (3,483) (1,176) 1,211 (3,655) (2,978) (2,744) 121,649 119,951 115,720 Provision for credit losses 81 66 (1) — — — (9,256) 17,480 5,585 Noninterest expense 1,802 1,373 1,067 — — — 71,343 66,656 65,269 Income/(loss) before income tax expense/(benefit) (5,366) (2,615) 145 (3,655) (2,978) (2,744) 59,562 35,815 44,866 Income tax expense/(benefit) (1,653) (865) (966) (3,655) (2,978) (b) (2,744) (b) 11,228 6,684 8,435 (b) Net income/(loss) $ (3,713) $ (1,750) $ 1,111 $ — $ — $ — $ 48,334 $ 29,131 $ 36,431 Average equity $ 79,968 $ 72,365 $ 68,407 $ — $ — $ — $ 250,968 $ 236,865 $ 232,907 Total assets 1,518,100 1,359,831 837,618 NA NA NA 3,743,567 3,384,757 2,686,477 (b) Return on equity NM NM NM NM NM NM 19 % 12 % 15 % Overhead ratio NM NM NM NM NM NM 59 56 56 (b) (a) Segment results on a managed basis reflect revenue on a FTE basis with the corresponding income tax impact recorded within income tax expense/(benefit). These adjustments are eliminated in reconciling items to arrive at the Firm’s reported U.S. GAAP results. (b) Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Parent Company (Tables)

Parent Company (Tables)	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Schedule of condensed financial information of Parent Company-only	The following tables present Parent Company-only financial statements. Statements of income and comprehensive income Year ended December 31, 2021 2020 2019 Income Dividends from subsidiaries and affiliates: Bank and bank holding company $ 10,000 $ 6,000 $ 26,000 Non-bank (a) — — — Interest income from subsidiaries 32 63 223 Other income/(expense) from subsidiaries: Bank and bank holding company 859 2,019 2,738 Non-bank 366 (569) 197 Other income/(expense) 1,137 205 (1,731) Total income 12,394 7,718 27,427 Expense Interest expense/(income) to subsidiaries and affiliates (a) 5,353 (8,830) (5,303) Other interest expense/(income) (1,349) 14,150 13,246 Noninterest expense 2,637 2,222 1,992 Total expense 6,641 7,542 9,935 Income before income tax benefit and undistributed net income of subsidiaries 5,753 176 17,492 Income tax benefit 1,329 1,324 2,033 Equity in undistributed net income of subsidiaries 41,252 27,631 16,906 Net income $ 48,334 $ 29,131 $ 36,431 Other comprehensive income/(loss), net (8,070) 6,417 3,076 Comprehensive income $ 40,264 $ 35,548 $ 39,507 Balance sheets December 31, (in millions) 2021 2020 Assets Cash and due from banks $ 36 $ 54 Deposits with banking subsidiaries 6,809 6,811 Trading assets 2,293 1,775 Advances to, and receivables from, subsidiaries: Bank and bank holding company 431 27 Non-bank 50 86 Investments (at equity) in subsidiaries and affiliates: Bank and bank holding company 545,635 508,602 Non-bank 1,007 1,011 Other assets 12,220 10,058 Total assets $ 568,481 $ 528,424 Liabilities and stockholders’ equity Borrowings from, and payables to, subsidiaries and affiliates (a) $ 28,039 $ 25,150 Short-term borrowings 1,018 924 Other liabilities 9,340 9,612 Long-term debt (b)(c) 235,957 213,384 Total liabilities (c) 274,354 249,070 Total stockholders’ equity 294,127 279,354 Total liabilities and stockholders’ equity $ 568,481 $ 528,424 Statements of cash flows Year ended December 31, 2021 2020 2019 Operating activities Net income $ 48,334 $ 29,131 $ 36,431 Less: Net income of subsidiaries and affiliates (a) 51,252 33,631 42,906 Parent company net loss (2,918) (4,500) (6,475) Cash dividends from subsidiaries and affiliates (a) 10,000 6,000 26,000 Other operating adjustments (12,677) 15,357 9,862 Net cash provided by/(used in) operating activities (5,595) 16,857 29,387 Investing activities Net change in: Advances to and investments in subsidiaries and affiliates, net (3,000) (2,663) (6) (e) All other investing activities, net 31 24 71 Net cash provided by/(used in) investing activities (2,969) (2,639) 65 Financing activities Net change in: Borrowings from subsidiaries and affiliates (a) 2,647 1,425 2,941 Short-term borrowings — (20) (56) Proceeds from long-term borrowings 49,169 37,312 25,569 Payments of long-term borrowings (15,543) (34,194) (21,226) Proceeds from issuance of preferred stock 7,350 4,500 5,000 Redemption of preferred stock (2,575) (1,430) (4,075) Treasury stock repurchased (18,408) (6,517) (24,001) Dividends paid (12,858) (12,690) (12,343) All other financing activities, net (1,238) (1,080) (1,290) Net cash provided by/(used in) financing activities 8,544 (12,694) (29,481) Net increase/(decrease) in cash and due from banks and deposits with banking subsidiaries (20) 1,524 (29) Cash and due from banks and deposits with banking subsidiaries at the beginning of the year 6,865 5,341 5,370 Cash and due from banks and deposits with banking subsidiaries at the end of the year $ 6,845 $ 6,865 $ 5,341 Cash interest paid $ 4,065 $ 5,445 $ 7,957 Cash income taxes paid, net (d) 15,259 5,366 3,910 (a) Affiliates include trusts that issued guaranteed capital debt securities (“issuer trusts”). (b) At December 31, 2021, long-term debt that contractually matures in 2022 through 2026 totaled $10.7 billion, $16.6 billion, $24.2 billion, $22.8 billion, and $24.7 billion, respectively. (c) Refer to Notes 20 and 28 for information regarding the Parent Company’s guarantees of its subsidiaries’ obligations. (d) Represents payments, net of refunds, made by the Parent Company to various taxing authorities and includes taxes paid on behalf of certain of its subsidiaries that are subsequently reimbursed. The reimbursements were $13.9 billion, $8.3 billion, and $6.4 billion for the years ended December 31, 2021, 2020, and 2019, respectively. (e) As a result of the merger of Chase Bank USA, N.A. with and into JPMorgan Chase Bank, N.A., JPMorgan Chase Bank, N.A. distributed $13.5 billion to the Parent company as a return of capital, which the Parent company contributed to the IHC.

Basis of Presentation (Details)

Basis of Presentation (Details) $ in Billions	Jan. 01, 2020USD ($)
Cumulative effect of change in accounting principles
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Decrease to retained earnings due to CECL adoption	$ 2.7

Fair Value Measurement - Recurr

Fair Value Measurement - Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	$ 545,287	$ 703,368
Derivative netting adjustments	(488,206)	(627,924)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	57,081	75,444
Trading assets	433,575	503,126
Available-for-sale securities	308,525	388,178
Loans	58,820	44,474
Mortgage servicing rights	5,494	3,276	$ 4,699	$ 6,130
Derivative payables, gross	535,044	688,887
Derivative netting adjustments	(484,928)	(618,264)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	50,116	70,623
Interest rate
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	270,585	391,648
Derivative netting adjustments	(248,611)	(355,923)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	21,974	35,725
Derivative payables, gross	240,731	353,987
Derivative netting adjustments	(232,537)	(340,975)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	8,194	13,012
Credit
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	9,839	13,345
Derivative netting adjustments	(8,808)	(12,665)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	1,031	680
Derivative payables, gross	10,912	14,832
Derivative netting adjustments	(10,032)	(12,837)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	880	1,995
Foreign exchange
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	169,579	206,260
Derivative netting adjustments	(156,954)	(190,479)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	12,625	15,781
Derivative payables, gross	175,746	215,926
Derivative netting adjustments	(161,649)	(194,493)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	14,097	21,433
Equity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	68,631	70,612
Derivative netting adjustments	(58,650)	(54,125)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	9,981	16,487
Derivative payables, gross	79,727	81,413
Derivative netting adjustments	(62,494)	(55,515)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	17,233	25,898
Commodity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	26,653	21,503
Derivative netting adjustments	(15,183)	(14,732)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	11,470	6,771
Derivative payables, gross	27,928	22,729
Derivative netting adjustments	(18,216)	(14,444)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	9,712	8,285
Total mortgage-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	83,562	126,390
Mortgage-backed securities, Commercial - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	4,949	2,856
U.S. Treasury, GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	177,463	201,951
Obligations of U.S. states and municipalities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	7,100	7,200
Available-for-sale securities	15,860	20,396
Non-U.S. government debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	16,209	22,928
Corporate debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	321	216
Asset-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	15,110
Asset-backed securities, collateralized loan obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	9,662	10,048
Fair Value Measured at Net Asset Value Per Share
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets	51	52
Fair value assets and liabilities measured on recurring basis - supplemental data
Alternative investments, net asset value, fair value	801	670
Other assets	750	618
Recurring
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Federal funds sold and securities purchased under resale agreements	252,720	238,015
Securities borrowed	81,463	52,983
Trading assets, debt and equity instruments	376,443	427,630
Derivative netting adjustments	(488,206)	(627,924)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	57,081	75,444
Trading assets	433,524	503,074
Available-for-sale securities	308,525	388,178
Loans	58,820	44,474
Mortgage servicing rights	5,494	3,276
Total assets measured at fair value on a recurring basis	1,154,549	1,243,209
Deposits	11,333	14,484
Federal funds purchased and securities loaned or sold under repurchase agreements	126,435	155,735
Short-term borrowings	20,015	16,893
Trading liabilities, Debt and equity instruments	114,577	99,558
Derivative netting adjustments	(484,928)	(618,264)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	50,116	70,623
Trading liabilities	164,693	170,181
Accounts payable and other liabilities	5,651	3,476
Beneficial interests issued by consolidated VIEs	12	41
Long-term debt	74,934	76,817
Total liabilities measured at fair value on a recurring basis	403,073	437,627
Recurring | Other assets
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Other assets	14,003	13,209
Fair value assets and liabilities measured on recurring basis - supplemental data
Other assets	14,753	13,827
Recurring | Interest rate
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative netting adjustments	(248,611)	(355,923)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	21,974	35,725
Derivative netting adjustments	(232,537)	(340,975)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	8,194	13,012
Recurring | Credit
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative netting adjustments	(8,808)	(12,665)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	1,031	680
Derivative netting adjustments	(10,032)	(12,837)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	880	1,995
Recurring | Foreign exchange
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative netting adjustments	(156,954)	(190,479)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	12,625	15,781
Derivative netting adjustments	(161,649)	(194,493)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	14,097	21,433
Recurring | Equity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative netting adjustments	(58,650)	(54,125)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	9,981	16,487
Derivative netting adjustments	(62,494)	(55,515)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	17,233	25,898
Recurring | Commodity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative netting adjustments	(15,183)	(14,732)
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	11,470	6,771
Derivative netting adjustments	(18,216)	(14,444)
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	9,712	8,285
Recurring | Total debt instruments
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	235,981	294,496
Recurring | Total mortgage-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	43,111	72,340
Available-for-sale securities	83,562	126,390
Recurring | Mortgage-backed securities, U.S. GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	39,209	68,844
Available-for-sale securities	72,543	113,301
Recurring | Mortgage-backed securities, Residential - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	2,386	2,166
Available-for-sale securities	6,070	10,233
Recurring | Mortgage-backed securities, Commercial - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	1,516	1,330
Available-for-sale securities	4,949	2,856
Recurring | U.S. Treasury, GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	77,708	115,259
Available-for-sale securities	177,463	201,951
Recurring | Obligations of U.S. states and municipalities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	7,075	7,192
Available-for-sale securities	15,860	20,396
Recurring | Certificates of deposit, bankers’ acceptances and commercial paper
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	852	1,230
Recurring | Non-U.S. government debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	71,644	67,625
Available-for-sale securities	16,209	22,928
Recurring | Corporate debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	24,823	21,524
Available-for-sale securities	321	216
Recurring | Loans
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	8,074	6,994
Recurring | Asset-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	2,694	2,332
Recurring | Asset-backed securities, collateralized loan obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	9,662	10,048
Recurring | Asset-backed securities, other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	5,448	6,249
Recurring | Equity securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	89,307	100,163
Recurring | Physical commodities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	26,145	11,571
Recurring | Other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	25,010	21,400
Recurring | US GSE obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	73,900	117,600
Recurring | Residential mortgage
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	26,200	15,100
Recurring | Commercial mortgage
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	8,200	6,300
Recurring | Residential conforming mortgage intended for sale to government agency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	13,600	8,400
Recurring | Level 1
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Federal funds sold and securities purchased under resale agreements	0	0
Securities borrowed	0	0
Trading assets, debt and equity instruments	187,770	234,452
Derivative receivables, gross	1,206	2,464
Trading assets	188,976	236,916
Available-for-sale securities	182,897	215,093
Loans	0	0
Mortgage servicing rights	0	0
Total assets measured at fair value on a recurring basis	381,431	460,119
Deposits	0	0
Federal funds purchased and securities loaned or sold under repurchase agreements	0	0
Short-term borrowings	0	0
Trading liabilities, Debt and equity instruments	87,831	82,669
Derivative payables, gross	1,104	2,628
Trading liabilities	88,935	85,297
Accounts payable and other liabilities	5,115	2,895
Beneficial interests issued by consolidated VIEs	0	0
Long-term debt	0	0
Total liabilities measured at fair value on a recurring basis	94,050	88,192
Recurring | Level 1 | Other assets
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Other assets	9,558	8,110
Recurring | Level 1 | Interest rate
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	1,072	2,318
Derivative payables, gross	981	2,496
Recurring | Level 1 | Credit
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	0	0
Derivative payables, gross	0	0
Recurring | Level 1 | Foreign exchange
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	134	146
Derivative payables, gross	123	132
Recurring | Level 1 | Equity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	0	0
Derivative payables, gross	0	0
Recurring | Level 1 | Commodity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	0	0
Derivative payables, gross	0	0
Recurring | Level 1 | Total debt instruments
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	95,509	131,035
Recurring | Level 1 | Total mortgage-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	4	7
Recurring | Level 1 | Mortgage-backed securities, U.S. GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	4	7
Recurring | Level 1 | Mortgage-backed securities, Residential - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	0	0
Recurring | Level 1 | Mortgage-backed securities, Commercial - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	0	0
Recurring | Level 1 | U.S. Treasury, GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	68,527	104,263
Available-for-sale securities	177,463	201,951
Recurring | Level 1 | Obligations of U.S. states and municipalities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	0	0
Recurring | Level 1 | Certificates of deposit, bankers’ acceptances and commercial paper
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 1 | Non-U.S. government debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	26,982	26,772
Available-for-sale securities	5,430	13,135
Recurring | Level 1 | Corporate debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	0	0
Recurring | Level 1 | Loans
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 1 | Asset-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 1 | Asset-backed securities, collateralized loan obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	0	0
Recurring | Level 1 | Asset-backed securities, other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	0	0
Recurring | Level 1 | Equity securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	86,904	97,035
Recurring | Level 1 | Physical commodities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	5,357	6,382
Recurring | Level 1 | Other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 2
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Federal funds sold and securities purchased under resale agreements	252,720	238,015
Securities borrowed	81,463	52,983
Trading assets, debt and equity instruments	186,394	190,555
Derivative receivables, gross	536,775	693,236
Trading assets	723,169	883,791
Available-for-sale securities	125,467	173,085
Loans	56,887	42,169
Mortgage servicing rights	0	0
Total assets measured at fair value on a recurring basis	1,243,845	1,394,604
Deposits	9,016	11,571
Federal funds purchased and securities loaned or sold under repurchase agreements	126,435	155,735
Short-term borrowings	17,534	14,473
Trading liabilities, Debt and equity instruments	26,716	16,838
Derivative payables, gross	521,740	673,598
Trading liabilities	548,456	690,436
Accounts payable and other liabilities	467	513
Beneficial interests issued by consolidated VIEs	12	41
Long-term debt	50,560	53,420
Total liabilities measured at fair value on a recurring basis	752,480	926,189
Recurring | Level 2 | Other assets
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Other assets	4,139	4,561
Recurring | Level 2 | Interest rate
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	267,493	387,023
Derivative payables, gross	237,714	349,442
Recurring | Level 2 | Credit
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	9,321	12,721
Derivative payables, gross	10,468	13,984
Recurring | Level 2 | Foreign exchange
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	168,590	205,127
Derivative payables, gross	174,349	214,373
Recurring | Level 2 | Equity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	65,139	67,093
Derivative payables, gross	72,609	74,032
Recurring | Level 2 | Commodity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	26,232	21,272
Derivative payables, gross	26,600	21,767
Recurring | Level 2 | Total debt instruments
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	139,015	161,363
Recurring | Level 2 | Total mortgage-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	42,808	71,860
Available-for-sale securities	83,558	126,383
Recurring | Level 2 | Mortgage-backed securities, U.S. GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	38,944	68,395
Available-for-sale securities	72,539	113,294
Recurring | Level 2 | Mortgage-backed securities, Residential - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	2,358	2,138
Available-for-sale securities	6,070	10,233
Recurring | Level 2 | Mortgage-backed securities, Commercial - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	1,506	1,327
Available-for-sale securities	4,949	2,856
Recurring | Level 2 | U.S. Treasury, GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	9,181	10,996
Available-for-sale securities	0	0
Recurring | Level 2 | Obligations of U.S. states and municipalities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	7,068	7,184
Available-for-sale securities	15,860	20,396
Recurring | Level 2 | Certificates of deposit, bankers’ acceptances and commercial paper
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	852	1,230
Recurring | Level 2 | Non-U.S. government debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	44,581	40,671
Available-for-sale securities	10,779	9,793
Recurring | Level 2 | Corporate debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	24,491	21,017
Available-for-sale securities	160	216
Recurring | Level 2 | Loans
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	7,366	6,101
Recurring | Level 2 | Asset-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	2,668	2,304
Recurring | Level 2 | Asset-backed securities, collateralized loan obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	9,662	10,048
Recurring | Level 2 | Asset-backed securities, other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	5,448	6,249
Recurring | Level 2 | Equity securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	1,741	2,652
Recurring | Level 2 | Physical commodities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	20,788	5,189
Recurring | Level 2 | Other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	24,850	21,351
Recurring | Level 3
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Federal funds sold and securities purchased under resale agreements	0	0
Securities borrowed	0	0
Trading assets, debt and equity instruments	2,279	2,623
Derivative receivables, gross	7,306	7,668
Trading assets	9,585	10,291
Available-for-sale securities	161	0
Loans	1,933	2,305
Mortgage servicing rights	5,494	3,276
Total assets measured at fair value on a recurring basis	17,479	16,410
Deposits	2,317	2,913
Federal funds purchased and securities loaned or sold under repurchase agreements	0	0
Short-term borrowings	2,481	2,420
Trading liabilities, Debt and equity instruments	30	51
Derivative payables, gross	12,200	12,661
Trading liabilities	12,230	12,712
Accounts payable and other liabilities	69	68
Beneficial interests issued by consolidated VIEs	0	0
Long-term debt	24,374	23,397
Total liabilities measured at fair value on a recurring basis	41,471	41,510
Recurring | Level 3 | Other assets
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Other assets	306	538
Recurring | Level 3 | Interest rate
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	2,020	2,307
Derivative payables, gross	2,036	2,049
Recurring | Level 3 | Credit
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	518	624
Derivative payables, gross	444	848
Recurring | Level 3 | Foreign exchange
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	855	987
Derivative payables, gross	1,274	1,421
Recurring | Level 3 | Equity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	3,492	3,519
Derivative payables, gross	7,118	7,381
Recurring | Level 3 | Commodity
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Derivative receivables, gross	421	231
Derivative payables, gross	1,328	962
Recurring | Level 3 | Total debt instruments
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	1,457	2,098
Recurring | Level 3 | Total mortgage-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	303	480
Available-for-sale securities	0	0
Recurring | Level 3 | Mortgage-backed securities, U.S. GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	265	449
Available-for-sale securities	0	0
Recurring | Level 3 | Mortgage-backed securities, Residential - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	28	28
Available-for-sale securities	0	0
Recurring | Level 3 | Mortgage-backed securities, Commercial - nonagency
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	10	3
Available-for-sale securities	0	0
Recurring | Level 3 | U.S. Treasury, GSEs and government agencies
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Available-for-sale securities	0	0
Recurring | Level 3 | Obligations of U.S. states and municipalities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	7	8
Available-for-sale securities	0	0
Recurring | Level 3 | Certificates of deposit, bankers’ acceptances and commercial paper
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 3 | Non-U.S. government debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	81	182
Available-for-sale securities	0	0
Recurring | Level 3 | Corporate debt securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	332	507
Available-for-sale securities	161	0
Recurring | Level 3 | Loans
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	708	893
Recurring | Level 3 | Asset-backed securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	26	28
Recurring | Level 3 | Asset-backed securities, collateralized loan obligations
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	0	0
Recurring | Level 3 | Asset-backed securities, other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Available-for-sale securities	0	0
Recurring | Level 3 | Equity securities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	662	476
Recurring | Level 3 | Physical commodities
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	0	0
Recurring | Level 3 | Other
Assets and liabilities measured at fair value on a recurring basis [Abstract]
Trading assets, debt and equity instruments	$ 160	$ 49

Fair Value Measurement - Level

Fair Value Measurement - Level 3 Inputs (Details) $ in Millions	Dec. 31, 2021USD ($)$ / MT$ / shares	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	$ 58,820	$ 44,474
MSRs	5,494	3,276	$ 4,699	$ 6,130
Equity securities without readily determinable fair values	$ 3,642	2,368
Assumed par value for price input (in dollars per share) | $ / shares	$ 100
Level 3 | Discounted cash flows | Credit correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.35
Level 3 | Discounted cash flows | Credit correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.65
Level 3 | Discounted cash flows | Credit correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.46
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Yield | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Yield | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.15
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Yield | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.04
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Prepayment speed | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Prepayment speed | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.15
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Prepayment speed | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.14
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Conditional default rate | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Conditional default rate | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.02
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Conditional default rate | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Loss severity | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Loss severity | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	1.10
Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans | Loss severity | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input	0.04
Level 3 | Discounted cash flows | Net interest rate derivatives | Prepayment speed | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0
Level 3 | Discounted cash flows | Net interest rate derivatives | Prepayment speed | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.30
Level 3 | Discounted cash flows | Net interest rate derivatives | Prepayment speed | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.08
Level 3 | Discounted cash flows | Net credit derivatives | Credit correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.35
Level 3 | Discounted cash flows | Net credit derivatives | Credit correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.65
Level 3 | Discounted cash flows | Net credit derivatives | Credit correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.46
Level 3 | Discounted cash flows | Net credit derivatives | Credit spread | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0001
Level 3 | Discounted cash flows | Net credit derivatives | Credit spread | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.4396
Level 3 | Discounted cash flows | Net credit derivatives | Credit spread | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0384
Level 3 | Discounted cash flows | Net credit derivatives | Recovery rate | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.35
Level 3 | Discounted cash flows | Net credit derivatives | Recovery rate | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.67
Level 3 | Discounted cash flows | Net credit derivatives | Recovery rate | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.51
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Prepayment speed | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.09
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Prepayment speed | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.09
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Prepayment speed | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.09
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Interest rate curve | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Interest rate curve | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.28
Level 3 | Discounted cash flows | Net foreign exchange derivatives | Interest rate curve | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.04
Level 3 | Market comparables | Commercial mortgage-backed securities and loans | Price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input | $ / shares	0
Level 3 | Market comparables | Commercial mortgage-backed securities and loans | Price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input | $ / shares	103
Level 3 | Market comparables | Commercial mortgage-backed securities and loans | Price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans, measurement input | $ / shares	84
Level 3 | Market comparables | Corporate debt securities | Price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	0
Level 3 | Market comparables | Corporate debt securities | Price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	154
Level 3 | Market comparables | Corporate debt securities | Price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	87
Level 3 | Market comparables | Loans | Price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans, measurement input | $ / shares	5
Level 3 | Market comparables | Loans | Price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans, measurement input | $ / shares	107
Level 3 | Market comparables | Loans | Price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans, measurement input | $ / shares	89
Level 3 | Market comparables | Non-U.S. government debt securities | Price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	87
Level 3 | Market comparables | Non-U.S. government debt securities | Price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	103
Level 3 | Market comparables | Non-U.S. government debt securities | Price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading, measurement input | $ / shares	96
Level 3 | Market comparables | Net credit derivatives | Price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0
Level 3 | Market comparables | Net credit derivatives | Price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	115
Level 3 | Market comparables | Net credit derivatives | Price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	80
Level 3 | Option pricing | Interest rate volatility | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.0005
Level 3 | Option pricing | Interest rate volatility | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.0544
Level 3 | Option pricing | Interest rate volatility | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.0106
Level 3 | Option pricing | Interest rate correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	(0.65)
Level 3 | Option pricing | Interest rate correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.87
Level 3 | Option pricing | Interest rate correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.25
Level 3 | Option pricing | IR-FX correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	(0.35)
Level 3 | Option pricing | IR-FX correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.50
Level 3 | Option pricing | IR-FX correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	(0.02)
Level 3 | Option pricing | Equity correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.17
Level 3 | Option pricing | Equity correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	1
Level 3 | Option pricing | Equity correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.55
Level 3 | Option pricing | Equity-FX correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	(0.79)
Level 3 | Option pricing | Equity-FX correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.59
Level 3 | Option pricing | Equity-FX correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	(0.27)
Level 3 | Option pricing | Equity-IR correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.15
Level 3 | Option pricing | Equity-IR correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.50
Level 3 | Option pricing | Equity-IR correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits, measurement inputs	0.27
Level 3 | Option pricing | Net interest rate derivatives | Interest rate volatility | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0005
Level 3 | Option pricing | Net interest rate derivatives | Interest rate volatility | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0544
Level 3 | Option pricing | Net interest rate derivatives | Interest rate volatility | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0106
Level 3 | Option pricing | Net interest rate derivatives | Interest rate spread volatility | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0011
Level 3 | Option pricing | Net interest rate derivatives | Interest rate spread volatility | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0023
Level 3 | Option pricing | Net interest rate derivatives | Interest rate spread volatility | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.0014
Level 3 | Option pricing | Net interest rate derivatives | Interest rate correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.65)
Level 3 | Option pricing | Net interest rate derivatives | Interest rate correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.87
Level 3 | Option pricing | Net interest rate derivatives | Interest rate correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.25
Level 3 | Option pricing | Net interest rate derivatives | IR-FX correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.35)
Level 3 | Option pricing | Net interest rate derivatives | IR-FX correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.50
Level 3 | Option pricing | Net interest rate derivatives | IR-FX correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.02)
Level 3 | Option pricing | Net foreign exchange derivatives | IR-FX correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.40)
Level 3 | Option pricing | Net foreign exchange derivatives | IR-FX correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.65
Level 3 | Option pricing | Net foreign exchange derivatives | IR-FX correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.17
Level 3 | Option pricing | Net equity derivatives | Forward equity price | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.63
Level 3 | Option pricing | Net equity derivatives | Forward equity price | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	1.22
Level 3 | Option pricing | Net equity derivatives | Forward equity price | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.99
Level 3 | Option pricing | Net equity derivatives | Equity volatility | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.04
Level 3 | Option pricing | Net equity derivatives | Equity volatility | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	1.32
Level 3 | Option pricing | Net equity derivatives | Equity volatility | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.32
Level 3 | Option pricing | Net equity derivatives | Equity correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.17
Level 3 | Option pricing | Net equity derivatives | Equity correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	1
Level 3 | Option pricing | Net equity derivatives | Equity correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.55
Level 3 | Option pricing | Net equity derivatives | Equity-FX correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.79)
Level 3 | Option pricing | Net equity derivatives | Equity-FX correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.59
Level 3 | Option pricing | Net equity derivatives | Equity-FX correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.27)
Level 3 | Option pricing | Net equity derivatives | Equity-IR correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.15
Level 3 | Option pricing | Net equity derivatives | Equity-IR correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.50
Level 3 | Option pricing | Net equity derivatives | Equity-IR correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.27
Level 3 | Option pricing | Net commodity derivatives | Oil commodity forward | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	631
Level 3 | Option pricing | Net commodity derivatives | Oil commodity forward | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	747
Level 3 | Option pricing | Net commodity derivatives | Oil commodity forward | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	689
Level 3 | Option pricing | Net commodity derivatives | Industrial metals commodity forward | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	2,610
Level 3 | Option pricing | Net commodity derivatives | Industrial metals commodity forward | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	3,482
Level 3 | Option pricing | Net commodity derivatives | Industrial metals commodity forward | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs | $ / MT	3,046
Level 3 | Option pricing | Net commodity derivatives | Commodity volatility | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.05
Level 3 | Option pricing | Net commodity derivatives | Commodity volatility | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	1.85
Level 3 | Option pricing | Net commodity derivatives | Commodity volatility | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.95
Level 3 | Option pricing | Net commodity derivatives | Commodity correlation | Minimum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	(0.50)
Level 3 | Option pricing | Net commodity derivatives | Commodity correlation | Maximum
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.76
Level 3 | Option pricing | Net commodity derivatives | Commodity correlation | Average
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability), measurement inputs	0.13
Recurring
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	$ 58,820	44,474
MSRs	5,494	3,276
Long-term debt, short-term borrowings, and deposits	403,073	437,627
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	1,933	2,305
MSRs	5,494	3,276
Long-term debt, short-term borrowings, and deposits	41,471	$ 41,510
Other level 3 assets and liabilities, net	1,062
Equity securities without readily determinable fair values	806
Recurring | Level 3 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Equity securities without readily determinable fair values	144
Recurring | Level 3 | Discounted cash flows
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
MSRs	5,494
Long-term debt, short-term borrowings, and deposits	936
Recurring | Level 3 | Discounted cash flows | Residential mortgage-backed securities and loans
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	1,181
Recurring | Level 3 | Discounted cash flows | Nontrading loans | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	888
Recurring | Level 3 | Discounted cash flows | Net interest rate derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	10
Recurring | Level 3 | Discounted cash flows | Net credit derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	26
Recurring | Level 3 | Discounted cash flows | Net foreign exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	(99)
Recurring | Level 3 | Discounted cash flows | Mortgage-backed securities, U.S. GSEs and government agencies | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	265
Recurring | Level 3 | Discounted cash flows | Residential mortgage-backed securities | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	28
Recurring | Level 3 | Market comparables | Commercial mortgage-backed securities and loans
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	391
Recurring | Level 3 | Market comparables | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading	493
Recurring | Level 3 | Market comparables | Loans
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	1,372
Recurring | Level 3 | Market comparables | Trading loans
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	668
Recurring | Level 3 | Market comparables | Trading loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	40
Recurring | Level 3 | Market comparables | Nontrading loans
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Loans	704
Recurring | Level 3 | Market comparables | Nontrading loans | Commercial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	341
Recurring | Level 3 | Market comparables | Non-U.S. government debt securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities, trading	81
Recurring | Level 3 | Market comparables | Net credit derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	48
Recurring | Level 3 | Market comparables | Commercial | Commercial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Debt securities and loans	10
Recurring | Level 3 | Option pricing
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Long-term debt, short-term borrowings, and deposits	28,236
Recurring | Level 3 | Option pricing | Net interest rate derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	(26)
Recurring | Level 3 | Option pricing | Net foreign exchange derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	(320)
Recurring | Level 3 | Option pricing | Net equity derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	(3,626)
Recurring | Level 3 | Option pricing | Net commodity derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Net derivative asset (liability)	$ (907)

Fair Value Measurement - Change

Fair Value Measurement - Changes in Level 3 Recurring Measurements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Net derivative receivables:
Beginning balance	$ (4,993)	$ (4,489)	$ (3,796)
Total realized/unrealized gains/(losses)	502	1,908	(794)
Purchases	1,662	2,121	579
Sales	(3,620)	(2,884)	(1,122)
Settlements	1,031	(446)	(89)
Transfers into level 3	445	(1,505)	(411)
Transfers (out of) level 3	79	302	1,144
Ending balance	(4,894)	(4,993)	(4,489)
Change in unrealized gains/(losses) related to financial instruments held	$ (145)	$ 42	$ (2,584)
Level 3 Rollforward Supplemental Data [Abstract]
Level 3 assets as a percentage of total firm assets at fair value	2.00%	1.00%	2.00%
Level 3 liabilities as a percentage of total firm liabilities at fair value	10.00%	9.00%	16.00%
Deposits
Liabilities:
Beginning balance	$ 2,913	$ 3,360	$ 4,169
Total realized/unrealized (gains)/losses	(80)	165	278
Purchases	0	0	0
Sales	0	0	0
Issuances	431	671	916
Settlements	(467)	(605)	(806)
Transfers into level 3	2	265	12
Transfers (out of) level 3	(482)	(943)	(1,209)
Ending balance	2,317	2,913	3,360
Change in unrealized (gains)/losses related to financials instruments held	(77)	455	307
Short-term borrowings
Liabilities:
Beginning balance	2,420	1,674	1,523
Total realized/unrealized (gains)/losses	(1,391)	(338)	229
Purchases	0	0	0
Sales	0	0	0
Issuances	6,823	5,140	3,441
Settlements	(5,308)	(4,115)	(3,356)
Transfers into level 3	9	105	85
Transfers (out of) level 3	(72)	(46)	(248)
Ending balance	2,481	2,420	1,674
Change in unrealized (gains)/losses related to financials instruments held	(83)	143	155
Total debt and equity instruments
Liabilities:
Beginning balance	51	41	50
Total realized/unrealized (gains)/losses	(8)	(2)	2
Purchases	(101)	(126)	(22)
Sales	38	14	41
Issuances	0	0	0
Settlements	0	(4)	1
Transfers into level 3	64	136	16
Transfers (out of) level 3	(14)	(8)	(47)
Ending balance	30	51	41
Change in unrealized (gains)/losses related to financials instruments held	(157)	(1)	3
Accounts payable and other liabilities
Liabilities:
Beginning balance	68	45	10
Total realized/unrealized (gains)/losses	8	33	(2)
Purchases	0	(87)	(84)
Sales	1	37	115
Issuances	0	0	0
Settlements	0	0	0
Transfers into level 3	0	47	6
Transfers (out of) level 3	(8)	(7)	0
Ending balance	69	68	45
Change in unrealized (gains)/losses related to financials instruments held	8	28	29
Beneficial interests issued by consolidated VIEs
Liabilities:
Beginning balance	0	0	1
Total realized/unrealized (gains)/losses	0	0	(1)
Purchases	0	0	0
Sales	0	0	0
Issuances	0	0	0
Settlements	0	0	0
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	0
Ending balance	0	0	0
Change in unrealized (gains)/losses related to financials instruments held	0	0	0
Long-term debt
Liabilities:
Beginning balance	23,397	23,339	19,418
Total realized/unrealized (gains)/losses	369	40	2,815
Purchases	0	0	0
Sales	0	0	0
Issuances	13,505	9,883	10,441
Settlements	(12,191)	(9,833)	(8,538)
Transfers into level 3	103	1,250	651
Transfers (out of) level 3	(809)	(1,282)	(1,448)
Ending balance	24,374	23,397	23,339
Change in unrealized (gains)/losses related to financials instruments held	87	1,920	2,822
DVA for fair value option elected liabilities
Level 3 Rollforward Supplemental Data [Abstract]
Unrealized (gains)/losses on liabilities recorded in OCI	258	221	319
Interest rate
Net derivative receivables:
Beginning balance	258	(332)	(38)
Total realized/unrealized gains/(losses)	1,789	2,682	(394)
Purchases	116	308	109
Sales	(192)	(148)	(125)
Settlements	(2,011)	(2,228)	5
Transfers into level 3	112	(332)	(7)
Transfers (out of) level 3	(88)	308	118
Ending balance	(16)	258	(332)
Change in unrealized gains/(losses) related to financial instruments held	282	325	(599)
Credit
Net derivative receivables:
Beginning balance	(224)	(139)	(107)
Total realized/unrealized gains/(losses)	130	(212)	(36)
Purchases	6	73	20
Sales	(12)	(154)	(9)
Settlements	146	181	8
Transfers into level 3	34	59	29
Transfers (out of) level 3	(6)	(32)	(44)
Ending balance	74	(224)	(139)
Change in unrealized gains/(losses) related to financial instruments held	141	(110)	(127)
Foreign exchange
Net derivative receivables:
Beginning balance	(434)	(607)	(297)
Total realized/unrealized gains/(losses)	(209)	49	(551)
Purchases	110	49	17
Sales	(110)	(24)	(67)
Settlements	222	83	312
Transfers into level 3	(12)	13	(22)
Transfers (out of) level 3	14	3	1
Ending balance	(419)	(434)	(607)
Change in unrealized gains/(losses) related to financial instruments held	13	116	(380)
Equity
Net derivative receivables:
Beginning balance	(3,862)	(3,395)	(2,225)
Total realized/unrealized gains/(losses)	(480)	(65)	(310)
Purchases	1,285	1,664	397
Sales	(2,813)	(2,317)	(573)
Settlements	1,758	1,162	(503)
Transfers into level 3	315	(935)	(405)
Transfers (out of) level 3	171	24	224
Ending balance	(3,626)	(3,862)	(3,395)
Change in unrealized gains/(losses) related to financial instruments held	(155)	(556)	(1,608)
Commodity
Net derivative receivables:
Beginning balance	(731)	(16)	(1,129)
Total realized/unrealized gains/(losses)	(728)	(546)	497
Purchases	145	27	36
Sales	(493)	(241)	(348)
Settlements	916	356	89
Transfers into level 3	(4)	(310)	(6)
Transfers (out of) level 3	(12)	(1)	845
Ending balance	(907)	(731)	(16)
Change in unrealized gains/(losses) related to financial instruments held	(426)	267	130
Total mortgage-backed securities
Assets:
Fair value, beginning balance	480	824	624
Total realized/unrealized gains/(losses)	(23)	(170)	(35)
Purchases	59	150	876
Sales	(98)	(154)	(422)
Settlements	(132)	(166)	(168)
Transfers into level 3	19	2	31
Transfers (out of) level 3	(2)	(6)	(82)
Fair value, ending balance	303	480	824
Change in unrealized gains/(losses) related to financial instruments held	(36)	(151)	(55)
Mortgage-backed securities, U.S. GSEs and government agencies
Assets:
Fair value, beginning balance	449	797	549
Total realized/unrealized gains/(losses)	(28)	(172)	(62)
Purchases	21	134	773
Sales	(67)	(149)	(310)
Settlements	(110)	(161)	(134)
Transfers into level 3	1	0	1
Transfers (out of) level 3	(1)	0	(20)
Fair value, ending balance	265	449	797
Change in unrealized gains/(losses) related to financial instruments held	(31)	(150)	(58)
Mortgage-backed securities, Residential - nonagency
Assets:
Fair value, beginning balance	28	23	64
Total realized/unrealized gains/(losses)	0	2	25
Purchases	26	15	83
Sales	(24)	(5)	(86)
Settlements	(5)	(4)	(20)
Transfers into level 3	4	0	15
Transfers (out of) level 3	(1)	(3)	(58)
Fair value, ending balance	28	28	23
Change in unrealized gains/(losses) related to financial instruments held	(3)	(1)	2
Mortgage-backed securities, Commercial - nonagency
Assets:
Fair value, beginning balance	3	4	11
Total realized/unrealized gains/(losses)	5	0	2
Purchases	12	1	20
Sales	(7)	0	(26)
Settlements	(17)	(1)	(14)
Transfers into level 3	14	2	15
Transfers (out of) level 3	0	(3)	(4)
Fair value, ending balance	10	3	4
Change in unrealized gains/(losses) related to financial instruments held	(2)	0	1
Total debt and equity instruments
Assets:
Fair value, beginning balance	2,623	2,685	3,200
Total realized/unrealized gains/(losses)	(33)	(52)	(22)
Purchases	2,503	2,810	2,289
Sales	(1,855)	(1,514)	(1,856)
Settlements	(531)	(1,099)	(426)
Transfers into level 3	1,000	1,754	805
Transfers (out of) level 3	(1,428)	(1,961)	(1,305)
Fair value, ending balance	2,279	2,623	2,685
Change in unrealized gains/(losses) related to financial instruments held	(388)	(23)	85
Total debt instruments
Assets:
Fair value, beginning balance	2,098	2,257	2,667
Total realized/unrealized gains/(losses)	(30)	(248)	55
Purchases	1,892	2,169	2,181
Sales	(1,687)	(1,129)	(1,727)
Settlements	(433)	(601)	(350)
Transfers into level 3	831	1,213	622
Transfers (out of) level 3	(1,214)	(1,563)	(1,191)
Fair value, ending balance	1,457	2,098	2,257
Change in unrealized gains/(losses) related to financial instruments held	(84)	(209)	12
Obligations of U.S. states and municipalities
Assets:
Fair value, beginning balance	8	10	689
Total realized/unrealized gains/(losses)	0	0	13
Purchases	0	0	85
Sales	0	(1)	(159)
Settlements	(1)	(1)	(8)
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	(610)
Fair value, ending balance	7	8	10
Change in unrealized gains/(losses) related to financial instruments held	0	0	13
Non-U.S. government debt securities
Assets:
Fair value, beginning balance	182	155	155
Total realized/unrealized gains/(losses)	(14)	21	1
Purchases	359	281	290
Sales	(332)	(245)	(287)
Settlements	(7)	(7)	0
Transfers into level 3	0	0	14
Transfers (out of) level 3	(107)	(23)	(18)
Fair value, ending balance	81	182	155
Change in unrealized gains/(losses) related to financial instruments held	(10)	11	4
Corporate debt securities
Assets:
Fair value, beginning balance	507	558	334
Total realized/unrealized gains/(losses)	(23)	(23)	47
Purchases	404	582	437
Sales	(489)	(205)	(247)
Settlements	(4)	(236)	(52)
Transfers into level 3	162	411	112
Transfers (out of) level 3	(225)	(580)	(73)
Fair value, ending balance	332	507	558
Change in unrealized gains/(losses) related to financial instruments held	(16)	(25)	40
Loans
Assets:
Fair value, beginning balance	893	673	738
Total realized/unrealized gains/(losses)	2	(73)	29
Purchases	994	1,112	456
Sales	(669)	(484)	(519)
Settlements	(287)	(182)	(82)
Transfers into level 3	648	791	437
Transfers (out of) level 3	(873)	(944)	(386)
Fair value, ending balance	708	893	673
Change in unrealized gains/(losses) related to financial instruments held	(20)	(40)	13
Asset-backed securities
Assets:
Fair value, beginning balance	28	37	127
Total realized/unrealized gains/(losses)	28	(3)	0
Purchases	76	44	37
Sales	(99)	(40)	(93)
Settlements	(2)	(9)	(40)
Transfers into level 3	2	9	28
Transfers (out of) level 3	(7)	(10)	(22)
Fair value, ending balance	26	28	37
Change in unrealized gains/(losses) related to financial instruments held	(2)	(4)	(3)
Equity securities
Assets:
Fair value, beginning balance	476	196	232
Total realized/unrealized gains/(losses)	(77)	(137)	(41)
Purchases	378	412	58
Sales	(168)	(376)	(103)
Settlements	0	(1)	(22)
Transfers into level 3	164	535	181
Transfers (out of) level 3	(111)	(153)	(109)
Fair value, ending balance	662	476	196
Change in unrealized gains/(losses) related to financial instruments held	(335)	(82)	(18)
Other
Assets:
Fair value, beginning balance	49	232	301
Total realized/unrealized gains/(losses)	74	333	(36)
Purchases	233	229	50
Sales	0	(9)	(26)
Settlements	(98)	(497)	(54)
Transfers into level 3	5	6	2
Transfers (out of) level 3	(103)	(245)	(5)
Fair value, ending balance	160	49	232
Change in unrealized gains/(losses) related to financial instruments held	31	268	91
Total available-for-sale securities
Assets:
Fair value, beginning balance	0	1	1
Total realized/unrealized gains/(losses)	(1)	0	0
Purchases	162	0	0
Sales	0	0	0
Settlements	0	(1)	0
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	0
Fair value, ending balance	161	0	1
Change in unrealized gains/(losses) related to financial instruments held	(1)	0	0
Available-for-sale securities, Mortgage-backed securities
Assets:
Fair value, beginning balance	0	1	1
Total realized/unrealized gains/(losses)	0	0	0
Purchases	0	0	0
Sales	0	0	0
Settlements	0	(1)	0
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	0
Fair value, ending balance	0	0	1
Change in unrealized gains/(losses) related to financial instruments held	0	0	0
Available-for-sale securities, Mortgage-backed securities, Corporate debt securities
Assets:
Fair value, beginning balance	0	0	0
Total realized/unrealized gains/(losses)	(1)	0	0
Purchases	162	0	0
Sales	0	0	0
Settlements	0	0	0
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	0
Fair value, ending balance	161	0	0
Change in unrealized gains/(losses) related to financial instruments held	(1)	0	0
Loans
Assets:
Fair value, beginning balance	2,305	516	856
Total realized/unrealized gains/(losses)	(87)	(243)	59
Purchases	612	962	236
Sales	(439)	(84)	(188)
Settlements	(965)	(733)	(482)
Transfers into level 3	1,301	2,571	188
Transfers (out of) level 3	(794)	(684)	(153)
Fair value, ending balance	1,933	2,305	516
Change in unrealized gains/(losses) related to financial instruments held	(59)	(18)	38
Mortgage servicing rights
Assets:
Fair value, beginning balance	3,276	4,699	6,130
Total realized/unrealized gains/(losses)	98	(1,540)	(1,180)
Purchases	3,022	1,192	1,489
Sales	(114)	(176)	(789)
Settlements	(788)	(899)	(951)
Transfers into level 3	0	0	0
Transfers (out of) level 3	0	0	0
Fair value, ending balance	5,494	3,276	4,699
Change in unrealized gains/(losses) related to financial instruments held	98	(1,540)	(1,180)
Other assets
Assets:
Fair value, beginning balance	538	917	1,161
Total realized/unrealized gains/(losses)	16	(63)	(150)
Purchases	9	75	229
Sales	(17)	(104)	(166)
Settlements	(239)	(320)	(156)
Transfers into level 3	0	40	6
Transfers (out of) level 3	(1)	(7)	(7)
Fair value, ending balance	306	538	917
Change in unrealized gains/(losses) related to financial instruments held	$ 11	$ (3)	$ (180)

Fair Value Measurement - Leve_2

Fair Value Measurement - Level 3 Analysis (Details) - Recurring - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Level 3 Analysis - Supplemental Data [Abstract]
Assets fair value	$ 1,154,549	$ 1,243,209
MSRs
Level 3 Analysis - Supplemental Data [Abstract]
Increase (decrease) in level 3 assets	2,200
Derivative receivables | Interest rate
Level 3 Analysis - Supplemental Data [Abstract]
Increase (decrease) in level 3 assets	(287)
Nontrading loans
Level 3 Analysis - Supplemental Data [Abstract]
Increase (decrease) in level 3 assets	(372)
Level 3
Level 3 Analysis - Supplemental Data [Abstract]
Assets fair value	17,479	$ 16,410
Increase (decrease) in level 3 assets	$ 1,100

Fair Value Measurement - Transf

Fair Value Measurement - Transfers (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Nontrading loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, assets	$ 1,301	$ 2,571	$ 188
Transfers from Level 3 into level 2, assets	794	684	153
Total debt and equity instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities	64	136	16
Transfers from level 3 into level 2, liabilities	14	8	47
Long-term debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities	103	1,250	651
Transfers from level 3 into level 2, liabilities	809	1,282	1,448
Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities	2	265	12
Transfers from level 3 into level 2, liabilities	482	943	1,209
Recurring | Derivative receivables | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, assets	1,500	2,600
Transfers from Level 3 into level 2, assets	1,900	2,400	1,100
Recurring | Nontrading loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, assets	1,300	2,600
Transfers from Level 3 into level 2, assets	794
Recurring | Total debt and equity instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities	1,000	1,800	993
Transfers from level 3 into level 2, liabilities	1,400	2,000	1,500
Recurring | Derivative payables | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities	1,200	3,500	904
Transfers from level 3 into level 2, liabilities	2,100	2,400	1,300
Recurring | Derivative payables | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities		880
Recurring | Derivative payables | Commodity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 3 into level 2, liabilities			962
Recurring | Long-term debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 2 into level 3, liabilities		1,200
Transfers from level 3 into level 2, liabilities	809	1,300	1,400
Recurring | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfers from level 3 into level 2, liabilities		943	1,200
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized/unrealized gains (losses), assets	495	10	(2,100)
Realized/unrealized gains (losses), liabilities	$ 1,100	$ 102	$ (3,300)

Fair Value Measurement - Impact

Fair Value Measurement - Impact of Credit Adjustments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Credit and funding adjustments:
Derivatives CVA	$ 362	$ (337)	$ 241
Derivatives FVA	$ 47	$ (64)	$ 199

Fair Value Measurement - Nonrec

Fair Value Measurement - Nonrecurring Basis (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities without readily determinable fair values	$ 3,642	$ 2,368
Net losses as a result of measurement alternative	(53)	(301)
Net gains as a result of measurement alternative	$ 432	167
Residential mortgage | Broker price opinion | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, liquidation value discount	12.00%
Residential mortgage | Broker price opinion | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, liquidation value discount	45.00%
Residential mortgage | Broker price opinion | Weighted average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, liquidation value discount	25.00%
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	$ 3,478	3,567
Total liabilities measured at fair value on a nonrecurring basis	3	12
Total nonrecurring fair value gains/(losses)	277	(933)	$ (92)
Nonrecurring | Accounts payable and other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value on a nonrecurring basis	3	12
Total nonrecurring fair value gains/(losses)	5	(11)	0
Nonrecurring | Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	1,862	2,583
Total nonrecurring fair value gains/(losses)	(72)	(393)	(274)
Nonrecurring | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	1,616	984
Total nonrecurring fair value gains/(losses)	344	(529)	182
Net losses as a result of measurement alternative		(134)
Net gains as a result of measurement alternative	379		$ 201
Nonrecurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	0	0
Total liabilities measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 1 | Accounts payable and other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 1 | Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 1 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	1,010	1,616
Total liabilities measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 2 | Accounts payable and other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value on a nonrecurring basis	0	0
Nonrecurring | Level 2 | Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	1,006	1,611
Nonrecurring | Level 2 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	4	5
Nonrecurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	2,468	1,951
Total liabilities measured at fair value on a nonrecurring basis	3	12
Nonrecurring | Level 3 | Accounts payable and other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total liabilities measured at fair value on a nonrecurring basis	3	12
Nonrecurring | Level 3 | Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	856	972
Nonrecurring | Level 3 | Residential mortgage
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	254
Nonrecurring | Level 3 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value on a nonrecurring basis	1,612	$ 979
Equity securities without readily determinable fair values	$ 1,500

Fair Value Measurement - Equity

Fair Value Measurement - Equity Securities Without Readily Determinable Fair Values (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)
Fair Value Disclosures [Abstract]
Carrying value	$ 3,642	$ 2,368
Upward carrying value changes	432	167
Downward carrying value changes/impairment	(53)	$ (301)
Cumulative upward carrying value changes	1,000
Cumulative downward carrying value changes/impairment	$ (369)
VISA | Common stock | Class B
Investment Holdings [Line Items]
Interest owned, included in other assets (in shares) | shares	40
Conversion rate	1.6181

Fair Value Measurement - Carryi

Fair Value Measurement - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financial assets
Cash and due from banks	$ 26,438	$ 24,874
Deposits with banks	714,396	502,735
Federal funds sold and securities purchased under resale agreements	261,698	296,284
Investment securities, held-to-maturity	362,628	205,472
Loans, net of allowance for loan losses	58,820	44,474
Financial liabilities
Beneficial interests issued by consolidated VIEs	10,750	17,578
Carrying value
Financial assets
Cash and due from banks	26,400	24,900
Deposits with banks	714,400	502,700
Accrued interest and accounts receivable	102,100	89,400
Federal funds sold and securities purchased under resale agreements	9,000	58,300
Securities borrowed	124,600	107,700
Investment securities, held-to-maturity	363,700	201,800
Loans, net of allowance for loan losses	1,002,500	940,100
Other	98,700	81,800
Financial liabilities
Deposits	2,451,000	2,129,800
Federal funds purchased and securities loaned or sold under repurchase agreements	67,900	59,500
Short-term borrowings	33,600	28,300
Accounts payable and other liabilities	217,600	186,600
Beneficial interests issued by consolidated VIEs	10,700	17,500
Long-term debt	226,000	204,800
Wholesale lending-related commitments	2,100	2,200
Fair value
Financial assets
Cash and due from banks	26,400	24,900
Deposits with banks	714,400	502,700
Accrued interest and accounts receivable	102,100	89,400
Federal funds sold and securities purchased under resale agreements	9,000	58,300
Securities borrowed	124,600	107,700
Investment securities, held-to-maturity	362,600	205,500
Loans, net of allowance for loan losses	1,023,200	966,500
Other	98,800	81,900
Financial liabilities
Deposits	2,451,000	2,128,900
Federal funds purchased and securities loaned or sold under repurchase agreements	67,900	59,500
Short-term borrowings	33,600	28,300
Accounts payable and other liabilities	217,000	186,200
Beneficial interests issued by consolidated VIEs	10,800	17,600
Long-term debt	232,600	212,400
Wholesale lending-related commitments	2,900	2,100
Fair value | Level 1
Financial assets
Cash and due from banks	26,400	24,900
Deposits with banks	714,400	502,700
Accrued interest and accounts receivable	0	0
Federal funds sold and securities purchased under resale agreements	0	0
Securities borrowed	0	0
Investment securities, held-to-maturity	183,300	53,200
Loans, net of allowance for loan losses	0	0
Other	0	0
Financial liabilities
Deposits	0	0
Federal funds purchased and securities loaned or sold under repurchase agreements	0	0
Short-term borrowings	0	0
Accounts payable and other liabilities	0	0
Beneficial interests issued by consolidated VIEs	0	0
Long-term debt	0	0
Wholesale lending-related commitments	0	0
Fair value | Level 2
Financial assets
Cash and due from banks	0	0
Deposits with banks	0	0
Accrued interest and accounts receivable	102,000	89,300
Federal funds sold and securities purchased under resale agreements	9,000	58,300
Securities borrowed	124,600	107,700
Investment securities, held-to-maturity	179,300	152,300
Loans, net of allowance for loan losses	202,100	210,900
Other	97,400	80,000
Financial liabilities
Deposits	2,451,000	2,128,900
Federal funds purchased and securities loaned or sold under repurchase agreements	67,900	59,500
Short-term borrowings	33,600	28,300
Accounts payable and other liabilities	212,100	181,900
Beneficial interests issued by consolidated VIEs	10,800	17,600
Long-term debt	229,500	209,200
Wholesale lending-related commitments	0	0
Fair value | Level 3
Financial assets
Cash and due from banks	0	0
Deposits with banks	0	0
Accrued interest and accounts receivable	100	100
Federal funds sold and securities purchased under resale agreements	0	0
Securities borrowed	0	0
Investment securities, held-to-maturity	0	0
Loans, net of allowance for loan losses	821,100	755,600
Other	1,400	1,900
Financial liabilities
Deposits	0	0
Federal funds purchased and securities loaned or sold under repurchase agreements	0	0
Short-term borrowings	0	0
Accounts payable and other liabilities	4,900	4,300
Beneficial interests issued by consolidated VIEs	0	0
Long-term debt	3,100	3,200
Wholesale lending-related commitments	$ 2,900	$ 2,100

Fair Value Option - Changes in

Fair Value Option - Changes in Fair Value Under the Fair Value Option (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Federal funds sold and securities purchased under resale agreements
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	$ (112)	$ 12	$ (36)
Federal funds sold and securities purchased under resale agreements | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(112)	12	(36)
Federal funds sold and securities purchased under resale agreements | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Securities borrowed
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(200)	143	133
Securities borrowed | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(200)	143	133
Securities borrowed | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Debt and equity instruments, excluding loans
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(2,172)	2,586	2,481
Debt and equity instruments, excluding loans | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(2,171)	2,587	2,482
Debt and equity instruments, excluding loans | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(1)	(1)	(1)
Loans reported as trading assets: Changes in instrument-specific credit risk
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	353	135	248
Loans reported as trading assets: Changes in instrument-specific credit risk | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	353	135	248
Loans reported as trading assets: Changes in instrument-specific credit risk | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Loans reported as trading assets: Other changes in fair value
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(8)	(19)	(1)
Loans reported as trading assets: Other changes in fair value | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(8)	(19)	(1)
Loans reported as trading assets: Other changes in fair value | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Loans: Changes in instrument-specific credit risk
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	582	197	477
Loans: Changes in instrument-specific credit risk | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	589	190	475
Loans: Changes in instrument-specific credit risk | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(7)	7	2
Loans: Other changes in fair value
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	1,917	3,709	1,491
Loans: Other changes in fair value | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(139)	470	267
Loans: Other changes in fair value | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	2,056	3,239	1,224
Other assets
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(14)	38	14
Other assets | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	12	103	8
Other assets | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(26)	(65)	6
Deposits
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(183)	(726)	(1,730)
Deposits | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(183)	(726)	(1,730)
Realized gains/(losses) due to instrument-specific credit risk	(15)	20	0
Deposits | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Federal funds purchased and securities loaned or sold under repurchase agreements
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	69	(6)	(8)
Federal funds purchased and securities loaned or sold under repurchase agreements | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	69	(6)	(8)
Federal funds purchased and securities loaned or sold under repurchase agreements | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Short-term borrowings
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(366)	294	(693)
Short-term borrowings | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(366)	294	(693)
Short-term borrowings | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Trading liabilities
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	7	2	6
Trading liabilities | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	7	2	6
Trading liabilities | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Other liabilities
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(17)	(94)	(16)
Other liabilities | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(17)	(94)	(16)
Other liabilities | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	0	0	0
Long-term debt
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(976)	(2,121)	(6,172)
Long-term debt | Principal transactions
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	(980)	(2,120)	(6,173)
Long-term debt | All other income
Changes in fair value under the fair value option election
Fair value option, changes in fair value gain (loss)	$ 4	$ (1)	$ 1

Fair Value Option - Aggregate D

Fair Value Option - Aggregate Differences (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Long-term beneficial interests
Performing loans, ninety days or more past due	$ 0	$ 0
Lending-related commitments, fair value option elected
Long-term beneficial interests
Contractual amount of lending-related commitments	11,900,000,000	18,100,000,000
Other guarantees and commitments, Carrying value	10,000,000	(39,000,000)
Contractual principal outstanding
Loans
Nonaccrual loans	4,181,000,000	5,253,000,000
All other performing loans	66,289,000,000	49,939,000,000
Total loans	70,763,000,000	55,520,000,000
Contractual principal outstanding | Principal-protected debt
Long-term debt
Total long-term debt	35,957,000,000	40,560,000,000
Contractual principal outstanding | Loans reported as trading assets
Loans
Nonaccrual loans	3,263,000,000	3,386,000,000
All other performing loans	8,594,000,000	7,917,000,000
Contractual principal outstanding | Loans
Loans
Nonaccrual loans	918,000,000	1,867,000,000
90 or more days past due and government guaranteed	293,000,000	328,000,000
All other performing loans	57,695,000,000	42,022,000,000
Fair value
Loans
Nonaccrual loans	1,343,000,000	2,062,000,000
All other performing loans	65,270,000,000	49,089,000,000
Total loans	66,894,000,000	51,468,000,000
Long-term debt
Total long-term debt	74,934,000,000	76,817,000,000
Long-term beneficial interests
Total long-term beneficial interests	12,000,000	41,000,000
Fair value | Principal-protected debt
Long-term debt
Total long-term debt	33,799,000,000	40,526,000,000
Fair value | Nonprincipal-protected debt
Long-term debt
Total long-term debt	41,135,000,000	36,291,000,000
Long-term beneficial interests
Total long-term beneficial interests	12,000,000	41,000,000
Fair value | Loans reported as trading assets
Loans
Nonaccrual loans	546,000,000	555,000,000
All other performing loans	7,528,000,000	6,439,000,000
Fair value | Loans
Loans
Nonaccrual loans	797,000,000	1,507,000,000
90 or more days past due and government guaranteed	281,000,000	317,000,000
All other performing loans	57,742,000,000	42,650,000,000
Fair value over/(under) contractual principal outstanding
Loans
Nonaccrual loans, Fair value over/(under) contractual principal outstanding	(2,838,000,000)	(3,191,000,000)
All other performing loans	(1,019,000,000)	(850,000,000)
Total loans	(3,869,000,000)	(4,052,000,000)
Fair value over/(under) contractual principal outstanding | Principal-protected debt
Long-term debt
Long-term debt, Fair value over/(under) contractual principal outstanding	(2,158,000,000)	(34,000,000)
Fair value over/(under) contractual principal outstanding | Loans reported as trading assets
Loans
Nonaccrual loans, Fair value over/(under) contractual principal outstanding	(2,717,000,000)	(2,831,000,000)
All other performing loans	(1,066,000,000)	(1,478,000,000)
Fair value over/(under) contractual principal outstanding | Loans
Loans
Nonaccrual loans, Fair value over/(under) contractual principal outstanding	(121,000,000)	(360,000,000)
90 or more days past due and government guaranteed, Fair value over/(under) contractual principal outstanding	(12,000,000)	(11,000,000)
All other performing loans	$ 47,000,000	$ 628,000,000

Fair Value Option - Structured

Fair Value Option - Structured Note Products by Balance Sheet Classification and Risk Component (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	$ 92,642	$ 93,739
Interest rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	38,988	43,251
Credit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	7,210	7,431
Foreign exchange
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	4,767	3,705
Equity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	41,269	38,857
Commodity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	408	495
Long-term debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	73,587	75,344
Long-term debt | Interest rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	34,127	38,129
Long-term debt | Credit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	6,352	6,409
Long-term debt | Foreign exchange
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	3,386	3,613
Long-term debt | Equity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	29,317	26,943
Long-term debt | Commodity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	405	250
Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	8,001	6,213
Short-term borrowings | Interest rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	1	65
Short-term borrowings | Credit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	858	1,022
Short-term borrowings | Foreign exchange
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	315	92
Short-term borrowings | Equity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	6,827	5,021
Short-term borrowings | Commodity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	0	13
Deposits
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	11,054	12,182
Deposits | Interest rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	4,860	5,057
Deposits | Credit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	0	0
Deposits | Foreign exchange
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	1,066	0
Deposits | Equity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	5,125	6,893
Deposits | Commodity
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total structured notes	3	232
Excluded amount of deposits linked to precious metals for which fair value option was not elected	$ 692	$ 739

Credit Risk Concentrations (Det

Credit Risk Concentrations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Concentration Risk [Line Items]
Credit exposure	$ 2,456,753	$ 2,301,695
On-balance sheet, Loans	1,077,714	1,012,853
On-balance sheet, Derivatives	57,081	75,444
Off-balance sheet	1,262,313	1,165,688
Available-for-sale securities	308,525	388,178
Held=to-maturity securities	363,707	201,821
Cash placed with banks	729,600	516,900
Obligations of U.S. states and municipalities
Concentration Risk [Line Items]
Trading assets	7,100	7,200
Available-for-sale securities	15,860	20,396
Held=to-maturity securities	13,985	12,751
Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	57,081	75,444
Consumer | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	1,253,470	1,178,620
On-balance sheet, Loans	477,602	462,795
Off-balance sheet	775,868	715,825
Consumer, excluding credit card
Concentration Risk [Line Items]
On-balance sheet, Loans	323,306	318,579
Consumer, excluding credit card | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	368,640	375,898
On-balance sheet, Loans	323,306	318,579
Off-balance sheet	45,334	57,319
Consumer, excluding credit card | Credit Concentration Risk | Paycheck Protection Program (PPP)
Concentration Risk [Line Items]
On-balance sheet, Loans	5,400	19,200
Credit card
Concentration Risk [Line Items]
On-balance sheet, Loans	154,296	144,216
Credit card | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	884,830	802,722
On-balance sheet, Loans	154,296	144,216
Off-balance sheet	730,534	658,506
Wholesale
Concentration Risk [Line Items]
On-balance sheet, Loans	600,112	550,058
Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	1,203,283	1,123,075
On-balance sheet, Loans	600,112	550,058
Off-balance sheet	486,445	449,863
Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	57,081	75,444
Wholesale | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	1,103,880	1,040,254
On-balance sheet, Loans	560,354	514,947
Off-balance sheet	486,445	449,863
Real Estate | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	1,113	1,385
Real Estate | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	155,069	148,498
On-balance sheet, Loans	119,753	118,299
Off-balance sheet	34,203	28,814
Individuals and Individual Entities | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	1,317	1,750
Individuals and Individual Entities | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	141,973	122,870
On-balance sheet, Loans	130,576	109,746
Off-balance sheet	10,080	11,374
Consumer & Retail | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	2,669	2,802
Consumer & Retail | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	122,789	108,437
On-balance sheet, Loans	39,588	39,013
Off-balance sheet	80,532	66,622
Technology, Media & Telecommunications | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	2,640	4,252
Technology, Media & Telecommunications | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	84,070	72,150
On-balance sheet, Loans	17,815	14,687
Off-balance sheet	63,615	53,211
Asset Managers | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	9,351	9,277
Asset Managers | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	81,228	66,573
On-balance sheet, Loans	41,031	31,059
Off-balance sheet	30,846	26,237
Industrials | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	1,224	1,851
Industrials | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	66,974	66,470
On-balance sheet, Loans	21,652	21,143
Off-balance sheet	44,098	43,476
Healthcare | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	2,575	3,252
Healthcare | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	59,014	60,118
On-balance sheet, Loans	18,587	19,405
Off-balance sheet	37,852	37,461
Banks & Finance Cos | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	4,418	8,044
Banks & Finance Cos | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	54,684	54,032
On-balance sheet, Loans	34,217	31,004
Off-balance sheet	16,049	14,984
Oil & Gas | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	6,034	1,643
Oil & Gas | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	42,606	39,159
On-balance sheet, Loans	11,039	11,267
Off-balance sheet	25,533	26,249
Automotive | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	720	5,995
Automotive | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	34,573	43,331
On-balance sheet, Loans	11,759	17,128
Off-balance sheet	22,094	20,208
State & Municipal Govt | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	1,563	2,347
State & Municipal Govt | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	33,216	38,286
On-balance sheet, Loans	15,322	18,054
Off-balance sheet	16,331	17,885
Utilities | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	3,736	3,340
Utilities | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	33,203	30,124
On-balance sheet, Loans	5,969	4,874
Off-balance sheet	23,498	21,910
Chemicals & Plastics | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	564	856
Chemicals & Plastics | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	17,660	17,176
On-balance sheet, Loans	5,033	4,884
Off-balance sheet	12,063	11,436
Metals & Mining | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	924	882
Metals & Mining | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	16,696	15,542
On-balance sheet, Loans	5,696	4,854
Off-balance sheet	10,076	9,806
Transportation | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	782	1,495
Transportation | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	14,635	16,232
On-balance sheet, Loans	5,453	6,566
Off-balance sheet	8,400	8,171
Insurance | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	2,700	2,527
Insurance | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	13,926	13,141
On-balance sheet, Loans	1,303	1,042
Off-balance sheet	9,923	9,572
Central Govt | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	6,837	12,313
Central Govt | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	11,317	17,025
On-balance sheet, Loans	2,889	3,396
Off-balance sheet	1,591	1,316
Financial Markets Infrastructure | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	2,487	3,757
Financial Markets Infrastructure | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	4,377	6,515
On-balance sheet, Loans	5	19
Off-balance sheet	1,885	2,739
Securities Firms | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	1,260	4,838
Securities Firms | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	4,180	8,048
On-balance sheet, Loans	469	469
Off-balance sheet	2,451	2,741
All other | Credit Concentration Risk
Concentration Risk [Line Items]
On-balance sheet, Derivatives	4,167	2,838
All other | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	111,690	96,527
On-balance sheet, Loans	72,198	58,038
Off-balance sheet	$ 35,325	$ 35,651
All other | Wholesale | Credit Concentration Risk | SPEs and Private education
Concentration Risk [Line Items]
Percentage of exposure secured	94.00%	92.00%
All other | Wholesale | Credit Concentration Risk | Civic organizations
Concentration Risk [Line Items]
Percentage of exposure secured	6.00%	8.00%
Loans held-for-sale and loans at fair value | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	$ 39,758	$ 35,111
On-balance sheet, Loans	39,758	35,111
Receivables from customers | Wholesale | Credit Concentration Risk
Concentration Risk [Line Items]
Credit exposure	$ 59,645	$ 47,710

Derivative Instruments - Notion

Derivative Instruments - Notional Amount of Derivative Contracts (Details) - USD ($) $ in Billions	Dec. 31, 2021	Dec. 31, 2020
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	$ 49,735	$ 47,175
Interest rate contracts
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	32,801	31,097
Swaps
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	24,075	20,990
Futures and forwards
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	2,520	3,057
Options | Written options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	3,018	3,375
Options | Purchased options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	3,188	3,675
Net credit derivatives
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	1,053	1,197
Foreign exchange contracts
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	13,259	12,450
Cross-currency swaps
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	4,112	3,924
Spot, futures and forwards
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	7,679	6,871
Options | Written options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	741	830
Options | Purchased options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	727	825
Equity contracts
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	2,003	1,866
Swaps
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	612	448
Futures and forwards
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	139	140
Options | Written options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	654	668
Options | Purchased options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	598	610
Commodity contracts
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	619	565
Swaps
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	185	138
Spot, futures and forwards
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	188	198
Options | Written options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	135	124
Options | Purchased options
Notional amount of derivative contracts outstanding [Abstract]
Derivative notional amounts	$ 111	$ 105

Derivative Instruments - Impact

Derivative Instruments - Impact on Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivatives, Fair Value [Line Items]
Gross derivative receivables	$ 545,287	$ 703,368
Net derivative receivables	57,081	75,444
Gross derivative payables	535,044	688,887
Net derivative payables	50,116	70,623
Interest rate
Derivatives, Fair Value [Line Items]
Gross derivative receivables	270,585	391,648
Net derivative receivables	21,974	35,725
Gross derivative payables	240,731	353,987
Net derivative payables	8,194	13,012
Credit
Derivatives, Fair Value [Line Items]
Gross derivative receivables	9,839	13,345
Net derivative receivables	1,031	680
Gross derivative payables	10,912	14,832
Net derivative payables	880	1,995
Foreign exchange
Derivatives, Fair Value [Line Items]
Gross derivative receivables	169,579	206,260
Net derivative receivables	12,625	15,781
Gross derivative payables	175,746	215,926
Net derivative payables	14,097	21,433
Equity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	68,631	70,612
Net derivative receivables	9,981	16,487
Gross derivative payables	79,727	81,413
Net derivative payables	17,233	25,898
Commodity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	26,653	21,503
Net derivative receivables	11,470	6,771
Gross derivative payables	27,928	22,729
Net derivative payables	9,712	8,285
Not designated as hedges
Derivatives, Fair Value [Line Items]
Gross derivative receivables	539,451	700,712
Gross derivative payables	526,829	685,295
Not designated as hedges | Interest rate
Derivatives, Fair Value [Line Items]
Gross derivative receivables	270,562	390,817
Gross derivative payables	240,731	353,987
Not designated as hedges | Credit
Derivatives, Fair Value [Line Items]
Gross derivative receivables	9,839	13,345
Gross derivative payables	10,912	14,832
Not designated as hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Gross derivative receivables	169,186	205,359
Gross derivative payables	174,622	214,229
Not designated as hedges | Equity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	68,631	70,612
Gross derivative payables	79,727	81,413
Not designated as hedges | Commodity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	21,233	20,579
Gross derivative payables	20,837	20,834
Designated as hedges
Derivatives, Fair Value [Line Items]
Gross derivative receivables	5,836	2,656
Gross derivative payables	8,215	3,592
Designated as hedges | Interest rate
Derivatives, Fair Value [Line Items]
Gross derivative receivables	23	831
Gross derivative payables	0	0
Designated as hedges | Credit
Derivatives, Fair Value [Line Items]
Gross derivative receivables	0	0
Gross derivative payables	0	0
Designated as hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Gross derivative receivables	393	901
Gross derivative payables	1,124	1,697
Designated as hedges | Equity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	0	0
Gross derivative payables	0	0
Designated as hedges | Commodity
Derivatives, Fair Value [Line Items]
Gross derivative receivables	5,420	924
Gross derivative payables	$ 7,091	$ 1,895

Derivative Instruments - Deriva

Derivative Instruments - Derivatives Netting (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	$ 528,471	$ 677,461
Amounts netted on the Consolidated balance sheets	(488,206)	(627,924)
Net derivative receivables	40,265	49,537
Derivative receivables where an appropriate legal opinion has not been either sought or obtained	16,816	25,907
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	545,287	703,368
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	57,081	75,444
Collateral not nettable on the Consolidated balance sheets, Net derivative receivables	(10,102)	(14,806)
Net amounts, Net derivative receivables	46,979	60,638
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	518,487	665,950
Amounts netted on the Consolidated balance sheets	(484,928)	(618,264)
Net derivative payables	33,559	47,686
Derivative payables where an appropriate legal opinion has not been either sought or obtained	16,557	22,937
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	535,044	688,887
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	50,116	70,623
Collateral not nettable on the Consolidated balance sheets, Net derivative payables	(5,872)	(11,964)
Net amounts, Net derivative payables	44,244	58,659
Net cash collateral receivables	67,600	88,000
Netted cash collateral payables	64,300	78,400
Interest rate contracts
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	266,595	386,108
Amounts netted on the Consolidated balance sheets	(248,611)	(355,923)
Net derivative receivables	17,984	30,185
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	270,585	391,648
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	21,974	35,725
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	239,563	352,282
Amounts netted on the Consolidated balance sheets	(232,537)	(340,975)
Net derivative payables	7,026	11,307
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	240,731	353,987
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	8,194	13,012
Interest rate contracts | OTC
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	251,953	367,214
Amounts netted on the Consolidated balance sheets	(234,283)	(337,609)
Net derivative receivables	17,670	29,605
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	223,576	332,214
Amounts netted on the Consolidated balance sheets	(216,757)	(321,140)
Net derivative payables	6,819	11,074
Interest rate contracts | OTC–cleared
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	14,144	18,340
Amounts netted on the Consolidated balance sheets	(13,839)	(17,919)
Net derivative receivables	305	421
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	15,695	19,710
Amounts netted on the Consolidated balance sheets	(15,492)	(19,494)
Net derivative payables	203	216
Interest rate contracts | Exchange-traded
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	498	554
Amounts netted on the Consolidated balance sheets	(489)	(395)
Net derivative receivables	9	159
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	292	358
Amounts netted on the Consolidated balance sheets	(288)	(341)
Net derivative payables	4	17
Credit contracts
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	9,706	13,220
Amounts netted on the Consolidated balance sheets	(8,808)	(12,665)
Net derivative receivables	898	555
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	9,839	13,345
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	1,031	680
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	10,700	14,386
Amounts netted on the Consolidated balance sheets	(10,032)	(12,837)
Net derivative payables	668	1,549
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	10,912	14,832
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	880	1,995
Credit contracts | OTC
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	8,035	8,894
Amounts netted on the Consolidated balance sheets	(7,177)	(8,356)
Net derivative receivables	858	538
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	9,021	10,311
Amounts netted on the Consolidated balance sheets	(8,421)	(8,781)
Net derivative payables	600	1,530
Credit contracts | OTC–cleared
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	1,671	4,326
Amounts netted on the Consolidated balance sheets	(1,631)	(4,309)
Net derivative receivables	40	17
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	1,679	4,075
Amounts netted on the Consolidated balance sheets	(1,611)	(4,056)
Net derivative payables	68	19
Foreign exchange contracts
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	166,980	202,218
Amounts netted on the Consolidated balance sheets	(156,954)	(190,479)
Net derivative receivables	10,026	11,739
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	169,579	206,260
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	12,625	15,781
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	172,323	211,673
Amounts netted on the Consolidated balance sheets	(161,649)	(194,493)
Net derivative payables	10,674	17,180
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	175,746	215,926
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	14,097	21,433
Foreign exchange contracts | OTC
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	166,185	201,349
Amounts netted on the Consolidated balance sheets	(156,251)	(189,655)
Net derivative receivables	9,934	11,694
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	171,610	210,803
Amounts netted on the Consolidated balance sheets	(160,946)	(193,672)
Net derivative payables	10,664	17,131
Foreign exchange contracts | OTC–cleared
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	789	834
Amounts netted on the Consolidated balance sheets	(703)	(819)
Net derivative receivables	86	15
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	706	836
Amounts netted on the Consolidated balance sheets	(703)	(819)
Net derivative payables	3	17
Foreign exchange contracts | Exchange-traded
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	6	35
Amounts netted on the Consolidated balance sheets	0	(5)
Net derivative receivables	6	30
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	7	34
Amounts netted on the Consolidated balance sheets	0	(2)
Net derivative payables	7	32
Equity contracts
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	61,799	58,138
Amounts netted on the Consolidated balance sheets	(58,650)	(54,125)
Net derivative receivables	3,149	4,013
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	68,631	70,612
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	9,981	16,487
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	72,000	69,821
Amounts netted on the Consolidated balance sheets	(62,494)	(55,515)
Net derivative payables	9,506	14,306
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	79,727	81,413
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	17,233	25,898
Equity contracts | OTC
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	25,704	29,844
Amounts netted on the Consolidated balance sheets	(23,977)	(27,374)
Net derivative receivables	1,727	2,470
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	31,379	35,330
Amounts netted on the Consolidated balance sheets	(27,830)	(28,763)
Net derivative payables	3,549	6,567
Equity contracts | Exchange-traded
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	36,095	28,294
Amounts netted on the Consolidated balance sheets	(34,673)	(26,751)
Net derivative receivables	1,422	1,543
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	40,621	34,491
Amounts netted on the Consolidated balance sheets	(34,664)	(26,752)
Net derivative payables	5,957	7,739
Commodity contracts
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	23,391	17,777
Amounts netted on the Consolidated balance sheets	(15,183)	(14,732)
Net derivative receivables	8,208	3,045
Total derivative receivables recognized on the Consolidated balance sheets, Gross derivate receivables	26,653	21,503
Total derivative receivables recognized on the Consolidated balance sheets, Net derivative receivables	11,470	6,771
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	23,901	17,788
Amounts netted on the Consolidated balance sheets	(18,216)	(14,444)
Net derivative payables	5,685	3,344
Total derivative payables recognized on the Consolidated balance sheets, Gross derivative payables	27,928	22,729
Total derivative payables recognized on the Consolidated balance sheets, Net derivative payables	9,712	8,285
Commodity contracts | OTC
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	15,063	10,924
Amounts netted on the Consolidated balance sheets	(6,868)	(7,901)
Net derivative receivables	8,195	3,023
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	14,874	10,365
Amounts netted on the Consolidated balance sheets	(9,667)	(7,544)
Net derivative payables	5,207	2,821
Commodity contracts | OTC–cleared
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	49	20
Amounts netted on the Consolidated balance sheets	(49)	(20)
Net derivative receivables	0	0
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	73	32
Amounts netted on the Consolidated balance sheets	(73)	(32)
Net derivative payables	0	0
Commodity contracts | Exchange-traded
Gross and Net Derivative Receivables by Contract and Settlement Type:
Gross derivative receivables	8,279	6,833
Amounts netted on the Consolidated balance sheets	(8,266)	(6,811)
Net derivative receivables	13	22
Gross and Net Derivative Payables by Contract and Settlement Type:
Gross derivative payables	8,954	7,391
Amounts netted on the Consolidated balance sheets	(8,476)	(6,868)
Net derivative payables	$ 478	$ 523

Derivative Instruments - Liquid

Derivative Instruments - Liquidity Risk and Credit-Related Contingent Features (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
OTC and OTC-cleared derivative payables containing downgrade triggers
Aggregate fair value of net derivative payables	$ 20,114	$ 26,945
Collateral posted	19,402	26,289
Single-notch downgrade
Liquidity impact of downgrade triggers on OTC and OTC-cleared derivatives
Amount of additional collateral to be posted upon downgrade	219	119
Amount required to settle contracts with termination triggers upon downgrade	98	153
Two-notch downgrade
Liquidity impact of downgrade triggers on OTC and OTC-cleared derivatives
Amount of additional collateral to be posted upon downgrade	1,577	1,243
Amount required to settle contracts with termination triggers upon downgrade	$ 787	$ 1,682

Derivative Instruments - Impa_2

Derivative Instruments - Impact on Statements of Income, Fair Value Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Gains/(losses) recorded in income
Derivatives	$ (15,249)	$ 1,248	$ 3,281
Hedged items	17,422	142	(1,897)
Income statement impact	2,173	1,390	1,384
Income statement impact of excluded components
Amortization approach	(286)	(457)	(866)
Changes in fair value	2,263	1,404	1,373
OCI impact
Derivatives - Gains/(losses) recorded in OCI	(26)	25	39
Interest rate
Gains/(losses) recorded in income
Derivatives	(4,323)	2,962	3,204
Hedged items	6,363	(1,889)	(2,373)
Income statement impact	2,040	1,073	831
Income statement impact of excluded components
Amortization approach	0	0	0
Changes in fair value	2,159	1,093	828
OCI impact
Derivatives - Gains/(losses) recorded in OCI	0	0	0
Foreign exchange
Gains/(losses) recorded in income
Derivatives	(1,317)	793	154
Hedged items	1,349	(619)	328
Income statement impact	32	174	482
Income statement impact of excluded components
Amortization approach	(286)	(457)	(866)
Changes in fair value	32	174	482
OCI impact
Derivatives - Gains/(losses) recorded in OCI	(26)	25	39
Commodity
Gains/(losses) recorded in income
Derivatives	(9,609)	(2,507)	(77)
Hedged items	9,710	2,650	148
Income statement impact	101	143	71
Income statement impact of excluded components
Amortization approach	0	0	0
Changes in fair value	72	137	63
OCI impact
Derivatives - Gains/(losses) recorded in OCI	$ 0	$ 0	$ 0

Derivative Instruments - Cumula

Derivative Instruments - Cumulative Fair Value Hedging Adjustments (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Commodity
Assets
Carrying amount of the hedged items	$ 25,700	$ 11,500
Long-term debt
Liabilities
Carrying amount of the hedged items	195,642	177,611
Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items:
Active hedging relationships	(1,999)	3,194
Discontinued hedging relationships	8,834	11,473
Total	6,835	14,667
Long-term debt | Not designated as hedges
Liabilities
Carrying amount of the hedged items	10,800	6,600
Beneficial interests issued by consolidated VIEs
Liabilities
Carrying amount of the hedged items	749	746
Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items:
Active hedging relationships	0	0
Discontinued hedging relationships	(1)	(3)
Total	(1)	(3)
Investment securities - AFS
Assets
Carrying amount of the hedged items	65,746	139,684
Cumulative amount of fair value hedging adjustments included in the carrying amount of hedged items:
Active hedging relationships	417	3,572
Discontinued hedging relationships	661	847
Total	1,078	4,419
Investment securities - AFS | Not designated as hedges
Assets
Carrying amount of the hedged items	$ 14,000	$ 14,500

Derivative Instruments - Impa_3

Derivative Instruments - Impact on Statements of Income, Cash Flow Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivatives gains/(losses) recorded in income and other comprehensive income/(loss)
Recognition of net gains related to cash flow hedges in Income	$ 671
Maximum length of time hedged in forecasted transactions, terminated cash flow hedges	8 years
Maximum length of time hedged in forecasted transactions, open cash flow hedges	6 years
Cash Flow Hedging
Derivatives gains/(losses) recorded in income and other comprehensive income/(loss)
Amounts reclassified from AOCI to income	$ 1,222	$ 570	$ (103)
Amounts recorded in OCI	(2,303)	3,623	122
Total change in OCI for period	(3,525)	3,053	225
Cash Flow Hedging | Interest rate
Derivatives gains/(losses) recorded in income and other comprehensive income/(loss)
Amounts reclassified from AOCI to income	1,032	570	(28)
Amounts recorded in OCI	(2,370)	3,582	(3)
Total change in OCI for period	(3,402)	3,012	25
Cash Flow Hedging | Foreign exchange
Derivatives gains/(losses) recorded in income and other comprehensive income/(loss)
Amounts reclassified from AOCI to income	190	0	(75)
Amounts recorded in OCI	67	41	125
Total change in OCI for period	$ (123)	$ 41	$ 200

Derivative Instruments - Impa_4

Derivative Instruments - Impact on Statements of Income, Net Investment Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other Income
Gains/(losses) recorded in income and other comprehensive income/(loss)
Net pre-tax gain (loss) reclassified related to liquidation of legal entity		$ 6	$ 7
Unrealized gains/(losses) on investment securities
Gains/(losses) recorded in income and other comprehensive income/(loss)
Net pre-tax gain (loss) reclassified related to liquidation of legal entity			18
Unrealized gains/(losses) on investment securities | Other Income
Gains/(losses) recorded in income and other comprehensive income/(loss)
Net pre-tax gain (loss) reclassified related to liquidation of legal entity	$ 0	3	18
Net Investment Hedging | Foreign exchange contracts
Gains/(losses) recorded in income and other comprehensive income/(loss)
Amounts recorded in income	(228)	(122)	72
Amounts recorded in OCI	$ 2,452	$ (1,408)	$ 64

Derivative Instruments - Impa_5

Derivative Instruments - Impact on Statements of Income, Risk Management Derivatives (Details) - Risk Management Activities - Not designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Gain (Loss) on Derivative Instruments, Net, Pretax [Abstract]
Derivatives gains/(losses) recorded in income	$ 1,078	$ 2,861	$ 1,456
Interest rate
Gain (Loss) on Derivative Instruments, Net, Pretax [Abstract]
Derivatives gains/(losses) recorded in income	1,078	2,994	1,491
Credit
Gain (Loss) on Derivative Instruments, Net, Pretax [Abstract]
Derivatives gains/(losses) recorded in income	(94)	(176)	(30)
Foreign exchange
Gain (Loss) on Derivative Instruments, Net, Pretax [Abstract]
Derivatives gains/(losses) recorded in income	$ 94	$ 43	$ (5)

Derivative Instruments - Credit

Derivative Instruments - Credit Derivatives (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Credit Derivatives - supplemental information
Tranche credit default swap realized credit loss protection	$ 1,000,000
Tranche credit default swap portfolio of exposure	10,000,000
Total credit derivatives and credit-related notes
Protection sold	(499,611,000,000)	$ (573,984,000,000)
Protection purchased with identical underlyings	537,766,000,000	609,365,000,000
Net protection (sold)/purchased	38,155,000,000	35,381,000,000
Other protection purchased	25,141,000,000	23,664,000,000
Total credit derivatives
Total credit derivatives and credit-related notes
Protection sold	(499,611,000,000)	(573,984,000,000)
Protection purchased with identical underlyings	537,766,000,000	609,365,000,000
Net protection (sold)/purchased	38,155,000,000	35,381,000,000
Other protection purchased	15,704,000,000	13,416,000,000
Credit default swaps
Total credit derivatives and credit-related notes
Protection sold	(443,481,000,000)	(533,900,000,000)
Protection purchased with identical underlyings	458,180,000,000	552,021,000,000
Net protection (sold)/purchased	14,699,000,000	18,121,000,000
Other protection purchased	2,269,000,000	2,786,000,000
Other credit derivatives
Total credit derivatives and credit-related notes
Protection sold	(56,130,000,000)	(40,084,000,000)
Protection purchased with identical underlyings	79,586,000,000	57,344,000,000
Net protection (sold)/purchased	23,456,000,000	17,260,000,000
Other protection purchased	13,435,000,000	10,630,000,000
Credit-related notes
Total credit derivatives and credit-related notes
Protection sold	0	0
Protection purchased with identical underlyings	0	0
Net protection (sold)/purchased	0	0
Other protection purchased	$ 9,437,000,000	$ 10,248,000,000

Derivative Instruments - Cred_2

Derivative Instruments - Credit Derivatives, Protection Sold, Notional and Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Protection sold credit derivatives and credit related notes ratings/maturity profile
Less than 1 year	$ (123,330)	$ (125,338)
From 1-5 years	(339,957)	(404,167)
More than 5 years	(36,324)	(44,479)
Total notional amount	(499,611)	(573,984)
Fair value of receivables	6,275	9,325
Fair value of payables	(2,626)	(3,376)
Net fair value	3,649	5,949
Investment-grade
Protection sold credit derivatives and credit related notes ratings/maturity profile
Less than 1 year	(91,155)	(93,529)
From 1-5 years	(255,106)	(306,830)
More than 5 years	(29,035)	(35,326)
Total notional amount	(375,296)	(435,685)
Fair value of receivables	3,645	5,372
Fair value of payables	(623)	(834)
Net fair value	3,022	4,538
Noninvestment-grade
Protection sold credit derivatives and credit related notes ratings/maturity profile
Less than 1 year	(32,175)	(31,809)
From 1-5 years	(84,851)	(97,337)
More than 5 years	(7,289)	(9,153)
Total notional amount	(124,315)	(138,299)
Fair value of receivables	2,630	3,953
Fair value of payables	(2,003)	(2,542)
Net fair value	$ 627	$ 1,411

Noninterest Revenue and Nonin_3

Noninterest Revenue and Noninterest Expense - Investment Banking Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Non interest Revenue [Line Items]
Underwriting	$ 8,822	$ 7,121	$ 5,161
Advisory	4,394	2,365	2,340
Total investment banking fees	13,216	9,486	7,501
Equity
Schedule of Non interest Revenue [Line Items]
Underwriting	3,969	2,759	1,648
Debt
Schedule of Non interest Revenue [Line Items]
Underwriting	$ 4,853	$ 4,362	$ 3,513

Noninterest Revenue and Nonin_4

Noninterest Revenue and Noninterest Expense - Principal Transactions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Non interest Revenue [Line Items]
Total trading revenue	$ 16,325	$ 17,840	$ 14,268
Private equity gains/(losses)	(21)	181	(250)
Principal transactions	16,304	18,021	14,018
Interest rate
Schedule of Non interest Revenue [Line Items]
Total trading revenue	1,646	2,575	2,739
Credit
Schedule of Non interest Revenue [Line Items]
Total trading revenue	2,691	2,753	1,628
Foreign exchange
Schedule of Non interest Revenue [Line Items]
Total trading revenue	2,787	4,253	3,179
Equity
Schedule of Non interest Revenue [Line Items]
Total trading revenue	7,773	6,171	5,589
Commodity
Schedule of Non interest Revenue [Line Items]
Total trading revenue	$ 1,428	$ 2,088	$ 1,133

Noninterest Revenue and Nonin_5

Noninterest Revenue and Noninterest Expense - Lending and Deposit-Related Fees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Noninterest Income (Expense) [Abstract]
Lending-related fees	$ 1,472	$ 1,271	$ 1,184
Deposit-related fees	5,560	5,240	5,442
Total lending- and deposit-related fees	$ 7,032	$ 6,511	$ 6,626

Noninterest Revenue and Nonin_6

Noninterest Revenue and Noninterest Expense - Asset Management, Administration and Commissions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Asset management fees
Investment management fees	$ 14,027	$ 11,694	$ 10,865
All other asset management fees	378	338	315
Total asset management fees	14,405	12,032	11,180
Total administration fees	2,554	2,249	2,197
Commissions and other fees
Brokerage commissions	3,046	2,959	2,439
All other commissions and fees	1,024	937	1,092
Total commissions and fees	4,070	3,896	3,531
Total asset management, administration and commissions	$ 21,029	$ 18,177	$ 16,908

Noninterest Revenue and Nonin_7

Noninterest Revenue and Noninterest Expense - Card Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Non interest Revenue [Line Items]
Credit cost amortization period	12 months
Direct loan origination costs amortization period	12 months
Total card income	$ 5,102	$ 4,435	$ 5,076
Interchange and merchant processing income
Schedule of Non interest Revenue [Line Items]
Total card income	23,592	18,563	20,370
Reward costs and partner payments
Schedule of Non interest Revenue [Line Items]
Total card income	(17,868)	(13,637)	(14,540)
Other card income
Schedule of Non interest Revenue [Line Items]
Total card income	$ (622)	$ (491)	$ (754)
Deferred revenues, recognition period	12 months
Minimum
Schedule of Non interest Revenue [Line Items]
Credit card revenue sharing agreement terms	5 years
Maximum
Schedule of Non interest Revenue [Line Items]
Credit card revenue sharing agreement terms	10 years

Noninterest Revenue and Nonin_8

Noninterest Revenue and Noninterest Expense - Components of Noninterest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Noninterest Income (Expense) [Abstract]
Legal expense	$ 426	$ 1,115	$ 239

Interest Income and Interest _3

Interest Income and Interest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Interest income
Loans	$ 41,537	$ 43,758	$ 51,855
Taxable securities	6,460	7,843	7,962
Non-taxable securities	1,063	1,184	1,329
Total investment securities	7,523	9,027	9,291
Trading assets - debt instruments	6,825	7,832	9,141
Federal funds sold and securities purchased under resale agreements	958	2,436	6,146
Securities borrowed	(385)	(302)	1,574
Deposits with banks	512	749	3,887
All other interest-earning assets	894	1,023	2,146
Total interest income	57,864	64,523	84,040
Interest expense
Interest bearing deposits	531	2,357	8,957
Federal funds purchased and securities loaned or sold under repurchase agreements	274	1,058	4,630
Short-term borrowings	126	372	1,248
Trading liabilities – debt and all other interest-bearing liabilities	257	195	2,585
Long-term debt	4,282	5,764	8,807
Beneficial interest issued by consolidated VIEs	83	214	568
Total interest expense	5,553	9,960	26,795
Net interest income	52,311	54,563	57,245
Provision for credit losses	(9,256)	17,480	5,585
Net interest income after provision for credit losses	$ 61,567	$ 37,083	$ 51,660

Pension and Other Postretirem_3

Pension and Other Postretirement Employee Benefit Plans - Defined Benefit Pension and OPEB Plans (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Projected benefit obligations	$ (18,046)	$ (19,137)
Fair value of plan assets	25,692	25,417
Net funded status	7,646	6,280
Accumulated other comprehensive income/(loss)	$ (453)	$ (1,586)
Weighted-average actuarial assumptions used to value benefit obligations
Discount rate	2.54%	2.17%

Pension and Other Postretirem_4

Pension and Other Postretirement Employee Benefit Plans - Gains and Losses (Details)	12 Months Ended
	Dec. 31, 2021
Defined benefit pension plans
Defined Benefit Plan Disclosure [Line Items]
Percent above which amortization of net gains and losses is included in annual net periodic benefit cost	10.00%

Pension and Other Postretirem_5

Pension and Other Postretirement Employee Benefit Plans - Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pension and OPEB plans
Total net periodic defined benefit plan cost/(credit)	$ (201)	$ (285)	$ 144
Total defined contribution plans	1,333	1,332	952
Total pension and OPEB cost included in noninterest expense	1,132	1,047	1,096
Total recognized in other comprehensive income	$ (1,129)	$ (214)	$ (1,157)
Weighted-average assumptions used to determine net periodic benefit costs
Discount rate	2.17%	2.93%	3.89%
Expected long-term rate of return on plan assets	2.97%	3.91%	5.08%

Pension and Other Postretirem_6

Pension and Other Postretirement Employee Benefit Plans - Investment Strategy and Weighted Average Asset Allocation (Details) - USD ($) $ in Billions	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Investments sponsored or managed by affiliates	$ 2.5	$ 2.7
Defined benefit pension plans | Debt securities | Minimum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	42.00%
Defined benefit pension plans | Debt securities | Maximum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	100.00%
Defined benefit pension plans | Equity securities | Minimum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	0.00%
Defined benefit pension plans | Equity securities | Maximum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	40.00%
Defined benefit pension plans | Real estate | Minimum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	0.00%
Defined benefit pension plans | Real estate | Maximum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	3.00%
Defined benefit pension plans | Alternatives | Minimum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	0.00%
Defined benefit pension plans | Alternatives | Maximum | U.S.
Defined Benefit Plan Disclosure [Line Items]
Asset allocation	12.00%

Pension and Other Postretirem_7

Pension and Other Postretirement Employee Benefit Plans - Fair Value Measurement of the Plans' Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 25,692	$ 25,417
Total fair value
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	22,028	22,367
Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,541	7,031
Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12,315	12,384
Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,172	2,952	$ 2,700
Assets measured at fair value using net asset value per share as practical expedient
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,960	3,651
Defined benefit pension plans
Defined Benefit Plan Disclosure [Line Items]
Net defined benefit pension plan payables not classified in fair value hierarchy	$ (296)	$ (601)

Pension and Other Postretirem_8

Pension and Other Postretirement Employee Benefit Plans - Changes In Level 3 Fair Value Measurements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Increase in investments classified in level 3 of the valuation hierarchy	$ 220	$ 263
Investments classified in level 3 of the valuation hierarchy	25,692	25,417
Unrealized gains	332	343
Offset for settlements	94	118
Level 3
Defined Benefit Plan Disclosure [Line Items]
Investments classified in level 3 of the valuation hierarchy	3,172	$ 2,952	$ 2,700
Transfers into Level 3	$ 33

Pension and Other Postretirem_9

Pension and Other Postretirement Employee Benefit Plans - Estimated Future Benefit Payments (Details) $ in Millions	Dec. 31, 2021USD ($)
Defined benefit pension and OPEB plans
2022	$ 1,124
2023	1,106
2024	1,082
2025	1,036
2026	1,016
Years 2027–2031	$ 4,740

Employee Share-Based Incentiv_3

Employee Share-Based Incentives - Employee Share-Based Awards (Details)	12 Months Ended
	Dec. 31, 2021shares
Long-Term Incentive Plan
Employee stock-based awards general disclosures
Shares of common stock available for issuance (in shares)	83,000,000
PSUs
Employee stock-based awards general disclosures
Award vesting period	3 years
Holding period	2 years
PSUs | Minimum
Employee stock-based awards general disclosures
Award vesting percentage	0.00%
Combined vesting and holding period	5 years
PSUs | Maximum
Employee stock-based awards general disclosures
Award vesting percentage	150.00%
Combined vesting and holding period	8 years
Stock Appreciation Rights (SARs)
Employee stock-based awards general disclosures
Award expiration period	10 years
Stock Appreciation Rights (SARs) | Chairman and CEO
Employee stock-based awards general disclosures
Awards granted (in shares)	1,500,000
Stock Appreciation Rights (SARs) | President and Chief Operating Officer
Employee stock-based awards general disclosures
Awards granted (in shares)	750,000
Stock options
Employee stock-based awards general disclosures
Award expiration period	10 years
1st 50% | RSUs
Employee stock-based awards general disclosures
Award vesting percentage	50.00%
Award vesting period	2 years
2nd 50% | RSUs
Employee stock-based awards general disclosures
Award vesting percentage	50.00%
Award vesting period	3 years

Employee Share-Based Incentiv_4

Employee Share-Based Incentives - RSUs, PSUs, SARS and Stock Options Activities (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
RSUs/PSUs
RSUs/PSUs Number of Units:
Outstanding, January 1 (in shares)	47,510
Granted (in shares)	20,347
Exercised or vested (in shares)	(20,235)
Forfeited (in shares)	(2,217)
Outstanding, December 31 (in shares)	45,405	47,510
RSUs/PSUs Weighted-Average Grant Date Fair Value:
Outstanding, January 1 (in dollars per share)	$ 112.85
Granted (in dollars per share)	138.98
Exercised or vested (in dollars per share)	107.26
Forfeited (in dollars per share)	126.77
Outstanding, December 31 (in dollars per share)	$ 126.32	$ 112.85
SARs/Options
Options/SARs Number of Awards:
Outstanding, January 1 (in shares)	3,124
Granted (in shares)	2,250
Exercised or vested (in shares)	(2,005)
Forfeited (in shares)	0
Canceled (in shares)	0
Outstanding, December 31 (in shares)	3,369	3,124
Exercisable, December 31 (in shares)	1,119
Options/SARs Weighted-Average Exercise Price:
Outstanding, January 1 (in dollars per share)	$ 41.25
Granted (in dollars per share)	152.19
Exercised or vested (in dollars per share)	39.08
Forfeited (in dollars per share)	0
Canceled (in dollars per share)	0
Outstanding, December 31 (in dollars per share)	116.62	$ 41.25
Exercisable, December 31 (in dollars per share)	$ 45.14
Weighted-average remaining contractual life, Outstanding	6 years 9 months 18 days
Weighted-average remaining contractual life, Exercisable	10 months 24 days
Aggregate intrinsic value, Outstanding	$ 141,872
Aggregate intrinsic value, Exercisable	127,030
RSUs
Options/SARs Weighted-Average Exercise Price:
Total fair value of RSUs that vested	2,900,000	$ 2,800,000	$ 2,900,000
Stock options
Options/SARs Weighted-Average Exercise Price:
Total intrinsic value of options exercised	$ 232,000	$ 182,000	$ 503,000

Employee Share-Based Incentiv_5

Employee Share-Based Incentives - Compensation Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Noncash compensation expense related to employee stock-based incentive plans
Cost of prior grants of RSUs, PSUs, SARs and stock options that are amortized over their applicable vesting periods	$ 1,161	$ 1,101	$ 1,141
Accrual of estimated costs of share-based awards to be granted in future periods, predominantly those to full-career eligible employees	1,768	1,350	1,115
Total noncash compensation expense related to employee share-based incentive plans	2,929	$ 2,451	$ 2,256
Compensation cost related to unvested awards not charged to net income	$ 862
Weighted-average period for cost expected to be amortized into compensation expense	1 year 9 months 18 days

Employee Share-Based Incentiv_6

Employee Share-Based Incentives - Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement [Abstract]
Tax benefit from compensation expense	$ 957	$ 837	$ 895

Investment Securities - Narrati

Investment Securities - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2020
Schedule of Held-to-maturity Securities [Line Items]
Amount of collateralized loan obligations transferred from AFS to HTM for capital management purposes	$ 104,500
Approximate percentage rated at least AA+		98.00%	98.00%
Allowance for credit losses on investment securities		$ 42	$ 78
Cumulative effect of change in accounting principles
Schedule of Held-to-maturity Securities [Line Items]
Allowance for credit losses on investment securities				$ 10
Unrealized gains/(losses) on investment securities
Schedule of Held-to-maturity Securities [Line Items]
Pretax unrealized gains included in AOCI on the securities at the date of transfer	$ 425

Investment Securities - Amortiz

Investment Securities - Amortized Costs, Fair Value (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Available-for-sale securities
Amortized cost	$ 308,254,000,000	$ 381,729,000,000
Gross unrealized gains	2,614,000,000	6,705,000,000
Gross unrealized losses	2,343,000,000	256,000,000
Fair value	308,525,000,000	388,178,000,000
Held-to-maturity securities
Amortized cost	363,707,000,000	201,821,000,000
Gross unrealized gains	2,110,000,000	3,712,000,000
Gross unrealized losses	3,189,000,000	61,000,000
Fair value	362,628,000,000	205,472,000,000
Total investment securities, net of allowance for credit losses
Amortized cost	671,961,000,000	583,550,000,000
Gross unrealized gains	4,724,000,000	10,417,000,000
Gross unrealized losses	5,532,000,000	317,000,000
Fair value	671,153,000,000	593,650,000,000
HTM securities purchased	111,800,000,000	12,400,000,000	$ 13,400,000,000
Allowance for credit losses on investment securities	42,000,000	78,000,000
Accrued interest receivables on investment securities	1,900,000,000	2,100,000,000
Accrued interest receivables reversed through interest income on HTM securities	0	0
Accrued interest receivables reversed through interest income on AFS securities	0	0
Total mortgage-backed securities
Available-for-sale securities
Amortized cost	83,754,000,000	123,795,000,000
Gross unrealized gains	821,000,000	2,687,000,000
Gross unrealized losses	1,013,000,000	92,000,000
Fair value	83,562,000,000	126,390,000,000
Held-to-maturity securities
Amortized cost	113,602,000,000	114,836,000,000
Gross unrealized gains	1,412,000,000	3,053,000,000
Gross unrealized losses	1,013,000,000	59,000,000
Fair value	114,001,000,000	117,830,000,000
U.S. GSEs and government agencies
Available-for-sale securities
Amortized cost	72,800,000,000	110,979,000,000
Gross unrealized gains	736,000,000	2,372,000,000
Gross unrealized losses	993,000,000	50,000,000
Fair value	72,543,000,000	113,301,000,000
Held-to-maturity securities
Amortized cost	102,556,000,000	107,889,000,000
Gross unrealized gains	1,400,000,000	2,968,000,000
Gross unrealized losses	853,000,000	29,000,000
Fair value	103,103,000,000	110,828,000,000
Residential: U.S.
Available-for-sale securities
Amortized cost	2,128,000,000	6,246,000,000
Gross unrealized gains	38,000,000	224,000,000
Gross unrealized losses	2,000,000	3,000,000
Fair value	2,164,000,000	6,467,000,000
Held-to-maturity securities
Amortized cost	7,316,000,000	4,345,000,000
Gross unrealized gains	1,000,000	8,000,000
Gross unrealized losses	106,000,000	30,000,000
Fair value	7,211,000,000	4,323,000,000
Residential: Non-U.S.
Available-for-sale securities
Amortized cost	3,882,000,000	3,751,000,000
Gross unrealized gains	25,000,000	20,000,000
Gross unrealized losses	1,000,000	5,000,000
Fair value	3,906,000,000	3,766,000,000
Commercial
Available-for-sale securities
Amortized cost	4,944,000,000	2,819,000,000
Gross unrealized gains	22,000,000	71,000,000
Gross unrealized losses	17,000,000	34,000,000
Fair value	4,949,000,000	2,856,000,000
Held-to-maturity securities
Amortized cost	3,730,000,000	2,602,000,000
Gross unrealized gains	11,000,000	77,000,000
Gross unrealized losses	54,000,000	0
Fair value	3,687,000,000	2,679,000,000
U.S. Treasury and government agencies
Available-for-sale securities
Amortized cost	178,038,000,000	199,910,000,000
Gross unrealized gains	668,000,000	2,141,000,000
Gross unrealized losses	1,243,000,000	100,000,000
Fair value	177,463,000,000	201,951,000,000
Held-to-maturity securities
Amortized cost	185,204,000,000	53,184,000,000
Gross unrealized gains	169,000,000	50,000,000
Gross unrealized losses	2,103,000,000	0
Fair value	183,270,000,000	53,234,000,000
Obligations of U.S. states and municipalities
Available-for-sale securities
Amortized cost	14,890,000,000	18,993,000,000
Gross unrealized gains	972,000,000	1,404,000,000
Gross unrealized losses	2,000,000	1,000,000
Fair value	15,860,000,000	20,396,000,000
Held-to-maturity securities
Amortized cost	13,985,000,000	12,751,000,000
Gross unrealized gains	453,000,000	519,000,000
Gross unrealized losses	44,000,000	0
Fair value	14,394,000,000	13,270,000,000
Non-U.S. government debt securities
Available-for-sale securities
Amortized cost	16,163,000,000	22,587,000,000
Gross unrealized gains	92,000,000	354,000,000
Gross unrealized losses	46,000,000	13,000,000
Fair value	16,209,000,000	22,928,000,000
Corporate debt securities
Available-for-sale securities
Amortized cost	332,000,000	215,000,000
Gross unrealized gains	8,000,000	4,000,000
Gross unrealized losses	19,000,000	3,000,000
Fair value	321,000,000	216,000,000
Asset-backed securities: Collateralized loan obligations
Available-for-sale securities
Amortized cost	9,674,000,000	10,055,000,000
Gross unrealized gains	6,000,000	24,000,000
Gross unrealized losses	18,000,000	31,000,000
Fair value	9,662,000,000	10,048,000,000
Held-to-maturity securities
Amortized cost	48,869,000,000	21,050,000,000
Gross unrealized gains	75,000,000	90,000,000
Gross unrealized losses	22,000,000	2,000,000
Fair value	48,922,000,000	21,138,000,000
Asset-backed securities: Other
Available-for-sale securities
Amortized cost	5,403,000,000	6,174,000,000
Gross unrealized gains	47,000,000	91,000,000
Gross unrealized losses	2,000,000	16,000,000
Fair value	5,448,000,000	6,249,000,000
Held-to-maturity securities
Amortized cost	2,047,000,000	0
Gross unrealized gains	1,000,000	0
Gross unrealized losses	7,000,000	0
Fair value	$ 2,041,000,000	$ 0

Investment Securities - Continu

Investment Securities - Continuous Unrealized Loss Position (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Available-for-sale securities
Less than 12 months, Fair value	$ 16,538	$ 12,133
Less than 12 months, Gross unrealized losses	65	57
12 months or more, Fair value	1,336	4,694
12 months or more, Gross unrealized losses	42	49
Total fair value	17,874	16,827
Total gross unrealized losses	107	106
Total mortgage-backed securities
Available-for-sale securities
Less than 12 months, Fair value	2,993	3,768
Less than 12 months, Gross unrealized losses	7	25
12 months or more, Fair value	394	391
12 months or more, Gross unrealized losses	13	17
Total fair value	3,387	4,159
Total gross unrealized losses	20	42
U.S. GSEs and government agencies
Available-for-sale securities
Total fair value	2,200	150
Residential: U.S.
Available-for-sale securities
Less than 12 months, Fair value	303	562
Less than 12 months, Gross unrealized losses	1	3
12 months or more, Fair value	45	32
12 months or more, Gross unrealized losses	1	0
Total fair value	348	594
Total gross unrealized losses	2	3
Residential: Non-U.S.
Available-for-sale securities
Less than 12 months, Fair value	133	2,507
Less than 12 months, Gross unrealized losses	1	4
12 months or more, Fair value	0	235
12 months or more, Gross unrealized losses	0	1
Total fair value	133	2,742
Total gross unrealized losses	1	5
Commercial
Available-for-sale securities
Less than 12 months, Fair value	2,557	699
Less than 12 months, Gross unrealized losses	5	18
12 months or more, Fair value	349	124
12 months or more, Gross unrealized losses	12	16
Total fair value	2,906	823
Total gross unrealized losses	17	34
Obligations of U.S. states and municipalities
Available-for-sale securities
Less than 12 months, Fair value	120	49
Less than 12 months, Gross unrealized losses	2	1
12 months or more, Fair value	0	0
12 months or more, Gross unrealized losses	0	0
Total fair value	120	49
Total gross unrealized losses	2	1
Non-U.S. government debt securities
Available-for-sale securities
Less than 12 months, Fair value	5,060	2,709
Less than 12 months, Gross unrealized losses	37	9
12 months or more, Fair value	510	968
12 months or more, Gross unrealized losses	9	4
Total fair value	5,570	3,677
Total gross unrealized losses	46	13
Corporate debt securities
Available-for-sale securities
Less than 12 months, Fair value	166	91
Less than 12 months, Gross unrealized losses	1	3
12 months or more, Fair value	46	5
12 months or more, Gross unrealized losses	18	0
Total fair value	212	96
Total gross unrealized losses	19	3
Asset-backed securities: Collateralized loan obligations
Available-for-sale securities
Less than 12 months, Fair value	8,110	5,248
Less than 12 months, Gross unrealized losses	18	18
12 months or more, Fair value	208	2,645
12 months or more, Gross unrealized losses	0	13
Total fair value	8,318	7,893
Total gross unrealized losses	18	31
Asset-backed securities: Other
Available-for-sale securities
Less than 12 months, Fair value	89	268
Less than 12 months, Gross unrealized losses	0	1
12 months or more, Fair value	178	685
12 months or more, Gross unrealized losses	2	15
Total fair value	267	953
Total gross unrealized losses	$ 2	$ 16

Investment Securities - Realize

Investment Securities - Realized Gain (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Securities gains and losses
Realized gains	$ 595	$ 3,080	$ 650
Realized losses	(940)	(2,278)	(392)
Investment securities gains/(losses)	(345)	802	$ 258
Provision for credit losses	$ (36)	$ 68

Investment Securities - Amort_2

Investment Securities - Amortized Cost, Fair Value, by Contract Maturity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 17,506
Due after one year through five years	157,321
Due after five years through 10 years	27,587
Due after 10 years	105,843
Amortized cost	308,257
Available-for-sale securities, Fair value
Due in one year or less	17,547
Due after one year through five years	156,601
Due after five years through 10 years	27,850
Due after 10 years	106,527
Fair value	$ 308,525	$ 388,178
Available-for-sale securities, Average yield
Due in one year or less	1.61%
Due after one year through five years	0.67%
Due after five years through 10 years	1.15%
Due after 10 years	2.37%
Average yield	1.35%
Held-to-maturity securities, Amortized cost
Due in one year or less	$ 25,741
Due after one year through five years	94,243
Due after five years through 10 years	92,742
Due after 10 years	151,020
Amortized cost	363,746
Held-to-maturity securities, Fair value
Due in one year or less	25,710
Due after one year through five years	93,141
Due after five years through 10 years	92,371
Due after 10 years	151,406
Fair value	$ 362,628	205,472
Held-to-maturity securities, Average yield
Due in one year or less	0.54%
Due after one year through five years	0.76%
Due after five years through 10 years	1.43%
Due after 10 years	2.53%
Average yield	1.65%
Supplemental information
US government agencies and US government sponsored enterprises residential mortgage-backed securities estimated duration	6 years
US government agencies and US government sponsored enterprises residential collateralized mortgage obligations estimated duration	4 years
Non-agency residential collateralized mortgage obligations estimated duration	3 years
Minimum
Supplemental information
Due period of mortgage-backed securities and collateralized mortgage obligations	10 years
Total mortgage-backed securities
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 8
Due after one year through five years	3,771
Due after five years through 10 years	4,823
Due after 10 years	75,155
Amortized cost	83,757
Available-for-sale securities, Fair value
Due in one year or less	8
Due after one year through five years	3,783
Due after five years through 10 years	5,094
Due after 10 years	74,677
Fair value	$ 83,562	126,390
Available-for-sale securities, Average yield
Due in one year or less	0.52%
Due after one year through five years	1.53%
Due after five years through 10 years	1.75%
Due after 10 years	2.25%
Average yield	2.19%
Held-to-maturity securities, Amortized cost
Due in one year or less	$ 0
Due after one year through five years	1,322
Due after five years through 10 years	11,495
Due after 10 years	100,791
Amortized cost	113,608
Held-to-maturity securities, Fair value
Due in one year or less	0
Due after one year through five years	1,338
Due after five years through 10 years	11,814
Due after 10 years	100,849
Fair value	$ 114,001	117,830
Held-to-maturity securities, Average yield
Due in one year or less	0.00%
Due after one year through five years	1.76%
Due after five years through 10 years	2.43%
Due after 10 years	2.83%
Average yield	2.78%
U.S. Treasury and government agencies
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 7,774
Due after one year through five years	146,817
Due after five years through 10 years	14,618
Due after 10 years	8,829
Amortized cost	178,038
Available-for-sale securities, Fair value
Due in one year or less	7,802
Due after one year through five years	146,050
Due after five years through 10 years	14,554
Due after 10 years	9,057
Fair value	$ 177,463	201,951
Available-for-sale securities, Average yield
Due in one year or less	1.01%
Due after one year through five years	0.55%
Due after five years through 10 years	0.61%
Due after 10 years	0.54%
Average yield	0.57%
Held-to-maturity securities, Amortized cost
Due in one year or less	$ 25,706
Due after one year through five years	92,845
Due after five years through 10 years	66,653
Due after 10 years	0
Amortized cost	185,204
Held-to-maturity securities, Fair value
Due in one year or less	25,675
Due after one year through five years	91,727
Due after five years through 10 years	65,868
Due after 10 years	0
Fair value	$ 183,270	53,234
Held-to-maturity securities, Average yield
Due in one year or less	0.54%
Due after one year through five years	0.74%
Due after five years through 10 years	1.26%
Due after 10 years	0.00%
Average yield	0.90%
Obligations of U.S. states and municipalities
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 13
Due after one year through five years	142
Due after five years through 10 years	1,285
Due after 10 years	13,450
Amortized cost	14,890
Available-for-sale securities, Fair value
Due in one year or less	13
Due after one year through five years	146
Due after five years through 10 years	1,346
Due after 10 years	14,355
Fair value	$ 15,860	20,396
Available-for-sale securities, Average yield
Due in one year or less	4.06%
Due after one year through five years	4.38%
Due after five years through 10 years	4.84%
Due after 10 years	4.89%
Average yield	4.88%
Held-to-maturity securities, Amortized cost
Due in one year or less	$ 35
Due after one year through five years	76
Due after five years through 10 years	1,192
Due after 10 years	12,715
Amortized cost	14,018
Held-to-maturity securities, Fair value
Due in one year or less	35
Due after one year through five years	76
Due after five years through 10 years	1,240
Due after 10 years	13,043
Fair value	$ 14,394	13,270
Held-to-maturity securities, Average yield
Due in one year or less	3.72%
Due after one year through five years	2.72%
Due after five years through 10 years	3.74%
Due after 10 years	3.83%
Average yield	3.82%
Non-U.S. government debt securities
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 7,211
Due after one year through five years	5,491
Due after five years through 10 years	3,461
Due after 10 years	0
Amortized cost	16,163
Available-for-sale securities, Fair value
Due in one year or less	7,224
Due after one year through five years	5,532
Due after five years through 10 years	3,453
Due after 10 years	0
Fair value	$ 16,209	22,928
Available-for-sale securities, Average yield
Due in one year or less	2.34%
Due after one year through five years	2.53%
Due after five years through 10 years	1.09%
Due after 10 years	0.00%
Average yield	2.14%
Corporate debt securities
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 0
Due after one year through five years	301
Due after five years through 10 years	31
Due after 10 years	0
Amortized cost	332
Available-for-sale securities, Fair value
Due in one year or less	0
Due after one year through five years	290
Due after five years through 10 years	31
Due after 10 years	0
Fair value	$ 321	$ 216
Available-for-sale securities, Average yield
Due in one year or less	0.00%
Due after one year through five years	10.03%
Due after five years through 10 years	1.61%
Due after 10 years	0.00%
Average yield	9.25%
Asset-backed securities
Available-for-sale securities, Amortized Cost:
Due in one year or less	$ 2,500
Due after one year through five years	799
Due after five years through 10 years	3,369
Due after 10 years	8,409
Amortized cost	15,077
Available-for-sale securities, Fair value
Due in one year or less	2,500
Due after one year through five years	800
Due after five years through 10 years	3,372
Due after 10 years	8,438
Fair value	$ 15,110
Available-for-sale securities, Average yield
Due in one year or less	1.35%
Due after one year through five years	1.88%
Due after five years through 10 years	1.25%
Due after 10 years	1.28%
Average yield	1.32%
Held-to-maturity securities, Amortized cost
Due in one year or less	$ 0
Due after one year through five years	0
Due after five years through 10 years	13,402
Due after 10 years	37,514
Amortized cost	50,916
Held-to-maturity securities, Fair value
Due in one year or less	0
Due after one year through five years	0
Due after five years through 10 years	13,449
Due after 10 years	37,514
Fair value	$ 50,963
Held-to-maturity securities, Average yield
Due in one year or less	0.00%
Due after one year through five years	0.00%
Due after five years through 10 years	1.18%
Due after 10 years	1.30%
Average yield	1.27%

Securities Financing Activiti_3

Securities Financing Activities - Schedule of Securities Purchased Under Resale Agreements, Netting & Securities Borrowed (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Securities purchased under resale agreements, Gross amounts	$ 604,724	$ 666,467
Securities purchased under resale agreements, Amounts netted on the Consolidated balance sheets	(343,093)	(370,183)
Securities purchased under resale agreements, Amounts presented on the Consolidated balance sheets	261,631	296,284
Securities purchased under resale agreements, Amounts not nettable on the Consolidated balance sheets	(245,588)	(273,206)
Securities purchased under resale agreements, Net amounts	16,043	23,078
Securities borrowed, Gross amounts	250,333	193,700
Securities borrowed, Amounts netted on the Consolidated balance sheets	(44,262)	(33,065)
Securities borrowed, Amounts presented on the Consolidated balance sheets	206,071	160,635
Securities borrowed, Amounts not nettable on the Consolidated balance sheets	(154,599)	(115,219)
Securities borrowed, Net amounts	51,472	45,416
Liabilities
Securities sold under repurchase agreements, Gross amounts	532,899	578,060
Securities sold under repurchase agreements, Amounts netted on the Consolidated balance sheets	(343,093)	(370,183)
Securities sold under repurchase agreements, Amounts presented on the Consolidated balance sheets	189,806	207,877
Securities sold under repurchase agreements, Amounts not nettable on the Consolidated balance sheets	(166,456)	(191,980)
Securities sold under repurchase agreements, Net amounts	23,350	15,897
Securities loaned and other, Gross amounts	52,610	41,366
Securities loaned and other, Amounts netted on the Consolidated balance sheets	(44,262)	(33,065)
Securities loaned and other, Amounts presented in the Consolidated balance sheets	8,348	8,301
Securities loaned and other, Amounts not nettable on the Consolidated balance sheets	(8,133)	(8,257)
Securities loaned and other, Net amounts	215	44
Securities purchased under resale agreements where an appropriate legal opinion has not been either sought or obtained, Gross asset balance	13,900	17,000
Securities borrowed where an appropriate legal opinion has not been either sought or obtained	46,400	42,100
Securities sold under agreements to repurchase	21,600	14,500
Securities loaned and other	198	8
Securities-For-Securities
Liabilities
Securities loaned and other, Amounts presented in the Consolidated balance sheets	$ 5,600	$ 3,400

Securities Financing Activiti_4

Securities Financing Activities - Schedule of Secured Financing Transactions by Assets Pledged & Remaining Maturity (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	$ 532,899	$ 578,060
Securities loaned and other	52,610	41,366
Overnight and continuous
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	195,035	238,667
Securities loaned and other	50,034	37,887
Up to 30 days
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	231,171	230,980
Securities loaned and other	1,701	1,647
30 – 90 days
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	47,201	70,777
Securities loaned and other	0	500
Greater than 90 days
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	59,492	37,636
Securities loaned and other	875	1,332
Mortgage-backed securities, U.S. GSEs and government agencies
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	37,046	56,744
Securities loaned and other	0	0
Mortgage-backed securities, Residential - nonagency
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	1,508	1,016
Securities loaned and other	0	0
Mortgage-backed securities, Commercial - nonagency
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	1,463	855
Securities loaned and other	0	0
U.S. Treasury, GSEs and government agencies
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	241,578	315,834
Securities loaned and other	358	143
Obligations of U.S. states and municipalities
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	1,916	1,525
Securities loaned and other	7	2
Non-U.S. government debt
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	174,971	157,563
Securities loaned and other	1,572	1,730
Corporate debt securities
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	38,180	22,849
Securities loaned and other	1,619	1,864
Asset-backed securities
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	1,211	694
Securities loaned and other	0	0
Equity securities
Securities Financing Transaction [Line Items]
Securities sold under repurchase agreements	35,026	20,980
Securities loaned and other	$ 49,054	$ 37,627

Securities Financing Activiti_5

Securities Financing Activities - Schedule of Transfers Not Qualifying for Sale Accounting (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Securities Financing Transactions Disclosures [Abstract]
Transfers not qualifying for sale accounting	$ 440	$ 598

Loans - Narrative (Details)

Loans - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)loan_segmentloan_payment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Loans and Leases Receivable Disclosure [Line Items]
Number of portfolio segments | loan_segment	3
Net gains on sales of loans	$ 261	$ (43)	$ 394
Net gains (losses) on sales of loans	$ 253	$ (36)
Residential real estate | Maximum
Loans and Leases Receivable Disclosure [Line Items]
Number of months before updating exterior opinion on home valuation	12 months
Commercial real estate | Minimum
Loans and Leases Receivable Disclosure [Line Items]
Number of months before updating collateral values on commercial real estate loans	6 months
Commercial real estate | Maximum
Loans and Leases Receivable Disclosure [Line Items]
Number of months before updating collateral values on commercial real estate loans	12 months
180 or more days past due | Residential real estate loans, unmodified credit card loans, and business banking loans
Loans and Leases Receivable Disclosure [Line Items]
Loans, charge-off criteria, period past due	180 days
120 or more days past due | Scored auto and modified credit card loans
Loans and Leases Receivable Disclosure [Line Items]
Loans, charge-off criteria, period past due	120 days
Less than 60 days until charge-off | Residential real estate and auto loans
Loans and Leases Receivable Disclosure [Line Items]
Period past due, credit analysis factors, charge off criteria	60 days
Consumer, excluding credit card | Minimum
Loans and Leases Receivable Disclosure [Line Items]
Number of months the borrower has performed under modified terms	6 months
Number of payments under modified terms to recognize interest on cash basis | loan_payment	6
Consumer, excluding credit card | 90 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Period past due, credit analysis factors, charge off criteria	90 days
Consumer, excluding credit card | 30 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Period past due, credit analysis factors, charge off criteria	30 days

Loans - By Portfolio Segment (D

Loans - By Portfolio Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loan balances by portfolio segment:
Retained loans	$ 1,010,206	$ 960,506	$ 945,601
Held-for-sale	8,688	7,873
At fair value	58,820	44,474
Total	1,077,714	1,012,853
Accrued interest receivables	2,700	2,900
Accrued interest receivables written off	56	121
Consumer, excluding credit card
Loan balances by portfolio segment:
Retained loans	295,556	302,127	294,999
Held-for-sale	1,287	1,305
At fair value	26,463	15,147
Total	323,306	318,579
Credit card
Loan balances by portfolio segment:
Retained loans	154,296	143,432
Held-for-sale	0	784
At fair value	0	0
Total	154,296	144,216
Wholesale
Loan balances by portfolio segment:
Retained loans	560,354	514,947	$ 481,678
Held-for-sale	7,401	5,784
At fair value	32,357	29,327
Total	$ 600,112	$ 550,058

Loans - Purchased, Sold and Rec

Loans - Purchased, Sold and Reclassified to Held-for-Sale (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Purchases	$ 1,637	$ 4,633	$ 2,573
Sales	31,821	18,268	53,919
Retained loans reclassified to held-for-sale	3,403	4,451	11,559
Consumer, excluding credit card
Loans and Leases Receivable Disclosure [Line Items]
Purchases	515	3,474	1,282
Sales	799	352	30,474
Retained loans reclassified to held-for-sale	1,225	2,084	9,188
Excluded purchases of retained loans predominantly sourced through the correspondent origination channel and underwritten in accordance with Firm standards	25,800	16,300	16,600
Credit card
Loans and Leases Receivable Disclosure [Line Items]
Purchases	0	0	0
Sales	0	0	0
Retained loans reclassified to held-for-sale	0	787	0
Wholesale
Loans and Leases Receivable Disclosure [Line Items]
Purchases	1,122	1,159	1,291
Sales	31,022	17,916	23,445
Retained loans reclassified to held-for-sale	$ 2,178	$ 1,580	$ 2,371

Loans - Consumer, Excluding Cre

Loans - Consumer, Excluding Credit Card Loan Portfolio (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 1,010,206	$ 960,506	$ 945,601
Consumer, excluding credit card
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	295,556	302,127	$ 294,999
Consumer, excluding credit card | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	224,795	225,302
Consumer, excluding credit card | Auto and other
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	70,761	76,825
Consumer, excluding credit card | Auto and other | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 5,400	$ 19,200

Loans - Consumer, Excluding C_2

Loans - Consumer, Excluding Credit Card Loan Portfolio, Residential Real Estate (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 1,010,206	$ 960,506	$ 945,601
Consumer, excluding credit card
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	295,556	302,127	$ 294,999
Consumer, excluding credit card | 30 or more days past due | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	31	40
Consumer, excluding credit card | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	68,755	56,588
Term loans originated in 2020/2019	48,368	31,859
Term loans originated in 2019/2018	18,476	13,930
Term loans originated in 2018/2017	7,981	20,450
Term loans originated in 2017/2016	11,739	28,025
Term loans originated prior to 2017/2016	50,794	50,736
Revolving loans within revolving period	6,409	7,945
Revolving loans converted to term loans	12,273	15,769
Total retained loans	$ 224,795	$ 225,302
% of 30 plus days past due to total retained loans, Term loans originated in 2021/2020	0.02%	0.02%
% of 30 plus days past due to total retained loans, Term loans originated in 2020/2019	0.07%	0.12%
% of 30 plus days past due to total retained loans, Term loans originated in 2019/2018	0.26%	0.22%
% of 30 plus days past due to total retained loans, Term loans originated in 2018/2017	0.65%	0.20%
% of 30 plus days past due to total retained loans, Term loans originated in 2017/2016	0.47%	0.17%
% of 30 plus days past due to total retained loans, Term loans originated prior to 2017/2016	3.18%	2.91%
% of 30 plus days past due to total retained loans, Revolving loans within the revolving period	0.27%	0.54%
% of 30 plus days past due to total retained loans, Revolving loans converted to term loans	3.80%	3.23%
% of 30 plus days past due to total retained loans	1.02%	0.98%
Consumer, excluding credit card | Residential real estate | Senior lien
Loans and Leases Receivable Disclosure [Line Items]
Percentage of total revolving loans that are senior lien loans	37.00%
Consumer, excluding credit card | Residential real estate | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 66	$ 76
Consumer, excluding credit card | Residential real estate | Current
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	68,742	56,576
Term loans originated in 2020/2019	48,334	31,820
Term loans originated in 2019/2018	18,428	13,900
Term loans originated in 2018/2017	7,929	20,410
Term loans originated in 2017/2016	11,684	27,978
Term loans originated prior to 2017/2016	49,147	49,218
Revolving loans within revolving period	6,392	7,902
Revolving loans converted to term loans	11,807	15,260
Total retained loans	222,463	223,064
Consumer, excluding credit card | Residential real estate | Current | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	35	36
Consumer, excluding credit card | Residential real estate | 30–149 days past due
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	13	9
Term loans originated in 2020/2019	23	25
Term loans originated in 2019/2018	27	20
Term loans originated in 2018/2017	27	22
Term loans originated in 2017/2016	22	29
Term loans originated prior to 2017/2016	578	674
Revolving loans within revolving period	11	21
Revolving loans converted to term loans	182	245
Total retained loans	883	1,045
Consumer, excluding credit card | Residential real estate | 30–149 days past due | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	11	16
Consumer, excluding credit card | Residential real estate | 150 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	0	3
Term loans originated in 2020/2019	11	14
Term loans originated in 2019/2018	21	10
Term loans originated in 2018/2017	25	18
Term loans originated in 2017/2016	33	18
Term loans originated prior to 2017/2016	1,069	844
Revolving loans within revolving period	6	22
Revolving loans converted to term loans	284	264
Total retained loans	1,449	1,193
Consumer, excluding credit card | Residential real estate | 150 or more days past due | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 20	$ 24

Loans - Consumer, Excluding C_3

Loans - Consumer, Excluding Credit Card Loan Portfolio, Residential Real Estate, Nonaccrual Loans and Other Credit Quality Indicators (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 1,010,206,000,000	$ 960,506,000,000	$ 945,601,000,000
Consumer, excluding credit card
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	295,556,000,000	302,127,000,000	$ 294,999,000,000
Consumer, excluding credit card | Residential real estate
Loans and Leases Receivable Disclosure [Line Items]
Nonaccrual loans	4,759,000,000	5,313,000,000
Retained loans	$ 224,795,000,000	$ 225,302,000,000
Weighted average LTV ratio	50.00%	54.00%
Weighted average FICO	$ 765	$ 763
Approximate percentage of Chapter 7 loans 30 days or more past due	7.00%
Interest income on nonaccrual loans recognized on a cash basis	$ 172,000,000	161,000,000
Consumer, excluding credit card | Residential real estate | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
90 or more days past due and still accruing	24,000,000	33,000,000
Retained loans	66,000,000	76,000,000
Consumer, excluding credit card | Residential real estate | 90 or more days past due | Not U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	0	0
Consumer, excluding credit card | Residential real estate | California
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	71,383,000,000	73,444,000,000
Consumer, excluding credit card | Residential real estate | New York
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	32,545,000,000	32,287,000,000
Consumer, excluding credit card | Residential real estate | Florida
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	16,182,000,000	13,981,000,000
Consumer, excluding credit card | Residential real estate | Texas
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	13,865,000,000	13,773,000,000
Consumer, excluding credit card | Residential real estate | Illinois
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	11,565,000,000	13,130,000,000
Consumer, excluding credit card | Residential real estate | Colorado
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	8,885,000,000	8,235,000,000
Consumer, excluding credit card | Residential real estate | Washington
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	8,292,000,000	7,917,000,000
Consumer, excluding credit card | Residential real estate | New Jersey
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	6,832,000,000	7,227,000,000
Consumer, excluding credit card | Residential real estate | Massachusetts
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	6,105,000,000	5,784,000,000
Consumer, excluding credit card | Residential real estate | Connecticut
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	5,242,000,000	5,024,000,000
Consumer, excluding credit card | Residential real estate | All other
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	43,899,000,000	44,500,000,000
Consumer, excluding credit card | Residential real estate | All other | U.S. government-guaranteed
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	66,000,000	76,000,000
Consumer, excluding credit card | Residential real estate | No FICO/LTV available
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	2,930,000,000	2,492,000,000
Consumer, excluding credit card | Residential real estate | Greater than 125% and refreshed FICO scores | Equal to or greater than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	2,000,000	6,000,000
Consumer, excluding credit card | Residential real estate | Greater than 125% and refreshed FICO scores | Less than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	2,000,000	12,000,000
Consumer, excluding credit card | Residential real estate | 101% to 125% and refreshed FICO scores | Equal to or greater than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	37,000,000	38,000,000
Consumer, excluding credit card | Residential real estate | 101% to 125% and refreshed FICO scores | Less than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	15,000,000	44,000,000
Consumer, excluding credit card | Residential real estate | 80% to 100% and refreshed FICO scores | Equal to or greater than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	2,701,000,000	2,177,000,000
Consumer, excluding credit card | Residential real estate | 80% to 100% and refreshed FICO scores | Less than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	89,000,000	239,000,000
Consumer, excluding credit card | Residential real estate | Lower than 80% and refreshed FICO scores | Equal to or greater than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	209,295,000,000	208,238,000,000
Consumer, excluding credit card | Residential real estate | Lower than 80% and refreshed FICO scores | Less than 660
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 9,658,000,000	$ 11,980,000,000

Loans - Consumer, Excluding C_4

Loans - Consumer, Excluding Credit Card Loan Portfolio, Loan Modifications, Nature and Extent of Modifications (Details) - Consumer, excluding credit card - Residential real estate $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)loan	Dec. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)loan
Financing Receivable, Impaired [Line Items]
New TDRs | $	$ 866	$ 819	$ 490
Percentage, sum of items by type, may exceed	100.00%
Trial Modification
Financing Receivable, Impaired [Line Items]
Number of loans modified	6,246	5,522	5,872
Permanent Modification
Financing Receivable, Impaired [Line Items]
Number of loans modified	4,588	6,850	4,918
Interest rate reduction
Financing Receivable, Impaired [Line Items]
Concession granted	74.00%	50.00%	77.00%
Term or payment extension
Financing Receivable, Impaired [Line Items]
Concession granted	53.00%	49.00%	71.00%
Principal and/or interest deferred
Financing Receivable, Impaired [Line Items]
Concession granted	23.00%	14.00%	13.00%
Principal forgiveness
Financing Receivable, Impaired [Line Items]
Concession granted	2.00%	2.00%	5.00%
Other
Financing Receivable, Impaired [Line Items]
Concession granted	36.00%	66.00%	63.00%

Loans - Consumer, Excluding C_5

Loans - Consumer, Excluding Credit Card Loan Portfolio, Financial Effects of Modifications and Redefaults (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)loan_payment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Financing Receivable, Impaired [Line Items]
Carrying value	$ 1,010,206	$ 960,506	$ 945,601
Consumer, excluding credit card
Financing Receivable, Impaired [Line Items]
Carrying value	$ 295,556	302,127	$ 294,999
Consumer, excluding credit card | Residential real estate
Financing Receivable, Impaired [Line Items]
Number of payments past due for deemed payment | loan_payment	2
Carrying value	$ 224,795	225,302
Consumer, excluding credit card | Residential real estate | In Process of Active or Suspended Foreclosure
Financing Receivable, Impaired [Line Items]
Carrying value	$ 619	$ 846
Consumer, excluding credit card | Residential real estate | Maximum
Financing Receivable, Impaired [Line Items]
Number of years before payment default under a modified loan	1 year
Number of months before a payment redefault under modified loans	12 months
Consumer, excluding credit card | Residential real estate | Permanent Modification
Financing Receivable, Impaired [Line Items]
Weighted-average interest rate of loans with interest rate reductions – before TDR	4.54%	5.09%	5.68%
Weighted-average interest rate of loans with interest rate reductions – after TDR	2.92%	3.28%	3.81%
Weighted-average remaining contractual term (in years) of loans with term or payment extensions – before TDR	23 years	22 years	20 years
Weighted-average remaining contractual term (in years) of loans with term or payment extensions – after TDR	38 years	39 years	39 years
Charge-offs recognized upon permanent modification	$ 0	$ 5	$ 1
Principal deferred	28	16	19
Principal forgiven	1	5	7
Balance of loans that redefaulted within one year of permanent modification	$ 160	$ 199	$ 166
Modifications, weighted-average remaining life	4 years

Loans - Consumer, Excluding C_6

Loans - Consumer, Excluding Credit Card Loan Portfolio, Auto and Other (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 1,010,206	$ 960,506	$ 945,601
Consumer, excluding credit card
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	295,556	302,127	$ 294,999
Consumer, excluding credit card | Auto and other
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	35,515	46,266
Term loans originated in 2020/2019	19,079	12,936
Term loans originated in 2019/2018	7,531	7,444
Term loans originated in 2018/2017	3,724	4,575
Term loans originated in 2017/2016	1,832	2,100
Term loans originated prior to 2017/2016	688	766
Revolving loans within revolving period	2,259	2,555
Revolving loans converted to term loans	133	183
Total retained loans	$ 70,761	$ 76,825
% of 30 plus days past due to total retained loans, Term loans originated in 2021/2020	0.54%	0.21%
% of 30 plus days past due to total retained loans, Term loans originated in 2020/2019	0.47%	0.83%
% of 30 plus days past due to total retained loans, Term loans originated in 2019/2018	1.17%	1.03%
% of 30 plus days past due to total retained loans, Term loans originated in 2018/2017	1.42%	1.18%
% of 30 plus days past due to total retained loans, Term loans originated in 2017/2016	1.75%	2.00%
% of 30 plus days past due to total retained loans, Term loans originated prior to 2017/2016	3.20%	3.13%
% of 30 plus days past due to total retained loans, Revolving loans within the revolving period	0.75%	1.49%
% of 30 plus days past due to total retained loans, Revolving loans converted to term loans	9.77%	13.66%
% of 30 plus days past due to total retained loans	1.66%	0.60%
Consumer, excluding credit card | Auto and other | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 5,400	$ 19,200
Consumer, excluding credit card | Auto and other | Current
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	35,323	46,169
Term loans originated in 2020/2019	18,324	12,829
Term loans originated in 2019/2018	7,443	7,367
Term loans originated in 2018/2017	3,671	4,521
Term loans originated in 2017/2016	1,800	2,058
Term loans originated prior to 2017/2016	666	742
Revolving loans within revolving period	2,242	2,517
Revolving loans converted to term loans	120	158
Total retained loans	69,589	76,361
Consumer, excluding credit card | Auto and other | Current | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	4,400	19,200
Term loans originated in 2020/2019	1,000
Consumer, excluding credit card | Auto and other | 30–119 days past due
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	192	97
Term loans originated in 2020/2019	720	107
Term loans originated in 2019/2018	88	77
Term loans originated in 2018/2017	53	53
Term loans originated in 2017/2016	31	42
Term loans originated prior to 2017/2016	21	23
Revolving loans within revolving period	12	30
Revolving loans converted to term loans	6	17
Total retained loans	1,123	446
Consumer, excluding credit card | Auto and other | 120 or more days past due
Loans and Leases Receivable Disclosure [Line Items]
Term loans originated in 2021/2020	0	0
Term loans originated in 2020/2019	35	0
Term loans originated in 2019/2018	0	0
Term loans originated in 2018/2017	0	1
Term loans originated in 2017/2016	1	0
Term loans originated prior to 2017/2016	1	1
Revolving loans within revolving period	5	8
Revolving loans converted to term loans	7	8
Total retained loans	49	$ 18
Consumer, excluding credit card | Auto and other | 30 or more days past due | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 667

Loans - Consumer, Excluding C_7

Loans - Consumer, Excluding Credit Card Loan Portfolio, Auto and Other, Nonaccrual Loans and Other Credit Quality Indicators (Details) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	$ 1,010,206,000,000	$ 960,506,000,000	$ 945,601,000,000
Consumer, excluding credit card
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	295,556,000,000	302,127,000,000	$ 294,999,000,000
Consumer, excluding credit card | Auto and other
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual loans	119,000,000	151,000,000
Retained loans	70,761,000,000	76,825,000,000
90 or more days past due and still accruing		0
Consumer, excluding credit card | Auto and other | Paycheck Protection Program (PPP)
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	5,400,000,000	19,200,000,000
Consumer, excluding credit card | Auto and other | Paycheck Protection Program (PPP) | 90 or more days past due
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual loans	35,000,000
Retained loans	506,000,000
Consumer, excluding credit card | Auto and other | Not U.S. government-guaranteed
Financing Receivable, Credit Quality Indicator [Line Items]
90 or more days past due and still accruing	0
Consumer, excluding credit card | Auto and other | California
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	11,163,000,000	12,302,000,000
Consumer, excluding credit card | Auto and other | Texas
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	7,859,000,000	8,235,000,000
Consumer, excluding credit card | Auto and other | New York
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	5,848,000,000	8,824,000,000
Consumer, excluding credit card | Auto and other | Florida
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	4,901,000,000	4,668,000,000
Consumer, excluding credit card | Auto and other | Illinois
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	2,930,000,000	3,768,000,000
Consumer, excluding credit card | Auto and other | New Jersey
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	2,355,000,000	2,646,000,000
Consumer, excluding credit card | Auto and other | Pennsylvania
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	2,004,000,000	1,924,000,000
Consumer, excluding credit card | Auto and other | Arizona
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	1,887,000,000	2,465,000,000
Consumer, excluding credit card | Auto and other | Ohio
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	1,843,000,000	2,163,000,000
Consumer, excluding credit card | Auto and other | Louisiana
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	1,801,000,000	1,808,000,000
Consumer, excluding credit card | Auto and other | All other
Financing Receivable, Credit Quality Indicator [Line Items]
Retained loans	$ 28,170,000,000	$ 28,022,000,000

Loans - Credit Card Loan Portfo

Loans - Credit Card Loan Portfolio, Delinquency Information (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 1,010,206	$ 960,506	$ 945,601
Credit card
Loans and Leases Receivable Disclosure [Line Items]
Revolving loans within revolving period	153,309	142,057
Revolving loans converted to term loans	987	1,375
Total retained loans	$ 154,296	$ 143,432
% of 30 plus days past due to total retained loans, Revolving loans within the revolving period	0.99%	1.60%
% of 30 plus days past due to total retained loans, Revolving loans converted to term loans	8.71%	9.89%
% of 30 plus days past due to total retained loans	1.04%	1.68%
% of 90 plus days past due to total retained loans, Revolving loans within the revolving period	0.48%	0.90%
% of 90 plus days past due to total retained loans, Revolving loans converted to term loans	2.74%	3.05%
% of 90 plus days past due to total retained loans	0.50%	0.92%
Credit card | Current and less than 30 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Revolving loans within revolving period	$ 151,798	$ 139,783
Revolving loans converted to term loans	901	1,239
Total retained loans	152,699	141,022
Credit card | 30–89 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Revolving loans within revolving period	770	997
Revolving loans converted to term loans	59	94
Total retained loans	829	1,091
Credit card | 90 or more days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Revolving loans within revolving period	741	1,277
Revolving loans converted to term loans	27	42
Total retained loans	$ 768	$ 1,319

Loans - Credit Card Loan Port_2

Loans - Credit Card Loan Portfolio, Other Credit Quality Indicators (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 1,010,206	$ 960,506	$ 945,601
Credit card
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 154,296	$ 143,432
Percentage of portfolio based on carrying value with estimated refreshed FICO scores, Equal to or greater than 660	88.50%	85.90%
Percentage of portfolio based on carrying value with estimated refreshed FICO scores, Less than 660	11.30%	13.90%
Percentage of portfolio based on carrying value with estimated refreshed FICO scores, No FICO available	0.20%	0.20%
Credit card | California
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 23,030	$ 20,921
Credit card | Texas
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	15,879	14,544
Credit card | New York
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	12,652	11,919
Credit card | Florida
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	10,412	9,562
Credit card | Illinois
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	8,530	8,006
Credit card | New Jersey
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	6,367	5,927
Credit card | Ohio
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	4,923	4,673
Credit card | Pennsylvania
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	4,708	4,476
Credit card | Colorado
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	4,573	4,092
Credit card | Michigan
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	3,773	3,553
Credit card | All other
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 59,449	$ 55,759

Loans - Credit Card Portfolio,

Loans - Credit Card Portfolio, Loan Modifications (Details) - Credit card $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)loan_payment	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Financing Receivable, Impaired [Line Items]
Fixed payment plan period	60 months
New enrollments, percent of total retained credit card loans (less than)	1.00%	1.00%	1.00%
Balance of new TDRs	$ 393	$ 818	$ 961
Weighted-average interest rate of loans – before TDR	17.75%	18.04%	19.07%
Weighted-average interest rate of loans – after TDR	5.14%	4.64%	4.70%
Loans that redefaulted within one year of modification	$ 57	$ 110	$ 148
Number of years before payment default under a modified loan	1 year
Modified loans, payment default, number of payments past due | loan_payment	2

Loans - Wholesale Loan Portfoli

Loans - Wholesale Loan Portfolio, Internal Risk Ratings (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 1,010,206	$ 960,506	$ 945,601
Wholesale
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 560,354	$ 514,947	$ 481,678
% of investment-grade to total retained loans	73.17%	73.65%
% of total criticized to total retained loans	2.39%	3.62%
% of criticized nonaccrual to total retained loans	0.37%	0.64%
Wholesale | Current and less than 30 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 554,980	$ 508,707
Wholesale | 30–89 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	3,114	2,865
Wholesale | 90 or more days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	206	57
Wholesale | 90 or more days past due | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	127
Wholesale | Investment-grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	410,011	379,273
Wholesale | Investment-grade | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	1,300	8,000
Wholesale | Total noninvestment- grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	150,343	135,674
Wholesale | Noncriticized
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	136,974	117,052
Wholesale | Criticized performing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	11,315	15,304
Wholesale | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	2,054	3,318
Wholesale | U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	437,931	406,846
Wholesale | Non-U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	122,423	108,101
Wholesale | Secured by real estate
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 118,835	$ 119,993
% of investment-grade to total retained loans	77.73%	75.13%
% of total criticized to total retained loans	3.34%	3.10%
% of criticized nonaccrual to total retained loans	0.27%	0.40%
Term loans originated in 2021/2020	$ 28,710	$ 22,002
Term loans originated in 2020/2019	19,856	25,897
Term loans originated in 2019/2018	21,829	18,334
Term loans originated in 2018/2017	11,909	15,402
Term loans originated in 2017/2016	10,159	17,349
Term loans originated prior to 2017/2016	24,679	19,421
Revolving loans within revolving period	1,684	1,587
Revolving loans converted to term loans	9	1
Wholesale | Secured by real estate | Current and less than 30 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	118,163	118,894
Wholesale | Secured by real estate | 30–89 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	331	601
Wholesale | Secured by real estate | 90 or more days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	15	15
Wholesale | Secured by real estate | Investment-grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	92,369	90,147
Term loans originated in 2021/2020	23,346	17,004
Term loans originated in 2020/2019	16,030	19,870
Term loans originated in 2019/2018	17,265	12,448
Term loans originated in 2018/2017	8,103	11,218
Term loans originated in 2017/2016	7,325	13,611
Term loans originated prior to 2017/2016	19,066	14,898
Revolving loans within revolving period	1,226	1,098
Revolving loans converted to term loans	8	0
Wholesale | Secured by real estate | Total noninvestment- grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	26,466	29,846
Term loans originated in 2021/2020	5,364	4,998
Term loans originated in 2020/2019	3,826	6,027
Term loans originated in 2019/2018	4,564	5,886
Term loans originated in 2018/2017	3,806	4,184
Term loans originated in 2017/2016	2,834	3,738
Term loans originated prior to 2017/2016	5,613	4,523
Revolving loans within revolving period	458	489
Revolving loans converted to term loans	1	1
Wholesale | Secured by real estate | Noncriticized
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	22,495	26,129
Wholesale | Secured by real estate | Criticized performing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	3,645	3,234
Wholesale | Secured by real estate | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 326	$ 483
% of criticized nonaccrual to total retained loans	0.27%	0.40%
Wholesale | Secured by real estate | U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 115,732	$ 116,990
Wholesale | Secured by real estate | Non-U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	3,103	3,003
Wholesale | Commercial and industrial
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 145,691	$ 142,709
% of investment-grade to total retained loans	52.02%	50.39%
% of total criticized to total retained loans	5.40%	9.05%
% of criticized nonaccrual to total retained loans	0.67%	1.35%
Term loans originated in 2021/2020	$ 40,656	$ 36,721
Term loans originated in 2020/2019	13,380	16,530
Term loans originated in 2019/2018	8,168	8,420
Term loans originated in 2018/2017	3,446	4,079
Term loans originated in 2017/2016	2,038	1,645
Term loans originated prior to 2017/2016	1,249	1,964
Revolving loans within revolving period	76,679	73,276
Revolving loans converted to term loans	75	74
Wholesale | Commercial and industrial | Current and less than 30 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	143,459	140,100
Wholesale | Commercial and industrial | 30–89 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	1,193	658
Wholesale | Commercial and industrial | 90 or more days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	70	20
Wholesale | Commercial and industrial | Investment-grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	75,783	71,917
Term loans originated in 2021/2020	21,342	21,233
Term loans originated in 2020/2019	6,268	7,341
Term loans originated in 2019/2018	3,609	2,950
Term loans originated in 2018/2017	1,269	1,756
Term loans originated in 2017/2016	1,108	1,034
Term loans originated prior to 2017/2016	819	1,178
Revolving loans within revolving period	41,367	36,424
Revolving loans converted to term loans	1	1
Wholesale | Commercial and industrial | Investment-grade | Paycheck Protection Program (PPP)
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	1,100	7,400
Term loans originated in 2021/2020	698
Term loans originated in 2020/2019	396
Wholesale | Commercial and industrial | Total noninvestment- grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	69,908	70,792
Term loans originated in 2021/2020	19,314	15,488
Term loans originated in 2020/2019	7,112	9,189
Term loans originated in 2019/2018	4,559	5,470
Term loans originated in 2018/2017	2,177	2,323
Term loans originated in 2017/2016	930	611
Term loans originated prior to 2017/2016	430	786
Revolving loans within revolving period	35,312	36,852
Revolving loans converted to term loans	74	73
Wholesale | Commercial and industrial | Noncriticized
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	62,039	57,870
Wholesale | Commercial and industrial | Criticized performing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	6,900	10,991
Wholesale | Commercial and industrial | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	969	1,931
Wholesale | Commercial and industrial | U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	106,449	109,273
Wholesale | Commercial and industrial | Non-U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	39,242	33,436
Wholesale | Other
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 295,828	$ 252,245
% of investment-grade to total retained loans	81.76%	86.11%
% of total criticized to total retained loans	0.52%	0.79%
% of criticized nonaccrual to total retained loans	0.26%	0.36%
Term loans originated in 2021/2020	$ 43,687	$ 38,238
Term loans originated in 2020/2019	20,228	13,347
Term loans originated in 2019/2018	7,580	9,115
Term loans originated in 2018/2017	3,820	7,357
Term loans originated in 2017/2016	4,086	4,264
Term loans originated prior to 2017/2016	8,118	8,787
Revolving loans within revolving period	207,703	170,234
Revolving loans converted to term loans	606	903
Wholesale | Other | Current and less than 30 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	293,358	249,713
Wholesale | Other | 30–89 days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	1,590	1,606
Wholesale | Other | 90 or more days past due and still accruing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	121	22
Wholesale | Other | Investment-grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	241,859	217,209
Term loans originated in 2021/2020	26,782	33,190
Term loans originated in 2020/2019	17,829	11,116
Term loans originated in 2019/2018	6,125	7,455
Term loans originated in 2018/2017	2,885	6,804
Term loans originated in 2017/2016	3,868	4,089
Term loans originated prior to 2017/2016	7,651	8,252
Revolving loans within revolving period	176,118	145,524
Revolving loans converted to term loans	601	779
Wholesale | Other | Total noninvestment- grade
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	53,969	35,036
Term loans originated in 2021/2020	16,905	5,048
Term loans originated in 2020/2019	2,399	2,231
Term loans originated in 2019/2018	1,455	1,660
Term loans originated in 2018/2017	935	553
Term loans originated in 2017/2016	218	175
Term loans originated prior to 2017/2016	467	535
Revolving loans within revolving period	31,585	24,710
Revolving loans converted to term loans	5	124
Wholesale | Other | Noncriticized
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	52,440	33,053
Wholesale | Other | Criticized performing
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	770	1,079
Wholesale | Other | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	759	904
Wholesale | Other | U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	215,750	180,583
Wholesale | Other | Non-U.S.
Loans and Leases Receivable Disclosure [Line Items]
Total retained loans	$ 80,078	$ 71,662

Loans - Wholesale Loan Portfo_2

Loans - Wholesale Loan Portfolio, Real Estate Class of Loans (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 1,010,206	$ 960,506	$ 945,601
Wholesale
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 560,354	$ 514,947	$ 481,678
% of total criticized to total retained loans secured by real estate	2.39%	3.62%
% of criticized nonaccrual loans to total retained loans secured by real estate	0.37%	0.64%
Wholesale | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 2,054	$ 3,318
Wholesale | Secured by real estate
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 118,835	$ 119,993
% of total criticized to total retained loans secured by real estate	3.34%	3.10%
% of criticized nonaccrual loans to total retained loans secured by real estate	0.27%	0.40%
Wholesale | Secured by real estate | Commercial construction and development
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 5,700	$ 6,400
Wholesale | Secured by real estate | Multifamily
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	73,801	73,078
Wholesale | Secured by real estate | Other Commercial
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	45,034	46,915
Wholesale | Secured by real estate | Criticized
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 3,971	$ 3,717
% of total criticized to total retained loans secured by real estate	3.34%	3.10%
Wholesale | Secured by real estate | Criticized | Multifamily
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 1,671	$ 1,144
% of total criticized to total retained loans secured by real estate	2.26%	1.57%
Wholesale | Secured by real estate | Criticized | Other Commercial
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 2,300	$ 2,573
% of total criticized to total retained loans secured by real estate	5.11%	5.48%
Wholesale | Secured by real estate | Criticized nonaccrual
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 326	$ 483
% of criticized nonaccrual loans to total retained loans secured by real estate	0.27%	0.40%
Wholesale | Secured by real estate | Criticized nonaccrual | Multifamily
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 91	$ 56
% of criticized nonaccrual loans to total retained loans secured by real estate	0.12%	0.08%
Wholesale | Secured by real estate | Criticized nonaccrual | Other Commercial
Loans and Leases Receivable Disclosure [Line Items]
Retained loans	$ 235	$ 427
% of criticized nonaccrual loans to total retained loans secured by real estate	0.52%	0.91%

Loans - Wholesale Loan Portfo_3

Loans - Wholesale Loan Portfolio, Nonaccrual (Details) - Wholesale - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Financing Receivable, Nonaccrual [Line Items]
With an allowance	$ 1,144	$ 2,818
Without an allowance	910	500
Total nonaccrual loans	2,054	3,318
Secured by real estate
Financing Receivable, Nonaccrual [Line Items]
With an allowance	254	351
Without an allowance	72	132
Total nonaccrual loans	326	483
Commercial and industrial
Financing Receivable, Nonaccrual [Line Items]
With an allowance	604	1,667
Without an allowance	365	264
Total nonaccrual loans	969	1,931
Other
Financing Receivable, Nonaccrual [Line Items]
With an allowance	286	800
Without an allowance	473	104
Total nonaccrual loans	$ 759	$ 904

Loans - Wholesale Loan Portfo_4

Loans - Wholesale Loan Portfolio, Loan Modifications (Details) - Wholesale - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financing Receivable, Impaired [Line Items]
New TDRs	$ 881	$ 734	$ 407
Loans modified in TDRs	$ 607	$ 954

Allowance for Credit Losses (De

Allowance for Credit Losses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 01, 2020
Allowance for loan losses
Beginning balance	$ 28,328	$ 13,123	$ 13,445
Gross charge-offs/Write-offs of PCI loans	4,564	6,836	6,810
Gross recoveries collected	(1,699)	(1,577)	(1,181)
Net charge-offs	2,865	5,259	5,629
Provision for loan losses	(9,071)	16,291	5,449
Other	(6)	1	9
Ending balance	16,386	28,328	13,123
Allowance for lending-related commitments
Beginning balance	2,409	1,191	1,055
Provision for lending-related commitments	(149)	1,121	136
Other	1	(1)	0
Ending balance	2,261	2,409	1,191
Total allowance for investment securities	42	78
Total allowance for credit losses	18,689	30,815	14,314
Allowance for loan losses by impairment methodology
Asset-specific	(89)	1,308	847
Portfolio-based	16,475	27,020	11,289
PCI			987
Total allowance for loan losses	16,386	28,328	13,123
Loans by impairment methodology
Asset-specific	17,161	21,629	8,536
Portfolio-based	993,045	938,877	916,702
PCI			20,363
Total retained loans	1,010,206	960,506	945,601
Collateral-dependent loans
Net charge-offs	2,865	5,259	5,629
Allowance for lending-related commitments by impairment methodology
Asset-specific	167	114	102
Portfolio-based	2,094	2,295	1,089
Total allowance for lending-related commitments	2,261	2,409	1,191
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Asset-specific	764	577	474
Portfolio-based	483,159	461,776	423,384
Total lending-related commitments	483,923	462,353	423,858
PCI loans
Allowance for loan losses
Gross charge-offs/Write-offs of PCI loans			151
Collateral-dependent loans
Allowance for loan losses
Net charge-offs	71	209	82
Collateral-dependent loans
Net charge-offs	71	209	82
Loans measured at fair value of collateral less cost to sell	5,089	5,144	2,140
Cumulative effect of change in accounting principles
Allowance for loan losses
Beginning balance		4,172
Ending balance			4,172
Allowance for lending-related commitments
Beginning balance		98
Ending balance			98
Total allowance for investment securities				$ 10
Allowance for loan losses by impairment methodology
Total allowance for loan losses			4,172
Allowance for lending-related commitments by impairment methodology
Total allowance for lending-related commitments			98
Consumer
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Decrease in allowance for credit losses	9,500
Consumer, excluding credit card
Allowance for loan losses
Beginning balance	3,636	2,538	3,434
Gross charge-offs/Write-offs of PCI loans	630	805	902
Gross recoveries collected	(619)	(631)	(536)
Net charge-offs	11	174	366
Provision for loan losses	(1,858)	974	(378)
Other	(2)	1	(1)
Ending balance	1,765	3,636	2,538
Allowance for lending-related commitments
Beginning balance	187	12	12
Provision for lending-related commitments	(75)	42	0
Other	1	0	0
Ending balance	113	187	12
Total allowance for credit losses	1,878	3,823	2,550
Allowance for loan losses by impairment methodology
Asset-specific	(665)	(7)	75
Portfolio-based	2,430	3,643	1,476
PCI			987
Total allowance for loan losses	1,765	3,636	2,538
Loans by impairment methodology
Asset-specific	13,919	16,648	5,961
Portfolio-based	281,637	285,479	268,675
PCI			20,363
Total retained loans	295,556	302,127	294,999
Collateral-dependent loans
Net charge-offs	11	174	366
Allowance for lending-related commitments by impairment methodology
Asset-specific	0	0	0
Portfolio-based	113	187	12
Total allowance for lending-related commitments	113	187	12
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Asset-specific	0	0	0
Portfolio-based	29,588	37,783	30,417
Total lending-related commitments	29,588	37,783	30,417
Credit card lending-related commitments not permitted to have an allowance for credit losses	15,700	19,500	9,800
Consumer, excluding credit card | PCI loans
Allowance for loan losses
Gross charge-offs/Write-offs of PCI loans			151
Consumer, excluding credit card | Collateral-dependent loans
Allowance for loan losses
Net charge-offs	33	133	46
Collateral-dependent loans
Net charge-offs	33	133	46
Loans measured at fair value of collateral less cost to sell	4,472	4,956	2,053
Consumer, excluding credit card | Cumulative effect of change in accounting principles
Allowance for loan losses
Beginning balance		297
Ending balance			297
Allowance for lending-related commitments
Beginning balance		133
Ending balance			133
Allowance for loan losses by impairment methodology
Total allowance for loan losses			297
Allowance for lending-related commitments by impairment methodology
Total allowance for lending-related commitments			133
Credit card
Allowance for loan losses
Beginning balance	17,800	5,683	5,184
Gross charge-offs/Write-offs of PCI loans	3,651	5,077	5,436
Gross recoveries collected	(939)	(791)	(588)
Net charge-offs	2,712	4,286	4,848
Provision for loan losses	(4,838)	10,886	5,348
Other	0	0	(1)
Ending balance	10,250	17,800	5,683
Allowance for lending-related commitments
Beginning balance	0	0	0
Provision for lending-related commitments	0	0	0
Other	0	0	0
Ending balance	0	0	0
Total allowance for credit losses	10,250	17,800	5,683
Allowance for loan losses by impairment methodology
Asset-specific	313	633	477
Portfolio-based	9,937	17,167	5,206
PCI			0
Total allowance for loan losses	10,250	17,800	5,683
Loans by impairment methodology
Asset-specific	987	1,375	1,452
Portfolio-based	153,309	142,057	167,472
PCI			0
Total retained loans	154,296	143,432	168,924
Collateral-dependent loans
Net charge-offs	2,712	4,286	4,848
Allowance for lending-related commitments by impairment methodology
Asset-specific	0	0	0
Portfolio-based	0	0	0
Total allowance for lending-related commitments	0	0	0
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Asset-specific	0	0	0
Portfolio-based	0	0	0
Total lending-related commitments	0	0	0
Credit card lending-related commitments not permitted to have an allowance for credit losses	730,500	658,500	650,700
Credit card | PCI loans
Allowance for loan losses
Gross charge-offs/Write-offs of PCI loans			0
Credit card | Collateral-dependent loans
Allowance for loan losses
Net charge-offs	0	0	0
Collateral-dependent loans
Net charge-offs	0	0	0
Loans measured at fair value of collateral less cost to sell	0	0	0
Credit card | Cumulative effect of change in accounting principles
Allowance for loan losses
Beginning balance		5,517
Ending balance			5,517
Allowance for lending-related commitments
Beginning balance		0
Ending balance			0
Allowance for loan losses by impairment methodology
Total allowance for loan losses			5,517
Allowance for lending-related commitments by impairment methodology
Total allowance for lending-related commitments			0
Wholesale
Allowance for loan losses
Beginning balance	6,892	4,902	4,827
Gross charge-offs/Write-offs of PCI loans	283	954	472
Gross recoveries collected	(141)	(155)	(57)
Net charge-offs	142	799	415
Provision for loan losses	(2,375)	4,431	479
Other	(4)	0	11
Ending balance	4,371	6,892	4,902
Allowance for lending-related commitments
Beginning balance	2,222	1,179	1,043
Provision for lending-related commitments	(74)	1,079	136
Other	0	(1)	0
Ending balance	2,148	2,222	1,179
Total allowance for credit losses	6,519	9,114	6,081
Allowance for loan losses by impairment methodology
Asset-specific	263	682	295
Portfolio-based	4,108	6,210	4,607
PCI			0
Total allowance for loan losses	4,371	6,892	4,902
Loans by impairment methodology
Asset-specific	2,255	3,606	1,123
Portfolio-based	558,099	511,341	480,555
PCI			0
Total retained loans	560,354	514,947	481,678
Collateral-dependent loans
Net charge-offs	142	799	415
Allowance for lending-related commitments by impairment methodology
Asset-specific	167	114	102
Portfolio-based	1,981	2,108	1,077
Total allowance for lending-related commitments	2,148	2,222	1,179
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Asset-specific	764	577	474
Portfolio-based	453,571	423,993	392,967
Total lending-related commitments	454,335	424,570	393,441
Credit card lending-related commitments not permitted to have an allowance for credit losses	32,100	25,300	24,100
Decrease in allowance for credit losses	2,600
Wholesale | PCI loans
Allowance for loan losses
Gross charge-offs/Write-offs of PCI loans			0
Wholesale | Collateral-dependent loans
Allowance for loan losses
Net charge-offs	38	76	36
Collateral-dependent loans
Net charge-offs	38	76	36
Loans measured at fair value of collateral less cost to sell	$ 617	188	87
Wholesale | Cumulative effect of change in accounting principles
Allowance for loan losses
Beginning balance		(1,642)
Ending balance			(1,642)
Allowance for lending-related commitments
Beginning balance		$ (35)
Ending balance			(35)
Allowance for loan losses by impairment methodology
Total allowance for loan losses			(1,642)
Allowance for lending-related commitments by impairment methodology
Total allowance for lending-related commitments			$ (35)

Variable Interest Entities - Cr

Variable Interest Entities - Credit Card Securitizations (Details) - Firm-sponsored credit card trusts - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Minimum undivided interest in credit card trusts	57.00%	39.00%
Undivided interests in Firm-sponsored credit card securitization trusts	$ 7,100,000,000	$ 5,400,000,000
Senior securities
Variable Interest Entity [Line Items]
Undivided interests in Firm-sponsored credit card securitization trusts	0	0
Subordinated securities
Variable Interest Entity [Line Items]
Undivided interests in Firm-sponsored credit card securitization trusts	$ 1,500,000,000	$ 1,500,000,000
Minimum
Variable Interest Entity [Line Items]
Minimum undivided interest in credit card trusts	5.00%

Variable Interest Entities - Fi

Variable Interest Entities - Firm Sponsored Variable Interest Entities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Firm-sponsored mortgage and other consumer securitization trusts
Total assets held by securitization VIEs	$ 216,745	$ 182,272
Retained securitization interests, risk-rated 'A' or better, at fair value	79.00%	73.00%
Corporate & Investment Bank
Firm-sponsored mortgage and other consumer securitization trusts
Senior securities purchased in connection with CIB's secondary market-making activities	$ 145	$ 105
Subordinated securities purchased in connection with CIB's secondary market-making activities	36	40
Residential mortgage | Investment-grade
Firm-sponsored mortgage and other consumer securitization trusts
Fair value of retained interests	1,600	1,300
Residential mortgage | Noninvestment-grade
Firm-sponsored mortgage and other consumer securitization trusts
Fair value of retained interests	131	41
Residential mortgage | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Total assets held by securitization VIEs	55,085	49,644
Residential mortgage | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Total assets held by securitization VIEs	10,966	12,896
Commercial and other
Firm-sponsored mortgage and other consumer securitization trusts
Total assets held by securitization VIEs	150,694	119,732
Commercial and other | Investment-grade
Firm-sponsored mortgage and other consumer securitization trusts
Fair value of retained interests	3,500	2,000
Commercial and other | Noninvestment-grade
Firm-sponsored mortgage and other consumer securitization trusts
Fair value of retained interests	929	753
VIEs consolidated by the Firm
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in consolidated securitization VIEs	969	1,739
VIEs consolidated by the Firm | Residential mortgage | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in consolidated securitization VIEs	942	1,693
VIEs consolidated by the Firm | Residential mortgage | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in consolidated securitization VIEs	27	46
VIEs consolidated by the Firm | Commercial and other
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in consolidated securitization VIEs	0	0
Nonconsolidated entities
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in nonconsolidated securitization VIEs with continuing involvement	150,842	145,770
Interest in securitized assets in nonconsolidated VIEs	6,206	4,073
Nonconsolidated entities | Trading assets
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	1,647	1,538
Nonconsolidated entities | Investment securities
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	3,958	2,273
Nonconsolidated entities | Other financial assets
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	601	262
Nonconsolidated entities | Residential mortgage | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in nonconsolidated securitization VIEs with continuing involvement	47,029	41,265
Interest in securitized assets in nonconsolidated VIEs	1,753	1,298
Nonconsolidated entities | Residential mortgage | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in nonconsolidated securitization VIEs with continuing involvement	10,115	12,154
Interest in securitized assets in nonconsolidated VIEs	2	9
Nonconsolidated entities | Residential mortgage | Trading assets | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	974	574
Nonconsolidated entities | Residential mortgage | Trading assets | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	2	9
Nonconsolidated entities | Residential mortgage | Investment securities | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	684	724
Nonconsolidated entities | Residential mortgage | Investment securities | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	0	0
Nonconsolidated entities | Residential mortgage | Other financial assets | Prime/Alt-A and option ARMs
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	95	0
Nonconsolidated entities | Residential mortgage | Other financial assets | Subprime
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	0	0
Nonconsolidated entities | Commercial and other
Firm-sponsored mortgage and other consumer securitization trusts
Assets held in nonconsolidated securitization VIEs with continuing involvement	93,698	92,351
Interest in securitized assets in nonconsolidated VIEs	4,451	2,766
Nonconsolidated entities | Commercial and other | Trading assets
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	671	955
Nonconsolidated entities | Commercial and other | Investment securities
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	3,274	1,549
Nonconsolidated entities | Commercial and other | Other financial assets
Firm-sponsored mortgage and other consumer securitization trusts
Interest in securitized assets in nonconsolidated VIEs	$ 506	$ 262

Variable Interest Entities - Re

Variable Interest Entities - Re-securitizations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Transfers of securities to VIEs
U.S. GSEs and government agencies	$ 53,923,000,000	$ 46,123,000,000	$ 25,852,000,000
Private label securities transferred to re-securitization VIEs	0	0	$ 0
U.S. GSEs and government agencies | Nonconsolidated re-securitization VIEs
Variable Interest Entity [Line Items]
Interest in VIEs	$ 1,947,000,000	$ 2,631,000,000

Variable Interest Entities - Mu

Variable Interest Entities - Multi-seller Conduits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Off-balance sheet lending-related financial commitments, contractual amount	$ 1,262,313	$ 1,165,688
Firm-administered multi-seller conduits
Variable Interest Entity [Line Items]
Commercial paper eliminated in consolidation	13,700	13,500
Firm-administered multi-seller conduits | Commercial and other
Variable Interest Entity [Line Items]
Off-balance sheet lending-related financial commitments, contractual amount	$ 13,400	$ 12,200
Maximum
Variable Interest Entity [Line Items]
Program-wide credit enhancement required amount	10.00%

Variable Interest Entities - Co

Variable Interest Entities - Consolidated VIE Assets and Liabilities (Details) - USD ($) $ in Millions		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		$ 433,575		$ 503,126
Loans		1,061,328		984,525
Other	[1]	181,498		151,539
Total assets		3,743,567	[2]	3,384,757	[2]	$ 2,686,477
Beneficial interests in VIE assets		10,750		17,578
Total liabilities	[2]	3,449,440		3,105,403
VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		2,010		1,934
Loans		33,024		37,619
Other		490		681
Total assets		35,524		40,234
Beneficial interests in VIE assets		10,750		17,578
Other		245		233
Total liabilities		10,995		17,811
Beneficial interests in VIE assets, long term		2,600		5,200
Firm-sponsored credit card trusts | VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		0		0
Loans		11,108		11,962
Other		102		148
Total assets		11,210		12,110
Beneficial interests in VIE assets		2,397		4,943
Other		1		3
Total liabilities		2,398		4,946
Firm-administered multi-seller conduits | VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		1		2
Loans		19,883		23,787
Other		71		188
Total assets		19,955		23,977
Beneficial interests in VIE assets		6,198		10,523
Other		41		33
Total liabilities		6,239		10,556
Municipal bond vehicles | VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		2,009		1,930
Loans		0		0
Other		2		2
Total assets		2,011		1,932
Beneficial interests in VIE assets		1,976		1,902
Other		0		0
Total liabilities		1,976		1,902
Mortgage securitization entities | VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		0		0
Loans		955		1,694
Other		32		94
Total assets		987		1,788
Beneficial interests in VIE assets		179		210
Other		85		108
Total liabilities		264		318
Other | VIEs consolidated by the Firm
Information on assets and liabilities related to VIEs that are consolidated by the Firm [Abstract]
Trading assets		0		2
Loans		1,078		176
Other		283		249
Total assets		1,361		427
Beneficial interests in VIE assets		0		0
Other		118		89
Total liabilities		$ 118		$ 89
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.
[2]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Variable Interest Entities - VI

Variable Interest Entities - VIEs Sponsored by Third Parties (Details) - USD ($) $ in Millions	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Variable Interest Entity [Line Items]
Fair value of assets held by VIE	$ 3,743,567	[1]	$ 3,384,757	[1]	$ 2,686,477
Tax credit vehicles | Nonconsolidated entities
Variable Interest Entity [Line Items]
Maximum exposure	26,800		23,600
Unfunded commitments	9,400		8,700
Municipal bond vehicles | Nonconsolidated entities
Variable Interest Entity [Line Items]
Maximum exposure	6,800		6,700
Fair value of assets held by VIE	$ 10,500		$ 10,500
[1]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Variable Interest Entities - Se

Variable Interest Entities - Securitization Activity (Details) - Nonconsolidated entities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Residential mortgage
Securitization activity [Abstract]
Principal securitized	$ 23,876	$ 7,103	$ 9,957
All cash flows during the period:
Proceeds received from loan sales as financial instruments	24,450	7,321	10,238
Servicing fees collected	153	211	287
Cash flows received on interests	$ 578	$ 801	$ 507
Weighted-average life (in years)	3 years 10 months 24 days	4 years 8 months 12 days	4 years 9 months 18 days
Weighted-average discount rate	3.30%	8.20%	7.40%
Commercial and other
Securitization activity [Abstract]
Principal securitized	$ 14,917	$ 6,624	$ 9,390
All cash flows during the period:
Proceeds received from loan sales as financial instruments	15,044	6,865	9,544
Servicing fees collected	1	1	2
Cash flows received on interests	$ 273	$ 239	$ 237
Weighted-average life (in years)	6 years	6 years 10 months 24 days	6 years 4 months 24 days
Weighted-average discount rate	1.20%	3.00%	4.10%

Variable Interest Entities - Lo

Variable Interest Entities - Loans Sold to Third-Party Sponsored Securitization Entities (Details) - Nonconsolidated entities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Summary of loan sale activities [Abstract]
Carrying value of loans sold	$ 105,035	$ 81,153	$ 92,349
Proceeds received from loan sales as cash	161	45	73
Proceeds from loan sales as securities	103,286	80,186	91,422
Total proceeds received from loan sales	103,447	80,231	91,495
Gains/(losses) on loan sales	$ 9	$ 6	$ 499

Variable Interest Entities - Sc

Variable Interest Entities - Schedule of Loans Repurchased and Option to Repurchase Delinquent Loans (Details) - Nonconsolidated entities - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Loans repurchased or option to repurchase	$ 1,022	$ 1,413
Real estate acquired through foreclosure	5	9
Residential mortgage
Variable Interest Entity [Line Items]
Real estate acquired through foreclosure	$ 36	$ 64

Variable Interest Entities - _2

Variable Interest Entities - Loan Delinquencies and Net Charge-offs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Securitized loans
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
90 days past due	$ 5,531	$ 13,352
Net liquidation losses	321	421
Securitized loans | Commercial and other
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
90 days past due	1,456	5,958
Net liquidation losses	288	30
Nonconsolidated entities
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
Securitized assets	150,842	145,770
Nonconsolidated entities | Commercial and other
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
Securitized assets	93,698	92,351
Prime/Alt-A and option ARMs | Securitized loans | Residential mortgage
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
90 days past due	2,466	4,988
Net liquidation losses	17	212
Prime/Alt-A and option ARMs | Nonconsolidated entities | Residential mortgage
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
Securitized assets	47,029	41,265
Subprime | Securitized loans | Residential mortgage
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
90 days past due	1,609	2,406
Net liquidation losses	16	179
Subprime | Nonconsolidated entities | Residential mortgage
Information about delinquencies, net charge-offs, and components of off-balance sheet securitized financial assets [Abstract]
Securitized assets	$ 10,115	$ 12,154

Goodwill and Mortgage Servici_3

Goodwill and Mortgage Servicing Rights - by Business Segment (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Total goodwill	$ 50,315	$ 49,248	$ 47,823	$ 47,471
Corporate
Goodwill [Line Items]
Total goodwill	727	0	0
Consumer & Community Banking
Goodwill [Line Items]
Total goodwill	31,474	31,311	30,133
Corporate & Investment Bank
Goodwill [Line Items]
Total goodwill	7,906	7,913	7,901
Commercial Banking
Goodwill [Line Items]
Total goodwill	2,986	2,985	2,982
Asset & Wealth Management
Goodwill [Line Items]
Total goodwill	$ 7,222	$ 7,039	$ 6,807

Goodwill and Mortgage Servici_4

Goodwill and Mortgage Servicing Rights - Changes During Period (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Changes in the carrying amount of goodwill [Abstract]
Balance at beginning of period	$ 49,248	$ 47,823	$ 47,471
Changes during the period from:
Business combinations	1,124	1,412	349
Other	(57)	13	3
Balance at end of period	$ 50,315	$ 49,248	$ 47,823

Goodwill and Mortgage Servici_5

Goodwill and Mortgage Servicing Rights - Mortgage Servicing Rights (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Mortgage servicing rights activity
Fair value at beginning of period	$ 3,276	$ 4,699	$ 6,130
MSR activity:
Originations of MSRs	1,659	944	1,384
Purchase of MSRs	1,363	248	105
Disposition of MSRs	(114)	(176)	(789)
Net additions/(dispositions)	2,908	1,016	700
Changes due to collection/realization of expected cash flows	(788)	(899)	(951)
Changes in valuation due to inputs and assumptions:
Changes due to market interest rates and other	404	(1,568)	(893)
Changes in valuation due to other inputs and assumptions:
Projected cash flows (e.g., cost to service)	109	(54)	(333)
Discount rates	0	199	153
Prepayment model changes and other	(415)	(117)	(107)
Total changes in valuation due to other inputs and assumptions	(306)	28	(287)
Total changes in valuation due to inputs and assumptions	98	(1,540)	(1,180)
Fair value at December 31,	5,494	3,276	4,699
Change in unrealized gains/(losses) included in income related to MSRs held at December 31,	98	(1,540)	(1,180)
Contractual service fees, late fees and other ancillary fees included in income	1,298	1,325	1,639
Third-party mortgage loans serviced at December 31,	520,000	448,000	522,000
Servicer advances, net of an allowance for uncollectible amounts, at December 31,	$ 1,600	$ 1,800	$ 2,000

Goodwill and Mortgage Servici_6

Goodwill and Mortgage Servicing Rights - Mortgage Fees and Related Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Risk management:
All other	$ 11	$ 12	$ 1
Mortgage fees and related income	2,170	3,091	2,036
Consumer & Community Banking
CCB mortgage fees and related income
Production revenue	2,215	2,629	1,618
Operating revenue:
Loan servicing revenue	1,257	1,367	1,533
Changes in MSR asset fair value due to collection/realization of expected cash flows	(788)	(899)	(951)
Total operating revenue	469	468	582
Risk management:
Changes in MSR asset fair value due to market interest rates and other	404	(1,568)	(893)
Other changes in MSR asset fair value due to other inputs and assumptions in model	(306)	28	(287)
Change in derivative fair value and other	(623)	1,522	1,015
Total risk management	(525)	(18)	(165)
Total net mortgage servicing revenue	(56)	450	417
Mortgage fees and related income	$ 2,159	$ 3,079	$ 2,035

Goodwill and Mortgage Servici_7

Goodwill and Mortgage Servicing Rights - Key Economic Assumptions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Weighted-average prepayment speed assumption (constant prepayment rate)	9.90%	14.90%
Impact on fair value of 10% adverse change	$ (210)	$ (206)
Impact on fair value of 20% adverse change	$ (404)	$ (392)
Weighted-average option adjusted spread	6.44%	7.19%
Impact on fair value of 100 basis points adverse change	$ (225)	$ (134)
Impact on fair value of 200 basis points adverse change	$ (433)	$ (258)

Deposits - Noninterest and Inte

Deposits - Noninterest and Interest-bearing (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
U.S. offices
Noninterest-bearing (included $8,115 and $9,873 at fair value)	$ 638,879	$ 572,711
Interest-bearing (included $629 and $2,567 at fair value)	1,432,578	1,197,032
Total deposits in U.S. offices	2,071,457	1,769,743
Non-U.S. offices
Noninterest-bearing (included $2,420 and $1,486 at fair value)	26,229	23,435
Interest-bearing (included $169 and $558 at fair value)	364,617	351,079
Total deposits in non-U.S. offices	390,846	374,514
Total deposits	2,462,303	2,144,257
Fair value
U.S. offices
Noninterest-bearing (included $8,115 and $9,873 at fair value)	8,115	9,873
Interest-bearing, fair value	629	2,567
Non-U.S. offices
Noninterest-bearing (included $2,420 and $1,486 at fair value)	2,420	1,486
Interest-bearing, fair value	$ 169	$ 558

Deposits - Time Deposits (Detai

Deposits - Time Deposits (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deposit Liability [Line Items]
Total	$ 93,505	$ 84,588
U.S. offices
Deposit Liability [Line Items]
Total	38,970	33,812
Non-U.S. offices
Deposit Liability [Line Items]
Total	$ 54,535	$ 50,776

Deposits - Maturities of Intere

Deposits - Maturities of Interest-Bearing Time Deposits (Details) $ in Millions	Dec. 31, 2021USD ($)
Maturities of interest bearing time deposits
2022	$ 98,400
2023	1,079
2024	279
2025	240
2026	990
After 5 years	616
Total	101,604
U.S.
Maturities of interest bearing time deposits
2022	47,595
2023	771
2024	269
2025	202
2026	169
After 5 years	484
Total	49,490
Non-U.S.
Maturities of interest bearing time deposits
2022	50,805
2023	308
2024	10
2025	38
2026	821
After 5 years	132
Total	$ 52,114

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Billions	Dec. 31, 2021USD ($)
Leases [Abstract]
Operating lease, general lease terms (or less)	20 years
Additional future operating lease commitments not yet commenced	$ 0.9
Operating leases not yet commenced, lease terms (up to)	22 years

Leases - Information Related to

Leases - Information Related to Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net	Property, Plant and Equipment, Net
Right-of-use assets	$ 7,888	$ 8,006
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Accounts Payable and Accrued Liabilities	Accounts Payable and Accrued Liabilities
Lease liabilities	$ 8,328	$ 8,508
Weighted average remaining lease term (in years)	8 years 6 months	8 years 8 months 12 days
Weighted average discount rate	3.40%	3.48%
Supplemental cash flow information
Cash paid for amounts included in the measurement of lease liabilities - operating cash flows	$ 1,656	$ 1,626
Supplemental non-cash information
Right-of-use assets obtained in exchange for operating lease obligations	1,167	1,350
Rental expense
Gross rental expense	2,086	2,094
Sublease rental income	(129)	(166)
Net rental expense	$ 1,957	$ 1,928

Leases - Future Payments Under

Leases - Future Payments Under Operating Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Operating Leases
2022	$ 1,572
2023	1,435
2024	1,285
2025	1,115
2026	862
After 2026	3,453
Total future minimum lease payments	9,722
Less: Imputed interest	(1,394)
Total	$ 8,328	$ 8,508

Leases - Carrying Value of Asse

Leases - Carrying Value of Assets Subject to Operating Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Carrying value of assets subject to operating leases, net of accumulated depreciation	$ 17,553	$ 21,155
Accumulated depreciation	$ 5,737	$ 6,388

Leases - Operating Lease Income

Leases - Operating Lease Income and Related Depreciation Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease income	$ 4,914	$ 5,539	$ 5,455
Depreciation expense	$ 3,380	$ 4,257	$ 4,157

Leases - Future Receipts Under

Leases - Future Receipts Under Operating Leases (Details) $ in Millions	Dec. 31, 2021USD ($)
Leases [Abstract]
2022	$ 2,984
2023	1,674
2024	559
2025	48
2026	43
After 2026	0
Total future minimum lease receipts	$ 5,308

Accounts Payable and Other Li_3

Accounts Payable and Other Liabilities (Details) - USD ($) $ in Millions		Dec. 31, 2021	Dec. 31, 2020
Accounts Payable and Accrued Liabilities [Abstract]
Brokerage payables		$ 169,172	$ 140,291
Other payables and liabilities		93,583	90,994
Total accounts payable and other liabilities	[1]	262,755	231,285
Credit card rewards liability		$ 9,800	$ 7,700
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Long-term Debt - Summary of Lon

Long-term Debt - Summary of Long-Term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Long-term debt carrying values by contractual maturity
Under 1 year	$ 22,776
1-5 years	124,204
After 5 years	154,025
Long-term debt	301,005	$ 281,685
Long Term Debt - Supplemental Information
Collateral used to secure Long-term debt	170,600	166,400
Zero-coupon notes	15,800	16,100
Zero-coupon notes - aggregate principal amount at maturity	46,400	$ 45,300
Redeemable long-term debt	185,000
Long term debt maturing in 2023	32,600
Long term debt maturing in 2024	36,400
Long term debt maturing in 2025	26,100
Long term debt maturing in 2026	$ 29,100
Weighted-average contractual interest rates for long term debt	2.67%	2.89%
Modified weighted-average interest rates total long-term debt	1.43%	1.59%
Guarantee of Indebtedness of Others
Long Term Debt - Supplemental Information
Guarantee liability	$ 16,400	$ 13,800
Long-term beneficial interests
Long-term debt carrying values by contractual maturity
Under 1 year	1,398
1-5 years	999
After 5 years	179
Long-term debt	$ 2,576	5,153
Under 1 year, Minimum	1.39%
1-5 years, Minimum	1.53%
After 5 years, Minimum	3.24%
Long Term Debt - Supplemental Information
Commercial paper and other short-term beneficial interests	$ 8,200	12,400
Recurring
Long Term Debt - Supplemental Information
Long-term debt accounted for at fair value	74,934	76,817
Beneficial interest, fair value disclosures	$ 12	$ 41
Weighted average | Long-term beneficial interests
Long-term debt carrying values by contractual maturity
Interest rate	1.57%	1.30%
Junior subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	$ 0
1-5 years	0
After 5 years	1,975
Long-term debt	$ 1,975	$ 2,035
Under 1 year, Minimum	0.00%
1-5 years, Minimum	0.00%
After 5 years, Minimum	3.20%
Junior subordinated debt | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	3.20%	3.26%
Secured debt
Long Term Debt - Supplemental Information
Long-term debt	$ 14,100	$ 17,200
Fixed rate | Long-term beneficial interests
Long-term debt carrying values by contractual maturity
Under 1 year	748
1-5 years	999
After 5 years	0
Long-term debt	1,747	2,369
Fixed rate | Junior subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	0
After 5 years	678
Long-term debt	678	738
Variable rate | Long-term beneficial interests
Long-term debt carrying values by contractual maturity
Under 1 year	650
1-5 years	0
After 5 years	179
Long-term debt	829	2,784
Variable rate | Junior subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	0
After 5 years	1,297
Long-term debt	1,297	1,297
Parent company
Long-term debt carrying values by contractual maturity
Under 1 year	10,745
1-5 years	88,275
After 5 years	134,962
Long-term debt	233,982	211,349
Long Term Debt - Supplemental Information
Long-term debt	235,957	$ 213,384
Long term debt maturing in 2023	16,600
Long term debt maturing in 2024	24,200
Long term debt maturing in 2025	22,800
Long term debt maturing in 2026	$ 24,700
Parent company | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year, Minimum	2.93%
1-5 years, Minimum	2.22%
After 5 years, Minimum	3.00%
Parent company | Senior debt | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	2.67%	2.97%
Parent company | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year, Minimum	0.00%
1-5 years, Minimum	4.21%
After 5 years, Minimum	4.28%
Parent company | Subordinated debt | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	4.24%	4.24%
Parent company | Fixed rate | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year	$ 9,900
1-5 years	71,001
After 5 years	121,469
Long-term debt	202,370	$ 180,208
Parent company | Fixed rate | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	8,168
After 5 years	10,101
Long-term debt	18,269	19,255
Parent company | Variable rate | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year	845
1-5 years	9,106
After 5 years	3,392
Long-term debt	13,343	11,877
Parent company | Variable rate | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	0
After 5 years	0
Long-term debt	0	9
Subsidiaries
Long-term debt carrying values by contractual maturity
Under 1 year	12,031
1-5 years	35,929
After 5 years	17,088
Long-term debt	$ 65,048	$ 68,301
Subsidiaries | Federal Home Loan Banks (“FHLB”) advances
Long-term debt carrying values by contractual maturity
Under 1 year, Minimum	5.53%
1-5 years, Minimum	0.19%
After 5 years, Minimum	6.14%
Subsidiaries | Federal Home Loan Banks (“FHLB”) advances | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	0.23%	0.34%
Subsidiaries | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year, Minimum	4.55%
1-5 years, Minimum	4.92%
After 5 years, Minimum	1.64%
Subsidiaries | Senior debt | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	2.09%	2.28%
Subsidiaries | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year, Minimum	0.00%
1-5 years, Minimum	8.25%
After 5 years, Minimum	0.00%
Subsidiaries | Subordinated debt | Weighted average
Long-term debt carrying values by contractual maturity
Interest rate	8.25%	8.25%
Subsidiaries | Fixed rate | Federal Home Loan Banks (“FHLB”) advances
Long-term debt carrying values by contractual maturity
Under 1 year	$ 8
1-5 years	45
After 5 years	57
Long-term debt	110	$ 123
Subsidiaries | Fixed rate | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year	775
1-5 years	4,701
After 5 years	10,028
Long-term debt	15,504	16,227
Subsidiaries | Fixed rate | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	287
After 5 years	0
Long-term debt	287	309
Subsidiaries | Variable rate | Federal Home Loan Banks (“FHLB”) advances
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	11,000
After 5 years	0
Long-term debt	11,000	14,000
Subsidiaries | Variable rate | Senior debt
Long-term debt carrying values by contractual maturity
Under 1 year	11,248
1-5 years	19,896
After 5 years	7,003
Long-term debt	38,147	37,642
Subsidiaries | Variable rate | Subordinated debt
Long-term debt carrying values by contractual maturity
Under 1 year	0
1-5 years	0
After 5 years	0
Long-term debt	$ 0	$ 0

Preferred Stock (Details)

Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 01, 2022	Jun. 01, 2021	Apr. 30, 2020	Mar. 01, 2020	Jun. 30, 2019	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares of preferred stock authorized to issue, in one or more series (in shares)						200,000,000	200,000,000
Preferred stock, par value (in dollars per share)						$ 1	$ 1
Shares (in shares)						3,483,750	3,006,250
Carrying value						$ 34,838	$ 30,063
Liquidation value and redemption price per share (in dollars per share)						$ 10,000
Aggregate liquidation value						$ 35,200
Series P
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	0
Carrying value						$ 0	$ 0
Issue date						Feb. 5, 2013
Contractual rate in effect						0.00%
Dividend declared per share (in dollars per share)						$ 0	$ 0	$ 545
Series P | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Mar. 1, 2018
Series T
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	0
Carrying value						$ 0	$ 0
Issue date						Jan. 30, 2014
Contractual rate in effect						0.00%
Dividend declared per share (in dollars per share)						$ 0	$ 0	167.50
Series T | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Mar. 1, 2019
Series W
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	0
Carrying value						$ 0	$ 0
Issue date						Jun. 23, 2014
Contractual rate in effect						0.00%
Dividend declared per share (in dollars per share)						$ 0	$ 0	472.50
Series W | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Sep. 1, 2019
Series Y
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	0
Carrying value						$ 0	$ 0
Issue date						Feb. 12, 2015
Contractual rate in effect				6.125%		0.00%
Dividend declared per share (in dollars per share)						$ 0	$ 153.13	612.52
Preferred stock, shares redeemed				$ 1,430
Series Y | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Mar. 1, 2020
Series AA
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	142,500
Carrying value						$ 0	$ 1,425
Issue date						Jun. 4, 2015
Contractual rate in effect		6.10%				0.00%
Dividend declared per share (in dollars per share)						$ 305	$ 610	610
Preferred stock, shares redeemed		$ 1,430
Series AA | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Sep. 1, 2020
Series BB
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						0	115,000
Carrying value						$ 0	$ 1,150
Issue date						Jul. 29, 2015
Contractual rate in effect		6.15%				0.00%
Dividend declared per share (in dollars per share)						$ 307.50	$ 615	615
Preferred stock, shares redeemed		$ 1,150
Series BB | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Sep. 1, 2020
Series DD
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						169,625	169,625
Carrying value						$ 1,696	$ 1,696
Issue date						Sep. 21, 2018
Contractual rate in effect						5.75%
Dividend declared per share (in dollars per share)						$ 575	$ 575	575
Series DD | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Dec. 1, 2023
Series EE
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						185,000	185,000
Carrying value						$ 1,850	$ 1,850
Issue date						Jan. 24, 2019
Contractual rate in effect						6.00%
Dividend declared per share (in dollars per share)						$ 600	$ 600	511.67
Series EE | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Mar. 1, 2024
Series GG
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						90,000	90,000
Carrying value						$ 900	$ 900
Issue date						Nov. 7, 2019
Contractual rate in effect						4.75%
Dividend declared per share (in dollars per share)						$ 475	$ 506.67
Series GG | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Dec. 1, 2024
Series JJ
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						150,000	0
Carrying value						$ 1,500	$ 0
Issue date						Mar. 17, 2021
Contractual rate in effect						4.55%
Dividend declared per share (in dollars per share)						$ 321.03
Series JJ | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Jun. 1, 2026
Series LL
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						185,000	0
Carrying value						$ 1,850	$ 0
Issue date						May 20, 2021
Contractual rate in effect						4.625%
Dividend declared per share (in dollars per share)						$ 245.39
Series LL | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Jun. 1, 2026
Series MM
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						200,000	0
Carrying value						$ 2,000	$ 0
Issue date						Jul. 29, 2021
Contractual rate in effect						4.20%
Dividend declared per share (in dollars per share)						$ 142.33
Series MM | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Sep. 1, 2026
Series I
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						293,375	293,375
Carrying value						$ 2,934	$ 2,934
Issue date						Apr. 23, 2008
Dividend declared per share (in dollars per share)						$ 370.38	$ 428.03	593.23
Series I | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.47%
Series I | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Apr. 30, 2018
Series Q
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						150,000	150,000
Carrying value						$ 1,500	$ 1,500
Issue date						Apr. 23, 2013
Contractual rate in effect						5.15%
Dividend declared per share (in dollars per share)						$ 515	$ 515	515
Series Q | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.25%
Series Q | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						May 1, 2023
Series R
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						150,000	150,000
Carrying value						$ 1,500	$ 1,500
Issue date						Jul. 29, 2013
Contractual rate in effect						6.00%
Dividend declared per share (in dollars per share)						$ 600	$ 600	600
Series R | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.30%
Series R | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Aug. 1, 2023
Series S
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						200,000	200,000
Carrying value						$ 2,000	$ 2,000
Issue date						Jan. 22, 2014
Contractual rate in effect						6.75%
Dividend declared per share (in dollars per share)						$ 675	$ 675	675
Series S | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.78%
Series S | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Feb. 1, 2024
Series U
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						100,000	100,000
Carrying value						$ 1,000	$ 1,000
Issue date						Mar. 10, 2014
Contractual rate in effect						6.125%
Dividend declared per share (in dollars per share)						$ 612.50	$ 612.50	612.50
Series U | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.33%
Series U | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Apr. 30, 2024
Series V
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						250,000	250,000
Carrying value						$ 2,500	$ 2,500
Issue date						Jun. 9, 2014
Contractual rate in effect					5.00%
Dividend declared per share (in dollars per share)					$ 250	$ 353.65	$ 436.85	534.09
Series V | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.32%
Series V | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Jul. 1, 2019
Series X
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						160,000	160,000
Carrying value						$ 1,600	$ 1,600
Issue date						Sep. 23, 2014
Contractual rate in effect						6.10%
Dividend declared per share (in dollars per share)						$ 610	$ 610	610
Series X | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.33%
Series X | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Oct. 1, 2024
Series Z
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						200,000	200,000
Carrying value						$ 2,000	$ 2,000
Issue date						Apr. 21, 2015
Contractual rate in effect			5.30%
Dividend declared per share (in dollars per share)			$ 265			$ 401.44	$ 453.52	530
Series Z | Subsequent Event
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock, shares redeemed	$ 2,000
Series Z | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.80%
Series Z | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						May 1, 2020
Series CC
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						125,750	125,750
Carrying value						$ 1,258	$ 1,258
Issue date						Oct. 20, 2017
Contractual rate in effect						4.625%
Dividend declared per share (in dollars per share)						$ 462.50	$ 462.50	462.50
Series CC | Three-month LIBOR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						2.58%
Series CC | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Nov. 1, 2022
Series FF
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						225,000	225,000
Carrying value						$ 2,250	$ 2,250
Issue date						Jul. 31, 2019
Contractual rate in effect						5.00%
Dividend declared per share (in dollars per share)						$ 500	$ 500	$ 251.39
Series FF | Term SOFR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.38%
Series FF | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Aug. 1, 2024
Series HH
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						300,000	300,000
Carrying value						$ 3,000	$ 3,000
Issue date						Jan. 23, 2020
Contractual rate in effect						4.60%
Dividend declared per share (in dollars per share)						$ 460	$ 470.22
Series HH | Term SOFR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						3.125%
Series HH | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Feb. 1, 2025
Series II
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						150,000	150,000
Carrying value						$ 1,500	$ 1,500
Issue date						Feb. 24, 2020
Contractual rate in effect						4.00%
Dividend declared per share (in dollars per share)						$ 400	$ 341.11
Series II | Term SOFR
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						2.745%
Series II | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Apr. 1, 2025
Series KK
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Shares (in shares)						200,000	0
Carrying value						$ 2,000	$ 0
Issue date						May 12, 2021
Contractual rate in effect						3.65%
Dividend declared per share (in dollars per share)						$ 201.76
Series KK | Five-year CMT
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock dividend rate, variable, basis spread						2.85%
Series KK | Minimum
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]
Earliest redemption date						Jun. 1, 2026

Common Stock - Narrative (Detai

Common Stock - Narrative (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 18, 2020
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	9,000,000,000	9,000,000,000
Common stock, par value (in dollars per share)	$ 1	$ 1
Stock repurchase program, authorized amount			$ 30,000,000,000
Common stock
Class of Stock [Line Items]
Common stock capital shares reserved for future issuance (in shares)	58,300,000

Common Stock - Shares Issued (D

Common Stock - Shares Issued (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Increase (Decrease) in Common Stock Shares
Total issued - balance at January 1 (in shares)	4,104,933,895	4,104,933,895	4,104,900,000	4,104,900,000
Total outstanding - balance at December 31 (in shares)	2,944,100,000	3,049,400,000	3,084,000,000
Increase (Decrease) in Treasury Stock Shares
Treasury - balance at January 1 (in shares)	(1,055,499,435)
Total treasury - balance at December 31 (in shares)	(1,160,784,750)	(1,055,499,435)
Treasury stock
Increase (Decrease) in Treasury Stock Shares
Treasury - balance at January 1 (in shares)	(1,055,500,000)	(1,020,900,000)	(829,100,000)
Repurchase (in shares)	(119,700,000)	(50,000,000)	(213,000,000)
Reissuance (in shares)	14,400,000	15,400,000	21,200,000
Reissuance: Employee stock purchase plans (in shares)	900,000	1,200,000	800,000
Total treasury - balance at December 31 (in shares)	(1,160,800,000)	(1,055,500,000)	(1,020,900,000)
Treasury stock | Employee benefits and compensation plans
Increase (Decrease) in Treasury Stock Shares
Reissuance (in shares)	13,500,000	14,200,000	20,400,000

Common Stock - Repurchases (Det

Common Stock - Repurchases (Details) - Common stock - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Total number of shares of common stock repurchased (in shares)	119.7	50	213
Aggregate purchase price of common stock repurchases	$ 18,448	$ 6,397	$ 24,121

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Basic earnings per share
Net income	$ 48,334	$ 29,131	$ 36,431
Less: Preferred stock dividends	1,600	1,583	1,587
Net income applicable to common equity	46,734	27,548	34,844
Less: Dividends and undistributed earnings allocated to participating securities	231	138	202
Net income applicable to common stockholders	$ 46,503	$ 27,410	$ 34,642
Total weighted-average basic shares outstanding (in shares)	3,021.5	3,082.4	3,221.5
Net income per share (in dollars per share)	$ 15.39	$ 8.89	$ 10.75
Diluted earnings per share
Net income applicable to common stockholders	$ 46,503	$ 27,410	$ 34,642
Total weighted-average basic shares outstanding (in shares)	3,021.5	3,082.4	3,221.5
Add: Dilutive impact of SARs and employee stock options, unvested PSUs and non-dividend-earning RSUs, and warrants (in shares)	5.1	5	8.9
Total weighted-average diluted shares outstanding (in shares)	3,026.6	3,087.4	3,230.4
Net income per share (in dollars per share)	$ 15.36	$ 8.88	$ 10.72

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income/(Loss) - Rollforward (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	$ 279,354	$ 261,330
Net change	(8,070)	6,417	$ 3,076
Ending balance	294,127	279,354	261,330
Accumulated other comprehensive income/(loss)
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	7,986	1,569	(1,507)
Net change	(8,070)	6,417	3,076
Ending balance	(84)	7,986	1,569
Unrealized gains/(losses) on investment securities
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	8,180	4,057	1,202
Net change	(5,540)	4,123	2,855
Ending balance	2,640	8,180	4,057
After-tax unamortized unrealized gains related to transfer of AFS securities to HTM	2,400
Translation adjustments, net of hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(473)	(707)	(727)
Net change	(461)	234	20
Ending balance	(934)	(473)	(707)
Fair value hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(112)	(131)	(161)
Net change	(19)	19	30
Ending balance	(131)	(112)	(131)
Cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	2,383	63	(109)
Net change	(2,679)	2,320	172
Ending balance	(296)	2,383	63
Defined benefit pension and OPEB plans
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(1,132)	(1,344)	(2,308)
Net change	922	212	964
Ending balance	(210)	(1,132)	(1,344)
DVA on fair value option elected liabilities
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Beginning balance	(860)	(369)	596
Net change	(293)	(491)	(965)
Ending balance	$ (1,153)	$ (860)	$ (369)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income/(Loss) - Components of Other Comprehensive Income/(Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Unrealized gains/(losses) on AFS securities:
Net change, Pre-tax	$ (10,099)	$ 8,066	$ 3,921
Net change, Tax effect	2,029	(1,649)	(845)
Total other comprehensive income/(loss), after–tax	(8,070)	6,417	3,076
Other Income
Unrealized gains/(losses) on AFS securities:
Net pre-tax gain (loss) reclassified related to liquidation of legal entity		6	7
Other Expense
Unrealized gains/(losses) on AFS securities:
Net pre-tax gain (loss) reclassified related to liquidation of legal entity	(7)		1
Unrealized gains/(losses) on investment securities
Unrealized gains/(losses) on AFS securities:
Net unrealized gains/(losses) arising during the period/Translation, Pre-tax	(7,634)	6,228	4,025
Net unrealized gains/(losses) arising during the period/Translation, Tax effect	1,832	(1,495)	(974)
Net unrealized gains/(losses) arising during the period/Translation, After-tax	(5,802)	4,733	3,051
Reclassification, Pre-tax	345	(802)	(258)
Reclassification, Tax effect	(83)	192	62
Reclassification, After-tax	262	(610)	(196)
Net change, Pre-tax	(7,289)	5,426	3,767
Net change, Tax effect	1,749	(1,303)	(912)
Total other comprehensive income/(loss), after–tax	(5,540)	4,123	2,855
Net pre-tax gain (loss) reclassified related to liquidation of legal entity			18
Unrealized gains/(losses) on investment securities | Other Income
Unrealized gains/(losses) on AFS securities:
Net pre-tax gain (loss) reclassified related to liquidation of legal entity	0	3	18
Translation adjustments
Unrealized gains/(losses) on AFS securities:
Net unrealized gains/(losses) arising during the period/Translation, Pre-tax	(2,447)	1,407	(49)
Net unrealized gains/(losses) arising during the period/Translation, Tax effect	125	(103)	33
Net unrealized gains/(losses) arising during the period/Translation, After-tax	(2,322)	1,304	(16)
Reclassification, Pre-tax	2,452	(1,411)	46
Reclassification, Tax effect	(591)	341	(10)
Reclassification, After-tax	1,861	(1,070)	36
Net change, Pre-tax	5	(4)	(3)
Net change, Tax effect	(466)	238	23
Total other comprehensive income/(loss), after–tax	(461)	234	20
Net pre-tax gain (loss) reclassified related to liquidation of legal entity			10
Translation adjustments | Other Income
Unrealized gains/(losses) on AFS securities:
Net pre-tax gain (loss) reclassified related to liquidation of legal entity		3
Fair value hedges, net of change
Unrealized gains/(losses) on AFS securities:
Net change, Pre-tax	(26)	25	39
Net change, Tax effect	7	(6)	(9)
Total other comprehensive income/(loss), after–tax	(19)	19	30
Cash flow hedges
Unrealized gains/(losses) on AFS securities:
Net unrealized gains/(losses) arising during the period/Translation, Pre-tax	(2,303)	3,623	122
Net unrealized gains/(losses) arising during the period/Translation, Tax effect	553	(870)	(28)
Net unrealized gains/(losses) arising during the period/Translation, After-tax	(1,750)	2,753	94
Reclassification, Pre-tax	(1,222)	(570)	103
Reclassification, Tax effect	293	137	(25)
Reclassification, After-tax	(929)	(433)	78
Net change, Pre-tax	(3,525)	3,053	225
Net change, Tax effect	846	(733)	(53)
Total other comprehensive income/(loss), after–tax	(2,679)	2,320	172
Defined benefit pension and OPEB plans
Unrealized gains/(losses) on AFS securities:
Net change, Pre-tax	1,129	214	1,157
Net change, Tax effect	(207)	(2)	(193)
Total other comprehensive income/(loss), after–tax	922	212	964
DVA on fair value option elected liabilities, net change
Unrealized gains/(losses) on AFS securities:
Net change, Pre-tax	(393)	(648)	(1,264)
Net change, Tax effect	100	157	299
Total other comprehensive income/(loss), after–tax	$ (293)	$ (491)	$ (965)

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of the applicable statutory U.S. income tax rate to the effective tax rate
Statutory U.S. federal tax rate	21.00%	21.00%	21.00%
Increase/(decrease) in tax rate resulting from:
U.S. state and local income taxes, net of U.S. federal income tax benefit	3.00%	2.50%	3.50%
Tax-exempt income	(0.90%)	(1.60%)	(1.40%)
Non-U.S. earnings	0.10%	1.40%	1.80%
Business tax credits	(4.20%)	(5.40%)	(3.80%)
Tax audit resolutions	0.00%	0.00%	(2.30%)
Other, net	(0.10%)	0.80%	0.00%
Effective tax rate	18.90%	18.70%	18.80%

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense/(Benefit) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current income tax expense/(benefit)
U.S. federal		$ 2,865	$ 5,759	$ 3,284
Non-U.S.		2,718	2,705	2,103
U.S. state and local		1,897	1,793	1,778
Total current income tax expense/(benefit)		7,480	10,257	7,165
Deferred income tax expense/(benefit)
U.S. federal		3,460	(2,776)	1,030
Non-U.S.		(101)	(126)	20
U.S. state and local		389	(671)	220
Total deferred income tax expense/(benefit)	[1]	3,748	(3,573)	1,270
Total income tax expense	[2]	11,228	6,684	8,435
Components of income tax expense/(benefit), supplemental information
Tax expense (benefits) recorded as a result of tax audit resolutions		69	(72)	(1,100)
Increase (decrease) to income tax allocated directly to equity		$ 2,000	$ (827)	$ (862)
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information on revisions to operating activities.
[2]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Income Taxes - Results from Non

Income Taxes - Results from Non-U.S. Earnings (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
U.S.	$ 50,126	$ 27,312	$ 36,991
Non-U.S.	9,436	8,503	7,875
Income/(loss) before income tax expense/(benefit)	$ 59,562	$ 35,815	$ 44,866

Income Taxes - Affordable Housi

Income Taxes - Affordable Housing Tax Credits (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Tax credit and other tax benefits	$ 1.7	$ 1.5	$ 1.5
Amount of amortization reported in income tax expense	1.3	1.2	$ 1.1
Carrying value of investments, reported in other assets	10.8	9.7
Amount of commitments, reported in account payable and other liabilities	$ 4.6	$ 3.8

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets
Allowance for loan losses	$ 4,345	$ 7,270
Employee benefits	987	1,104
Accrued expenses and other	3,955	3,332
Non-U.S. operations	900	849
Tax attribute carryforwards	615	757
Gross deferred tax assets	10,802	13,312
Valuation allowance	(378)	(560)
Deferred tax assets, net of valuation allowance	10,424	12,752
Deferred tax liabilities
Depreciation and amortization	3,289	3,329
Mortgage servicing rights, net of hedges	2,049	2,184
Leasing transactions	4,227	5,124
Other, net	4,459	6,025
Gross deferred tax liabilities	14,024	16,662
Net deferred tax (liabilities)/assets	(3,600)	$ (3,910)
FTC carryforwards	258
U.S. federal
Deferred tax liabilities
NOL carryforwards	972
Other tax attributes	359
Non-U.S.
Deferred tax liabilities
NOL carryforwards	210
State and local
Deferred tax liabilities
NOL carryforwards	$ 1,100

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Unrecognized tax benefits that would impact effective tax rate	$ 3,400	$ 3,100	$ 2,800
Amount of potential increase or decrease in gross balance of unrecognized tax benefits	300
Reconciliation of the beginning and ending amount of unrecognized tax benefits
Balance at January 1,	4,250	4,024	4,861
Increases based on tax positions related to the current period	798	685	871
Increases based on tax positions related to prior periods	393	362	10
Decreases based on tax positions related to prior periods	(657)	(705)	(706)
Decreases related to cash settlements with taxing authorities	(148)	(116)	(1,012)
Balance at December 31,	4,636	4,250	4,024
Income tax expense, penalties and interest expense
Penalties and interest expense/(benefit)	174	147	$ (52)
Penalties and interest accrued	$ 1,100	$ 1,000

Restricted Cash, Other Restri_3

Restricted Cash, Other Restricted Assets and Intercompany Funds Transfers (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Jan. 01, 2022	Dec. 31, 2020
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash	$ 19.7		$ 24.4
Cash and securities pledged with clearing organizations for benefit of customers	47.5		37.2
Fair value of securities restricted in relation to customer activity	$ 30		1.3
Disclosure of Restrictions on Dividends, Loans and Advances Disclosure [Abstract]
Percentage of total capital loans limited to	10.00%
Percentage of total capital (limited to) for aggregate covered transactions	20.00%
Deposits with banks
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash	$ 18.4		22.7
Cash and due from banks
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash	1.3		1.7
Segregated for the benefit of securities and cleared derivative customers
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash	14.6		19.3
Cash reserves at non-U.S. central banks and held for other general purposes
Restricted Cash and Cash Equivalents Items [Line Items]
Total restricted cash	$ 5.1		$ 5.1
Bank and Bank Holding Company Subsidiaries | Subsequent Event
Disclosure of Restrictions on Dividends, Loans and Advances Disclosure [Abstract]
Aggregate dividends payable		$ 20

Regulatory Capital (Details)

Regulatory Capital (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Cumulative effect of change in accounting principles
Adjustments to Capital for Deferred Tax Liabilities [Abstract]
SLR, minimum requirement	$ 2,900
JPMorgan Chase & Co.
Leverage-based capital metrics:
Adjusted average assets	$ 3,782,035	$ 3,353,319
Tier 1 leverage ratio	0.065	0.070
Total leverage exposure	$ 4,571,789	$ 3,401,542
SLR	0.054	0.069
Basel III Standardized | JPMorgan Chase & Co.
Risk-based capital metrics:
CET1 capital	$ 213,942	$ 205,078
Tier 1 capital	246,162	234,844
Total capital	274,900	269,923
Risk-weighted assets	$ 1,638,900	$ 1,560,609
CET1 capital ratio	13.10%	13.10%
Tier 1 capital ratio	0.150	0.150
Total capital ratio	0.168	0.173
Basel III Advanced | JPMorgan Chase & Co.
Risk-based capital metrics:
CET1 capital	$ 213,942	$ 205,078
Tier 1 capital	246,162	234,844
Total capital	265,796	257,228
Risk-weighted assets	$ 1,547,920	$ 1,484,431
CET1 capital ratio	13.80%	13.80%
Tier 1 capital ratio	0.159	0.158
Total capital ratio	0.172	0.173
BHC | Basel III
Well capitalized risk-based capital ratios
Tier 1 capital	0.060	0.060
Total capital	0.100	0.100
Leverage-based capital metrics:
Tier 1 leverage	0.040	0.040
SLR	5.00%	5.00%
Adjustments to Capital for Deferred Tax Liabilities [Abstract]
GSIB surcharge	3.50%	3.50%
Countercyclical buffer	0	0
SLR, minimum requirement	0.030	0.030
SLR, supplementary leverage buffer	2.00%	2.00%
BHC | Basel III Standardized
Risk-based capital ratios
CET1 capital	0.112	0.113
Tier 1 capital	0.127	0.128
Total capital	0.147	0.148
Adjustments to Capital for Deferred Tax Liabilities [Abstract]
Stress capital buffer	3.20%	3.20%
BHC | Basel III Advanced
Risk-based capital ratios
CET1 capital	0.105	0.105
Tier 1 capital	0.120	0.120
Total capital	0.140	0.140
Adjustments to Capital for Deferred Tax Liabilities [Abstract]
Capital conservation buffer	2.50%	2.50%
IDI | Basel III
Well capitalized risk-based capital ratios
CET1 capital	0.065	0.065
Tier 1 capital	0.080	0.080
Total capital	0.100	0.100
Leverage-based capital metrics:
Tier 1 leverage	0.040	0.040
SLR	6.00%	6.00%
Well capitalized leverage-based capital ratios
Tier 1 leverage	0.050	0.050
SLR	0.060	0.060
Adjustments to Capital for Deferred Tax Liabilities [Abstract]
Capital conservation buffer	2.50%	2.50%
SLR, minimum requirement	0.030	0.030
SLR, supplementary leverage buffer	3.00%	3.00%
IDI | Basel III Standardized
Risk-based capital ratios
CET1 capital	0.070	0.070
Tier 1 capital	0.085	0.085
Total capital	0.105	0.105
IDI | Basel III Advanced
Risk-based capital ratios
CET1 capital	0.070	0.070
Tier 1 capital	0.085	0.085
Total capital	0.105	0.105
JPMorgan Chase Bank, N.A.
Leverage-based capital metrics:
Adjusted average assets	$ 3,334,925	$ 2,970,285
Tier 1 leverage ratio	0.080	0.079
Total leverage exposure	$ 4,119,286	$ 3,688,797
SLR	0.065	0.063
JPMorgan Chase Bank, N.A. | Basel III Standardized
Risk-based capital metrics:
CET1 capital	$ 266,907	$ 234,235
Tier 1 capital	266,910	234,237
Total capital	281,826	252,045
Risk-weighted assets	$ 1,582,280	$ 1,492,138
CET1 capital ratio	16.90%	15.70%
Tier 1 capital ratio	0.169	0.157
Total capital ratio	0.178	0.169
JPMorgan Chase Bank, N.A. | Basel III Advanced
Risk-based capital metrics:
CET1 capital	$ 266,907	$ 234,235
Tier 1 capital	266,910	234,237
Total capital	272,299	239,673
Risk-weighted assets	$ 1,392,847	$ 1,343,185
CET1 capital ratio	19.20%	17.40%
Tier 1 capital ratio	0.192	0.174
Total capital ratio	0.195	0.178

Off-balance Sheet Lending-rel_3

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	$ 1,262,313	$ 1,165,688
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	878,499
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	178,112
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	170,209
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	35,493
Off-balance sheet lending-related financial commitments, Carrying value	2,624	2,753
Total consumer
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	775,868	715,825
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	757,570
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	2,216
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	5,797
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	10,285
Off-balance sheet lending-related financial commitments, Carrying value	102	148
Total consumer, excluding credit card
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	45,334	57,319
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	27,036
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	2,216
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	5,797
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	10,285
Off-balance sheet lending-related financial commitments, Carrying value	102	148
Residential real estate
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	32,996	46,047
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	15,649
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	2,216
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	5,797
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	9,334
Off-balance sheet lending-related financial commitments, Carrying value	100	148
Auto and other
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	12,338	11,272
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	11,387
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	0
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	0
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	951
Off-balance sheet lending-related financial commitments, Carrying value	2	0
Credit card
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	730,534	658,506
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	730,534
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	0
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	0
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	0
Off-balance sheet lending-related financial commitments, Carrying value	0	0
Total wholesale
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	486,445	449,863
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	120,929
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	175,896
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	164,412
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	25,208
Off-balance sheet lending-related financial commitments, Carrying value	2,522	2,605
Other unfunded commitments to extend credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	453,467	415,828
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	101,983
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	167,137
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	160,301
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	24,046
Off-balance sheet lending-related financial commitments, Carrying value	2,037	2,148
Off balance sheet lending related financial instruments guarantees and other commitments - supplemental information [Abstract]
Risk participations for other unfunded commitments to extend credit	44	72
Standby letters of credit and other financial guarantees
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	28,530	30,982
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	15,092
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	8,261
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	4,015
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	1,162
Off-balance sheet lending-related financial commitments, Carrying value	476	443
Other guarantees and commitments, Carrying value	353	363
Off balance sheet lending related financial instruments guarantees and other commitments - supplemental information [Abstract]
Risk participations for standby letters of credit and other financial guarantees	7,900	8,500
Other letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total lending-related commitments	4,448	3,053
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring in 1 year or less	3,854
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 1 year through 3 years	498
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 3 years through 5 years	96
Off-balance sheet lending-related financial commitments, Contractual amount, Expiring after 5 years	0
Off-balance sheet lending-related financial commitments, Carrying value	9	14
Other guarantees and commitments, Carrying value	0	0
Off balance sheet lending related financial instruments guarantees and other commitments - supplemental information [Abstract]
Risk participations for other letters of credit	451	357
Securities lending indemnification agreements and guarantees
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	337,770	250,418
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	337,770
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	0
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	0
Other guarantees and commitments, Contractual amount, Expiring after 5 years	0
Other guarantees and commitments, Carrying value	0	0
Off balance sheet lending related financial instruments guarantees and other commitments - supplemental information [Abstract]
Indemnification agreement securities lending guarantees collateral held in support of	357,400	264,300
Derivatives qualifying as guarantees
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	55,730	54,415
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	3,119
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	396
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	12,296
Other guarantees and commitments, Contractual amount, Expiring after 5 years	39,919
Other guarantees and commitments, Carrying value	475	322
Unsettled resale and securities borrowed agreements
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	103,681	102,355
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	101,553
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	2,128
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	0
Other guarantees and commitments, Contractual amount, Expiring after 5 years	0
Other guarantees and commitments, Carrying value	1	2
Unsettled repurchase and securities loaned agreements
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	74,263	104,901
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	73,631
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	632
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	0
Other guarantees and commitments, Contractual amount, Expiring after 5 years	0
Other guarantees and commitments, Carrying value	0	(1)
Mortgage repurchase liability
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Loan sale and securitization-related indemnifications, Mortgage repurchase liability, Carrying value	61	84
Loans sold with recourse
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Loan sale and securitization-related indemnifications, Loans sold with recourse, Contractual amount	827	889
Loan sale and securitization-related indemnifications, Loans sold with recourse, Carrying value	19	23
Exchange & clearing house guarantees and commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	182,701	142,003
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	182,701
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	0
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	0
Other guarantees and commitments, Contractual amount, Expiring after 5 years	0
Other guarantees and commitments, Carrying value	0	0
Other guarantees and commitments
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Other guarantees and commitments, Contractual amount	10,490	9,639
Other guarantees and commitments, Contractual amount, Expiring in 1 year or less	5,028
Other guarantees and commitments, Contractual amount, Expiring after 1 year through 3 years	2,980
Other guarantees and commitments, Contractual amount, Expiring after 3 years through 5 years	283
Other guarantees and commitments, Contractual amount, Expiring after 5 years	2,199
Other guarantees and commitments, Carrying value	$ 69	$ 52
Days Past Due, 60 or More | Credit card
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Line of credit close criteria, period past due	60 days

Off-balance Sheet Lending-rel_4

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments - Standby Letters of Credit, Other Financial Guarantees and Other Letters of Credit (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Standby letters of credit and other financial guarantees and other letters of credit [Abstract]
Total lending-related commitments	$ 1,262,313	$ 1,165,688
Allowance for lending-related commitments	2,261	2,409	$ 1,191	$ 1,055
Total carrying value	2,624	2,753
Standby letters of credit and other financial guarantees
Standby letters of credit and other financial guarantees and other letters of credit [Abstract]
Investment-grade	19,998	22,850
Noninvestment-grade	8,532	8,132
Total lending-related commitments	28,530	30,982
Allowance for lending-related commitments	123	80
Guarantee liability	353	363
Total carrying value	476	443
Commitments with collateral	14,511	17,238
Other letters of credit
Standby letters of credit and other financial guarantees and other letters of credit [Abstract]
Investment-grade	3,087	2,263
Noninvestment-grade	1,361	790
Total lending-related commitments	4,448	3,053
Allowance for lending-related commitments	9	14
Guarantee liability	0	0
Total carrying value	9	14
Commitments with collateral	$ 999	$ 498

Off-balance Sheet Lending-rel_5

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments - Securities Lending Indemnifications (Details)	12 Months Ended
	Dec. 31, 2021
Off-Balance Sheet Lending-Related Financial Instruments, Guarantees and Other Commitments [Abstract]
Percentage exceeding value of securities for obtaining cash or other highly liquid collateral	100.00%
Percentage exceeding value of resale agreements for obtaining collateral	100.00%

Off-balance Sheet Lending-rel_6

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments - Derivatives Qualifying as Guarantees (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Notional amounts
Stable value contracts with contractually limited exposure	$ 49,735,000	$ 47,175,000
Derivatives qualifying as guarantees
Notional amounts
Derivative guarantees	55,730	54,415
Stable value contracts with contractually limited exposure	29,778	27,752
Maximum exposure of stable value contracts with contractually limited exposure	2,882	2,803
Fair value
Derivative payables	$ 475	$ 322
Maximum | Put option
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Term of written put option	5 years

Off-balance Sheet Lending-rel_7

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments - Loan Sales- and Securitization-Related Indemnifications (Details) - Loans sold with recourse - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Loans sold with recourse
Unpaid principal balance of loans sold with recourse	$ 827	$ 889
Carrying value of related liability for recourse obligations	$ 19	$ 23

Off-balance Sheet Lending-rel_8

Off-balance Sheet Lending-related Financial Instruments, Guarantees, and Other Commitments - Other Off-Balance Sheet Arrangements (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
JPMorgan Chase Financial Company LLC
Other off-balance sheet arrangements - supplemental information [Abstract]
Direct-owned and consolidated finance subsidiary ownership	100.00%
Merchant Services
Other off-balance sheet arrangements - supplemental information [Abstract]
Aggregate volume processed by electronic payment services business	$ 1,886.7	$ 1,597.3	$ 1,511.5

Pledged Assets and Collateral -

Pledged Assets and Collateral - Pledged Assets and Collateral (Details) - USD ($) $ in Billions	Dec. 31, 2021	Dec. 31, 2020
Significant components of assets pledged
Assets that may be sold or repledged or otherwise used by secured parties	$ 126.3	$ 166.6
Assets that may not be sold or repledged or otherwise used by secured parties	112	113.9
Total pledged assets	714.7	735.8
Collateral Received that Can be Resold or Repledged
Collateral permitted to be sold or repledged, delivered, or otherwise used	1,471.3	1,451.7
Collateral sold, repledged, delivered or otherwise used	1,111	1,038.9
Investment securities
Significant components of assets pledged
Total pledged assets	80.1	80.2
Loans
Significant components of assets pledged
Total pledged assets	428.5	420.5
Trading assets and other
Significant components of assets pledged
Total pledged assets	206.1	235.1
Assets pledged at Federal Reserve banks and FHLBs
Significant components of assets pledged
Total pledged assets	$ 476.4	$ 455.3

Litigation (Details)

Litigation (Details)

1 Months Ended

12 Months Ended

36 Months Ended

Dec. 31, 2021USD ($)

Aug. 31, 2021USD ($)

Oct. 31, 2020claim

May 31, 2020USD ($)

Dec. 31, 2019USD ($)

Sep. 30, 2018USD ($)

Nov. 30, 2017USD ($)

Dec. 31, 2021USD ($)claimcount

Dec. 31, 2020USD ($)defendant

Dec. 31, 2019USD ($)

Dec. 31, 2012USD ($)action

Dec. 31, 2013USD ($)

Dec. 31, 2012fund

Loss Contingencies [Line Items]

Legal expense

$ 426,000,000

$ 1,115,000,000

$ 239,000,000

Threatened or Pending Litigation | Minimum

Loss Contingencies [Line Items]

Loss contingency range of possible loss

$ 0

0

Threatened or Pending Litigation | Maximum

Loss Contingencies [Line Items]

Loss contingency range of possible loss

1,500,000,000

$ 1,500,000,000

Amrapali Litigation | JPMorgan India Private Limited

Loss Contingencies [Line Items]

Number of offshore funds formerly managed by JPMorgan Chase entities | fund

2

Amount of claim

$ 31,500,000

$ 25,000,000

Federal Republic of Nigeria Litigation | Federal Government of Nigeria and Two Major International Oil Companies

Loss Contingencies [Line Items]

Amount paid out of monies in account following settlement of dispute

$ 1,100,000,000

Federal Republic of Nigeria Litigation | Federal Republic of Nigeria

Loss Contingencies [Line Items]

Amount of claim

$ 875,000,000

Foreign Exchange Investigations and Litigation

Loss Contingencies [Line Items]

Loss contingency, exemption of disqualification period

5 years

Loss contingency disqualification period

10 years

Number of other defendants that agreed in principle to settle class action | defendant

11

Settlement amount

$ 10,000,000

Inquiry Concerning Preservation Requirements | SEC | J.P. Morgan Securities LLC

Loss Contingencies [Line Items]

Penalty paid

125,000,000

Inquiry Concerning Preservation Requirements | CFTC | J.P. Morgan Securities LLC, JPMorgan Chase Bank, N.A. and J.P. Morgan Securities plc

Loss Contingencies [Line Items]

Penalty paid

$ 75,000,000

Interchange Litigation

Loss Contingencies [Line Items]

Number of claims settled | action

2

Interchange Litigation | The Defendants

Loss Contingencies [Line Items]

Settlement amount

$ 900,000,000

$ 5,300,000,000

Payments for legal settlement

$ 700,000,000

Metals and U.S. Treasuries Investigations and Litigation and Related Inquiries

Loss Contingencies [Line Items]

Settlement amount

$ 920,000,000

Number of claims settled | claim

3

Number of counts of wire fraud charged | count

2

Period after which criminal information will be dismissed with full compliance with all obligations

3 years

Number of claims filed | claim

2

International Operations (Detai

International Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Entity-Wide Information by Geographic Areas
Revenue	$ 121,649		$ 119,951		$ 115,720
Expense	62,087		84,136		70,854
Income/(loss) before income tax expense/(benefit)	59,562		35,815		44,866
Net income	48,334		29,131		36,431
Total assets	3,743,567	[1]	3,384,757	[1]	2,686,477
Total international
Entity-Wide Information by Geographic Areas
Revenue	28,971		28,595		25,546
Expense	18,794		18,135		16,481
Income/(loss) before income tax expense/(benefit)	10,177		10,460		9,065
Net income	7,380		7,335		6,234
Total assets	857,458		845,220		622,212
Europe/Middle East/Africa
Entity-Wide Information by Geographic Areas
Revenue	16,561		16,566		15,887
Expense	10,833		10,987		9,860
Income/(loss) before income tax expense/(benefit)	5,728		5,579		6,027
Net income	4,202		3,868		4,158
Total assets	517,904		530,687		391,369
U.K.
Entity-Wide Information by Geographic Areas
Total assets	365,000		353,000		309,000
Asia-Pacific
Entity-Wide Information by Geographic Areas
Revenue	9,654		9,289		7,254
Expense	6,372		5,558		5,060
Income/(loss) before income tax expense/(benefit)	3,282		3,731		2,194
Net income	2,300		2,630		1,467
Total assets	277,897		252,553		183,023
Latin America/Caribbean
Entity-Wide Information by Geographic Areas
Revenue	2,756		2,740		2,405
Expense	1,589		1,590		1,561
Income/(loss) before income tax expense/(benefit)	1,167		1,150		844
Net income	878		837		609
Total assets	61,657		61,980		47,820
North America
Entity-Wide Information by Geographic Areas
Revenue	92,678		91,356		90,174
Expense	43,293		66,001		54,373
Income/(loss) before income tax expense/(benefit)	49,385		25,355		35,801
Net income	40,954		21,796		30,197
Total assets	$ 2,886,109		$ 2,539,537		$ 2,064,265
[1]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Business Segments - Narrative (

Business Segments - Narrative (Details) $ in Trillions	12 Months Ended
	Dec. 31, 2021USD ($)segment
Segment Reporting Information [Line Items]
Number of major reportable business segments	4
Commercial Banking
Segment Reporting Information [Line Items]
Number of primary client segments	3
Asset & Wealth Management
Segment Reporting Information [Line Items]
AWM client assets | $	$ 4.3

Business Segments (Details)

Business Segments (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Segment results and reconciliation
Noninterest revenue		$ 69,338		$ 65,388		$ 58,475
Net interest income		52,311		54,563		57,245
Total net revenue		121,649		119,951		115,720
Provision for credit losses		(9,256)		17,480		5,585
Noninterest expense		71,343		66,656		65,269
Income/(loss) before income tax expense/(benefit)		59,562		35,815		44,866
Income tax expense/(benefit)	[1]	11,228		6,684		8,435
Net income/(loss)		48,334		29,131		36,431
Average equity		250,968		236,865		232,907
Total assets		$ 3,743,567	[2]	$ 3,384,757	[2]	$ 2,686,477
Return on equity		19.00%		12.00%		15.00%
Overhead ratio		59.00%		56.00%		56.00%
Operating Segments | Consumer & Community Banking
Segment results and reconciliation
Noninterest revenue		$ 17,286		$ 17,740		$ 17,796
Net interest income		32,787		33,528		37,337
Total net revenue		50,073		51,268		55,133
Provision for credit losses		(6,989)		12,312		4,954
Noninterest expense		29,256		27,990		28,276
Income/(loss) before income tax expense/(benefit)		27,806		10,966		21,903
Income tax expense/(benefit)		6,876		2,749		5,362
Net income/(loss)		20,930		8,217		16,541
Average equity		50,000		52,000		52,000
Total assets		$ 500,370		$ 496,705		$ 541,367
Return on equity		41.00%		15.00%		31.00%
Overhead ratio		58.00%		55.00%		51.00%
Operating Segments | Corporate & Investment Bank
Segment results and reconciliation
Noninterest revenue		$ 38,209		$ 35,120		$ 30,060
Net interest income		13,540		14,164		9,205
Total net revenue		51,749		49,284		39,265
Provision for credit losses		(1,174)		2,726		277
Noninterest expense		25,325		23,538		22,444
Income/(loss) before income tax expense/(benefit)		27,598		23,020		16,544
Income tax expense/(benefit)		6,464		5,926		4,590
Net income/(loss)		21,134		17,094		11,954
Average equity		83,000		80,000		80,000
Total assets		$ 1,259,896		$ 1,095,926		$ 913,803
Return on equity		25.00%		20.00%		14.00%
Overhead ratio		49.00%		48.00%		57.00%
Operating Segments | Commercial Banking
Segment results and reconciliation
Noninterest revenue		$ 3,929		$ 3,067		$ 2,710
Net interest income		6,079		6,246		6,554
Total net revenue		10,008		9,313		9,264
Provision for credit losses		(947)		2,113		296
Noninterest expense		4,041		3,798		3,735
Income/(loss) before income tax expense/(benefit)		6,914		3,402		5,233
Income tax expense/(benefit)		1,668		824		1,275
Net income/(loss)		5,246		2,578		3,958
Average equity		24,000		22,000		22,000
Total assets		$ 230,776		$ 228,911		$ 220,514
Return on equity		21.00%		11.00%		17.00%
Overhead ratio		40.00%		41.00%		40.00%
Operating Segments | Asset & Wealth Management
Segment results and reconciliation
Noninterest revenue		$ 13,071		$ 10,822		$ 10,236
Net interest income		3,886		3,418		3,355
Total net revenue		16,957		14,240		13,591
Provision for credit losses		(227)		263		59
Noninterest expense		10,919		9,957		9,747
Income/(loss) before income tax expense/(benefit)		6,265		4,020		3,785
Income tax expense/(benefit)		1,528		1,028		918
Net income/(loss)		4,737		2,992		2,867
Average equity		14,000		10,500		10,500
Total assets		$ 234,425		$ 203,384		$ 173,175
Return on equity		33.00%		28.00%		26.00%
Overhead ratio		64.00%		70.00%		72.00%
Corporate
Segment results and reconciliation
Noninterest revenue		$ 68		$ 1,199		$ (114)
Net interest income		(3,551)		(2,375)		1,325
Total net revenue		(3,483)		(1,176)		1,211
Provision for credit losses		81		66		(1)
Noninterest expense		1,802		1,373		1,067
Income/(loss) before income tax expense/(benefit)		(5,366)		(2,615)		145
Income tax expense/(benefit)		(1,653)		(865)		(966)
Net income/(loss)		(3,713)		(1,750)		1,111
Average equity		79,968		72,365		68,407
Total assets		1,518,100		1,359,831		837,618
Reconciling Items
Segment results and reconciliation
Noninterest revenue		(3,225)		(2,560)		(2,213)
Net interest income		(430)		(418)		(531)
Total net revenue		(3,655)		(2,978)		(2,744)
Provision for credit losses		0		0		0
Noninterest expense		0		0		0
Income/(loss) before income tax expense/(benefit)		(3,655)		(2,978)		(2,744)
Income tax expense/(benefit)		(3,655)		(2,978)		(2,744)
Net income/(loss)		0		0		0
Average equity		$ 0		$ 0		$ 0
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.
[2]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Parent Company - Statements of

Parent Company - Statements of Income and Comprehensive Income (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income
Other income/(expense)		$ 69,338	$ 65,388	$ 58,475
Total income		121,649	119,951	115,720
Expense
Other interest expense/(income)		(52,311)	(54,563)	(57,245)
Noninterest expense		5,469	5,941	5,087
Income tax benefit	[1]	(11,228)	(6,684)	(8,435)
Net income/(loss)		48,334	29,131	36,431
Comprehensive income		40,264	35,548	39,507
JPMorgan Chase & Co.
Income
Interest income from subsidiaries		32	63	223
Other income/(expense)		1,137	205	(1,731)
Total income		12,394	7,718	27,427
Expense
Interest expense/(income) to subsidiaries and affiliates		5,353	(8,830)	(5,303)
Other interest expense/(income)		(1,349)	14,150	13,246
Noninterest expense		2,637	2,222	1,992
Total expense		6,641	7,542	9,935
Income before income tax benefit and undistributed net income of subsidiaries		5,753	176	17,492
Income tax benefit		1,329	1,324	2,033
Equity in undistributed net income of subsidiaries		41,252	27,631	16,906
Net income/(loss)		48,334	29,131	36,431
Other comprehensive income/(loss), net		(8,070)	6,417	3,076
Comprehensive income		40,264	35,548	39,507
Bank and bank holding company | JPMorgan Chase & Co.
Income
Dividends from subsidiaries and affiliates		10,000	6,000	26,000
Other income/(expense) from subsidiaries		859	2,019	2,738
Non-bank | JPMorgan Chase & Co.
Income
Dividends from subsidiaries and affiliates		0	0	0
Other income/(expense) from subsidiaries		$ 366	$ (569)	$ 197
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.

Parent Company - Balance Sheets

Parent Company - Balance Sheets (Details) - USD ($) $ in Millions		Dec. 31, 2021		Dec. 31, 2020		Dec. 31, 2019
Assets
Cash and due from banks		$ 26,438		$ 24,874
Trading assets		433,575		503,126
Other assets	[1]	181,498		151,539
Total assets		3,743,567	[2]	3,384,757	[2]	$ 2,686,477
Liabilities and stockholders’ equity
Total liabilities	[2]	3,449,440		3,105,403
Total stockholders’ equity		294,127		279,354		$ 261,330
Total liabilities and stockholders’ equity		3,743,567		3,384,757
JPMorgan Chase & Co.
Assets
Cash and due from banks		36		54
Deposits with banking subsidiaries		6,809		6,811
Trading assets		2,293		1,775
Other assets		12,220		10,058
Total assets		568,481		528,424
Liabilities and stockholders’ equity
Borrowings from, and payables to, subsidiaries and affiliates		28,039		25,150
Short-term borrowings		1,018		924
Other liabilities		9,340		9,612
Long-term debt		235,957		213,384
Total liabilities		274,354		249,070
Total stockholders’ equity		294,127		279,354
Total liabilities and stockholders’ equity		568,481		528,424
Bank and bank holding company | JPMorgan Chase & Co.
Assets
Advances to, and receivables from, subsidiaries		431		27
Investments (at equity) in subsidiaries and affiliates		545,635		508,602
Non-bank | JPMorgan Chase & Co.
Assets
Advances to, and receivables from, subsidiaries		50		86
Investments (at equity) in subsidiaries and affiliates		$ 1,007		$ 1,011
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information.
[2]	The following table presents information on assets and liabilities related to VIEs that are consolidated by the Firm at December 31, 2021 and 2020. The assets of the consolidated VIEs are used to settle the liabilities of those entities. The holders of the beneficial interests do not have recourse to the general credit of JPMorgan Chase. The assets and liabilities in the table below include third-party assets and liabilities of consolidated VIEs and exclude intercompany balances that eliminate in consolidation. Refer to Note 14 for a further discussion. December 31, (in millions) 2021 2020 Assets Trading assets $ 2,010 $ 1,934 Loans 33,024 37,619 All other assets 490 681 Total assets $ 35,524 $ 40,234 Liabilities Beneficial interests issued by consolidated VIEs $ 10,750 $ 17,578 All other liabilities 245 233 Total liabilities $ 10,995 $ 17,811

Parent Company - Statements o_2

Parent Company - Statements of Cash Flows (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income/(loss)		$ 48,334	$ 29,131	$ 36,431
Other operating adjustments		(398)	3,115	2,233
Net cash provided by/(used in) operating activities		78,084	(79,910)	4,092
Investing activities
All other investing activities, net		(11,044)	(7,341)	(5,035)
Net cash (used in) investing activities		(129,344)	(261,912)	(52,059)
Financing activities
Net change in: Short-term borrowings				(28,561)
Proceeds from long-term borrowings		82,409	78,686	61,085
Payments of long-term borrowings		(54,932)	(105,055)	(69,610)
Proceeds from issuance of preferred stock		7,350	4,500	5,000
Redemption of preferred stock		(2,575)	(1,430)	(4,075)
Treasury stock repurchased		(18,408)	(6,517)	(24,001)
Dividends paid		(12,858)	(12,690)	(12,343)
All other financing activities, net		(1,477)	(927)	(1,146)
Net cash provided by financing activities		275,993	596,645	32,987
Net increase/(decrease) in cash and due from banks and deposits with banks		213,225	263,978	(15,162)
Cash and due from banks and deposits with banks at the beginning of the period		527,609	263,631	278,793
Cash and due from banks and deposits with banks at the end of the period		740,834	527,609	263,631
Cash interest paid		5,142	13,077	29,918
Cash income taxes paid, net	[1]	18,737	8,140	6,224
JPMorgan Chase & Co.
Operating activities
Net income/(loss)		48,334	29,131	36,431
Less: Net income of subsidiaries and affiliates		51,252	33,631	42,906
Parent company net loss		(2,918)	(4,500)	(6,475)
Cash dividends from subsidiaries and affiliates		10,000	6,000	26,000
Other operating adjustments		(12,677)	15,357	9,862
Net cash provided by/(used in) operating activities		(5,595)	16,857	29,387
Investing activities
Net change in: Advances to and investments in subsidiaries and affiliates, net		(3,000)	(2,663)	(6)
All other investing activities, net		31	24	71
Net cash (used in) investing activities		(2,969)	(2,639)	65
Financing activities
Net change in: Borrowings from subsidiaries and affiliates		2,647	1,425	2,941
Net change in: Short-term borrowings		0	(20)	(56)
Proceeds from long-term borrowings		49,169	37,312	25,569
Payments of long-term borrowings		(15,543)	(34,194)	(21,226)
Proceeds from issuance of preferred stock		7,350	4,500	5,000
Redemption of preferred stock		(2,575)	(1,430)	(4,075)
Treasury stock repurchased		(18,408)	(6,517)	(24,001)
Dividends paid		(12,858)	(12,690)	(12,343)
All other financing activities, net		(1,238)	(1,080)	(1,290)
Net cash provided by financing activities		8,544	(12,694)	(29,481)
Net increase/(decrease) in cash and due from banks and deposits with banks		(20)	1,524	(29)
Cash and due from banks and deposits with banks at the beginning of the period		6,865	5,341	5,370
Cash and due from banks and deposits with banks at the end of the period		6,845	6,865	5,341
Cash interest paid		4,065	5,445	7,957
Cash income taxes paid, net		$ 15,259	$ 5,366	$ 3,910
[1]	Prior-period amounts have been revised to conform with the current presentation. Refer to Note 25 for further information on revisions to operating activities.

Parent Company - Footnote Infor

Parent Company - Footnote Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Long-term Debt, Fiscal Year Maturity [Abstract]
2022	$ 22,776
2023	32,600
2024	36,400
2025	26,100
2026	29,100
Reimbursements from income taxes paid on behalf of certain subsidiaries	13,900	$ 8,300	$ 6,400
JPMorgan Chase & Co.
Long-term Debt, Fiscal Year Maturity [Abstract]
2022	10,745
2023	16,600
2024	24,200
2025	22,800
2026	24,700
JPMorgan Chase & Co. | JPMorgan Chase Bank, N.A.
Long-term Debt, Fiscal Year Maturity [Abstract]
Distributions received as return of capital	$ 13,500